data_1hd1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1hd1 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.519 ' CG ' ' HG ' ' A' ' 144' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.302 0.572 . . . . 0.0 110.239 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.546 ' CE ' ' CD1' ' A' ' 101' ' ' ILE . 12.6 ptm -147.58 175.2 11.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.189 -0.944 . . . . 0.0 110.411 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.712 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 2.5 t80 -119.73 130.87 55.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.465 -0.772 . . . . 0.0 109.252 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.546 ' CD1' ' CE ' ' A' ' 99' ' ' MET . 3.7 mm -117.05 105.04 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.245 -0.91 . . . . 0.0 109.715 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.512 ' HA2' ' CB ' ' A' ' 140' ' ' PHE . . . -97.34 139.22 14.36 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.737 -1.221 . . . . 0.0 110.12 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.51 33.9 2.38 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.474 ' HB2' ' HA ' ' A' ' 140' ' ' PHE . 1.8 mm? -84.68 148.72 26.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.106 -1.232 . . . . 0.0 110.004 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.476 ' O ' ' OG1' ' A' ' 108' ' ' THR . 0.0 OUTLIER -76.52 147.5 37.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.158 -0.963 . . . . 0.0 110.799 -179.529 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -52.07 -17.19 0.96 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.304 -0.873 . . . . 0.0 110.99 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.86 35.55 4.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.904 -1.122 . . . . 0.0 111.163 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.533 ' HB ' ' HG ' ' A' ' 128' ' ' LEU . 1.5 m -88.35 171.29 10.26 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.986 -1.071 . . . . 0.0 110.057 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.478 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 73.0 p -149.12 170.56 18.13 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.178 -0.951 . . . . 0.0 110.242 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.532 ' O ' ' CB ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -70.5 -11.2 60.77 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.138 -0.977 . . . . 0.0 109.922 179.792 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -87.44 -58.68 2.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 110.539 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 5.4 p30 -60.56 -32.39 71.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.12 -0.988 . . . . 0.0 110.167 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.528 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 9.2 tp -79.96 -42.84 23.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.095 -1.003 . . . . 0.0 109.577 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 4.3 ttmt -63.21 -46.47 86.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.869 . . . . 0.0 109.346 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.413 ' O ' ' C ' ' A' ' 116' ' ' TYR . 1.5 t70 -66.05 -49.17 68.59 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.139 -0.976 . . . . 0.0 109.35 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.413 ' C ' ' O ' ' A' ' 115' ' ' ASP . 67.8 t80 -48.31 -35.4 12.23 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.765 -1.174 . . . . 0.0 108.065 177.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.544 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 11.7 m-85 -90.73 -3.58 57.35 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.25 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.8 t -71.66 -9.5 58.36 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.075 -1.016 . . . . 0.0 109.294 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.66 -15.81 53.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.377 -0.827 . . . . 0.0 110.034 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.585 ' CE2' HG21 ' A' ' 154' ' ' VAL . 70.2 m-85 -89.52 -40.9 12.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.326 -0.859 . . . . 0.0 109.44 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -177.49 -156.2 15.64 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.53 157.77 17.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.138 -1.213 . . . . 0.0 110.195 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.457 HG21 ' HA ' ' A' ' 145' ' ' PHE . 1.9 t -134.75 131.23 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.212 -0.93 . . . . 0.0 111.167 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -94.99 -24.65 4.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -146.42 159.06 43.88 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.999 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.474 ' O ' ' CG ' ' A' ' 110' ' ' LYS . 40.5 t -170.47 105.56 0.29 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.848 0.832 . . . . 0.0 109.347 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.68 166.15 11.63 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.474 0.654 . . . . 0.0 110.979 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.533 ' HG ' ' HB ' ' A' ' 108' ' ' THR . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.413 -0.805 . . . . 0.0 110.268 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.512 ' CB ' ' HA2' ' A' ' 102' ' ' GLY . 46.3 p90 . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 121.526 0.679 . . . . 0.0 111.093 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.471 ' HA3' ' HA ' ' A' ' 128' ' ' LEU . . . -136.82 -170.65 11.99 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.712 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 13.9 m-85 -128.65 160.71 31.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.069 -1.254 . . . . 0.0 110.492 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.529 ' CG2' HG13 ' A' ' 101' ' ' ILE . 4.1 t -134.22 140.4 46.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.371 -0.831 . . . . 0.0 108.944 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.519 ' HG ' ' CG ' ' A' ' 98' ' ' LYS . 3.1 mp -132.07 98.81 4.53 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.161 -0.962 . . . . 0.0 109.704 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.538 ' CE2' HG13 ' A' ' 154' ' ' VAL . 39.4 m-85 -71.04 170.23 13.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.434 -0.791 . . . . 0.0 110.635 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 18.2 tttt -96.18 -18.93 19.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.369 -0.832 . . . . 0.0 110.994 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.527 ' OE1' ' CB ' ' A' ' 149' ' ' GLU . 2.4 tm-20 -131.39 162.33 30.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.862 -1.149 . . . . 0.0 110.686 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 34.5 p -74.69 -47.44 31.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.913 . . . . 0.0 109.547 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.527 ' CB ' ' OE1' ' A' ' 147' ' ' GLU . 0.5 OUTLIER -54.41 -35.08 62.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.369 -0.832 . . . . 0.0 109.752 179.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.485 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 3.1 p -68.76 -40.93 79.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 109.889 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.517 ' CG2' ' HB2' ' A' ' 145' ' ' PHE . 5.6 t -66.67 -53.14 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 110.286 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.481 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -51.89 -37.78 53.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 0.0 109.955 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.46 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -59.23 -62.07 2.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.334 -0.854 . . . . 0.0 110.082 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.585 HG21 ' CE2' ' A' ' 120' ' ' PHE . 3.3 p -55.36 -20.5 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.198 -0.939 . . . . 0.0 110.141 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.509 ' N ' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -89.82 -13.19 37.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.364 -0.835 . . . . 0.0 109.686 179.381 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.8 OUTLIER -61.12 -33.5 73.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.226 -0.921 . . . . 0.0 109.614 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.516 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.0 tt0 -142.3 104.46 4.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.287 -0.883 . . . . 0.0 110.065 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.5 pttm -81.8 20.26 0.98 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.229 -0.919 . . . . 0.0 111.037 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -87.58 62.9 7.32 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.594 ' HB2' HG13 ' A' ' 167' ' ' ILE . 14.2 m170 -86.76 -169.34 2.59 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.309 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 160' ' ' HIS . 33.3 ttpt 179.86 74.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.35 -0.844 . . . . 0.0 110.317 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.506 ' CD2' HD13 ' A' ' 113' ' ' LEU . 3.8 pp -103.69 157.56 16.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 0.0 109.989 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 1.5 m-80 58.38 15.19 3.32 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.183 -0.948 . . . . 0.0 110.228 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.98 20.15 61.63 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp -150.82 146.89 26.66 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.303 -1.116 . . . . 0.0 110.152 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 1.4 p -69.36 -174.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.052 -1.03 . . . . 0.0 110.163 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.594 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -150.61 178.24 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.163 -0.96 . . . . 0.0 110.352 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -126.01 93.2 44.32 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.54 -0.725 . . . . 0.0 109.386 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -77.58 135.85 14.97 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.245 1.655 . . . . 0.0 110.643 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.418 ' O ' ' HB2' ' A' ' 99' ' ' MET . 0.0 OUTLIER -146.76 -177.92 5.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.319 -0.863 . . . . 0.0 110.268 179.607 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 . . . . . 0 C--N 1.303 -1.454 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.953 179.047 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.542 ' HG2' ' CD1' ' A' ' 144' ' ' LEU . 14.7 mtmt . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.001 0.429 . . . . 0.0 110.09 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.541 ' HE1' ' CD1' ' A' ' 101' ' ' ILE . 7.9 ptm -133.39 172.31 12.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.118 -0.989 . . . . 0.0 110.562 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.698 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 2.1 t80 -120.99 130.07 53.66 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.608 -0.682 . . . . 0.0 110.041 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.541 ' CD1' ' HE1' ' A' ' 99' ' ' MET . 3.8 mm -112.66 95.27 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.294 -0.879 . . . . 0.0 109.469 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.514 ' HA2' ' CB ' ' A' ' 140' ' ' PHE . . . -89.75 127.01 8.53 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 127.48 34.01 0.59 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.5 ' HG ' HD22 ' A' ' 128' ' ' LEU . 2.3 mm? -89.38 152.95 21.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.048 -1.266 . . . . 0.0 110.186 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.476 ' O ' ' OG1' ' A' ' 108' ' ' THR . 0.0 OUTLIER -90.49 152.67 20.84 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.291 -0.88 . . . . 0.0 111.234 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.46 -22.69 3.25 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.445 -0.785 . . . . 0.0 110.765 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -107.04 28.82 7.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.028 -1.045 . . . . 0.0 111.765 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.536 ' HB ' ' CD2' ' A' ' 128' ' ' LEU . 0.8 OUTLIER -90.44 170.8 9.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.752 -1.218 . . . . 0.0 109.798 179.17 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.467 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 28.7 p -145.94 159.16 43.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.227 -0.921 . . . . 0.0 110.155 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.487 ' CE ' ' O ' ' A' ' 126' ' ' CYS . 0.7 OUTLIER -62.91 -12.76 27.36 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.171 -0.955 . . . . 0.0 109.639 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.49 -59.31 2.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.367 -0.833 . . . . 0.0 110.377 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -52.61 -41.93 64.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.056 -1.028 . . . . 0.0 109.909 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.469 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 10.6 tp -70.3 -48.82 54.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.911 . . . . 0.0 109.577 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -52.1 -48.01 64.97 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.428 -0.795 . . . . 0.0 109.772 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 54.7 m-20 -67.41 -50.74 58.18 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.16 -0.962 . . . . 0.0 110.296 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.412 ' C ' ' O ' ' A' ' 115' ' ' ASP . 73.0 t80 -47.78 -34.01 7.96 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 118.532 -1.267 . . . . 0.0 108.528 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.512 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 15.3 m-85 -91.14 -7.24 52.09 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.869 -0.732 . . . . 0.0 111.351 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.484 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 1.9 t -71.02 -7.35 45.76 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.956 -1.09 . . . . 0.0 109.225 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -82.88 -14.42 54.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 0.0 110.285 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.512 ' CD2' ' HA ' ' A' ' 117' ' ' PHE . 89.1 m-85 -88.8 -56.02 3.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.073 -1.017 . . . . 0.0 109.275 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.454 ' HA3' ' HB3' ' A' ' 150' ' ' SER . . . -162.02 -162.27 13.02 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -83.06 151.03 25.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -1.192 . . . . 0.0 110.061 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.499 HG21 ' CD1' ' A' ' 145' ' ' PHE . 1.9 t -128.8 130.03 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.357 -0.839 . . . . 0.0 110.484 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.01 -24.68 5.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.459 ' HB2' ' CB ' ' A' ' 144' ' ' LEU . 4.2 m-20 -151.06 171.27 17.59 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 118.526 -1.27 . . . . 0.0 112.364 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.487 ' O ' ' CE ' ' A' ' 110' ' ' LYS . 9.6 t -170.38 155.59 5.24 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.66 151.74 32.93 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.876 -1.14 . . . . 0.0 110.937 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.556 ' O ' ' CD1' ' A' ' 128' ' ' LEU . 1.6 tm? . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.531 -0.73 . . . . 0.0 109.703 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.576 ' CD1' ' CZ ' ' A' ' 100' ' ' PHE . 35.5 p90 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.287 0.565 . . . . 0.0 110.786 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -150.4 -171.05 18.32 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.698 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 19.7 m-85 -131.38 171.36 13.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.153 -1.204 . . . . 0.0 110.719 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.493 ' CG2' HG13 ' A' ' 101' ' ' ILE . 32.0 t -147.46 129.06 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.542 ' CD1' ' HG2' ' A' ' 98' ' ' LYS . 3.8 mm? -114.53 101.6 9.27 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.584 -0.697 . . . . 0.0 109.821 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.547 ' HB2' ' CG2' ' A' ' 151' ' ' VAL . 8.2 m-85 -78.36 170.15 17.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 110.78 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' A' ' 146' ' ' LYS . 0.1 OUTLIER -89.87 -26.61 20.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.614 -0.679 . . . . 0.0 110.562 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.493 ' OE2' ' CB ' ' A' ' 149' ' ' GLU . 1.0 OUTLIER -143.08 161.76 37.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.785 -1.197 . . . . 0.0 111.181 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 18.7 m -64.37 -31.7 73.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.441 -0.787 . . . . 0.0 110.091 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.493 ' CB ' ' OE2' ' A' ' 147' ' ' GLU . 0.1 OUTLIER -60.29 -38.67 84.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 0.0 110.012 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 22.4 p -71.27 -36.76 71.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.458 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.547 ' CG2' ' HB2' ' A' ' 145' ' ' PHE . 3.5 t -76.12 -45.42 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.987 -1.071 . . . . 0.0 110.805 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 153' ' ' LYS . 0.2 OUTLIER -61.58 -33.89 74.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.143 -0.973 . . . . 0.0 110.126 -179.555 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 152' ' ' ASP . 6.6 tttt -70.37 -42.2 72.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -0.918 . . . . 0.0 110.041 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.513 ' CG1' ' O ' ' A' ' 151' ' ' VAL . 7.4 p -72.67 -27.35 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.145 -0.972 . . . . 0.0 110.458 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.493 ' N ' HG11 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -80.39 -34.87 36.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.939 . . . . 0.0 110.288 -179.751 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -45.37 -42.6 10.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 109.342 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.561 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -118.76 87.25 2.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.397 -0.814 . . . . 0.0 109.65 179.335 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.476 ' HB2' ' CG ' ' A' ' 169' ' ' PRO . 3.4 pttt -85.94 17.45 3.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.892 . . . . 0.0 110.542 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -87.52 63.85 7.83 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.561 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 11.7 m170 -86.56 -167.59 1.93 Allowed 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.726 -177.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt 179.2 67.99 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.496 -0.753 . . . . 0.0 109.601 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.463 HD23 HG22 ' A' ' 167' ' ' ILE . 2.6 pp -99.8 148.42 24.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.346 -0.847 . . . . 0.0 110.076 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.445 ' CB ' ' O ' ' A' ' 162' ' ' LEU . 0.4 OUTLIER 64.18 20.77 12.32 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.184 -0.948 . . . . 0.0 109.517 -179.401 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.9 26.05 70.08 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.37 147.35 27.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.273 -1.134 . . . . 0.0 110.726 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.8 t -80.31 173.12 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.347 -0.846 . . . . 0.0 109.252 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.475 HG23 HG23 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -141.66 163.56 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.087 -1.008 . . . . 0.0 110.9 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -112.26 96.77 36.69 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.611 -0.681 . . . . 0.0 109.235 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.476 ' CG ' ' HB2' ' A' ' 158' ' ' LYS . 49.2 Cg_endo -76.65 119.47 5.19 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.205 1.634 . . . . 0.0 110.524 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -136.42 -163.5 1.42 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 110.293 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.299 -1.608 0 C-N-CA 119.811 -0.755 . . . . 0.0 110.48 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.469 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 4.5 mttp . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.185 0.517 . . . . 0.0 109.996 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.539 ' HE1' ' CD1' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -139.88 179.72 6.44 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.229 -0.919 . . . . 0.0 110.107 179.716 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.727 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 2.5 t80 -125.26 128.93 49.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.361 -0.837 . . . . 0.0 110.807 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.539 ' CD1' ' HE1' ' A' ' 99' ' ' MET . 4.7 mm -107.37 96.19 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.465 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -89.92 145.71 18.38 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.243 -178.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.499 ' O ' ' HD2' ' A' ' 165' ' ' LYS . . . 96.99 17.68 31.68 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.471 ' HB2' ' HA ' ' A' ' 140' ' ' PHE . 1.4 mm? -54.73 166.47 0.47 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.636 -1.508 . . . . 0.0 109.737 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.445 ' O ' ' OG1' ' A' ' 108' ' ' THR . 0.3 OUTLIER -90.89 140.72 29.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.132 -0.98 . . . . 0.0 110.114 179.511 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 20.6 m0 -49.75 -19.87 0.72 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.154 -0.966 . . . . 0.0 110.472 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -113.57 26.38 10.44 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.126 -0.984 . . . . 0.0 111.18 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 105' ' ' SER . 0.8 OUTLIER -89.09 166.13 14.06 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.983 -1.073 . . . . 0.0 109.952 179.568 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.471 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 31.7 p -145.42 -176.8 5.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.191 -0.943 . . . . 0.0 110.399 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.463 ' O ' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -84.57 -14.86 47.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 109.595 179.663 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.44 -44.86 15.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.871 . . . . 0.0 109.857 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 32.5 p-10 -77.35 -38.29 50.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.842 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.489 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 19.7 tp -69.84 -42.69 73.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.099 -1.001 . . . . 0.0 109.351 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -59.85 -50.72 72.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 0.0 109.234 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.402 ' O ' ' HB3' ' A' ' 118' ' ' SER . 17.1 t70 -64.04 -46.66 83.41 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.195 -0.941 . . . . 0.0 109.346 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.622 ' CD2' HD23 ' A' ' 162' ' ' LEU . 68.4 t80 -48.0 -36.35 12.58 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.556 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 15.1 m-85 -91.75 -3.46 56.18 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.843 -0.536 . . . . 0.0 111.489 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 12.4 t -70.63 -5.73 31.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.905 -1.122 . . . . 0.0 109.55 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.01 -13.29 44.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.378 -0.826 . . . . 0.0 110.039 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.593 ' CD2' ' HA ' ' A' ' 154' ' ' VAL . 79.8 m-85 -89.57 -45.36 9.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.366 -0.834 . . . . 0.0 109.84 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -176.16 -172.98 41.41 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.53 ' O ' ' CB ' ' A' ' 146' ' ' LYS . 19.1 mm-40 -81.3 115.43 20.67 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.142 -1.211 . . . . 0.0 110.199 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.579 HG21 ' CD1' ' A' ' 145' ' ' PHE . 2.0 t -91.14 133.84 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.269 -0.894 . . . . 0.0 111.018 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.91 -25.65 5.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.445 ' O ' HG11 ' A' ' 123' ' ' VAL . 4.0 m-20 -148.26 160.93 42.46 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.034 -1.067 . . . . 0.0 111.837 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 5.7 t -170.11 149.94 3.64 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.418 HG21 ' N ' ' A' ' 128' ' ' LEU . 0.9 OUTLIER -150.7 164.78 35.3 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.042 -1.036 . . . . 0.0 111.098 -178.484 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.503 ' O ' HD12 ' A' ' 128' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.499 ' O ' ' CD1' ' A' ' 140' ' ' PHE . 21.7 p90 . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 121.64 0.734 . . . . 0.0 111.526 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 128' ' ' LEU . . . -121.38 -174.55 14.85 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.727 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 15.2 m-85 -129.43 165.85 20.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.15 -1.206 . . . . 0.0 110.776 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.481 HG22 HG13 ' A' ' 101' ' ' ILE . 3.8 t -139.41 133.34 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.454 -0.779 . . . . 0.0 109.214 178.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.469 ' HG ' ' HG2' ' A' ' 98' ' ' LYS . 5.4 mp -123.96 92.77 3.75 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.61 -0.682 . . . . 0.0 109.312 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.579 ' CD1' HG21 ' A' ' 123' ' ' VAL . 17.7 m-85 -69.18 164.4 22.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.416 -0.802 . . . . 0.0 110.784 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.53 ' CB ' ' O ' ' A' ' 122' ' ' GLU . 10.8 tttp -93.4 -22.03 19.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.473 -0.767 . . . . 0.0 110.615 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.459 ' O ' HG22 ' A' ' 151' ' ' VAL . 14.8 tt0 -126.7 144.24 50.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.765 -1.209 . . . . 0.0 110.462 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 51.1 m -61.84 -35.51 78.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.966 . . . . 0.0 109.634 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.473 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 0.1 OUTLIER -63.2 -47.64 81.71 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.318 -0.864 . . . . 0.0 109.843 179.603 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 2.3 p -57.84 -37.38 73.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.326 -0.859 . . . . 0.0 109.881 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 145' ' ' PHE . 2.8 t -66.23 -57.95 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.118 -0.989 . . . . 0.0 110.027 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.473 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -52.26 -29.83 24.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.094 -1.003 . . . . 0.0 110.012 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.471 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 6.7 mttt -68.68 -38.6 80.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.29 -0.881 . . . . 0.0 110.19 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.593 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 9.9 p -77.16 -17.71 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.209 -0.932 . . . . 0.0 110.046 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.501 ' N ' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -90.21 -39.62 12.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 110.537 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 1.0 OUTLIER -52.87 -34.75 56.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.971 -1.081 . . . . 0.0 109.795 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.505 ' O ' ' NE2' ' A' ' 160' ' ' HIS . 4.2 mt-30 -117.69 88.47 2.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.486 -0.759 . . . . 0.0 109.747 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.475 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 6.8 pttt -86.62 26.09 1.15 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 110.946 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.08 62.06 6.61 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.525 ' HB2' HG13 ' A' ' 167' ' ' ILE . 11.6 m170 -87.2 154.88 20.38 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.61 -177.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 165' ' ' LYS . 41.4 mttm -150.8 85.45 1.36 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.351 -0.843 . . . . 0.0 109.783 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.622 HD23 ' CD2' ' A' ' 116' ' ' TYR . 1.0 OUTLIER -99.77 138.01 37.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.354 -0.841 . . . . 0.0 109.714 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 10.8 m120 59.37 19.44 7.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.259 -0.901 . . . . 0.0 110.318 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.29 32.11 29.32 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.533 ' CE ' ' O ' ' A' ' 166' ' ' VAL . 0.9 OUTLIER -150.18 149.97 30.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.186 -1.184 . . . . 0.0 110.208 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.533 ' O ' ' CE ' ' A' ' 165' ' ' LYS . 26.4 t -90.01 159.52 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.078 -1.014 . . . . 0.0 110.383 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.525 HG13 ' HB2' ' A' ' 160' ' ' HIS . 1.3 pt -120.46 -176.57 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 122.071 0.939 . . . . 0.0 111.219 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -123.41 81.6 53.18 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -74.21 131.08 14.84 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.305 1.687 . . . . 0.0 110.877 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.407 ' O ' ' CB ' ' A' ' 99' ' ' MET . 2.1 mmtm -147.25 -166.9 2.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.458 -0.776 . . . . 0.0 110.3 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 . . . . . 0 C--N 1.301 -1.54 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.1 179.502 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.501 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.289 0.566 . . . . 0.0 110.331 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.52 ' SD ' ' CG1' ' A' ' 143' ' ' VAL . 0.0 OUTLIER -136.47 166.45 23.47 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.445 -0.784 . . . . 0.0 109.178 179.385 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.734 ' CE1' ' CE1' ' A' ' 142' ' ' PHE . 15.6 t80 -112.2 148.52 33.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.963 -1.085 . . . . 0.0 110.623 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.514 ' CG2' ' CD1' ' A' ' 167' ' ' ILE . 8.8 mm -123.09 108.33 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.643 -0.661 . . . . 0.0 110.095 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.527 ' HA2' ' CB ' ' A' ' 140' ' ' PHE . . . -101.85 128.68 9.64 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.61 38.03 0.64 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.508 HD21 ' CD2' ' A' ' 128' ' ' LEU . 1.1 mp -90.06 153.77 20.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.14 -1.212 . . . . 0.0 110.234 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.493 ' O ' ' OG1' ' A' ' 108' ' ' THR . 3.1 m -82.4 154.35 25.24 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.256 -0.902 . . . . 0.0 110.411 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 12.1 m-90 -57.54 -14.17 4.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.118 -0.989 . . . . 0.0 110.369 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.41 ' OD1' ' HB3' ' A' ' 105' ' ' SER . 4.6 p-10 -108.57 21.76 16.85 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.928 -1.107 . . . . 0.0 111.613 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.505 ' HB ' HD22 ' A' ' 128' ' ' LEU . 0.2 OUTLIER -85.99 149.6 25.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.883 -1.136 . . . . 0.0 109.986 179.425 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.445 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 72.5 p -134.97 162.9 31.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 110.175 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 126' ' ' CYS . 26.9 mtmt -60.4 -14.18 17.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 109.845 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -82.77 -59.65 2.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.405 -0.81 . . . . 0.0 110.655 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 1.6 p-10 -63.41 -35.05 79.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.103 -0.998 . . . . 0.0 110.258 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 15.0 tp -72.91 -51.61 17.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.184 -0.947 . . . . 0.0 109.964 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 110' ' ' LYS . 4.6 tttt -56.63 -37.95 71.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -0.955 . . . . 0.0 109.695 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.445 ' O ' ' C ' ' A' ' 116' ' ' TYR . 3.1 m-20 -73.14 -54.82 7.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.381 -0.824 . . . . 0.0 110.038 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.445 ' C ' ' O ' ' A' ' 115' ' ' ASP . 71.1 t80 -46.61 -31.93 3.15 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.719 -1.192 . . . . 0.0 108.356 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.564 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 18.7 m-85 -91.45 -11.29 38.03 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.789 -0.765 . . . . 0.0 111.423 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 115' ' ' ASP . 0.5 OUTLIER -71.14 -5.75 34.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.94 -1.1 . . . . 0.0 109.372 178.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.6 ttpt -84.92 -12.8 52.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.378 -0.826 . . . . 0.0 110.212 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.593 ' CD1' ' HA ' ' A' ' 154' ' ' VAL . 84.8 m-85 -89.59 -44.45 10.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 110.001 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.531 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -174.53 -152.55 9.22 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -90.4 146.96 23.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.229 -1.159 . . . . 0.0 110.633 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.442 HG21 ' HA ' ' A' ' 145' ' ' PHE . 1.7 t -129.24 129.8 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.446 -0.783 . . . . 0.0 110.088 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.415 HG21 ' CG ' ' A' ' 146' ' ' LYS . 2.2 t -88.8 -25.38 5.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.462 ' HB3' HD21 ' A' ' 144' ' ' LEU . 13.7 m-20 -150.88 166.91 29.12 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.389 -1.324 . . . . 0.0 112.309 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.468 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 11.8 t -167.22 135.87 2.65 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.462 0.649 . . . . 0.0 109.301 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.519 HG21 ' N ' ' A' ' 128' ' ' LEU . 0.8 OUTLIER -131.33 165.76 22.72 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.386 -0.821 . . . . 0.0 109.92 -179.388 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.522 ' C ' ' CD2' ' A' ' 128' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.312 -0.867 . . . . 0.0 109.566 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.527 ' CB ' ' HA2' ' A' ' 102' ' ' GLY . 18.9 p90 . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 121.77 0.795 . . . . 0.0 111.651 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.467 ' HA3' HD23 ' A' ' 104' ' ' LEU . . . -140.0 -179.0 17.41 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.734 ' CE1' ' CE1' ' A' ' 100' ' ' PHE . 18.0 m-85 -128.17 156.94 42.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.213 -1.169 . . . . 0.0 110.786 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.52 ' CG1' ' SD ' ' A' ' 99' ' ' MET . 8.9 t -138.22 131.77 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.501 ' HG ' ' HG2' ' A' ' 98' ' ' LYS . 6.5 mp -116.84 107.61 14.83 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.512 -0.743 . . . . 0.0 109.926 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.541 ' CD1' ' HB2' ' A' ' 150' ' ' SER . 10.4 m-85 -80.27 167.73 19.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.409 -0.807 . . . . 0.0 110.919 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.415 ' CG ' HG21 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -97.73 -23.67 15.82 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.493 -0.755 . . . . 0.0 110.664 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.478 ' HG3' ' OG ' ' A' ' 150' ' ' SER . 0.9 OUTLIER -142.07 160.37 40.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.748 -1.22 . . . . 0.0 110.934 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.4 t -64.25 -31.81 73.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 0.0 109.861 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.484 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 6.2 mt-10 -60.28 -46.9 88.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.287 -0.883 . . . . 0.0 109.869 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.541 ' HB2' ' CD1' ' A' ' 145' ' ' PHE . 37.0 p -60.97 -40.99 95.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.273 -0.892 . . . . 0.0 110.257 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.499 HG21 ' CB ' ' A' ' 145' ' ' PHE . 3.2 t -69.72 -46.2 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.126 -0.984 . . . . 0.0 110.758 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.484 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -52.46 -38.19 58.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.094 -1.004 . . . . 0.0 109.959 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.47 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 0.6 OUTLIER -66.42 -60.88 2.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 0.0 110.389 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.593 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 12.6 p -48.97 -22.77 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.052 -1.03 . . . . 0.0 110.332 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.443 ' N ' HG11 ' A' ' 154' ' ' VAL . 2.0 ttt -89.93 -24.79 21.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.178 -0.951 . . . . 0.0 109.744 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.47 ' OD2' ' O ' ' A' ' 153' ' ' LYS . 0.2 OUTLIER -53.81 -36.14 62.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.269 -0.894 . . . . 0.0 109.47 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.56 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -131.18 102.07 5.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.336 -0.852 . . . . 0.0 110.085 179.473 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt -85.12 23.54 1.24 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -0.946 . . . . 0.0 110.936 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -87.96 57.45 4.33 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.56 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 17.5 m-70 -87.9 65.45 8.32 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.691 -176.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 166' ' ' VAL . 5.6 ttpp -81.81 72.29 8.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.059 -1.025 . . . . 0.0 109.671 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 163' ' ' ASN . 0.5 OUTLIER -94.02 156.06 16.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 109.945 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 1.6 m-80 56.72 21.43 5.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.173 -0.954 . . . . 0.0 109.46 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 75.52 23.46 73.1 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.69 138.86 20.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -1.093 . . . . 0.0 110.618 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 160' ' ' HIS . 3.6 t -80.27 -179.54 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 109.233 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.534 HD13 ' CB ' ' A' ' 160' ' ' HIS . 1.0 OUTLIER -141.7 170.99 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.973 -1.08 . . . . 0.0 111.52 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 102' ' ' GLY . 10.9 t0 -116.71 92.19 37.17 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 46.1 Cg_endo -72.15 136.72 27.48 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.312 1.69 . . . . 0.0 111.287 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -138.04 -178.95 5.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.52 -0.737 . . . . 0.0 109.703 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.553 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.484 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.539 ' HG2' ' CD2' ' A' ' 144' ' ' LEU . 9.9 mtpt . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.53 ' HE1' ' CD1' ' A' ' 101' ' ' ILE . 5.9 ptm -141.98 175.5 9.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.122 -0.986 . . . . 0.0 110.883 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.688 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 1.7 t80 -119.7 129.27 54.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.597 -0.689 . . . . 0.0 109.69 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.536 HG13 ' CG2' ' A' ' 143' ' ' VAL . 3.1 mm -109.88 94.18 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.301 -0.875 . . . . 0.0 109.453 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -97.22 112.14 4.4 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 141.32 38.73 0.08 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 140' ' ' PHE . 5.4 mp -89.9 164.6 14.52 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.231 -1.158 . . . . 0.0 110.102 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.468 ' N ' ' OG1' ' A' ' 108' ' ' THR . 0.6 OUTLIER -81.56 -171.73 3.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.322 -0.861 . . . . 0.0 109.862 179.715 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 17.3 m0 -83.85 -9.86 58.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.182 -0.949 . . . . 0.0 110.414 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.48 19.75 8.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 110.399 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.471 ' O ' HD23 ' A' ' 128' ' ' LEU . 2.5 m -63.52 159.7 18.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.109 -0.994 . . . . 0.0 109.773 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.479 ' HA ' HD21 ' A' ' 128' ' ' LEU . 63.7 p -149.57 171.73 16.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.907 . . . . 0.0 110.448 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.509 ' O ' ' CB ' ' A' ' 114' ' ' LYS . 5.9 ttpt -71.32 -11.0 60.67 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.412 -0.805 . . . . 0.0 109.127 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -84.0 -49.18 9.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.452 -0.78 . . . . 0.0 110.411 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.44 ' C ' ' OD1' ' A' ' 112' ' ' ASP . 0.2 OUTLIER -75.83 -31.72 59.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.961 -1.087 . . . . 0.0 110.199 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.462 HD22 ' CG2' ' A' ' 143' ' ' VAL . 1.7 tp -77.08 -43.44 34.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.02 -1.05 . . . . 0.0 109.593 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.509 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 17.3 tttt -59.97 -45.19 93.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.196 -0.94 . . . . 0.0 109.605 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 116' ' ' TYR . 0.6 OUTLIER -74.97 -42.03 58.4 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.178 -0.951 . . . . 0.0 109.526 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.615 ' CD2' ' CD2' ' A' ' 162' ' ' LEU . 72.5 t80 -48.32 -36.21 13.87 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 118.733 -1.187 . . . . 0.0 107.98 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.613 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 19.2 m-85 -91.48 -13.53 32.06 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.985 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 12.7 t -61.29 -14.28 25.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.114 -0.991 . . . . 0.0 109.594 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.72 -11.42 58.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.403 -0.81 . . . . 0.0 110.191 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.613 ' CD1' ' HA ' ' A' ' 117' ' ' PHE . 53.4 m-85 -89.54 -63.71 1.25 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.105 -0.997 . . . . 0.0 109.24 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -159.18 -177.57 32.39 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.5 133.84 48.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.063 -1.257 . . . . 0.0 110.414 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.408 HG11 ' O ' ' A' ' 125' ' ' ASP . 1.9 t -109.72 133.64 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.332 -0.855 . . . . 0.0 110.885 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.476 ' O ' ' OD1' ' A' ' 125' ' ' ASP . 2.1 t -89.68 -28.25 5.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.534 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 0.8 OUTLIER -147.26 164.64 32.57 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 118.906 -1.118 . . . . 0.0 112.604 -178.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.425 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 36.9 t -170.34 140.37 1.85 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.423 HG21 ' N ' ' A' ' 128' ' ' LEU . 0.9 OUTLIER -150.64 161.25 42.95 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.962 -177.773 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.479 HD21 ' HA ' ' A' ' 109' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.587 ' CD1' ' CZ ' ' A' ' 100' ' ' PHE . 2.6 p90 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 120.942 0.401 . . . . 0.0 110.52 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -142.66 -161.84 8.98 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.688 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 17.4 m-85 -126.87 163.21 24.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.159 -1.2 . . . . 0.0 111.306 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.573 HG22 ' CE2' ' A' ' 117' ' ' PHE . 4.0 t -138.49 138.05 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.539 ' CD2' ' HG2' ' A' ' 98' ' ' LYS . 4.6 mp -127.04 107.45 10.06 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.315 -0.866 . . . . 0.0 110.11 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.607 ' CZ ' ' CG2' ' A' ' 154' ' ' VAL . 26.3 m-85 -80.65 151.63 28.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.361 -0.837 . . . . 0.0 110.51 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -75.78 -17.04 60.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.49 -0.756 . . . . 0.0 110.917 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.484 ' O ' ' OG ' ' A' ' 150' ' ' SER . 7.4 tt0 -137.63 154.39 49.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.836 -1.165 . . . . 0.0 110.901 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.448 ' N ' ' HG2' ' A' ' 147' ' ' GLU . 0.4 OUTLIER -65.42 -39.28 91.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 109.601 179.45 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.473 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 3.0 tt0 -57.65 -51.3 70.09 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.331 -0.855 . . . . 0.0 109.688 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.484 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 1.4 p -52.7 -34.39 51.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.761 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.541 ' CG2' ' HB2' ' A' ' 145' ' ' PHE . 2.4 t -74.84 -49.79 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.307 -0.87 . . . . 0.0 110.503 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.473 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -52.97 -35.2 58.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.139 -0.976 . . . . 0.0 110.447 -179.489 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.475 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 0.4 OUTLIER -71.78 -49.87 34.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.227 -0.921 . . . . 0.0 110.464 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.607 ' CG2' ' CZ ' ' A' ' 145' ' ' PHE . 18.0 t -56.02 -22.53 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.901 -1.124 . . . . 0.0 110.043 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 32.1 mmm -87.32 -46.08 10.0 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.151 -0.968 . . . . 0.0 110.157 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.475 ' OD2' ' O ' ' A' ' 153' ' ' LYS . 0.5 OUTLIER -47.19 -37.2 9.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.117 -0.99 . . . . 0.0 109.811 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.576 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 0.6 OUTLIER -111.16 85.33 2.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.122 -0.986 . . . . 0.0 110.101 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.02 18.19 2.16 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.28 -0.887 . . . . 0.0 110.824 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.414 ' OE1' ' HG2' ' A' ' 157' ' ' GLN . 31.9 mp0 -87.67 60.84 6.18 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 177.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.576 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 15.1 m-70 -87.07 179.57 6.65 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.557 -177.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 160' ' ' HIS . 14.2 ttmt -179.21 88.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.323 -0.861 . . . . 0.0 110.154 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.615 ' CD2' ' CD2' ' A' ' 116' ' ' TYR . 2.1 mp -102.93 140.89 36.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.175 -0.953 . . . . 0.0 109.583 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 25.6 m120 57.04 16.72 3.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.267 -0.896 . . . . 0.0 109.734 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.35 32.59 27.88 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.11 123.3 10.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.193 -1.181 . . . . 0.0 110.482 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.407 ' O ' ' O ' ' A' ' 103' ' ' GLY . 16.9 t -57.66 172.63 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 0.0 109.926 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.508 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.7 OUTLIER -132.7 178.27 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.195 -0.941 . . . . 0.0 111.019 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 102' ' ' GLY . 10.3 t70 -127.9 80.25 72.39 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 42.8 Cg_endo -70.41 131.22 19.88 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.069 1.563 . . . . 0.0 111.241 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.401 ' O ' ' CB ' ' A' ' 99' ' ' MET . 4.6 mmtm -146.73 -174.01 4.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.401 -0.812 . . . . 0.0 110.302 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.385 0 O-C-N 121.463 -0.773 . . . . 0.0 110.487 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.54 ' HG2' ' CD1' ' A' ' 144' ' ' LEU . 12.5 mtmm . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.344 0.592 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.524 ' SD ' ' CG1' ' A' ' 143' ' ' VAL . 0.0 OUTLIER -145.33 160.0 42.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.656 179.2 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.72 ' CE1' ' CE1' ' A' ' 142' ' ' PHE . 13.1 t80 -113.61 146.07 40.29 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.414 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.531 HG13 ' CG2' ' A' ' 143' ' ' VAL . 12.7 mm -123.61 91.39 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.531 -0.731 . . . . 0.0 110.123 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 167' ' ' ILE . . . -91.34 178.77 41.79 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.65 10.89 61.25 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.482 ' HB2' ' CA ' ' A' ' 140' ' ' PHE . 4.9 mp -73.36 163.72 27.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.098 -1.237 . . . . 0.0 110.349 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.503 ' HB3' ' ND2' ' A' ' 163' ' ' ASN . 13.3 t -90.37 -176.86 4.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.331 -0.856 . . . . 0.0 109.615 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.547 ' N ' ' CD1' ' A' ' 106' ' ' TRP . 37.0 m0 -87.67 23.21 2.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.081 -1.012 . . . . 0.0 110.143 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -144.25 9.5 1.44 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -0.9 . . . . 0.0 110.47 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.454 ' C ' ' HG ' ' A' ' 128' ' ' LEU . 0.2 OUTLIER -73.41 172.47 11.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.106 -0.996 . . . . 0.0 109.822 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.471 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 71.4 p -150.36 166.41 30.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.132 -0.98 . . . . 0.0 110.366 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 114' ' ' LYS . 0.8 OUTLIER -67.68 -15.38 63.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.219 -0.925 . . . . 0.0 109.529 179.532 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -80.8 -62.66 1.6 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.315 -0.866 . . . . 0.0 110.38 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 109' ' ' THR . 1.1 p-10 -55.87 -37.75 69.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 110.249 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.438 HD13 HD12 ' A' ' 162' ' ' LEU . 13.3 tp -72.09 -41.46 67.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.156 -0.965 . . . . 0.0 110.178 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 110' ' ' LYS . 0.1 OUTLIER -60.87 -47.03 88.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.201 -0.937 . . . . 0.0 110.292 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 116' ' ' TYR . 26.4 t0 -69.91 -48.39 58.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.035 -1.041 . . . . 0.0 110.034 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.407 ' C ' ' O ' ' A' ' 115' ' ' ASP . 75.0 t80 -48.28 -34.89 11.14 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.62 -1.232 . . . . 0.0 108.104 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.585 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 13.5 m-85 -91.66 -8.08 48.13 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.409 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.5 m -71.15 -9.1 57.5 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.891 -1.131 . . . . 0.0 108.951 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -81.74 -16.09 52.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.6 -0.687 . . . . 0.0 110.091 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.585 ' CD1' ' HA ' ' A' ' 117' ' ' PHE . 70.7 m-85 -89.1 -55.35 3.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.179 -0.951 . . . . 0.0 109.153 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.535 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -164.57 -163.36 17.48 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.24 140.94 29.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.114 -1.227 . . . . 0.0 110.351 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 1.9 t -112.75 133.5 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.308 -0.87 . . . . 0.0 110.823 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.411 HG21 ' HD2' ' A' ' 146' ' ' LYS . 2.2 t -89.22 -25.64 5.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.531 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 1.0 OUTLIER -148.53 165.45 31.17 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.667 -1.213 . . . . 0.0 112.045 -179.203 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.461 ' CB ' ' CG ' ' A' ' 114' ' ' LYS . 14.3 t -170.52 148.68 3.14 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.497 HG21 ' N ' ' A' ' 128' ' ' LEU . 0.8 OUTLIER -150.28 162.28 40.81 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.116 -0.99 . . . . 0.0 110.599 -178.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.514 ' C ' ' CD1' ' A' ' 128' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.446 -0.784 . . . . 0.0 109.692 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.482 ' CA ' ' HB2' ' A' ' 104' ' ' LEU . 16.9 p90 . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 121.528 0.68 . . . . 0.0 110.965 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 127' ' ' THR . . . -125.42 173.69 17.45 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.72 ' CE1' ' CE1' ' A' ' 100' ' ' PHE . 10.1 m-85 -116.51 158.15 24.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.185 -1.185 . . . . 0.0 110.234 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.531 ' CG2' HG13 ' A' ' 101' ' ' ILE . 25.8 t -138.46 124.88 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.933 0.873 . . . . 0.0 109.939 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.54 ' CD1' ' HG2' ' A' ' 98' ' ' LYS . 1.6 mm? -110.27 111.65 23.09 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.572 ' CD1' ' HB2' ' A' ' 150' ' ' SER . 11.7 m-85 -82.01 151.59 27.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.971 -1.081 . . . . 0.0 111.052 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.411 ' HD2' HG21 ' A' ' 124' ' ' VAL . 30.4 tttt -81.28 -25.24 36.7 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.674 -0.641 . . . . 0.0 111.157 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.461 ' OE2' ' HB3' ' A' ' 149' ' ' GLU . 1.0 OUTLIER -144.48 146.37 32.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.703 -1.248 . . . . 0.0 111.231 -179.333 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.3 t -49.17 -35.13 16.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.154 -0.966 . . . . 0.0 109.554 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.47 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 0.6 OUTLIER -55.78 -51.61 66.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.348 -0.845 . . . . 0.0 109.972 179.725 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.572 ' HB2' ' CD1' ' A' ' 145' ' ' PHE . 67.1 p -56.99 -36.68 70.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.297 -0.877 . . . . 0.0 110.322 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.53 HG21 ' CB ' ' A' ' 145' ' ' PHE . 3.1 t -72.22 -53.6 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.075 -1.016 . . . . 0.0 110.393 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.47 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -47.78 -35.52 10.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.062 -1.023 . . . . 0.0 110.051 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.485 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -69.25 -52.0 31.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.898 . . . . 0.0 110.375 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.585 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 2.1 p -65.15 -14.39 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.989 -1.07 . . . . 0.0 110.17 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 28.1 tpp -90.48 -36.76 14.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.348 -0.845 . . . . 0.0 110.618 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 1.6 p-10 -57.73 -17.59 16.28 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.124 -0.985 . . . . 0.0 110.115 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.532 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 8.9 tp-100 -139.5 76.87 1.59 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.329 -0.857 . . . . 0.0 109.437 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.589 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -81.84 10.3 6.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.906 . . . . 0.0 110.666 -179.426 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -88.09 67.88 8.99 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.589 ' CD2' ' HA ' ' A' ' 158' ' ' LYS . 77.5 m-70 -86.41 174.71 8.82 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.51 0.671 . . . . 0.0 110.901 -177.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.54 ' CD ' ' O ' ' A' ' 160' ' ' HIS . 1.1 mppt? -168.95 74.17 0.09 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.523 -0.735 . . . . 0.0 109.226 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.466 ' O ' ' CB ' ' A' ' 163' ' ' ASN . 0.9 OUTLIER -109.89 155.8 21.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.38 -0.825 . . . . 0.0 110.178 -179.442 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.503 ' ND2' ' HB3' ' A' ' 105' ' ' SER . 0.3 OUTLIER 66.59 9.13 6.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.265 -0.897 . . . . 0.0 109.639 -179.348 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 89.08 15.38 59.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -150.92 163.49 38.57 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.051 -1.264 . . . . 0.0 110.671 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 2.9 t -84.9 178.28 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 109.53 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.553 ' CG1' ' HB2' ' A' ' 160' ' ' HIS . 0.7 OUTLIER -134.15 169.0 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.966 -1.084 . . . . 0.0 111.04 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 102' ' ' GLY . 9.5 t70 -112.34 88.22 10.44 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 167' ' ' ILE . 48.7 Cg_endo -77.14 119.66 5.1 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.259 1.663 . . . . 0.0 110.607 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.5 mttp -135.64 175.25 9.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 0.0 110.544 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 171' ' ' ARG . 9.3 ptp180 . . . . . 0 C--N 1.303 -1.449 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.27 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.493 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 9.8 mttt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.155 0.503 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.524 ' HE1' ' CD1' ' A' ' 101' ' ' ILE . 6.9 ptm -141.29 174.67 10.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.313 -0.867 . . . . 0.0 110.181 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.697 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 2.3 t80 -115.15 129.11 56.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.388 -0.82 . . . . 0.0 110.176 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.543 HG13 ' CG2' ' A' ' 143' ' ' VAL . 4.2 mm -111.53 95.94 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.287 -0.883 . . . . 0.0 109.251 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -93.13 113.92 4.57 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 145.08 34.51 0.07 OUTLIER Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.533 ' N ' HD21 ' A' ' 104' ' ' LEU . 3.5 mm? -91.17 151.82 20.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.088 -1.242 . . . . 0.0 110.116 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.423 ' HB3' ' HB3' ' A' ' 163' ' ' ASN . 52.7 p -75.27 -178.46 3.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.195 -0.941 . . . . 0.0 109.988 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -82.1 6.42 16.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -0.923 . . . . 0.0 110.364 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 2.9 p-10 -140.61 32.23 1.85 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.311 -0.868 . . . . 0.0 110.04 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.436 ' HB ' ' CD2' ' A' ' 128' ' ' LEU . 18.1 m -77.7 154.35 32.17 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.313 -0.867 . . . . 0.0 110.344 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.487 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 12.2 p -126.05 161.78 26.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.224 -0.923 . . . . 0.0 110.358 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.545 ' CG ' ' HA ' ' A' ' 127' ' ' THR . 0.3 OUTLIER -64.76 -20.47 66.37 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.089 -1.007 . . . . 0.0 110.121 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -88.61 -47.22 8.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.231 -0.918 . . . . 0.0 110.955 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -60.13 -30.42 69.27 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.941 -1.099 . . . . 0.0 109.881 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.515 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 27.0 tp -84.19 -45.91 12.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.218 -0.926 . . . . 0.0 109.47 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -33.03 67.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.889 . . . . 0.0 109.254 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' A' ' 118' ' ' SER . 0.2 OUTLIER -75.37 -55.04 6.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.28 -0.888 . . . . 0.0 109.675 179.632 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.448 ' C ' ' O ' ' A' ' 115' ' ' ASP . 64.8 t80 -46.55 -31.6 2.88 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.664 -1.214 . . . . 0.0 108.256 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.526 ' CD1' ' CE2' ' A' ' 120' ' ' PHE . 14.5 m-85 -91.35 -12.31 35.31 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.23 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 115' ' ' ASP . 44.0 t -67.47 -9.26 40.43 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.869 -1.144 . . . . 0.0 109.015 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -79.26 -16.23 56.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.407 -0.808 . . . . 0.0 110.438 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.58 ' CE1' HG21 ' A' ' 154' ' ' VAL . 90.4 m-85 -88.89 -53.18 4.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.155 -0.965 . . . . 0.0 109.685 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -164.15 -159.16 10.67 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.03 135.09 33.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -1.123 . . . . 0.0 110.262 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.473 HG21 ' HA ' ' A' ' 145' ' ' PHE . 2.0 t -111.83 133.66 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.294 -0.879 . . . . 0.0 110.59 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 t -88.73 -25.58 5.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.447 ' O ' HG11 ' A' ' 123' ' ' VAL . 0.9 OUTLIER -150.67 168.93 22.87 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.603 -1.239 . . . . 0.0 112.293 -179.056 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.526 ' O ' ' CD ' ' A' ' 110' ' ' LYS . 38.8 t -167.15 149.16 5.98 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.545 ' HA ' ' CG ' ' A' ' 110' ' ' LYS . 0.9 OUTLIER -150.78 147.82 27.76 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.869 -1.144 . . . . 0.0 111.563 -178.354 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.541 ' O ' ' CD1' ' A' ' 128' ' ' LEU . 2.3 tm? . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.486 ' HA ' HD21 ' A' ' 104' ' ' LEU . 3.3 p90 . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.019 0.438 . . . . 0.0 110.335 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -150.78 -165.46 12.78 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.466 -1.35 . . . . 0.0 110.5 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.697 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 16.4 m-85 -126.71 157.33 39.37 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.416 -1.049 . . . . 0.0 111.22 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.543 ' CG2' HG13 ' A' ' 101' ' ' ILE . 2.8 t -130.34 134.39 62.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.493 ' HG ' ' HG2' ' A' ' 98' ' ' LYS . 6.2 mp -121.82 90.2 3.26 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.104 -0.997 . . . . 0.0 110.333 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.52 ' CE2' HG12 ' A' ' 154' ' ' VAL . 29.6 m-85 -64.36 167.9 6.33 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.529 0.681 . . . . 0.0 109.98 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -103.05 -7.51 21.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.362 -0.837 . . . . 0.0 110.73 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.529 ' OE1' ' CB ' ' A' ' 149' ' ' GLU . 0.9 OUTLIER -141.14 161.51 37.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.889 -1.132 . . . . 0.0 110.936 -179.524 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 4.8 t -75.26 -43.14 53.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 109.66 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.529 ' CB ' ' OE1' ' A' ' 147' ' ' GLU . 0.5 OUTLIER -60.62 -29.99 69.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.326 -0.859 . . . . 0.0 109.702 179.506 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.499 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 7.2 p -71.68 -40.58 69.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.041 -1.037 . . . . 0.0 109.431 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.494 ' CG2' ' HB2' ' A' ' 145' ' ' PHE . 8.3 t -72.42 -40.97 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -0.939 . . . . 0.0 110.154 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -67.6 -24.46 65.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.998 -1.063 . . . . 0.0 109.548 179.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.484 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 0.7 OUTLIER -74.39 -40.57 61.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.396 -0.815 . . . . 0.0 109.703 179.5 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.58 HG21 ' CE1' ' A' ' 120' ' ' PHE . 11.4 p -79.56 -17.3 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.149 -0.97 . . . . 0.0 110.011 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -88.57 -32.31 18.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.497 -0.752 . . . . 0.0 110.388 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.484 ' OD2' ' O ' ' A' ' 153' ' ' LYS . 0.3 OUTLIER -51.92 -32.13 31.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.054 -1.029 . . . . 0.0 109.681 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.506 ' O ' ' NE2' ' A' ' 160' ' ' HIS . 1.4 mt-30 -130.05 96.96 4.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.308 -0.87 . . . . 0.0 110.028 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.481 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -89.54 24.68 2.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.13 -0.981 . . . . 0.0 110.264 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -88.1 62.16 6.66 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.52 ' HB2' ' CG1' ' A' ' 167' ' ' ILE . 11.5 m170 -86.9 178.8 6.86 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.942 -177.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 7.7 ttpt -175.27 68.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.383 -0.823 . . . . 0.0 109.823 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.531 ' CD2' HG22 ' A' ' 167' ' ' ILE . 2.4 pp -99.9 152.88 19.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.867 . . . . 0.0 109.814 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 5.4 m120 56.05 32.89 20.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.144 -0.973 . . . . 0.0 109.415 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 60.59 29.3 69.36 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.26 138.8 20.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.241 -1.152 . . . . 0.0 110.524 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.19 176.9 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.934 . . . . 0.0 109.375 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.531 HG22 ' CD2' ' A' ' 162' ' ' LEU . 1.3 pt -137.19 -175.62 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.0 -1.063 . . . . 0.0 111.209 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -140.77 93.79 8.36 Favored Pre-proline 0 C--N 1.301 -1.515 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -77.11 115.26 3.95 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.378 1.725 . . . . 0.0 110.603 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.65 171.48 9.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.331 -0.856 . . . . 0.0 110.327 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.3 -1.559 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.229 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.51 ' CG ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.189 0.519 . . . . 0.0 109.943 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.536 ' CE ' ' O ' ' A' ' 170' ' ' LYS . 6.0 mtp -140.09 179.26 6.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.129 -0.982 . . . . 0.0 110.376 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.694 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 2.4 t80 -124.42 136.54 54.13 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.45 -0.781 . . . . 0.0 110.077 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.485 HG13 ' CG2' ' A' ' 143' ' ' VAL . 6.0 mm -122.19 106.08 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.12 -0.988 . . . . 0.0 110.009 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.552 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -103.27 139.84 14.62 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.88 10.85 8.83 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.461 ' CD2' HG23 ' A' ' 108' ' ' THR . 4.3 mp -65.66 159.62 24.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.312 -1.11 . . . . 0.0 110.479 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.528 ' N ' ' OG1' ' A' ' 108' ' ' THR . 0.1 OUTLIER -83.94 177.11 8.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.37 -0.831 . . . . 0.0 109.823 179.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.564 ' N ' ' CD1' ' A' ' 106' ' ' TRP . 12.1 m0 -73.53 -23.75 60.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.153 -0.967 . . . . 0.0 110.352 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -104.97 11.77 33.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 110.887 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.528 ' OG1' ' N ' ' A' ' 105' ' ' SER . 1.8 m -60.92 161.24 8.49 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.986 -1.072 . . . . 0.0 110.023 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.486 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 68.3 p -150.33 179.53 8.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.342 -0.849 . . . . 0.0 110.391 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 23.2 ttmt -77.14 -19.07 57.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.387 -0.821 . . . . 0.0 109.342 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.56 -52.98 8.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.444 -0.785 . . . . 0.0 110.894 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 109' ' ' THR . 24.1 p-10 -70.01 -40.81 75.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.036 -1.04 . . . . 0.0 110.553 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.557 HD13 ' CE2' ' A' ' 117' ' ' PHE . 24.4 tp -65.1 -50.05 67.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.964 -1.085 . . . . 0.0 109.792 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -57.82 -32.5 67.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.914 . . . . 0.0 110.139 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.462 ' O ' ' C ' ' A' ' 116' ' ' TYR . 3.1 m-20 -80.0 -54.69 5.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.145 -0.972 . . . . 0.0 110.255 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.462 ' C ' ' O ' ' A' ' 115' ' ' ASP . 59.0 t80 -45.97 -32.6 2.83 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 118.711 -1.196 . . . . 0.0 108.177 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.621 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 12.8 m-85 -90.83 -17.14 27.08 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.22 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 115' ' ' ASP . 22.6 t -60.22 -20.47 58.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.981 -1.075 . . . . 0.0 109.445 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -74.92 -11.84 60.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.442 -0.786 . . . . 0.0 109.978 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.621 ' CD1' ' HA ' ' A' ' 117' ' ' PHE . 61.3 m-85 -89.78 -72.73 0.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.282 -0.886 . . . . 0.0 109.172 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.488 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -148.76 152.28 24.34 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.45 ' HB3' ' HE2' ' A' ' 146' ' ' LYS . 1.4 mt-10 -45.23 128.45 7.59 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.227 -1.161 . . . . 0.0 110.76 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.421 HG21 ' CD1' ' A' ' 145' ' ' PHE . 1.8 t -106.71 132.06 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.425 -0.797 . . . . 0.0 110.214 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.17 -24.4 5.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.403 ' HB2' ' CB ' ' A' ' 144' ' ' LEU . 1.9 m-20 -150.81 161.24 43.04 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 118.447 -1.301 . . . . 0.0 112.33 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.475 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 43.3 t -161.37 147.78 14.41 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.453 HG21 ' N ' ' A' ' 128' ' ' LEU . 0.9 OUTLIER -151.25 154.7 37.31 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 118.538 -1.265 . . . . 0.0 111.842 -178.165 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.521 ' O ' ' CD1' ' A' ' 128' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.563 ' CD2' ' CZ ' ' A' ' 100' ' ' PHE . 8.7 p90 . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 121.219 0.533 . . . . 0.0 110.629 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -144.91 -159.78 8.23 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.694 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 17.9 m-85 -129.28 170.2 13.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.317 -1.107 . . . . 0.0 111.279 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.485 ' CG2' HG13 ' A' ' 101' ' ' ILE . 3.1 t -145.03 128.3 11.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.51 ' HG ' ' CG ' ' A' ' 98' ' ' LYS . 6.6 mp -116.0 104.35 11.49 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.417 -0.802 . . . . 0.0 109.752 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.622 ' CZ ' ' CG2' ' A' ' 154' ' ' VAL . 52.6 m-85 -78.21 148.69 33.9 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.582 -0.699 . . . . 0.0 110.699 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.45 ' HE2' ' HB3' ' A' ' 122' ' ' GLU . 1.8 ttmt -59.98 -38.22 81.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.641 -0.662 . . . . 0.0 111.061 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.46 ' O ' ' OG ' ' A' ' 150' ' ' SER . 0.5 OUTLIER -133.87 149.49 51.34 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.969 -1.082 . . . . 0.0 111.186 -179.321 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.488 ' HA ' HG22 ' A' ' 151' ' ' VAL . 7.9 p -52.45 -27.92 18.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.322 -0.861 . . . . 0.0 109.824 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.485 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 1.9 mm-40 -62.74 -56.35 18.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.388 -0.82 . . . . 0.0 109.93 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.488 ' CB ' ' HA3' ' A' ' 121' ' ' GLY . 3.5 p -51.7 -32.15 28.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.171 -0.956 . . . . 0.0 109.757 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.553 ' CG2' ' HB2' ' A' ' 145' ' ' PHE . 17.7 t -65.81 -57.84 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.322 -0.861 . . . . 0.0 110.189 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.485 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 1.1 p30 -51.5 -28.89 14.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.172 -0.955 . . . . 0.0 109.99 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.47 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -68.28 -44.36 75.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.444 -0.785 . . . . 0.0 110.004 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.622 ' CG2' ' CZ ' ' A' ' 145' ' ' PHE . 3.8 t -69.86 -18.33 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.103 -0.998 . . . . 0.0 109.973 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.55 -23.96 21.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.88 . . . . 0.0 110.02 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.4 OUTLIER -55.41 -35.54 65.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 109.821 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.589 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -127.16 95.5 4.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.814 . . . . 0.0 109.583 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.447 ' HG3' ' HD2' ' A' ' 169' ' ' PRO . 9.5 tmtt? -85.29 12.43 8.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.904 . . . . 0.0 110.561 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -87.5 66.15 8.9 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 177.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.589 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 13.6 m-70 -87.2 177.76 7.08 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.487 -177.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.453 ' CG ' ' O ' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -174.18 70.51 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.285 -0.885 . . . . 0.0 110.085 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.475 HD23 ' CD1' ' A' ' 113' ' ' LEU . 3.6 pp -96.09 154.33 17.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 109.73 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.475 ' HB2' ' CD1' ' A' ' 162' ' ' LEU . 0.9 OUTLIER 58.99 15.38 3.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.898 . . . . 0.0 109.969 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.16 24.58 54.39 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -150.07 149.09 29.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -1.166 . . . . 0.0 110.702 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.1 t -77.2 176.12 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.438 -0.789 . . . . 0.0 109.7 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.531 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -142.38 -176.13 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.131 -0.98 . . . . 0.0 110.971 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 102' ' ' GLY . 60.8 t0 -127.87 94.03 38.14 Favored Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.447 ' HD2' ' HG3' ' A' ' 158' ' ' LYS . 49.8 Cg_endo -74.85 113.64 3.84 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.395 1.734 . . . . 0.0 111.71 -178.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.536 ' O ' ' CE ' ' A' ' 99' ' ' MET . 1.0 OUTLIER -130.51 -171.63 2.6 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.607 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.491 ' HA ' ' HG2' ' A' ' 99' ' ' MET . 14.7 mtp180 . . . . . 0 C--N 1.297 -1.714 0 C-N-CA 118.861 -1.136 . . . . 0.0 110.363 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 18.1 mttp . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.22 0.533 . . . . 0.0 110.294 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.537 ' HE1' ' CD1' ' A' ' 101' ' ' ILE . 17.3 ptm -144.33 175.5 10.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.157 -0.964 . . . . 0.0 110.621 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.697 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 2.4 t80 -117.3 135.36 53.89 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.533 -0.729 . . . . 0.0 109.174 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.537 ' CD1' ' HE1' ' A' ' 99' ' ' MET . 4.9 mm -119.42 110.56 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.182 -0.949 . . . . 0.0 109.78 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -111.37 98.71 1.05 Allowed Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.046 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 168.35 33.67 0.02 OUTLIER Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.534 ' CG ' HG23 ' A' ' 108' ' ' THR . 3.8 mm? -90.71 159.59 16.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -1.208 . . . . 0.0 109.808 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.457 ' N ' ' OG1' ' A' ' 108' ' ' THR . 14.0 t -85.33 -175.38 5.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.1 -1.0 . . . . 0.0 109.815 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 73.4 t90 -69.65 -33.37 72.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.062 -1.024 . . . . 0.0 110.148 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -103.77 48.13 0.86 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.204 -0.935 . . . . 0.0 110.335 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.534 HG23 ' CG ' ' A' ' 104' ' ' LEU . 19.8 m -88.02 155.03 20.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -0.988 . . . . 0.0 110.335 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.456 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 46.3 p -143.67 156.04 44.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.456 -0.778 . . . . 0.0 109.935 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.429 ' O ' ' CB ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -62.42 -14.7 43.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.065 -1.022 . . . . 0.0 109.453 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.9 mmtt -74.06 -56.08 5.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.363 -0.836 . . . . 0.0 110.013 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 12.1 p30 -69.06 -20.75 64.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.136 -0.978 . . . . 0.0 109.934 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.524 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 15.8 tp -86.73 -54.84 4.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.889 . . . . 0.0 109.641 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.429 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 10.3 tttm -54.01 -35.59 62.07 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.456 -0.777 . . . . 0.0 109.73 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 116' ' ' TYR . 12.8 m-20 -76.16 -52.51 9.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.192 -0.943 . . . . 0.0 109.782 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.442 ' C ' ' O ' ' A' ' 115' ' ' ASP . 65.4 t80 -47.63 -33.74 7.08 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.723 -1.191 . . . . 0.0 108.063 178.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.581 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 15.3 m-85 -91.96 -9.7 42.07 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.394 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.6 t -72.34 -4.02 27.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.051 -1.031 . . . . 0.0 109.386 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -89.95 -11.37 41.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.544 -0.723 . . . . 0.0 110.429 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.587 ' CE1' ' HA ' ' A' ' 154' ' ' VAL . 90.8 m-85 -88.59 -52.48 5.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.124 -0.985 . . . . 0.0 109.643 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -164.77 -161.81 14.52 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 146' ' ' LYS . 4.1 tt0 -86.02 115.24 23.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.221 -1.164 . . . . 0.0 110.446 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 1.9 t -94.11 132.07 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.303 -0.873 . . . . 0.0 110.912 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.38 -24.21 5.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.524 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 5.5 m-20 -147.75 163.05 37.92 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 118.766 -1.174 . . . . 0.0 112.373 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 44.0 t -170.15 140.63 1.97 Allowed 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.462 ' CG2' ' N ' ' A' ' 128' ' ' LEU . 0.9 OUTLIER -150.73 168.16 25.2 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 118.675 -1.21 . . . . 0.0 112.01 -177.781 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.462 ' N ' ' CG2' ' A' ' 127' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.503 ' HA ' HD21 ' A' ' 104' ' ' LEU . 4.1 p90 . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 120.97 0.414 . . . . 0.0 110.469 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 128' ' ' LEU . . . -134.87 -166.15 11.04 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.968 -1.111 . . . . 0.0 110.418 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.697 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 16.5 m-85 -122.84 168.1 12.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.418 -1.048 . . . . 0.0 111.325 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.533 ' CG2' HG13 ' A' ' 101' ' ' ILE . 8.9 t -144.76 134.04 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.524 ' HB2' ' CB ' ' A' ' 125' ' ' ASP . 3.1 mp -121.59 101.5 7.64 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.301 -0.874 . . . . 0.0 110.368 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.537 ' CE2' HG12 ' A' ' 154' ' ' VAL . 12.6 m-85 -76.42 158.08 31.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.296 -0.877 . . . . 0.0 110.382 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 122' ' ' GLU . 24.4 tptp -85.28 -11.94 53.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.819 . . . . 0.0 111.205 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.521 ' OE1' ' CB ' ' A' ' 149' ' ' GLU . 2.6 tt0 -144.92 151.06 38.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.75 -1.219 . . . . 0.0 110.883 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 19.9 m -61.98 -36.91 82.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.9 . . . . 0.0 109.437 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.521 ' CB ' ' OE1' ' A' ' 147' ' ' GLU . 2.3 tt0 -62.11 -56.18 21.45 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.329 -0.857 . . . . 0.0 109.42 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.484 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 49.7 p -45.6 -37.0 5.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.149 -0.969 . . . . 0.0 109.361 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.528 HG21 ' CB ' ' A' ' 145' ' ' PHE . 2.9 t -74.3 -35.15 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 0.0 109.635 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.465 ' OD2' ' O ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -66.01 -28.08 68.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -0.872 . . . . 0.0 109.521 179.583 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.479 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 4.2 mttm -74.99 -48.51 23.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.377 -0.827 . . . . 0.0 109.908 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.587 ' HA ' ' CE1' ' A' ' 120' ' ' PHE . 9.0 p -66.13 -18.28 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.009 -1.057 . . . . 0.0 109.916 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 5.3 ttt -89.95 -43.51 10.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.262 -0.899 . . . . 0.0 110.115 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.479 ' OD2' ' O ' ' A' ' 153' ' ' LYS . 0.5 OUTLIER -46.39 -33.78 4.15 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.175 -0.953 . . . . 0.0 109.766 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.571 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 3.2 tt0 -119.43 90.26 3.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.29 -0.881 . . . . 0.0 110.105 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.482 ' O ' ' HG2' ' A' ' 158' ' ' LYS . 38.3 ttpt -87.14 19.77 3.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.325 -0.859 . . . . 0.0 110.295 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.6 58.28 4.83 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 177.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.576 ' CG ' HD13 ' A' ' 167' ' ' ILE . 13.7 m-70 -86.47 173.78 9.4 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.372 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -177.64 67.94 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.439 -0.788 . . . . 0.0 109.467 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.474 HD22 HG22 ' A' ' 167' ' ' ILE . 0.9 OUTLIER -97.04 157.69 15.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.413 -0.804 . . . . 0.0 110.152 -179.575 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 58.17 16.45 3.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 109.627 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 81.29 21.94 61.6 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.54 149.65 30.21 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.1 -1.235 . . . . 0.0 110.394 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 1.1 p -76.95 -177.28 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.177 -0.952 . . . . 0.0 109.668 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.576 HD13 ' CG ' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -135.78 166.76 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.956 -1.09 . . . . 0.0 111.651 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -117.31 88.86 29.44 Favored Pre-proline 0 C--N 1.303 -1.436 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.462 ' HD2' ' HD2' ' A' ' 158' ' ' LYS . 46.7 Cg_endo -72.7 132.02 18.09 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.359 1.715 . . . . 0.0 111.184 -178.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 99' ' ' MET . 2.5 mttm -147.9 -169.8 3.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.53 -0.731 . . . . 0.0 109.964 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.541 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.222 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.548 ' CG ' ' HG ' ' A' ' 144' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.237 0.542 . . . . 0.0 110.527 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.526 ' CE ' ' HB ' ' A' ' 143' ' ' VAL . 0.0 OUTLIER -123.38 167.25 14.07 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.193 -0.942 . . . . 0.0 108.84 178.711 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.691 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 1.6 t80 -105.73 125.28 50.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.06 -1.025 . . . . 0.0 110.305 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.564 HG22 ' CE2' ' A' ' 117' ' ' PHE . 16.5 mm -116.95 94.92 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 110.169 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 167' ' ' ILE . . . -92.71 178.28 39.36 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.47 6.74 70.29 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 140' ' ' PHE . 3.1 mm? -61.68 164.13 6.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.094 -1.239 . . . . 0.0 109.536 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.05 177.78 6.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.042 -1.036 . . . . 0.0 109.97 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.422 ' CD1' ' N ' ' A' ' 106' ' ' TRP . 33.3 m95 -84.99 19.23 2.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.223 -0.923 . . . . 0.0 110.217 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -148.12 21.88 1.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.9 . . . . 0.0 109.878 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.447 HG23 HD13 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -76.1 169.37 18.32 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.203 -0.935 . . . . 0.0 110.639 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.465 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 82.8 p -150.42 151.36 32.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.437 -0.789 . . . . 0.0 109.98 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.467 ' HD3' ' O ' ' A' ' 126' ' ' CYS . 7.1 ttpt -56.08 -16.34 4.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.162 -0.961 . . . . 0.0 109.881 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -80.15 -57.98 3.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.37 -0.831 . . . . 0.0 111.11 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 1.5 p-10 -65.38 -40.31 93.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.06 -1.025 . . . . 0.0 110.844 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.517 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 20.2 tp -69.05 -48.54 62.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.019 -1.051 . . . . 0.0 109.984 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.461 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 11.7 tttt -52.16 -40.47 61.49 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.234 -0.916 . . . . 0.0 110.127 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.471 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 4.2 t0 -74.69 -50.86 16.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.234 -0.916 . . . . 0.0 110.257 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.448 ' C ' ' O ' ' A' ' 115' ' ' ASP . 78.1 t80 -46.21 -34.85 4.66 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.402 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.564 ' CE2' HG22 ' A' ' 101' ' ' ILE . 9.1 m-85 -91.63 -12.45 34.17 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.441 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.471 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 0.9 OUTLIER -72.65 -5.26 36.26 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.917 -1.115 . . . . 0.0 108.998 178.5 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 119' ' ' LYS . 2.1 tttm -85.77 -12.27 51.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.521 -0.737 . . . . 0.0 110.347 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.58 ' CE1' HG21 ' A' ' 154' ' ' VAL . 93.0 m-85 -88.9 -51.54 5.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.021 -1.049 . . . . 0.0 109.286 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.454 ' HA3' ' HB3' ' A' ' 150' ' ' SER . . . -158.71 -161.17 10.85 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -86.01 142.5 28.72 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.144 -1.209 . . . . 0.0 109.896 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.516 HG21 ' CD1' ' A' ' 145' ' ' PHE . 1.8 t -127.48 133.9 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.169 -0.957 . . . . 0.0 110.923 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.479 HG22 ' CE ' ' A' ' 146' ' ' LYS . 2.3 t -94.73 -22.03 5.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -149.82 170.68 18.19 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 118.049 -1.46 . . . . 0.0 113.135 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.467 ' O ' ' HD3' ' A' ' 110' ' ' LYS . 16.2 t -170.85 131.48 0.84 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.36 162.08 25.58 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.448 -0.783 . . . . 0.0 111.45 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.552 ' HA ' ' HA3' ' A' ' 141' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.803 0 O-C-N 121.362 -0.836 . . . . 0.0 110.294 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.503 ' CD2' ' CZ ' ' A' ' 100' ' ' PHE . 3.1 p90 . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.239 0.542 . . . . 0.0 110.542 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' A' ' 128' ' ' LEU . . . -139.24 -169.07 11.47 Favored Glycine 0 N--CA 1.488 2.114 0 C-N-CA 119.804 -1.189 . . . . 0.0 110.494 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.691 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 9.9 m-85 -124.48 170.6 10.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.732 -0.864 . . . . 0.0 110.008 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.535 ' CG2' HG13 ' A' ' 101' ' ' ILE . 35.7 t -141.59 140.93 30.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.548 ' HG ' ' CG ' ' A' ' 98' ' ' LYS . 5.8 mp -124.83 107.94 11.42 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.783 -178.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.581 ' CE2' HG13 ' A' ' 154' ' ' VAL . 42.9 m-85 -82.68 165.58 19.86 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.518 -0.739 . . . . 0.0 110.344 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.479 ' CE ' HG22 ' A' ' 124' ' ' VAL . 10.6 ttmt -86.77 -24.65 25.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.439 -0.788 . . . . 0.0 111.002 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.476 ' O ' ' OG ' ' A' ' 150' ' ' SER . 0.7 OUTLIER -145.02 155.16 43.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.786 -1.196 . . . . 0.0 110.92 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 25.6 p -55.19 -35.8 65.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.271 -0.893 . . . . 0.0 109.948 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.479 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 1.0 OUTLIER -52.97 -54.14 39.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.425 -0.797 . . . . 0.0 110.008 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 3.6 p -57.59 -39.44 76.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.187 -0.945 . . . . 0.0 110.233 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.453 ' O ' HG11 ' A' ' 154' ' ' VAL . 6.6 t -62.0 -44.69 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.12 -0.988 . . . . 0.0 110.62 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.479 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.5 OUTLIER -67.16 -27.56 67.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.044 -1.035 . . . . 0.0 110.097 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.473 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -70.75 -32.36 69.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.847 . . . . 0.0 110.163 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.581 HG13 ' CE2' ' A' ' 145' ' ' PHE . 6.0 p -90.66 -20.87 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.158 -0.964 . . . . 0.0 110.329 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.529 ' N ' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -89.04 -34.5 16.77 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.371 -0.83 . . . . 0.0 109.892 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 8.4 p-10 -47.38 -31.9 4.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.295 -0.878 . . . . 0.0 109.865 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.517 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -131.95 94.95 3.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.976 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.465 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -89.52 27.31 1.5 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.127 -0.983 . . . . 0.0 110.431 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -89.03 55.66 3.42 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.533 ' HB2' HG13 ' A' ' 167' ' ' ILE . 12.2 m170 -86.23 176.31 8.01 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.684 -177.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -177.21 75.05 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.46 -0.775 . . . . 0.0 109.452 179.718 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' A' ' 163' ' ' ASN . 1.5 pp -98.49 157.99 15.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.321 -0.862 . . . . 0.0 109.948 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 0.8 OUTLIER 60.04 13.92 4.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.328 -0.858 . . . . 0.0 109.675 -179.265 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 85.43 20.85 55.94 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 161' ' ' LYS . 5.8 mttt -151.21 150.55 30.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.086 -1.243 . . . . 0.0 110.736 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 161' ' ' LYS . 1.3 p -74.71 -178.79 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.4 -0.813 . . . . 0.0 109.683 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.533 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.1 OUTLIER -135.39 -171.78 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.097 -1.002 . . . . 0.0 110.701 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 102' ' ' GLY . 23.9 t0 -132.71 84.63 49.68 Favored Pre-proline 0 N--CA 1.488 1.473 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.93 127.18 10.53 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.218 1.641 . . . . 0.0 111.033 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.55 -173.48 4.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.462 -0.774 . . . . 0.0 109.794 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 . . . . . 0 C--N 1.301 -1.543 0 C-N-CA 119.499 -0.881 . . . . 0.0 110.566 179.364 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.457 ' HA ' ' HG ' ' A' ' 144' ' ' LEU . 8.2 mttp . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.372 0.606 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.491 ' HE1' ' CD1' ' A' ' 101' ' ' ILE . 5.4 ptm -138.73 169.56 17.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 109.982 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.699 ' CE2' ' CZ ' ' A' ' 142' ' ' PHE . 2.5 t80 -112.72 138.68 49.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.904 . . . . 0.0 110.593 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.491 ' CD1' ' HE1' ' A' ' 99' ' ' MET . 2.8 mm -121.85 110.77 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.418 -0.801 . . . . 0.0 109.822 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.442 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -108.57 123.92 7.21 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 138.89 33.63 0.18 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.473 HD11 ' HA ' ' A' ' 140' ' ' PHE . 2.2 mp -90.5 159.37 16.54 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.139 -1.212 . . . . 0.0 110.323 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.6 t -84.06 -170.3 3.01 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.208 -0.932 . . . . 0.0 110.32 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 20.2 m0 -87.53 4.1 44.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.208 -0.932 . . . . 0.0 110.332 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -138.0 22.99 2.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.205 -0.935 . . . . 0.0 110.15 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.51 ' O ' ' CD2' ' A' ' 128' ' ' LEU . 2.8 m -68.06 163.28 22.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.171 -0.956 . . . . 0.0 110.059 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.469 ' OG1' ' OD2' ' A' ' 112' ' ' ASP . 30.3 p -148.61 153.76 38.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.198 -0.939 . . . . 0.0 110.171 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.548 ' O ' ' CB ' ' A' ' 114' ' ' LYS . 10.5 ttpt -58.4 -15.34 10.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.225 -0.922 . . . . 0.0 109.735 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.35 -54.61 6.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.219 -0.925 . . . . 0.0 110.273 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 3.2 p30 -70.12 -30.29 67.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.235 -0.916 . . . . 0.0 110.574 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.525 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 14.7 tp -81.11 -48.97 11.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.021 . . . . 0.0 109.996 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.548 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 1.3 tttt -55.04 -35.87 64.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.154 -0.966 . . . . 0.0 109.716 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 5.3 m-20 -79.59 -47.69 15.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.919 . . . . 0.0 109.748 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.409 ' C ' ' O ' ' A' ' 115' ' ' ASP . 75.6 t80 -48.23 -36.73 14.46 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 118.566 -1.253 . . . . 0.0 107.995 178.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.545 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 16.3 m-85 -91.56 -11.7 36.52 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.948 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.421 ' HB3' ' HA ' ' A' ' 115' ' ' ASP . 29.2 t -71.08 -6.49 39.57 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.907 -1.12 . . . . 0.0 108.81 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -83.47 -15.74 48.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.407 -0.808 . . . . 0.0 110.036 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.563 ' CD2' HG21 ' A' ' 154' ' ' VAL . 72.8 m-85 -89.18 -39.74 13.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.274 -0.891 . . . . 0.0 109.122 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.414 ' HA3' ' HB3' ' A' ' 150' ' ' SER . . . -174.19 176.99 46.57 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.486 ' O ' ' CB ' ' A' ' 146' ' ' LYS . 0.9 OUTLIER -73.83 118.17 16.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.234 -1.156 . . . . 0.0 110.466 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.467 HG21 ' HA ' ' A' ' 145' ' ' PHE . 1.8 t -93.36 130.62 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.26 -0.9 . . . . 0.0 111.375 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.411 HG11 ' OD1' ' A' ' 125' ' ' ASP . 2.2 t -90.28 -23.73 5.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.489 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -142.76 153.02 42.9 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 118.984 -1.087 . . . . 0.0 112.09 -179.106 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 49.6 t -161.66 145.56 12.69 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.28 156.73 42.1 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.702 -1.199 . . . . 0.0 111.566 -178.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.52 ' C ' ' CD1' ' A' ' 128' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.524 ' CD1' ' CZ ' ' A' ' 100' ' ' PHE . 11.6 p90 . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 120.982 0.42 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.404 ' C ' ' CD1' ' A' ' 142' ' ' PHE . . . -153.91 -159.41 9.15 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.944 -1.263 . . . . 0.0 109.944 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.699 ' CZ ' ' CE2' ' A' ' 100' ' ' PHE . 18.9 m-85 -129.32 170.87 13.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -1.172 . . . . 0.0 111.429 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.484 ' CG2' HG13 ' A' ' 101' ' ' ILE . 7.3 t -145.9 129.83 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.489 ' HB2' ' CB ' ' A' ' 125' ' ' ASP . 7.6 mp -120.84 102.96 8.71 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.398 -0.814 . . . . 0.0 110.355 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.57 ' CE2' HG22 ' A' ' 154' ' ' VAL . 26.2 m-85 -74.71 165.08 25.81 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.587 0.708 . . . . 0.0 110.899 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 122' ' ' GLU . 17.5 ttpt -85.27 -26.5 26.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.512 -0.742 . . . . 0.0 111.104 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.495 ' HG3' ' OG ' ' A' ' 150' ' ' SER . 0.1 OUTLIER -137.11 142.05 42.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.654 -1.279 . . . . 0.0 110.772 -179.757 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 75.1 m -50.52 -30.67 13.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 109.996 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.487 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 1.8 mm-40 -59.25 -48.1 82.88 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.272 -0.892 . . . . 0.0 110.042 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.495 ' OG ' ' HG3' ' A' ' 147' ' ' GLU . 11.2 p -62.75 -32.33 73.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.235 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.521 ' CG2' ' HB2' ' A' ' 145' ' ' PHE . 2.7 t -73.94 -55.31 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.065 -1.022 . . . . 0.0 110.103 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.487 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.1 OUTLIER -51.47 -27.14 9.59 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.159 -0.963 . . . . 0.0 109.341 179.772 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.475 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 8.7 tmtt? -69.5 -61.73 1.67 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.459 -0.775 . . . . 0.0 109.708 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.57 HG22 ' CE2' ' A' ' 145' ' ' PHE . 23.4 t -45.33 -28.65 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.127 -0.983 . . . . 0.0 109.948 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 6.7 ttt -77.46 -41.15 40.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.371 -0.831 . . . . 0.0 110.462 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.475 ' OD2' ' O ' ' A' ' 153' ' ' LYS . 0.4 OUTLIER -48.19 -22.99 0.74 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.132 -0.98 . . . . 0.0 109.962 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.569 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 3.0 pt20 -140.44 90.89 2.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.286 -0.884 . . . . 0.0 110.135 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.74 16.38 5.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.122 -0.986 . . . . 0.0 110.372 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -87.67 63.64 7.63 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.569 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 11.7 m-70 -87.35 -179.76 6.45 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.648 -177.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 166' ' ' VAL . 16.2 ttmt -179.06 74.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.26 -0.9 . . . . 0.0 110.23 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.494 HD22 ' CD1' ' A' ' 167' ' ' ILE . 1.8 pp -96.07 151.38 19.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 109.873 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 0.5 OUTLIER 61.39 12.36 4.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.232 -0.917 . . . . 0.0 110.217 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 88.2 23.01 39.06 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 4.3 mtpp -150.12 138.96 20.89 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.183 -1.187 . . . . 0.0 110.579 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 161' ' ' LYS . 4.2 p -66.78 -179.39 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.311 -0.868 . . . . 0.0 109.995 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.543 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -145.13 176.74 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.176 -0.953 . . . . 0.0 110.642 -179.55 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 102' ' ' GLY . 34.2 t0 -128.09 90.78 46.44 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 52.3 Cg_endo -78.44 139.36 16.31 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 124.118 1.588 . . . . 0.0 110.862 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.08 -173.01 4.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.922 . . . . 0.0 110.122 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 . . . . . 0 C--N 1.302 -1.482 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.319 179.378 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.462 ' HB3' ' HG ' ' A' ' 144' ' ' LEU . 43.3 mttt . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.448 0.642 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.529 ' SD ' ' CG1' ' A' ' 143' ' ' VAL . 0.0 OUTLIER -134.49 165.78 24.39 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.779 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.719 ' CE1' ' CE1' ' A' ' 142' ' ' PHE . 17.4 t80 -111.78 144.35 41.23 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.077 -1.014 . . . . 0.0 110.67 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.519 ' CD1' ' HE3' ' A' ' 99' ' ' MET . 3.2 mm -117.63 96.53 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.555 -0.716 . . . . 0.0 109.227 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -93.99 120.39 6.31 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.84 -1.172 . . . . 0.0 110.627 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 133.65 35.03 0.29 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.518 HD23 ' CG2' ' A' ' 167' ' ' ILE . 4.0 mm? -90.21 161.64 15.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.12 -1.224 . . . . 0.0 110.106 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.494 ' N ' ' OG1' ' A' ' 108' ' ' THR . 0.1 OUTLIER -90.64 160.4 15.9 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.212 -0.93 . . . . 0.0 110.332 179.835 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -62.14 -10.92 11.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.052 -1.03 . . . . 0.0 110.218 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -116.09 12.68 15.64 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.143 -0.973 . . . . 0.0 111.321 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.553 ' HB ' ' CD1' ' A' ' 128' ' ' LEU . 0.3 OUTLIER -76.84 169.89 17.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.829 -1.169 . . . . 0.0 110.034 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.44 HG21 ' O ' ' A' ' 108' ' ' THR . 33.8 p -149.89 155.45 40.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.15 -0.969 . . . . 0.0 109.887 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 114' ' ' LYS . 1.9 pttp -63.6 -11.06 21.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.159 -0.963 . . . . 0.0 109.663 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -78.65 -61.96 1.84 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.0 110.42 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 0.9 OUTLIER -62.5 -41.41 98.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.084 -1.01 . . . . 0.0 110.182 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.567 HD22 ' CD2' ' A' ' 117' ' ' PHE . 6.9 tt -64.79 -61.14 2.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 109.752 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 110' ' ' LYS . 14.3 ttpt -44.44 -34.92 2.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 109.433 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 118' ' ' SER . 0.5 OUTLIER -72.94 -54.38 8.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.144 -0.972 . . . . 0.0 109.2 179.187 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.435 ' C ' ' O ' ' A' ' 115' ' ' ASP . 48.1 t80 -47.69 -28.39 2.4 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.567 ' CD2' HD22 ' A' ' 113' ' ' LEU . 20.1 m-85 -91.21 -12.41 35.4 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.232 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 115' ' ' ASP . 95.1 p -65.4 -10.18 31.45 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.922 -1.111 . . . . 0.0 109.406 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.0 tptt -81.73 -14.78 56.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.466 -0.771 . . . . 0.0 110.544 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.594 ' CE1' ' HA ' ' A' ' 154' ' ' VAL . 92.3 m-85 -89.17 -61.91 1.6 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.145 -0.972 . . . . 0.0 109.498 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.49 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -155.95 -163.5 12.3 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.76 126.41 35.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -1.212 . . . . 0.0 110.352 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.43 HG11 ' O ' ' A' ' 125' ' ' ASP . 1.6 t -101.05 129.63 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.205 -0.935 . . . . 0.0 111.062 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -90.07 -23.01 6.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.5 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 2.2 m-20 -145.51 162.16 38.04 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 118.663 -1.215 . . . . 0.0 112.288 -178.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.428 ' CB ' ' HD3' ' A' ' 114' ' ' LYS . 9.2 t -169.95 143.98 2.66 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.528 ' CG2' ' N ' ' A' ' 128' ' ' LEU . 0.9 OUTLIER -150.59 173.85 13.65 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 110.39 -178.709 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.553 ' CD1' ' HB ' ' A' ' 108' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 O-C-N 121.403 -0.811 . . . . 0.0 110.003 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.521 ' HB2' ' HA2' ' A' ' 102' ' ' GLY . 17.5 p90 . . . . . 0 N--CA 1.499 2.018 0 CA-C-O 121.395 0.617 . . . . 0.0 111.512 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.473 ' CA ' ' HA ' ' A' ' 128' ' ' LEU . . . -115.68 178.47 17.64 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.719 ' CE1' ' CE1' ' A' ' 100' ' ' PHE . 13.3 m-85 -126.07 160.66 29.52 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.517 -0.99 . . . . 0.0 110.804 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.529 ' CG1' ' SD ' ' A' ' 99' ' ' MET . 19.5 t -145.07 141.75 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.584 -0.698 . . . . 0.0 109.237 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.5 ' HB2' ' CB ' ' A' ' 125' ' ' ASP . 6.3 mp -127.31 102.71 7.03 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.515 -0.74 . . . . 0.0 109.536 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.492 ' CB ' HG21 ' A' ' 151' ' ' VAL . 29.2 m-85 -74.44 153.08 39.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.472 -0.768 . . . . 0.0 110.614 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.7 tttt -83.47 -18.98 36.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.476 -0.765 . . . . 0.0 110.882 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.483 ' O ' ' OG ' ' A' ' 150' ' ' SER . 5.7 tt0 -134.36 154.63 51.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.794 -1.191 . . . . 0.0 110.895 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.9 t -67.39 -39.09 85.58 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.229 -0.919 . . . . 0.0 109.232 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.507 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 1.7 tt0 -59.63 -49.78 76.43 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.496 -0.752 . . . . 0.0 109.686 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.49 ' CB ' ' HA3' ' A' ' 121' ' ' GLY . 4.8 p -52.94 -37.97 61.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.159 -0.963 . . . . 0.0 109.498 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.492 HG21 ' CB ' ' A' ' 145' ' ' PHE . 5.7 t -68.27 -46.98 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -0.88 . . . . 0.0 109.921 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.507 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -57.05 -33.32 67.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.218 -0.926 . . . . 0.0 109.562 179.688 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.475 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 19.9 mttt -63.71 -50.98 67.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.434 -0.791 . . . . 0.0 109.905 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.594 ' HA ' ' CE1' ' A' ' 120' ' ' PHE . 10.5 p -69.42 -10.77 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.962 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.21 -30.97 17.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.397 -0.814 . . . . 0.0 109.948 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 1.6 p-10 -55.29 -23.5 23.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.152 -0.968 . . . . 0.0 110.388 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.516 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 0.8 OUTLIER -139.72 94.76 2.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 0.0 109.961 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.539 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 3.1 pttp -89.91 15.06 10.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.158 -0.963 . . . . 0.0 110.606 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -87.94 67.77 9.09 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.576 ' HB2' ' CG1' ' A' ' 167' ' ' ILE . 84.9 m-70 -86.94 151.9 22.89 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.324 -177.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 160' ' ' HIS . 23.6 mttt -146.9 72.45 1.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.463 -0.773 . . . . 0.0 109.599 178.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.415 HD12 HD13 ' A' ' 113' ' ' LEU . 0.7 OUTLIER -106.43 151.9 24.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.0 110.579 -179.538 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.519 ' OD1' ' CG2' ' A' ' 108' ' ' THR . 0.7 OUTLIER 59.61 20.75 9.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.298 -0.876 . . . . 0.0 110.123 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.94 26.46 71.07 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.61 150.37 33.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.311 -1.111 . . . . 0.0 110.446 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.412 HG11 ' N ' ' A' ' 167' ' ' ILE . 57.7 t -92.15 160.6 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.33 -0.856 . . . . 0.0 109.745 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.576 ' CG1' ' HB2' ' A' ' 160' ' ' HIS . 3.8 pt -125.41 -177.65 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.014 -1.054 . . . . 0.0 111.602 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 102' ' ' GLY . 1.8 t70 -129.5 94.31 32.96 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.473 ' CG ' ' HB2' ' A' ' 158' ' ' LYS . 47.9 Cg_endo -74.44 124.3 8.8 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 124.302 1.685 . . . . 0.0 111.048 -178.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.457 ' O ' ' CB ' ' A' ' 99' ' ' MET . 4.7 mttm -150.24 -165.6 2.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.425 -0.797 . . . . 0.0 109.961 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 . . . . . 0 C--N 1.299 -1.611 0 C-N-CA 119.654 -0.819 . . . . 0.0 109.345 178.876 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.471 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 26.9 mtmt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.061 0.457 . . . . 0.0 109.797 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.528 ' HE1' ' CD1' ' A' ' 101' ' ' ILE . 8.5 ptm -136.13 178.55 6.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.154 -0.966 . . . . 0.0 110.762 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.725 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 1.7 t80 -119.88 130.94 55.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.495 -0.753 . . . . 0.0 109.948 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.549 HG13 ' CG2' ' A' ' 143' ' ' VAL . 3.8 mm -114.21 90.42 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.435 -0.791 . . . . 0.0 109.149 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -92.48 148.64 19.21 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.1 23.19 6.82 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.542 ' CD1' ' O ' ' A' ' 101' ' ' ILE . 5.9 mp -82.74 163.36 21.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.992 -1.299 . . . . 0.0 109.995 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.479 ' O ' ' OG1' ' A' ' 108' ' ' THR . 0.4 OUTLIER -91.52 178.55 5.91 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.315 -0.866 . . . . 0.0 111.051 -179.665 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -72.64 -4.14 29.15 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.292 -0.88 . . . . 0.0 109.936 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.56 14.2 12.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.18 -0.95 . . . . 0.0 111.178 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.486 ' HB ' HD21 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -75.35 157.91 33.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.959 -1.088 . . . . 0.0 109.355 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 68.1 p -150.49 174.22 13.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.165 -0.959 . . . . 0.0 110.704 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 126' ' ' CYS . 8.2 ttpt -66.93 -17.59 64.98 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.511 -0.743 . . . . 0.0 109.35 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -61.31 1.92 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.352 -0.843 . . . . 0.0 110.807 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 14.6 p30 -63.84 -18.15 63.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.997 -1.064 . . . . 0.0 109.879 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.516 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 36.8 tp -87.95 -53.55 4.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.898 . . . . 0.0 109.331 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.534 ' HB2' ' CB ' ' A' ' 126' ' ' CYS . 7.0 tmtt? -61.68 -38.57 88.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.558 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.493 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 6.3 t70 -72.5 -54.87 8.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.249 -0.907 . . . . 0.0 110.035 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.563 ' CG ' HD11 ' A' ' 162' ' ' LEU . 55.4 t80 -49.46 -30.28 7.87 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.395 -1.322 . . . . 0.0 108.0 178.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.559 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 12.9 m-85 -90.71 -9.13 47.88 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 119.736 -0.786 . . . . 0.0 111.122 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.493 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 0.1 OUTLIER -69.07 -14.16 62.86 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.83 -1.169 . . . . 0.0 108.708 178.41 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -18.65 60.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.534 -0.729 . . . . 0.0 110.056 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.559 ' CD1' ' HA ' ' A' ' 117' ' ' PHE . 71.2 m-85 -89.03 -64.34 1.16 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.23 -0.918 . . . . 0.0 109.176 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.406 ' HA3' ' HB2' ' A' ' 150' ' ' SER . . . -152.68 175.53 31.22 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.65 146.68 51.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.061 -1.258 . . . . 0.0 110.211 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' A' ' 145' ' ' PHE . 2.0 t -123.06 132.14 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.357 -0.839 . . . . 0.0 110.674 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.1 -24.5 5.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.432 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 1.0 OUTLIER -145.18 160.64 41.14 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 118.797 -1.161 . . . . 0.0 112.258 -179.163 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.534 ' CB ' ' HB2' ' A' ' 114' ' ' LYS . 34.1 t -169.57 118.9 0.64 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.415 HG21 ' N ' ' A' ' 128' ' ' LEU . 0.8 OUTLIER -118.56 166.68 12.42 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.498 -0.751 . . . . 0.0 110.823 -178.573 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.506 HD11 ' O ' ' A' ' 128' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.501 -0.749 . . . . 0.0 109.739 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.522 ' CD2' ' CZ ' ' A' ' 100' ' ' PHE . 19.1 p90 . . . . . 0 N--CA 1.498 1.938 0 CA-C-O 121.623 0.725 . . . . 0.0 111.884 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 128' ' ' LEU . . . -135.76 -179.27 16.43 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.725 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 7.8 m-85 -123.02 167.08 14.08 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.119 -1.224 . . . . 0.0 110.767 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.549 ' CG2' HG13 ' A' ' 101' ' ' ILE . 3.5 t -142.89 134.23 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.376 -0.828 . . . . 0.0 109.474 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.471 ' HG ' ' HG2' ' A' ' 98' ' ' LYS . 5.0 mp -120.87 103.44 9.08 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.42 -0.8 . . . . 0.0 109.786 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.52 ' CZ ' HG23 ' A' ' 154' ' ' VAL . 16.5 m-85 -77.49 169.52 18.16 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.453 -0.78 . . . . 0.0 110.899 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -84.36 -32.57 24.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.694 -0.629 . . . . 0.0 111.039 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.478 ' HG3' ' OG ' ' A' ' 150' ' ' SER . 0.3 OUTLIER -135.9 158.49 44.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.803 -1.186 . . . . 0.0 110.616 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.63 -31.56 72.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.293 -0.879 . . . . 0.0 110.28 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.476 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 0.0 OUTLIER -61.81 -45.54 93.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.936 . . . . 0.0 110.079 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.478 ' OG ' ' HG3' ' A' ' 147' ' ' GLU . 43.0 p -63.59 -40.06 95.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.353 -0.842 . . . . 0.0 110.297 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.513 ' CG2' ' HB2' ' A' ' 145' ' ' PHE . 5.2 t -60.41 -59.06 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.096 -1.003 . . . . 0.0 109.823 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.476 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.5 OUTLIER -53.06 -41.69 65.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.103 -0.998 . . . . 0.0 109.439 179.612 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.464 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 9.7 tttt -51.83 -35.84 45.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.337 -0.852 . . . . 0.0 109.813 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.521 HG11 ' CE2' ' A' ' 120' ' ' PHE . 3.7 t -82.32 -22.5 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.277 -0.89 . . . . 0.0 110.4 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 6.7 tmm? -86.05 -24.52 26.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.869 . . . . 0.0 110.375 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 40.8 p30 -65.83 -13.18 59.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.17 -0.956 . . . . 0.0 110.162 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.58 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 8.5 tt0 -142.37 88.21 2.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.92 . . . . 0.0 109.815 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.412 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -86.49 19.4 2.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.286 -0.884 . . . . 0.0 110.594 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -87.99 58.9 5.05 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.58 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 16.4 m-70 -86.58 -168.3 2.19 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.898 -177.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.484 ' CE ' ' C ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -176.31 64.94 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.582 -0.699 . . . . 0.0 109.406 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.563 HD11 ' CG ' ' A' ' 116' ' ' TYR . 10.6 tp -89.2 147.32 24.22 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.452 -0.78 . . . . 0.0 110.228 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.44 ' OD1' ' HB3' ' A' ' 105' ' ' SER . 0.1 OUTLIER 59.91 20.31 9.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.348 -0.845 . . . . 0.0 109.66 -179.604 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.484 ' C ' ' CE ' ' A' ' 161' ' ' LYS . . . 80.57 20.1 67.03 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.11 149.48 30.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -1.167 . . . . 0.0 110.202 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.463 HG11 ' N ' ' A' ' 167' ' ' ILE . 28.9 t -67.7 163.9 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 109.963 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.528 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.1 OUTLIER -120.95 -177.54 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.175 -0.953 . . . . 0.0 111.021 -179.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -133.07 83.28 52.06 Favored Pre-proline 0 C--N 1.304 -1.391 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.36 131.31 14.95 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.267 1.667 . . . . 0.0 110.559 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.1 mmtm -145.02 -176.79 5.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.326 -0.859 . . . . 0.0 110.307 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 . . . . . 0 C--N 1.3 -1.564 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.363 179.253 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.539 ' CG ' ' HG ' ' A' ' 144' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.237 0.541 . . . . 0.0 110.505 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.542 ' HE1' ' CD1' ' A' ' 101' ' ' ILE . 7.7 ptm -115.15 176.89 4.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.296 -0.878 . . . . 0.0 109.736 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.711 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 1.2 t80 -116.55 125.52 52.0 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.351 -0.843 . . . . 0.0 110.155 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.542 ' CD1' ' HE1' ' A' ' 99' ' ' MET . 1.3 mm -110.48 92.55 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.515 -0.741 . . . . 0.0 109.081 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -94.49 125.59 8.36 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.844 -1.169 . . . . 0.0 110.233 -179.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 131.97 2.01 4.37 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.577 HD21 ' HA ' ' A' ' 140' ' ' PHE . 3.9 mm? -52.45 162.28 0.56 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.212 -1.169 . . . . 0.0 110.003 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.479 ' HB2' ' HB3' ' A' ' 163' ' ' ASN . 0.5 OUTLIER -87.33 -176.75 5.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.174 -0.954 . . . . 0.0 110.302 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -75.67 -22.92 56.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.287 -0.883 . . . . 0.0 110.282 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 29.1 p-10 -113.99 41.64 2.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.939 . . . . 0.0 110.163 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.523 HG23 ' CD1' ' A' ' 104' ' ' LEU . 0.7 OUTLIER -86.3 130.5 34.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 110.471 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.467 ' OG1' ' OD2' ' A' ' 112' ' ' ASP . 38.4 p -117.01 149.74 39.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.294 -0.879 . . . . 0.0 109.871 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.512 ' CG ' ' HA ' ' A' ' 127' ' ' THR . 3.8 mtpt -55.9 -16.36 4.58 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.182 -0.949 . . . . 0.0 110.057 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.418 ' HE2' ' HA ' ' A' ' 112' ' ' ASP . 0.3 OUTLIER -75.35 -56.68 4.48 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.183 -0.948 . . . . 0.0 110.779 -179.766 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 2.9 p30 -65.53 -34.09 77.44 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.002 -1.061 . . . . 0.0 110.915 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.536 HD13 ' CD2' ' A' ' 162' ' ' LEU . 12.4 tp -75.6 -55.44 5.66 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.986 -1.071 . . . . 0.0 109.876 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.437 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -49.17 -41.55 37.01 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.217 -0.927 . . . . 0.0 109.818 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.447 ' O ' ' C ' ' A' ' 116' ' ' TYR . 2.3 m-20 -75.83 -48.5 21.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.896 . . . . 0.0 110.218 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.572 ' CD2' HD21 ' A' ' 162' ' ' LEU . 70.1 t80 -47.15 -33.35 5.1 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.665 -1.214 . . . . 0.0 108.261 178.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.586 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 18.1 m-85 -91.2 -14.75 30.47 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.035 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 115' ' ' ASP . 40.2 t -63.45 -12.39 30.97 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.94 -1.1 . . . . 0.0 109.316 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -80.86 -13.42 58.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.475 -0.765 . . . . 0.0 110.008 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.586 ' CD1' ' HA ' ' A' ' 117' ' ' PHE . 67.4 m-85 -88.9 -36.53 15.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.249 -0.907 . . . . 0.0 109.479 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -177.44 -164.64 31.33 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.461 ' HB3' ' HG3' ' A' ' 146' ' ' LYS . 0.4 OUTLIER -88.84 108.76 19.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.188 -1.184 . . . . 0.0 110.27 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.578 HG21 ' CD1' ' A' ' 145' ' ' PHE . 1.8 t -90.3 130.06 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.234 -0.916 . . . . 0.0 111.163 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.459 ' O ' ' OD1' ' A' ' 125' ' ' ASP . 2.1 t -89.46 -23.16 6.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.473 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 3.8 m-20 -147.58 167.88 23.41 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 118.345 -1.342 . . . . 0.0 112.901 -178.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 25.9 t -169.03 148.05 4.0 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.512 ' HA ' ' CG ' ' A' ' 110' ' ' LYS . 0.9 OUTLIER -151.27 162.69 40.44 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.652 -1.219 . . . . 0.0 111.926 -177.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.504 ' O ' ' CD1' ' A' ' 128' ' ' LEU . 1.1 tm? . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.665 ' CD1' ' CZ ' ' A' ' 100' ' ' PHE . 2.6 p90 . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 121.649 0.738 . . . . 0.0 111.496 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 127' ' ' THR . . . -121.91 -175.9 15.02 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.711 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 7.2 m-85 -120.04 171.73 8.25 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.02 -1.283 . . . . 0.0 110.987 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.482 ' HB ' ' HG3' ' A' ' 99' ' ' MET . 6.4 t -140.76 129.42 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.539 ' HG ' ' CG ' ' A' ' 98' ' ' LYS . 6.3 mp -111.25 100.54 9.15 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.432 -0.792 . . . . 0.0 110.088 -178.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.578 ' CD1' HG21 ' A' ' 123' ' ' VAL . 8.1 m-85 -81.05 162.76 23.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.591 -0.693 . . . . 0.0 110.893 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.461 ' HG3' ' HB3' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -61.66 -48.86 78.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.523 -0.736 . . . . 0.0 110.073 179.225 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.459 ' OE1' ' HB3' ' A' ' 146' ' ' LYS . 1.4 pm0 -144.51 171.55 14.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.267 -0.896 . . . . 0.0 110.667 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.415 ' HA ' HG22 ' A' ' 151' ' ' VAL . 0.2 OUTLIER -55.67 -43.05 75.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.238 -0.914 . . . . 0.0 109.979 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.466 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 0.1 OUTLIER -42.1 -51.68 4.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 110.336 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 2.2 p -66.32 -36.55 83.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.199 -0.938 . . . . 0.0 110.446 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.415 HG22 ' HA ' ' A' ' 148' ' ' SER . 5.3 t -66.38 -56.65 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.074 -1.016 . . . . 0.0 110.446 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.466 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.7 OUTLIER -50.3 -38.78 43.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.141 -0.974 . . . . 0.0 109.666 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.486 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -57.33 -47.75 80.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.407 -0.808 . . . . 0.0 109.57 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.572 HG22 ' CE2' ' A' ' 145' ' ' PHE . 11.4 t -60.25 -31.98 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -0.876 . . . . 0.0 109.909 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 156' ' ' ASP . 6.4 mtt -75.5 -26.55 58.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.304 -0.872 . . . . 0.0 110.084 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.9 OUTLIER -46.71 -27.72 1.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.934 -1.104 . . . . 0.0 108.642 179.256 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.556 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 5.0 mt-30 -143.4 114.11 7.6 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.706 -0.621 . . . . 0.0 109.357 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.08 20.39 14.58 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.27 -0.894 . . . . 0.0 110.187 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -88.39 57.39 4.22 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.558 ' CE1' HG11 ' A' ' 154' ' ' VAL . 12.1 m-70 -87.13 81.76 7.91 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.327 -176.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -78.35 70.23 4.67 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.179 -0.95 . . . . 0.0 109.263 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.572 HD21 ' CD2' ' A' ' 116' ' ' TYR . 15.9 tp -87.96 145.49 25.99 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.443 -0.785 . . . . 0.0 110.235 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.479 ' HB3' ' HB2' ' A' ' 105' ' ' SER . 0.8 OUTLIER 58.09 22.62 9.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.349 -0.845 . . . . 0.0 109.661 -179.584 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 75.83 22.59 74.28 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.93 144.63 26.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -1.108 . . . . 0.0 110.319 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 160' ' ' HIS . 3.8 t -78.27 160.87 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 109.674 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.498 ' CG1' ' HB2' ' A' ' 160' ' ' HIS . 1.3 pt -123.58 -174.98 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.114 -0.991 . . . . 0.0 111.046 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.55 ' N ' ' O ' ' A' ' 102' ' ' GLY . 5.6 t70 -128.91 89.81 47.71 Favored Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.71 125.52 9.54 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.399 1.736 . . . . 0.0 110.655 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -150.27 -164.02 1.92 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.453 -0.779 . . . . 0.0 110.215 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.56 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.179 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.538 ' HG2' ' CD1' ' A' ' 144' ' ' LEU . 2.8 mtpp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.214 0.53 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.585 ' CE ' ' CD1' ' A' ' 101' ' ' ILE . 17.4 ttp -147.17 154.66 41.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.21 -0.931 . . . . 0.0 110.105 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.694 ' CE2' ' CZ ' ' A' ' 142' ' ' PHE . 2.3 t80 -110.15 135.4 51.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.359 -0.838 . . . . 0.0 109.994 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.585 ' CD1' ' CE ' ' A' ' 99' ' ' MET . 3.6 mm -112.87 97.66 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.28 -0.888 . . . . 0.0 109.48 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.537 ' HA2' ' CB ' ' A' ' 140' ' ' PHE . . . -89.36 109.32 3.58 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 134.06 36.86 0.24 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.549 ' CD1' HG22 ' A' ' 108' ' ' THR . 0.4 OUTLIER -83.68 149.22 26.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.335 -1.097 . . . . 0.0 109.442 179.507 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.417 ' CB ' ' OG1' ' A' ' 108' ' ' THR . 0.0 OUTLIER -69.8 146.24 51.55 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.054 -1.029 . . . . 0.0 109.545 179.478 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -62.03 -11.2 12.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.271 -0.893 . . . . 0.0 110.115 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.61 16.22 13.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.251 -0.906 . . . . 0.0 110.595 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.549 HG22 ' CD1' ' A' ' 104' ' ' LEU . 11.0 m -70.27 174.43 5.6 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.122 -0.986 . . . . 0.0 110.408 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.463 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 31.2 p -148.39 154.32 39.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.384 -0.822 . . . . 0.0 109.575 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 114' ' ' LYS . 13.7 mtmt -57.97 -16.86 13.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.337 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.47 -62.02 1.77 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.192 -0.942 . . . . 0.0 111.172 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 6.6 p30 -57.94 -28.37 64.23 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.038 -1.039 . . . . 0.0 110.775 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.521 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 16.0 tp -78.86 -40.53 32.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.983 -1.073 . . . . 0.0 109.696 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 110' ' ' LYS . 3.9 ttpt -55.37 -59.26 5.05 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.123 -0.986 . . . . 0.0 109.711 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.471 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 63.3 m-20 -61.78 -40.83 96.54 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.2 -0.937 . . . . 0.0 109.213 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.573 ' CG ' HD22 ' A' ' 162' ' ' LEU . 69.8 t80 -47.35 -40.48 17.42 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.203 177.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.497 ' CD1' ' CE2' ' A' ' 120' ' ' PHE . 27.0 m-85 -91.6 -4.56 55.16 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.673 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.471 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 1.4 m -70.16 -6.36 33.69 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.783 -1.198 . . . . 0.0 109.221 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.414 ' HA ' ' HE3' ' A' ' 119' ' ' LYS . 0.5 OUTLIER -80.46 -18.66 48.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.367 -0.833 . . . . 0.0 110.23 -179.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.543 ' CG ' ' CG2' ' A' ' 154' ' ' VAL . 70.1 m-85 -89.49 -68.35 0.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.675 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -147.43 -165.11 11.61 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.47 ' O ' ' CB ' ' A' ' 146' ' ' LYS . 0.6 OUTLIER -90.3 119.82 30.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.159 -1.201 . . . . 0.0 110.863 -179.706 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.511 ' CG1' ' O ' ' A' ' 125' ' ' ASP . 1.9 t -91.96 132.34 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -0.856 . . . . 0.0 110.244 179.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.406 HG11 ' OD2' ' A' ' 125' ' ' ASP . 2.1 t -89.07 -26.88 5.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.511 ' O ' ' CG1' ' A' ' 123' ' ' VAL . 1.4 m-20 -145.63 167.25 23.53 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.226 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.414 ' SG ' HD22 ' A' ' 113' ' ' LEU . 42.3 t -165.74 150.35 8.47 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.636 -0.665 . . . . 0.0 109.363 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.519 ' CG2' ' N ' ' A' ' 128' ' ' LEU . 0.9 OUTLIER -149.95 174.08 13.1 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.368 -0.833 . . . . 0.0 109.862 -179.099 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.527 ' C ' ' CD1' ' A' ' 128' ' ' LEU . 2.8 pp . . . . . 0 C--N 1.302 -1.46 0 O-C-N 121.426 -0.796 . . . . 0.0 110.068 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.594 ' CD1' ' CZ ' ' A' ' 100' ' ' PHE . 42.2 p90 . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 121.144 0.497 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.514 ' CA ' ' HA ' ' A' ' 128' ' ' LEU . . . -162.7 -164.64 18.16 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.694 ' CZ ' ' CE2' ' A' ' 100' ' ' PHE . 28.1 m-85 -140.37 167.19 22.74 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.893 -1.357 . . . . 0.0 111.27 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.471 ' C ' ' CD2' ' A' ' 144' ' ' LEU . 3.0 t -148.99 133.75 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.538 ' CD1' ' HG2' ' A' ' 98' ' ' LYS . 3.2 mm? -116.12 94.33 4.61 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.665 -0.647 . . . . 0.0 109.569 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.591 ' CE2' HG22 ' A' ' 154' ' ' VAL . 9.1 m-85 -73.0 161.18 30.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.418 -0.801 . . . . 0.0 110.992 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.47 ' CB ' ' O ' ' A' ' 122' ' ' GLU . 18.0 tptt -80.71 -39.4 27.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.594 -0.691 . . . . 0.0 111.182 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.519 ' OE2' ' CB ' ' A' ' 149' ' ' GLU . 0.7 OUTLIER -133.66 158.48 43.13 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.853 -1.154 . . . . 0.0 110.851 -179.305 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 78.0 p -63.23 -27.7 69.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 109.964 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.519 ' CB ' ' OE2' ' A' ' 147' ' ' GLU . 0.3 OUTLIER -64.41 -43.47 94.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.371 -0.83 . . . . 0.0 109.761 179.721 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.494 ' CB ' ' HA3' ' A' ' 121' ' ' GLY . 11.5 p -64.46 -41.18 96.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.109 -0.994 . . . . 0.0 109.653 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.526 HG21 ' CB ' ' A' ' 145' ' ' PHE . 2.9 t -65.46 -45.44 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.635 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.449 ' OD2' ' O ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -54.23 -36.02 63.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.125 -0.984 . . . . 0.0 109.182 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.471 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 6.7 tttt -62.88 -43.58 98.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.469 -0.769 . . . . 0.0 109.379 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.591 HG22 ' CE2' ' A' ' 145' ' ' PHE . 20.5 t -64.7 -42.18 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.294 -0.879 . . . . 0.0 110.09 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 2.8 ttp -71.75 -21.71 61.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.331 -0.856 . . . . 0.0 109.944 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.0 OUTLIER -52.26 -31.49 32.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.14 -0.975 . . . . 0.0 109.423 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.526 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 0.8 OUTLIER -147.97 108.36 4.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.46 -0.775 . . . . 0.0 109.819 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.438 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -87.8 36.14 0.75 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.216 -0.928 . . . . 0.0 110.71 -179.658 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -89.33 48.96 1.68 Allowed 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 176.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.558 ' HB2' HG13 ' A' ' 167' ' ' ILE . 17.8 m-70 -87.68 93.75 9.53 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.267 -177.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -103.07 87.19 2.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 0.0 110.215 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.573 HD22 ' CG ' ' A' ' 116' ' ' TYR . 0.4 OUTLIER -90.48 141.67 28.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.169 -0.957 . . . . 0.0 109.64 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 15.1 m120 50.42 23.78 1.37 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.138 -0.977 . . . . 0.0 110.215 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.72 37.25 26.98 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.96 136.24 18.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.165 -1.197 . . . . 0.0 110.272 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 160' ' ' HIS . 34.9 t -81.59 164.74 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.24 -0.913 . . . . 0.0 110.154 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.558 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.6 OUTLIER -128.68 174.17 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.186 -0.946 . . . . 0.0 110.709 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 102' ' ' GLY . 16.1 t0 -119.97 94.34 48.51 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.96 111.86 3.27 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.158 1.61 . . . . 0.0 110.83 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.536 ' O ' ' CG ' ' A' ' 99' ' ' MET . 2.1 mttt -125.72 152.87 44.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.572 -0.705 . . . . 0.0 109.652 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.296 -1.734 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.987 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.472 ' HG2' HD22 ' A' ' 144' ' ' LEU . 3.7 mtpp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.271 0.558 . . . . 0.0 110.294 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.549 ' HE1' ' CD1' ' A' ' 101' ' ' ILE . 4.0 ptm -141.41 170.11 16.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.334 -0.854 . . . . 0.0 109.98 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.723 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 2.2 t80 -112.96 142.84 45.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.907 . . . . 0.0 110.489 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.549 ' CD1' ' HE1' ' A' ' 99' ' ' MET . 15.9 mm -131.22 99.14 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.306 -0.871 . . . . 0.0 109.548 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -99.83 132.85 11.08 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.809 -1.186 . . . . 0.0 110.557 -179.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 166' ' ' VAL . . . 127.9 28.03 0.9 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.531 ' CD1' HG22 ' A' ' 108' ' ' THR . 3.4 mm? -87.97 167.5 13.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.004 -1.292 . . . . 0.0 110.082 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.438 ' N ' ' OG1' ' A' ' 108' ' ' THR . 3.1 p -88.43 144.48 26.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.857 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 15.7 m-90 -45.74 -21.38 0.11 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.153 -0.967 . . . . 0.0 110.422 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 105' ' ' SER . 4.6 t0 -112.29 44.57 1.41 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.842 -1.162 . . . . 0.0 110.103 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.531 HG22 ' CD1' ' A' ' 104' ' ' LEU . 87.6 m -90.67 167.74 12.29 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.145 -0.972 . . . . 0.0 110.713 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.443 ' N ' HG23 ' A' ' 108' ' ' THR . 64.1 p -146.42 152.09 38.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.379 -0.826 . . . . 0.0 109.862 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 114' ' ' LYS . 7.6 pttm -63.7 -11.95 30.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.125 -0.984 . . . . 0.0 109.482 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.59 -56.23 4.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.373 -0.83 . . . . 0.0 110.525 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.427 ' OD1' ' C ' ' A' ' 112' ' ' ASP . 0.6 OUTLIER -63.74 -36.76 84.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.118 -0.989 . . . . 0.0 109.938 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.462 HD11 HD13 ' A' ' 104' ' ' LEU . 3.6 tp -73.49 -45.16 55.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 109.746 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 5.8 ttpt -57.11 -38.88 74.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.296 -0.878 . . . . 0.0 109.555 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 118' ' ' SER . 83.8 m-20 -74.08 -49.77 22.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.239 -0.913 . . . . 0.0 109.736 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.422 ' C ' ' O ' ' A' ' 115' ' ' ASP . 65.2 t80 -47.75 -33.2 6.77 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 118.669 -1.212 . . . . 0.0 108.154 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.597 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 17.1 m-85 -91.03 -11.92 37.36 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.972 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 115' ' ' ASP . 0.4 OUTLIER -64.34 -13.17 48.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.005 -1.059 . . . . 0.0 109.133 179.06 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -80.44 -13.2 59.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.432 -0.793 . . . . 0.0 109.839 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.597 ' CD1' ' HA ' ' A' ' 117' ' ' PHE . 64.1 m-85 -89.45 -64.27 1.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.298 -0.877 . . . . 0.0 109.48 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.406 ' HA3' ' HB3' ' A' ' 150' ' ' SER . . . -153.19 -170.36 19.33 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -85.27 119.87 26.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.182 -1.187 . . . . 0.0 110.24 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.54 HG21 ' CD1' ' A' ' 145' ' ' PHE . 1.9 t -93.92 130.08 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.144 -0.972 . . . . 0.0 111.048 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.405 ' O ' ' OD1' ' A' ' 125' ' ' ASP . 2.2 t -89.37 -26.02 5.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.491 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 2.2 m-20 -143.98 161.61 38.3 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.24 -0.984 . . . . 0.0 111.704 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 45.1 t -166.27 120.76 1.15 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.635 -0.665 . . . . 0.0 109.302 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.481 HG21 ' N ' ' A' ' 128' ' ' LEU . 0.8 OUTLIER -114.52 167.99 10.25 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.384 -0.822 . . . . 0.0 110.294 -179.063 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.581 ' O ' ' CD1' ' A' ' 128' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 110.766 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.523 ' HB2' ' HA2' ' A' ' 102' ' ' GLY . 18.9 p90 . . . . . 0 N--CA 1.497 1.919 0 CA-C-O 121.619 0.724 . . . . 0.0 111.416 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.525 ' CA ' ' HA ' ' A' ' 128' ' ' LEU . . . -129.04 170.6 20.11 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.723 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 6.6 m-85 -114.31 173.05 6.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -1.149 . . . . 0.0 110.763 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.472 ' HB ' ' HE1' ' A' ' 99' ' ' MET . 13.8 t -146.18 137.51 19.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.491 ' HB2' ' CB ' ' A' ' 125' ' ' ASP . 5.8 mp -123.12 101.18 7.25 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.416 -0.803 . . . . 0.0 109.727 -179.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.552 ' CE2' HG22 ' A' ' 154' ' ' VAL . 18.7 m-85 -75.53 152.43 37.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.369 -0.832 . . . . 0.0 110.245 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.23 -25.59 55.22 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.426 -0.796 . . . . 0.0 111.087 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.496 ' O ' ' OG ' ' A' ' 150' ' ' SER . 11.9 tt0 -133.04 147.36 52.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.677 -1.264 . . . . 0.0 110.765 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.442 ' N ' ' HG2' ' A' ' 147' ' ' GLU . 7.4 t -56.47 -45.87 80.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.086 -1.009 . . . . 0.0 109.442 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.498 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 14.1 tt0 -49.75 -60.99 2.38 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.498 -0.751 . . . . 0.0 109.993 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 0.2 OUTLIER -43.23 -39.72 3.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.19 -0.944 . . . . 0.0 109.716 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.535 HG21 ' CB ' ' A' ' 145' ' ' PHE . 5.3 t -66.2 -51.05 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.899 . . . . 0.0 110.262 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.498 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.3 OUTLIER -52.16 -27.18 13.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.133 -0.979 . . . . 0.0 109.924 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.459 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 5.8 mmtt -72.67 -49.42 31.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.459 -0.776 . . . . 0.0 110.317 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.552 HG22 ' CE2' ' A' ' 145' ' ' PHE . 5.6 t -63.93 -18.7 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.097 -1.002 . . . . 0.0 110.339 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 12.7 mmt -85.53 -38.23 18.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.121 -0.987 . . . . 0.0 110.489 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.2 OUTLIER -48.67 -34.64 12.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.118 -0.989 . . . . 0.0 110.233 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.529 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.6 mt-30 -128.51 94.89 3.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.312 -0.867 . . . . 0.0 110.013 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.574 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -90.39 21.84 3.69 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.154 -0.966 . . . . 0.0 110.412 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.554 ' CG ' ' O ' ' A' ' 159' ' ' GLU . 2.1 tt0 -88.39 67.21 8.58 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 177.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.574 ' CD2' ' HA ' ' A' ' 158' ' ' LYS . 87.3 m-70 -86.41 176.5 7.84 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.266 -177.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 160' ' ' HIS . 0.3 OUTLIER 179.62 74.3 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.487 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.46 ' O ' ' CB ' ' A' ' 163' ' ' ASN . 1.4 pp -110.95 153.99 24.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.405 -0.809 . . . . 0.0 110.326 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 162' ' ' LEU . 0.3 OUTLIER 67.09 8.56 6.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.378 -0.826 . . . . 0.0 109.859 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.448 ' O ' ' HG2' ' A' ' 165' ' ' LYS . . . 89.38 18.14 53.51 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 164' ' ' GLY . 37.5 mmtt -150.28 161.45 42.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.129 -1.218 . . . . 0.0 110.353 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 160' ' ' HIS . 4.2 p -87.14 177.36 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.355 -0.841 . . . . 0.0 110.232 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.539 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.6 OUTLIER -135.29 -168.05 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.216 -0.928 . . . . 0.0 110.943 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 102' ' ' GLY . 8.4 t70 -143.04 87.05 8.9 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.444 ' HA ' HD11 ' A' ' 101' ' ' ILE . 43.8 Cg_endo -71.88 131.69 18.73 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.314 1.691 . . . . 0.0 110.73 -178.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.82 166.25 27.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.443 -0.785 . . . . 0.0 110.26 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 . . . . . 0 C--N 1.3 -1.548 0 C-N-CA 119.264 -0.975 . . . . 0.0 109.869 178.631 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.5 ' HA ' ' HG ' ' A' ' 144' ' ' LEU . 70.0 mttt . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.143 0.496 . . . . 0.0 110.026 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.465 ' SD ' ' HA ' ' A' ' 171' ' ' ARG . 10.2 mmm -142.19 177.42 8.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 110.763 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.741 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 3.6 t80 -132.85 142.51 48.99 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.544 -0.722 . . . . 0.0 110.203 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.541 HG13 ' CG2' ' A' ' 143' ' ' VAL . 4.2 mm -125.57 98.86 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.293 -0.879 . . . . 0.0 109.792 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -98.82 130.07 10.1 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 134.15 3.53 3.13 Favored Glycine 0 N--CA 1.492 2.383 0 O-C-N 121.123 -1.222 . . . . 0.0 110.163 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.483 ' HB2' ' CA ' ' A' ' 140' ' ' PHE . 6.7 mp -64.86 166.16 9.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.073 -1.251 . . . . 0.0 110.186 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.6 p -90.72 -174.56 4.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.297 -0.877 . . . . 0.0 109.793 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -87.48 16.82 5.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.0 109.968 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -144.56 16.61 1.65 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.309 -0.87 . . . . 0.0 110.454 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.457 HG21 ' OD1' ' A' ' 112' ' ' ASP . 11.3 m -73.43 168.16 19.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.939 -1.101 . . . . 0.0 109.78 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.467 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 29.8 p -144.6 152.04 39.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.134 -0.979 . . . . 0.0 110.604 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.436 ' O ' ' HB3' ' A' ' 114' ' ' LYS . 4.2 ttpt -53.51 -19.61 3.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.141 -0.974 . . . . 0.0 109.578 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.1 OUTLIER -72.12 -55.1 7.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.394 -0.817 . . . . 0.0 110.285 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 109' ' ' THR . 0.4 OUTLIER -65.71 -33.14 75.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.124 -0.985 . . . . 0.0 109.95 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.501 HD13 ' CD2' ' A' ' 162' ' ' LEU . 5.7 tp -73.85 -51.7 15.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 109.804 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 110' ' ' LYS . 1.1 ttpm? -60.0 -39.37 85.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 110.155 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 111' ' ' LYS . 0.5 OUTLIER -76.33 -54.38 6.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.081 -1.012 . . . . 0.0 110.572 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.466 ' HB2' HD12 ' A' ' 162' ' ' LEU . 65.4 t80 -46.39 -32.49 3.25 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.683 -1.207 . . . . 0.0 108.302 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.596 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 17.4 m-85 -91.23 -13.54 32.62 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.894 -0.723 . . . . 0.0 111.302 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 115' ' ' ASP . 5.7 t -64.11 -11.26 28.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.946 -1.096 . . . . 0.0 109.424 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.418 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 0.8 OUTLIER -83.83 -12.41 55.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.411 -0.805 . . . . 0.0 110.545 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.596 ' CD1' ' HA ' ' A' ' 117' ' ' PHE . 81.6 m-85 -89.03 -50.05 6.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.063 -1.023 . . . . 0.0 109.354 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.532 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -164.89 -164.73 20.88 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.408 ' O ' ' CB ' ' A' ' 146' ' ' LYS . 1.2 tt0 -90.12 107.67 19.27 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.388 -1.066 . . . . 0.0 110.086 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.506 HG21 ' CD1' ' A' ' 145' ' ' PHE . 1.8 t -89.46 132.34 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 111.19 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.454 HG11 ' OD1' ' A' ' 125' ' ' ASP . 2.4 t -90.15 -23.34 6.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.539 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 0.4 OUTLIER -143.51 158.98 43.23 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 118.525 -1.27 . . . . 0.0 112.848 -178.801 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.43 ' SG ' HD22 ' A' ' 113' ' ' LEU . 6.2 t -169.24 147.76 3.81 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.463 ' CG2' ' N ' ' A' ' 128' ' ' LEU . 0.8 OUTLIER -150.8 169.96 20.42 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.992 -1.067 . . . . 0.0 110.828 -178.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.516 ' C ' ' CD1' ' A' ' 128' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.662 -0.649 . . . . 0.0 109.473 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.483 ' CA ' ' HB2' ' A' ' 104' ' ' LEU . 13.9 p90 . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.306 0.574 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.491 ' HA3' ' HA ' ' A' ' 128' ' ' LEU . . . -126.61 -165.8 12.05 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.741 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 10.7 m-85 -129.45 168.6 16.1 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.415 -1.05 . . . . 0.0 110.414 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.541 ' CG2' HG13 ' A' ' 101' ' ' ILE . 3.5 t -145.66 144.95 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.418 -0.801 . . . . 0.0 109.378 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.539 ' HB2' ' CB ' ' A' ' 125' ' ' ASP . 4.5 mp -134.09 98.31 4.1 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.565 -0.709 . . . . 0.0 109.828 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.506 ' CD1' HG21 ' A' ' 123' ' ' VAL . 38.2 m-85 -76.4 160.45 29.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.528 -0.732 . . . . 0.0 110.47 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.408 ' CB ' ' O ' ' A' ' 122' ' ' GLU . 4.6 tttm -104.0 -3.07 25.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.484 -0.76 . . . . 0.0 111.011 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.51 ' OE1' ' CB ' ' A' ' 149' ' ' GLU . 1.1 tt0 -139.97 145.41 37.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.865 -1.147 . . . . 0.0 110.706 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.5 p -59.95 -36.5 77.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.99 -1.069 . . . . 0.0 109.296 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.51 ' CB ' ' OE1' ' A' ' 147' ' ' GLU . 0.4 OUTLIER -63.06 -53.99 45.07 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.425 -0.797 . . . . 0.0 109.792 179.398 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.532 ' CB ' ' HA3' ' A' ' 121' ' ' GLY . 60.9 p -48.59 -34.32 11.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.076 -1.015 . . . . 0.0 109.664 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.464 ' O ' HG11 ' A' ' 154' ' ' VAL . 3.4 t -78.55 -47.7 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.416 -0.803 . . . . 0.0 110.185 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -61.23 -22.28 64.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.968 -1.082 . . . . 0.0 109.336 179.775 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.474 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -76.19 -58.8 3.07 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.441 -0.787 . . . . 0.0 109.866 179.597 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.591 ' HA ' ' CE2' ' A' ' 120' ' ' PHE . 5.3 p -55.6 -20.9 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.048 -1.032 . . . . 0.0 109.979 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.47 ' N ' HG11 ' A' ' 154' ' ' VAL . 2.6 ttp -88.06 -29.96 20.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.408 -0.808 . . . . 0.0 110.384 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.474 ' OD2' ' O ' ' A' ' 153' ' ' LYS . 0.2 OUTLIER -53.78 -36.46 62.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 109.705 179.964 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.584 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 0.7 OUTLIER -128.5 97.51 4.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.352 -0.843 . . . . 0.0 109.509 179.634 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -88.2 10.5 19.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.245 -0.91 . . . . 0.0 110.757 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.451 ' CG ' ' O ' ' A' ' 159' ' ' GLU . 3.2 pt-20 -87.38 68.51 9.76 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 11.6 m-70 -87.75 -167.38 1.86 Allowed 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.613 -177.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -176.44 73.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.512 -0.743 . . . . 0.0 109.818 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.501 ' CD2' HD13 ' A' ' 113' ' ' LEU . 10.1 tp -88.56 134.75 33.78 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.285 -0.885 . . . . 0.0 110.127 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.451 ' OD1' HG21 ' A' ' 108' ' ' THR . 2.3 m120 58.21 24.48 11.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.83 . . . . 0.0 109.961 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 75.9 33.29 51.17 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.75 134.23 16.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -1.184 . . . . 0.0 110.527 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 75.5 t -65.37 162.22 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 109.742 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.474 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -126.41 177.56 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.104 -0.998 . . . . 0.0 110.79 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 102' ' ' GLY . 23.8 t0 -124.18 90.1 51.13 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.84 113.37 3.74 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.313 1.691 . . . . 0.0 111.339 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.46 ' O ' ' SD ' ' A' ' 99' ' ' MET . 24.6 mmtt -131.29 169.15 16.37 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.542 -0.724 . . . . 0.0 109.334 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.465 ' HA ' ' SD ' ' A' ' 99' ' ' MET . 5.8 mtp85 . . . . . 0 C--N 1.296 -1.73 0 C-N-CA 118.499 -1.28 . . . . 0.0 109.806 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.479 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 12.8 mttt . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.207 0.527 . . . . 0.0 109.816 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.528 ' HE1' ' CD1' ' A' ' 101' ' ' ILE . 10.9 ptm -126.05 175.25 7.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.086 -1.009 . . . . 0.0 110.475 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.709 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 1.6 t80 -121.38 122.85 40.73 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.528 ' CD1' ' HE1' ' A' ' 99' ' ' MET . 3.7 mm -108.36 96.91 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 109.382 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.489 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -89.61 98.4 2.44 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 156.87 36.52 0.02 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.505 HD11 ' CG2' ' A' ' 108' ' ' THR . 3.5 mm? -90.45 155.67 18.76 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.181 -1.188 . . . . 0.0 110.007 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.485 ' N ' ' OG1' ' A' ' 108' ' ' THR . 0.0 OUTLIER -78.45 -171.98 2.69 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.205 -0.934 . . . . 0.0 109.754 179.543 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.415 ' N ' ' OG ' ' A' ' 105' ' ' SER . 7.1 m0 -84.0 -17.77 39.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.02 -1.05 . . . . 0.0 110.32 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -122.84 31.02 6.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.909 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.505 ' CG2' HD11 ' A' ' 104' ' ' LEU . 6.9 m -76.69 149.98 36.38 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.384 -0.822 . . . . 0.0 110.406 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.467 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 28.3 p -130.18 149.14 52.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.352 -0.843 . . . . 0.0 109.961 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.48 ' HG2' ' N ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -57.64 -17.78 16.58 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.127 -0.983 . . . . 0.0 109.16 179.256 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.48 ' N ' ' HG2' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -65.71 -58.61 5.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.502 -0.748 . . . . 0.0 109.978 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 109' ' ' THR . 1.7 p-10 -67.48 -42.49 82.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.105 -0.997 . . . . 0.0 110.097 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.465 HD22 HG22 ' A' ' 143' ' ' VAL . 26.2 tp -60.54 -48.46 81.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 109.703 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.522 ' CD ' HG13 ' A' ' 123' ' ' VAL . 27.6 ttpt -58.29 -31.97 67.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.313 -0.867 . . . . 0.0 109.748 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 118' ' ' SER . 86.8 m-20 -78.03 -54.31 6.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.274 -0.891 . . . . 0.0 110.199 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.454 ' C ' ' O ' ' A' ' 115' ' ' ASP . 62.7 t80 -47.18 -31.52 3.66 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 118.586 -1.246 . . . . 0.0 108.066 178.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.596 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 16.7 m-85 -90.35 -16.28 29.49 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.836 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 115' ' ' ASP . 22.4 t -61.45 -15.92 41.93 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.894 -1.129 . . . . 0.0 108.536 178.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.23 -18.01 61.28 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.533 0.682 . . . . 0.0 109.834 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.596 ' CD1' ' HA ' ' A' ' 117' ' ' PHE . 55.2 m-85 -89.48 -58.47 2.51 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.623 0.725 . . . . 0.0 109.414 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.32 -162.96 12.0 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -90.58 135.08 33.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.962 -1.316 . . . . 0.0 110.005 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.522 HG13 ' CD ' ' A' ' 114' ' ' LYS . 1.9 t -109.19 132.83 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.223 -0.923 . . . . 0.0 110.744 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.23 -26.24 5.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.409 ' CB ' HD21 ' A' ' 144' ' ' LEU . 6.7 m-20 -148.76 162.94 38.76 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 118.715 -1.194 . . . . 0.0 112.413 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 11.6 t -164.94 143.42 6.53 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.523 ' CG2' ' N ' ' A' ' 128' ' ' LEU 0.25 1.0 OUTLIER -150.71 170.96 17.95 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 118.679 -1.209 . . . . 0.0 112.093 -177.318 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.523 ' N ' ' CG2' ' A' ' 127' ' ' THR . 8.5 tp . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.608 ' CD2' ' CZ ' ' A' ' 100' ' ' PHE . 18.7 p90 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.148 0.499 . . . . 0.0 110.68 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 128' ' ' LEU . . . -147.52 -164.11 11.02 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.709 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 14.6 m-85 -130.19 172.21 12.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.157 -1.201 . . . . 0.0 111.348 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.524 ' HB ' ' CG ' ' A' ' 99' ' ' MET . 3.9 t -146.47 145.58 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.479 ' HG ' ' HG2' ' A' ' 98' ' ' LYS . 5.3 mp -130.59 106.03 8.23 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.984 -1.072 . . . . 0.0 109.898 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.462 ' CB ' HG21 ' A' ' 151' ' ' VAL . 15.9 m-85 -78.82 166.28 22.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.501 -0.75 . . . . 0.0 111.046 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -80.9 -31.97 34.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.696 -0.627 . . . . 0.0 110.408 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.477 ' O ' ' OG ' ' A' ' 150' ' ' SER . 0.3 OUTLIER -143.09 152.03 41.4 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.108 -0.995 . . . . 0.0 110.64 -179.619 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.421 ' HA ' HG22 ' A' ' 151' ' ' VAL . 1.5 m -50.88 -41.0 57.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.915 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.488 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 2.8 tt0 -48.51 -62.92 1.25 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.326 -0.859 . . . . 0.0 110.159 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 4.4 p -48.14 -36.07 12.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.0 109.947 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.479 ' O ' HG11 ' A' ' 154' ' ' VAL . 4.6 t -68.56 -52.71 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.12 -0.988 . . . . 0.0 110.362 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.488 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -57.75 -35.1 70.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.974 -1.079 . . . . 0.0 109.783 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.47 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.1 OUTLIER -65.69 -33.82 76.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.368 -0.832 . . . . 0.0 110.162 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.591 HG21 ' CE2' ' A' ' 120' ' ' PHE . 5.9 p -87.86 -19.6 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.025 -1.047 . . . . 0.0 110.336 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.504 ' N ' HG11 ' A' ' 154' ' ' VAL . 24.8 ttt -89.09 -25.76 21.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.946 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 4.5 p-10 -52.37 -32.24 37.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -0.903 . . . . 0.0 109.618 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.558 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -131.4 90.0 2.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.344 -0.848 . . . . 0.0 109.595 179.572 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.406 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -83.97 18.18 2.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.151 -0.968 . . . . 0.0 111.011 -179.482 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -87.68 64.3 7.95 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 177.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.558 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 14.1 m170 -87.05 -169.84 2.8 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.11 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 160' ' ' HIS . 5.9 ttpt 177.55 66.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.468 HD22 HG12 ' A' ' 167' ' ' ILE . 1.3 pp -101.67 157.85 16.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.844 . . . . 0.0 110.105 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 59.5 15.33 4.43 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.163 -0.961 . . . . 0.0 109.461 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.51 21.44 64.32 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.5 146.59 26.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -1.174 . . . . 0.0 110.715 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 51.1 t -76.99 176.39 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.418 -0.801 . . . . 0.0 109.088 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.519 HD13 ' ND1' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -143.16 166.45 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.904 -1.122 . . . . 0.0 111.544 -179.458 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -115.55 82.88 10.35 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 45.1 Cg_endo -72.9 130.28 15.41 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.214 1.639 . . . . 0.0 111.155 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.1 -164.88 2.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.581 -0.699 . . . . 0.0 110.046 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.299 -1.614 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.06 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.436 ' HA ' ' HG ' ' A' ' 144' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.226 0.536 . . . . 0.0 110.183 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.548 ' CE ' ' O ' ' A' ' 170' ' ' LYS . 6.4 mtp -143.11 173.89 11.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.148 -0.97 . . . . 0.0 110.432 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.691 ' CE2' ' CZ ' ' A' ' 142' ' ' PHE . 2.4 t80 -122.84 134.92 54.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.608 -0.683 . . . . 0.0 110.575 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.521 HG13 ' CG2' ' A' ' 143' ' ' VAL . 15.1 mm -122.68 106.73 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.27 -0.894 . . . . 0.0 109.73 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -103.21 119.38 6.38 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.713 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 128.53 47.83 0.16 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.521 ' CD1' HG22 ' A' ' 108' ' ' THR . 2.3 mm? -90.56 167.67 12.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.118 -1.225 . . . . 0.0 110.354 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.513 ' HB3' ' CB ' ' A' ' 163' ' ' ASN . 0.4 OUTLIER -90.16 138.9 31.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.272 -0.893 . . . . 0.0 110.19 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -44.96 -22.77 0.1 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.881 -1.137 . . . . 0.0 110.718 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 105' ' ' SER . 6.7 t0 -114.86 38.53 3.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.106 -0.996 . . . . 0.0 111.134 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.521 HG22 ' CD1' ' A' ' 104' ' ' LEU . 1.5 m -87.36 161.85 17.68 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.74 -1.225 . . . . 0.0 109.998 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 69.3 p -139.82 154.54 47.36 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.42 -0.8 . . . . 0.0 109.867 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 126' ' ' CYS . 4.9 mttp -58.85 -14.33 8.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.134 -0.979 . . . . 0.0 110.134 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.41 ' HE2' ' HE2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -81.04 -55.82 4.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.861 . . . . 0.0 110.702 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -63.38 -44.29 95.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.003 -1.061 . . . . 0.0 110.466 -179.491 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.524 HD23 ' CG2' ' A' ' 143' ' ' VAL . 0.6 OUTLIER -65.72 -46.89 77.22 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.895 -1.128 . . . . 0.0 109.586 179.681 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.454 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 7.2 ttpp -54.1 -40.78 67.59 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.146 -0.971 . . . . 0.0 109.82 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 116' ' ' TYR . 69.7 m-20 -75.38 -47.27 28.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 109.707 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.634 ' CZ ' ' CD2' ' A' ' 162' ' ' LEU . 52.7 t80 -47.51 -34.65 7.79 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 118.841 -1.144 . . . . 0.0 108.089 178.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.511 ' CE2' HG23 ' A' ' 143' ' ' VAL . 11.5 m-85 -91.2 -13.78 32.23 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.116 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 115' ' ' ASP . 7.2 m -64.87 -12.67 51.32 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.76 -1.212 . . . . 0.0 108.431 178.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.42 -26.69 61.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.581 -0.699 . . . . 0.0 110.39 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.492 ' CE1' HG21 ' A' ' 154' ' ' VAL . 28.2 m-85 -88.67 -57.19 3.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.094 -1.004 . . . . 0.0 109.197 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -159.52 167.52 35.16 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.31 156.52 22.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.138 -1.213 . . . . 0.0 109.913 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.441 HG11 ' O ' ' A' ' 125' ' ' ASP . 1.7 t -125.27 129.91 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.179 -0.951 . . . . 0.0 110.922 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.523 ' CG2' ' HG2' ' A' ' 146' ' ' LYS . 2.2 t -89.64 -25.34 5.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.522 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 2.7 m-20 -140.61 161.45 37.72 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.773 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.489 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 6.8 t -169.95 128.49 0.91 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.666 0.746 . . . . 0.0 109.708 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.412 ' OG1' ' HB2' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -125.88 146.74 49.7 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.605 -0.684 . . . . 0.0 110.875 -178.502 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.49 ' O ' ' CD1' ' A' ' 128' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 110.083 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.499 ' HB2' ' HA2' ' A' ' 102' ' ' GLY . 1.7 p90 . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.034 0.445 . . . . 0.0 110.545 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -159.68 177.94 35.98 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.691 ' CZ ' ' CE2' ' A' ' 100' ' ' PHE . 19.4 m-85 -113.57 171.26 7.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.117 -1.225 . . . . 0.0 110.754 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.524 ' CG2' HD23 ' A' ' 113' ' ' LEU . 25.1 t -148.89 127.72 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.553 -0.717 . . . . 0.0 109.351 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.522 ' HB2' ' CB ' ' A' ' 125' ' ' ASP . 6.6 mp -115.96 103.95 11.11 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.546 -0.721 . . . . 0.0 110.214 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.466 ' HB2' ' CG2' ' A' ' 151' ' ' VAL . 46.0 m-85 -75.73 162.3 28.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.575 -0.703 . . . . 0.0 110.417 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.523 ' HG2' ' CG2' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -85.29 -23.61 28.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.535 -0.728 . . . . 0.0 111.117 -179.303 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.53 ' OE1' ' CB ' ' A' ' 149' ' ' GLU . 0.6 OUTLIER -128.78 158.75 37.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.747 -1.221 . . . . 0.0 110.988 -179.568 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.3 p -71.88 -44.49 63.66 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.318 -0.864 . . . . 0.0 109.335 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.53 ' CB ' ' OE1' ' A' ' 147' ' ' GLU . 0.3 OUTLIER -55.87 -40.57 73.12 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.415 -0.803 . . . . 0.0 109.54 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.486 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 1.4 p -62.47 -34.19 76.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.153 -0.967 . . . . 0.0 109.356 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.483 ' O ' HG11 ' A' ' 154' ' ' VAL . 5.2 t -73.93 -52.89 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.213 -0.93 . . . . 0.0 110.216 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.469 ' OD2' ' O ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -51.49 -38.52 54.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.01 -1.056 . . . . 0.0 109.878 -179.781 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.479 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -65.04 -46.63 80.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.325 -0.859 . . . . 0.0 110.024 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.492 HG21 ' CE1' ' A' ' 120' ' ' PHE . 1.4 p -66.12 -13.31 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.029 -1.044 . . . . 0.0 109.963 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.437 ' HE2' ' HA ' ' A' ' 170' ' ' LYS . 2.3 tpt -89.61 -52.94 4.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.348 -0.845 . . . . 0.0 110.748 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.5 OUTLIER -53.07 -31.25 40.64 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.071 -1.018 . . . . 0.0 110.017 -179.734 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.504 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.1 mm100 -112.65 78.37 1.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.299 -0.876 . . . . 0.0 109.686 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.566 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 10.6 pttp -86.86 25.65 1.26 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.27 -0.894 . . . . 0.0 111.014 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -88.2 67.08 8.7 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.566 ' CD2' ' HA ' ' A' ' 158' ' ' LYS . 84.1 m-70 -86.39 -179.99 6.77 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.727 -177.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 160' ' ' HIS . 23.0 ttpt -179.93 83.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.402 -0.811 . . . . 0.0 109.684 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.634 ' CD2' ' CZ ' ' A' ' 116' ' ' TYR . 0.1 OUTLIER -101.96 146.17 28.24 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.175 -0.953 . . . . 0.0 109.707 -179.456 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.513 ' CB ' ' HB3' ' A' ' 105' ' ' SER . 6.4 m120 53.8 18.26 1.51 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.931 . . . . 0.0 109.996 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 83.23 28.83 35.45 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -145.71 143.53 29.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.132 -1.216 . . . . 0.0 110.427 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.3 t -79.9 169.82 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.957 . . . . 0.0 110.303 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.522 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.7 OUTLIER -131.07 -178.66 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.208 -0.932 . . . . 0.0 110.702 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 102' ' ' GLY . 16.7 t70 -119.93 83.22 29.68 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.51 ' CG ' ' HB2' ' A' ' 158' ' ' LYS . 47.5 Cg_endo -72.62 114.24 3.96 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.353 1.712 . . . . 0.0 110.986 -178.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.548 ' O ' ' CE ' ' A' ' 99' ' ' MET . 2.4 mtmp? -136.03 173.36 11.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.512 -0.743 . . . . 0.0 109.246 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.518 ' HA ' ' HG2' ' A' ' 99' ' ' MET . 0.2 OUTLIER . . . . . 0 C--N 1.295 -1.789 0 C-N-CA 118.689 -1.205 . . . . 0.0 109.876 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.488 ' HA ' ' HG ' ' A' ' 144' ' ' LEU . 47.3 mttt . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.344 0.593 . . . . 0.0 110.506 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.463 ' SD ' ' O ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -143.29 -174.9 4.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.892 . . . . 0.0 110.217 179.724 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.716 ' CE1' ' CE1' ' A' ' 142' ' ' PHE . 10.5 t80 -143.08 148.5 36.77 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.304 -0.872 . . . . 0.0 110.526 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.533 HG13 ' CG2' ' A' ' 143' ' ' VAL . 4.0 mm -125.04 108.58 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.504 -0.748 . . . . 0.0 110.14 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -103.25 118.27 6.01 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 133.86 41.29 0.17 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.581 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 4.0 mm? -90.26 155.03 19.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.337 -1.096 . . . . 0.0 109.916 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.49 ' N ' ' OG1' ' A' ' 108' ' ' THR . 24.1 p -72.08 -176.78 1.85 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.154 -0.966 . . . . 0.0 110.318 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 83.7 t90 -75.11 -27.08 59.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.174 -0.954 . . . . 0.0 110.326 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -113.72 37.16 3.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.215 -0.928 . . . . 0.0 110.22 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.49 ' OG1' ' N ' ' A' ' 105' ' ' SER . 1.5 m -77.55 149.03 34.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.13 -0.981 . . . . 0.0 110.271 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.481 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 44.0 p -130.5 159.63 36.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.292 -0.88 . . . . 0.0 110.455 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.457 ' HB2' ' HA ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -65.26 -14.72 61.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.18 -0.95 . . . . 0.0 109.911 179.702 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -82.54 -53.88 5.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 110.842 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.481 ' OD1' ' O ' ' A' ' 109' ' ' THR . 0.7 OUTLIER -61.77 -35.65 78.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.979 -1.076 . . . . 0.0 110.284 -179.553 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.482 ' CD1' HD23 ' A' ' 162' ' ' LEU . 23.6 tp -71.62 -56.46 5.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 109.931 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.428 ' HB2' ' CB ' ' A' ' 126' ' ' CYS . 1.9 tttt -51.39 -34.44 34.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.182 -0.949 . . . . 0.0 109.733 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 118' ' ' SER . 0.5 OUTLIER -73.93 -55.03 6.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 109.906 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.441 ' C ' ' O ' ' A' ' 115' ' ' ASP . 60.2 t80 -47.36 -31.19 3.76 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.531 -1.268 . . . . 0.0 108.118 178.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.564 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 12.8 m-85 -90.72 -10.43 43.06 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.166 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -65.09 -10.96 34.58 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.839 -1.163 . . . . 0.0 109.386 179.233 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -80.77 -16.65 53.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.477 -0.765 . . . . 0.0 109.991 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.564 ' CD1' ' HA ' ' A' ' 117' ' ' PHE . 75.7 m-85 -88.76 -62.66 1.44 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 109.399 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -157.72 164.99 33.4 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 146' ' ' LYS . 19.4 mt-10 -62.15 119.58 9.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.017 -1.284 . . . . 0.0 110.176 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.0 t -89.62 135.38 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 110.617 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.15 -23.73 6.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.461 ' HB2' ' HB2' ' A' ' 144' ' ' LEU . 6.5 m-20 -152.22 157.04 40.9 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 118.443 -1.303 . . . . 0.0 112.575 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.428 ' CB ' ' HB2' ' A' ' 114' ' ' LYS . 26.2 t -164.47 141.88 6.58 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.457 ' HA ' ' HB2' ' A' ' 110' ' ' LYS . 0.9 OUTLIER -151.22 166.19 31.64 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.582 -1.247 . . . . 0.0 112.348 -177.532 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.496 ' C ' ' CD1' ' A' ' 128' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.718 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.515 ' HA ' HD21 ' A' ' 104' ' ' LEU . 12.0 p90 . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.869 0.842 . . . . 0.0 111.894 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.524 ' O ' ' CE1' ' A' ' 100' ' ' PHE . . . -121.0 -176.44 15.42 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.716 ' CE1' ' CE1' ' A' ' 100' ' ' PHE . 8.0 m-85 -122.68 166.18 15.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.879 -1.365 . . . . 0.0 110.94 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.533 ' CG2' HG13 ' A' ' 101' ' ' ILE . 2.5 t -146.6 139.77 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.456 -0.777 . . . . 0.0 109.727 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.488 ' HG ' ' HA ' ' A' ' 98' ' ' LYS . 5.9 mp -127.71 111.61 13.88 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.605 -0.685 . . . . 0.0 109.307 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.608 ' CZ ' ' CG2' ' A' ' 154' ' ' VAL . 38.6 m-85 -79.41 150.69 31.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.684 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 122' ' ' GLU . 18.0 tttm -75.25 -19.8 59.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.433 -0.792 . . . . 0.0 110.901 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.527 ' OE1' ' CB ' ' A' ' 149' ' ' GLU . 3.5 tt0 -138.63 157.89 45.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.813 -1.18 . . . . 0.0 111.111 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 4.4 p -67.61 -41.76 83.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 109.439 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.527 ' CB ' ' OE1' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -56.97 -55.53 33.49 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.29 -0.881 . . . . 0.0 109.41 179.417 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.493 ' CB ' ' HA3' ' A' ' 121' ' ' GLY . 4.0 p -45.71 -44.29 13.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.075 -1.016 . . . . 0.0 109.277 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.52 HG21 ' CB ' ' A' ' 145' ' ' PHE . 16.9 t -58.43 -47.81 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.905 . . . . 0.0 109.83 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.482 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.3 OUTLIER -58.64 -35.52 72.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.085 -1.01 . . . . 0.0 109.476 179.618 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.469 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 9.4 mmtt -63.35 -28.5 70.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.473 -0.767 . . . . 0.0 109.591 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.608 ' CG2' ' CZ ' ' A' ' 145' ' ' PHE . 2.8 t -88.87 -34.19 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.362 -0.836 . . . . 0.0 109.897 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.408 ' O ' ' C ' ' A' ' 156' ' ' ASP . 1.1 ttp -73.2 -36.6 66.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.863 . . . . 0.0 110.511 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 31.5 p-10 -44.63 -29.27 0.72 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.083 -1.01 . . . . 0.0 110.254 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.518 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -136.9 98.78 3.85 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.165 -0.96 . . . . 0.0 110.393 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.63 10.14 16.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.0 -1.062 . . . . 0.0 109.891 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 27.5 mp0 -88.14 68.48 9.09 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 177.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.549 ' HB2' HG13 ' A' ' 167' ' ' ILE . 41.3 m-70 -86.09 -168.7 2.33 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.589 -177.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.455 ' O ' ' CG ' ' A' ' 161' ' ' LYS . 0.0 OUTLIER 177.9 73.11 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.36 -0.837 . . . . 0.0 110.021 179.802 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.482 HD23 ' CD1' ' A' ' 113' ' ' LEU . 2.4 pp -110.07 151.51 27.12 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.311 -0.868 . . . . 0.0 109.853 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.462 ' HB3' ' HB3' ' A' ' 105' ' ' SER . 0.2 OUTLIER 63.13 18.09 10.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.149 -0.969 . . . . 0.0 109.861 -179.507 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 75.35 25.17 68.94 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -149.82 154.28 38.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -1.173 . . . . 0.0 110.66 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' A' ' 167' ' ' ILE . 24.1 t -84.81 167.4 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.379 -0.825 . . . . 0.0 109.688 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.549 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.9 OUTLIER -133.68 175.52 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.137 -0.977 . . . . 0.0 111.15 -179.493 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 102' ' ' GLY . 31.6 t0 -120.08 89.81 43.38 Favored Pre-proline 0 C--N 1.303 -1.426 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.64 120.41 6.43 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.172 1.617 . . . . 0.0 110.891 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.463 ' O ' ' SD ' ' A' ' 99' ' ' MET . 0.1 OUTLIER -140.47 169.63 17.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.885 . . . . 0.0 109.908 179.461 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.462 ' HA ' ' HG2' ' A' ' 99' ' ' MET . 19.4 ptp180 . . . . . 0 C--N 1.3 -1.574 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.542 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.519 ' CG ' ' HG ' ' A' ' 144' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.302 0.572 . . . . 0.0 110.239 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.546 ' CE ' ' CD1' ' A' ' 101' ' ' ILE . 12.6 ptm -147.58 175.2 11.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.189 -0.944 . . . . 0.0 110.411 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.712 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 2.5 t80 -119.73 130.87 55.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.465 -0.772 . . . . 0.0 109.252 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.546 ' CD1' ' CE ' ' A' ' 99' ' ' MET . 3.7 mm -117.05 105.04 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.245 -0.91 . . . . 0.0 109.715 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.512 ' HA2' ' CB ' ' A' ' 140' ' ' PHE . . . -97.34 139.22 14.36 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.737 -1.221 . . . . 0.0 110.12 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.51 33.9 2.38 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.529 ' CB ' HD22 ' A' ' 130' ' ' LEU . 1.8 mm? -84.68 148.72 26.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.106 -1.232 . . . . 0.0 110.004 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.48 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -76.52 147.5 37.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.158 -0.963 . . . . 0.0 110.799 -179.529 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.585 ' CD1' ' HA ' ' A' ' 132' ' ' PRO . 1.1 t90 -52.07 -17.19 0.96 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.304 -0.873 . . . . 0.0 110.99 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.423 ' HA ' ' HG3' ' A' ' 132' ' ' PRO . 0.7 OUTLIER -117.86 35.55 4.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.904 -1.122 . . . . 0.0 111.163 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.533 ' HB ' ' HG ' ' A' ' 128' ' ' LEU . 1.5 m -88.35 171.29 10.26 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.986 -1.071 . . . . 0.0 110.057 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.478 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 73.0 p -149.12 170.56 18.13 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.178 -0.951 . . . . 0.0 110.242 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.532 ' O ' ' CB ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -70.5 -11.2 60.77 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.138 -0.977 . . . . 0.0 109.922 179.792 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -87.44 -58.68 2.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 110.539 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 5.4 p30 -60.56 -32.39 71.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.12 -0.988 . . . . 0.0 110.167 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.528 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 9.2 tp -79.96 -42.84 23.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.095 -1.003 . . . . 0.0 109.577 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 4.3 ttmt -63.21 -46.47 86.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.869 . . . . 0.0 109.346 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.413 ' O ' ' C ' ' A' ' 116' ' ' TYR . 1.5 t70 -66.05 -49.17 68.59 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.139 -0.976 . . . . 0.0 109.35 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.413 ' C ' ' O ' ' A' ' 115' ' ' ASP . 67.8 t80 -48.31 -35.4 12.23 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.765 -1.174 . . . . 0.0 108.065 177.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.544 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 11.7 m-85 -90.73 -3.58 57.35 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.25 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.8 t -71.66 -9.5 58.36 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.075 -1.016 . . . . 0.0 109.294 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.66 -15.81 53.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.377 -0.827 . . . . 0.0 110.034 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.585 ' CE2' HG21 ' A' ' 154' ' ' VAL . 70.2 m-85 -89.52 -40.9 12.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.326 -0.859 . . . . 0.0 109.44 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -177.49 -156.2 15.64 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.53 157.77 17.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.138 -1.213 . . . . 0.0 110.195 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.457 HG21 ' HA ' ' A' ' 145' ' ' PHE . 1.9 t -134.75 131.23 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.212 -0.93 . . . . 0.0 111.167 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -94.99 -24.65 4.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -146.42 159.06 43.88 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.999 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.474 ' O ' ' CG ' ' A' ' 110' ' ' LYS . 40.5 t -170.47 105.56 0.29 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.848 0.832 . . . . 0.0 109.347 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.68 166.15 11.63 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.474 0.654 . . . . 0.0 110.979 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.533 ' HG ' ' HB ' ' A' ' 108' ' ' THR . 1.0 OUTLIER -146.37 104.26 3.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.413 -0.805 . . . . 0.0 110.268 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 140' ' ' PHE . 0.0 OUTLIER -89.93 77.39 6.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.138 -0.976 . . . . 0.0 109.517 179.62 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.56 ' CA ' ' HA ' ' A' ' 137' ' ' SER . 0.3 OUTLIER -149.36 21.08 0.95 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -45.85 109.26 0.93 Allowed Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.524 -0.735 . . . . 0.0 111.122 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.585 ' HA ' ' CD1' ' A' ' 106' ' ' TRP . 51.3 Cg_endo -84.13 -14.65 7.09 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.097 1.577 . . . . 0.0 110.285 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.506 ' CG2' ' N ' ' A' ' 134' ' ' THR . 0.1 OUTLIER -101.62 -41.0 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.312 -0.868 . . . . 0.0 110.517 -179.526 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.506 ' N ' ' CG2' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -89.19 21.39 3.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.279 -0.888 . . . . 0.0 110.506 -179.604 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 134' ' ' THR . . . 45.04 25.74 1.08 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.97 30.46 5.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.334 -1.097 . . . . 0.0 109.959 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.56 ' HA ' ' CA ' ' A' ' 130' ' ' LEU . 88.5 p -82.63 108.59 16.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.204 -0.935 . . . . 0.0 110.398 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.501 ' CD ' ' HG2' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -89.61 -5.46 57.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.275 -0.891 . . . . 0.0 110.051 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.51 ' N ' HD23 ' A' ' 130' ' ' LEU . . . 89.84 3.86 73.24 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 120.077 -1.059 . . . . 0.0 110.675 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.543 ' O ' ' CB ' ' A' ' 129' ' ' LYS . 46.3 p90 -161.34 165.35 29.16 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.711 -1.464 . . . . 0.0 111.093 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.471 ' HA3' ' HA ' ' A' ' 128' ' ' LEU . . . -136.82 -170.65 11.99 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.712 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 13.9 m-85 -128.65 160.71 31.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.069 -1.254 . . . . 0.0 110.492 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.529 ' CG2' HG13 ' A' ' 101' ' ' ILE . 4.1 t -134.22 140.4 46.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.371 -0.831 . . . . 0.0 108.944 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.519 ' HG ' ' CG ' ' A' ' 98' ' ' LYS . 3.1 mp -132.07 98.81 4.53 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.161 -0.962 . . . . 0.0 109.704 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.538 ' CE2' HG13 ' A' ' 154' ' ' VAL . 39.4 m-85 -71.04 170.23 13.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.434 -0.791 . . . . 0.0 110.635 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 18.2 tttt -96.18 -18.93 19.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.369 -0.832 . . . . 0.0 110.994 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.527 ' OE1' ' CB ' ' A' ' 149' ' ' GLU . 2.4 tm-20 -131.39 162.33 30.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.862 -1.149 . . . . 0.0 110.686 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 34.5 p -74.69 -47.44 31.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.913 . . . . 0.0 109.547 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.527 ' CB ' ' OE1' ' A' ' 147' ' ' GLU . 0.5 OUTLIER -54.41 -35.08 62.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.369 -0.832 . . . . 0.0 109.752 179.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.485 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 3.1 p -68.76 -40.93 79.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 109.889 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.517 ' CG2' ' HB2' ' A' ' 145' ' ' PHE . 5.6 t -66.67 -53.14 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 110.286 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.481 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -51.89 -37.78 53.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 0.0 109.955 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.46 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -59.23 -62.07 2.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.334 -0.854 . . . . 0.0 110.082 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.585 HG21 ' CE2' ' A' ' 120' ' ' PHE . 3.3 p -55.36 -20.5 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.198 -0.939 . . . . 0.0 110.141 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.509 ' N ' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -89.82 -13.19 37.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.364 -0.835 . . . . 0.0 109.686 179.381 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.8 OUTLIER -61.12 -33.5 73.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.226 -0.921 . . . . 0.0 109.614 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.516 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.0 tt0 -142.3 104.46 4.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.287 -0.883 . . . . 0.0 110.065 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.5 pttm -81.8 20.26 0.98 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.229 -0.919 . . . . 0.0 111.037 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -87.58 62.9 7.32 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.594 ' HB2' HG13 ' A' ' 167' ' ' ILE . 14.2 m170 -86.76 -169.34 2.59 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.309 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 160' ' ' HIS . 33.3 ttpt 179.86 74.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.35 -0.844 . . . . 0.0 110.317 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.506 ' CD2' HD13 ' A' ' 113' ' ' LEU . 3.8 pp -103.69 157.56 16.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 0.0 109.989 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 1.5 m-80 58.38 15.19 3.32 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.183 -0.948 . . . . 0.0 110.228 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.98 20.15 61.63 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp -150.82 146.89 26.66 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.303 -1.116 . . . . 0.0 110.152 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 1.4 p -69.36 -174.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.052 -1.03 . . . . 0.0 110.163 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.594 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -150.61 178.24 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.163 -0.96 . . . . 0.0 110.352 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -126.01 93.2 44.32 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.54 -0.725 . . . . 0.0 109.386 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -77.58 135.85 14.97 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.245 1.655 . . . . 0.0 110.643 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.418 ' O ' ' HB2' ' A' ' 99' ' ' MET . 0.0 OUTLIER -146.76 -177.92 5.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.319 -0.863 . . . . 0.0 110.268 179.607 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.483 ' O ' ' O ' ' A' ' 172' ' ' ALA . 1.6 mtt180 -91.83 45.27 1.21 Allowed 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.953 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 171' ' ' ARG . . . . . . . . 0 C--N 1.301 -1.518 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.987 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.542 ' HG2' ' CD1' ' A' ' 144' ' ' LEU . 14.7 mtmt . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.001 0.429 . . . . 0.0 110.09 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.541 ' HE1' ' CD1' ' A' ' 101' ' ' ILE . 7.9 ptm -133.39 172.31 12.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.118 -0.989 . . . . 0.0 110.562 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.698 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 2.1 t80 -120.99 130.07 53.66 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.608 -0.682 . . . . 0.0 110.041 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.541 ' CD1' ' HE1' ' A' ' 99' ' ' MET . 3.8 mm -112.66 95.27 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.294 -0.879 . . . . 0.0 109.469 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.514 ' HA2' ' CB ' ' A' ' 140' ' ' PHE . . . -89.75 127.01 8.53 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 127.48 34.01 0.59 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.537 ' CB ' HD22 ' A' ' 130' ' ' LEU . 2.3 mm? -89.38 152.95 21.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.048 -1.266 . . . . 0.0 110.186 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.476 ' O ' ' OG1' ' A' ' 108' ' ' THR . 0.0 OUTLIER -90.49 152.67 20.84 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.291 -0.88 . . . . 0.0 111.234 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.474 ' HA ' HD11 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -51.46 -22.69 3.25 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.445 -0.785 . . . . 0.0 110.765 179.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -107.04 28.82 7.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.028 -1.045 . . . . 0.0 111.765 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.536 ' HB ' ' CD2' ' A' ' 128' ' ' LEU . 0.8 OUTLIER -90.44 170.8 9.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.752 -1.218 . . . . 0.0 109.798 179.17 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.467 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 28.7 p -145.94 159.16 43.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.227 -0.921 . . . . 0.0 110.155 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.487 ' CE ' ' O ' ' A' ' 126' ' ' CYS . 0.7 OUTLIER -62.91 -12.76 27.36 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.171 -0.955 . . . . 0.0 109.639 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.49 -59.31 2.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.367 -0.833 . . . . 0.0 110.377 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -52.61 -41.93 64.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.056 -1.028 . . . . 0.0 109.909 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.469 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 10.6 tp -70.3 -48.82 54.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.911 . . . . 0.0 109.577 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -52.1 -48.01 64.97 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.428 -0.795 . . . . 0.0 109.772 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 54.7 m-20 -67.41 -50.74 58.18 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.16 -0.962 . . . . 0.0 110.296 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.412 ' C ' ' O ' ' A' ' 115' ' ' ASP . 73.0 t80 -47.78 -34.01 7.96 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 118.532 -1.267 . . . . 0.0 108.528 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.512 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 15.3 m-85 -91.14 -7.24 52.09 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.869 -0.732 . . . . 0.0 111.351 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.484 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 1.9 t -71.02 -7.35 45.76 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.956 -1.09 . . . . 0.0 109.225 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -82.88 -14.42 54.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 0.0 110.285 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.512 ' CD2' ' HA ' ' A' ' 117' ' ' PHE . 89.1 m-85 -88.8 -56.02 3.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.073 -1.017 . . . . 0.0 109.275 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.454 ' HA3' ' HB3' ' A' ' 150' ' ' SER . . . -162.02 -162.27 13.02 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -83.06 151.03 25.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -1.192 . . . . 0.0 110.061 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.499 HG21 ' CD1' ' A' ' 145' ' ' PHE . 1.9 t -128.8 130.03 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.357 -0.839 . . . . 0.0 110.484 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.01 -24.68 5.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.459 ' HB2' ' CB ' ' A' ' 144' ' ' LEU . 4.2 m-20 -151.06 171.27 17.59 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 118.526 -1.27 . . . . 0.0 112.364 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.487 ' O ' ' CE ' ' A' ' 110' ' ' LYS . 9.6 t -170.38 155.59 5.24 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.66 151.74 32.93 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.876 -1.14 . . . . 0.0 110.937 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.556 ' O ' ' CD1' ' A' ' 128' ' ' LEU . 1.6 tm? -128.89 100.56 5.72 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.531 -0.73 . . . . 0.0 109.703 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 140' ' ' PHE . 0.2 OUTLIER -85.92 77.5 9.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.248 -0.907 . . . . 0.0 109.219 179.657 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.566 ' CA ' ' HA ' ' A' ' 137' ' ' SER . 0.4 OUTLIER -149.82 27.69 0.79 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 2.5 m-20 -40.9 107.66 0.49 Allowed Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.526 -0.734 . . . . 0.0 111.243 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.444 ' HG3' ' O ' ' A' ' 106' ' ' TRP . 51.6 Cg_endo -86.83 -18.84 2.84 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 124.088 1.572 . . . . 0.0 110.739 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.565 ' CG2' ' N ' ' A' ' 134' ' ' THR . 0.1 OUTLIER -92.73 -45.28 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.071 -1.018 . . . . 0.0 110.837 -179.293 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.565 ' N ' ' CG2' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -89.51 0.24 57.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.934 . . . . 0.0 110.324 -179.529 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 69.48 12.54 66.79 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.427 ' C ' ' HB2' ' A' ' 131' ' ' ASP . 0.8 OUTLIER -88.49 26.02 1.56 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -1.133 . . . . 0.0 110.17 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.566 ' HA ' ' CA ' ' A' ' 130' ' ' LEU . 0.9 OUTLIER -72.22 116.3 12.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.39 -0.819 . . . . 0.0 109.902 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.562 ' HB3' ' CE2' ' A' ' 140' ' ' PHE . 0.0 OUTLIER -89.01 -3.93 58.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.154 -0.966 . . . . 0.0 109.977 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.502 ' N ' HD23 ' A' ' 130' ' ' LEU . . . 86.39 1.4 86.02 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.576 ' CD1' ' CZ ' ' A' ' 100' ' ' PHE . 35.5 p90 -155.22 -178.23 7.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.87 -1.37 . . . . 0.0 110.786 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -150.4 -171.05 18.32 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.698 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 19.7 m-85 -131.38 171.36 13.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.153 -1.204 . . . . 0.0 110.719 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.493 ' CG2' HG13 ' A' ' 101' ' ' ILE . 32.0 t -147.46 129.06 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.542 ' CD1' ' HG2' ' A' ' 98' ' ' LYS . 3.8 mm? -114.53 101.6 9.27 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.584 -0.697 . . . . 0.0 109.821 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.547 ' HB2' ' CG2' ' A' ' 151' ' ' VAL . 8.2 m-85 -78.36 170.15 17.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 110.78 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' A' ' 146' ' ' LYS . 0.1 OUTLIER -89.87 -26.61 20.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.614 -0.679 . . . . 0.0 110.562 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.493 ' OE2' ' CB ' ' A' ' 149' ' ' GLU . 1.0 OUTLIER -143.08 161.76 37.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.785 -1.197 . . . . 0.0 111.181 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 18.7 m -64.37 -31.7 73.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.441 -0.787 . . . . 0.0 110.091 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.493 ' CB ' ' OE2' ' A' ' 147' ' ' GLU . 0.1 OUTLIER -60.29 -38.67 84.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 0.0 110.012 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 22.4 p -71.27 -36.76 71.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.458 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.547 ' CG2' ' HB2' ' A' ' 145' ' ' PHE . 3.5 t -76.12 -45.42 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.987 -1.071 . . . . 0.0 110.805 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 153' ' ' LYS . 0.2 OUTLIER -61.58 -33.89 74.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.143 -0.973 . . . . 0.0 110.126 -179.555 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 152' ' ' ASP . 6.6 tttt -70.37 -42.2 72.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -0.918 . . . . 0.0 110.041 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.513 ' CG1' ' O ' ' A' ' 151' ' ' VAL . 7.4 p -72.67 -27.35 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.145 -0.972 . . . . 0.0 110.458 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.493 ' N ' HG11 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -80.39 -34.87 36.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.939 . . . . 0.0 110.288 -179.751 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -45.37 -42.6 10.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 109.342 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.561 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -118.76 87.25 2.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.397 -0.814 . . . . 0.0 109.65 179.335 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.476 ' HB2' ' CG ' ' A' ' 169' ' ' PRO . 3.4 pttt -85.94 17.45 3.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.892 . . . . 0.0 110.542 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -87.52 63.85 7.83 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.561 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 11.7 m170 -86.56 -167.59 1.93 Allowed 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.726 -177.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt 179.2 67.99 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.496 -0.753 . . . . 0.0 109.601 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.463 HD23 HG22 ' A' ' 167' ' ' ILE . 2.6 pp -99.8 148.42 24.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.346 -0.847 . . . . 0.0 110.076 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.445 ' CB ' ' O ' ' A' ' 162' ' ' LEU . 0.4 OUTLIER 64.18 20.77 12.32 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.184 -0.948 . . . . 0.0 109.517 -179.401 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.9 26.05 70.08 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.37 147.35 27.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.273 -1.134 . . . . 0.0 110.726 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.8 t -80.31 173.12 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.347 -0.846 . . . . 0.0 109.252 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.475 HG23 HG23 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -141.66 163.56 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.087 -1.008 . . . . 0.0 110.9 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -112.26 96.77 36.69 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.611 -0.681 . . . . 0.0 109.235 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.476 ' CG ' ' HB2' ' A' ' 158' ' ' LYS . 49.2 Cg_endo -76.65 119.47 5.19 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.205 1.634 . . . . 0.0 110.524 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -136.42 -163.5 1.42 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 110.293 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.13 -170.89 2.8 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.811 -0.755 . . . . 0.0 110.48 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.449 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.446 -0.784 . . . . 0.0 109.911 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.469 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 4.5 mttp . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.185 0.517 . . . . 0.0 109.996 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.539 ' HE1' ' CD1' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -139.88 179.72 6.44 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.229 -0.919 . . . . 0.0 110.107 179.716 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.727 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 2.5 t80 -125.26 128.93 49.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.361 -0.837 . . . . 0.0 110.807 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.539 ' CD1' ' HE1' ' A' ' 99' ' ' MET . 4.7 mm -107.37 96.19 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.465 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -89.92 145.71 18.38 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.243 -178.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.499 ' O ' ' HD2' ' A' ' 165' ' ' LYS . . . 96.99 17.68 31.68 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.519 ' C ' ' CD1' ' A' ' 130' ' ' LEU . 1.4 mm? -54.73 166.47 0.47 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.636 -1.508 . . . . 0.0 109.737 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.482 ' C ' ' CD1' ' A' ' 130' ' ' LEU . 0.3 OUTLIER -90.89 140.72 29.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.132 -0.98 . . . . 0.0 110.114 179.511 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.512 ' HA ' HD21 ' A' ' 130' ' ' LEU . 20.6 m0 -49.75 -19.87 0.72 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.154 -0.966 . . . . 0.0 110.472 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -113.57 26.38 10.44 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.126 -0.984 . . . . 0.0 111.18 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 105' ' ' SER . 0.8 OUTLIER -89.09 166.13 14.06 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.983 -1.073 . . . . 0.0 109.952 179.568 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.471 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 31.7 p -145.42 -176.8 5.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.191 -0.943 . . . . 0.0 110.399 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.463 ' O ' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -84.57 -14.86 47.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 109.595 179.663 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.44 -44.86 15.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.871 . . . . 0.0 109.857 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 32.5 p-10 -77.35 -38.29 50.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.842 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.489 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 19.7 tp -69.84 -42.69 73.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.099 -1.001 . . . . 0.0 109.351 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -59.85 -50.72 72.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 0.0 109.234 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.402 ' O ' ' HB3' ' A' ' 118' ' ' SER . 17.1 t70 -64.04 -46.66 83.41 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.195 -0.941 . . . . 0.0 109.346 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.622 ' CD2' HD23 ' A' ' 162' ' ' LEU . 68.4 t80 -48.0 -36.35 12.58 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.556 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 15.1 m-85 -91.75 -3.46 56.18 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.843 -0.536 . . . . 0.0 111.489 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 12.4 t -70.63 -5.73 31.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.905 -1.122 . . . . 0.0 109.55 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.01 -13.29 44.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.378 -0.826 . . . . 0.0 110.039 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.593 ' CD2' ' HA ' ' A' ' 154' ' ' VAL . 79.8 m-85 -89.57 -45.36 9.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.366 -0.834 . . . . 0.0 109.84 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -176.16 -172.98 41.41 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.53 ' O ' ' CB ' ' A' ' 146' ' ' LYS . 19.1 mm-40 -81.3 115.43 20.67 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.142 -1.211 . . . . 0.0 110.199 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.579 HG21 ' CD1' ' A' ' 145' ' ' PHE . 2.0 t -91.14 133.84 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.269 -0.894 . . . . 0.0 111.018 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.91 -25.65 5.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.445 ' O ' HG11 ' A' ' 123' ' ' VAL . 4.0 m-20 -148.26 160.93 42.46 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.034 -1.067 . . . . 0.0 111.837 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 5.7 t -170.11 149.94 3.64 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.418 HG21 ' N ' ' A' ' 128' ' ' LEU . 0.9 OUTLIER -150.7 164.78 35.3 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.042 -1.036 . . . . 0.0 111.098 -178.484 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.534 HD23 ' N ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -140.77 129.15 22.49 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.009 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.534 ' N ' HD23 ' A' ' 128' ' ' LEU . 0.4 OUTLIER -111.77 71.33 0.74 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.172 -0.955 . . . . 0.0 110.156 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.541 ' CD2' ' HA2' ' A' ' 139' ' ' GLY . 5.6 mt -151.62 14.65 0.66 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.478 -0.764 . . . . 0.0 110.638 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -50.75 113.83 4.09 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.172 -0.955 . . . . 0.0 110.952 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -84.98 0.1 9.02 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.892 1.469 . . . . 0.0 110.906 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.496 HD11 HG21 ' A' ' 133' ' ' ILE . 0.1 OUTLIER -94.97 -32.59 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.023 -1.048 . . . . 0.0 110.49 -179.585 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.47 -12.7 39.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 0.0 110.149 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.22 38.14 35.16 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.52 25.37 2.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -1.199 . . . . 0.0 110.225 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.54 ' CA ' ' HA ' ' A' ' 130' ' ' LEU . 5.5 p -60.01 116.85 4.45 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.364 -0.835 . . . . 0.0 109.555 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.586 ' HG2' ' CZ ' ' A' ' 140' ' ' PHE . 0.0 OUTLIER -89.3 -16.7 30.52 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.142 -0.973 . . . . 0.0 110.235 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.541 ' HA2' ' CD2' ' A' ' 130' ' ' LEU . . . 91.05 19.16 43.86 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 120.035 -1.078 . . . . 0.0 111.048 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.586 ' CZ ' ' HG2' ' A' ' 138' ' ' ARG . 21.7 p90 -166.89 144.3 4.82 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.58 -1.541 . . . . 0.0 111.526 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 128' ' ' LEU . . . -121.38 -174.55 14.85 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.727 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 15.2 m-85 -129.43 165.85 20.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.15 -1.206 . . . . 0.0 110.776 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.481 HG22 HG13 ' A' ' 101' ' ' ILE . 3.8 t -139.41 133.34 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.454 -0.779 . . . . 0.0 109.214 178.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.469 ' HG ' ' HG2' ' A' ' 98' ' ' LYS . 5.4 mp -123.96 92.77 3.75 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.61 -0.682 . . . . 0.0 109.312 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.579 ' CD1' HG21 ' A' ' 123' ' ' VAL . 17.7 m-85 -69.18 164.4 22.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.416 -0.802 . . . . 0.0 110.784 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.53 ' CB ' ' O ' ' A' ' 122' ' ' GLU . 10.8 tttp -93.4 -22.03 19.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.473 -0.767 . . . . 0.0 110.615 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.459 ' O ' HG22 ' A' ' 151' ' ' VAL . 14.8 tt0 -126.7 144.24 50.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.765 -1.209 . . . . 0.0 110.462 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 51.1 m -61.84 -35.51 78.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.966 . . . . 0.0 109.634 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.473 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 0.1 OUTLIER -63.2 -47.64 81.71 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.318 -0.864 . . . . 0.0 109.843 179.603 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 2.3 p -57.84 -37.38 73.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.326 -0.859 . . . . 0.0 109.881 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 145' ' ' PHE . 2.8 t -66.23 -57.95 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.118 -0.989 . . . . 0.0 110.027 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.473 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -52.26 -29.83 24.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.094 -1.003 . . . . 0.0 110.012 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.471 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 6.7 mttt -68.68 -38.6 80.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.29 -0.881 . . . . 0.0 110.19 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.593 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 9.9 p -77.16 -17.71 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.209 -0.932 . . . . 0.0 110.046 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.501 ' N ' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -90.21 -39.62 12.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 110.537 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 1.0 OUTLIER -52.87 -34.75 56.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.971 -1.081 . . . . 0.0 109.795 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.505 ' O ' ' NE2' ' A' ' 160' ' ' HIS . 4.2 mt-30 -117.69 88.47 2.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.486 -0.759 . . . . 0.0 109.747 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.475 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 6.8 pttt -86.62 26.09 1.15 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 110.946 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.08 62.06 6.61 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.525 ' HB2' HG13 ' A' ' 167' ' ' ILE . 11.6 m170 -87.2 154.88 20.38 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.61 -177.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 165' ' ' LYS . 41.4 mttm -150.8 85.45 1.36 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.351 -0.843 . . . . 0.0 109.783 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.622 HD23 ' CD2' ' A' ' 116' ' ' TYR . 1.0 OUTLIER -99.77 138.01 37.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.354 -0.841 . . . . 0.0 109.714 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 10.8 m120 59.37 19.44 7.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.259 -0.901 . . . . 0.0 110.318 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.29 32.11 29.32 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.533 ' CE ' ' O ' ' A' ' 166' ' ' VAL . 0.9 OUTLIER -150.18 149.97 30.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.186 -1.184 . . . . 0.0 110.208 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.533 ' O ' ' CE ' ' A' ' 165' ' ' LYS . 26.4 t -90.01 159.52 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.078 -1.014 . . . . 0.0 110.383 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.525 HG13 ' HB2' ' A' ' 160' ' ' HIS . 1.3 pt -120.46 -176.57 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 122.071 0.939 . . . . 0.0 111.219 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -123.41 81.6 53.18 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -74.21 131.08 14.84 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.305 1.687 . . . . 0.0 110.877 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.407 ' O ' ' CB ' ' A' ' 99' ' ' MET . 2.1 mmtm -147.25 -166.9 2.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.458 -0.776 . . . . 0.0 110.3 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -89.87 -170.77 2.92 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.1 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 98' ' ' LYS . . . . . . . . 0 C--N 1.302 -1.483 0 O-C-N 121.267 -0.895 . . . . 0.0 110.376 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.501 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.289 0.566 . . . . 0.0 110.331 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.52 ' SD ' ' CG1' ' A' ' 143' ' ' VAL . 0.0 OUTLIER -136.47 166.45 23.47 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.445 -0.784 . . . . 0.0 109.178 179.385 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.734 ' CE1' ' CE1' ' A' ' 142' ' ' PHE . 15.6 t80 -112.2 148.52 33.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.963 -1.085 . . . . 0.0 110.623 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.514 ' CG2' ' CD1' ' A' ' 167' ' ' ILE . 8.8 mm -123.09 108.33 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.643 -0.661 . . . . 0.0 110.095 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.527 ' HA2' ' CB ' ' A' ' 140' ' ' PHE . . . -101.85 128.68 9.64 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.61 38.03 0.64 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.508 HD21 ' CD2' ' A' ' 128' ' ' LEU . 1.1 mp -90.06 153.77 20.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.14 -1.212 . . . . 0.0 110.234 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.493 ' O ' ' OG1' ' A' ' 108' ' ' THR . 3.1 m -82.4 154.35 25.24 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.256 -0.902 . . . . 0.0 110.411 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.487 ' O ' ' HD3' ' A' ' 132' ' ' PRO . 12.1 m-90 -57.54 -14.17 4.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.118 -0.989 . . . . 0.0 110.369 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.41 ' OD1' ' HB3' ' A' ' 105' ' ' SER . 4.6 p-10 -108.57 21.76 16.85 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.928 -1.107 . . . . 0.0 111.613 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.505 ' HB ' HD22 ' A' ' 128' ' ' LEU . 0.2 OUTLIER -85.99 149.6 25.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.883 -1.136 . . . . 0.0 109.986 179.425 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.445 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 72.5 p -134.97 162.9 31.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 110.175 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 126' ' ' CYS . 26.9 mtmt -60.4 -14.18 17.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 109.845 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -82.77 -59.65 2.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.405 -0.81 . . . . 0.0 110.655 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 1.6 p-10 -63.41 -35.05 79.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.103 -0.998 . . . . 0.0 110.258 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 15.0 tp -72.91 -51.61 17.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.184 -0.947 . . . . 0.0 109.964 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 110' ' ' LYS . 4.6 tttt -56.63 -37.95 71.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -0.955 . . . . 0.0 109.695 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.445 ' O ' ' C ' ' A' ' 116' ' ' TYR . 3.1 m-20 -73.14 -54.82 7.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.381 -0.824 . . . . 0.0 110.038 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.445 ' C ' ' O ' ' A' ' 115' ' ' ASP . 71.1 t80 -46.61 -31.93 3.15 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.719 -1.192 . . . . 0.0 108.356 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.564 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 18.7 m-85 -91.45 -11.29 38.03 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.789 -0.765 . . . . 0.0 111.423 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 115' ' ' ASP . 0.5 OUTLIER -71.14 -5.75 34.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.94 -1.1 . . . . 0.0 109.372 178.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.6 ttpt -84.92 -12.8 52.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.378 -0.826 . . . . 0.0 110.212 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.593 ' CD1' ' HA ' ' A' ' 154' ' ' VAL . 84.8 m-85 -89.59 -44.45 10.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 110.001 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.531 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -174.53 -152.55 9.22 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -90.4 146.96 23.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.229 -1.159 . . . . 0.0 110.633 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.442 HG21 ' HA ' ' A' ' 145' ' ' PHE . 1.7 t -129.24 129.8 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.446 -0.783 . . . . 0.0 110.088 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.415 HG21 ' CG ' ' A' ' 146' ' ' LYS . 2.2 t -88.8 -25.38 5.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.462 ' HB3' HD21 ' A' ' 144' ' ' LEU . 13.7 m-20 -150.88 166.91 29.12 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.389 -1.324 . . . . 0.0 112.309 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.468 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 11.8 t -167.22 135.87 2.65 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.462 0.649 . . . . 0.0 109.301 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.519 HG21 ' N ' ' A' ' 128' ' ' LEU . 0.8 OUTLIER -131.33 165.76 22.72 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.386 -0.821 . . . . 0.0 109.92 -179.388 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.529 HD23 ' N ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -150.54 128.93 12.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.312 -0.867 . . . . 0.0 109.566 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.535 ' O ' ' CD2' ' A' ' 130' ' ' LEU . 2.8 mmpt? -119.67 82.39 1.87 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.294 -0.879 . . . . 0.0 109.774 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.567 ' CD2' ' N ' ' A' ' 140' ' ' PHE . 0.3 OUTLIER -149.55 21.94 0.92 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.353 0.597 . . . . 0.0 109.844 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.472 ' O ' ' HB3' ' A' ' 137' ' ' SER . 5.6 m-20 -71.71 115.23 35.68 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.184 -0.948 . . . . 0.0 110.918 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 106' ' ' TRP . 51.4 Cg_endo -89.07 -19.93 1.5 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.947 1.498 . . . . 0.0 110.343 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.463 HD11 ' O ' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -89.57 -33.11 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.215 -0.928 . . . . 0.0 109.97 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.444 ' OG1' ' HB3' ' A' ' 131' ' ' ASP . 0.2 OUTLIER -89.74 -9.2 50.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.276 -0.89 . . . . 0.0 110.192 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 74.19 33.7 56.39 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.78 29.56 5.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.226 -1.161 . . . . 0.0 110.118 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.555 ' HA ' ' CA ' ' A' ' 130' ' ' LEU . 5.8 p -88.39 102.8 15.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.26 -0.9 . . . . 0.0 110.032 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.589 ' HB3' ' CE2' ' A' ' 140' ' ' PHE . 0.1 OUTLIER -89.55 -2.59 58.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.351 -0.843 . . . . 0.0 110.131 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.53 ' CA ' HD23 ' A' ' 130' ' ' LEU . . . 90.6 7.95 66.25 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 120.188 -1.006 . . . . 0.0 110.742 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.589 ' CE2' ' HB3' ' A' ' 138' ' ' ARG . 18.9 p90 -159.64 171.65 19.22 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.529 -1.571 . . . . 0.0 111.651 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.467 ' HA3' HD23 ' A' ' 104' ' ' LEU . . . -140.0 -179.0 17.41 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.734 ' CE1' ' CE1' ' A' ' 100' ' ' PHE . 18.0 m-85 -128.17 156.94 42.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.213 -1.169 . . . . 0.0 110.786 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.52 ' CG1' ' SD ' ' A' ' 99' ' ' MET . 8.9 t -138.22 131.77 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.501 ' HG ' ' HG2' ' A' ' 98' ' ' LYS . 6.5 mp -116.84 107.61 14.83 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.512 -0.743 . . . . 0.0 109.926 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.541 ' CD1' ' HB2' ' A' ' 150' ' ' SER . 10.4 m-85 -80.27 167.73 19.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.409 -0.807 . . . . 0.0 110.919 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.415 ' CG ' HG21 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -97.73 -23.67 15.82 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.493 -0.755 . . . . 0.0 110.664 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.478 ' HG3' ' OG ' ' A' ' 150' ' ' SER . 0.9 OUTLIER -142.07 160.37 40.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.748 -1.22 . . . . 0.0 110.934 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.4 t -64.25 -31.81 73.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 0.0 109.861 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.484 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 6.2 mt-10 -60.28 -46.9 88.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.287 -0.883 . . . . 0.0 109.869 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.541 ' HB2' ' CD1' ' A' ' 145' ' ' PHE . 37.0 p -60.97 -40.99 95.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.273 -0.892 . . . . 0.0 110.257 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.499 HG21 ' CB ' ' A' ' 145' ' ' PHE . 3.2 t -69.72 -46.2 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.126 -0.984 . . . . 0.0 110.758 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.484 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -52.46 -38.19 58.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.094 -1.004 . . . . 0.0 109.959 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.47 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 0.6 OUTLIER -66.42 -60.88 2.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 0.0 110.389 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.593 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 12.6 p -48.97 -22.77 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.052 -1.03 . . . . 0.0 110.332 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.443 ' N ' HG11 ' A' ' 154' ' ' VAL . 2.0 ttt -89.93 -24.79 21.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.178 -0.951 . . . . 0.0 109.744 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.47 ' OD2' ' O ' ' A' ' 153' ' ' LYS . 0.2 OUTLIER -53.81 -36.14 62.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.269 -0.894 . . . . 0.0 109.47 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.56 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -131.18 102.07 5.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.336 -0.852 . . . . 0.0 110.085 179.473 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt -85.12 23.54 1.24 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -0.946 . . . . 0.0 110.936 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -87.96 57.45 4.33 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.56 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 17.5 m-70 -87.9 65.45 8.32 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.691 -176.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 166' ' ' VAL . 5.6 ttpp -81.81 72.29 8.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.059 -1.025 . . . . 0.0 109.671 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 163' ' ' ASN . 0.5 OUTLIER -94.02 156.06 16.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 109.945 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 1.6 m-80 56.72 21.43 5.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.173 -0.954 . . . . 0.0 109.46 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 75.52 23.46 73.1 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.69 138.86 20.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -1.093 . . . . 0.0 110.618 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 160' ' ' HIS . 3.6 t -80.27 -179.54 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 109.233 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.534 HD13 ' CB ' ' A' ' 160' ' ' HIS . 1.0 OUTLIER -141.7 170.99 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.973 -1.08 . . . . 0.0 111.52 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 102' ' ' GLY . 10.9 t0 -116.71 92.19 37.17 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 46.1 Cg_endo -72.15 136.72 27.48 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.312 1.69 . . . . 0.0 111.287 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -138.04 -178.95 5.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.52 -0.737 . . . . 0.0 109.703 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 172' ' ' ALA . 0.2 OUTLIER -91.61 50.78 1.76 Allowed 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.484 179.21 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.476 ' N ' ' HA ' ' A' ' 99' ' ' MET . . . . . . . . 0 N--CA 1.493 1.675 0 O-C-N 121.473 -0.767 . . . . 0.0 110.495 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.539 ' HG2' ' CD2' ' A' ' 144' ' ' LEU . 9.9 mtpt . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.53 ' HE1' ' CD1' ' A' ' 101' ' ' ILE . 5.9 ptm -141.98 175.5 9.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.122 -0.986 . . . . 0.0 110.883 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.688 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 1.7 t80 -119.7 129.27 54.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.597 -0.689 . . . . 0.0 109.69 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.536 HG13 ' CG2' ' A' ' 143' ' ' VAL . 3.1 mm -109.88 94.18 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.301 -0.875 . . . . 0.0 109.453 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -97.22 112.14 4.4 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 141.32 38.73 0.08 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 140' ' ' PHE . 5.4 mp -89.9 164.6 14.52 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.231 -1.158 . . . . 0.0 110.102 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.468 ' N ' ' OG1' ' A' ' 108' ' ' THR . 0.6 OUTLIER -81.56 -171.73 3.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.322 -0.861 . . . . 0.0 109.862 179.715 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 17.3 m0 -83.85 -9.86 58.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.182 -0.949 . . . . 0.0 110.414 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.48 19.75 8.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 110.399 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.471 ' O ' HD23 ' A' ' 128' ' ' LEU . 2.5 m -63.52 159.7 18.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.109 -0.994 . . . . 0.0 109.773 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.479 ' HA ' HD21 ' A' ' 128' ' ' LEU . 63.7 p -149.57 171.73 16.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.907 . . . . 0.0 110.448 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.509 ' O ' ' CB ' ' A' ' 114' ' ' LYS . 5.9 ttpt -71.32 -11.0 60.67 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.412 -0.805 . . . . 0.0 109.127 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -84.0 -49.18 9.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.452 -0.78 . . . . 0.0 110.411 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.44 ' C ' ' OD1' ' A' ' 112' ' ' ASP . 0.2 OUTLIER -75.83 -31.72 59.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.961 -1.087 . . . . 0.0 110.199 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.462 HD22 ' CG2' ' A' ' 143' ' ' VAL . 1.7 tp -77.08 -43.44 34.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.02 -1.05 . . . . 0.0 109.593 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.509 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 17.3 tttt -59.97 -45.19 93.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.196 -0.94 . . . . 0.0 109.605 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 116' ' ' TYR . 0.6 OUTLIER -74.97 -42.03 58.4 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.178 -0.951 . . . . 0.0 109.526 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.615 ' CD2' ' CD2' ' A' ' 162' ' ' LEU . 72.5 t80 -48.32 -36.21 13.87 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 118.733 -1.187 . . . . 0.0 107.98 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.613 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 19.2 m-85 -91.48 -13.53 32.06 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.985 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 12.7 t -61.29 -14.28 25.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.114 -0.991 . . . . 0.0 109.594 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.72 -11.42 58.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.403 -0.81 . . . . 0.0 110.191 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.613 ' CD1' ' HA ' ' A' ' 117' ' ' PHE . 53.4 m-85 -89.54 -63.71 1.25 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.105 -0.997 . . . . 0.0 109.24 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -159.18 -177.57 32.39 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.5 133.84 48.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.063 -1.257 . . . . 0.0 110.414 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.408 HG11 ' O ' ' A' ' 125' ' ' ASP . 1.9 t -109.72 133.64 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.332 -0.855 . . . . 0.0 110.885 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.476 ' O ' ' OD1' ' A' ' 125' ' ' ASP . 2.1 t -89.68 -28.25 5.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.534 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 0.8 OUTLIER -147.26 164.64 32.57 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 118.906 -1.118 . . . . 0.0 112.604 -178.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.425 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 36.9 t -170.34 140.37 1.85 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.423 HG21 ' N ' ' A' ' 128' ' ' LEU . 0.9 OUTLIER -150.64 161.25 42.95 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.962 -177.773 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.479 HD21 ' HA ' ' A' ' 109' ' ' THR . 0.2 OUTLIER -119.32 117.92 29.85 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.024 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.596 ' HB3' ' CZ ' ' A' ' 140' ' ' PHE . 0.3 OUTLIER -96.7 130.17 43.97 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 110.152 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.476 ' O ' ' HD3' ' A' ' 132' ' ' PRO . 0.5 OUTLIER -111.01 176.35 5.06 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 120.193 -0.603 . . . . 0.0 109.774 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.516 ' N ' ' HB2' ' A' ' 138' ' ' ARG . 1.0 OUTLIER -59.55 110.07 2.45 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 120.944 -1.098 . . . . 0.0 109.963 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 130' ' ' LEU . 48.7 Cg_endo -78.63 -24.85 7.06 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.894 1.471 . . . . 0.0 110.803 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.456 HD11 HG22 ' A' ' 133' ' ' ILE . 0.2 OUTLIER -96.44 -33.17 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.166 -0.959 . . . . 0.0 110.484 -179.715 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.71 -10.56 45.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.249 -0.907 . . . . 0.0 110.224 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 69.07 22.23 75.87 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -127.29 -164.76 1.39 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.219 -1.165 . . . . 0.0 110.251 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.9 p -90.25 122.27 33.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 110.338 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.516 ' HB2' ' N ' ' A' ' 131' ' ' ASP . 0.2 OUTLIER -89.3 -26.41 21.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.314 -0.866 . . . . 0.0 109.252 179.354 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.84 52.33 2.46 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 120.371 -0.918 . . . . 0.0 111.62 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.596 ' CZ ' ' HB3' ' A' ' 129' ' ' LYS . 2.6 p90 -170.3 138.67 1.62 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.626 -1.514 . . . . 0.0 110.52 178.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.484 ' HA2' ' HB2' ' A' ' 129' ' ' LYS . . . -142.66 -161.84 8.98 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.688 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 17.4 m-85 -126.87 163.21 24.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.159 -1.2 . . . . 0.0 111.306 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.573 HG22 ' CE2' ' A' ' 117' ' ' PHE . 4.0 t -138.49 138.05 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.539 ' CD2' ' HG2' ' A' ' 98' ' ' LYS . 4.6 mp -127.04 107.45 10.06 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.315 -0.866 . . . . 0.0 110.11 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.607 ' CZ ' ' CG2' ' A' ' 154' ' ' VAL . 26.3 m-85 -80.65 151.63 28.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.361 -0.837 . . . . 0.0 110.51 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -75.78 -17.04 60.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.49 -0.756 . . . . 0.0 110.917 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.484 ' O ' ' OG ' ' A' ' 150' ' ' SER . 7.4 tt0 -137.63 154.39 49.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.836 -1.165 . . . . 0.0 110.901 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.448 ' N ' ' HG2' ' A' ' 147' ' ' GLU . 0.4 OUTLIER -65.42 -39.28 91.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 109.601 179.45 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.473 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 3.0 tt0 -57.65 -51.3 70.09 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.331 -0.855 . . . . 0.0 109.688 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.484 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 1.4 p -52.7 -34.39 51.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.761 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.541 ' CG2' ' HB2' ' A' ' 145' ' ' PHE . 2.4 t -74.84 -49.79 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.307 -0.87 . . . . 0.0 110.503 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.473 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -52.97 -35.2 58.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.139 -0.976 . . . . 0.0 110.447 -179.489 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.475 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 0.4 OUTLIER -71.78 -49.87 34.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.227 -0.921 . . . . 0.0 110.464 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.607 ' CG2' ' CZ ' ' A' ' 145' ' ' PHE . 18.0 t -56.02 -22.53 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.901 -1.124 . . . . 0.0 110.043 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 32.1 mmm -87.32 -46.08 10.0 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.151 -0.968 . . . . 0.0 110.157 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.475 ' OD2' ' O ' ' A' ' 153' ' ' LYS . 0.5 OUTLIER -47.19 -37.2 9.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.117 -0.99 . . . . 0.0 109.811 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.576 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 0.6 OUTLIER -111.16 85.33 2.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.122 -0.986 . . . . 0.0 110.101 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.02 18.19 2.16 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.28 -0.887 . . . . 0.0 110.824 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.414 ' OE1' ' HG2' ' A' ' 157' ' ' GLN . 31.9 mp0 -87.67 60.84 6.18 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 177.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.576 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 15.1 m-70 -87.07 179.57 6.65 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.557 -177.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 160' ' ' HIS . 14.2 ttmt -179.21 88.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.323 -0.861 . . . . 0.0 110.154 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.615 ' CD2' ' CD2' ' A' ' 116' ' ' TYR . 2.1 mp -102.93 140.89 36.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.175 -0.953 . . . . 0.0 109.583 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 25.6 m120 57.04 16.72 3.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.267 -0.896 . . . . 0.0 109.734 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.35 32.59 27.88 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.11 123.3 10.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.193 -1.181 . . . . 0.0 110.482 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.407 ' O ' ' O ' ' A' ' 103' ' ' GLY . 16.9 t -57.66 172.63 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 0.0 109.926 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.508 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.7 OUTLIER -132.7 178.27 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.195 -0.941 . . . . 0.0 111.019 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 102' ' ' GLY . 10.3 t70 -127.9 80.25 72.39 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 42.8 Cg_endo -70.41 131.22 19.88 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.069 1.563 . . . . 0.0 111.241 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.401 ' O ' ' CB ' ' A' ' 99' ' ' MET . 4.6 mmtm -146.73 -174.01 4.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.401 -0.812 . . . . 0.0 110.302 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.74 -171.07 2.77 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.463 -0.773 . . . . 0.0 110.487 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.326 -0.858 . . . . 0.0 110.145 179.854 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.54 ' HG2' ' CD1' ' A' ' 144' ' ' LEU . 12.5 mtmm . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.344 0.592 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.524 ' SD ' ' CG1' ' A' ' 143' ' ' VAL . 0.0 OUTLIER -145.33 160.0 42.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.656 179.2 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.72 ' CE1' ' CE1' ' A' ' 142' ' ' PHE . 13.1 t80 -113.61 146.07 40.29 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.414 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.531 HG13 ' CG2' ' A' ' 143' ' ' VAL . 12.7 mm -123.61 91.39 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.531 -0.731 . . . . 0.0 110.123 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 167' ' ' ILE . . . -91.34 178.77 41.79 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.65 10.89 61.25 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.482 ' HB2' ' CA ' ' A' ' 140' ' ' PHE . 4.9 mp -73.36 163.72 27.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.098 -1.237 . . . . 0.0 110.349 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.503 ' HB3' ' ND2' ' A' ' 163' ' ' ASN . 13.3 t -90.37 -176.86 4.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.331 -0.856 . . . . 0.0 109.615 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.547 ' N ' ' CD1' ' A' ' 106' ' ' TRP . 37.0 m0 -87.67 23.21 2.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.081 -1.012 . . . . 0.0 110.143 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -144.25 9.5 1.44 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -0.9 . . . . 0.0 110.47 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.466 ' O ' ' CD1' ' A' ' 130' ' ' LEU . 0.2 OUTLIER -73.41 172.47 11.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.106 -0.996 . . . . 0.0 109.822 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.471 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 71.4 p -150.36 166.41 30.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.132 -0.98 . . . . 0.0 110.366 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 114' ' ' LYS . 0.8 OUTLIER -67.68 -15.38 63.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.219 -0.925 . . . . 0.0 109.529 179.532 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -80.8 -62.66 1.6 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.315 -0.866 . . . . 0.0 110.38 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 109' ' ' THR . 1.1 p-10 -55.87 -37.75 69.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 110.249 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.438 HD13 HD12 ' A' ' 162' ' ' LEU . 13.3 tp -72.09 -41.46 67.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.156 -0.965 . . . . 0.0 110.178 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 110' ' ' LYS . 0.1 OUTLIER -60.87 -47.03 88.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.201 -0.937 . . . . 0.0 110.292 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 116' ' ' TYR . 26.4 t0 -69.91 -48.39 58.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.035 -1.041 . . . . 0.0 110.034 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.407 ' C ' ' O ' ' A' ' 115' ' ' ASP . 75.0 t80 -48.28 -34.89 11.14 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.62 -1.232 . . . . 0.0 108.104 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.585 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 13.5 m-85 -91.66 -8.08 48.13 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.409 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.5 m -71.15 -9.1 57.5 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.891 -1.131 . . . . 0.0 108.951 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -81.74 -16.09 52.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.6 -0.687 . . . . 0.0 110.091 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.585 ' CD1' ' HA ' ' A' ' 117' ' ' PHE . 70.7 m-85 -89.1 -55.35 3.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.179 -0.951 . . . . 0.0 109.153 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.535 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -164.57 -163.36 17.48 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.24 140.94 29.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.114 -1.227 . . . . 0.0 110.351 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 1.9 t -112.75 133.5 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.308 -0.87 . . . . 0.0 110.823 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.411 HG21 ' HD2' ' A' ' 146' ' ' LYS . 2.2 t -89.22 -25.64 5.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.531 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 1.0 OUTLIER -148.53 165.45 31.17 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.667 -1.213 . . . . 0.0 112.045 -179.203 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.461 ' CB ' ' CG ' ' A' ' 114' ' ' LYS . 14.3 t -170.52 148.68 3.14 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.497 HG21 ' N ' ' A' ' 128' ' ' LEU . 0.8 OUTLIER -150.28 162.28 40.81 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.116 -0.99 . . . . 0.0 110.599 -178.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.535 ' CD2' ' N ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -142.95 130.48 21.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.446 -0.784 . . . . 0.0 109.692 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.64 ' CB ' ' CE1' ' A' ' 140' ' ' PHE . 10.4 mmtm -105.34 104.0 13.64 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.345 -0.847 . . . . 0.0 109.552 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.523 HD21 ' CD1' ' A' ' 128' ' ' LEU . 0.3 OUTLIER -145.55 13.42 1.36 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.466 ' HB2' ' CB ' ' A' ' 136' ' ' ARG . 12.9 m-20 -40.15 100.83 0.22 Allowed Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.461 -0.774 . . . . 0.0 110.562 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 130' ' ' LEU . 50.7 Cg_endo -79.46 -18.05 11.06 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.174 1.618 . . . . 0.0 110.595 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.482 ' CG2' ' N ' ' A' ' 134' ' ' THR . 0.1 OUTLIER -96.2 -39.56 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.214 -0.929 . . . . 0.0 110.285 -179.677 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.482 ' N ' ' CG2' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -89.91 9.81 26.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.191 -0.943 . . . . 0.0 110.438 -179.767 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.23 16.09 40.36 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.466 ' CB ' ' HB2' ' A' ' 131' ' ' ASP . 0.3 OUTLIER -92.68 19.97 6.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.172 -1.193 . . . . 0.0 110.222 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 130' ' ' LEU . 42.4 p -90.92 78.49 6.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.619 -0.675 . . . . 0.0 110.214 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.606 ' HB3' ' CD1' ' A' ' 140' ' ' PHE . 0.0 OUTLIER -88.97 11.63 17.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.069 -1.02 . . . . 0.0 109.254 179.388 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 62.93 66.77 2.38 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.64 ' CE1' ' CB ' ' A' ' 129' ' ' LYS . 16.9 p90 -170.34 131.42 0.96 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.92 -1.341 . . . . 0.0 110.965 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 127' ' ' THR . . . -125.42 173.69 17.45 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.72 ' CE1' ' CE1' ' A' ' 100' ' ' PHE . 10.1 m-85 -116.51 158.15 24.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.185 -1.185 . . . . 0.0 110.234 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.531 ' CG2' HG13 ' A' ' 101' ' ' ILE . 25.8 t -138.46 124.88 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.933 0.873 . . . . 0.0 109.939 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.54 ' CD1' ' HG2' ' A' ' 98' ' ' LYS . 1.6 mm? -110.27 111.65 23.09 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.572 ' CD1' ' HB2' ' A' ' 150' ' ' SER . 11.7 m-85 -82.01 151.59 27.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.971 -1.081 . . . . 0.0 111.052 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.411 ' HD2' HG21 ' A' ' 124' ' ' VAL . 30.4 tttt -81.28 -25.24 36.7 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.674 -0.641 . . . . 0.0 111.157 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.461 ' OE2' ' HB3' ' A' ' 149' ' ' GLU . 1.0 OUTLIER -144.48 146.37 32.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.703 -1.248 . . . . 0.0 111.231 -179.333 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.3 t -49.17 -35.13 16.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.154 -0.966 . . . . 0.0 109.554 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.47 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 0.6 OUTLIER -55.78 -51.61 66.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.348 -0.845 . . . . 0.0 109.972 179.725 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.572 ' HB2' ' CD1' ' A' ' 145' ' ' PHE . 67.1 p -56.99 -36.68 70.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.297 -0.877 . . . . 0.0 110.322 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.53 HG21 ' CB ' ' A' ' 145' ' ' PHE . 3.1 t -72.22 -53.6 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.075 -1.016 . . . . 0.0 110.393 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.47 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -47.78 -35.52 10.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.062 -1.023 . . . . 0.0 110.051 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.485 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -69.25 -52.0 31.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.898 . . . . 0.0 110.375 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.585 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 2.1 p -65.15 -14.39 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.989 -1.07 . . . . 0.0 110.17 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 28.1 tpp -90.48 -36.76 14.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.348 -0.845 . . . . 0.0 110.618 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 1.6 p-10 -57.73 -17.59 16.28 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.124 -0.985 . . . . 0.0 110.115 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.532 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 8.9 tp-100 -139.5 76.87 1.59 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.329 -0.857 . . . . 0.0 109.437 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.589 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -81.84 10.3 6.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.906 . . . . 0.0 110.666 -179.426 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -88.09 67.88 8.99 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.589 ' CD2' ' HA ' ' A' ' 158' ' ' LYS . 77.5 m-70 -86.41 174.71 8.82 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.51 0.671 . . . . 0.0 110.901 -177.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.54 ' CD ' ' O ' ' A' ' 160' ' ' HIS . 1.1 mppt? -168.95 74.17 0.09 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.523 -0.735 . . . . 0.0 109.226 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.466 ' O ' ' CB ' ' A' ' 163' ' ' ASN . 0.9 OUTLIER -109.89 155.8 21.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.38 -0.825 . . . . 0.0 110.178 -179.442 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.503 ' ND2' ' HB3' ' A' ' 105' ' ' SER . 0.3 OUTLIER 66.59 9.13 6.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.265 -0.897 . . . . 0.0 109.639 -179.348 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 89.08 15.38 59.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -150.92 163.49 38.57 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.051 -1.264 . . . . 0.0 110.671 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 2.9 t -84.9 178.28 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 109.53 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.553 ' CG1' ' HB2' ' A' ' 160' ' ' HIS . 0.7 OUTLIER -134.15 169.0 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.966 -1.084 . . . . 0.0 111.04 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 102' ' ' GLY . 9.5 t70 -112.34 88.22 10.44 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 167' ' ' ILE . 48.7 Cg_endo -77.14 119.66 5.1 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.259 1.663 . . . . 0.0 110.607 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.5 mttp -135.64 175.25 9.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 0.0 110.544 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 171' ' ' ARG . 9.3 ptp180 -91.81 52.72 2.07 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.27 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.277 -0.889 . . . . 0.0 110.377 -179.978 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.493 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 9.8 mttt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.155 0.503 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.524 ' HE1' ' CD1' ' A' ' 101' ' ' ILE . 6.9 ptm -141.29 174.67 10.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.313 -0.867 . . . . 0.0 110.181 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.697 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 2.3 t80 -115.15 129.11 56.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.388 -0.82 . . . . 0.0 110.176 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.543 HG13 ' CG2' ' A' ' 143' ' ' VAL . 4.2 mm -111.53 95.94 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.287 -0.883 . . . . 0.0 109.251 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -93.13 113.92 4.57 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 145.08 34.51 0.07 OUTLIER Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.533 ' N ' HD21 ' A' ' 104' ' ' LEU . 3.5 mm? -91.17 151.82 20.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.088 -1.242 . . . . 0.0 110.116 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.423 ' HB3' ' HB3' ' A' ' 163' ' ' ASN . 52.7 p -75.27 -178.46 3.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.195 -0.941 . . . . 0.0 109.988 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.471 ' HA ' ' CB ' ' A' ' 137' ' ' SER . 7.7 m0 -82.1 6.42 16.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -0.923 . . . . 0.0 110.364 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 2.9 p-10 -140.61 32.23 1.85 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.311 -0.868 . . . . 0.0 110.04 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.436 ' HB ' ' CD2' ' A' ' 128' ' ' LEU . 18.1 m -77.7 154.35 32.17 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.313 -0.867 . . . . 0.0 110.344 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.487 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 12.2 p -126.05 161.78 26.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.224 -0.923 . . . . 0.0 110.358 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.545 ' CG ' ' HA ' ' A' ' 127' ' ' THR . 0.3 OUTLIER -64.76 -20.47 66.37 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.089 -1.007 . . . . 0.0 110.121 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -88.61 -47.22 8.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.231 -0.918 . . . . 0.0 110.955 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -60.13 -30.42 69.27 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.941 -1.099 . . . . 0.0 109.881 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.515 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 27.0 tp -84.19 -45.91 12.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.218 -0.926 . . . . 0.0 109.47 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -33.03 67.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.889 . . . . 0.0 109.254 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' A' ' 118' ' ' SER . 0.2 OUTLIER -75.37 -55.04 6.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.28 -0.888 . . . . 0.0 109.675 179.632 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.448 ' C ' ' O ' ' A' ' 115' ' ' ASP . 64.8 t80 -46.55 -31.6 2.88 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.664 -1.214 . . . . 0.0 108.256 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.526 ' CD1' ' CE2' ' A' ' 120' ' ' PHE . 14.5 m-85 -91.35 -12.31 35.31 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.23 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 115' ' ' ASP . 44.0 t -67.47 -9.26 40.43 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.869 -1.144 . . . . 0.0 109.015 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -79.26 -16.23 56.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.407 -0.808 . . . . 0.0 110.438 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.58 ' CE1' HG21 ' A' ' 154' ' ' VAL . 90.4 m-85 -88.89 -53.18 4.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.155 -0.965 . . . . 0.0 109.685 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -164.15 -159.16 10.67 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.03 135.09 33.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -1.123 . . . . 0.0 110.262 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.473 HG21 ' HA ' ' A' ' 145' ' ' PHE . 2.0 t -111.83 133.66 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.294 -0.879 . . . . 0.0 110.59 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 t -88.73 -25.58 5.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.447 ' O ' HG11 ' A' ' 123' ' ' VAL . 0.9 OUTLIER -150.67 168.93 22.87 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.603 -1.239 . . . . 0.0 112.293 -179.056 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.526 ' O ' ' CD ' ' A' ' 110' ' ' LYS . 38.8 t -167.15 149.16 5.98 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.545 ' HA ' ' CG ' ' A' ' 110' ' ' LYS . 0.9 OUTLIER -150.78 147.82 27.76 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.869 -1.144 . . . . 0.0 111.563 -178.354 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.541 ' O ' ' CD1' ' A' ' 128' ' ' LEU . 2.3 tm? -116.49 98.8 6.75 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.546 ' CB ' ' O ' ' A' ' 140' ' ' PHE . 1.9 tmtm? -74.71 132.61 41.8 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.257 -0.902 . . . . 0.0 111.29 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.423 ' C ' ' HB2' ' A' ' 138' ' ' ARG . 0.6 OUTLIER -107.21 -145.87 0.39 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.428 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 4.6 m-20 -91.14 121.65 67.51 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.092 -1.005 . . . . 0.0 109.652 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -82.12 22.18 0.89 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.74 1.389 . . . . 0.0 111.384 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.572 ' CG2' ' N ' ' A' ' 134' ' ' THR . 0.3 OUTLIER -140.37 -46.8 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.798 -1.188 . . . . 0.0 110.641 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.572 ' N ' ' CG2' ' A' ' 133' ' ' ILE . 0.8 OUTLIER -101.22 -9.6 21.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 110.578 -179.436 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.39 -0.66 87.47 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.502 ' O ' ' HB2' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -78.25 -173.89 3.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.209 -1.171 . . . . 0.0 110.184 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.471 ' CB ' ' HA ' ' A' ' 106' ' ' TRP . 1.9 m -91.64 123.71 35.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.208 -0.933 . . . . 0.0 110.449 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.454 ' O ' ' HD3' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -89.1 -26.98 21.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 108.83 179.11 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.434 ' C ' ' HB2' ' A' ' 104' ' ' LEU . . . 90.62 50.05 3.02 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.685 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.546 ' O ' ' CB ' ' A' ' 129' ' ' LYS . 3.3 p90 -168.26 142.45 3.35 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.651 -1.499 . . . . 0.0 110.335 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 129' ' ' LYS . . . -150.78 -165.46 12.78 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.466 -1.35 . . . . 0.0 110.5 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.697 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 16.4 m-85 -126.71 157.33 39.37 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.416 -1.049 . . . . 0.0 111.22 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.543 ' CG2' HG13 ' A' ' 101' ' ' ILE . 2.8 t -130.34 134.39 62.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.493 ' HG ' ' HG2' ' A' ' 98' ' ' LYS . 6.2 mp -121.82 90.2 3.26 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.104 -0.997 . . . . 0.0 110.333 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.52 ' CE2' HG12 ' A' ' 154' ' ' VAL . 29.6 m-85 -64.36 167.9 6.33 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.529 0.681 . . . . 0.0 109.98 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -103.05 -7.51 21.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.362 -0.837 . . . . 0.0 110.73 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.529 ' OE1' ' CB ' ' A' ' 149' ' ' GLU . 0.9 OUTLIER -141.14 161.51 37.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.889 -1.132 . . . . 0.0 110.936 -179.524 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 4.8 t -75.26 -43.14 53.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 109.66 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.529 ' CB ' ' OE1' ' A' ' 147' ' ' GLU . 0.5 OUTLIER -60.62 -29.99 69.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.326 -0.859 . . . . 0.0 109.702 179.506 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.499 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 7.2 p -71.68 -40.58 69.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.041 -1.037 . . . . 0.0 109.431 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.494 ' CG2' ' HB2' ' A' ' 145' ' ' PHE . 8.3 t -72.42 -40.97 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -0.939 . . . . 0.0 110.154 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -67.6 -24.46 65.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.998 -1.063 . . . . 0.0 109.548 179.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.484 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 0.7 OUTLIER -74.39 -40.57 61.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.396 -0.815 . . . . 0.0 109.703 179.5 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.58 HG21 ' CE1' ' A' ' 120' ' ' PHE . 11.4 p -79.56 -17.3 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.149 -0.97 . . . . 0.0 110.011 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -88.57 -32.31 18.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.497 -0.752 . . . . 0.0 110.388 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.484 ' OD2' ' O ' ' A' ' 153' ' ' LYS . 0.3 OUTLIER -51.92 -32.13 31.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.054 -1.029 . . . . 0.0 109.681 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.506 ' O ' ' NE2' ' A' ' 160' ' ' HIS . 1.4 mt-30 -130.05 96.96 4.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.308 -0.87 . . . . 0.0 110.028 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.481 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -89.54 24.68 2.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.13 -0.981 . . . . 0.0 110.264 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -88.1 62.16 6.66 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.52 ' HB2' ' CG1' ' A' ' 167' ' ' ILE . 11.5 m170 -86.9 178.8 6.86 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.942 -177.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 7.7 ttpt -175.27 68.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.383 -0.823 . . . . 0.0 109.823 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.531 ' CD2' HG22 ' A' ' 167' ' ' ILE . 2.4 pp -99.9 152.88 19.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.867 . . . . 0.0 109.814 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 5.4 m120 56.05 32.89 20.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.144 -0.973 . . . . 0.0 109.415 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 60.59 29.3 69.36 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.26 138.8 20.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.241 -1.152 . . . . 0.0 110.524 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.19 176.9 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.934 . . . . 0.0 109.375 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.531 HG22 ' CD2' ' A' ' 162' ' ' LEU . 1.3 pt -137.19 -175.62 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.0 -1.063 . . . . 0.0 111.209 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -140.77 93.79 8.36 Favored Pre-proline 0 C--N 1.301 -1.515 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -77.11 115.26 3.95 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.378 1.725 . . . . 0.0 110.603 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.65 171.48 9.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.331 -0.856 . . . . 0.0 110.327 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.95 171.49 9.08 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.229 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.356 -0.84 . . . . 0.0 109.948 -179.86 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.51 ' CG ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.189 0.519 . . . . 0.0 109.943 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.536 ' CE ' ' O ' ' A' ' 170' ' ' LYS . 6.0 mtp -140.09 179.26 6.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.129 -0.982 . . . . 0.0 110.376 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.694 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 2.4 t80 -124.42 136.54 54.13 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.45 -0.781 . . . . 0.0 110.077 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.485 HG13 ' CG2' ' A' ' 143' ' ' VAL . 6.0 mm -122.19 106.08 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.12 -0.988 . . . . 0.0 110.009 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.552 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -103.27 139.84 14.62 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.88 10.85 8.83 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.461 ' CD2' HG23 ' A' ' 108' ' ' THR . 4.3 mp -65.66 159.62 24.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.312 -1.11 . . . . 0.0 110.479 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.528 ' N ' ' OG1' ' A' ' 108' ' ' THR . 0.1 OUTLIER -83.94 177.11 8.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.37 -0.831 . . . . 0.0 109.823 179.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.564 ' N ' ' CD1' ' A' ' 106' ' ' TRP . 12.1 m0 -73.53 -23.75 60.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.153 -0.967 . . . . 0.0 110.352 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -104.97 11.77 33.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 110.887 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.528 ' OG1' ' N ' ' A' ' 105' ' ' SER . 1.8 m -60.92 161.24 8.49 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.986 -1.072 . . . . 0.0 110.023 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.486 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 68.3 p -150.33 179.53 8.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.342 -0.849 . . . . 0.0 110.391 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 23.2 ttmt -77.14 -19.07 57.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.387 -0.821 . . . . 0.0 109.342 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.56 -52.98 8.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.444 -0.785 . . . . 0.0 110.894 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 109' ' ' THR . 24.1 p-10 -70.01 -40.81 75.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.036 -1.04 . . . . 0.0 110.553 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.557 HD13 ' CE2' ' A' ' 117' ' ' PHE . 24.4 tp -65.1 -50.05 67.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.964 -1.085 . . . . 0.0 109.792 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -57.82 -32.5 67.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.914 . . . . 0.0 110.139 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.462 ' O ' ' C ' ' A' ' 116' ' ' TYR . 3.1 m-20 -80.0 -54.69 5.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.145 -0.972 . . . . 0.0 110.255 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.462 ' C ' ' O ' ' A' ' 115' ' ' ASP . 59.0 t80 -45.97 -32.6 2.83 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 118.711 -1.196 . . . . 0.0 108.177 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.621 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 12.8 m-85 -90.83 -17.14 27.08 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.22 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 115' ' ' ASP . 22.6 t -60.22 -20.47 58.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.981 -1.075 . . . . 0.0 109.445 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -74.92 -11.84 60.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.442 -0.786 . . . . 0.0 109.978 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.621 ' CD1' ' HA ' ' A' ' 117' ' ' PHE . 61.3 m-85 -89.78 -72.73 0.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.282 -0.886 . . . . 0.0 109.172 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.488 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -148.76 152.28 24.34 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.45 ' HB3' ' HE2' ' A' ' 146' ' ' LYS . 1.4 mt-10 -45.23 128.45 7.59 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.227 -1.161 . . . . 0.0 110.76 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.421 HG21 ' CD1' ' A' ' 145' ' ' PHE . 1.8 t -106.71 132.06 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.425 -0.797 . . . . 0.0 110.214 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.17 -24.4 5.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.403 ' HB2' ' CB ' ' A' ' 144' ' ' LEU . 1.9 m-20 -150.81 161.24 43.04 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 118.447 -1.301 . . . . 0.0 112.33 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.475 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 43.3 t -161.37 147.78 14.41 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.453 HG21 ' N ' ' A' ' 128' ' ' LEU . 0.9 OUTLIER -151.25 154.7 37.31 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 118.538 -1.265 . . . . 0.0 111.842 -178.165 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.521 ' O ' ' CD1' ' A' ' 128' ' ' LEU . 0.4 OUTLIER -115.94 113.01 22.69 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.104 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.543 ' HB3' ' CZ ' ' A' ' 140' ' ' PHE . 0.0 OUTLIER -94.64 135.03 36.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.08 -1.013 . . . . 0.0 111.794 -178.252 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.459 ' C ' ' HB2' ' A' ' 138' ' ' ARG . 2.2 mp -100.89 -144.81 0.34 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.498 ' OD1' ' CA ' ' A' ' 138' ' ' ARG . 1.2 m-20 -88.74 123.1 68.56 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.623 -1.298 . . . . 0.0 109.885 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.11 -11.13 23.17 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.842 1.443 . . . . 0.0 111.14 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' A' ' 134' ' ' THR . 0.1 OUTLIER -128.17 -38.64 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.956 -1.09 . . . . 0.0 110.514 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.477 ' N ' ' CG2' ' A' ' 133' ' ' ILE . 16.5 m -89.91 -22.87 21.79 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.191 -0.943 . . . . 0.0 110.129 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.403 ' C ' ' HB2' ' A' ' 131' ' ' ASP . . . 87.51 -43.46 3.19 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.488 ' O ' ' HB2' ' A' ' 131' ' ' ASP . 15.9 ttt-85 -52.59 152.13 3.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.149 -1.206 . . . . 0.0 110.411 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.1 m -52.31 124.17 12.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.136 -0.977 . . . . 0.0 110.42 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.498 ' CA ' ' OD1' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -89.41 -22.71 22.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.08 179.306 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.79 47.39 3.69 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.983 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.563 ' CD2' ' CZ ' ' A' ' 100' ' ' PHE . 8.7 p90 -168.15 146.12 4.32 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.456 -1.614 . . . . 0.0 110.629 178.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.476 ' HA2' ' HB2' ' A' ' 129' ' ' LYS . . . -144.91 -159.78 8.23 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.694 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 17.9 m-85 -129.28 170.2 13.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.317 -1.107 . . . . 0.0 111.279 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.485 ' CG2' HG13 ' A' ' 101' ' ' ILE . 3.1 t -145.03 128.3 11.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.51 ' HG ' ' CG ' ' A' ' 98' ' ' LYS . 6.6 mp -116.0 104.35 11.49 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.417 -0.802 . . . . 0.0 109.752 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.622 ' CZ ' ' CG2' ' A' ' 154' ' ' VAL . 52.6 m-85 -78.21 148.69 33.9 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.582 -0.699 . . . . 0.0 110.699 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.45 ' HE2' ' HB3' ' A' ' 122' ' ' GLU . 1.8 ttmt -59.98 -38.22 81.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.641 -0.662 . . . . 0.0 111.061 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.46 ' O ' ' OG ' ' A' ' 150' ' ' SER . 0.5 OUTLIER -133.87 149.49 51.34 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.969 -1.082 . . . . 0.0 111.186 -179.321 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.488 ' HA ' HG22 ' A' ' 151' ' ' VAL . 7.9 p -52.45 -27.92 18.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.322 -0.861 . . . . 0.0 109.824 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.485 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 1.9 mm-40 -62.74 -56.35 18.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.388 -0.82 . . . . 0.0 109.93 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.488 ' CB ' ' HA3' ' A' ' 121' ' ' GLY . 3.5 p -51.7 -32.15 28.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.171 -0.956 . . . . 0.0 109.757 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.553 ' CG2' ' HB2' ' A' ' 145' ' ' PHE . 17.7 t -65.81 -57.84 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.322 -0.861 . . . . 0.0 110.189 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.485 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 1.1 p30 -51.5 -28.89 14.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.172 -0.955 . . . . 0.0 109.99 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.47 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -68.28 -44.36 75.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.444 -0.785 . . . . 0.0 110.004 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.622 ' CG2' ' CZ ' ' A' ' 145' ' ' PHE . 3.8 t -69.86 -18.33 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.103 -0.998 . . . . 0.0 109.973 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.55 -23.96 21.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.88 . . . . 0.0 110.02 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.4 OUTLIER -55.41 -35.54 65.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 109.821 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.589 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -127.16 95.5 4.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.814 . . . . 0.0 109.583 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.447 ' HG3' ' HD2' ' A' ' 169' ' ' PRO . 9.5 tmtt? -85.29 12.43 8.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.904 . . . . 0.0 110.561 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -87.5 66.15 8.9 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 177.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.589 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 13.6 m-70 -87.2 177.76 7.08 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.487 -177.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.453 ' CG ' ' O ' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -174.18 70.51 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.285 -0.885 . . . . 0.0 110.085 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.475 HD23 ' CD1' ' A' ' 113' ' ' LEU . 3.6 pp -96.09 154.33 17.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 109.73 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.475 ' HB2' ' CD1' ' A' ' 162' ' ' LEU . 0.9 OUTLIER 58.99 15.38 3.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.898 . . . . 0.0 109.969 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.16 24.58 54.39 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -150.07 149.09 29.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -1.166 . . . . 0.0 110.702 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.1 t -77.2 176.12 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.438 -0.789 . . . . 0.0 109.7 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.531 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -142.38 -176.13 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.131 -0.98 . . . . 0.0 110.971 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 102' ' ' GLY . 60.8 t0 -127.87 94.03 38.14 Favored Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.447 ' HD2' ' HG3' ' A' ' 158' ' ' LYS . 49.8 Cg_endo -74.85 113.64 3.84 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.395 1.734 . . . . 0.0 111.71 -178.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.536 ' O ' ' CE ' ' A' ' 99' ' ' MET . 1.0 OUTLIER -130.51 -171.63 2.6 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.607 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.491 ' HA ' ' HG2' ' A' ' 99' ' ' MET . 14.7 mtp180 -92.48 -172.56 3.11 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 118.861 -1.136 . . . . 0.0 110.363 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.459 ' HB1' ' CA ' ' A' ' 99' ' ' MET . . . . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.907 . . . . 0.0 110.122 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 18.1 mttp . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.22 0.533 . . . . 0.0 110.294 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.537 ' HE1' ' CD1' ' A' ' 101' ' ' ILE . 17.3 ptm -144.33 175.5 10.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.157 -0.964 . . . . 0.0 110.621 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.697 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 2.4 t80 -117.3 135.36 53.89 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.533 -0.729 . . . . 0.0 109.174 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.537 ' CD1' ' HE1' ' A' ' 99' ' ' MET . 4.9 mm -119.42 110.56 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.182 -0.949 . . . . 0.0 109.78 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -111.37 98.71 1.05 Allowed Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.046 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 168.35 33.67 0.02 OUTLIER Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.534 ' CG ' HG23 ' A' ' 108' ' ' THR . 3.8 mm? -90.71 159.59 16.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -1.208 . . . . 0.0 109.808 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.457 ' N ' ' OG1' ' A' ' 108' ' ' THR . 14.0 t -85.33 -175.38 5.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.1 -1.0 . . . . 0.0 109.815 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 73.4 t90 -69.65 -33.37 72.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.062 -1.024 . . . . 0.0 110.148 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -103.77 48.13 0.86 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.204 -0.935 . . . . 0.0 110.335 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.534 HG23 ' CG ' ' A' ' 104' ' ' LEU . 19.8 m -88.02 155.03 20.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -0.988 . . . . 0.0 110.335 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.456 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 46.3 p -143.67 156.04 44.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.456 -0.778 . . . . 0.0 109.935 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.429 ' O ' ' CB ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -62.42 -14.7 43.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.065 -1.022 . . . . 0.0 109.453 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.9 mmtt -74.06 -56.08 5.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.363 -0.836 . . . . 0.0 110.013 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 12.1 p30 -69.06 -20.75 64.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.136 -0.978 . . . . 0.0 109.934 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.524 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 15.8 tp -86.73 -54.84 4.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.889 . . . . 0.0 109.641 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.429 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 10.3 tttm -54.01 -35.59 62.07 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.456 -0.777 . . . . 0.0 109.73 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 116' ' ' TYR . 12.8 m-20 -76.16 -52.51 9.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.192 -0.943 . . . . 0.0 109.782 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.442 ' C ' ' O ' ' A' ' 115' ' ' ASP . 65.4 t80 -47.63 -33.74 7.08 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.723 -1.191 . . . . 0.0 108.063 178.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.581 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 15.3 m-85 -91.96 -9.7 42.07 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.394 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.6 t -72.34 -4.02 27.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.051 -1.031 . . . . 0.0 109.386 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -89.95 -11.37 41.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.544 -0.723 . . . . 0.0 110.429 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.587 ' CE1' ' HA ' ' A' ' 154' ' ' VAL . 90.8 m-85 -88.59 -52.48 5.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.124 -0.985 . . . . 0.0 109.643 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -164.77 -161.81 14.52 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 146' ' ' LYS . 4.1 tt0 -86.02 115.24 23.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.221 -1.164 . . . . 0.0 110.446 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 1.9 t -94.11 132.07 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.303 -0.873 . . . . 0.0 110.912 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.38 -24.21 5.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.524 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 5.5 m-20 -147.75 163.05 37.92 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 118.766 -1.174 . . . . 0.0 112.373 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 44.0 t -170.15 140.63 1.97 Allowed 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.462 ' CG2' ' N ' ' A' ' 128' ' ' LEU . 0.9 OUTLIER -150.73 168.16 25.2 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 118.675 -1.21 . . . . 0.0 112.01 -177.781 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.462 ' N ' ' CG2' ' A' ' 127' ' ' THR . 0.0 OUTLIER -123.6 124.86 43.73 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.217 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.572 ' HB3' ' CZ ' ' A' ' 140' ' ' PHE . 0.1 OUTLIER -99.7 131.23 45.82 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.988 -1.07 . . . . 0.0 110.979 -178.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 137' ' ' SER . 0.5 OUTLIER -135.66 -179.89 5.92 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.565 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -87.4 111.29 40.45 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.104 -0.998 . . . . 0.0 109.999 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 130' ' ' LEU . 49.5 Cg_endo -80.28 1.11 9.52 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.0 1.526 . . . . 0.0 110.899 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.54 ' CG2' ' N ' ' A' ' 134' ' ' THR . 0.1 OUTLIER -104.38 -42.98 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.087 -1.008 . . . . 0.0 110.481 -179.793 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.54 ' N ' ' CG2' ' A' ' 133' ' ' ILE . 0.5 OUTLIER -95.85 7.38 46.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.135 -0.978 . . . . 0.0 110.291 -179.734 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.35 25.05 53.97 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.47 158.8 23.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.36 -1.082 . . . . 0.0 110.308 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.495 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 0.1 OUTLIER -90.12 139.17 30.89 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.27 -0.894 . . . . 0.0 110.446 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.47 ' HD3' ' CE2' ' A' ' 140' ' ' PHE . 8.3 ttt180 -90.97 -24.19 20.19 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.61 43.18 4.93 Favored Glycine 0 N--CA 1.487 2.051 0 C-N-CA 120.305 -0.95 . . . . 0.0 111.152 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 129' ' ' LYS . 4.1 p90 -160.71 134.31 6.82 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.494 -1.592 . . . . 0.0 110.469 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 128' ' ' LEU . . . -134.87 -166.15 11.04 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.968 -1.111 . . . . 0.0 110.418 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.697 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 16.5 m-85 -122.84 168.1 12.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.418 -1.048 . . . . 0.0 111.325 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.533 ' CG2' HG13 ' A' ' 101' ' ' ILE . 8.9 t -144.76 134.04 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.524 ' HB2' ' CB ' ' A' ' 125' ' ' ASP . 3.1 mp -121.59 101.5 7.64 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.301 -0.874 . . . . 0.0 110.368 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.537 ' CE2' HG12 ' A' ' 154' ' ' VAL . 12.6 m-85 -76.42 158.08 31.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.296 -0.877 . . . . 0.0 110.382 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 122' ' ' GLU . 24.4 tptp -85.28 -11.94 53.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.819 . . . . 0.0 111.205 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.521 ' OE1' ' CB ' ' A' ' 149' ' ' GLU . 2.6 tt0 -144.92 151.06 38.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.75 -1.219 . . . . 0.0 110.883 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 19.9 m -61.98 -36.91 82.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.9 . . . . 0.0 109.437 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.521 ' CB ' ' OE1' ' A' ' 147' ' ' GLU . 2.3 tt0 -62.11 -56.18 21.45 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.329 -0.857 . . . . 0.0 109.42 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.484 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 49.7 p -45.6 -37.0 5.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.149 -0.969 . . . . 0.0 109.361 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.528 HG21 ' CB ' ' A' ' 145' ' ' PHE . 2.9 t -74.3 -35.15 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 0.0 109.635 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.465 ' OD2' ' O ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -66.01 -28.08 68.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -0.872 . . . . 0.0 109.521 179.583 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.479 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 4.2 mttm -74.99 -48.51 23.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.377 -0.827 . . . . 0.0 109.908 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.587 ' HA ' ' CE1' ' A' ' 120' ' ' PHE . 9.0 p -66.13 -18.28 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.009 -1.057 . . . . 0.0 109.916 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 5.3 ttt -89.95 -43.51 10.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.262 -0.899 . . . . 0.0 110.115 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.479 ' OD2' ' O ' ' A' ' 153' ' ' LYS . 0.5 OUTLIER -46.39 -33.78 4.15 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.175 -0.953 . . . . 0.0 109.766 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.571 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 3.2 tt0 -119.43 90.26 3.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.29 -0.881 . . . . 0.0 110.105 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.482 ' O ' ' HG2' ' A' ' 158' ' ' LYS . 38.3 ttpt -87.14 19.77 3.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.325 -0.859 . . . . 0.0 110.295 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.6 58.28 4.83 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 177.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.576 ' CG ' HD13 ' A' ' 167' ' ' ILE . 13.7 m-70 -86.47 173.78 9.4 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.372 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -177.64 67.94 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.439 -0.788 . . . . 0.0 109.467 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.474 HD22 HG22 ' A' ' 167' ' ' ILE . 0.9 OUTLIER -97.04 157.69 15.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.413 -0.804 . . . . 0.0 110.152 -179.575 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 58.17 16.45 3.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 109.627 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 81.29 21.94 61.6 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.54 149.65 30.21 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.1 -1.235 . . . . 0.0 110.394 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 1.1 p -76.95 -177.28 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.177 -0.952 . . . . 0.0 109.668 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.576 HD13 ' CG ' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -135.78 166.76 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.956 -1.09 . . . . 0.0 111.651 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -117.31 88.86 29.44 Favored Pre-proline 0 C--N 1.303 -1.436 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.462 ' HD2' ' HD2' ' A' ' 158' ' ' LYS . 46.7 Cg_endo -72.7 132.02 18.09 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.359 1.715 . . . . 0.0 111.184 -178.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 99' ' ' MET . 2.5 mttm -147.9 -169.8 3.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.53 -0.731 . . . . 0.0 109.964 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.32 -168.99 2.18 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.222 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.359 -0.838 . . . . 0.0 110.161 -179.735 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.548 ' CG ' ' HG ' ' A' ' 144' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.237 0.542 . . . . 0.0 110.527 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.526 ' CE ' ' HB ' ' A' ' 143' ' ' VAL . 0.0 OUTLIER -123.38 167.25 14.07 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.193 -0.942 . . . . 0.0 108.84 178.711 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.691 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 1.6 t80 -105.73 125.28 50.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.06 -1.025 . . . . 0.0 110.305 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.564 HG22 ' CE2' ' A' ' 117' ' ' PHE . 16.5 mm -116.95 94.92 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 110.169 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 167' ' ' ILE . . . -92.71 178.28 39.36 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.47 6.74 70.29 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 140' ' ' PHE . 3.1 mm? -61.68 164.13 6.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.094 -1.239 . . . . 0.0 109.536 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.05 177.78 6.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.042 -1.036 . . . . 0.0 109.97 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.522 ' HA ' ' CD1' ' A' ' 130' ' ' LEU . 33.3 m95 -84.99 19.23 2.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.223 -0.923 . . . . 0.0 110.217 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.503 ' CA ' HD23 ' A' ' 130' ' ' LEU . 37.6 t70 -148.12 21.88 1.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.9 . . . . 0.0 109.878 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.541 ' N ' HD23 ' A' ' 130' ' ' LEU . 0.2 OUTLIER -76.1 169.37 18.32 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.203 -0.935 . . . . 0.0 110.639 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.465 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 82.8 p -150.42 151.36 32.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.437 -0.789 . . . . 0.0 109.98 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.467 ' HD3' ' O ' ' A' ' 126' ' ' CYS . 7.1 ttpt -56.08 -16.34 4.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.162 -0.961 . . . . 0.0 109.881 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -80.15 -57.98 3.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.37 -0.831 . . . . 0.0 111.11 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 1.5 p-10 -65.38 -40.31 93.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.06 -1.025 . . . . 0.0 110.844 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.517 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 20.2 tp -69.05 -48.54 62.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.019 -1.051 . . . . 0.0 109.984 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.461 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 11.7 tttt -52.16 -40.47 61.49 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.234 -0.916 . . . . 0.0 110.127 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.471 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 4.2 t0 -74.69 -50.86 16.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.234 -0.916 . . . . 0.0 110.257 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.448 ' C ' ' O ' ' A' ' 115' ' ' ASP . 78.1 t80 -46.21 -34.85 4.66 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.402 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.564 ' CE2' HG22 ' A' ' 101' ' ' ILE . 9.1 m-85 -91.63 -12.45 34.17 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.441 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.471 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 0.9 OUTLIER -72.65 -5.26 36.26 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.917 -1.115 . . . . 0.0 108.998 178.5 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 119' ' ' LYS . 2.1 tttm -85.77 -12.27 51.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.521 -0.737 . . . . 0.0 110.347 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.58 ' CE1' HG21 ' A' ' 154' ' ' VAL . 93.0 m-85 -88.9 -51.54 5.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.021 -1.049 . . . . 0.0 109.286 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.454 ' HA3' ' HB3' ' A' ' 150' ' ' SER . . . -158.71 -161.17 10.85 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -86.01 142.5 28.72 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.144 -1.209 . . . . 0.0 109.896 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.516 HG21 ' CD1' ' A' ' 145' ' ' PHE . 1.8 t -127.48 133.9 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.169 -0.957 . . . . 0.0 110.923 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.479 HG22 ' CE ' ' A' ' 146' ' ' LYS . 2.3 t -94.73 -22.03 5.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -149.82 170.68 18.19 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 118.049 -1.46 . . . . 0.0 113.135 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.467 ' O ' ' HD3' ' A' ' 110' ' ' LYS . 16.2 t -170.85 131.48 0.84 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.36 162.08 25.58 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.448 -0.783 . . . . 0.0 111.45 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.552 ' HA ' ' HA3' ' A' ' 141' ' ' GLY . 0.1 OUTLIER -149.53 126.32 11.1 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.362 -0.836 . . . . 0.0 110.294 179.219 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.474 ' N ' ' CD2' ' A' ' 128' ' ' LEU . 25.8 tptt -91.11 101.69 14.43 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.541 HD23 ' N ' ' A' ' 108' ' ' THR . 13.6 tp -150.69 55.76 0.91 Allowed 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.69 -178.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.534 ' CB ' ' HB2' ' A' ' 136' ' ' ARG . 4.4 m-20 -51.03 114.69 5.08 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 120.851 -1.156 . . . . 0.0 109.987 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -77.49 -49.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.869 1.457 . . . . 0.0 111.376 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.475 HD11 HG21 ' A' ' 133' ' ' ILE . 0.2 OUTLIER -91.31 -24.31 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.033 -1.042 . . . . 0.0 111.035 -179.14 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -89.17 9.78 24.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.114 -0.991 . . . . 0.0 110.01 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 134' ' ' THR . . . 42.86 29.76 0.87 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.534 ' HB2' ' CB ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -105.43 23.07 14.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.165 -1.197 . . . . 0.0 110.308 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 130' ' ' LEU . 17.1 p -72.6 103.51 3.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.406 -0.809 . . . . 0.0 109.466 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.43 ' CB ' ' CD1' ' A' ' 140' ' ' PHE . 4.6 mtp-105 -88.6 16.56 6.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.918 . . . . 0.0 109.336 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.409 ' C ' ' HB2' ' A' ' 104' ' ' LEU . . . 48.77 55.11 11.81 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.503 ' CD2' ' CZ ' ' A' ' 100' ' ' PHE . 3.1 p90 -167.39 138.07 2.98 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.787 -1.419 . . . . 0.0 110.542 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' A' ' 128' ' ' LEU . . . -139.24 -169.07 11.47 Favored Glycine 0 N--CA 1.488 2.114 0 C-N-CA 119.804 -1.189 . . . . 0.0 110.494 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.691 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 9.9 m-85 -124.48 170.6 10.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.732 -0.864 . . . . 0.0 110.008 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.535 ' CG2' HG13 ' A' ' 101' ' ' ILE . 35.7 t -141.59 140.93 30.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.548 ' HG ' ' CG ' ' A' ' 98' ' ' LYS . 5.8 mp -124.83 107.94 11.42 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.783 -178.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.581 ' CE2' HG13 ' A' ' 154' ' ' VAL . 42.9 m-85 -82.68 165.58 19.86 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.518 -0.739 . . . . 0.0 110.344 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.479 ' CE ' HG22 ' A' ' 124' ' ' VAL . 10.6 ttmt -86.77 -24.65 25.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.439 -0.788 . . . . 0.0 111.002 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.476 ' O ' ' OG ' ' A' ' 150' ' ' SER . 0.7 OUTLIER -145.02 155.16 43.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.786 -1.196 . . . . 0.0 110.92 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 25.6 p -55.19 -35.8 65.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.271 -0.893 . . . . 0.0 109.948 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.479 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 1.0 OUTLIER -52.97 -54.14 39.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.425 -0.797 . . . . 0.0 110.008 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 3.6 p -57.59 -39.44 76.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.187 -0.945 . . . . 0.0 110.233 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.453 ' O ' HG11 ' A' ' 154' ' ' VAL . 6.6 t -62.0 -44.69 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.12 -0.988 . . . . 0.0 110.62 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.479 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.5 OUTLIER -67.16 -27.56 67.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.044 -1.035 . . . . 0.0 110.097 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.473 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -70.75 -32.36 69.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.847 . . . . 0.0 110.163 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.581 HG13 ' CE2' ' A' ' 145' ' ' PHE . 6.0 p -90.66 -20.87 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.158 -0.964 . . . . 0.0 110.329 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.529 ' N ' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -89.04 -34.5 16.77 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.371 -0.83 . . . . 0.0 109.892 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 8.4 p-10 -47.38 -31.9 4.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.295 -0.878 . . . . 0.0 109.865 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.517 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -131.95 94.95 3.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.976 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.465 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -89.52 27.31 1.5 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.127 -0.983 . . . . 0.0 110.431 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -89.03 55.66 3.42 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.533 ' HB2' HG13 ' A' ' 167' ' ' ILE . 12.2 m170 -86.23 176.31 8.01 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.684 -177.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -177.21 75.05 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.46 -0.775 . . . . 0.0 109.452 179.718 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' A' ' 163' ' ' ASN . 1.5 pp -98.49 157.99 15.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.321 -0.862 . . . . 0.0 109.948 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 0.8 OUTLIER 60.04 13.92 4.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.328 -0.858 . . . . 0.0 109.675 -179.265 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 85.43 20.85 55.94 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 161' ' ' LYS . 5.8 mttt -151.21 150.55 30.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.086 -1.243 . . . . 0.0 110.736 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 161' ' ' LYS . 1.3 p -74.71 -178.79 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.4 -0.813 . . . . 0.0 109.683 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.533 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.1 OUTLIER -135.39 -171.78 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.097 -1.002 . . . . 0.0 110.701 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 102' ' ' GLY . 23.9 t0 -132.71 84.63 49.68 Favored Pre-proline 0 N--CA 1.488 1.473 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.93 127.18 10.53 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.218 1.641 . . . . 0.0 111.033 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.55 -173.48 4.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.462 -0.774 . . . . 0.0 109.794 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -91.99 -168.9 2.11 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.499 -0.881 . . . . 0.0 110.566 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.609 -0.682 . . . . 0.0 109.946 -179.839 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.457 ' HA ' ' HG ' ' A' ' 144' ' ' LEU . 8.2 mttp . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.372 0.606 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.491 ' HE1' ' CD1' ' A' ' 101' ' ' ILE . 5.4 ptm -138.73 169.56 17.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 109.982 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.699 ' CE2' ' CZ ' ' A' ' 142' ' ' PHE . 2.5 t80 -112.72 138.68 49.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.904 . . . . 0.0 110.593 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.491 ' CD1' ' HE1' ' A' ' 99' ' ' MET . 2.8 mm -121.85 110.77 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.418 -0.801 . . . . 0.0 109.822 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.442 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -108.57 123.92 7.21 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 138.89 33.63 0.18 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.473 HD11 ' HA ' ' A' ' 140' ' ' PHE . 2.2 mp -90.5 159.37 16.54 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.139 -1.212 . . . . 0.0 110.323 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.6 t -84.06 -170.3 3.01 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.208 -0.932 . . . . 0.0 110.32 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 20.2 m0 -87.53 4.1 44.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.208 -0.932 . . . . 0.0 110.332 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -138.0 22.99 2.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.205 -0.935 . . . . 0.0 110.15 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.51 ' O ' ' CD2' ' A' ' 128' ' ' LEU . 2.8 m -68.06 163.28 22.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.171 -0.956 . . . . 0.0 110.059 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.469 ' OG1' ' OD2' ' A' ' 112' ' ' ASP . 30.3 p -148.61 153.76 38.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.198 -0.939 . . . . 0.0 110.171 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.548 ' O ' ' CB ' ' A' ' 114' ' ' LYS . 10.5 ttpt -58.4 -15.34 10.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.225 -0.922 . . . . 0.0 109.735 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.35 -54.61 6.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.219 -0.925 . . . . 0.0 110.273 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 3.2 p30 -70.12 -30.29 67.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.235 -0.916 . . . . 0.0 110.574 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.525 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 14.7 tp -81.11 -48.97 11.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.021 . . . . 0.0 109.996 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.548 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 1.3 tttt -55.04 -35.87 64.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.154 -0.966 . . . . 0.0 109.716 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 5.3 m-20 -79.59 -47.69 15.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.919 . . . . 0.0 109.748 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.409 ' C ' ' O ' ' A' ' 115' ' ' ASP . 75.6 t80 -48.23 -36.73 14.46 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 118.566 -1.253 . . . . 0.0 107.995 178.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.545 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 16.3 m-85 -91.56 -11.7 36.52 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.948 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.421 ' HB3' ' HA ' ' A' ' 115' ' ' ASP . 29.2 t -71.08 -6.49 39.57 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.907 -1.12 . . . . 0.0 108.81 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -83.47 -15.74 48.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.407 -0.808 . . . . 0.0 110.036 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.563 ' CD2' HG21 ' A' ' 154' ' ' VAL . 72.8 m-85 -89.18 -39.74 13.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.274 -0.891 . . . . 0.0 109.122 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.414 ' HA3' ' HB3' ' A' ' 150' ' ' SER . . . -174.19 176.99 46.57 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.486 ' O ' ' CB ' ' A' ' 146' ' ' LYS . 0.9 OUTLIER -73.83 118.17 16.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.234 -1.156 . . . . 0.0 110.466 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.467 HG21 ' HA ' ' A' ' 145' ' ' PHE . 1.8 t -93.36 130.62 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.26 -0.9 . . . . 0.0 111.375 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.411 HG11 ' OD1' ' A' ' 125' ' ' ASP . 2.2 t -90.28 -23.73 5.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.489 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -142.76 153.02 42.9 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 118.984 -1.087 . . . . 0.0 112.09 -179.106 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 49.6 t -161.66 145.56 12.69 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.28 156.73 42.1 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.702 -1.199 . . . . 0.0 111.566 -178.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.52 ' C ' ' CD1' ' A' ' 128' ' ' LEU . 0.1 OUTLIER -123.46 110.37 15.01 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.46 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.595 ' HG2' ' CZ ' ' A' ' 140' ' ' PHE . 4.5 tppt? -76.44 113.04 13.59 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.065 -1.022 . . . . 0.0 110.183 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.514 ' CA ' ' HA ' ' A' ' 137' ' ' SER . 0.6 OUTLIER -124.62 -165.91 1.45 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.519 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.437 ' HB2' ' C ' ' A' ' 135' ' ' GLY . 0.5 OUTLIER -90.86 112.14 51.9 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.891 -1.131 . . . . 0.0 109.794 179.1 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.65 -4.63 15.67 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.882 1.464 . . . . 0.0 111.229 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.541 ' CG2' ' N ' ' A' ' 134' ' ' THR . 0.1 OUTLIER -134.16 -43.76 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.972 -1.08 . . . . 0.0 110.781 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.541 ' N ' ' CG2' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -89.49 -9.37 50.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.099 -1.001 . . . . 0.0 110.701 -179.631 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 137' ' ' SER . . . 80.02 -49.05 3.67 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.429 ' O ' ' CG ' ' A' ' 131' ' ' ASP . 6.1 mtt180 -47.59 93.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.119 -1.224 . . . . 0.0 110.536 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.514 ' HA ' ' CA ' ' A' ' 130' ' ' LEU . 1.4 t -42.09 159.89 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.309 -0.87 . . . . 0.0 110.79 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.519 ' HB3' ' CE2' ' A' ' 140' ' ' PHE . 12.5 mtt180 -89.19 -15.33 33.96 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.284 -0.885 . . . . 0.0 108.62 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 91.3 31.55 9.57 Favored Glycine 0 N--CA 1.486 2.0 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.408 178.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.595 ' CZ ' ' HG2' ' A' ' 129' ' ' LYS . 11.6 p90 -167.09 158.14 11.96 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.239 -1.742 . . . . 0.0 110.964 178.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.404 ' C ' ' CD1' ' A' ' 142' ' ' PHE . . . -153.91 -159.41 9.15 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.944 -1.263 . . . . 0.0 109.944 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.699 ' CZ ' ' CE2' ' A' ' 100' ' ' PHE . 18.9 m-85 -129.32 170.87 13.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -1.172 . . . . 0.0 111.429 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.484 ' CG2' HG13 ' A' ' 101' ' ' ILE . 7.3 t -145.9 129.83 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.489 ' HB2' ' CB ' ' A' ' 125' ' ' ASP . 7.6 mp -120.84 102.96 8.71 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.398 -0.814 . . . . 0.0 110.355 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.57 ' CE2' HG22 ' A' ' 154' ' ' VAL . 26.2 m-85 -74.71 165.08 25.81 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.587 0.708 . . . . 0.0 110.899 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 122' ' ' GLU . 17.5 ttpt -85.27 -26.5 26.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.512 -0.742 . . . . 0.0 111.104 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.495 ' HG3' ' OG ' ' A' ' 150' ' ' SER . 0.1 OUTLIER -137.11 142.05 42.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.654 -1.279 . . . . 0.0 110.772 -179.757 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 75.1 m -50.52 -30.67 13.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 109.996 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.487 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 1.8 mm-40 -59.25 -48.1 82.88 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.272 -0.892 . . . . 0.0 110.042 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.495 ' OG ' ' HG3' ' A' ' 147' ' ' GLU . 11.2 p -62.75 -32.33 73.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.235 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.521 ' CG2' ' HB2' ' A' ' 145' ' ' PHE . 2.7 t -73.94 -55.31 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.065 -1.022 . . . . 0.0 110.103 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.487 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.1 OUTLIER -51.47 -27.14 9.59 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.159 -0.963 . . . . 0.0 109.341 179.772 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.475 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 8.7 tmtt? -69.5 -61.73 1.67 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.459 -0.775 . . . . 0.0 109.708 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.57 HG22 ' CE2' ' A' ' 145' ' ' PHE . 23.4 t -45.33 -28.65 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.127 -0.983 . . . . 0.0 109.948 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 6.7 ttt -77.46 -41.15 40.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.371 -0.831 . . . . 0.0 110.462 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.475 ' OD2' ' O ' ' A' ' 153' ' ' LYS . 0.4 OUTLIER -48.19 -22.99 0.74 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.132 -0.98 . . . . 0.0 109.962 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.569 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 3.0 pt20 -140.44 90.89 2.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.286 -0.884 . . . . 0.0 110.135 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.74 16.38 5.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.122 -0.986 . . . . 0.0 110.372 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -87.67 63.64 7.63 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.569 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 11.7 m-70 -87.35 -179.76 6.45 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.648 -177.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 166' ' ' VAL . 16.2 ttmt -179.06 74.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.26 -0.9 . . . . 0.0 110.23 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.494 HD22 ' CD1' ' A' ' 167' ' ' ILE . 1.8 pp -96.07 151.38 19.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 109.873 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 0.5 OUTLIER 61.39 12.36 4.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.232 -0.917 . . . . 0.0 110.217 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 88.2 23.01 39.06 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 4.3 mtpp -150.12 138.96 20.89 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.183 -1.187 . . . . 0.0 110.579 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 161' ' ' LYS . 4.2 p -66.78 -179.39 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.311 -0.868 . . . . 0.0 109.995 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.543 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -145.13 176.74 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.176 -0.953 . . . . 0.0 110.642 -179.55 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 102' ' ' GLY . 34.2 t0 -128.09 90.78 46.44 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 52.3 Cg_endo -78.44 139.36 16.31 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 124.118 1.588 . . . . 0.0 110.862 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.08 -173.01 4.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.922 . . . . 0.0 110.122 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -91.0 -168.06 1.98 Allowed 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.319 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' A' ' 98' ' ' LYS . . . . . . . . 0 C--N 1.3 -1.545 0 O-C-N 121.427 -0.795 . . . . 0.0 110.319 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.462 ' HB3' ' HG ' ' A' ' 144' ' ' LEU . 43.3 mttt . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.448 0.642 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.529 ' SD ' ' CG1' ' A' ' 143' ' ' VAL . 0.0 OUTLIER -134.49 165.78 24.39 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.779 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.719 ' CE1' ' CE1' ' A' ' 142' ' ' PHE . 17.4 t80 -111.78 144.35 41.23 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.077 -1.014 . . . . 0.0 110.67 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.519 ' CD1' ' HE3' ' A' ' 99' ' ' MET . 3.2 mm -117.63 96.53 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.555 -0.716 . . . . 0.0 109.227 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -93.99 120.39 6.31 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.84 -1.172 . . . . 0.0 110.627 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 133.65 35.03 0.29 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.531 ' CB ' HD13 ' A' ' 130' ' ' LEU . 4.0 mm? -90.21 161.64 15.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.12 -1.224 . . . . 0.0 110.106 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.529 ' O ' ' CD1' ' A' ' 130' ' ' LEU . 0.1 OUTLIER -90.64 160.4 15.9 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.212 -0.93 . . . . 0.0 110.332 179.835 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.522 ' HA ' ' CD2' ' A' ' 130' ' ' LEU . 5.2 m-90 -62.14 -10.92 11.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.052 -1.03 . . . . 0.0 110.218 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -116.09 12.68 15.64 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.143 -0.973 . . . . 0.0 111.321 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.553 ' HB ' ' CD1' ' A' ' 128' ' ' LEU . 0.3 OUTLIER -76.84 169.89 17.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.829 -1.169 . . . . 0.0 110.034 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.44 HG21 ' O ' ' A' ' 108' ' ' THR . 33.8 p -149.89 155.45 40.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.15 -0.969 . . . . 0.0 109.887 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 114' ' ' LYS . 1.9 pttp -63.6 -11.06 21.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.159 -0.963 . . . . 0.0 109.663 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -78.65 -61.96 1.84 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.0 110.42 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 0.9 OUTLIER -62.5 -41.41 98.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.084 -1.01 . . . . 0.0 110.182 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.567 HD22 ' CD2' ' A' ' 117' ' ' PHE . 6.9 tt -64.79 -61.14 2.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 109.752 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 110' ' ' LYS . 14.3 ttpt -44.44 -34.92 2.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 109.433 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 118' ' ' SER . 0.5 OUTLIER -72.94 -54.38 8.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.144 -0.972 . . . . 0.0 109.2 179.187 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.435 ' C ' ' O ' ' A' ' 115' ' ' ASP . 48.1 t80 -47.69 -28.39 2.4 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.567 ' CD2' HD22 ' A' ' 113' ' ' LEU . 20.1 m-85 -91.21 -12.41 35.4 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.232 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 115' ' ' ASP . 95.1 p -65.4 -10.18 31.45 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.922 -1.111 . . . . 0.0 109.406 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.0 tptt -81.73 -14.78 56.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.466 -0.771 . . . . 0.0 110.544 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.594 ' CE1' ' HA ' ' A' ' 154' ' ' VAL . 92.3 m-85 -89.17 -61.91 1.6 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.145 -0.972 . . . . 0.0 109.498 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.49 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -155.95 -163.5 12.3 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.76 126.41 35.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -1.212 . . . . 0.0 110.352 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.43 HG11 ' O ' ' A' ' 125' ' ' ASP . 1.6 t -101.05 129.63 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.205 -0.935 . . . . 0.0 111.062 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -90.07 -23.01 6.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.5 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 2.2 m-20 -145.51 162.16 38.04 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 118.663 -1.215 . . . . 0.0 112.288 -178.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.428 ' CB ' ' HD3' ' A' ' 114' ' ' LYS . 9.2 t -169.95 143.98 2.66 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.528 ' CG2' ' N ' ' A' ' 128' ' ' LEU . 0.9 OUTLIER -150.59 173.85 13.65 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 110.39 -178.709 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.553 ' CD1' ' HB ' ' A' ' 108' ' ' THR . 0.1 OUTLIER -143.85 125.49 15.0 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.403 -0.811 . . . . 0.0 110.003 179.266 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 140' ' ' PHE . 7.8 tptp -96.65 64.92 2.17 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 6.0 mt -150.76 18.78 0.8 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 2.7 m-20 -44.11 105.94 0.48 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.645 -0.66 . . . . 0.0 111.178 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -80.08 -5.06 13.58 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.199 1.631 . . . . 0.0 110.145 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.483 ' CD1' ' O ' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -96.23 -36.92 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 110.267 -179.806 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.446 ' N ' ' CG2' ' A' ' 133' ' ' ILE . 0.8 OUTLIER -92.78 1.97 57.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 110.247 -179.742 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.88 17.9 58.96 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.9 mtp85 -106.95 32.73 4.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.304 -1.115 . . . . 0.0 110.108 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 130' ' ' LEU . 0.6 OUTLIER -71.73 130.86 42.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.205 -0.935 . . . . 0.0 110.018 -179.766 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.601 ' HB3' ' CE2' ' A' ' 140' ' ' PHE . 0.1 OUTLIER -109.26 -8.41 15.11 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.31 -0.869 . . . . 0.0 110.081 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.44 ' HA2' HD22 ' A' ' 130' ' ' LEU . . . 91.3 14.77 56.86 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 120.323 -0.941 . . . . 0.0 111.902 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.601 ' CE2' ' HB3' ' A' ' 138' ' ' ARG . 17.5 p90 -157.68 146.92 19.8 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.264 -1.727 . . . . 0.0 111.512 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.473 ' CA ' ' HA ' ' A' ' 128' ' ' LEU . . . -115.68 178.47 17.64 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.719 ' CE1' ' CE1' ' A' ' 100' ' ' PHE . 13.3 m-85 -126.07 160.66 29.52 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.517 -0.99 . . . . 0.0 110.804 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.529 ' CG1' ' SD ' ' A' ' 99' ' ' MET . 19.5 t -145.07 141.75 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.584 -0.698 . . . . 0.0 109.237 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.5 ' HB2' ' CB ' ' A' ' 125' ' ' ASP . 6.3 mp -127.31 102.71 7.03 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.515 -0.74 . . . . 0.0 109.536 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.492 ' CB ' HG21 ' A' ' 151' ' ' VAL . 29.2 m-85 -74.44 153.08 39.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.472 -0.768 . . . . 0.0 110.614 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.7 tttt -83.47 -18.98 36.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.476 -0.765 . . . . 0.0 110.882 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.483 ' O ' ' OG ' ' A' ' 150' ' ' SER . 5.7 tt0 -134.36 154.63 51.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.794 -1.191 . . . . 0.0 110.895 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.9 t -67.39 -39.09 85.58 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.229 -0.919 . . . . 0.0 109.232 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.507 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 1.7 tt0 -59.63 -49.78 76.43 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.496 -0.752 . . . . 0.0 109.686 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.49 ' CB ' ' HA3' ' A' ' 121' ' ' GLY . 4.8 p -52.94 -37.97 61.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.159 -0.963 . . . . 0.0 109.498 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.492 HG21 ' CB ' ' A' ' 145' ' ' PHE . 5.7 t -68.27 -46.98 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -0.88 . . . . 0.0 109.921 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.507 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -57.05 -33.32 67.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.218 -0.926 . . . . 0.0 109.562 179.688 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.475 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 19.9 mttt -63.71 -50.98 67.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.434 -0.791 . . . . 0.0 109.905 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.594 ' HA ' ' CE1' ' A' ' 120' ' ' PHE . 10.5 p -69.42 -10.77 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.962 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.21 -30.97 17.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.397 -0.814 . . . . 0.0 109.948 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 1.6 p-10 -55.29 -23.5 23.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.152 -0.968 . . . . 0.0 110.388 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.516 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 0.8 OUTLIER -139.72 94.76 2.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 0.0 109.961 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.539 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 3.1 pttp -89.91 15.06 10.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.158 -0.963 . . . . 0.0 110.606 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -87.94 67.77 9.09 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.576 ' HB2' ' CG1' ' A' ' 167' ' ' ILE . 84.9 m-70 -86.94 151.9 22.89 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.324 -177.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 160' ' ' HIS . 23.6 mttt -146.9 72.45 1.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.463 -0.773 . . . . 0.0 109.599 178.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.415 HD12 HD13 ' A' ' 113' ' ' LEU . 0.7 OUTLIER -106.43 151.9 24.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.0 110.579 -179.538 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.519 ' OD1' ' CG2' ' A' ' 108' ' ' THR . 0.7 OUTLIER 59.61 20.75 9.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.298 -0.876 . . . . 0.0 110.123 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.94 26.46 71.07 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.61 150.37 33.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.311 -1.111 . . . . 0.0 110.446 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.412 HG11 ' N ' ' A' ' 167' ' ' ILE . 57.7 t -92.15 160.6 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.33 -0.856 . . . . 0.0 109.745 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.576 ' CG1' ' HB2' ' A' ' 160' ' ' HIS . 3.8 pt -125.41 -177.65 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.014 -1.054 . . . . 0.0 111.602 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 102' ' ' GLY . 1.8 t70 -129.5 94.31 32.96 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.473 ' CG ' ' HB2' ' A' ' 158' ' ' LYS . 47.9 Cg_endo -74.44 124.3 8.8 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 124.302 1.685 . . . . 0.0 111.048 -178.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.457 ' O ' ' CB ' ' A' ' 99' ' ' MET . 4.7 mttm -150.24 -165.6 2.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.425 -0.797 . . . . 0.0 109.961 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -90.55 -170.73 2.82 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.654 -0.819 . . . . 0.0 109.345 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.004 -1.06 . . . . 0.0 110.596 -179.933 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.471 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 26.9 mtmt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.061 0.457 . . . . 0.0 109.797 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.528 ' HE1' ' CD1' ' A' ' 101' ' ' ILE . 8.5 ptm -136.13 178.55 6.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.154 -0.966 . . . . 0.0 110.762 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.725 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 1.7 t80 -119.88 130.94 55.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.495 -0.753 . . . . 0.0 109.948 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.549 HG13 ' CG2' ' A' ' 143' ' ' VAL . 3.8 mm -114.21 90.42 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.435 -0.791 . . . . 0.0 109.149 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -92.48 148.64 19.21 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.1 23.19 6.82 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.588 ' CB ' ' CD1' ' A' ' 130' ' ' LEU . 5.9 mp -82.74 163.36 21.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.992 -1.299 . . . . 0.0 109.995 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.524 ' O ' ' CD1' ' A' ' 130' ' ' LEU . 0.4 OUTLIER -91.52 178.55 5.91 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.315 -0.866 . . . . 0.0 111.051 -179.665 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.44 ' HA ' HD21 ' A' ' 130' ' ' LEU . 6.1 m-90 -72.64 -4.14 29.15 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.292 -0.88 . . . . 0.0 109.936 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.56 14.2 12.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.18 -0.95 . . . . 0.0 111.178 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.49 ' OG1' HD11 ' A' ' 130' ' ' LEU . 0.1 OUTLIER -75.35 157.91 33.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.959 -1.088 . . . . 0.0 109.355 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 68.1 p -150.49 174.22 13.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.165 -0.959 . . . . 0.0 110.704 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 126' ' ' CYS . 8.2 ttpt -66.93 -17.59 64.98 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.511 -0.743 . . . . 0.0 109.35 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -61.31 1.92 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.352 -0.843 . . . . 0.0 110.807 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 14.6 p30 -63.84 -18.15 63.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.997 -1.064 . . . . 0.0 109.879 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.516 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 36.8 tp -87.95 -53.55 4.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.898 . . . . 0.0 109.331 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.534 ' HB2' ' CB ' ' A' ' 126' ' ' CYS . 7.0 tmtt? -61.68 -38.57 88.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.558 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.493 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 6.3 t70 -72.5 -54.87 8.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.249 -0.907 . . . . 0.0 110.035 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.563 ' CG ' HD11 ' A' ' 162' ' ' LEU . 55.4 t80 -49.46 -30.28 7.87 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.395 -1.322 . . . . 0.0 108.0 178.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.559 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 12.9 m-85 -90.71 -9.13 47.88 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 119.736 -0.786 . . . . 0.0 111.122 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.493 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 0.1 OUTLIER -69.07 -14.16 62.86 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.83 -1.169 . . . . 0.0 108.708 178.41 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -18.65 60.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.534 -0.729 . . . . 0.0 110.056 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.559 ' CD1' ' HA ' ' A' ' 117' ' ' PHE . 71.2 m-85 -89.03 -64.34 1.16 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.23 -0.918 . . . . 0.0 109.176 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.406 ' HA3' ' HB2' ' A' ' 150' ' ' SER . . . -152.68 175.53 31.22 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.65 146.68 51.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.061 -1.258 . . . . 0.0 110.211 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' A' ' 145' ' ' PHE . 2.0 t -123.06 132.14 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.357 -0.839 . . . . 0.0 110.674 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.1 -24.5 5.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.432 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 1.0 OUTLIER -145.18 160.64 41.14 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 118.797 -1.161 . . . . 0.0 112.258 -179.163 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.534 ' CB ' ' HB2' ' A' ' 114' ' ' LYS . 34.1 t -169.57 118.9 0.64 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.415 HG21 ' N ' ' A' ' 128' ' ' LEU . 0.8 OUTLIER -118.56 166.68 12.42 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.498 -0.751 . . . . 0.0 110.823 -178.573 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.543 ' CD2' ' HB2' ' A' ' 130' ' ' LEU . 0.3 OUTLIER -146.92 125.65 12.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.501 -0.749 . . . . 0.0 109.739 179.252 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.515 ' N ' HD23 ' A' ' 128' ' ' LEU . 1.9 tptp -104.04 73.79 1.17 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.142 -0.974 . . . . 0.0 109.449 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.588 ' CD1' ' CB ' ' A' ' 104' ' ' LEU . 3.0 mt -151.42 32.27 0.58 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.864 -0.523 . . . . 0.0 110.257 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.1 111.55 7.47 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.248 -0.907 . . . . 0.0 110.727 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 130' ' ' LEU . 52.1 Cg_endo -82.71 8.87 4.32 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 124.026 1.54 . . . . 0.0 110.973 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.558 ' CG2' ' N ' ' A' ' 134' ' ' THR . 0.2 OUTLIER -96.62 -46.24 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.974 -1.078 . . . . 0.0 110.37 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.558 ' N ' ' CG2' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -93.2 7.99 42.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.128 -0.983 . . . . 0.0 110.08 179.729 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 64.36 30.92 79.19 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -113.66 27.61 9.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -1.144 . . . . 0.0 110.378 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.581 ' HA ' ' HA ' ' A' ' 130' ' ' LEU . 96.9 p -88.06 116.08 25.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 109.875 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -103.74 -6.05 21.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.174 -0.954 . . . . 0.0 110.554 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.567 ' HA2' ' CD2' ' A' ' 130' ' ' LEU . . . 90.74 34.17 7.96 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.715 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.522 ' CD2' ' CZ ' ' A' ' 100' ' ' PHE . 19.1 p90 -162.88 145.86 10.79 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.307 -1.701 . . . . 0.0 111.884 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 128' ' ' LEU . . . -135.76 -179.27 16.43 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.725 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 7.8 m-85 -123.02 167.08 14.08 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.119 -1.224 . . . . 0.0 110.767 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.549 ' CG2' HG13 ' A' ' 101' ' ' ILE . 3.5 t -142.89 134.23 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.376 -0.828 . . . . 0.0 109.474 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.471 ' HG ' ' HG2' ' A' ' 98' ' ' LYS . 5.0 mp -120.87 103.44 9.08 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.42 -0.8 . . . . 0.0 109.786 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.52 ' CZ ' HG23 ' A' ' 154' ' ' VAL . 16.5 m-85 -77.49 169.52 18.16 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.453 -0.78 . . . . 0.0 110.899 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -84.36 -32.57 24.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.694 -0.629 . . . . 0.0 111.039 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.478 ' HG3' ' OG ' ' A' ' 150' ' ' SER . 0.3 OUTLIER -135.9 158.49 44.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.803 -1.186 . . . . 0.0 110.616 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.63 -31.56 72.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.293 -0.879 . . . . 0.0 110.28 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.476 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 0.0 OUTLIER -61.81 -45.54 93.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.936 . . . . 0.0 110.079 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.478 ' OG ' ' HG3' ' A' ' 147' ' ' GLU . 43.0 p -63.59 -40.06 95.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.353 -0.842 . . . . 0.0 110.297 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.513 ' CG2' ' HB2' ' A' ' 145' ' ' PHE . 5.2 t -60.41 -59.06 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.096 -1.003 . . . . 0.0 109.823 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.476 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.5 OUTLIER -53.06 -41.69 65.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.103 -0.998 . . . . 0.0 109.439 179.612 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.464 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 9.7 tttt -51.83 -35.84 45.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.337 -0.852 . . . . 0.0 109.813 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.521 HG11 ' CE2' ' A' ' 120' ' ' PHE . 3.7 t -82.32 -22.5 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.277 -0.89 . . . . 0.0 110.4 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 6.7 tmm? -86.05 -24.52 26.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.869 . . . . 0.0 110.375 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 40.8 p30 -65.83 -13.18 59.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.17 -0.956 . . . . 0.0 110.162 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.58 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 8.5 tt0 -142.37 88.21 2.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.92 . . . . 0.0 109.815 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.412 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -86.49 19.4 2.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.286 -0.884 . . . . 0.0 110.594 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -87.99 58.9 5.05 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.58 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 16.4 m-70 -86.58 -168.3 2.19 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.898 -177.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.484 ' CE ' ' C ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -176.31 64.94 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.582 -0.699 . . . . 0.0 109.406 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.563 HD11 ' CG ' ' A' ' 116' ' ' TYR . 10.6 tp -89.2 147.32 24.22 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.452 -0.78 . . . . 0.0 110.228 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.44 ' OD1' ' HB3' ' A' ' 105' ' ' SER . 0.1 OUTLIER 59.91 20.31 9.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.348 -0.845 . . . . 0.0 109.66 -179.604 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.484 ' C ' ' CE ' ' A' ' 161' ' ' LYS . . . 80.57 20.1 67.03 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.11 149.48 30.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -1.167 . . . . 0.0 110.202 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.463 HG11 ' N ' ' A' ' 167' ' ' ILE . 28.9 t -67.7 163.9 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 109.963 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.528 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.1 OUTLIER -120.95 -177.54 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.175 -0.953 . . . . 0.0 111.021 -179.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -133.07 83.28 52.06 Favored Pre-proline 0 C--N 1.304 -1.391 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.36 131.31 14.95 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.267 1.667 . . . . 0.0 110.559 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.1 mmtm -145.02 -176.79 5.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.326 -0.859 . . . . 0.0 110.307 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 -91.67 -169.58 2.33 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.363 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.461 -0.775 . . . . 0.0 110.059 179.955 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.539 ' CG ' ' HG ' ' A' ' 144' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.237 0.541 . . . . 0.0 110.505 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.542 ' HE1' ' CD1' ' A' ' 101' ' ' ILE . 7.7 ptm -115.15 176.89 4.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.296 -0.878 . . . . 0.0 109.736 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.711 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 1.2 t80 -116.55 125.52 52.0 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.351 -0.843 . . . . 0.0 110.155 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.542 ' CD1' ' HE1' ' A' ' 99' ' ' MET . 1.3 mm -110.48 92.55 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.515 -0.741 . . . . 0.0 109.081 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -94.49 125.59 8.36 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.844 -1.169 . . . . 0.0 110.233 -179.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 131.97 2.01 4.37 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.577 HD21 ' HA ' ' A' ' 140' ' ' PHE . 3.9 mm? -52.45 162.28 0.56 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.212 -1.169 . . . . 0.0 110.003 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.479 ' HB2' ' HB3' ' A' ' 163' ' ' ASN . 0.5 OUTLIER -87.33 -176.75 5.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.174 -0.954 . . . . 0.0 110.302 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.461 ' CD1' ' OG ' ' A' ' 137' ' ' SER . 1.4 t90 -75.67 -22.92 56.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.287 -0.883 . . . . 0.0 110.282 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 29.1 p-10 -113.99 41.64 2.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.939 . . . . 0.0 110.163 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.523 HG23 ' CD1' ' A' ' 104' ' ' LEU . 0.7 OUTLIER -86.3 130.5 34.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 110.471 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.467 ' OG1' ' OD2' ' A' ' 112' ' ' ASP . 38.4 p -117.01 149.74 39.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.294 -0.879 . . . . 0.0 109.871 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.512 ' CG ' ' HA ' ' A' ' 127' ' ' THR . 3.8 mtpt -55.9 -16.36 4.58 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.182 -0.949 . . . . 0.0 110.057 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.418 ' HE2' ' HA ' ' A' ' 112' ' ' ASP . 0.3 OUTLIER -75.35 -56.68 4.48 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.183 -0.948 . . . . 0.0 110.779 -179.766 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 2.9 p30 -65.53 -34.09 77.44 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.002 -1.061 . . . . 0.0 110.915 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.536 HD13 ' CD2' ' A' ' 162' ' ' LEU . 12.4 tp -75.6 -55.44 5.66 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.986 -1.071 . . . . 0.0 109.876 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.437 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -49.17 -41.55 37.01 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.217 -0.927 . . . . 0.0 109.818 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.447 ' O ' ' C ' ' A' ' 116' ' ' TYR . 2.3 m-20 -75.83 -48.5 21.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.896 . . . . 0.0 110.218 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.572 ' CD2' HD21 ' A' ' 162' ' ' LEU . 70.1 t80 -47.15 -33.35 5.1 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.665 -1.214 . . . . 0.0 108.261 178.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.586 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 18.1 m-85 -91.2 -14.75 30.47 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.035 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 115' ' ' ASP . 40.2 t -63.45 -12.39 30.97 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.94 -1.1 . . . . 0.0 109.316 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -80.86 -13.42 58.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.475 -0.765 . . . . 0.0 110.008 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.586 ' CD1' ' HA ' ' A' ' 117' ' ' PHE . 67.4 m-85 -88.9 -36.53 15.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.249 -0.907 . . . . 0.0 109.479 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -177.44 -164.64 31.33 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.461 ' HB3' ' HG3' ' A' ' 146' ' ' LYS . 0.4 OUTLIER -88.84 108.76 19.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.188 -1.184 . . . . 0.0 110.27 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.578 HG21 ' CD1' ' A' ' 145' ' ' PHE . 1.8 t -90.3 130.06 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.234 -0.916 . . . . 0.0 111.163 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.459 ' O ' ' OD1' ' A' ' 125' ' ' ASP . 2.1 t -89.46 -23.16 6.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.473 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 3.8 m-20 -147.58 167.88 23.41 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 118.345 -1.342 . . . . 0.0 112.901 -178.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 25.9 t -169.03 148.05 4.0 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.512 ' HA ' ' CG ' ' A' ' 110' ' ' LYS . 0.9 OUTLIER -151.27 162.69 40.44 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.652 -1.219 . . . . 0.0 111.926 -177.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.504 ' O ' ' CD1' ' A' ' 128' ' ' LEU . 1.1 tm? -127.81 111.61 13.84 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.588 ' HB3' ' CE2' ' A' ' 140' ' ' PHE . 0.5 OUTLIER -92.63 134.74 34.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.086 -1.009 . . . . 0.0 111.205 -178.753 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.416 ' HA ' ' H ' ' A' ' 138' ' ' ARG . 4.5 mt -105.62 -157.9 0.63 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.842 -0.537 . . . . 0.0 109.654 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 66.4 m-20 -88.21 112.59 50.51 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.108 -0.995 . . . . 0.0 109.581 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -74.2 -12.53 23.31 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.969 1.51 . . . . 0.0 111.435 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.554 ' CG2' ' N ' ' A' ' 134' ' ' THR . 0.1 OUTLIER -105.04 -45.16 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.959 -1.088 . . . . 0.0 110.798 -179.551 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.554 ' N ' ' CG2' ' A' ' 133' ' ' ILE . 70.8 p -91.54 -16.73 26.73 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.154 -0.966 . . . . 0.0 110.332 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.84 -27.01 7.62 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' A' ' 131' ' ' ASP . 4.6 mmp_? -65.62 -175.05 0.24 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.323 -1.104 . . . . 0.0 110.288 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.461 ' OG ' ' CD1' ' A' ' 106' ' ' TRP . 1.3 m -90.59 129.88 36.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.4 -0.813 . . . . 0.0 110.161 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.57 ' HD2' ' CE2' ' A' ' 140' ' ' PHE . 4.2 ttt180 -88.7 -25.1 22.53 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.44 49.07 3.32 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.634 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.665 ' CD1' ' CZ ' ' A' ' 100' ' ' PHE . 2.6 p90 -159.98 116.94 2.53 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.45 -1.617 . . . . 0.0 111.496 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 127' ' ' THR . . . -121.91 -175.9 15.02 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.711 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 7.2 m-85 -120.04 171.73 8.25 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.02 -1.283 . . . . 0.0 110.987 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.482 ' HB ' ' HG3' ' A' ' 99' ' ' MET . 6.4 t -140.76 129.42 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.539 ' HG ' ' CG ' ' A' ' 98' ' ' LYS . 6.3 mp -111.25 100.54 9.15 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.432 -0.792 . . . . 0.0 110.088 -178.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.578 ' CD1' HG21 ' A' ' 123' ' ' VAL . 8.1 m-85 -81.05 162.76 23.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.591 -0.693 . . . . 0.0 110.893 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.461 ' HG3' ' HB3' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -61.66 -48.86 78.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.523 -0.736 . . . . 0.0 110.073 179.225 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.459 ' OE1' ' HB3' ' A' ' 146' ' ' LYS . 1.4 pm0 -144.51 171.55 14.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.267 -0.896 . . . . 0.0 110.667 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.415 ' HA ' HG22 ' A' ' 151' ' ' VAL . 0.2 OUTLIER -55.67 -43.05 75.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.238 -0.914 . . . . 0.0 109.979 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.466 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 0.1 OUTLIER -42.1 -51.68 4.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 110.336 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 2.2 p -66.32 -36.55 83.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.199 -0.938 . . . . 0.0 110.446 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.415 HG22 ' HA ' ' A' ' 148' ' ' SER . 5.3 t -66.38 -56.65 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.074 -1.016 . . . . 0.0 110.446 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.466 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.7 OUTLIER -50.3 -38.78 43.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.141 -0.974 . . . . 0.0 109.666 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.486 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -57.33 -47.75 80.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.407 -0.808 . . . . 0.0 109.57 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.572 HG22 ' CE2' ' A' ' 145' ' ' PHE . 11.4 t -60.25 -31.98 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -0.876 . . . . 0.0 109.909 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 156' ' ' ASP . 6.4 mtt -75.5 -26.55 58.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.304 -0.872 . . . . 0.0 110.084 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.9 OUTLIER -46.71 -27.72 1.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.934 -1.104 . . . . 0.0 108.642 179.256 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.556 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 5.0 mt-30 -143.4 114.11 7.6 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.706 -0.621 . . . . 0.0 109.357 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.08 20.39 14.58 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.27 -0.894 . . . . 0.0 110.187 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -88.39 57.39 4.22 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.558 ' CE1' HG11 ' A' ' 154' ' ' VAL . 12.1 m-70 -87.13 81.76 7.91 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.327 -176.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -78.35 70.23 4.67 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.179 -0.95 . . . . 0.0 109.263 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.572 HD21 ' CD2' ' A' ' 116' ' ' TYR . 15.9 tp -87.96 145.49 25.99 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.443 -0.785 . . . . 0.0 110.235 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.479 ' HB3' ' HB2' ' A' ' 105' ' ' SER . 0.8 OUTLIER 58.09 22.62 9.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.349 -0.845 . . . . 0.0 109.661 -179.584 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 75.83 22.59 74.28 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.93 144.63 26.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -1.108 . . . . 0.0 110.319 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 160' ' ' HIS . 3.8 t -78.27 160.87 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 109.674 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.498 ' CG1' ' HB2' ' A' ' 160' ' ' HIS . 1.3 pt -123.58 -174.98 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.114 -0.991 . . . . 0.0 111.046 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.55 ' N ' ' O ' ' A' ' 102' ' ' GLY . 5.6 t70 -128.91 89.81 47.71 Favored Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.71 125.52 9.54 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.399 1.736 . . . . 0.0 110.655 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -150.27 -164.02 1.92 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.453 -0.779 . . . . 0.0 110.215 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.39 -167.02 1.74 Allowed 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.179 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.517 0 O-C-N 121.315 -0.866 . . . . 0.0 110.691 -179.172 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.538 ' HG2' ' CD1' ' A' ' 144' ' ' LEU . 2.8 mtpp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.214 0.53 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.585 ' CE ' ' CD1' ' A' ' 101' ' ' ILE . 17.4 ttp -147.17 154.66 41.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.21 -0.931 . . . . 0.0 110.105 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.694 ' CE2' ' CZ ' ' A' ' 142' ' ' PHE . 2.3 t80 -110.15 135.4 51.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.359 -0.838 . . . . 0.0 109.994 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.585 ' CD1' ' CE ' ' A' ' 99' ' ' MET . 3.6 mm -112.87 97.66 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.28 -0.888 . . . . 0.0 109.48 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.537 ' HA2' ' CB ' ' A' ' 140' ' ' PHE . . . -89.36 109.32 3.58 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 134.06 36.86 0.24 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.549 ' CD1' HG22 ' A' ' 108' ' ' THR . 0.4 OUTLIER -83.68 149.22 26.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.335 -1.097 . . . . 0.0 109.442 179.507 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.472 ' O ' HD11 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -69.8 146.24 51.55 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.054 -1.029 . . . . 0.0 109.545 179.478 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.557 ' CE2' ' HB2' ' A' ' 137' ' ' SER . 0.8 OUTLIER -62.03 -11.2 12.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.271 -0.893 . . . . 0.0 110.115 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.61 16.22 13.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.251 -0.906 . . . . 0.0 110.595 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.549 HG22 ' CD1' ' A' ' 104' ' ' LEU . 11.0 m -70.27 174.43 5.6 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.122 -0.986 . . . . 0.0 110.408 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.463 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 31.2 p -148.39 154.32 39.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.384 -0.822 . . . . 0.0 109.575 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 114' ' ' LYS . 13.7 mtmt -57.97 -16.86 13.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.337 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.47 -62.02 1.77 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.192 -0.942 . . . . 0.0 111.172 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 6.6 p30 -57.94 -28.37 64.23 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.038 -1.039 . . . . 0.0 110.775 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.521 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 16.0 tp -78.86 -40.53 32.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.983 -1.073 . . . . 0.0 109.696 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 110' ' ' LYS . 3.9 ttpt -55.37 -59.26 5.05 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.123 -0.986 . . . . 0.0 109.711 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.471 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 63.3 m-20 -61.78 -40.83 96.54 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.2 -0.937 . . . . 0.0 109.213 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.573 ' CG ' HD22 ' A' ' 162' ' ' LEU . 69.8 t80 -47.35 -40.48 17.42 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.203 177.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.497 ' CD1' ' CE2' ' A' ' 120' ' ' PHE . 27.0 m-85 -91.6 -4.56 55.16 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.673 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.471 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 1.4 m -70.16 -6.36 33.69 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.783 -1.198 . . . . 0.0 109.221 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.414 ' HA ' ' HE3' ' A' ' 119' ' ' LYS . 0.5 OUTLIER -80.46 -18.66 48.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.367 -0.833 . . . . 0.0 110.23 -179.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.543 ' CG ' ' CG2' ' A' ' 154' ' ' VAL . 70.1 m-85 -89.49 -68.35 0.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.675 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -147.43 -165.11 11.61 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.47 ' O ' ' CB ' ' A' ' 146' ' ' LYS . 0.6 OUTLIER -90.3 119.82 30.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.159 -1.201 . . . . 0.0 110.863 -179.706 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.511 ' CG1' ' O ' ' A' ' 125' ' ' ASP . 1.9 t -91.96 132.34 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -0.856 . . . . 0.0 110.244 179.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.406 HG11 ' OD2' ' A' ' 125' ' ' ASP . 2.1 t -89.07 -26.88 5.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.511 ' O ' ' CG1' ' A' ' 123' ' ' VAL . 1.4 m-20 -145.63 167.25 23.53 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.226 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.414 ' SG ' HD22 ' A' ' 113' ' ' LEU . 42.3 t -165.74 150.35 8.47 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.636 -0.665 . . . . 0.0 109.363 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.519 ' CG2' ' N ' ' A' ' 128' ' ' LEU . 0.9 OUTLIER -149.95 174.08 13.1 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.368 -0.833 . . . . 0.0 109.862 -179.099 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.558 ' CD1' ' HG ' ' A' ' 130' ' ' LEU . 2.8 pp -149.7 165.43 32.41 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.426 -0.796 . . . . 0.0 110.068 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 140' ' ' PHE . 5.4 mmtt -140.96 71.58 1.37 Allowed 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.719 0.771 . . . . 0.0 109.042 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.603 ' CA ' ' HA ' ' A' ' 137' ' ' SER . 0.9 OUTLIER -150.65 18.62 0.81 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -179.55 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.482 ' O ' ' OG ' ' A' ' 137' ' ' SER . 2.4 m-20 -39.14 99.3 0.19 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.559 -0.713 . . . . 0.0 111.045 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 130' ' ' LEU . 53.5 Cg_endo -79.23 -24.12 6.94 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.156 1.609 . . . . 0.0 110.574 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.45 ' C ' ' CD1' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -89.8 -34.63 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.177 -0.952 . . . . 0.0 110.344 -179.579 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.42 ' N ' HG21 ' A' ' 133' ' ' ILE . 0.1 OUTLIER -89.42 -0.59 57.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.201 -0.937 . . . . 0.0 109.854 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 64.53 19.78 65.08 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.2 27.64 8.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.32 -1.106 . . . . 0.0 110.271 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.603 ' HA ' ' CA ' ' A' ' 130' ' ' LEU . 0.9 OUTLIER -73.94 133.75 43.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.301 -0.874 . . . . 0.0 109.359 179.562 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.595 ' HB3' ' CE2' ' A' ' 140' ' ' PHE . 1.6 mtp180 -116.76 -0.44 12.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.8 -1.188 . . . . 0.0 110.816 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 91.41 6.38 66.28 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.899 -1.143 . . . . 0.0 111.535 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.595 ' CE2' ' HB3' ' A' ' 138' ' ' ARG . 42.2 p90 -149.76 -170.21 3.58 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.39 -1.653 . . . . 0.0 111.197 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.514 ' CA ' ' HA ' ' A' ' 128' ' ' LEU . . . -162.7 -164.64 18.16 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.694 ' CZ ' ' CE2' ' A' ' 100' ' ' PHE . 28.1 m-85 -140.37 167.19 22.74 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.893 -1.357 . . . . 0.0 111.27 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.471 ' C ' ' CD2' ' A' ' 144' ' ' LEU . 3.0 t -148.99 133.75 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.538 ' CD1' ' HG2' ' A' ' 98' ' ' LYS . 3.2 mm? -116.12 94.33 4.61 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.665 -0.647 . . . . 0.0 109.569 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.591 ' CE2' HG22 ' A' ' 154' ' ' VAL . 9.1 m-85 -73.0 161.18 30.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.418 -0.801 . . . . 0.0 110.992 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.47 ' CB ' ' O ' ' A' ' 122' ' ' GLU . 18.0 tptt -80.71 -39.4 27.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.594 -0.691 . . . . 0.0 111.182 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.519 ' OE2' ' CB ' ' A' ' 149' ' ' GLU . 0.7 OUTLIER -133.66 158.48 43.13 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.853 -1.154 . . . . 0.0 110.851 -179.305 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 78.0 p -63.23 -27.7 69.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 109.964 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.519 ' CB ' ' OE2' ' A' ' 147' ' ' GLU . 0.3 OUTLIER -64.41 -43.47 94.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.371 -0.83 . . . . 0.0 109.761 179.721 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.494 ' CB ' ' HA3' ' A' ' 121' ' ' GLY . 11.5 p -64.46 -41.18 96.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.109 -0.994 . . . . 0.0 109.653 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.526 HG21 ' CB ' ' A' ' 145' ' ' PHE . 2.9 t -65.46 -45.44 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.635 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.449 ' OD2' ' O ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -54.23 -36.02 63.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.125 -0.984 . . . . 0.0 109.182 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.471 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 6.7 tttt -62.88 -43.58 98.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.469 -0.769 . . . . 0.0 109.379 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.591 HG22 ' CE2' ' A' ' 145' ' ' PHE . 20.5 t -64.7 -42.18 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.294 -0.879 . . . . 0.0 110.09 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 2.8 ttp -71.75 -21.71 61.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.331 -0.856 . . . . 0.0 109.944 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.0 OUTLIER -52.26 -31.49 32.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.14 -0.975 . . . . 0.0 109.423 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.526 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 0.8 OUTLIER -147.97 108.36 4.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.46 -0.775 . . . . 0.0 109.819 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.438 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -87.8 36.14 0.75 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.216 -0.928 . . . . 0.0 110.71 -179.658 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -89.33 48.96 1.68 Allowed 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 176.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.558 ' HB2' HG13 ' A' ' 167' ' ' ILE . 17.8 m-70 -87.68 93.75 9.53 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.267 -177.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -103.07 87.19 2.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 0.0 110.215 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.573 HD22 ' CG ' ' A' ' 116' ' ' TYR . 0.4 OUTLIER -90.48 141.67 28.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.169 -0.957 . . . . 0.0 109.64 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 15.1 m120 50.42 23.78 1.37 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.138 -0.977 . . . . 0.0 110.215 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.72 37.25 26.98 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.96 136.24 18.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.165 -1.197 . . . . 0.0 110.272 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 160' ' ' HIS . 34.9 t -81.59 164.74 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.24 -0.913 . . . . 0.0 110.154 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.558 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.6 OUTLIER -128.68 174.17 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.186 -0.946 . . . . 0.0 110.709 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 102' ' ' GLY . 16.1 t0 -119.97 94.34 48.51 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.96 111.86 3.27 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.158 1.61 . . . . 0.0 110.83 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.536 ' O ' ' CG ' ' A' ' 99' ' ' MET . 2.1 mttt -125.72 152.87 44.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.572 -0.705 . . . . 0.0 109.652 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.54 159.64 15.82 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.987 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.465 0 O-C-N 121.323 -0.86 . . . . 0.0 110.781 -179.257 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.472 ' HG2' HD22 ' A' ' 144' ' ' LEU . 3.7 mtpp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.271 0.558 . . . . 0.0 110.294 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.549 ' HE1' ' CD1' ' A' ' 101' ' ' ILE . 4.0 ptm -141.41 170.11 16.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.334 -0.854 . . . . 0.0 109.98 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.723 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 2.2 t80 -112.96 142.84 45.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.907 . . . . 0.0 110.489 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.549 ' CD1' ' HE1' ' A' ' 99' ' ' MET . 15.9 mm -131.22 99.14 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.306 -0.871 . . . . 0.0 109.548 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -99.83 132.85 11.08 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.809 -1.186 . . . . 0.0 110.557 -179.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 166' ' ' VAL . . . 127.9 28.03 0.9 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.531 ' CD1' HG22 ' A' ' 108' ' ' THR . 3.4 mm? -87.97 167.5 13.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.004 -1.292 . . . . 0.0 110.082 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.472 ' O ' HD23 ' A' ' 130' ' ' LEU . 3.1 p -88.43 144.48 26.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.857 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.506 ' O ' ' O ' ' A' ' 130' ' ' LEU . 15.7 m-90 -45.74 -21.38 0.11 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.153 -0.967 . . . . 0.0 110.422 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 105' ' ' SER . 4.6 t0 -112.29 44.57 1.41 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.842 -1.162 . . . . 0.0 110.103 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.531 HG22 ' CD1' ' A' ' 104' ' ' LEU . 87.6 m -90.67 167.74 12.29 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.145 -0.972 . . . . 0.0 110.713 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.443 ' N ' HG23 ' A' ' 108' ' ' THR . 64.1 p -146.42 152.09 38.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.379 -0.826 . . . . 0.0 109.862 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 114' ' ' LYS . 7.6 pttm -63.7 -11.95 30.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.125 -0.984 . . . . 0.0 109.482 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.59 -56.23 4.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.373 -0.83 . . . . 0.0 110.525 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.427 ' OD1' ' C ' ' A' ' 112' ' ' ASP . 0.6 OUTLIER -63.74 -36.76 84.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.118 -0.989 . . . . 0.0 109.938 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.462 HD11 HD13 ' A' ' 104' ' ' LEU . 3.6 tp -73.49 -45.16 55.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 109.746 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 5.8 ttpt -57.11 -38.88 74.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.296 -0.878 . . . . 0.0 109.555 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 118' ' ' SER . 83.8 m-20 -74.08 -49.77 22.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.239 -0.913 . . . . 0.0 109.736 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.422 ' C ' ' O ' ' A' ' 115' ' ' ASP . 65.2 t80 -47.75 -33.2 6.77 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 118.669 -1.212 . . . . 0.0 108.154 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.597 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 17.1 m-85 -91.03 -11.92 37.36 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.972 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 115' ' ' ASP . 0.4 OUTLIER -64.34 -13.17 48.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.005 -1.059 . . . . 0.0 109.133 179.06 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -80.44 -13.2 59.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.432 -0.793 . . . . 0.0 109.839 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.597 ' CD1' ' HA ' ' A' ' 117' ' ' PHE . 64.1 m-85 -89.45 -64.27 1.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.298 -0.877 . . . . 0.0 109.48 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.406 ' HA3' ' HB3' ' A' ' 150' ' ' SER . . . -153.19 -170.36 19.33 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -85.27 119.87 26.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.182 -1.187 . . . . 0.0 110.24 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.54 HG21 ' CD1' ' A' ' 145' ' ' PHE . 1.9 t -93.92 130.08 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.144 -0.972 . . . . 0.0 111.048 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.405 ' O ' ' OD1' ' A' ' 125' ' ' ASP . 2.2 t -89.37 -26.02 5.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.491 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 2.2 m-20 -143.98 161.61 38.3 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.24 -0.984 . . . . 0.0 111.704 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 45.1 t -166.27 120.76 1.15 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.635 -0.665 . . . . 0.0 109.302 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.481 HG21 ' N ' ' A' ' 128' ' ' LEU . 0.8 OUTLIER -114.52 167.99 10.25 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.384 -0.822 . . . . 0.0 110.294 -179.063 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.581 ' O ' ' CD1' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -151.85 125.04 8.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 110.766 179.243 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 140' ' ' PHE . 0.2 OUTLIER -106.58 71.79 0.88 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.705 -1.247 . . . . 0.0 109.151 179.242 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.563 ' CA ' ' HA ' ' A' ' 137' ' ' SER . 1.4 mp -146.71 7.67 0.97 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.779 -0.576 . . . . 0.0 110.218 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' A' ' 137' ' ' SER . 7.7 m-20 -53.2 107.03 0.74 Allowed Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.03 -1.044 . . . . 0.0 110.669 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 130' ' ' LEU . 51.3 Cg_endo -79.95 -4.27 13.23 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.044 1.549 . . . . 0.0 110.53 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.553 ' CG2' ' N ' ' A' ' 134' ' ' THR . 0.0 OUTLIER -93.61 -43.63 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.145 -0.972 . . . . 0.0 110.323 -179.675 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.553 ' N ' ' CG2' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -90.01 24.66 2.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 110.046 -179.668 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 46.65 25.25 2.11 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -111.9 27.47 9.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.374 -1.074 . . . . 0.0 110.269 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.563 ' HA ' ' CA ' ' A' ' 130' ' ' LEU . 33.1 p -88.52 111.26 21.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 110.057 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.613 ' HB3' ' CE2' ' A' ' 140' ' ' PHE . 0.0 OUTLIER -99.33 -6.47 27.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.296 -179.707 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.42 ' HA2' ' CD2' ' A' ' 130' ' ' LEU . . . 91.17 7.02 66.06 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 120.171 -1.014 . . . . 0.0 111.389 178.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.613 ' CE2' ' HB3' ' A' ' 138' ' ' ARG . 18.9 p90 -148.39 149.0 30.97 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.504 -1.586 . . . . 0.0 111.416 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.525 ' CA ' ' HA ' ' A' ' 128' ' ' LEU . . . -129.04 170.6 20.11 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.723 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 6.6 m-85 -114.31 173.05 6.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -1.149 . . . . 0.0 110.763 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.472 ' HB ' ' HE1' ' A' ' 99' ' ' MET . 13.8 t -146.18 137.51 19.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.491 ' HB2' ' CB ' ' A' ' 125' ' ' ASP . 5.8 mp -123.12 101.18 7.25 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.416 -0.803 . . . . 0.0 109.727 -179.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.552 ' CE2' HG22 ' A' ' 154' ' ' VAL . 18.7 m-85 -75.53 152.43 37.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.369 -0.832 . . . . 0.0 110.245 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.23 -25.59 55.22 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.426 -0.796 . . . . 0.0 111.087 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.496 ' O ' ' OG ' ' A' ' 150' ' ' SER . 11.9 tt0 -133.04 147.36 52.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.677 -1.264 . . . . 0.0 110.765 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.442 ' N ' ' HG2' ' A' ' 147' ' ' GLU . 7.4 t -56.47 -45.87 80.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.086 -1.009 . . . . 0.0 109.442 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.498 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 14.1 tt0 -49.75 -60.99 2.38 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.498 -0.751 . . . . 0.0 109.993 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 0.2 OUTLIER -43.23 -39.72 3.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.19 -0.944 . . . . 0.0 109.716 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.535 HG21 ' CB ' ' A' ' 145' ' ' PHE . 5.3 t -66.2 -51.05 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.899 . . . . 0.0 110.262 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.498 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.3 OUTLIER -52.16 -27.18 13.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.133 -0.979 . . . . 0.0 109.924 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.459 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 5.8 mmtt -72.67 -49.42 31.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.459 -0.776 . . . . 0.0 110.317 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.552 HG22 ' CE2' ' A' ' 145' ' ' PHE . 5.6 t -63.93 -18.7 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.097 -1.002 . . . . 0.0 110.339 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 12.7 mmt -85.53 -38.23 18.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.121 -0.987 . . . . 0.0 110.489 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.2 OUTLIER -48.67 -34.64 12.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.118 -0.989 . . . . 0.0 110.233 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.529 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.6 mt-30 -128.51 94.89 3.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.312 -0.867 . . . . 0.0 110.013 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.574 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -90.39 21.84 3.69 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.154 -0.966 . . . . 0.0 110.412 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.554 ' CG ' ' O ' ' A' ' 159' ' ' GLU . 2.1 tt0 -88.39 67.21 8.58 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 177.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.574 ' CD2' ' HA ' ' A' ' 158' ' ' LYS . 87.3 m-70 -86.41 176.5 7.84 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.266 -177.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 160' ' ' HIS . 0.3 OUTLIER 179.62 74.3 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.487 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.46 ' O ' ' CB ' ' A' ' 163' ' ' ASN . 1.4 pp -110.95 153.99 24.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.405 -0.809 . . . . 0.0 110.326 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 162' ' ' LEU . 0.3 OUTLIER 67.09 8.56 6.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.378 -0.826 . . . . 0.0 109.859 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.448 ' O ' ' HG2' ' A' ' 165' ' ' LYS . . . 89.38 18.14 53.51 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 164' ' ' GLY . 37.5 mmtt -150.28 161.45 42.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.129 -1.218 . . . . 0.0 110.353 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 160' ' ' HIS . 4.2 p -87.14 177.36 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.355 -0.841 . . . . 0.0 110.232 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.539 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.6 OUTLIER -135.29 -168.05 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.216 -0.928 . . . . 0.0 110.943 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 102' ' ' GLY . 8.4 t70 -143.04 87.05 8.9 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.444 ' HA ' HD11 ' A' ' 101' ' ' ILE . 43.8 Cg_endo -71.88 131.69 18.73 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.314 1.691 . . . . 0.0 110.73 -178.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.82 166.25 27.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.443 -0.785 . . . . 0.0 110.26 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 172' ' ' ALA . 1.3 ttp180 -92.07 48.13 1.4 Allowed 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.264 -0.975 . . . . 0.0 109.869 178.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 171' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.47 -0.769 . . . . 0.0 110.449 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.5 ' HA ' ' HG ' ' A' ' 144' ' ' LEU . 70.0 mttt . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.143 0.496 . . . . 0.0 110.026 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.465 ' SD ' ' HA ' ' A' ' 171' ' ' ARG . 10.2 mmm -142.19 177.42 8.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 110.763 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.741 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 3.6 t80 -132.85 142.51 48.99 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.544 -0.722 . . . . 0.0 110.203 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.541 HG13 ' CG2' ' A' ' 143' ' ' VAL . 4.2 mm -125.57 98.86 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.293 -0.879 . . . . 0.0 109.792 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -98.82 130.07 10.1 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 134.15 3.53 3.13 Favored Glycine 0 N--CA 1.492 2.383 0 O-C-N 121.123 -1.222 . . . . 0.0 110.163 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.483 ' HB2' ' CA ' ' A' ' 140' ' ' PHE . 6.7 mp -64.86 166.16 9.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.073 -1.251 . . . . 0.0 110.186 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.6 p -90.72 -174.56 4.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.297 -0.877 . . . . 0.0 109.793 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -87.48 16.82 5.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.0 109.968 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -144.56 16.61 1.65 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.309 -0.87 . . . . 0.0 110.454 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.46 ' O ' HD21 ' A' ' 130' ' ' LEU . 11.3 m -73.43 168.16 19.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.939 -1.101 . . . . 0.0 109.78 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.467 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 29.8 p -144.6 152.04 39.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.134 -0.979 . . . . 0.0 110.604 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.436 ' O ' ' HB3' ' A' ' 114' ' ' LYS . 4.2 ttpt -53.51 -19.61 3.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.141 -0.974 . . . . 0.0 109.578 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.1 OUTLIER -72.12 -55.1 7.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.394 -0.817 . . . . 0.0 110.285 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 109' ' ' THR . 0.4 OUTLIER -65.71 -33.14 75.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.124 -0.985 . . . . 0.0 109.95 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.501 HD13 ' CD2' ' A' ' 162' ' ' LEU . 5.7 tp -73.85 -51.7 15.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 109.804 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 110' ' ' LYS . 1.1 ttpm? -60.0 -39.37 85.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 110.155 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 111' ' ' LYS . 0.5 OUTLIER -76.33 -54.38 6.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.081 -1.012 . . . . 0.0 110.572 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.466 ' HB2' HD12 ' A' ' 162' ' ' LEU . 65.4 t80 -46.39 -32.49 3.25 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.683 -1.207 . . . . 0.0 108.302 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.596 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 17.4 m-85 -91.23 -13.54 32.62 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.894 -0.723 . . . . 0.0 111.302 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 115' ' ' ASP . 5.7 t -64.11 -11.26 28.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.946 -1.096 . . . . 0.0 109.424 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.418 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 0.8 OUTLIER -83.83 -12.41 55.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.411 -0.805 . . . . 0.0 110.545 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.596 ' CD1' ' HA ' ' A' ' 117' ' ' PHE . 81.6 m-85 -89.03 -50.05 6.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.063 -1.023 . . . . 0.0 109.354 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.532 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -164.89 -164.73 20.88 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.408 ' O ' ' CB ' ' A' ' 146' ' ' LYS . 1.2 tt0 -90.12 107.67 19.27 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.388 -1.066 . . . . 0.0 110.086 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.506 HG21 ' CD1' ' A' ' 145' ' ' PHE . 1.8 t -89.46 132.34 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 111.19 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.454 HG11 ' OD1' ' A' ' 125' ' ' ASP . 2.4 t -90.15 -23.34 6.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.539 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 0.4 OUTLIER -143.51 158.98 43.23 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 118.525 -1.27 . . . . 0.0 112.848 -178.801 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.43 ' SG ' HD22 ' A' ' 113' ' ' LEU . 6.2 t -169.24 147.76 3.81 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.463 ' CG2' ' N ' ' A' ' 128' ' ' LEU . 0.8 OUTLIER -150.8 169.96 20.42 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.992 -1.067 . . . . 0.0 110.828 -178.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.563 ' CD2' ' N ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -144.4 135.29 25.05 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.662 -0.649 . . . . 0.0 109.473 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.595 ' HG2' ' CE1' ' A' ' 140' ' ' PHE . 0.0 OUTLIER -105.24 103.75 13.34 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.12 -0.987 . . . . 0.0 109.483 179.182 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.556 ' O ' ' CD1' ' A' ' 130' ' ' LEU . 0.2 OUTLIER -143.8 19.25 1.82 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.51 0.671 . . . . 0.0 109.279 -179.708 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 130' ' ' LEU . 1.2 m-20 -39.24 99.35 0.19 Allowed Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.276 -0.89 . . . . 0.0 110.809 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 130' ' ' LEU . 53.6 Cg_endo -83.56 -17.89 6.02 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.107 1.583 . . . . 0.0 110.51 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.459 HG21 HD11 ' A' ' 133' ' ' ILE . 0.1 OUTLIER -93.34 -37.11 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.246 -0.909 . . . . 0.0 110.694 -179.406 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.439 ' N ' HG21 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -91.7 -0.64 57.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.105 -0.997 . . . . 0.0 110.175 -179.838 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 67.61 41.73 89.25 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.427 ' HD3' ' HB ' ' A' ' 134' ' ' THR . 21.9 mtp85 -123.55 25.34 8.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -1.134 . . . . 0.0 110.079 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.516 ' HA ' ' HA ' ' A' ' 130' ' ' LEU . 60.4 p -89.2 83.2 6.48 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.499 -0.75 . . . . 0.0 109.935 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -88.53 15.61 7.74 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.069 -1.02 . . . . 0.0 109.332 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 60.34 67.32 2.2 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.595 ' CE1' ' HG2' ' A' ' 129' ' ' LYS . 13.9 p90 -170.44 134.41 1.13 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.082 -1.246 . . . . 0.0 110.484 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.491 ' HA3' ' HA ' ' A' ' 128' ' ' LEU . . . -126.61 -165.8 12.05 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.741 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 10.7 m-85 -129.45 168.6 16.1 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.415 -1.05 . . . . 0.0 110.414 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.541 ' CG2' HG13 ' A' ' 101' ' ' ILE . 3.5 t -145.66 144.95 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.418 -0.801 . . . . 0.0 109.378 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.539 ' HB2' ' CB ' ' A' ' 125' ' ' ASP . 4.5 mp -134.09 98.31 4.1 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.565 -0.709 . . . . 0.0 109.828 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.506 ' CD1' HG21 ' A' ' 123' ' ' VAL . 38.2 m-85 -76.4 160.45 29.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.528 -0.732 . . . . 0.0 110.47 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.408 ' CB ' ' O ' ' A' ' 122' ' ' GLU . 4.6 tttm -104.0 -3.07 25.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.484 -0.76 . . . . 0.0 111.011 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.51 ' OE1' ' CB ' ' A' ' 149' ' ' GLU . 1.1 tt0 -139.97 145.41 37.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.865 -1.147 . . . . 0.0 110.706 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.5 p -59.95 -36.5 77.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.99 -1.069 . . . . 0.0 109.296 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.51 ' CB ' ' OE1' ' A' ' 147' ' ' GLU . 0.4 OUTLIER -63.06 -53.99 45.07 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.425 -0.797 . . . . 0.0 109.792 179.398 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.532 ' CB ' ' HA3' ' A' ' 121' ' ' GLY . 60.9 p -48.59 -34.32 11.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.076 -1.015 . . . . 0.0 109.664 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.464 ' O ' HG11 ' A' ' 154' ' ' VAL . 3.4 t -78.55 -47.7 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.416 -0.803 . . . . 0.0 110.185 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -61.23 -22.28 64.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.968 -1.082 . . . . 0.0 109.336 179.775 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.474 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -76.19 -58.8 3.07 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.441 -0.787 . . . . 0.0 109.866 179.597 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.591 ' HA ' ' CE2' ' A' ' 120' ' ' PHE . 5.3 p -55.6 -20.9 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.048 -1.032 . . . . 0.0 109.979 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.47 ' N ' HG11 ' A' ' 154' ' ' VAL . 2.6 ttp -88.06 -29.96 20.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.408 -0.808 . . . . 0.0 110.384 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.474 ' OD2' ' O ' ' A' ' 153' ' ' LYS . 0.2 OUTLIER -53.78 -36.46 62.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 109.705 179.964 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.584 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 0.7 OUTLIER -128.5 97.51 4.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.352 -0.843 . . . . 0.0 109.509 179.634 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -88.2 10.5 19.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.245 -0.91 . . . . 0.0 110.757 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.451 ' CG ' ' O ' ' A' ' 159' ' ' GLU . 3.2 pt-20 -87.38 68.51 9.76 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 11.6 m-70 -87.75 -167.38 1.86 Allowed 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.613 -177.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -176.44 73.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.512 -0.743 . . . . 0.0 109.818 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.501 ' CD2' HD13 ' A' ' 113' ' ' LEU . 10.1 tp -88.56 134.75 33.78 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.285 -0.885 . . . . 0.0 110.127 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.451 ' OD1' HG21 ' A' ' 108' ' ' THR . 2.3 m120 58.21 24.48 11.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.83 . . . . 0.0 109.961 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 75.9 33.29 51.17 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.75 134.23 16.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -1.184 . . . . 0.0 110.527 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 75.5 t -65.37 162.22 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 109.742 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.474 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -126.41 177.56 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.104 -0.998 . . . . 0.0 110.79 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 102' ' ' GLY . 23.8 t0 -124.18 90.1 51.13 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.84 113.37 3.74 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.313 1.691 . . . . 0.0 111.339 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.46 ' O ' ' SD ' ' A' ' 99' ' ' MET . 24.6 mmtt -131.29 169.15 16.37 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.542 -0.724 . . . . 0.0 109.334 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.465 ' HA ' ' SD ' ' A' ' 99' ' ' MET . 5.8 mtp85 -92.41 47.27 1.3 Allowed 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.499 -1.28 . . . . 0.0 109.806 178.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 171' ' ' ARG . . . . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.406 -0.808 . . . . 0.0 110.22 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.479 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 12.8 mttt . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.207 0.527 . . . . 0.0 109.816 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.528 ' HE1' ' CD1' ' A' ' 101' ' ' ILE . 10.9 ptm -126.05 175.25 7.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.086 -1.009 . . . . 0.0 110.475 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.709 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 1.6 t80 -121.38 122.85 40.73 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.528 ' CD1' ' HE1' ' A' ' 99' ' ' MET . 3.7 mm -108.36 96.91 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 109.382 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.489 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -89.61 98.4 2.44 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 156.87 36.52 0.02 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.505 HD11 ' CG2' ' A' ' 108' ' ' THR . 3.5 mm? -90.45 155.67 18.76 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.181 -1.188 . . . . 0.0 110.007 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.485 ' N ' ' OG1' ' A' ' 108' ' ' THR . 0.0 OUTLIER -78.45 -171.98 2.69 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.205 -0.934 . . . . 0.0 109.754 179.543 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.415 ' N ' ' OG ' ' A' ' 105' ' ' SER . 7.1 m0 -84.0 -17.77 39.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.02 -1.05 . . . . 0.0 110.32 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -122.84 31.02 6.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.909 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.505 ' CG2' HD11 ' A' ' 104' ' ' LEU . 6.9 m -76.69 149.98 36.38 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.384 -0.822 . . . . 0.0 110.406 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.467 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 28.3 p -130.18 149.14 52.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.352 -0.843 . . . . 0.0 109.961 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.48 ' HG2' ' N ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -57.64 -17.78 16.58 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.127 -0.983 . . . . 0.0 109.16 179.256 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.48 ' N ' ' HG2' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -65.71 -58.61 5.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.502 -0.748 . . . . 0.0 109.978 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 109' ' ' THR . 1.7 p-10 -67.48 -42.49 82.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.105 -0.997 . . . . 0.0 110.097 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.465 HD22 HG22 ' A' ' 143' ' ' VAL . 26.2 tp -60.54 -48.46 81.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 109.703 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.522 ' CD ' HG13 ' A' ' 123' ' ' VAL . 27.6 ttpt -58.29 -31.97 67.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.313 -0.867 . . . . 0.0 109.748 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 118' ' ' SER . 86.8 m-20 -78.03 -54.31 6.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.274 -0.891 . . . . 0.0 110.199 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.454 ' C ' ' O ' ' A' ' 115' ' ' ASP . 62.7 t80 -47.18 -31.52 3.66 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 118.586 -1.246 . . . . 0.0 108.066 178.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.596 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 16.7 m-85 -90.35 -16.28 29.49 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.836 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 115' ' ' ASP . 22.4 t -61.45 -15.92 41.93 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.894 -1.129 . . . . 0.0 108.536 178.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.23 -18.01 61.28 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.533 0.682 . . . . 0.0 109.834 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.596 ' CD1' ' HA ' ' A' ' 117' ' ' PHE . 55.2 m-85 -89.48 -58.47 2.51 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.623 0.725 . . . . 0.0 109.414 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.32 -162.96 12.0 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -90.58 135.08 33.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.962 -1.316 . . . . 0.0 110.005 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.522 HG13 ' CD ' ' A' ' 114' ' ' LYS . 1.9 t -109.19 132.83 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.223 -0.923 . . . . 0.0 110.744 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.23 -26.24 5.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.409 ' CB ' HD21 ' A' ' 144' ' ' LEU . 6.7 m-20 -148.76 162.94 38.76 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 118.715 -1.194 . . . . 0.0 112.413 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 11.6 t -164.94 143.42 6.53 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.523 ' CG2' ' N ' ' A' ' 128' ' ' LEU 0.25 1.0 OUTLIER -150.71 170.96 17.95 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 118.679 -1.209 . . . . 0.0 112.093 -177.318 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.523 ' N ' ' CG2' ' A' ' 127' ' ' THR . 8.5 tp -121.59 141.4 51.12 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.589 ' HG3' ' CE1' ' A' ' 142' ' ' PHE . 9.5 mmtm -117.55 124.13 47.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.82 -1.175 . . . . 0.0 111.09 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.596 ' CD2' ' N ' ' A' ' 130' ' ' LEU . 0.5 OUTLIER -118.51 -161.31 0.83 Allowed 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.787 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.458 ' HB3' ' OG1' ' A' ' 134' ' ' THR . 3.6 m-20 -90.44 110.22 39.38 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.292 -0.88 . . . . 0.0 110.499 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 130' ' ' LEU . 46.9 Cg_endo -73.95 -0.27 9.26 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.9 1.474 . . . . 0.0 110.118 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.538 HG21 ' CG2' ' A' ' 134' ' ' THR . 0.0 OUTLIER -114.4 -40.1 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 110.16 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.538 ' CG2' HG21 ' A' ' 133' ' ' ILE . 15.8 p -89.85 -12.21 39.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.931 . . . . 0.0 110.049 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 72.13 15.11 76.55 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.486 ' O ' ' HB3' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -117.96 -179.66 3.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.248 -1.148 . . . . 0.0 110.454 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.483 ' HA ' ' HB3' ' A' ' 130' ' ' LEU . 5.9 m -74.9 154.3 38.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.414 -0.804 . . . . 0.0 110.773 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.57 ' HB3' ' CD1' ' A' ' 140' ' ' PHE . 0.0 OUTLIER -115.54 -13.76 11.54 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.413 -0.804 . . . . 0.0 109.045 179.093 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 91.21 22.21 33.03 Favored Glycine 0 N--CA 1.486 2.012 0 C-N-CA 120.367 -0.92 . . . . 0.0 111.844 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.608 ' CD2' ' CZ ' ' A' ' 100' ' ' PHE . 18.7 p90 -155.56 153.63 30.47 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.109 -1.818 . . . . 0.0 110.68 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.458 ' HA2' ' HB2' ' A' ' 129' ' ' LYS . . . -147.52 -164.11 11.02 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.709 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 14.6 m-85 -130.19 172.21 12.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.157 -1.201 . . . . 0.0 111.348 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.524 ' HB ' ' CG ' ' A' ' 99' ' ' MET . 3.9 t -146.47 145.58 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.479 ' HG ' ' HG2' ' A' ' 98' ' ' LYS . 5.3 mp -130.59 106.03 8.23 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.984 -1.072 . . . . 0.0 109.898 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.462 ' CB ' HG21 ' A' ' 151' ' ' VAL . 15.9 m-85 -78.82 166.28 22.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.501 -0.75 . . . . 0.0 111.046 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -80.9 -31.97 34.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.696 -0.627 . . . . 0.0 110.408 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.477 ' O ' ' OG ' ' A' ' 150' ' ' SER . 0.3 OUTLIER -143.09 152.03 41.4 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.108 -0.995 . . . . 0.0 110.64 -179.619 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.421 ' HA ' HG22 ' A' ' 151' ' ' VAL . 1.5 m -50.88 -41.0 57.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.915 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.488 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 2.8 tt0 -48.51 -62.92 1.25 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.326 -0.859 . . . . 0.0 110.159 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 4.4 p -48.14 -36.07 12.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.0 109.947 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.479 ' O ' HG11 ' A' ' 154' ' ' VAL . 4.6 t -68.56 -52.71 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.12 -0.988 . . . . 0.0 110.362 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.488 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -57.75 -35.1 70.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.974 -1.079 . . . . 0.0 109.783 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.47 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.1 OUTLIER -65.69 -33.82 76.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.368 -0.832 . . . . 0.0 110.162 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.591 HG21 ' CE2' ' A' ' 120' ' ' PHE . 5.9 p -87.86 -19.6 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.025 -1.047 . . . . 0.0 110.336 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.504 ' N ' HG11 ' A' ' 154' ' ' VAL . 24.8 ttt -89.09 -25.76 21.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.946 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 4.5 p-10 -52.37 -32.24 37.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -0.903 . . . . 0.0 109.618 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.558 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -131.4 90.0 2.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.344 -0.848 . . . . 0.0 109.595 179.572 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.406 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -83.97 18.18 2.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.151 -0.968 . . . . 0.0 111.011 -179.482 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -87.68 64.3 7.95 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 177.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.558 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 14.1 m170 -87.05 -169.84 2.8 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.11 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 160' ' ' HIS . 5.9 ttpt 177.55 66.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.468 HD22 HG12 ' A' ' 167' ' ' ILE . 1.3 pp -101.67 157.85 16.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.844 . . . . 0.0 110.105 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 59.5 15.33 4.43 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.163 -0.961 . . . . 0.0 109.461 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.51 21.44 64.32 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.5 146.59 26.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -1.174 . . . . 0.0 110.715 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 51.1 t -76.99 176.39 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.418 -0.801 . . . . 0.0 109.088 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.519 HD13 ' ND1' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -143.16 166.45 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.904 -1.122 . . . . 0.0 111.544 -179.458 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -115.55 82.88 10.35 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 45.1 Cg_endo -72.9 130.28 15.41 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.214 1.639 . . . . 0.0 111.155 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.1 -164.88 2.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.581 -0.699 . . . . 0.0 110.046 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.9 -173.09 3.57 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.06 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.336 -0.852 . . . . 0.0 110.383 -179.614 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.436 ' HA ' ' HG ' ' A' ' 144' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.226 0.536 . . . . 0.0 110.183 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.548 ' CE ' ' O ' ' A' ' 170' ' ' LYS . 6.4 mtp -143.11 173.89 11.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.148 -0.97 . . . . 0.0 110.432 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.691 ' CE2' ' CZ ' ' A' ' 142' ' ' PHE . 2.4 t80 -122.84 134.92 54.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.608 -0.683 . . . . 0.0 110.575 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.521 HG13 ' CG2' ' A' ' 143' ' ' VAL . 15.1 mm -122.68 106.73 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.27 -0.894 . . . . 0.0 109.73 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -103.21 119.38 6.38 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.713 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 128.53 47.83 0.16 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.55 ' CB ' HD13 ' A' ' 130' ' ' LEU . 2.3 mm? -90.56 167.67 12.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.118 -1.225 . . . . 0.0 110.354 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.513 ' HB3' ' CB ' ' A' ' 163' ' ' ASN . 0.4 OUTLIER -90.16 138.9 31.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.272 -0.893 . . . . 0.0 110.19 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.541 ' HA ' ' CD2' ' A' ' 130' ' ' LEU . 5.9 m-90 -44.96 -22.77 0.1 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.881 -1.137 . . . . 0.0 110.718 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 105' ' ' SER . 6.7 t0 -114.86 38.53 3.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.106 -0.996 . . . . 0.0 111.134 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.521 HG22 ' CD1' ' A' ' 104' ' ' LEU . 1.5 m -87.36 161.85 17.68 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.74 -1.225 . . . . 0.0 109.998 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 69.3 p -139.82 154.54 47.36 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.42 -0.8 . . . . 0.0 109.867 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 126' ' ' CYS . 4.9 mttp -58.85 -14.33 8.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.134 -0.979 . . . . 0.0 110.134 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.41 ' HE2' ' HE2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -81.04 -55.82 4.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.861 . . . . 0.0 110.702 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -63.38 -44.29 95.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.003 -1.061 . . . . 0.0 110.466 -179.491 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.524 HD23 ' CG2' ' A' ' 143' ' ' VAL . 0.6 OUTLIER -65.72 -46.89 77.22 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.895 -1.128 . . . . 0.0 109.586 179.681 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.454 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 7.2 ttpp -54.1 -40.78 67.59 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.146 -0.971 . . . . 0.0 109.82 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 116' ' ' TYR . 69.7 m-20 -75.38 -47.27 28.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 109.707 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.634 ' CZ ' ' CD2' ' A' ' 162' ' ' LEU . 52.7 t80 -47.51 -34.65 7.79 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 118.841 -1.144 . . . . 0.0 108.089 178.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.511 ' CE2' HG23 ' A' ' 143' ' ' VAL . 11.5 m-85 -91.2 -13.78 32.23 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.116 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 115' ' ' ASP . 7.2 m -64.87 -12.67 51.32 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.76 -1.212 . . . . 0.0 108.431 178.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.42 -26.69 61.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.581 -0.699 . . . . 0.0 110.39 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.492 ' CE1' HG21 ' A' ' 154' ' ' VAL . 28.2 m-85 -88.67 -57.19 3.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.094 -1.004 . . . . 0.0 109.197 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -159.52 167.52 35.16 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.31 156.52 22.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.138 -1.213 . . . . 0.0 109.913 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.441 HG11 ' O ' ' A' ' 125' ' ' ASP . 1.7 t -125.27 129.91 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.179 -0.951 . . . . 0.0 110.922 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.523 ' CG2' ' HG2' ' A' ' 146' ' ' LYS . 2.2 t -89.64 -25.34 5.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.522 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 2.7 m-20 -140.61 161.45 37.72 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.773 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.489 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 6.8 t -169.95 128.49 0.91 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.666 0.746 . . . . 0.0 109.708 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.412 ' OG1' ' HB2' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -125.88 146.74 49.7 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.605 -0.684 . . . . 0.0 110.875 -178.502 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.565 ' CD2' ' HB2' ' A' ' 130' ' ' LEU . 1.0 OUTLIER -131.97 100.37 5.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 110.083 179.319 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 140' ' ' PHE . 0.1 OUTLIER -81.83 68.29 8.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.207 -0.933 . . . . 0.0 109.863 179.832 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 5.7 mt -152.31 35.03 0.51 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.671 -0.643 . . . . 0.0 109.74 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.442 ' HB3' ' OG1' ' A' ' 134' ' ' THR . 8.6 m-20 -49.42 114.03 3.69 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.32 -0.863 . . . . 0.0 110.727 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -82.42 -6.23 11.83 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.97 1.511 . . . . 0.0 110.715 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.498 ' CD1' ' O ' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -109.65 -30.27 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.083 -1.011 . . . . 0.0 110.768 -179.514 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.442 ' OG1' ' HB3' ' A' ' 131' ' ' ASP . 0.2 OUTLIER -89.27 -5.63 57.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.127 -0.983 . . . . 0.0 110.447 -179.504 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 69.17 6.76 54.99 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.72 39.59 1.36 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -1.144 . . . . 0.0 110.269 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -82.73 115.8 21.81 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.893 . . . . 0.0 110.179 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.534 ' HB3' ' CD1' ' A' ' 140' ' ' PHE . 1.4 mpt_? -89.74 -16.84 29.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.175 -0.953 . . . . 0.0 109.544 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.523 ' HA2' ' CG ' ' A' ' 130' ' ' LEU . . . 90.71 28.33 16.57 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.542 ' O ' ' CB ' ' A' ' 129' ' ' LYS . 1.7 p90 -164.82 165.95 20.13 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.022 -1.281 . . . . 0.0 110.545 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -159.68 177.94 35.98 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.691 ' CZ ' ' CE2' ' A' ' 100' ' ' PHE . 19.4 m-85 -113.57 171.26 7.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.117 -1.225 . . . . 0.0 110.754 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.524 ' CG2' HD23 ' A' ' 113' ' ' LEU . 25.1 t -148.89 127.72 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.553 -0.717 . . . . 0.0 109.351 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.522 ' HB2' ' CB ' ' A' ' 125' ' ' ASP . 6.6 mp -115.96 103.95 11.11 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.546 -0.721 . . . . 0.0 110.214 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.466 ' HB2' ' CG2' ' A' ' 151' ' ' VAL . 46.0 m-85 -75.73 162.3 28.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.575 -0.703 . . . . 0.0 110.417 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.523 ' HG2' ' CG2' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -85.29 -23.61 28.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.535 -0.728 . . . . 0.0 111.117 -179.303 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.53 ' OE1' ' CB ' ' A' ' 149' ' ' GLU . 0.6 OUTLIER -128.78 158.75 37.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.747 -1.221 . . . . 0.0 110.988 -179.568 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.3 p -71.88 -44.49 63.66 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.318 -0.864 . . . . 0.0 109.335 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.53 ' CB ' ' OE1' ' A' ' 147' ' ' GLU . 0.3 OUTLIER -55.87 -40.57 73.12 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.415 -0.803 . . . . 0.0 109.54 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.486 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 1.4 p -62.47 -34.19 76.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.153 -0.967 . . . . 0.0 109.356 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.483 ' O ' HG11 ' A' ' 154' ' ' VAL . 5.2 t -73.93 -52.89 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.213 -0.93 . . . . 0.0 110.216 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.469 ' OD2' ' O ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -51.49 -38.52 54.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.01 -1.056 . . . . 0.0 109.878 -179.781 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.479 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -65.04 -46.63 80.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.325 -0.859 . . . . 0.0 110.024 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.492 HG21 ' CE1' ' A' ' 120' ' ' PHE . 1.4 p -66.12 -13.31 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.029 -1.044 . . . . 0.0 109.963 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.437 ' HE2' ' HA ' ' A' ' 170' ' ' LYS . 2.3 tpt -89.61 -52.94 4.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.348 -0.845 . . . . 0.0 110.748 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.5 OUTLIER -53.07 -31.25 40.64 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.071 -1.018 . . . . 0.0 110.017 -179.734 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.504 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.1 mm100 -112.65 78.37 1.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.299 -0.876 . . . . 0.0 109.686 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.566 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 10.6 pttp -86.86 25.65 1.26 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.27 -0.894 . . . . 0.0 111.014 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -88.2 67.08 8.7 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.566 ' CD2' ' HA ' ' A' ' 158' ' ' LYS . 84.1 m-70 -86.39 -179.99 6.77 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.727 -177.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 160' ' ' HIS . 23.0 ttpt -179.93 83.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.402 -0.811 . . . . 0.0 109.684 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.634 ' CD2' ' CZ ' ' A' ' 116' ' ' TYR . 0.1 OUTLIER -101.96 146.17 28.24 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.175 -0.953 . . . . 0.0 109.707 -179.456 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.513 ' CB ' ' HB3' ' A' ' 105' ' ' SER . 6.4 m120 53.8 18.26 1.51 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.931 . . . . 0.0 109.996 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 83.23 28.83 35.45 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -145.71 143.53 29.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.132 -1.216 . . . . 0.0 110.427 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.3 t -79.9 169.82 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.957 . . . . 0.0 110.303 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.522 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.7 OUTLIER -131.07 -178.66 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.208 -0.932 . . . . 0.0 110.702 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 102' ' ' GLY . 16.7 t70 -119.93 83.22 29.68 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.51 ' CG ' ' HB2' ' A' ' 158' ' ' LYS . 47.5 Cg_endo -72.62 114.24 3.96 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.353 1.712 . . . . 0.0 110.986 -178.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.548 ' O ' ' CE ' ' A' ' 99' ' ' MET . 2.4 mtmp? -136.03 173.36 11.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.512 -0.743 . . . . 0.0 109.246 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.518 ' HA ' ' HG2' ' A' ' 99' ' ' MET . 0.2 OUTLIER -92.29 -166.08 1.47 Allowed 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 118.689 -1.205 . . . . 0.0 109.876 178.596 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.649 0 O-C-N 121.473 -0.767 . . . . 0.0 110.564 -179.242 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.488 ' HA ' ' HG ' ' A' ' 144' ' ' LEU . 47.3 mttt . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.344 0.593 . . . . 0.0 110.506 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.463 ' SD ' ' O ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -143.29 -174.9 4.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.892 . . . . 0.0 110.217 179.724 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.716 ' CE1' ' CE1' ' A' ' 142' ' ' PHE . 10.5 t80 -143.08 148.5 36.77 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.304 -0.872 . . . . 0.0 110.526 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.533 HG13 ' CG2' ' A' ' 143' ' ' VAL . 4.0 mm -125.04 108.58 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.504 -0.748 . . . . 0.0 110.14 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -103.25 118.27 6.01 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 133.86 41.29 0.17 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.581 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 4.0 mm? -90.26 155.03 19.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.337 -1.096 . . . . 0.0 109.916 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.49 ' N ' ' OG1' ' A' ' 108' ' ' THR . 24.1 p -72.08 -176.78 1.85 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.154 -0.966 . . . . 0.0 110.318 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 83.7 t90 -75.11 -27.08 59.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.174 -0.954 . . . . 0.0 110.326 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -113.72 37.16 3.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.215 -0.928 . . . . 0.0 110.22 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.49 ' OG1' ' N ' ' A' ' 105' ' ' SER . 1.5 m -77.55 149.03 34.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.13 -0.981 . . . . 0.0 110.271 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.481 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 44.0 p -130.5 159.63 36.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.292 -0.88 . . . . 0.0 110.455 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.457 ' HB2' ' HA ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -65.26 -14.72 61.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.18 -0.95 . . . . 0.0 109.911 179.702 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -82.54 -53.88 5.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 110.842 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.481 ' OD1' ' O ' ' A' ' 109' ' ' THR . 0.7 OUTLIER -61.77 -35.65 78.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.979 -1.076 . . . . 0.0 110.284 -179.553 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.482 ' CD1' HD23 ' A' ' 162' ' ' LEU . 23.6 tp -71.62 -56.46 5.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 109.931 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.428 ' HB2' ' CB ' ' A' ' 126' ' ' CYS . 1.9 tttt -51.39 -34.44 34.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.182 -0.949 . . . . 0.0 109.733 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 118' ' ' SER . 0.5 OUTLIER -73.93 -55.03 6.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 109.906 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.441 ' C ' ' O ' ' A' ' 115' ' ' ASP . 60.2 t80 -47.36 -31.19 3.76 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.531 -1.268 . . . . 0.0 108.118 178.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.564 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 12.8 m-85 -90.72 -10.43 43.06 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.166 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -65.09 -10.96 34.58 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.839 -1.163 . . . . 0.0 109.386 179.233 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -80.77 -16.65 53.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.477 -0.765 . . . . 0.0 109.991 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.564 ' CD1' ' HA ' ' A' ' 117' ' ' PHE . 75.7 m-85 -88.76 -62.66 1.44 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 109.399 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -157.72 164.99 33.4 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 146' ' ' LYS . 19.4 mt-10 -62.15 119.58 9.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.017 -1.284 . . . . 0.0 110.176 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.0 t -89.62 135.38 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 110.617 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.15 -23.73 6.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.461 ' HB2' ' HB2' ' A' ' 144' ' ' LEU . 6.5 m-20 -152.22 157.04 40.9 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 118.443 -1.303 . . . . 0.0 112.575 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.428 ' CB ' ' HB2' ' A' ' 114' ' ' LYS . 26.2 t -164.47 141.88 6.58 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.457 ' HA ' ' HB2' ' A' ' 110' ' ' LYS . 0.9 OUTLIER -151.22 166.19 31.64 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.582 -1.247 . . . . 0.0 112.348 -177.532 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.496 ' C ' ' CD1' ' A' ' 128' ' ' LEU . 0.4 OUTLIER -122.23 124.28 43.45 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.024 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 140' ' ' PHE . 0.4 OUTLIER -111.93 139.78 47.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.786 -1.196 . . . . 0.0 111.767 -178.433 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.504 ' CD2' ' HA ' ' A' ' 137' ' ' SER . 1.5 mp -109.51 -144.46 0.39 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.019 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.5 ' HB2' ' N ' ' A' ' 136' ' ' ARG . 31.0 m-20 -80.33 125.63 80.73 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.145 -0.972 . . . . 0.0 110.129 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.41 -16.83 19.12 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.916 1.482 . . . . 0.0 111.075 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.434 ' C ' HD11 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -122.78 -35.79 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.081 -1.012 . . . . 0.0 110.372 -179.795 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.429 ' OG1' ' HB3' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -89.95 -26.81 20.2 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 110.169 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.05 -18.0 34.03 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.5 ' N ' ' HB2' ' A' ' 131' ' ' ASP . 12.4 ttp180 -72.85 149.98 43.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.222 -1.163 . . . . 0.0 110.276 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.504 ' HA ' ' CD2' ' A' ' 130' ' ' LEU . 32.7 m -43.64 145.55 0.63 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 110.352 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.571 ' HG2' ' CD1' ' A' ' 140' ' ' PHE . 4.4 ttt-85 -117.33 -23.88 7.63 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.24 36.24 7.17 Favored Glycine 0 N--CA 1.485 1.913 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.426 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 129' ' ' LYS . 12.0 p90 -157.42 125.46 5.46 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.285 -1.715 . . . . 0.0 111.894 178.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.524 ' O ' ' CE1' ' A' ' 100' ' ' PHE . . . -121.0 -176.44 15.42 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.716 ' CE1' ' CE1' ' A' ' 100' ' ' PHE . 8.0 m-85 -122.68 166.18 15.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.879 -1.365 . . . . 0.0 110.94 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.533 ' CG2' HG13 ' A' ' 101' ' ' ILE . 2.5 t -146.6 139.77 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.456 -0.777 . . . . 0.0 109.727 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.488 ' HG ' ' HA ' ' A' ' 98' ' ' LYS . 5.9 mp -127.71 111.61 13.88 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.605 -0.685 . . . . 0.0 109.307 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.608 ' CZ ' ' CG2' ' A' ' 154' ' ' VAL . 38.6 m-85 -79.41 150.69 31.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.684 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 122' ' ' GLU . 18.0 tttm -75.25 -19.8 59.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.433 -0.792 . . . . 0.0 110.901 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.527 ' OE1' ' CB ' ' A' ' 149' ' ' GLU . 3.5 tt0 -138.63 157.89 45.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.813 -1.18 . . . . 0.0 111.111 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 4.4 p -67.61 -41.76 83.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 109.439 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.527 ' CB ' ' OE1' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -56.97 -55.53 33.49 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.29 -0.881 . . . . 0.0 109.41 179.417 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.493 ' CB ' ' HA3' ' A' ' 121' ' ' GLY . 4.0 p -45.71 -44.29 13.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.075 -1.016 . . . . 0.0 109.277 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.52 HG21 ' CB ' ' A' ' 145' ' ' PHE . 16.9 t -58.43 -47.81 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.905 . . . . 0.0 109.83 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.482 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.3 OUTLIER -58.64 -35.52 72.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.085 -1.01 . . . . 0.0 109.476 179.618 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.469 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 9.4 mmtt -63.35 -28.5 70.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.473 -0.767 . . . . 0.0 109.591 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.608 ' CG2' ' CZ ' ' A' ' 145' ' ' PHE . 2.8 t -88.87 -34.19 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.362 -0.836 . . . . 0.0 109.897 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.408 ' O ' ' C ' ' A' ' 156' ' ' ASP . 1.1 ttp -73.2 -36.6 66.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.863 . . . . 0.0 110.511 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 31.5 p-10 -44.63 -29.27 0.72 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.083 -1.01 . . . . 0.0 110.254 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.518 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -136.9 98.78 3.85 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.165 -0.96 . . . . 0.0 110.393 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.63 10.14 16.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.0 -1.062 . . . . 0.0 109.891 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 27.5 mp0 -88.14 68.48 9.09 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 177.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.549 ' HB2' HG13 ' A' ' 167' ' ' ILE . 41.3 m-70 -86.09 -168.7 2.33 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.589 -177.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.455 ' O ' ' CG ' ' A' ' 161' ' ' LYS . 0.0 OUTLIER 177.9 73.11 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.36 -0.837 . . . . 0.0 110.021 179.802 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.482 HD23 ' CD1' ' A' ' 113' ' ' LEU . 2.4 pp -110.07 151.51 27.12 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.311 -0.868 . . . . 0.0 109.853 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.462 ' HB3' ' HB3' ' A' ' 105' ' ' SER . 0.2 OUTLIER 63.13 18.09 10.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.149 -0.969 . . . . 0.0 109.861 -179.507 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 75.35 25.17 68.94 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -149.82 154.28 38.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -1.173 . . . . 0.0 110.66 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' A' ' 167' ' ' ILE . 24.1 t -84.81 167.4 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.379 -0.825 . . . . 0.0 109.688 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.549 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.9 OUTLIER -133.68 175.52 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.137 -0.977 . . . . 0.0 111.15 -179.493 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 102' ' ' GLY . 31.6 t0 -120.08 89.81 43.38 Favored Pre-proline 0 C--N 1.303 -1.426 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.64 120.41 6.43 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.172 1.617 . . . . 0.0 110.891 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.463 ' O ' ' SD ' ' A' ' 99' ' ' MET . 0.1 OUTLIER -140.47 169.63 17.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.885 . . . . 0.0 109.908 179.461 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.462 ' HA ' ' HG2' ' A' ' 99' ' ' MET . 19.4 ptp180 -91.75 -176.17 4.38 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.542 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.36 -0.837 . . . . 0.0 110.446 -179.589 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.523 ' CG ' ' HG ' ' A' ' 144' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.302 0.572 . . . . 0.0 110.239 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.547 ' CE ' HD11 ' A' ' 101' ' ' ILE . 12.6 ptm -147.58 175.2 11.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.189 -0.944 . . . . 0.0 110.411 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.767 ' C ' HD13 ' A' ' 101' ' ' ILE . 2.5 t80 -119.73 130.87 55.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.465 -0.772 . . . . 0.0 109.252 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.767 HD13 ' C ' ' A' ' 100' ' ' PHE . 3.7 mm -117.05 105.04 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.245 -0.91 . . . . 0.0 109.715 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.536 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -97.34 139.22 14.36 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.737 -1.221 . . . . 0.0 110.12 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.51 33.9 2.38 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 1.078 HD12 HG21 ' A' ' 108' ' ' THR . 1.8 mm? -84.68 148.72 26.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.106 -1.232 . . . . 0.0 110.004 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.447 ' O ' ' OG1' ' A' ' 108' ' ' THR . 0.0 OUTLIER -76.52 147.5 37.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.158 -0.963 . . . . 0.0 110.799 -179.529 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -52.07 -17.19 0.96 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.304 -0.873 . . . . 0.0 110.99 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.86 35.55 4.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.904 -1.122 . . . . 0.0 111.163 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . 1.078 HG21 HD12 ' A' ' 104' ' ' LEU . 1.5 m -88.35 171.29 10.26 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.986 -1.071 . . . . 0.0 110.057 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.478 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 73.0 p -149.12 170.56 18.13 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.178 -0.951 . . . . 0.0 110.242 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.532 ' O ' ' CB ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -70.5 -11.2 60.77 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.138 -0.977 . . . . 0.0 109.922 179.792 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -87.44 -58.68 2.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 110.539 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 5.4 p30 -60.56 -32.39 71.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.12 -0.988 . . . . 0.0 110.167 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 1.053 HD13 HD11 ' A' ' 104' ' ' LEU . 9.2 tp -79.96 -42.84 23.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.095 -1.003 . . . . 0.0 109.577 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 4.3 ttmt -63.21 -46.47 86.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.869 . . . . 0.0 109.346 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.413 ' O ' ' C ' ' A' ' 116' ' ' TYR . 1.5 t70 -66.05 -49.17 68.59 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.139 -0.976 . . . . 0.0 109.35 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.413 ' C ' ' O ' ' A' ' 115' ' ' ASP . 67.8 t80 -48.31 -35.4 12.23 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.765 -1.174 . . . . 0.0 108.065 177.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.611 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 11.7 m-85 -90.73 -3.58 57.35 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.25 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.8 t -71.66 -9.5 58.36 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.075 -1.016 . . . . 0.0 109.294 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.66 -15.81 53.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.377 -0.827 . . . . 0.0 110.034 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.839 ' CE2' HG23 ' A' ' 154' ' ' VAL . 70.2 m-85 -89.52 -40.9 12.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.326 -0.859 . . . . 0.0 109.44 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -177.49 -156.2 15.64 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.53 157.77 17.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.138 -1.213 . . . . 0.0 110.195 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 1.9 t -134.75 131.23 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.212 -0.93 . . . . 0.0 111.167 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -94.99 -24.65 4.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -146.42 159.06 43.88 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.999 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.751 ' SG ' HD23 ' A' ' 113' ' ' LEU . 40.5 t -170.47 105.56 0.29 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.848 0.832 . . . . 0.0 109.347 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.68 166.15 11.63 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.474 0.654 . . . . 0.0 110.979 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.919 HD13 ' O ' ' A' ' 128' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.413 -0.805 . . . . 0.0 110.268 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.536 ' HB2' ' HA2' ' A' ' 102' ' ' GLY . 46.3 p90 . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 121.526 0.679 . . . . 0.0 111.093 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.511 ' HA3' ' HA ' ' A' ' 128' ' ' LEU . . . -136.82 -170.65 11.99 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.712 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 13.9 m-85 -128.65 160.71 31.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.069 -1.254 . . . . 0.0 110.492 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.6 ' O ' HD12 ' A' ' 144' ' ' LEU . 4.1 t -134.22 140.4 46.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.371 -0.831 . . . . 0.0 108.944 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.6 HD12 ' O ' ' A' ' 143' ' ' VAL . 3.1 mp -132.07 98.81 4.53 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.161 -0.962 . . . . 0.0 109.704 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.948 ' HB2' HG22 ' A' ' 151' ' ' VAL . 39.4 m-85 -71.04 170.23 13.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.434 -0.791 . . . . 0.0 110.635 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 18.2 tttt -96.18 -18.93 19.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.369 -0.832 . . . . 0.0 110.994 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.865 ' O ' HG23 ' A' ' 151' ' ' VAL . 2.4 tm-20 -131.39 162.33 30.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.862 -1.149 . . . . 0.0 110.686 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 34.5 p -74.69 -47.44 31.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.913 . . . . 0.0 109.547 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.535 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 0.5 OUTLIER -54.41 -35.08 62.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.369 -0.832 . . . . 0.0 109.752 179.701 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.485 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 3.1 p -68.76 -40.93 79.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 109.889 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.948 HG22 ' HB2' ' A' ' 145' ' ' PHE . 5.6 t -66.67 -53.14 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 110.286 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.535 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -51.89 -37.78 53.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 0.0 109.955 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.46 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -59.23 -62.07 2.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.334 -0.854 . . . . 0.0 110.082 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.839 HG23 ' CE2' ' A' ' 120' ' ' PHE . 3.3 p -55.36 -20.5 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.198 -0.939 . . . . 0.0 110.141 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.82 -13.19 37.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.364 -0.835 . . . . 0.0 109.686 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.8 OUTLIER -61.12 -33.5 73.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.226 -0.921 . . . . 0.0 109.614 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.516 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.0 tt0 -142.3 104.46 4.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.287 -0.883 . . . . 0.0 110.065 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.5 pttm -81.8 20.26 0.98 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.229 -0.919 . . . . 0.0 111.037 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -87.58 62.9 7.32 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.77 ' HE1' HG22 ' A' ' 154' ' ' VAL . 14.2 m170 -86.76 -169.34 2.59 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.309 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 160' ' ' HIS . 33.3 ttpt 179.86 74.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.35 -0.844 . . . . 0.0 110.317 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.851 HD12 ' HB2' ' A' ' 163' ' ' ASN . 3.8 pp -103.69 157.56 16.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 0.0 109.989 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.851 ' HB2' HD12 ' A' ' 162' ' ' LEU . 1.5 m-80 58.38 15.19 3.32 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.183 -0.948 . . . . 0.0 110.228 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.98 20.15 61.63 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp -150.82 146.89 26.66 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.303 -1.116 . . . . 0.0 110.152 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 160' ' ' HIS . 1.4 p -69.36 -174.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.052 -1.03 . . . . 0.0 110.163 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.638 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -150.61 178.24 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.163 -0.96 . . . . 0.0 110.352 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -126.01 93.2 44.32 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.54 -0.725 . . . . 0.0 109.386 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 48.2 Cg_endo -77.58 135.85 14.97 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.245 1.655 . . . . 0.0 110.643 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 99' ' ' MET . 0.0 OUTLIER -146.76 -177.92 5.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.319 -0.863 . . . . 0.0 110.268 179.607 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 . . . . . 0 C--N 1.303 -1.454 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.953 179.047 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.528 ' HG2' ' CD1' ' A' ' 144' ' ' LEU . 14.7 mtmt . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.001 0.429 . . . . 0.0 110.09 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.535 ' HE2' HD11 ' A' ' 101' ' ' ILE . 7.9 ptm -133.39 172.31 12.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.118 -0.989 . . . . 0.0 110.562 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.766 ' C ' HD13 ' A' ' 101' ' ' ILE . 2.1 t80 -120.99 130.07 53.66 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.608 -0.682 . . . . 0.0 110.041 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.766 HD13 ' C ' ' A' ' 100' ' ' PHE . 3.8 mm -112.66 95.27 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.294 -0.879 . . . . 0.0 109.469 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.532 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -89.75 127.01 8.53 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 127.48 34.01 0.59 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 1.064 HD12 HG21 ' A' ' 108' ' ' THR . 2.3 mm? -89.38 152.95 21.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.048 -1.266 . . . . 0.0 110.186 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.466 ' O ' ' OG1' ' A' ' 108' ' ' THR . 0.0 OUTLIER -90.49 152.67 20.84 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.291 -0.88 . . . . 0.0 111.234 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.46 -22.69 3.25 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.445 -0.785 . . . . 0.0 110.765 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -107.04 28.82 7.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.028 -1.045 . . . . 0.0 111.765 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . 1.064 HG21 HD12 ' A' ' 104' ' ' LEU . 0.8 OUTLIER -90.44 170.8 9.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.752 -1.218 . . . . 0.0 109.798 179.17 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.467 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 28.7 p -145.94 159.16 43.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.227 -0.921 . . . . 0.0 110.155 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.487 ' CE ' ' O ' ' A' ' 126' ' ' CYS . 0.7 OUTLIER -62.91 -12.76 27.36 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.171 -0.955 . . . . 0.0 109.639 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.49 -59.31 2.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.367 -0.833 . . . . 0.0 110.377 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -52.61 -41.93 64.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.056 -1.028 . . . . 0.0 109.909 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.8 HD13 HD11 ' A' ' 104' ' ' LEU . 10.6 tp -70.3 -48.82 54.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.911 . . . . 0.0 109.577 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -52.1 -48.01 64.97 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.428 -0.795 . . . . 0.0 109.772 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.544 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 54.7 m-20 -67.41 -50.74 58.18 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.16 -0.962 . . . . 0.0 110.296 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.412 ' C ' ' O ' ' A' ' 115' ' ' ASP . 73.0 t80 -47.78 -34.01 7.96 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 118.532 -1.267 . . . . 0.0 108.528 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.577 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 15.3 m-85 -91.14 -7.24 52.09 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.869 -0.732 . . . . 0.0 111.351 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.544 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 1.9 t -71.02 -7.35 45.76 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.956 -1.09 . . . . 0.0 109.225 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -82.88 -14.42 54.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 0.0 110.285 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.577 ' CD2' ' HA ' ' A' ' 117' ' ' PHE . 89.1 m-85 -88.8 -56.02 3.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.073 -1.017 . . . . 0.0 109.275 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.47 ' HA3' ' HB3' ' A' ' 150' ' ' SER . . . -162.02 -162.27 13.02 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -83.06 151.03 25.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -1.192 . . . . 0.0 110.061 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.9 t -128.8 130.03 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.357 -0.839 . . . . 0.0 110.484 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.01 -24.68 5.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.538 ' O ' HG13 ' A' ' 123' ' ' VAL . 4.2 m-20 -151.06 171.27 17.59 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 118.526 -1.27 . . . . 0.0 112.364 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.608 ' SG ' HD23 ' A' ' 113' ' ' LEU . 9.6 t -170.38 155.59 5.24 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.66 151.74 32.93 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.876 -1.14 . . . . 0.0 110.937 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.928 HD13 ' O ' ' A' ' 128' ' ' LEU . 1.6 tm? . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.531 -0.73 . . . . 0.0 109.703 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.576 ' CD1' ' CZ ' ' A' ' 100' ' ' PHE . 35.5 p90 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.287 0.565 . . . . 0.0 110.786 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -150.4 -171.05 18.32 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.698 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 19.7 m-85 -131.38 171.36 13.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.153 -1.204 . . . . 0.0 110.719 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.58 ' O ' HD22 ' A' ' 144' ' ' LEU . 32.0 t -147.46 129.06 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.58 HD22 ' O ' ' A' ' 143' ' ' VAL . 3.8 mm? -114.53 101.6 9.27 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.584 -0.697 . . . . 0.0 109.821 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.754 ' HB2' HG22 ' A' ' 151' ' ' VAL . 8.2 m-85 -78.36 170.15 17.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 110.78 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.444 ' O ' ' HE2' ' A' ' 146' ' ' LYS . 0.1 OUTLIER -89.87 -26.61 20.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.614 -0.679 . . . . 0.0 110.562 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.493 ' OE2' ' CB ' ' A' ' 149' ' ' GLU . 1.0 OUTLIER -143.08 161.76 37.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.785 -1.197 . . . . 0.0 111.181 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 18.7 m -64.37 -31.7 73.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.441 -0.787 . . . . 0.0 110.091 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.493 ' CB ' ' OE2' ' A' ' 147' ' ' GLU . 0.1 OUTLIER -60.29 -38.67 84.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 0.0 110.012 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 22.4 p -71.27 -36.76 71.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.458 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.754 HG22 ' HB2' ' A' ' 145' ' ' PHE . 3.5 t -76.12 -45.42 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.987 -1.071 . . . . 0.0 110.805 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 153' ' ' LYS . 0.2 OUTLIER -61.58 -33.89 74.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.143 -0.973 . . . . 0.0 110.126 -179.555 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 152' ' ' ASP . 6.6 tttt -70.37 -42.2 72.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -0.918 . . . . 0.0 110.041 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 151' ' ' VAL . 7.4 p -72.67 -27.35 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.145 -0.972 . . . . 0.0 110.458 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.405 ' O ' ' C ' ' A' ' 156' ' ' ASP . 0.2 OUTLIER -80.39 -34.87 36.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.939 . . . . 0.0 110.288 -179.751 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.489 ' OD1' ' HG2' ' A' ' 157' ' ' GLN . 0.0 OUTLIER -45.37 -42.6 10.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 109.342 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.561 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -118.76 87.25 2.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.397 -0.814 . . . . 0.0 109.65 179.335 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.497 ' HB2' ' CG ' ' A' ' 169' ' ' PRO . 3.4 pttt -85.94 17.45 3.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.892 . . . . 0.0 110.542 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -87.52 63.85 7.83 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.561 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 11.7 m170 -86.56 -167.59 1.93 Allowed 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.726 -177.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt 179.2 67.99 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.496 -0.753 . . . . 0.0 109.601 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.801 HD12 ' HB2' ' A' ' 163' ' ' ASN . 2.6 pp -99.8 148.42 24.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.346 -0.847 . . . . 0.0 110.076 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.801 ' HB2' HD12 ' A' ' 162' ' ' LEU . 0.4 OUTLIER 64.18 20.77 12.32 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.184 -0.948 . . . . 0.0 109.517 -179.401 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.9 26.05 70.08 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.37 147.35 27.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.273 -1.134 . . . . 0.0 110.726 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 167' ' ' ILE . 4.8 t -80.31 173.12 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.347 -0.846 . . . . 0.0 109.252 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.503 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -141.66 163.56 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.087 -1.008 . . . . 0.0 110.9 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -112.26 96.77 36.69 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.611 -0.681 . . . . 0.0 109.235 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.497 ' CG ' ' HB2' ' A' ' 158' ' ' LYS . 49.2 Cg_endo -76.65 119.47 5.19 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.205 1.634 . . . . 0.0 110.524 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -136.42 -163.5 1.42 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 110.293 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.299 -1.608 0 C-N-CA 119.811 -0.755 . . . . 0.0 110.48 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.478 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 4.5 mttp . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.185 0.517 . . . . 0.0 109.996 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.666 ' HE2' HD11 ' A' ' 101' ' ' ILE . 0.6 OUTLIER -139.88 179.72 6.44 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.229 -0.919 . . . . 0.0 110.107 179.716 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.727 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 2.5 t80 -125.26 128.93 49.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.361 -0.837 . . . . 0.0 110.807 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.666 HD11 ' HE2' ' A' ' 99' ' ' MET . 4.7 mm -107.37 96.19 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.494 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -89.92 145.71 18.38 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.243 -178.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.512 ' O ' ' HD2' ' A' ' 165' ' ' LYS . . . 96.99 17.68 31.68 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.758 ' CD1' HG21 ' A' ' 108' ' ' THR . 1.4 mm? -54.73 166.47 0.47 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.636 -1.508 . . . . 0.0 109.737 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.423 ' N ' ' OG1' ' A' ' 108' ' ' THR . 0.3 OUTLIER -90.89 140.72 29.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.132 -0.98 . . . . 0.0 110.114 179.511 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 20.6 m0 -49.75 -19.87 0.72 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.154 -0.966 . . . . 0.0 110.472 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -113.57 26.38 10.44 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.126 -0.984 . . . . 0.0 111.18 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.758 HG21 ' CD1' ' A' ' 104' ' ' LEU . 0.8 OUTLIER -89.09 166.13 14.06 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.983 -1.073 . . . . 0.0 109.952 179.568 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.471 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 31.7 p -145.42 -176.8 5.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.191 -0.943 . . . . 0.0 110.399 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.463 ' O ' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -84.57 -14.86 47.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 109.595 179.663 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.44 -44.86 15.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.871 . . . . 0.0 109.857 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 32.5 p-10 -77.35 -38.29 50.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.842 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.73 HD13 HD11 ' A' ' 104' ' ' LEU . 19.7 tp -69.84 -42.69 73.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.099 -1.001 . . . . 0.0 109.351 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -59.85 -50.72 72.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 0.0 109.234 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' A' ' 118' ' ' SER . 17.1 t70 -64.04 -46.66 83.41 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.195 -0.941 . . . . 0.0 109.346 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.688 ' CD2' HD21 ' A' ' 162' ' ' LEU . 68.4 t80 -48.0 -36.35 12.58 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.622 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 15.1 m-85 -91.75 -3.46 56.18 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.843 -0.536 . . . . 0.0 111.489 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 12.4 t -70.63 -5.73 31.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.905 -1.122 . . . . 0.0 109.55 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.01 -13.29 44.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.378 -0.826 . . . . 0.0 110.039 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.831 ' CE2' HG23 ' A' ' 154' ' ' VAL . 79.8 m-85 -89.57 -45.36 9.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.366 -0.834 . . . . 0.0 109.84 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -176.16 -172.98 41.41 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.53 ' O ' ' CB ' ' A' ' 146' ' ' LYS . 19.1 mm-40 -81.3 115.43 20.67 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.142 -1.211 . . . . 0.0 110.199 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 125' ' ' ASP . 2.0 t -91.14 133.84 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.269 -0.894 . . . . 0.0 111.018 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.91 -25.65 5.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.538 ' O ' HG13 ' A' ' 123' ' ' VAL . 4.0 m-20 -148.26 160.93 42.46 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.034 -1.067 . . . . 0.0 111.837 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 5.7 t -170.11 149.94 3.64 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.7 164.78 35.3 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.042 -1.036 . . . . 0.0 111.098 -178.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.756 HD22 ' C ' ' A' ' 128' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.504 ' HA ' ' HB2' ' A' ' 104' ' ' LEU . 21.7 p90 . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 121.64 0.734 . . . . 0.0 111.526 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.698 ' H ' HD23 ' A' ' 104' ' ' LEU . . . -121.38 -174.55 14.85 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.727 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 15.2 m-85 -129.43 165.85 20.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.15 -1.206 . . . . 0.0 110.776 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.592 ' C ' HD12 ' A' ' 144' ' ' LEU . 3.8 t -139.41 133.34 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.454 -0.779 . . . . 0.0 109.214 178.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.592 HD12 ' C ' ' A' ' 143' ' ' VAL . 5.4 mp -123.96 92.77 3.75 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.61 -0.682 . . . . 0.0 109.312 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 1.044 ' HB2' HG22 ' A' ' 151' ' ' VAL . 17.7 m-85 -69.18 164.4 22.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.416 -0.802 . . . . 0.0 110.784 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.53 ' CB ' ' O ' ' A' ' 122' ' ' GLU . 10.8 tttp -93.4 -22.03 19.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.473 -0.767 . . . . 0.0 110.615 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.864 ' O ' HG23 ' A' ' 151' ' ' VAL . 14.8 tt0 -126.7 144.24 50.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.765 -1.209 . . . . 0.0 110.462 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 51.1 m -61.84 -35.51 78.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.966 . . . . 0.0 109.634 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.532 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 0.1 OUTLIER -63.2 -47.64 81.71 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.318 -0.864 . . . . 0.0 109.843 179.603 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 2.3 p -57.84 -37.38 73.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.326 -0.859 . . . . 0.0 109.881 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 1.044 HG22 ' HB2' ' A' ' 145' ' ' PHE . 2.8 t -66.23 -57.95 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.118 -0.989 . . . . 0.0 110.027 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.532 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -52.26 -29.83 24.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.094 -1.003 . . . . 0.0 110.012 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.471 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 6.7 mttt -68.68 -38.6 80.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.29 -0.881 . . . . 0.0 110.19 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.961 HG12 ' O ' ' A' ' 151' ' ' VAL . 9.9 p -77.16 -17.71 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.209 -0.932 . . . . 0.0 110.046 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.764 ' SD ' HG12 ' A' ' 151' ' ' VAL . 0.0 OUTLIER -90.21 -39.62 12.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 110.537 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 1.0 OUTLIER -52.87 -34.75 56.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.971 -1.081 . . . . 0.0 109.795 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.505 ' O ' ' NE2' ' A' ' 160' ' ' HIS . 4.2 mt-30 -117.69 88.47 2.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.486 -0.759 . . . . 0.0 109.747 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.52 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 6.8 pttt -86.62 26.09 1.15 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 110.946 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.08 62.06 6.61 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.656 ' HE1' HG22 ' A' ' 154' ' ' VAL . 11.6 m170 -87.2 154.88 20.38 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.61 -177.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 165' ' ' LYS . 41.4 mttm -150.8 85.45 1.36 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.351 -0.843 . . . . 0.0 109.783 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.793 HD12 ' H ' ' A' ' 162' ' ' LEU . 1.0 OUTLIER -99.77 138.01 37.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.354 -0.841 . . . . 0.0 109.714 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.682 ' OD1' HG23 ' A' ' 108' ' ' THR . 10.8 m120 59.37 19.44 7.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.259 -0.901 . . . . 0.0 110.318 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.29 32.11 29.32 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.533 ' CE ' ' O ' ' A' ' 166' ' ' VAL . 0.9 OUTLIER -150.18 149.97 30.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.186 -1.184 . . . . 0.0 110.208 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 160' ' ' HIS . 26.4 t -90.01 159.52 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.078 -1.014 . . . . 0.0 110.383 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.572 HG13 ' HB2' ' A' ' 160' ' ' HIS . 1.3 pt -120.46 -176.57 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 122.071 0.939 . . . . 0.0 111.219 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -123.41 81.6 53.18 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -74.21 131.08 14.84 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.305 1.687 . . . . 0.0 110.877 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.407 ' O ' ' CB ' ' A' ' 99' ' ' MET . 2.1 mmtm -147.25 -166.9 2.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.458 -0.776 . . . . 0.0 110.3 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 . . . . . 0 C--N 1.301 -1.54 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.1 179.502 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.512 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.289 0.566 . . . . 0.0 110.331 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.885 ' CE ' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -136.47 166.45 23.47 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.445 -0.784 . . . . 0.0 109.178 179.385 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.846 ' O ' HD13 ' A' ' 101' ' ' ILE . 15.6 t80 -112.2 148.52 33.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.963 -1.085 . . . . 0.0 110.623 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.885 HD11 ' CE ' ' A' ' 99' ' ' MET . 8.8 mm -123.09 108.33 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.643 -0.661 . . . . 0.0 110.095 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.54 ' HA2' ' CB ' ' A' ' 140' ' ' PHE . . . -101.85 128.68 9.64 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.61 38.03 0.64 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.9 ' CD2' HD23 ' A' ' 128' ' ' LEU . 1.1 mp -90.06 153.77 20.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.14 -1.212 . . . . 0.0 110.234 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.459 ' O ' ' OG1' ' A' ' 108' ' ' THR . 3.1 m -82.4 154.35 25.24 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.256 -0.902 . . . . 0.0 110.411 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 12.1 m-90 -57.54 -14.17 4.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.118 -0.989 . . . . 0.0 110.369 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.422 ' OD1' ' HB3' ' A' ' 105' ' ' SER . 4.6 p-10 -108.57 21.76 16.85 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.928 -1.107 . . . . 0.0 111.613 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.465 ' HB ' HD23 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -85.99 149.6 25.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.883 -1.136 . . . . 0.0 109.986 179.425 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.445 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 72.5 p -134.97 162.9 31.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 110.175 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 126' ' ' CYS . 26.9 mtmt -60.4 -14.18 17.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 109.845 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -82.77 -59.65 2.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.405 -0.81 . . . . 0.0 110.655 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 1.6 p-10 -63.41 -35.05 79.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.103 -0.998 . . . . 0.0 110.258 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 15.0 tp -72.91 -51.61 17.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.184 -0.947 . . . . 0.0 109.964 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 110' ' ' LYS . 4.6 tttt -56.63 -37.95 71.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -0.955 . . . . 0.0 109.695 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.471 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 3.1 m-20 -73.14 -54.82 7.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.381 -0.824 . . . . 0.0 110.038 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.552 ' HE2' ' CD2' ' A' ' 160' ' ' HIS . 71.1 t80 -46.61 -31.93 3.15 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.719 -1.192 . . . . 0.0 108.356 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.629 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 18.7 m-85 -91.45 -11.29 38.03 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.789 -0.765 . . . . 0.0 111.423 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.471 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 0.5 OUTLIER -71.14 -5.75 34.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.94 -1.1 . . . . 0.0 109.372 178.755 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.6 ttpt -84.92 -12.8 52.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.378 -0.826 . . . . 0.0 110.212 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.629 ' CD2' ' HA ' ' A' ' 117' ' ' PHE . 84.8 m-85 -89.59 -44.45 10.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 110.001 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.53 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -174.53 -152.55 9.22 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -90.4 146.96 23.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.229 -1.159 . . . . 0.0 110.633 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.7 t -129.24 129.8 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.446 -0.783 . . . . 0.0 110.088 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.482 HG23 ' CG ' ' A' ' 146' ' ' LYS . 2.2 t -88.8 -25.38 5.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.49 ' HB3' HD22 ' A' ' 144' ' ' LEU . 13.7 m-20 -150.88 166.91 29.12 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.389 -1.324 . . . . 0.0 112.309 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 11.8 t -167.22 135.87 2.65 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.462 0.649 . . . . 0.0 109.301 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.33 165.76 22.72 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.386 -0.821 . . . . 0.0 109.92 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.982 HD13 ' O ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.312 -0.867 . . . . 0.0 109.566 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.54 ' CB ' ' HA2' ' A' ' 102' ' ' GLY . 18.9 p90 . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 121.77 0.795 . . . . 0.0 111.651 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.531 ' N ' HD13 ' A' ' 104' ' ' LEU . . . -140.0 -179.0 17.41 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.734 ' CE1' ' CE1' ' A' ' 100' ' ' PHE . 18.0 m-85 -128.17 156.94 42.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.213 -1.169 . . . . 0.0 110.786 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.659 ' O ' HD12 ' A' ' 144' ' ' LEU . 8.9 t -138.22 131.77 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.659 HD12 ' O ' ' A' ' 143' ' ' VAL . 6.5 mp -116.84 107.61 14.83 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.512 -0.743 . . . . 0.0 109.926 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.645 ' CB ' HG22 ' A' ' 151' ' ' VAL . 10.4 m-85 -80.27 167.73 19.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.409 -0.807 . . . . 0.0 110.919 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.482 ' CG ' HG23 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -97.73 -23.67 15.82 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.493 -0.755 . . . . 0.0 110.664 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.61 ' O ' HG23 ' A' ' 151' ' ' VAL . 0.9 OUTLIER -142.07 160.37 40.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.748 -1.22 . . . . 0.0 110.934 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.4 t -64.25 -31.81 73.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 0.0 109.861 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.54 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 6.2 mt-10 -60.28 -46.9 88.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.287 -0.883 . . . . 0.0 109.869 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.535 ' HB2' ' CD1' ' A' ' 145' ' ' PHE . 37.0 p -60.97 -40.99 95.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.273 -0.892 . . . . 0.0 110.257 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.765 ' O ' HG12 ' A' ' 154' ' ' VAL . 3.2 t -69.72 -46.2 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.126 -0.984 . . . . 0.0 110.758 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.54 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -52.46 -38.19 58.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.094 -1.004 . . . . 0.0 109.959 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.47 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 0.6 OUTLIER -66.42 -60.88 2.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 0.0 110.389 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.765 HG12 ' O ' ' A' ' 151' ' ' VAL . 12.6 p -48.97 -22.77 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.052 -1.03 . . . . 0.0 110.332 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 2.0 ttt -89.93 -24.79 21.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.178 -0.951 . . . . 0.0 109.744 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.47 ' OD2' ' O ' ' A' ' 153' ' ' LYS . 0.2 OUTLIER -53.81 -36.14 62.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.269 -0.894 . . . . 0.0 109.47 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.584 ' O ' ' CE1' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -131.18 102.07 5.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.336 -0.852 . . . . 0.0 110.085 179.473 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt -85.12 23.54 1.24 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -0.946 . . . . 0.0 110.936 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -87.96 57.45 4.33 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.807 ' O ' HD23 ' A' ' 162' ' ' LEU . 25.8 m80 -87.9 65.45 8.32 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.691 -176.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.6 ttpp -81.81 72.29 8.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.059 -1.025 . . . . 0.0 109.671 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.807 HD23 ' O ' ' A' ' 160' ' ' HIS . 0.5 OUTLIER -94.02 156.06 16.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 109.945 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 1.6 m-80 56.72 21.43 5.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.173 -0.954 . . . . 0.0 109.46 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 75.52 23.46 73.1 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.69 138.86 20.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -1.093 . . . . 0.0 110.618 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.597 HG12 ' H ' ' A' ' 167' ' ' ILE . 3.6 t -80.27 -179.54 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 109.233 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.597 ' H ' HG12 ' A' ' 166' ' ' VAL . 1.0 OUTLIER -141.7 170.99 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.973 -1.08 . . . . 0.0 111.52 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 102' ' ' GLY . 10.9 t0 -116.71 92.19 37.17 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 46.1 Cg_endo -72.15 136.72 27.48 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.312 1.69 . . . . 0.0 111.287 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -138.04 -178.95 5.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.52 -0.737 . . . . 0.0 109.703 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.553 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.484 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.548 ' HG2' ' CD2' ' A' ' 144' ' ' LEU . 9.9 mtpt . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.51 ' CG ' ' O ' ' A' ' 143' ' ' VAL . 5.9 ptm -141.98 175.5 9.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.122 -0.986 . . . . 0.0 110.883 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.688 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 1.7 t80 -119.7 129.27 54.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.597 -0.689 . . . . 0.0 109.69 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.646 HD13 ' C ' ' A' ' 100' ' ' PHE . 3.1 mm -109.88 94.18 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.301 -0.875 . . . . 0.0 109.453 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.533 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -97.22 112.14 4.4 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 141.32 38.73 0.08 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.689 HD21 HD13 ' A' ' 113' ' ' LEU . 5.4 mp -89.9 164.6 14.52 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.231 -1.158 . . . . 0.0 110.102 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' A' ' 163' ' ' ASN . 0.6 OUTLIER -81.56 -171.73 3.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.322 -0.861 . . . . 0.0 109.862 179.715 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 17.3 m0 -83.85 -9.86 58.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.182 -0.949 . . . . 0.0 110.414 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.48 19.75 8.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 110.399 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.781 HG23 ' OD1' ' A' ' 163' ' ' ASN . 2.5 m -63.52 159.7 18.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.109 -0.994 . . . . 0.0 109.773 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.477 HG23 ' C ' ' A' ' 108' ' ' THR . 63.7 p -149.57 171.73 16.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.907 . . . . 0.0 110.448 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.509 ' O ' ' CB ' ' A' ' 114' ' ' LYS . 5.9 ttpt -71.32 -11.0 60.67 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.412 -0.805 . . . . 0.0 109.127 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -84.0 -49.18 9.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.452 -0.78 . . . . 0.0 110.411 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -75.83 -31.72 59.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.961 -1.087 . . . . 0.0 110.199 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.972 HD23 ' SG ' ' A' ' 126' ' ' CYS . 1.7 tp -77.08 -43.44 34.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.02 -1.05 . . . . 0.0 109.593 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.509 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 17.3 tttt -59.97 -45.19 93.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.196 -0.94 . . . . 0.0 109.605 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 116' ' ' TYR . 0.6 OUTLIER -74.97 -42.03 58.4 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.178 -0.951 . . . . 0.0 109.526 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.793 ' CD2' HD21 ' A' ' 162' ' ' LEU . 72.5 t80 -48.32 -36.21 13.87 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 118.733 -1.187 . . . . 0.0 107.98 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.683 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 19.2 m-85 -91.48 -13.53 32.06 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.985 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 12.7 t -61.29 -14.28 25.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.114 -0.991 . . . . 0.0 109.594 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.72 -11.42 58.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.403 -0.81 . . . . 0.0 110.191 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.937 ' CD2' HG22 ' A' ' 154' ' ' VAL . 53.4 m-85 -89.54 -63.71 1.25 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.105 -0.997 . . . . 0.0 109.24 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -159.18 -177.57 32.39 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.5 133.84 48.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.063 -1.257 . . . . 0.0 110.414 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.9 t -109.72 133.64 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.332 -0.855 . . . . 0.0 110.885 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.476 ' O ' ' OD1' ' A' ' 125' ' ' ASP . 2.1 t -89.68 -28.25 5.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.56 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 0.8 OUTLIER -147.26 164.64 32.57 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 118.906 -1.118 . . . . 0.0 112.604 -178.923 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.972 ' SG ' HD23 ' A' ' 113' ' ' LEU . 36.9 t -170.34 140.37 1.85 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.64 161.25 42.95 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.962 -177.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.765 HD22 ' O ' ' A' ' 108' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.628 ' HA ' HD13 ' A' ' 104' ' ' LEU . 2.6 p90 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 120.942 0.401 . . . . 0.0 110.52 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -142.66 -161.84 8.98 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.688 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 17.4 m-85 -126.87 163.21 24.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.159 -1.2 . . . . 0.0 111.306 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.655 HG21 ' CE2' ' A' ' 117' ' ' PHE . 4.0 t -138.49 138.05 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.56 ' HB2' ' CB ' ' A' ' 125' ' ' ASP . 4.6 mp -127.04 107.45 10.06 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.315 -0.866 . . . . 0.0 110.11 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 1.127 ' CZ ' HG21 ' A' ' 154' ' ' VAL . 26.3 m-85 -80.65 151.63 28.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.361 -0.837 . . . . 0.0 110.51 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -75.78 -17.04 60.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.49 -0.756 . . . . 0.0 110.917 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.829 ' O ' HG23 ' A' ' 151' ' ' VAL . 7.4 tt0 -137.63 154.39 49.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.836 -1.165 . . . . 0.0 110.901 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.443 ' N ' ' HG2' ' A' ' 147' ' ' GLU . 0.4 OUTLIER -65.42 -39.28 91.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 109.601 179.45 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.524 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 3.0 tt0 -57.65 -51.3 70.09 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.331 -0.855 . . . . 0.0 109.688 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.803 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.4 p -52.7 -34.39 51.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.761 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 1.009 HG22 ' HB2' ' A' ' 145' ' ' PHE . 2.4 t -74.84 -49.79 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.307 -0.87 . . . . 0.0 110.503 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.524 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -52.97 -35.2 58.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.139 -0.976 . . . . 0.0 110.447 -179.489 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.487 ' HA ' ' OD2' ' A' ' 156' ' ' ASP . 0.4 OUTLIER -71.78 -49.87 34.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.227 -0.921 . . . . 0.0 110.464 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 1.127 HG21 ' CZ ' ' A' ' 145' ' ' PHE . 18.0 t -56.02 -22.53 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.901 -1.124 . . . . 0.0 110.043 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 32.1 mmm -87.32 -46.08 10.0 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.151 -0.968 . . . . 0.0 110.157 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.487 ' OD2' ' HA ' ' A' ' 153' ' ' LYS . 0.5 OUTLIER -47.19 -37.2 9.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.117 -0.99 . . . . 0.0 109.811 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.576 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 0.6 OUTLIER -111.16 85.33 2.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.122 -0.986 . . . . 0.0 110.101 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.02 18.19 2.16 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.28 -0.887 . . . . 0.0 110.824 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.424 ' OE1' ' HG2' ' A' ' 157' ' ' GLN . 31.9 mp0 -87.67 60.84 6.18 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 177.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.714 ' ND1' HD11 ' A' ' 167' ' ' ILE . 15.1 m-70 -87.07 179.57 6.65 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.557 -177.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 160' ' ' HIS . 14.2 ttmt -179.21 88.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.323 -0.861 . . . . 0.0 110.154 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.793 HD21 ' CD2' ' A' ' 116' ' ' TYR . 2.1 mp -102.93 140.89 36.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.175 -0.953 . . . . 0.0 109.583 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.781 ' OD1' HG23 ' A' ' 108' ' ' THR . 25.6 m120 57.04 16.72 3.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.267 -0.896 . . . . 0.0 109.734 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.35 32.59 27.88 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.11 123.3 10.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.193 -1.181 . . . . 0.0 110.482 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 167' ' ' ILE . 16.9 t -57.66 172.63 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 0.0 109.926 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.714 HD11 ' ND1' ' A' ' 160' ' ' HIS . 0.7 OUTLIER -132.7 178.27 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.195 -0.941 . . . . 0.0 111.019 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 102' ' ' GLY . 10.3 t70 -127.9 80.25 72.39 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 42.8 Cg_endo -70.41 131.22 19.88 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.069 1.563 . . . . 0.0 111.241 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.401 ' O ' ' CB ' ' A' ' 99' ' ' MET . 4.6 mmtm -146.73 -174.01 4.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.401 -0.812 . . . . 0.0 110.302 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.385 0 O-C-N 121.463 -0.773 . . . . 0.0 110.487 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.525 ' HG2' ' CD1' ' A' ' 144' ' ' LEU . 12.5 mtmm . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.344 0.592 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.926 ' CE ' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -145.33 160.0 42.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.656 179.2 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.836 ' O ' HD13 ' A' ' 101' ' ' ILE . 13.1 t80 -113.61 146.07 40.29 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.414 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.926 HD11 ' CE ' ' A' ' 99' ' ' MET . 12.7 mm -123.61 91.39 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.531 -0.731 . . . . 0.0 110.123 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 167' ' ' ILE . . . -91.34 178.77 41.79 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.65 10.89 61.25 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.722 HD13 ' H ' ' A' ' 141' ' ' GLY . 4.9 mp -73.36 163.72 27.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.098 -1.237 . . . . 0.0 110.349 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.521 ' HB3' ' ND2' ' A' ' 163' ' ' ASN . 13.3 t -90.37 -176.86 4.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.331 -0.856 . . . . 0.0 109.615 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.547 ' CD1' ' N ' ' A' ' 106' ' ' TRP . 37.0 m0 -87.67 23.21 2.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.081 -1.012 . . . . 0.0 110.143 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -144.25 9.5 1.44 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -0.9 . . . . 0.0 110.47 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.861 HG23 ' OD1' ' A' ' 163' ' ' ASN . 0.2 OUTLIER -73.41 172.47 11.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.106 -0.996 . . . . 0.0 109.822 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.512 HG23 ' C ' ' A' ' 108' ' ' THR . 71.4 p -150.36 166.41 30.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.132 -0.98 . . . . 0.0 110.366 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 114' ' ' LYS . 0.8 OUTLIER -67.68 -15.38 63.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.219 -0.925 . . . . 0.0 109.529 179.532 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -80.8 -62.66 1.6 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.315 -0.866 . . . . 0.0 110.38 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 109' ' ' THR . 1.1 p-10 -55.87 -37.75 69.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 110.249 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.646 HD23 ' SG ' ' A' ' 126' ' ' CYS . 13.3 tp -72.09 -41.46 67.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.156 -0.965 . . . . 0.0 110.178 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 110' ' ' LYS . 0.1 OUTLIER -60.87 -47.03 88.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.201 -0.937 . . . . 0.0 110.292 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 116' ' ' TYR . 26.4 t0 -69.91 -48.39 58.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.035 -1.041 . . . . 0.0 110.034 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.407 ' C ' ' O ' ' A' ' 115' ' ' ASP . 75.0 t80 -48.28 -34.89 11.14 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.62 -1.232 . . . . 0.0 108.104 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.655 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 13.5 m-85 -91.66 -8.08 48.13 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.409 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.5 m -71.15 -9.1 57.5 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.891 -1.131 . . . . 0.0 108.951 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -81.74 -16.09 52.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.6 -0.687 . . . . 0.0 110.091 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.655 ' CD1' ' HA ' ' A' ' 117' ' ' PHE . 70.7 m-85 -89.1 -55.35 3.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.179 -0.951 . . . . 0.0 109.153 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.531 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -164.57 -163.36 17.48 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.24 140.94 29.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.114 -1.227 . . . . 0.0 110.351 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.9 t -112.75 133.5 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.308 -0.87 . . . . 0.0 110.823 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.22 -25.64 5.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.561 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 1.0 OUTLIER -148.53 165.45 31.17 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.667 -1.213 . . . . 0.0 112.045 -179.203 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.646 ' SG ' HD23 ' A' ' 113' ' ' LEU . 14.3 t -170.52 148.68 3.14 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.45 ' O ' ' HA3' ' A' ' 141' ' ' GLY . 0.8 OUTLIER -150.28 162.28 40.81 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.116 -0.99 . . . . 0.0 110.599 -178.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.931 HD13 ' O ' ' A' ' 128' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.446 -0.784 . . . . 0.0 109.692 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.496 ' CA ' ' HB2' ' A' ' 104' ' ' LEU . 16.9 p90 . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 121.528 0.68 . . . . 0.0 110.965 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.722 ' H ' HD13 ' A' ' 104' ' ' LEU . . . -125.42 173.69 17.45 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.72 ' CE1' ' CE1' ' A' ' 100' ' ' PHE . 10.1 m-85 -116.51 158.15 24.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.185 -1.185 . . . . 0.0 110.234 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.557 ' CG2' HG13 ' A' ' 101' ' ' ILE . 25.8 t -138.46 124.88 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.933 0.873 . . . . 0.0 109.939 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.561 ' HB2' ' CB ' ' A' ' 125' ' ' ASP . 1.6 mm? -110.27 111.65 23.09 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.658 ' CB ' HG22 ' A' ' 151' ' ' VAL . 11.7 m-85 -82.01 151.59 27.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.971 -1.081 . . . . 0.0 111.052 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 30.4 tttt -81.28 -25.24 36.7 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.674 -0.641 . . . . 0.0 111.157 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.486 ' OE2' ' HB3' ' A' ' 149' ' ' GLU . 1.0 OUTLIER -144.48 146.37 32.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.703 -1.248 . . . . 0.0 111.231 -179.333 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.3 t -49.17 -35.13 16.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.154 -0.966 . . . . 0.0 109.554 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.533 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 0.6 OUTLIER -55.78 -51.61 66.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.348 -0.845 . . . . 0.0 109.972 179.725 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.56 ' HB2' ' CD1' ' A' ' 145' ' ' PHE . 67.1 p -56.99 -36.68 70.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.297 -0.877 . . . . 0.0 110.322 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.658 HG22 ' CB ' ' A' ' 145' ' ' PHE . 3.1 t -72.22 -53.6 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.075 -1.016 . . . . 0.0 110.393 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.533 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -47.78 -35.52 10.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.062 -1.023 . . . . 0.0 110.051 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.485 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -69.25 -52.0 31.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.898 . . . . 0.0 110.375 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.603 HG12 ' O ' ' A' ' 151' ' ' VAL . 2.1 p -65.15 -14.39 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.989 -1.07 . . . . 0.0 110.17 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 28.1 tpp -90.48 -36.76 14.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.348 -0.845 . . . . 0.0 110.618 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 1.6 p-10 -57.73 -17.59 16.28 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.124 -0.985 . . . . 0.0 110.115 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.532 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 8.9 tp-100 -139.5 76.87 1.59 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.329 -0.857 . . . . 0.0 109.437 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.632 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -81.84 10.3 6.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.906 . . . . 0.0 110.666 -179.426 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.409 ' HB2' ' OE1' ' A' ' 157' ' ' GLN . 8.9 mm-40 -88.09 67.88 8.99 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.678 ' O ' HG13 ' A' ' 166' ' ' VAL . 77.5 m-70 -86.41 174.71 8.82 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.51 0.671 . . . . 0.0 110.901 -177.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.602 ' HG3' HG22 ' A' ' 166' ' ' VAL . 1.1 mppt? -168.95 74.17 0.09 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.523 -0.735 . . . . 0.0 109.226 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.696 ' H ' HD23 ' A' ' 162' ' ' LEU . 0.9 OUTLIER -109.89 155.8 21.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.38 -0.825 . . . . 0.0 110.178 -179.442 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.861 ' OD1' HG23 ' A' ' 108' ' ' THR . 0.3 OUTLIER 66.59 9.13 6.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.265 -0.897 . . . . 0.0 109.639 -179.348 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 89.08 15.38 59.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -150.92 163.49 38.57 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.051 -1.264 . . . . 0.0 110.671 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.678 HG13 ' O ' ' A' ' 160' ' ' HIS . 2.9 t -84.9 178.28 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 109.53 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.624 HD11 ' CG ' ' A' ' 160' ' ' HIS . 0.7 OUTLIER -134.15 169.0 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.966 -1.084 . . . . 0.0 111.04 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 102' ' ' GLY . 9.5 t70 -112.34 88.22 10.44 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 167' ' ' ILE . 48.7 Cg_endo -77.14 119.66 5.1 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.259 1.663 . . . . 0.0 110.607 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.5 mttp -135.64 175.25 9.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 0.0 110.544 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 171' ' ' ARG . 9.3 ptp180 . . . . . 0 C--N 1.303 -1.449 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.27 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.504 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 9.8 mttt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.155 0.503 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.499 ' HG2' ' O ' ' A' ' 143' ' ' VAL . 6.9 ptm -141.29 174.67 10.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.313 -0.867 . . . . 0.0 110.181 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.697 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 2.3 t80 -115.15 129.11 56.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.388 -0.82 . . . . 0.0 110.176 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.677 HD13 ' C ' ' A' ' 100' ' ' PHE . 4.2 mm -111.53 95.94 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.287 -0.883 . . . . 0.0 109.251 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -93.13 113.92 4.57 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.468 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 145.08 34.51 0.07 OUTLIER Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 1.09 HD12 HG21 ' A' ' 108' ' ' THR . 3.5 mm? -91.17 151.82 20.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.088 -1.242 . . . . 0.0 110.116 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.441 ' HB3' ' HB3' ' A' ' 163' ' ' ASN . 52.7 p -75.27 -178.46 3.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.195 -0.941 . . . . 0.0 109.988 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -82.1 6.42 16.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -0.923 . . . . 0.0 110.364 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 107' ' ' ASP . 2.9 p-10 -140.61 32.23 1.85 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.311 -0.868 . . . . 0.0 110.04 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . 1.09 HG21 HD12 ' A' ' 104' ' ' LEU . 18.1 m -77.7 154.35 32.17 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.313 -0.867 . . . . 0.0 110.344 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.487 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 12.2 p -126.05 161.78 26.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.224 -0.923 . . . . 0.0 110.358 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.559 ' CG ' ' HA ' ' A' ' 127' ' ' THR . 0.3 OUTLIER -64.76 -20.47 66.37 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.089 -1.007 . . . . 0.0 110.121 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -88.61 -47.22 8.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.231 -0.918 . . . . 0.0 110.955 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -60.13 -30.42 69.27 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.941 -1.099 . . . . 0.0 109.881 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.642 HD13 HD11 ' A' ' 104' ' ' LEU . 27.0 tp -84.19 -45.91 12.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.218 -0.926 . . . . 0.0 109.47 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -33.03 67.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.889 . . . . 0.0 109.254 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' A' ' 118' ' ' SER . 0.2 OUTLIER -75.37 -55.04 6.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.28 -0.888 . . . . 0.0 109.675 179.632 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.448 ' C ' ' O ' ' A' ' 115' ' ' ASP . 64.8 t80 -46.55 -31.6 2.88 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.664 -1.214 . . . . 0.0 108.256 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.579 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 14.5 m-85 -91.35 -12.31 35.31 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.23 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 115' ' ' ASP . 44.0 t -67.47 -9.26 40.43 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.869 -1.144 . . . . 0.0 109.015 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -79.26 -16.23 56.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.407 -0.808 . . . . 0.0 110.438 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.953 ' CZ ' HG23 ' A' ' 154' ' ' VAL . 90.4 m-85 -88.89 -53.18 4.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.155 -0.965 . . . . 0.0 109.685 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -164.15 -159.16 10.67 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.03 135.09 33.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -1.123 . . . . 0.0 110.262 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.563 HG13 ' O ' ' A' ' 125' ' ' ASP . 2.0 t -111.83 133.66 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.294 -0.879 . . . . 0.0 110.59 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.42 HG23 ' HD2' ' A' ' 146' ' ' LYS . 2.1 t -88.73 -25.58 5.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.563 ' O ' HG13 ' A' ' 123' ' ' VAL . 0.9 OUTLIER -150.67 168.93 22.87 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.603 -1.239 . . . . 0.0 112.293 -179.056 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.526 ' O ' ' CD ' ' A' ' 110' ' ' LYS . 38.8 t -167.15 149.16 5.98 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.559 ' HA ' ' CG ' ' A' ' 110' ' ' LYS . 0.9 OUTLIER -150.78 147.82 27.76 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.869 -1.144 . . . . 0.0 111.563 -178.354 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.834 HD13 ' O ' ' A' ' 128' ' ' LEU . 2.3 tm? . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.762 ' HA ' HD23 ' A' ' 104' ' ' LEU . 3.3 p90 . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.019 0.438 . . . . 0.0 110.335 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -150.78 -165.46 12.78 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.466 -1.35 . . . . 0.0 110.5 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.697 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 16.4 m-85 -126.71 157.33 39.37 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.416 -1.049 . . . . 0.0 111.22 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.628 ' O ' HD12 ' A' ' 144' ' ' LEU . 2.8 t -130.34 134.39 62.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 143' ' ' VAL . 6.2 mp -121.82 90.2 3.26 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.104 -0.997 . . . . 0.0 110.333 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.796 ' HB2' HG22 ' A' ' 151' ' ' VAL . 29.6 m-85 -64.36 167.9 6.33 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.529 0.681 . . . . 0.0 109.98 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.42 ' HD2' HG23 ' A' ' 124' ' ' VAL . 7.9 tttt -103.05 -7.51 21.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.362 -0.837 . . . . 0.0 110.73 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.722 ' O ' HG23 ' A' ' 151' ' ' VAL . 0.9 OUTLIER -141.14 161.51 37.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.889 -1.132 . . . . 0.0 110.936 -179.524 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 4.8 t -75.26 -43.14 53.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 109.66 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.529 ' CB ' ' OE1' ' A' ' 147' ' ' GLU . 0.5 OUTLIER -60.62 -29.99 69.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.326 -0.859 . . . . 0.0 109.702 179.506 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.499 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 7.2 p -71.68 -40.58 69.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.041 -1.037 . . . . 0.0 109.431 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.796 HG22 ' HB2' ' A' ' 145' ' ' PHE . 8.3 t -72.42 -40.97 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -0.939 . . . . 0.0 110.154 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -67.6 -24.46 65.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.998 -1.063 . . . . 0.0 109.548 179.801 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.484 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 0.7 OUTLIER -74.39 -40.57 61.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.396 -0.815 . . . . 0.0 109.703 179.5 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.953 HG23 ' CZ ' ' A' ' 120' ' ' PHE . 11.4 p -79.56 -17.3 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.149 -0.97 . . . . 0.0 110.011 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -88.57 -32.31 18.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.497 -0.752 . . . . 0.0 110.388 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.484 ' OD2' ' O ' ' A' ' 153' ' ' LYS . 0.3 OUTLIER -51.92 -32.13 31.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.054 -1.029 . . . . 0.0 109.681 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.506 ' O ' ' NE2' ' A' ' 160' ' ' HIS . 1.4 mt-30 -130.05 96.96 4.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.308 -0.87 . . . . 0.0 110.028 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.523 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -89.54 24.68 2.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.13 -0.981 . . . . 0.0 110.264 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -88.1 62.16 6.66 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.692 ' ND1' HD11 ' A' ' 167' ' ' ILE . 11.5 m170 -86.9 178.8 6.86 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.942 -177.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 7.7 ttpt -175.27 68.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.383 -0.823 . . . . 0.0 109.823 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.679 HD11 HD13 ' A' ' 104' ' ' LEU . 2.4 pp -99.9 152.88 19.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.867 . . . . 0.0 109.814 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.523 ' HB2' HD12 ' A' ' 162' ' ' LEU . 5.4 m120 56.05 32.89 20.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.144 -0.973 . . . . 0.0 109.415 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 60.59 29.3 69.36 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.26 138.8 20.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.241 -1.152 . . . . 0.0 110.524 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.542 HG12 ' H ' ' A' ' 167' ' ' ILE . 21.6 t -75.19 176.9 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.934 . . . . 0.0 109.375 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.692 HD11 ' ND1' ' A' ' 160' ' ' HIS . 1.3 pt -137.19 -175.62 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.0 -1.063 . . . . 0.0 111.209 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -140.77 93.79 8.36 Favored Pre-proline 0 C--N 1.301 -1.515 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -77.11 115.26 3.95 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.378 1.725 . . . . 0.0 110.603 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.65 171.48 9.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.331 -0.856 . . . . 0.0 110.327 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.3 -1.559 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.229 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.517 ' CG ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.189 0.519 . . . . 0.0 109.943 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.647 ' HE2' ' O ' ' A' ' 170' ' ' LYS . 6.0 mtp -140.09 179.26 6.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.129 -0.982 . . . . 0.0 110.376 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.811 ' O ' HD13 ' A' ' 101' ' ' ILE . 2.4 t80 -124.42 136.54 54.13 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.45 -0.781 . . . . 0.0 110.077 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.811 HD13 ' O ' ' A' ' 100' ' ' PHE . 6.0 mm -122.19 106.08 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.12 -0.988 . . . . 0.0 110.009 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.552 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -103.27 139.84 14.62 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.88 10.85 8.83 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.86 HD21 HD22 ' A' ' 113' ' ' LEU . 4.3 mp -65.66 159.62 24.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.312 -1.11 . . . . 0.0 110.479 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.528 ' N ' ' OG1' ' A' ' 108' ' ' THR . 0.1 OUTLIER -83.94 177.11 8.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.37 -0.831 . . . . 0.0 109.823 179.541 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.564 ' CD1' ' N ' ' A' ' 106' ' ' TRP . 12.1 m0 -73.53 -23.75 60.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.153 -0.967 . . . . 0.0 110.352 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -104.97 11.77 33.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 110.887 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.618 HG21 ' HG ' ' A' ' 104' ' ' LEU . 1.8 m -60.92 161.24 8.49 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.986 -1.072 . . . . 0.0 110.023 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.51 HG23 ' C ' ' A' ' 108' ' ' THR . 68.3 p -150.33 179.53 8.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.342 -0.849 . . . . 0.0 110.391 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 23.2 ttmt -77.14 -19.07 57.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.387 -0.821 . . . . 0.0 109.342 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.56 -52.98 8.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.444 -0.785 . . . . 0.0 110.894 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 109' ' ' THR . 24.1 p-10 -70.01 -40.81 75.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.036 -1.04 . . . . 0.0 110.553 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.86 HD22 HD21 ' A' ' 104' ' ' LEU . 24.4 tp -65.1 -50.05 67.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.964 -1.085 . . . . 0.0 109.792 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -57.82 -32.5 67.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.914 . . . . 0.0 110.139 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.462 ' O ' ' C ' ' A' ' 116' ' ' TYR . 3.1 m-20 -80.0 -54.69 5.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.145 -0.972 . . . . 0.0 110.255 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.717 ' HE2' ' HD2' ' A' ' 160' ' ' HIS . 59.0 t80 -45.97 -32.6 2.83 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 118.711 -1.196 . . . . 0.0 108.177 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.743 ' HE2' HD11 ' A' ' 113' ' ' LEU . 12.8 m-85 -90.83 -17.14 27.08 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.22 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 115' ' ' ASP . 22.6 t -60.22 -20.47 58.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.981 -1.075 . . . . 0.0 109.445 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -74.92 -11.84 60.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.442 -0.786 . . . . 0.0 109.978 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.69 ' HB3' HG22 ' A' ' 154' ' ' VAL . 61.3 m-85 -89.78 -72.73 0.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.282 -0.886 . . . . 0.0 109.172 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -148.76 152.28 24.34 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.491 ' HB3' ' HE2' ' A' ' 146' ' ' LYS . 1.4 mt-10 -45.23 128.45 7.59 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.227 -1.161 . . . . 0.0 110.76 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.8 t -106.71 132.06 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.425 -0.797 . . . . 0.0 110.214 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.17 -24.4 5.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.442 ' O ' HG13 ' A' ' 123' ' ' VAL . 1.9 m-20 -150.81 161.24 43.04 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 118.447 -1.301 . . . . 0.0 112.33 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.481 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 43.3 t -161.37 147.78 14.41 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -151.25 154.7 37.31 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 118.538 -1.265 . . . . 0.0 111.842 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.943 HD13 ' O ' ' A' ' 128' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.563 ' CD2' ' CZ ' ' A' ' 100' ' ' PHE . 8.7 p90 . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 121.219 0.533 . . . . 0.0 110.629 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -144.91 -159.78 8.23 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.694 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 17.9 m-85 -129.28 170.2 13.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.317 -1.107 . . . . 0.0 111.279 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.506 ' O ' HD12 ' A' ' 144' ' ' LEU . 3.1 t -145.03 128.3 11.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.517 ' HG ' ' CG ' ' A' ' 98' ' ' LYS . 6.6 mp -116.0 104.35 11.49 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.417 -0.802 . . . . 0.0 109.752 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 1.181 ' CZ ' HG21 ' A' ' 154' ' ' VAL . 52.6 m-85 -78.21 148.69 33.9 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.582 -0.699 . . . . 0.0 110.699 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.491 ' HE2' ' HB3' ' A' ' 122' ' ' GLU . 1.8 ttmt -59.98 -38.22 81.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.641 -0.662 . . . . 0.0 111.061 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.472 ' OE2' ' HB2' ' A' ' 149' ' ' GLU . 0.5 OUTLIER -133.87 149.49 51.34 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.969 -1.082 . . . . 0.0 111.186 -179.321 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.9 p -52.45 -27.92 18.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.322 -0.861 . . . . 0.0 109.824 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.544 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 1.9 mm-40 -62.74 -56.35 18.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.388 -0.82 . . . . 0.0 109.93 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.631 ' O ' HG23 ' A' ' 154' ' ' VAL . 3.5 p -51.7 -32.15 28.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.171 -0.956 . . . . 0.0 109.757 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.796 HG22 ' HB2' ' A' ' 145' ' ' PHE . 17.7 t -65.81 -57.84 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.322 -0.861 . . . . 0.0 110.189 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.544 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 1.1 p30 -51.5 -28.89 14.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.172 -0.955 . . . . 0.0 109.99 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.47 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -68.28 -44.36 75.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.444 -0.785 . . . . 0.0 110.004 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 1.181 HG21 ' CZ ' ' A' ' 145' ' ' PHE . 3.8 t -69.86 -18.33 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.103 -0.998 . . . . 0.0 109.973 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.55 -23.96 21.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.88 . . . . 0.0 110.02 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.4 OUTLIER -55.41 -35.54 65.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 109.821 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.621 ' O ' ' CE1' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -127.16 95.5 4.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.814 . . . . 0.0 109.583 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.474 ' HG3' ' HD2' ' A' ' 169' ' ' PRO . 9.5 tmtt? -85.29 12.43 8.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.904 . . . . 0.0 110.561 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -87.5 66.15 8.9 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 177.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.717 ' HD2' ' HE2' ' A' ' 116' ' ' TYR . 21.1 m80 -87.2 177.76 7.08 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.487 -177.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.639 ' HG3' HG22 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -174.18 70.51 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.285 -0.885 . . . . 0.0 110.085 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.886 HD12 ' HB2' ' A' ' 163' ' ' ASN . 3.6 pp -96.09 154.33 17.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 109.73 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.886 ' HB2' HD12 ' A' ' 162' ' ' LEU . 0.9 OUTLIER 58.99 15.38 3.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.898 . . . . 0.0 109.969 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.16 24.58 54.39 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -150.07 149.09 29.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -1.166 . . . . 0.0 110.702 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.639 HG22 ' HG3' ' A' ' 161' ' ' LYS . 30.1 t -77.2 176.12 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.438 -0.789 . . . . 0.0 109.7 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.579 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -142.38 -176.13 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.131 -0.98 . . . . 0.0 110.971 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 102' ' ' GLY . 60.8 t0 -127.87 94.03 38.14 Favored Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.474 ' HD2' ' HG3' ' A' ' 158' ' ' LYS . 49.8 Cg_endo -74.85 113.64 3.84 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.395 1.734 . . . . 0.0 111.71 -178.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.647 ' O ' ' HE2' ' A' ' 99' ' ' MET . 1.0 OUTLIER -130.51 -171.63 2.6 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.607 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.508 ' HA ' ' HG2' ' A' ' 99' ' ' MET . 14.7 mtp180 . . . . . 0 C--N 1.297 -1.714 0 C-N-CA 118.861 -1.136 . . . . 0.0 110.363 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.553 ' HD3' HD21 ' A' ' 144' ' ' LEU . 18.1 mttp . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.22 0.533 . . . . 0.0 110.294 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.556 ' CE ' HD11 ' A' ' 101' ' ' ILE . 17.3 ptm -144.33 175.5 10.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.157 -0.964 . . . . 0.0 110.621 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.8 ' C ' HD13 ' A' ' 101' ' ' ILE . 2.4 t80 -117.3 135.36 53.89 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.533 -0.729 . . . . 0.0 109.174 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.8 HD13 ' C ' ' A' ' 100' ' ' PHE . 4.9 mm -119.42 110.56 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.182 -0.949 . . . . 0.0 109.78 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.447 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -111.37 98.71 1.05 Allowed Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.046 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 168.35 33.67 0.02 OUTLIER Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 1.007 HD12 HG21 ' A' ' 108' ' ' THR . 3.8 mm? -90.71 159.59 16.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -1.208 . . . . 0.0 109.808 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.457 ' N ' ' OG1' ' A' ' 108' ' ' THR . 14.0 t -85.33 -175.38 5.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.1 -1.0 . . . . 0.0 109.815 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 73.4 t90 -69.65 -33.37 72.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.062 -1.024 . . . . 0.0 110.148 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -103.77 48.13 0.86 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.204 -0.935 . . . . 0.0 110.335 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . 1.007 HG21 HD12 ' A' ' 104' ' ' LEU . 19.8 m -88.02 155.03 20.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -0.988 . . . . 0.0 110.335 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.456 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 46.3 p -143.67 156.04 44.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.456 -0.778 . . . . 0.0 109.935 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.438 ' O ' ' HB3' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -62.42 -14.7 43.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.065 -1.022 . . . . 0.0 109.453 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.9 mmtt -74.06 -56.08 5.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.363 -0.836 . . . . 0.0 110.013 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 12.1 p30 -69.06 -20.75 64.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.136 -0.978 . . . . 0.0 109.934 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 1.004 HD13 HD11 ' A' ' 104' ' ' LEU . 15.8 tp -86.73 -54.84 4.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.889 . . . . 0.0 109.641 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.438 ' HB3' ' O ' ' A' ' 110' ' ' LYS . 10.3 tttm -54.01 -35.59 62.07 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.456 -0.777 . . . . 0.0 109.73 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 116' ' ' TYR . 12.8 m-20 -76.16 -52.51 9.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.192 -0.943 . . . . 0.0 109.782 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.533 ' HH ' ' CG ' ' A' ' 160' ' ' HIS . 65.4 t80 -47.63 -33.74 7.08 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.723 -1.191 . . . . 0.0 108.063 178.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.648 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 15.3 m-85 -91.96 -9.7 42.07 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.394 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.426 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 7.6 t -72.34 -4.02 27.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.051 -1.031 . . . . 0.0 109.386 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -89.95 -11.37 41.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.544 -0.723 . . . . 0.0 110.429 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.648 ' CD2' ' HA ' ' A' ' 117' ' ' PHE . 90.8 m-85 -88.59 -52.48 5.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.124 -0.985 . . . . 0.0 109.643 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -164.77 -161.81 14.52 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 146' ' ' LYS . 4.1 tt0 -86.02 115.24 23.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.221 -1.164 . . . . 0.0 110.446 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.9 t -94.11 132.07 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.303 -0.873 . . . . 0.0 110.912 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.38 -24.21 5.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.551 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 5.5 m-20 -147.75 163.05 37.92 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 118.766 -1.174 . . . . 0.0 112.373 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 44.0 t -170.15 140.63 1.97 Allowed 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.462 ' CG2' ' N ' ' A' ' 128' ' ' LEU . 0.9 OUTLIER -150.73 168.16 25.2 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 118.675 -1.21 . . . . 0.0 112.01 -177.781 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.734 HD22 ' O ' ' A' ' 108' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.683 ' HA ' HD23 ' A' ' 104' ' ' LEU . 4.1 p90 . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 120.97 0.414 . . . . 0.0 110.469 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 128' ' ' LEU . . . -134.87 -166.15 11.04 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.968 -1.111 . . . . 0.0 110.418 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.697 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 16.5 m-85 -122.84 168.1 12.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.418 -1.048 . . . . 0.0 111.325 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.558 ' CG2' HG13 ' A' ' 101' ' ' ILE . 8.9 t -144.76 134.04 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.553 HD21 ' HD3' ' A' ' 98' ' ' LYS . 3.1 mp -121.59 101.5 7.64 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.301 -0.874 . . . . 0.0 110.368 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.839 ' HB2' HG22 ' A' ' 151' ' ' VAL . 12.6 m-85 -76.42 158.08 31.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.296 -0.877 . . . . 0.0 110.382 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 122' ' ' GLU . 24.4 tptp -85.28 -11.94 53.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.819 . . . . 0.0 111.205 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.792 ' O ' HG23 ' A' ' 151' ' ' VAL . 2.6 tt0 -144.92 151.06 38.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.75 -1.219 . . . . 0.0 110.883 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 19.9 m -61.98 -36.91 82.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.9 . . . . 0.0 109.437 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.521 ' CB ' ' OE1' ' A' ' 147' ' ' GLU . 2.3 tt0 -62.11 -56.18 21.45 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.329 -0.857 . . . . 0.0 109.42 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 49.7 p -45.6 -37.0 5.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.149 -0.969 . . . . 0.0 109.361 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.839 HG22 ' HB2' ' A' ' 145' ' ' PHE . 2.9 t -74.3 -35.15 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 0.0 109.635 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.52 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -66.01 -28.08 68.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -0.872 . . . . 0.0 109.521 179.583 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.479 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 4.2 mttm -74.99 -48.51 23.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.377 -0.827 . . . . 0.0 109.908 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.699 HG23 ' HE1' ' A' ' 160' ' ' HIS . 9.0 p -66.13 -18.28 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.009 -1.057 . . . . 0.0 109.916 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 5.3 ttt -89.95 -43.51 10.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.262 -0.899 . . . . 0.0 110.115 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.479 ' OD2' ' O ' ' A' ' 153' ' ' LYS . 0.5 OUTLIER -46.39 -33.78 4.15 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.175 -0.953 . . . . 0.0 109.766 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.571 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 3.2 tt0 -119.43 90.26 3.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.29 -0.881 . . . . 0.0 110.105 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 158' ' ' LYS . 38.3 ttpt -87.14 19.77 3.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.325 -0.859 . . . . 0.0 110.295 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.6 58.28 4.83 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 177.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.974 ' ND1' HD11 ' A' ' 167' ' ' ILE . 13.7 m-70 -86.47 173.78 9.4 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.372 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -177.64 67.94 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.439 -0.788 . . . . 0.0 109.467 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.806 HD11 ' CD1' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -97.04 157.69 15.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.413 -0.804 . . . . 0.0 110.152 -179.575 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.466 ' HB2' HD12 ' A' ' 162' ' ' LEU . 0.4 OUTLIER 58.17 16.45 3.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 109.627 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 81.29 21.94 61.6 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.54 149.65 30.21 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.1 -1.235 . . . . 0.0 110.394 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 160' ' ' HIS . 1.1 p -76.95 -177.28 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.177 -0.952 . . . . 0.0 109.668 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.974 HD11 ' ND1' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -135.78 166.76 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.956 -1.09 . . . . 0.0 111.651 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -117.31 88.86 29.44 Favored Pre-proline 0 C--N 1.303 -1.436 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.491 ' HD2' ' HD2' ' A' ' 158' ' ' LYS . 46.7 Cg_endo -72.7 132.02 18.09 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.359 1.715 . . . . 0.0 111.184 -178.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 99' ' ' MET . 2.5 mttm -147.9 -169.8 3.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.53 -0.731 . . . . 0.0 109.964 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.541 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.222 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.56 ' CG ' ' HG ' ' A' ' 144' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.237 0.542 . . . . 0.0 110.527 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.885 ' HE2' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -123.38 167.25 14.07 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.193 -0.942 . . . . 0.0 108.84 178.711 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.691 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 1.6 t80 -105.73 125.28 50.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.06 -1.025 . . . . 0.0 110.305 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.885 HD11 ' HE2' ' A' ' 99' ' ' MET . 16.5 mm -116.95 94.92 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 110.169 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.603 ' O ' HG22 ' A' ' 167' ' ' ILE . . . -92.71 178.28 39.36 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.47 6.74 70.29 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.981 HD12 HG21 ' A' ' 108' ' ' THR . 3.1 mm? -61.68 164.13 6.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.094 -1.239 . . . . 0.0 109.536 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.423 ' HB3' ' HB3' ' A' ' 163' ' ' ASN . 0.9 OUTLIER -89.05 177.78 6.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.042 -1.036 . . . . 0.0 109.97 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.422 ' CD1' ' N ' ' A' ' 106' ' ' TRP . 33.3 m95 -84.99 19.23 2.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.223 -0.923 . . . . 0.0 110.217 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -148.12 21.88 1.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.9 . . . . 0.0 109.878 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.981 HG21 HD12 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -76.1 169.37 18.32 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.203 -0.935 . . . . 0.0 110.639 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.497 HG23 ' C ' ' A' ' 108' ' ' THR . 82.8 p -150.42 151.36 32.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.437 -0.789 . . . . 0.0 109.98 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.486 ' HD3' ' O ' ' A' ' 126' ' ' CYS . 7.1 ttpt -56.08 -16.34 4.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.162 -0.961 . . . . 0.0 109.881 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -80.15 -57.98 3.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.37 -0.831 . . . . 0.0 111.11 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 1.5 p-10 -65.38 -40.31 93.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.06 -1.025 . . . . 0.0 110.844 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.881 HD13 HD11 ' A' ' 104' ' ' LEU . 20.2 tp -69.05 -48.54 62.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.019 -1.051 . . . . 0.0 109.984 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 110' ' ' LYS . 11.7 tttt -52.16 -40.47 61.49 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.234 -0.916 . . . . 0.0 110.127 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.532 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 4.2 t0 -74.69 -50.86 16.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.234 -0.916 . . . . 0.0 110.257 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.448 ' C ' ' O ' ' A' ' 115' ' ' ASP . 78.1 t80 -46.21 -34.85 4.66 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.402 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.616 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 9.1 m-85 -91.63 -12.45 34.17 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.441 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.532 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 0.9 OUTLIER -72.65 -5.26 36.26 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.917 -1.115 . . . . 0.0 108.998 178.5 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.486 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 2.1 tttm -85.77 -12.27 51.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.521 -0.737 . . . . 0.0 110.347 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.616 ' CD2' ' HA ' ' A' ' 117' ' ' PHE . 93.0 m-85 -88.9 -51.54 5.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.021 -1.049 . . . . 0.0 109.286 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.473 ' HA3' ' HB3' ' A' ' 150' ' ' SER . . . -158.71 -161.17 10.85 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -86.01 142.5 28.72 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.144 -1.209 . . . . 0.0 109.896 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.471 HG23 ' CD1' ' A' ' 145' ' ' PHE . 1.8 t -127.48 133.9 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.169 -0.957 . . . . 0.0 110.923 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.592 HG23 ' CE ' ' A' ' 146' ' ' LYS . 2.3 t -94.73 -22.03 5.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.425 ' O ' HG13 ' A' ' 123' ' ' VAL . 1.9 m-20 -149.82 170.68 18.19 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 118.049 -1.46 . . . . 0.0 113.135 -178.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.486 ' O ' ' HD3' ' A' ' 110' ' ' LYS . 16.2 t -170.85 131.48 0.84 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.36 162.08 25.58 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.448 -0.783 . . . . 0.0 111.45 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.983 HD13 ' O ' ' A' ' 128' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.803 0 O-C-N 121.362 -0.836 . . . . 0.0 110.294 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.503 ' CD2' ' CZ ' ' A' ' 100' ' ' PHE . 3.1 p90 . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.239 0.542 . . . . 0.0 110.542 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.602 ' HA3' ' HA ' ' A' ' 128' ' ' LEU . . . -139.24 -169.07 11.47 Favored Glycine 0 N--CA 1.488 2.114 0 C-N-CA 119.804 -1.189 . . . . 0.0 110.494 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.691 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 9.9 m-85 -124.48 170.6 10.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.732 -0.864 . . . . 0.0 110.008 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.638 ' C ' HD12 ' A' ' 144' ' ' LEU . 35.7 t -141.59 140.93 30.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.638 HD12 ' C ' ' A' ' 143' ' ' VAL . 5.8 mp -124.83 107.94 11.42 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.783 -178.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.766 ' CE2' HG11 ' A' ' 154' ' ' VAL . 42.9 m-85 -82.68 165.58 19.86 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.518 -0.739 . . . . 0.0 110.344 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.592 ' CE ' HG23 ' A' ' 124' ' ' VAL . 10.6 ttmt -86.77 -24.65 25.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.439 -0.788 . . . . 0.0 111.002 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.524 ' O ' HG23 ' A' ' 151' ' ' VAL . 0.7 OUTLIER -145.02 155.16 43.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.786 -1.196 . . . . 0.0 110.92 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 25.6 p -55.19 -35.8 65.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.271 -0.893 . . . . 0.0 109.948 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.544 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 1.0 OUTLIER -52.97 -54.14 39.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.425 -0.797 . . . . 0.0 110.008 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.485 ' OG ' ' HG3' ' A' ' 147' ' ' GLU . 3.6 p -57.59 -39.44 76.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.187 -0.945 . . . . 0.0 110.233 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.626 ' O ' HG12 ' A' ' 154' ' ' VAL . 6.6 t -62.0 -44.69 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.12 -0.988 . . . . 0.0 110.62 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.544 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.5 OUTLIER -67.16 -27.56 67.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.044 -1.035 . . . . 0.0 110.097 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.473 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -70.75 -32.36 69.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.847 . . . . 0.0 110.163 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.766 HG11 ' CE2' ' A' ' 145' ' ' PHE . 6.0 p -90.66 -20.87 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.158 -0.964 . . . . 0.0 110.329 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.04 -34.5 16.77 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.371 -0.83 . . . . 0.0 109.892 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 8.4 p-10 -47.38 -31.9 4.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.295 -0.878 . . . . 0.0 109.865 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.517 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -131.95 94.95 3.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.976 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.499 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -89.52 27.31 1.5 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.127 -0.983 . . . . 0.0 110.431 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -89.03 55.66 3.42 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.811 ' O ' HG23 ' A' ' 166' ' ' VAL . 12.2 m170 -86.23 176.31 8.01 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.684 -177.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -177.21 75.05 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.46 -0.775 . . . . 0.0 109.452 179.718 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.624 HD11 HD13 ' A' ' 104' ' ' LEU . 1.5 pp -98.49 157.99 15.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.321 -0.862 . . . . 0.0 109.948 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 0.8 OUTLIER 60.04 13.92 4.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.328 -0.858 . . . . 0.0 109.675 -179.265 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 85.43 20.85 55.94 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 161' ' ' LYS . 5.8 mttt -151.21 150.55 30.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.086 -1.243 . . . . 0.0 110.736 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 160' ' ' HIS . 1.3 p -74.71 -178.79 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.4 -0.813 . . . . 0.0 109.683 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.603 HG22 ' O ' ' A' ' 102' ' ' GLY . 0.1 OUTLIER -135.39 -171.78 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.097 -1.002 . . . . 0.0 110.701 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 102' ' ' GLY . 23.9 t0 -132.71 84.63 49.68 Favored Pre-proline 0 N--CA 1.488 1.473 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.51 ' HA ' HD13 ' A' ' 101' ' ' ILE . 47.8 Cg_endo -74.93 127.18 10.53 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.218 1.641 . . . . 0.0 111.033 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.55 -173.48 4.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.462 -0.774 . . . . 0.0 109.794 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 . . . . . 0 C--N 1.301 -1.543 0 C-N-CA 119.499 -0.881 . . . . 0.0 110.566 179.364 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.509 ' HD3' HD21 ' A' ' 144' ' ' LEU . 8.2 mttp . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.372 0.606 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.659 ' CE ' HD11 ' A' ' 101' ' ' ILE . 5.4 ptm -138.73 169.56 17.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 109.982 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.795 ' C ' HD13 ' A' ' 101' ' ' ILE . 2.5 t80 -112.72 138.68 49.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.904 . . . . 0.0 110.593 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.795 HD13 ' C ' ' A' ' 100' ' ' PHE . 2.8 mm -121.85 110.77 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.418 -0.801 . . . . 0.0 109.822 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.477 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -108.57 123.92 7.21 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 138.89 33.63 0.18 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.739 HD21 HD22 ' A' ' 113' ' ' LEU . 2.2 mp -90.5 159.37 16.54 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.139 -1.212 . . . . 0.0 110.323 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.6 t -84.06 -170.3 3.01 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.208 -0.932 . . . . 0.0 110.32 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 20.2 m0 -87.53 4.1 44.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.208 -0.932 . . . . 0.0 110.332 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -138.0 22.99 2.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.205 -0.935 . . . . 0.0 110.15 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.712 HG21 ' CD2' ' A' ' 104' ' ' LEU . 2.8 m -68.06 163.28 22.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.171 -0.956 . . . . 0.0 110.059 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.457 HG23 ' C ' ' A' ' 108' ' ' THR . 30.3 p -148.61 153.76 38.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.198 -0.939 . . . . 0.0 110.171 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.548 ' O ' ' CB ' ' A' ' 114' ' ' LYS . 10.5 ttpt -58.4 -15.34 10.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.225 -0.922 . . . . 0.0 109.735 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.35 -54.61 6.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.219 -0.925 . . . . 0.0 110.273 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 3.2 p30 -70.12 -30.29 67.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.235 -0.916 . . . . 0.0 110.574 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.739 HD22 HD21 ' A' ' 104' ' ' LEU . 14.7 tp -81.11 -48.97 11.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.021 . . . . 0.0 109.996 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.548 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 1.3 tttt -55.04 -35.87 64.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.154 -0.966 . . . . 0.0 109.716 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.478 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 5.3 m-20 -79.59 -47.69 15.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.919 . . . . 0.0 109.748 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.799 ' HE2' ' HD2' ' A' ' 160' ' ' HIS . 75.6 t80 -48.23 -36.73 14.46 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 118.566 -1.253 . . . . 0.0 107.995 178.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.692 ' CD2' HG21 ' A' ' 143' ' ' VAL . 16.3 m-85 -91.56 -11.7 36.52 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.948 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.478 ' HB3' ' HA ' ' A' ' 115' ' ' ASP . 29.2 t -71.08 -6.49 39.57 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.907 -1.12 . . . . 0.0 108.81 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 11.4 tttt -83.47 -15.74 48.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.407 -0.808 . . . . 0.0 110.036 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.909 ' CG ' HG22 ' A' ' 154' ' ' VAL . 72.8 m-85 -89.18 -39.74 13.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.274 -0.891 . . . . 0.0 109.122 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.448 ' HA3' ' HB3' ' A' ' 150' ' ' SER . . . -174.19 176.99 46.57 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 0.9 OUTLIER -73.83 118.17 16.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.234 -1.156 . . . . 0.0 110.466 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.8 t -93.36 130.62 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.26 -0.9 . . . . 0.0 111.375 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -90.28 -23.73 5.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.522 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -142.76 153.02 42.9 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 118.984 -1.087 . . . . 0.0 112.09 -179.106 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 49.6 t -161.66 145.56 12.69 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.28 156.73 42.1 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.702 -1.199 . . . . 0.0 111.566 -178.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.736 ' C ' HD12 ' A' ' 128' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.524 ' CD1' ' CZ ' ' A' ' 100' ' ' PHE . 11.6 p90 . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 120.982 0.42 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.404 ' C ' ' CD1' ' A' ' 142' ' ' PHE . . . -153.91 -159.41 9.15 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.944 -1.263 . . . . 0.0 109.944 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.699 ' CZ ' ' CE2' ' A' ' 100' ' ' PHE . 18.9 m-85 -129.32 170.87 13.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -1.172 . . . . 0.0 111.429 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.692 HG21 ' CD2' ' A' ' 117' ' ' PHE . 7.3 t -145.9 129.83 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.633 HD12 ' C ' ' A' ' 143' ' ' VAL . 7.6 mp -120.84 102.96 8.71 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.398 -0.814 . . . . 0.0 110.355 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.901 ' CE2' HG21 ' A' ' 154' ' ' VAL . 26.2 m-85 -74.71 165.08 25.81 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.587 0.708 . . . . 0.0 110.899 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 17.5 ttpt -85.27 -26.5 26.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.512 -0.742 . . . . 0.0 111.104 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.504 ' HG3' ' OG ' ' A' ' 150' ' ' SER . 0.1 OUTLIER -137.11 142.05 42.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.654 -1.279 . . . . 0.0 110.772 -179.757 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 75.1 m -50.52 -30.67 13.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 109.996 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.545 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 1.8 mm-40 -59.25 -48.1 82.88 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.272 -0.892 . . . . 0.0 110.042 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.53 ' O ' HG23 ' A' ' 154' ' ' VAL . 11.2 p -62.75 -32.33 73.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.235 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.889 HG22 ' HB2' ' A' ' 145' ' ' PHE . 2.7 t -73.94 -55.31 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.065 -1.022 . . . . 0.0 110.103 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.545 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.1 OUTLIER -51.47 -27.14 9.59 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.159 -0.963 . . . . 0.0 109.341 179.772 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.475 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 8.7 tmtt? -69.5 -61.73 1.67 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.459 -0.775 . . . . 0.0 109.708 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.909 HG22 ' CG ' ' A' ' 120' ' ' PHE . 23.4 t -45.33 -28.65 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.127 -0.983 . . . . 0.0 109.948 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 6.7 ttt -77.46 -41.15 40.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.371 -0.831 . . . . 0.0 110.462 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.475 ' OD2' ' O ' ' A' ' 153' ' ' LYS . 0.4 OUTLIER -48.19 -22.99 0.74 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.132 -0.98 . . . . 0.0 109.962 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.629 ' O ' ' CE1' ' A' ' 160' ' ' HIS . 3.0 pt20 -140.44 90.89 2.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.286 -0.884 . . . . 0.0 110.135 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.74 16.38 5.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.122 -0.986 . . . . 0.0 110.372 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -87.67 63.64 7.63 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.799 ' HD2' ' HE2' ' A' ' 116' ' ' TYR . 14.5 m80 -87.35 -179.76 6.45 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.648 -177.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 165' ' ' LYS . 16.2 ttmt -179.06 74.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.26 -0.9 . . . . 0.0 110.23 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.585 HD12 ' HB2' ' A' ' 163' ' ' ASN . 1.8 pp -96.07 151.38 19.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 109.873 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.585 ' HB2' HD12 ' A' ' 162' ' ' LEU . 0.5 OUTLIER 61.39 12.36 4.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.232 -0.917 . . . . 0.0 110.217 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 88.2 23.01 39.06 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 161' ' ' LYS . 4.3 mtpp -150.12 138.96 20.89 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.183 -1.187 . . . . 0.0 110.579 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 160' ' ' HIS . 4.2 p -66.78 -179.39 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.311 -0.868 . . . . 0.0 109.995 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.651 HD11 ' HB3' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -145.13 176.74 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.176 -0.953 . . . . 0.0 110.642 -179.55 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 102' ' ' GLY . 34.2 t0 -128.09 90.78 46.44 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.526 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 52.3 Cg_endo -78.44 139.36 16.31 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 124.118 1.588 . . . . 0.0 110.862 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.08 -173.01 4.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.922 . . . . 0.0 110.122 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 . . . . . 0 C--N 1.302 -1.482 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.319 179.378 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.452 ' HB3' ' HG ' ' A' ' 144' ' ' LEU . 43.3 mttt . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.448 0.642 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.793 ' CE ' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -134.49 165.78 24.39 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.779 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.728 ' C ' HD13 ' A' ' 101' ' ' ILE . 17.4 t80 -111.78 144.35 41.23 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.077 -1.014 . . . . 0.0 110.67 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.793 HD11 ' CE ' ' A' ' 99' ' ' MET . 3.2 mm -117.63 96.53 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.555 -0.716 . . . . 0.0 109.227 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.565 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -93.99 120.39 6.31 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.84 -1.172 . . . . 0.0 110.627 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.52 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 133.65 35.03 0.29 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.957 HD11 HD12 ' A' ' 113' ' ' LEU . 4.0 mm? -90.21 161.64 15.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.12 -1.224 . . . . 0.0 110.106 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.494 ' N ' ' OG1' ' A' ' 108' ' ' THR . 0.1 OUTLIER -90.64 160.4 15.9 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.212 -0.93 . . . . 0.0 110.332 179.835 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -62.14 -10.92 11.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.052 -1.03 . . . . 0.0 110.218 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -116.09 12.68 15.64 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.143 -0.973 . . . . 0.0 111.321 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . 1.04 HG23 ' CG ' ' A' ' 163' ' ' ASN . 0.3 OUTLIER -76.84 169.89 17.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.829 -1.169 . . . . 0.0 110.034 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.485 HG23 ' C ' ' A' ' 108' ' ' THR . 33.8 p -149.89 155.45 40.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.15 -0.969 . . . . 0.0 109.887 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 114' ' ' LYS . 1.9 pttp -63.6 -11.06 21.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.159 -0.963 . . . . 0.0 109.663 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -78.65 -61.96 1.84 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.0 110.42 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 0.9 OUTLIER -62.5 -41.41 98.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.084 -1.01 . . . . 0.0 110.182 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.957 HD12 HD11 ' A' ' 104' ' ' LEU . 6.9 tt -64.79 -61.14 2.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 109.752 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 110' ' ' LYS . 14.3 ttpt -44.44 -34.92 2.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 109.433 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 118' ' ' SER . 0.5 OUTLIER -72.94 -54.38 8.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.144 -0.972 . . . . 0.0 109.2 179.187 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.435 ' C ' ' O ' ' A' ' 115' ' ' ASP . 48.1 t80 -47.69 -28.39 2.4 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.622 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 20.1 m-85 -91.21 -12.41 35.4 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.232 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 115' ' ' ASP . 95.1 p -65.4 -10.18 31.45 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.922 -1.111 . . . . 0.0 109.406 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.0 tptt -81.73 -14.78 56.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.466 -0.771 . . . . 0.0 110.544 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.622 ' CD2' ' HA ' ' A' ' 117' ' ' PHE . 92.3 m-85 -89.17 -61.91 1.6 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.145 -0.972 . . . . 0.0 109.498 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.495 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -155.95 -163.5 12.3 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 146' ' ' LYS . 0.6 OUTLIER -88.76 126.41 35.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -1.212 . . . . 0.0 110.352 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.6 t -101.05 129.63 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.205 -0.935 . . . . 0.0 111.062 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.472 HG23 ' HB2' ' A' ' 146' ' ' LYS . 2.2 t -90.07 -23.01 6.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.528 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 2.2 m-20 -145.51 162.16 38.04 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 118.663 -1.215 . . . . 0.0 112.288 -178.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.446 ' CB ' ' HD3' ' A' ' 114' ' ' LYS . 9.2 t -169.95 143.98 2.66 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.528 ' CG2' ' N ' ' A' ' 128' ' ' LEU . 0.9 OUTLIER -150.59 173.85 13.65 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 110.39 -178.709 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.713 HD13 ' O ' ' A' ' 108' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 O-C-N 121.403 -0.811 . . . . 0.0 110.003 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.565 ' HB2' ' HA2' ' A' ' 102' ' ' GLY . 17.5 p90 . . . . . 0 N--CA 1.499 2.018 0 CA-C-O 121.395 0.617 . . . . 0.0 111.512 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.725 ' H ' HD23 ' A' ' 104' ' ' LEU . . . -115.68 178.47 17.64 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.719 ' CE1' ' CE1' ' A' ' 100' ' ' PHE . 13.3 m-85 -126.07 160.66 29.52 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.517 -0.99 . . . . 0.0 110.804 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.673 ' C ' HD12 ' A' ' 144' ' ' LEU . 19.5 t -145.07 141.75 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.584 -0.698 . . . . 0.0 109.237 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.673 HD12 ' C ' ' A' ' 143' ' ' VAL . 6.3 mp -127.31 102.71 7.03 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.515 -0.74 . . . . 0.0 109.536 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.817 ' HB2' HG22 ' A' ' 151' ' ' VAL . 29.2 m-85 -74.44 153.08 39.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.472 -0.768 . . . . 0.0 110.614 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.472 ' HB2' HG23 ' A' ' 124' ' ' VAL . 10.7 tttt -83.47 -18.98 36.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.476 -0.765 . . . . 0.0 110.882 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.811 ' O ' HG23 ' A' ' 151' ' ' VAL . 5.7 tt0 -134.36 154.63 51.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.794 -1.191 . . . . 0.0 110.895 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.9 t -67.39 -39.09 85.58 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.229 -0.919 . . . . 0.0 109.232 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.563 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 1.7 tt0 -59.63 -49.78 76.43 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.496 -0.752 . . . . 0.0 109.686 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.495 ' CB ' ' HA3' ' A' ' 121' ' ' GLY . 4.8 p -52.94 -37.97 61.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.159 -0.963 . . . . 0.0 109.498 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.817 HG22 ' HB2' ' A' ' 145' ' ' PHE . 5.7 t -68.27 -46.98 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -0.88 . . . . 0.0 109.921 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.563 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -57.05 -33.32 67.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.218 -0.926 . . . . 0.0 109.562 179.688 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.475 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 19.9 mttt -63.71 -50.98 67.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.434 -0.791 . . . . 0.0 109.905 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.725 HG12 ' O ' ' A' ' 151' ' ' VAL . 10.5 p -69.42 -10.77 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.962 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.21 -30.97 17.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.397 -0.814 . . . . 0.0 109.948 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 1.6 p-10 -55.29 -23.5 23.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.152 -0.968 . . . . 0.0 110.388 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.516 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 0.8 OUTLIER -139.72 94.76 2.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 0.0 109.961 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.58 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 3.1 pttp -89.91 15.06 10.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.158 -0.963 . . . . 0.0 110.606 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -87.94 67.77 9.09 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.611 ' HB2' ' CG1' ' A' ' 167' ' ' ILE . 84.9 m-70 -86.94 151.9 22.89 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.324 -177.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 160' ' ' HIS . 23.6 mttt -146.9 72.45 1.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.463 -0.773 . . . . 0.0 109.599 178.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.466 HD11 ' CD1' ' A' ' 104' ' ' LEU . 0.7 OUTLIER -106.43 151.9 24.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.0 110.579 -179.538 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 1.04 ' CG ' HG23 ' A' ' 108' ' ' THR . 0.7 OUTLIER 59.61 20.75 9.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.298 -0.876 . . . . 0.0 110.123 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.94 26.46 71.07 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.61 150.37 33.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.311 -1.111 . . . . 0.0 110.446 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.407 ' O ' ' HA3' ' A' ' 103' ' ' GLY . 57.7 t -92.15 160.6 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.33 -0.856 . . . . 0.0 109.745 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.611 ' CG1' ' HB2' ' A' ' 160' ' ' HIS . 3.8 pt -125.41 -177.65 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.014 -1.054 . . . . 0.0 111.602 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 102' ' ' GLY . 1.8 t70 -129.5 94.31 32.96 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.49 ' CG ' ' HB2' ' A' ' 158' ' ' LYS . 47.9 Cg_endo -74.44 124.3 8.8 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 124.302 1.685 . . . . 0.0 111.048 -178.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.457 ' O ' ' CB ' ' A' ' 99' ' ' MET . 4.7 mttm -150.24 -165.6 2.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.425 -0.797 . . . . 0.0 109.961 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 . . . . . 0 C--N 1.299 -1.611 0 C-N-CA 119.654 -0.819 . . . . 0.0 109.345 178.876 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.485 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 26.9 mtmt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.061 0.457 . . . . 0.0 109.797 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.578 ' HE2' HD11 ' A' ' 101' ' ' ILE . 8.5 ptm -136.13 178.55 6.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.154 -0.966 . . . . 0.0 110.762 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.748 ' C ' HD13 ' A' ' 101' ' ' ILE . 1.7 t80 -119.88 130.94 55.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.495 -0.753 . . . . 0.0 109.948 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.748 HD13 ' C ' ' A' ' 100' ' ' PHE . 3.8 mm -114.21 90.42 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.435 -0.791 . . . . 0.0 109.149 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -92.48 148.64 19.21 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.1 23.19 6.82 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.788 HD22 HD23 ' A' ' 128' ' ' LEU . 5.9 mp -82.74 163.36 21.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.992 -1.299 . . . . 0.0 109.995 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.479 ' O ' ' OG1' ' A' ' 108' ' ' THR . 0.4 OUTLIER -91.52 178.55 5.91 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.315 -0.866 . . . . 0.0 111.051 -179.665 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -72.64 -4.14 29.15 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.292 -0.88 . . . . 0.0 109.936 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.56 14.2 12.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.18 -0.95 . . . . 0.0 111.178 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.583 ' HB ' HD23 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -75.35 157.91 33.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.959 -1.088 . . . . 0.0 109.355 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.492 HG23 ' C ' ' A' ' 108' ' ' THR . 68.1 p -150.49 174.22 13.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.165 -0.959 . . . . 0.0 110.704 -179.081 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 126' ' ' CYS . 8.2 ttpt -66.93 -17.59 64.98 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.511 -0.743 . . . . 0.0 109.35 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -61.31 1.92 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.352 -0.843 . . . . 0.0 110.807 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 14.6 p30 -63.84 -18.15 63.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.997 -1.064 . . . . 0.0 109.879 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.74 ' HA ' HD21 ' A' ' 162' ' ' LEU . 36.8 tp -87.95 -53.55 4.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.898 . . . . 0.0 109.331 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.532 ' HB2' ' CB ' ' A' ' 126' ' ' CYS . 7.0 tmtt? -61.68 -38.57 88.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.558 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.551 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 6.3 t70 -72.5 -54.87 8.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.249 -0.907 . . . . 0.0 110.035 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.811 ' CG ' HD13 ' A' ' 162' ' ' LEU . 55.4 t80 -49.46 -30.28 7.87 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.395 -1.322 . . . . 0.0 108.0 178.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.665 ' HZ ' HD12 ' A' ' 167' ' ' ILE . 12.9 m-85 -90.71 -9.13 47.88 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 119.736 -0.786 . . . . 0.0 111.122 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.551 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 0.1 OUTLIER -69.07 -14.16 62.86 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.83 -1.169 . . . . 0.0 108.708 178.41 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -18.65 60.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.534 -0.729 . . . . 0.0 110.056 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.806 ' CG ' HG22 ' A' ' 154' ' ' VAL . 71.2 m-85 -89.03 -64.34 1.16 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.23 -0.918 . . . . 0.0 109.176 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 150' ' ' SER . . . -152.68 175.53 31.22 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.65 146.68 51.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.061 -1.258 . . . . 0.0 110.211 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 125' ' ' ASP . 2.0 t -123.06 132.14 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.357 -0.839 . . . . 0.0 110.674 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.1 -24.5 5.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.584 ' O ' HG13 ' A' ' 123' ' ' VAL . 1.0 OUTLIER -145.18 160.64 41.14 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 118.797 -1.161 . . . . 0.0 112.258 -179.163 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.532 ' CB ' ' HB2' ' A' ' 114' ' ' LYS . 34.1 t -169.57 118.9 0.64 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.402 ' CG2' ' N ' ' A' ' 128' ' ' LEU . 0.8 OUTLIER -118.56 166.68 12.42 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.498 -0.751 . . . . 0.0 110.823 -178.573 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.788 HD23 HD22 ' A' ' 104' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.501 -0.749 . . . . 0.0 109.739 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.522 ' CD2' ' CZ ' ' A' ' 100' ' ' PHE . 19.1 p90 . . . . . 0 N--CA 1.498 1.938 0 CA-C-O 121.623 0.725 . . . . 0.0 111.884 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 128' ' ' LEU . . . -135.76 -179.27 16.43 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.725 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 7.8 m-85 -123.02 167.08 14.08 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.119 -1.224 . . . . 0.0 110.767 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.572 ' CG2' HG13 ' A' ' 101' ' ' ILE . 3.5 t -142.89 134.23 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.376 -0.828 . . . . 0.0 109.474 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.485 ' HG ' ' HG2' ' A' ' 98' ' ' LYS . 5.0 mp -120.87 103.44 9.08 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.42 -0.8 . . . . 0.0 109.786 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 1.032 ' CZ ' HG21 ' A' ' 154' ' ' VAL . 16.5 m-85 -77.49 169.52 18.16 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.453 -0.78 . . . . 0.0 110.899 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -84.36 -32.57 24.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.694 -0.629 . . . . 0.0 111.039 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.663 ' O ' HG23 ' A' ' 151' ' ' VAL . 0.3 OUTLIER -135.9 158.49 44.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.803 -1.186 . . . . 0.0 110.616 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.63 -31.56 72.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.293 -0.879 . . . . 0.0 110.28 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.538 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 0.0 OUTLIER -61.81 -45.54 93.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.936 . . . . 0.0 110.079 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.763 ' O ' HG23 ' A' ' 154' ' ' VAL . 43.0 p -63.59 -40.06 95.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.353 -0.842 . . . . 0.0 110.297 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.955 HG22 ' HB2' ' A' ' 145' ' ' PHE . 5.2 t -60.41 -59.06 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.096 -1.003 . . . . 0.0 109.823 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.538 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.5 OUTLIER -53.06 -41.69 65.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.103 -0.998 . . . . 0.0 109.439 179.612 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.464 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 9.7 tttt -51.83 -35.84 45.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.337 -0.852 . . . . 0.0 109.813 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 1.032 HG21 ' CZ ' ' A' ' 145' ' ' PHE . 3.7 t -82.32 -22.5 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.277 -0.89 . . . . 0.0 110.4 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 6.7 tmm? -86.05 -24.52 26.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.869 . . . . 0.0 110.375 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 40.8 p30 -65.83 -13.18 59.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.17 -0.956 . . . . 0.0 110.162 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.58 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 8.5 tt0 -142.37 88.21 2.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.92 . . . . 0.0 109.815 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.447 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -86.49 19.4 2.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.286 -0.884 . . . . 0.0 110.594 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -87.99 58.9 5.05 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.581 ' HB2' HG13 ' A' ' 167' ' ' ILE . 16.4 m-70 -86.58 -168.3 2.19 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.898 -177.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.484 ' CE ' ' C ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -176.31 64.94 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.582 -0.699 . . . . 0.0 109.406 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.811 HD13 ' CG ' ' A' ' 116' ' ' TYR . 10.6 tp -89.2 147.32 24.22 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.452 -0.78 . . . . 0.0 110.228 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.575 ' OD1' HG23 ' A' ' 108' ' ' THR . 0.1 OUTLIER 59.91 20.31 9.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.348 -0.845 . . . . 0.0 109.66 -179.604 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.484 ' C ' ' CE ' ' A' ' 161' ' ' LYS . . . 80.57 20.1 67.03 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.11 149.48 30.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -1.167 . . . . 0.0 110.202 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.9 t -67.7 163.9 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 109.963 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.665 HD12 ' HZ ' ' A' ' 117' ' ' PHE . 0.1 OUTLIER -120.95 -177.54 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.175 -0.953 . . . . 0.0 111.021 -179.412 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -133.07 83.28 52.06 Favored Pre-proline 0 C--N 1.304 -1.391 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.36 131.31 14.95 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.267 1.667 . . . . 0.0 110.559 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.1 mmtm -145.02 -176.79 5.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.326 -0.859 . . . . 0.0 110.307 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 . . . . . 0 C--N 1.3 -1.564 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.363 179.253 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.547 ' CG ' ' HG ' ' A' ' 144' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.237 0.541 . . . . 0.0 110.505 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.636 ' HE2' ' CD1' ' A' ' 101' ' ' ILE . 7.7 ptm -115.15 176.89 4.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.296 -0.878 . . . . 0.0 109.736 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.711 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 1.2 t80 -116.55 125.52 52.0 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.351 -0.843 . . . . 0.0 110.155 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.662 HG13 HG23 ' A' ' 143' ' ' VAL . 1.3 mm -110.48 92.55 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.515 -0.741 . . . . 0.0 109.081 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -94.49 125.59 8.36 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.844 -1.169 . . . . 0.0 110.233 -179.146 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 131.97 2.01 4.37 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.964 HD12 ' CG2' ' A' ' 108' ' ' THR . 3.9 mm? -52.45 162.28 0.56 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.212 -1.169 . . . . 0.0 110.003 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.478 ' HB2' ' HB3' ' A' ' 163' ' ' ASN . 0.5 OUTLIER -87.33 -176.75 5.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.174 -0.954 . . . . 0.0 110.302 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -75.67 -22.92 56.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.287 -0.883 . . . . 0.0 110.282 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 29.1 p-10 -113.99 41.64 2.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.939 . . . . 0.0 110.163 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.964 ' CG2' HD12 ' A' ' 104' ' ' LEU . 0.7 OUTLIER -86.3 130.5 34.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 110.471 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.44 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 38.4 p -117.01 149.74 39.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.294 -0.879 . . . . 0.0 109.871 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.548 ' CG ' ' HA ' ' A' ' 127' ' ' THR . 3.8 mtpt -55.9 -16.36 4.58 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.182 -0.949 . . . . 0.0 110.057 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.35 -56.68 4.48 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.183 -0.948 . . . . 0.0 110.779 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 2.9 p30 -65.53 -34.09 77.44 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.002 -1.061 . . . . 0.0 110.915 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.903 HD13 HD11 ' A' ' 104' ' ' LEU . 12.4 tp -75.6 -55.44 5.66 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.986 -1.071 . . . . 0.0 109.876 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.437 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -49.17 -41.55 37.01 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.217 -0.927 . . . . 0.0 109.818 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.447 ' O ' ' C ' ' A' ' 116' ' ' TYR . 2.3 m-20 -75.83 -48.5 21.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.896 . . . . 0.0 110.218 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.948 ' CD1' HD13 ' A' ' 162' ' ' LEU . 70.1 t80 -47.15 -33.35 5.1 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.665 -1.214 . . . . 0.0 108.261 178.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.658 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 18.1 m-85 -91.2 -14.75 30.47 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.035 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 115' ' ' ASP . 40.2 t -63.45 -12.39 30.97 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.94 -1.1 . . . . 0.0 109.316 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -80.86 -13.42 58.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.475 -0.765 . . . . 0.0 110.008 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 1.015 ' CD2' HG22 ' A' ' 154' ' ' VAL . 67.4 m-85 -88.9 -36.53 15.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.249 -0.907 . . . . 0.0 109.479 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -177.44 -164.64 31.33 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.492 ' HB3' ' HG3' ' A' ' 146' ' ' LYS . 0.4 OUTLIER -88.84 108.76 19.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.188 -1.184 . . . . 0.0 110.27 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.563 HG23 ' CD1' ' A' ' 145' ' ' PHE . 1.8 t -90.3 130.06 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.234 -0.916 . . . . 0.0 111.163 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.459 ' O ' ' OD1' ' A' ' 125' ' ' ASP . 2.1 t -89.46 -23.16 6.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.569 ' CB ' HD22 ' A' ' 144' ' ' LEU . 3.8 m-20 -147.58 167.88 23.41 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 118.345 -1.342 . . . . 0.0 112.901 -178.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.807 ' SG ' HD23 ' A' ' 113' ' ' LEU . 25.9 t -169.03 148.05 4.0 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.548 ' HA ' ' CG ' ' A' ' 110' ' ' LYS . 0.9 OUTLIER -151.27 162.69 40.44 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.652 -1.219 . . . . 0.0 111.926 -177.907 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.865 HD13 ' O ' ' A' ' 128' ' ' LEU . 1.1 tm? . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.665 ' CD1' ' CZ ' ' A' ' 100' ' ' PHE . 2.6 p90 . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 121.649 0.738 . . . . 0.0 111.496 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 127' ' ' THR . . . -121.91 -175.9 15.02 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.711 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 7.2 m-85 -120.04 171.73 8.25 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.02 -1.283 . . . . 0.0 110.987 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.662 HG23 HG13 ' A' ' 101' ' ' ILE . 6.4 t -140.76 129.42 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.569 HD22 ' CB ' ' A' ' 125' ' ' ASP . 6.3 mp -111.25 100.54 9.15 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.432 -0.792 . . . . 0.0 110.088 -178.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 1.009 ' CE2' HG21 ' A' ' 154' ' ' VAL . 8.1 m-85 -81.05 162.76 23.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.591 -0.693 . . . . 0.0 110.893 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.492 ' HG3' ' HB3' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -61.66 -48.86 78.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.523 -0.736 . . . . 0.0 110.073 179.225 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.551 ' O ' HG23 ' A' ' 151' ' ' VAL . 1.4 pm0 -144.51 171.55 14.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.267 -0.896 . . . . 0.0 110.667 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 149' ' ' GLU . 0.2 OUTLIER -55.67 -43.05 75.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.238 -0.914 . . . . 0.0 109.979 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.525 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 0.1 OUTLIER -42.1 -51.68 4.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 110.336 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.697 ' O ' HG23 ' A' ' 154' ' ' VAL . 2.2 p -66.32 -36.55 83.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.199 -0.938 . . . . 0.0 110.446 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.663 HG22 ' HB2' ' A' ' 145' ' ' PHE . 5.3 t -66.38 -56.65 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.074 -1.016 . . . . 0.0 110.446 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.525 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.7 OUTLIER -50.3 -38.78 43.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.141 -0.974 . . . . 0.0 109.666 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.486 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -57.33 -47.75 80.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.407 -0.808 . . . . 0.0 109.57 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 1.015 HG22 ' CD2' ' A' ' 120' ' ' PHE . 11.4 t -60.25 -31.98 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -0.876 . . . . 0.0 109.909 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 156' ' ' ASP . 6.4 mtt -75.5 -26.55 58.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.304 -0.872 . . . . 0.0 110.084 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.9 OUTLIER -46.71 -27.72 1.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.934 -1.104 . . . . 0.0 108.642 179.256 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.678 ' O ' ' CE1' ' A' ' 160' ' ' HIS . 5.0 mt-30 -143.4 114.11 7.6 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.706 -0.621 . . . . 0.0 109.357 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.08 20.39 14.58 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.27 -0.894 . . . . 0.0 110.187 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -88.39 57.39 4.22 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.678 ' CE1' ' O ' ' A' ' 157' ' ' GLN . 18.5 m80 -87.13 81.76 7.91 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.327 -176.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -78.35 70.23 4.67 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.179 -0.95 . . . . 0.0 109.263 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.948 HD13 ' CD1' ' A' ' 116' ' ' TYR . 15.9 tp -87.96 145.49 25.99 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.443 -0.785 . . . . 0.0 110.235 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 105' ' ' SER . 0.8 OUTLIER 58.09 22.62 9.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.349 -0.845 . . . . 0.0 109.661 -179.584 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 75.83 22.59 74.28 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.93 144.63 26.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -1.108 . . . . 0.0 110.319 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 160' ' ' HIS . 3.8 t -78.27 160.87 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 109.674 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.525 ' CG1' ' HB2' ' A' ' 160' ' ' HIS . 1.3 pt -123.58 -174.98 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.114 -0.991 . . . . 0.0 111.046 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.55 ' N ' ' O ' ' A' ' 102' ' ' GLY . 5.6 t70 -128.91 89.81 47.71 Favored Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 47.6 Cg_endo -74.71 125.52 9.54 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.399 1.736 . . . . 0.0 110.655 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -150.27 -164.02 1.92 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.453 -0.779 . . . . 0.0 110.215 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.56 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.179 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.671 ' HE3' HD11 ' A' ' 144' ' ' LEU . 2.8 mtpp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.214 0.53 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.585 ' CE ' ' CD1' ' A' ' 101' ' ' ILE . 17.4 ttp -147.17 154.66 41.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.21 -0.931 . . . . 0.0 110.105 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.694 ' CE2' ' CZ ' ' A' ' 142' ' ' PHE . 2.3 t80 -110.15 135.4 51.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.359 -0.838 . . . . 0.0 109.994 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.585 ' CD1' ' CE ' ' A' ' 99' ' ' MET . 3.6 mm -112.87 97.66 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.28 -0.888 . . . . 0.0 109.48 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.545 ' HA2' ' CB ' ' A' ' 140' ' ' PHE . . . -89.36 109.32 3.58 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.508 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 134.06 36.86 0.24 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.867 HD12 HG21 ' A' ' 108' ' ' THR . 0.4 OUTLIER -83.68 149.22 26.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.335 -1.097 . . . . 0.0 109.442 179.507 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.51 ' CB ' ' HG1' ' A' ' 108' ' ' THR . 0.0 OUTLIER -69.8 146.24 51.55 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.054 -1.029 . . . . 0.0 109.545 179.478 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -62.03 -11.2 12.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.271 -0.893 . . . . 0.0 110.115 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.61 16.22 13.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.251 -0.906 . . . . 0.0 110.595 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.867 HG21 HD12 ' A' ' 104' ' ' LEU . 11.0 m -70.27 174.43 5.6 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.122 -0.986 . . . . 0.0 110.408 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.51 ' H ' HG22 ' A' ' 108' ' ' THR . 31.2 p -148.39 154.32 39.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.384 -0.822 . . . . 0.0 109.575 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.511 ' O ' ' HB2' ' A' ' 114' ' ' LYS . 13.7 mtmt -57.97 -16.86 13.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.337 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.47 -62.02 1.77 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.192 -0.942 . . . . 0.0 111.172 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 6.6 p30 -57.94 -28.37 64.23 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.038 -1.039 . . . . 0.0 110.775 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.823 HD13 HD11 ' A' ' 104' ' ' LEU . 16.0 tp -78.86 -40.53 32.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.983 -1.073 . . . . 0.0 109.696 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 110' ' ' LYS . 3.9 ttpt -55.37 -59.26 5.05 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.123 -0.986 . . . . 0.0 109.711 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.514 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 63.3 m-20 -61.78 -40.83 96.54 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.2 -0.937 . . . . 0.0 109.213 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.558 ' CG ' HD23 ' A' ' 162' ' ' LEU . 69.8 t80 -47.35 -40.48 17.42 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.203 177.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.665 ' HE2' HD11 ' A' ' 113' ' ' LEU . 27.0 m-85 -91.6 -4.56 55.16 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.673 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.514 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 1.4 m -70.16 -6.36 33.69 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.783 -1.198 . . . . 0.0 109.221 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.415 ' HA ' ' HE3' ' A' ' 119' ' ' LYS . 0.5 OUTLIER -80.46 -18.66 48.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.367 -0.833 . . . . 0.0 110.23 -179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 1.04 ' CG ' HG22 ' A' ' 154' ' ' VAL . 70.1 m-85 -89.49 -68.35 0.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.675 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.499 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -147.43 -165.11 11.61 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.47 ' O ' ' CB ' ' A' ' 146' ' ' LYS . 0.6 OUTLIER -90.3 119.82 30.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.159 -1.201 . . . . 0.0 110.863 -179.706 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.701 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.9 t -91.96 132.34 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -0.856 . . . . 0.0 110.244 179.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.4 HG12 ' OD2' ' A' ' 125' ' ' ASP . 2.1 t -89.07 -26.88 5.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.701 ' O ' HG13 ' A' ' 123' ' ' VAL . 1.4 m-20 -145.63 167.25 23.53 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.226 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 42.3 t -165.74 150.35 8.47 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.636 -0.665 . . . . 0.0 109.363 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.519 ' CG2' ' N ' ' A' ' 128' ' ' LEU . 0.9 OUTLIER -149.95 174.08 13.1 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.368 -0.833 . . . . 0.0 109.862 -179.099 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.782 ' C ' HD12 ' A' ' 128' ' ' LEU . 2.8 pp . . . . . 0 C--N 1.302 -1.46 0 O-C-N 121.426 -0.796 . . . . 0.0 110.068 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.594 ' CD1' ' CZ ' ' A' ' 100' ' ' PHE . 42.2 p90 . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 121.144 0.497 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.553 ' CA ' ' HA ' ' A' ' 128' ' ' LEU . . . -162.7 -164.64 18.16 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.694 ' CZ ' ' CE2' ' A' ' 100' ' ' PHE . 28.1 m-85 -140.37 167.19 22.74 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.893 -1.357 . . . . 0.0 111.27 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.675 ' O ' HD22 ' A' ' 144' ' ' LEU . 3.0 t -148.99 133.75 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.675 HD22 ' O ' ' A' ' 143' ' ' VAL . 3.2 mm? -116.12 94.33 4.61 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.665 -0.647 . . . . 0.0 109.569 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.946 ' CZ ' HG21 ' A' ' 154' ' ' VAL . 9.1 m-85 -73.0 161.18 30.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.418 -0.801 . . . . 0.0 110.992 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.47 ' CB ' ' O ' ' A' ' 122' ' ' GLU . 18.0 tptt -80.71 -39.4 27.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.594 -0.691 . . . . 0.0 111.182 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.609 ' O ' HG23 ' A' ' 151' ' ' VAL . 0.7 OUTLIER -133.66 158.48 43.13 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.853 -1.154 . . . . 0.0 110.851 -179.305 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 78.0 p -63.23 -27.7 69.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 109.964 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.519 ' CB ' ' OE2' ' A' ' 147' ' ' GLU . 0.3 OUTLIER -64.41 -43.47 94.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.371 -0.83 . . . . 0.0 109.761 179.721 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.499 ' CB ' ' HA3' ' A' ' 121' ' ' GLY . 11.5 p -64.46 -41.18 96.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.109 -0.994 . . . . 0.0 109.653 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.794 HG22 ' CB ' ' A' ' 145' ' ' PHE . 2.9 t -65.46 -45.44 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.635 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.449 ' OD2' ' O ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -54.23 -36.02 63.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.125 -0.984 . . . . 0.0 109.182 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.471 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 6.7 tttt -62.88 -43.58 98.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.469 -0.769 . . . . 0.0 109.379 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 1.04 HG22 ' CG ' ' A' ' 120' ' ' PHE . 20.5 t -64.7 -42.18 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.294 -0.879 . . . . 0.0 110.09 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 2.8 ttp -71.75 -21.71 61.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.331 -0.856 . . . . 0.0 109.944 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.0 OUTLIER -52.26 -31.49 32.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.14 -0.975 . . . . 0.0 109.423 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.526 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 0.4 OUTLIER -147.97 108.36 4.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.46 -0.775 . . . . 0.0 109.819 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.8 36.14 0.75 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.216 -0.928 . . . . 0.0 110.71 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -89.33 48.96 1.68 Allowed 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 176.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.837 ' CB ' HD11 ' A' ' 167' ' ' ILE . 20.2 m80 -87.68 93.75 9.53 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.267 -177.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -103.07 87.19 2.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 0.0 110.215 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.707 HD12 ' H ' ' A' ' 162' ' ' LEU . 0.4 OUTLIER -90.48 141.67 28.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.169 -0.957 . . . . 0.0 109.64 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 15.1 m120 50.42 23.78 1.37 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.138 -0.977 . . . . 0.0 110.215 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.72 37.25 26.98 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.96 136.24 18.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.165 -1.197 . . . . 0.0 110.272 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 160' ' ' HIS . 34.9 t -81.59 164.74 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.24 -0.913 . . . . 0.0 110.154 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.837 HD11 ' CB ' ' A' ' 160' ' ' HIS . 0.6 OUTLIER -128.68 174.17 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.186 -0.946 . . . . 0.0 110.709 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 102' ' ' GLY . 16.1 t0 -119.97 94.34 48.51 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.96 111.86 3.27 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.158 1.61 . . . . 0.0 110.83 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.536 ' O ' ' CG ' ' A' ' 99' ' ' MET . 2.1 mttt -125.72 152.87 44.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.572 -0.705 . . . . 0.0 109.652 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.296 -1.734 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.987 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.427 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 3.7 mtpp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.271 0.558 . . . . 0.0 110.294 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.988 ' CE ' HD11 ' A' ' 101' ' ' ILE . 4.0 ptm -141.41 170.11 16.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.334 -0.854 . . . . 0.0 109.98 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.881 ' O ' HD13 ' A' ' 101' ' ' ILE . 2.2 t80 -112.96 142.84 45.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.907 . . . . 0.0 110.489 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.988 HD11 ' CE ' ' A' ' 99' ' ' MET . 15.9 mm -131.22 99.14 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.306 -0.871 . . . . 0.0 109.548 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.566 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -99.83 132.85 11.08 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.809 -1.186 . . . . 0.0 110.557 -179.002 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.443 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 127.9 28.03 0.9 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.773 HD11 HD13 ' A' ' 113' ' ' LEU . 3.4 mm? -87.97 167.5 13.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.004 -1.292 . . . . 0.0 110.082 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.435 ' N ' ' OG1' ' A' ' 108' ' ' THR . 3.1 p -88.43 144.48 26.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.857 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 15.7 m-90 -45.74 -21.38 0.11 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.153 -0.967 . . . . 0.0 110.422 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 105' ' ' SER . 4.6 t0 -112.29 44.57 1.41 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.842 -1.162 . . . . 0.0 110.103 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.702 HG21 HD12 ' A' ' 104' ' ' LEU . 87.6 m -90.67 167.74 12.29 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.145 -0.972 . . . . 0.0 110.713 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.532 ' N ' HG22 ' A' ' 108' ' ' THR . 64.1 p -146.42 152.09 38.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.379 -0.826 . . . . 0.0 109.862 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 114' ' ' LYS . 7.6 pttm -63.7 -11.95 30.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.125 -0.984 . . . . 0.0 109.482 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.59 -56.23 4.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.373 -0.83 . . . . 0.0 110.525 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.427 ' OD1' ' C ' ' A' ' 112' ' ' ASP . 0.6 OUTLIER -63.74 -36.76 84.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.118 -0.989 . . . . 0.0 109.938 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.773 HD13 HD11 ' A' ' 104' ' ' LEU . 3.6 tp -73.49 -45.16 55.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 109.746 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 5.8 ttpt -57.11 -38.88 74.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.296 -0.878 . . . . 0.0 109.555 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.501 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 83.8 m-20 -74.08 -49.77 22.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.239 -0.913 . . . . 0.0 109.736 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.422 ' C ' ' O ' ' A' ' 115' ' ' ASP . 65.2 t80 -47.75 -33.2 6.77 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 118.669 -1.212 . . . . 0.0 108.154 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.667 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 17.1 m-85 -91.03 -11.92 37.36 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.972 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.501 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 0.4 OUTLIER -64.34 -13.17 48.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.005 -1.059 . . . . 0.0 109.133 179.06 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -80.44 -13.2 59.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.432 -0.793 . . . . 0.0 109.839 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.995 ' CD2' HG22 ' A' ' 154' ' ' VAL . 64.1 m-85 -89.45 -64.27 1.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.298 -0.877 . . . . 0.0 109.48 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.434 ' HA3' ' HB3' ' A' ' 150' ' ' SER . . . -153.19 -170.36 19.33 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -85.27 119.87 26.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.182 -1.187 . . . . 0.0 110.24 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.614 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.9 t -93.92 130.08 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.144 -0.972 . . . . 0.0 111.048 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.405 ' O ' ' OD1' ' A' ' 125' ' ' ASP . 2.2 t -89.37 -26.02 5.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.614 ' O ' HG13 ' A' ' 123' ' ' VAL . 2.2 m-20 -143.98 161.61 38.3 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.24 -0.984 . . . . 0.0 111.704 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.591 ' SG ' HD23 ' A' ' 113' ' ' LEU . 45.1 t -166.27 120.76 1.15 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.635 -0.665 . . . . 0.0 109.302 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.412 ' CG2' ' N ' ' A' ' 128' ' ' LEU . 0.8 OUTLIER -114.52 167.99 10.25 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.384 -0.822 . . . . 0.0 110.294 -179.063 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.894 HD13 ' O ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 110.766 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.566 ' HB2' ' HA2' ' A' ' 102' ' ' GLY . 18.9 p90 . . . . . 0 N--CA 1.497 1.919 0 CA-C-O 121.619 0.724 . . . . 0.0 111.416 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.541 ' CA ' ' HA ' ' A' ' 128' ' ' LEU . . . -129.04 170.6 20.11 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.723 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 6.6 m-85 -114.31 173.05 6.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -1.149 . . . . 0.0 110.763 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.625 ' HB ' ' HE2' ' A' ' 99' ' ' MET . 13.8 t -146.18 137.51 19.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.558 HD12 ' C ' ' A' ' 143' ' ' VAL . 5.8 mp -123.12 101.18 7.25 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.416 -0.803 . . . . 0.0 109.727 -179.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 1.072 ' CZ ' HG21 ' A' ' 154' ' ' VAL . 18.7 m-85 -75.53 152.43 37.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.369 -0.832 . . . . 0.0 110.245 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.23 -25.59 55.22 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.426 -0.796 . . . . 0.0 111.087 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.668 ' O ' HG23 ' A' ' 151' ' ' VAL . 11.9 tt0 -133.04 147.36 52.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.677 -1.264 . . . . 0.0 110.765 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.447 ' N ' ' HG2' ' A' ' 147' ' ' GLU . 7.4 t -56.47 -45.87 80.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.086 -1.009 . . . . 0.0 109.442 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.555 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 14.1 tt0 -49.75 -60.99 2.38 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.498 -0.751 . . . . 0.0 109.993 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.471 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 0.2 OUTLIER -43.23 -39.72 3.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.19 -0.944 . . . . 0.0 109.716 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.894 HG22 ' HB2' ' A' ' 145' ' ' PHE . 5.3 t -66.2 -51.05 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.899 . . . . 0.0 110.262 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.555 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.3 OUTLIER -52.16 -27.18 13.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.133 -0.979 . . . . 0.0 109.924 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.459 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 5.8 mmtt -72.67 -49.42 31.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.459 -0.776 . . . . 0.0 110.317 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 1.072 HG21 ' CZ ' ' A' ' 145' ' ' PHE . 5.6 t -63.93 -18.7 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.097 -1.002 . . . . 0.0 110.339 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 12.7 mmt -85.53 -38.23 18.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.121 -0.987 . . . . 0.0 110.489 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.2 OUTLIER -48.67 -34.64 12.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.118 -0.989 . . . . 0.0 110.233 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.529 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.6 mt-30 -128.51 94.89 3.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.312 -0.867 . . . . 0.0 110.013 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.621 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -90.39 21.84 3.69 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.154 -0.966 . . . . 0.0 110.412 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.554 ' CG ' ' O ' ' A' ' 159' ' ' GLU . 2.1 tt0 -88.39 67.21 8.58 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 177.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.624 ' HB3' HD11 ' A' ' 167' ' ' ILE . 87.3 m-70 -86.41 176.5 7.84 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.266 -177.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 160' ' ' HIS . 0.3 OUTLIER 179.62 74.3 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.487 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.693 HD12 ' HB2' ' A' ' 163' ' ' ASN . 1.4 pp -110.95 153.99 24.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.405 -0.809 . . . . 0.0 110.326 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.693 ' HB2' HD12 ' A' ' 162' ' ' LEU . 0.3 OUTLIER 67.09 8.56 6.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.378 -0.826 . . . . 0.0 109.859 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' A' ' 165' ' ' LYS . . . 89.38 18.14 53.51 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 164' ' ' GLY . 37.5 mmtt -150.28 161.45 42.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.129 -1.218 . . . . 0.0 110.353 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.523 HG22 ' H ' ' A' ' 167' ' ' ILE . 4.2 p -87.14 177.36 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.355 -0.841 . . . . 0.0 110.232 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.625 HD13 HD23 ' A' ' 162' ' ' LEU . 0.6 OUTLIER -135.29 -168.05 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.216 -0.928 . . . . 0.0 110.943 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 102' ' ' GLY . 8.4 t70 -143.04 87.05 8.9 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 43.8 Cg_endo -71.88 131.69 18.73 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.314 1.691 . . . . 0.0 110.73 -178.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.82 166.25 27.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.443 -0.785 . . . . 0.0 110.26 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 . . . . . 0 C--N 1.3 -1.548 0 C-N-CA 119.264 -0.975 . . . . 0.0 109.869 178.631 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.503 ' HA ' ' HG ' ' A' ' 144' ' ' LEU . 70.0 mttt . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.143 0.496 . . . . 0.0 110.026 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.474 ' HE3' ' HB3' ' A' ' 99' ' ' MET . 10.2 mmm -142.19 177.42 8.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 110.763 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.741 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 3.6 t80 -132.85 142.51 48.99 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.544 -0.722 . . . . 0.0 110.203 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.65 HD13 ' O ' ' A' ' 100' ' ' PHE . 4.2 mm -125.57 98.86 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.293 -0.879 . . . . 0.0 109.792 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -98.82 130.07 10.1 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 134.15 3.53 3.13 Favored Glycine 0 N--CA 1.492 2.383 0 O-C-N 121.123 -1.222 . . . . 0.0 110.163 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.899 HD21 HD13 ' A' ' 113' ' ' LEU . 6.7 mp -64.86 166.16 9.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.073 -1.251 . . . . 0.0 110.186 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.6 p -90.72 -174.56 4.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.297 -0.877 . . . . 0.0 109.793 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -87.48 16.82 5.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.0 109.968 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -144.56 16.61 1.65 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.309 -0.87 . . . . 0.0 110.454 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.811 HG23 ' OD1' ' A' ' 163' ' ' ASN . 11.3 m -73.43 168.16 19.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.939 -1.101 . . . . 0.0 109.78 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.467 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 29.8 p -144.6 152.04 39.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.134 -0.979 . . . . 0.0 110.604 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 114' ' ' LYS . 4.2 ttpt -53.51 -19.61 3.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.141 -0.974 . . . . 0.0 109.578 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.1 OUTLIER -72.12 -55.1 7.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.394 -0.817 . . . . 0.0 110.285 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 109' ' ' THR . 0.4 OUTLIER -65.71 -33.14 75.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.124 -0.985 . . . . 0.0 109.95 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.907 HD12 ' CD2' ' A' ' 162' ' ' LEU . 5.7 tp -73.85 -51.7 15.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 109.804 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 110' ' ' LYS . 1.1 ttpm? -60.0 -39.37 85.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 110.155 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 116' ' ' TYR . 0.5 OUTLIER -76.33 -54.38 6.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.081 -1.012 . . . . 0.0 110.572 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.719 ' CG ' HD13 ' A' ' 162' ' ' LEU . 65.4 t80 -46.39 -32.49 3.25 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.683 -1.207 . . . . 0.0 108.302 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.665 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 17.4 m-85 -91.23 -13.54 32.62 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.894 -0.723 . . . . 0.0 111.302 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 115' ' ' ASP . 5.7 t -64.11 -11.26 28.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.946 -1.096 . . . . 0.0 109.424 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 0.8 OUTLIER -83.83 -12.41 55.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.411 -0.805 . . . . 0.0 110.545 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.665 ' CD1' ' HA ' ' A' ' 117' ' ' PHE . 81.6 m-85 -89.03 -50.05 6.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.063 -1.023 . . . . 0.0 109.354 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.537 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -164.89 -164.73 20.88 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.408 ' O ' ' CB ' ' A' ' 146' ' ' LYS . 1.2 tt0 -90.12 107.67 19.27 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.388 -1.066 . . . . 0.0 110.086 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.8 t -89.46 132.34 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 111.19 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.433 HG12 ' OD1' ' A' ' 125' ' ' ASP . 2.4 t -90.15 -23.34 6.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.568 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 0.4 OUTLIER -143.51 158.98 43.23 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 118.525 -1.27 . . . . 0.0 112.848 -178.801 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.803 ' SG ' HD23 ' A' ' 113' ' ' LEU . 6.2 t -169.24 147.76 3.81 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.501 ' O ' HD22 ' A' ' 113' ' ' LEU . 0.8 OUTLIER -150.8 169.96 20.42 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.992 -1.067 . . . . 0.0 110.828 -178.92 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.965 HD13 ' O ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.662 -0.649 . . . . 0.0 109.473 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.491 ' CA ' ' HB2' ' A' ' 104' ' ' LEU . 13.9 p90 . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.306 0.574 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.614 ' H ' HD13 ' A' ' 104' ' ' LEU . . . -126.61 -165.8 12.05 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.741 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 10.7 m-85 -129.45 168.6 16.1 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.415 -1.05 . . . . 0.0 110.414 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.698 ' C ' HD12 ' A' ' 144' ' ' LEU . 3.5 t -145.66 144.95 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.418 -0.801 . . . . 0.0 109.378 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.698 HD12 ' C ' ' A' ' 143' ' ' VAL . 4.5 mp -134.09 98.31 4.1 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.565 -0.709 . . . . 0.0 109.828 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.703 ' HB2' HG22 ' A' ' 151' ' ' VAL . 38.2 m-85 -76.4 160.45 29.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.528 -0.732 . . . . 0.0 110.47 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.408 ' CB ' ' O ' ' A' ' 122' ' ' GLU . 4.6 tttm -104.0 -3.07 25.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.484 -0.76 . . . . 0.0 111.011 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.777 ' O ' HG23 ' A' ' 151' ' ' VAL . 1.1 tt0 -139.97 145.41 37.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.865 -1.147 . . . . 0.0 110.706 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.5 p -59.95 -36.5 77.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.99 -1.069 . . . . 0.0 109.296 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.51 ' CB ' ' OE1' ' A' ' 147' ' ' GLU . 0.4 OUTLIER -63.06 -53.99 45.07 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.425 -0.797 . . . . 0.0 109.792 179.398 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.537 ' CB ' ' HA3' ' A' ' 121' ' ' GLY . 60.9 p -48.59 -34.32 11.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.076 -1.015 . . . . 0.0 109.664 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 147' ' ' GLU . 3.4 t -78.55 -47.7 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.416 -0.803 . . . . 0.0 110.185 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -61.23 -22.28 64.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.968 -1.082 . . . . 0.0 109.336 179.775 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.474 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -76.19 -58.8 3.07 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.441 -0.787 . . . . 0.0 109.866 179.597 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.654 HG23 ' CE2' ' A' ' 120' ' ' PHE . 5.3 p -55.6 -20.9 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.048 -1.032 . . . . 0.0 109.979 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 2.6 ttp -88.06 -29.96 20.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.408 -0.808 . . . . 0.0 110.384 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.474 ' OD2' ' O ' ' A' ' 153' ' ' LYS . 0.2 OUTLIER -53.78 -36.46 62.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 109.705 179.964 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.584 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 0.7 OUTLIER -128.5 97.51 4.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.352 -0.843 . . . . 0.0 109.509 179.634 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -88.2 10.5 19.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.245 -0.91 . . . . 0.0 110.757 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.451 ' CG ' ' O ' ' A' ' 159' ' ' GLU . 3.2 pt-20 -87.38 68.51 9.76 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 11.6 m-70 -87.75 -167.38 1.86 Allowed 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.613 -177.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -176.44 73.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.512 -0.743 . . . . 0.0 109.818 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.907 ' CD2' HD12 ' A' ' 113' ' ' LEU . 10.1 tp -88.56 134.75 33.78 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.285 -0.885 . . . . 0.0 110.127 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.811 ' OD1' HG23 ' A' ' 108' ' ' THR . 2.3 m120 58.21 24.48 11.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.83 . . . . 0.0 109.961 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 75.9 33.29 51.17 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.75 134.23 16.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -1.184 . . . . 0.0 110.527 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 167' ' ' ILE . 75.5 t -65.37 162.22 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 109.742 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.513 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -126.41 177.56 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.104 -0.998 . . . . 0.0 110.79 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 102' ' ' GLY . 23.8 t0 -124.18 90.1 51.13 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.84 113.37 3.74 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.313 1.691 . . . . 0.0 111.339 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.461 ' HE2' ' OD2' ' A' ' 168' ' ' ASP . 24.6 mmtt -131.29 169.15 16.37 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.542 -0.724 . . . . 0.0 109.334 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.439 ' HA ' ' SD ' ' A' ' 99' ' ' MET . 5.8 mtp85 . . . . . 0 C--N 1.296 -1.73 0 C-N-CA 118.499 -1.28 . . . . 0.0 109.806 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.481 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 12.8 mttt . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.207 0.527 . . . . 0.0 109.816 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.677 ' SD ' HD11 ' A' ' 101' ' ' ILE . 10.9 ptm -126.05 175.25 7.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.086 -1.009 . . . . 0.0 110.475 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.709 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 1.6 t80 -121.38 122.85 40.73 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.677 HD11 ' SD ' ' A' ' 99' ' ' MET . 3.7 mm -108.36 96.91 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 109.382 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -89.61 98.4 2.44 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 156.87 36.52 0.02 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.924 HD12 HG21 ' A' ' 108' ' ' THR . 3.5 mm? -90.45 155.67 18.76 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.181 -1.188 . . . . 0.0 110.007 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.485 ' N ' ' OG1' ' A' ' 108' ' ' THR . 0.0 OUTLIER -78.45 -171.98 2.69 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.205 -0.934 . . . . 0.0 109.754 179.543 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.415 ' N ' ' OG ' ' A' ' 105' ' ' SER . 7.1 m0 -84.0 -17.77 39.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.02 -1.05 . . . . 0.0 110.32 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -122.84 31.02 6.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.909 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.924 HG21 HD12 ' A' ' 104' ' ' LEU . 6.9 m -76.69 149.98 36.38 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.384 -0.822 . . . . 0.0 110.406 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.467 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 28.3 p -130.18 149.14 52.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.352 -0.843 . . . . 0.0 109.961 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.482 ' HG2' ' N ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -57.64 -17.78 16.58 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.127 -0.983 . . . . 0.0 109.16 179.256 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.482 ' N ' ' HG2' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -65.71 -58.61 5.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.502 -0.748 . . . . 0.0 109.978 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 109' ' ' THR . 1.7 p-10 -67.48 -42.49 82.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.105 -0.997 . . . . 0.0 110.097 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.552 HD13 HD11 ' A' ' 104' ' ' LEU . 26.2 tp -60.54 -48.46 81.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 109.703 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.625 ' HG3' HG11 ' A' ' 123' ' ' VAL . 27.6 ttpt -58.29 -31.97 67.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.313 -0.867 . . . . 0.0 109.748 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 118' ' ' SER . 86.8 m-20 -78.03 -54.31 6.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.274 -0.891 . . . . 0.0 110.199 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.454 ' C ' ' O ' ' A' ' 115' ' ' ASP . 62.7 t80 -47.18 -31.52 3.66 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 118.586 -1.246 . . . . 0.0 108.066 178.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.663 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 16.7 m-85 -90.35 -16.28 29.49 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.836 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 115' ' ' ASP . 22.4 t -61.45 -15.92 41.93 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.894 -1.129 . . . . 0.0 108.536 178.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.23 -18.01 61.28 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.533 0.682 . . . . 0.0 109.834 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 1.093 ' CE2' HG23 ' A' ' 154' ' ' VAL . 55.2 m-85 -89.48 -58.47 2.51 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.623 0.725 . . . . 0.0 109.414 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.32 -162.96 12.0 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -90.58 135.08 33.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.962 -1.316 . . . . 0.0 110.005 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.625 HG11 ' HG3' ' A' ' 114' ' ' LYS . 1.9 t -109.19 132.83 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.223 -0.923 . . . . 0.0 110.744 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.23 -26.24 5.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.49 ' O ' HG13 ' A' ' 123' ' ' VAL . 6.7 m-20 -148.76 162.94 38.76 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 118.715 -1.194 . . . . 0.0 112.413 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 11.6 t -164.94 143.42 6.53 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.523 ' CG2' ' N ' ' A' ' 128' ' ' LEU 0.25 1.0 OUTLIER -150.71 170.96 17.95 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 118.679 -1.209 . . . . 0.0 112.093 -177.318 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.573 HD22 ' O ' ' A' ' 108' ' ' THR . 8.5 tp . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.608 ' CD2' ' CZ ' ' A' ' 100' ' ' PHE . 18.7 p90 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.148 0.499 . . . . 0.0 110.68 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 128' ' ' LEU . . . -147.52 -164.11 11.02 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.709 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 14.6 m-85 -130.19 172.21 12.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.157 -1.201 . . . . 0.0 111.348 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.816 ' O ' HD12 ' A' ' 144' ' ' LEU . 3.9 t -146.47 145.58 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.816 HD12 ' O ' ' A' ' 143' ' ' VAL . 5.3 mp -130.59 106.03 8.23 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.984 -1.072 . . . . 0.0 109.898 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.752 ' HB2' HG22 ' A' ' 151' ' ' VAL . 15.9 m-85 -78.82 166.28 22.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.501 -0.75 . . . . 0.0 111.046 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -80.9 -31.97 34.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.696 -0.627 . . . . 0.0 110.408 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.561 ' O ' HG23 ' A' ' 151' ' ' VAL . 0.3 OUTLIER -143.09 152.03 41.4 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.108 -0.995 . . . . 0.0 110.64 -179.619 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.5 m -50.88 -41.0 57.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.915 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.546 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 2.8 tt0 -48.51 -62.92 1.25 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.326 -0.859 . . . . 0.0 110.159 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.479 ' OG ' ' HG3' ' A' ' 147' ' ' GLU . 4.4 p -48.14 -36.07 12.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.0 109.947 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.792 ' O ' HG12 ' A' ' 154' ' ' VAL . 4.6 t -68.56 -52.71 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.12 -0.988 . . . . 0.0 110.362 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.546 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -57.75 -35.1 70.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.974 -1.079 . . . . 0.0 109.783 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.47 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.1 OUTLIER -65.69 -33.82 76.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.368 -0.832 . . . . 0.0 110.162 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 1.093 HG23 ' CE2' ' A' ' 120' ' ' PHE . 5.9 p -87.86 -19.6 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.025 -1.047 . . . . 0.0 110.336 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 24.8 ttt -89.09 -25.76 21.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.946 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 4.5 p-10 -52.37 -32.24 37.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -0.903 . . . . 0.0 109.618 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.558 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -131.4 90.0 2.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.344 -0.848 . . . . 0.0 109.595 179.572 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.45 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -83.97 18.18 2.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.151 -0.968 . . . . 0.0 111.011 -179.482 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -87.68 64.3 7.95 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 177.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.715 ' ND1' HD11 ' A' ' 167' ' ' ILE . 14.1 m170 -87.05 -169.84 2.8 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.11 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 160' ' ' HIS . 5.9 ttpt 177.55 66.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.622 HD12 ' HB2' ' A' ' 163' ' ' ASN . 1.3 pp -101.67 157.85 16.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.844 . . . . 0.0 110.105 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.622 ' HB2' HD12 ' A' ' 162' ' ' LEU . 0.3 OUTLIER 59.5 15.33 4.43 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.163 -0.961 . . . . 0.0 109.461 -179.405 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.51 21.44 64.32 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.5 146.59 26.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -1.174 . . . . 0.0 110.715 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.574 HG12 ' N ' ' A' ' 167' ' ' ILE . 51.1 t -76.99 176.39 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.418 -0.801 . . . . 0.0 109.088 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.715 HD11 ' ND1' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -143.16 166.45 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.904 -1.122 . . . . 0.0 111.544 -179.458 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -115.55 82.88 10.35 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.517 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 45.1 Cg_endo -72.9 130.28 15.41 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.214 1.639 . . . . 0.0 111.155 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.1 -164.88 2.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.581 -0.699 . . . . 0.0 110.046 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.299 -1.614 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.06 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.406 ' HA ' ' HG ' ' A' ' 144' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.226 0.536 . . . . 0.0 110.183 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.644 ' HE2' ' O ' ' A' ' 170' ' ' LYS . 6.4 mtp -143.11 173.89 11.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.148 -0.97 . . . . 0.0 110.432 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.7 ' O ' HD13 ' A' ' 101' ' ' ILE . 2.4 t80 -122.84 134.92 54.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.608 -0.683 . . . . 0.0 110.575 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.7 HD13 ' O ' ' A' ' 100' ' ' PHE . 15.1 mm -122.68 106.73 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.27 -0.894 . . . . 0.0 109.73 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -103.21 119.38 6.38 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.713 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 128.53 47.83 0.16 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 1.065 HD12 HG21 ' A' ' 108' ' ' THR . 2.3 mm? -90.56 167.67 12.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.118 -1.225 . . . . 0.0 110.354 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.532 ' HB3' ' CB ' ' A' ' 163' ' ' ASN . 0.4 OUTLIER -90.16 138.9 31.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.272 -0.893 . . . . 0.0 110.19 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -44.96 -22.77 0.1 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.881 -1.137 . . . . 0.0 110.718 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 105' ' ' SER . 6.7 t0 -114.86 38.53 3.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.106 -0.996 . . . . 0.0 111.134 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . 1.065 HG21 HD12 ' A' ' 104' ' ' LEU . 1.5 m -87.36 161.85 17.68 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.74 -1.225 . . . . 0.0 109.998 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 69.3 p -139.82 154.54 47.36 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.42 -0.8 . . . . 0.0 109.867 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 126' ' ' CYS . 4.9 mttp -58.85 -14.33 8.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.134 -0.979 . . . . 0.0 110.134 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.436 ' HE2' ' HE2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -81.04 -55.82 4.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.861 . . . . 0.0 110.702 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -63.38 -44.29 95.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.003 -1.061 . . . . 0.0 110.466 -179.491 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.805 ' CD1' HD11 ' A' ' 104' ' ' LEU . 0.6 OUTLIER -65.72 -46.89 77.22 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.895 -1.128 . . . . 0.0 109.586 179.681 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.454 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 7.2 ttpp -54.1 -40.78 67.59 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.146 -0.971 . . . . 0.0 109.82 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 116' ' ' TYR . 69.7 m-20 -75.38 -47.27 28.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 109.707 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.685 ' CD2' HD22 ' A' ' 162' ' ' LEU . 52.7 t80 -47.51 -34.65 7.79 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 118.841 -1.144 . . . . 0.0 108.089 178.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.546 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 11.5 m-85 -91.2 -13.78 32.23 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.116 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 115' ' ' ASP . 7.2 m -64.87 -12.67 51.32 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.76 -1.212 . . . . 0.0 108.431 178.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.42 -26.69 61.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.581 -0.699 . . . . 0.0 110.39 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.546 ' CD2' ' HA ' ' A' ' 117' ' ' PHE . 28.2 m-85 -88.67 -57.19 3.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.094 -1.004 . . . . 0.0 109.197 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.487 ' HA3' ' HB3' ' A' ' 150' ' ' SER . . . -159.52 167.52 35.16 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.31 156.52 22.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.138 -1.213 . . . . 0.0 109.913 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.628 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.7 t -125.27 129.91 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.179 -0.951 . . . . 0.0 110.922 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.904 HG23 ' HG2' ' A' ' 146' ' ' LYS . 2.2 t -89.64 -25.34 5.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.628 ' O ' HG13 ' A' ' 123' ' ' VAL . 2.7 m-20 -140.61 161.45 37.72 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.773 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.616 ' SG ' HD23 ' A' ' 113' ' ' LEU . 6.8 t -169.95 128.49 0.91 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.666 0.746 . . . . 0.0 109.708 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.428 ' OG1' ' HB2' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -125.88 146.74 49.7 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.605 -0.684 . . . . 0.0 110.875 -178.502 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.868 HD13 ' O ' ' A' ' 128' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 110.083 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.536 ' HB2' ' HA2' ' A' ' 102' ' ' GLY . 1.7 p90 . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.034 0.445 . . . . 0.0 110.545 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -159.68 177.94 35.98 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.691 ' CZ ' ' CE2' ' A' ' 100' ' ' PHE . 19.4 m-85 -113.57 171.26 7.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.117 -1.225 . . . . 0.0 110.754 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.719 ' CG2' HD21 ' A' ' 113' ' ' LEU . 25.1 t -148.89 127.72 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.553 -0.717 . . . . 0.0 109.351 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.549 ' HB2' ' CB ' ' A' ' 125' ' ' ASP . 6.6 mp -115.96 103.95 11.11 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.546 -0.721 . . . . 0.0 110.214 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.824 ' HB2' HG22 ' A' ' 151' ' ' VAL . 46.0 m-85 -75.73 162.3 28.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.575 -0.703 . . . . 0.0 110.417 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.904 ' HG2' HG23 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -85.29 -23.61 28.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.535 -0.728 . . . . 0.0 111.117 -179.303 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.828 ' O ' HG23 ' A' ' 151' ' ' VAL . 0.6 OUTLIER -128.78 158.75 37.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.747 -1.221 . . . . 0.0 110.988 -179.568 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.3 p -71.88 -44.49 63.66 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.318 -0.864 . . . . 0.0 109.335 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.53 ' CB ' ' OE1' ' A' ' 147' ' ' GLU . 0.3 OUTLIER -55.87 -40.57 73.12 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.415 -0.803 . . . . 0.0 109.54 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.487 ' HB3' ' HA3' ' A' ' 121' ' ' GLY . 1.4 p -62.47 -34.19 76.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.153 -0.967 . . . . 0.0 109.356 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.828 HG23 ' O ' ' A' ' 147' ' ' GLU . 5.2 t -73.93 -52.89 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.213 -0.93 . . . . 0.0 110.216 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.506 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -51.49 -38.52 54.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.01 -1.056 . . . . 0.0 109.878 -179.781 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.479 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -65.04 -46.63 80.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.325 -0.859 . . . . 0.0 110.024 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.804 HG12 ' O ' ' A' ' 151' ' ' VAL . 1.4 p -66.12 -13.31 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.029 -1.044 . . . . 0.0 109.963 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.425 ' CE ' ' HA ' ' A' ' 170' ' ' LYS . 2.3 tpt -89.61 -52.94 4.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.348 -0.845 . . . . 0.0 110.748 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.5 OUTLIER -53.07 -31.25 40.64 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.071 -1.018 . . . . 0.0 110.017 -179.734 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.504 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.1 mm100 -112.65 78.37 1.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.299 -0.876 . . . . 0.0 109.686 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.613 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 10.6 pttp -86.86 25.65 1.26 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.27 -0.894 . . . . 0.0 111.014 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -88.2 67.08 8.7 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.613 ' CD2' ' HA ' ' A' ' 158' ' ' LYS . 84.1 m-70 -86.39 -179.99 6.77 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.727 -177.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.66 ' C ' HD23 ' A' ' 162' ' ' LEU . 23.0 ttpt -179.93 83.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.402 -0.811 . . . . 0.0 109.684 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.808 HD11 HD13 ' A' ' 167' ' ' ILE . 0.1 OUTLIER -101.96 146.17 28.24 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.175 -0.953 . . . . 0.0 109.707 -179.456 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.532 ' CB ' ' HB3' ' A' ' 105' ' ' SER . 6.4 m120 53.8 18.26 1.51 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.931 . . . . 0.0 109.996 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 83.23 28.83 35.45 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -145.71 143.53 29.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.132 -1.216 . . . . 0.0 110.427 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 167' ' ' ILE . 17.3 t -79.9 169.82 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.957 . . . . 0.0 110.303 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.808 HD13 HD11 ' A' ' 162' ' ' LEU . 0.7 OUTLIER -131.07 -178.66 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.208 -0.932 . . . . 0.0 110.702 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 102' ' ' GLY . 16.7 t70 -119.93 83.22 29.68 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.526 ' HG2' ' HB2' ' A' ' 158' ' ' LYS . 47.5 Cg_endo -72.62 114.24 3.96 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.353 1.712 . . . . 0.0 110.986 -178.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.644 ' O ' ' HE2' ' A' ' 99' ' ' MET . 2.4 mtmp? -136.03 173.36 11.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.512 -0.743 . . . . 0.0 109.246 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.527 ' HA ' ' HG2' ' A' ' 99' ' ' MET . 0.2 OUTLIER . . . . . 0 C--N 1.295 -1.789 0 C-N-CA 118.689 -1.205 . . . . 0.0 109.876 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.487 ' HA ' ' HG ' ' A' ' 144' ' ' LEU . 47.3 mttt . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.344 0.593 . . . . 0.0 110.506 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.494 ' HG3' HG13 ' A' ' 151' ' ' VAL . 0.0 OUTLIER -143.29 -174.9 4.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.892 . . . . 0.0 110.217 179.724 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.95 ' O ' HD13 ' A' ' 101' ' ' ILE . 10.5 t80 -143.08 148.5 36.77 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.304 -0.872 . . . . 0.0 110.526 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.95 HD13 ' O ' ' A' ' 100' ' ' PHE . 4.0 mm -125.04 108.58 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.504 -0.748 . . . . 0.0 110.14 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -103.25 118.27 6.01 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.416 ' C ' HD22 ' A' ' 104' ' ' LEU . . . 133.86 41.29 0.17 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.983 HD12 HG21 ' A' ' 108' ' ' THR . 4.0 mm? -90.26 155.03 19.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.337 -1.096 . . . . 0.0 109.916 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.49 ' N ' ' OG1' ' A' ' 108' ' ' THR . 24.1 p -72.08 -176.78 1.85 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.154 -0.966 . . . . 0.0 110.318 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 83.7 t90 -75.11 -27.08 59.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.174 -0.954 . . . . 0.0 110.326 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -113.72 37.16 3.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.215 -0.928 . . . . 0.0 110.22 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.983 HG21 HD12 ' A' ' 104' ' ' LEU . 1.5 m -77.55 149.03 34.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.13 -0.981 . . . . 0.0 110.271 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.481 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 44.0 p -130.5 159.63 36.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.292 -0.88 . . . . 0.0 110.455 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.486 ' HB2' ' HA ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -65.26 -14.72 61.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.18 -0.95 . . . . 0.0 109.911 179.702 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -82.54 -53.88 5.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 110.842 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.481 ' OD1' ' O ' ' A' ' 109' ' ' THR . 0.7 OUTLIER -61.77 -35.65 78.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.979 -1.076 . . . . 0.0 110.284 -179.553 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.705 HD13 HD11 ' A' ' 104' ' ' LEU . 23.6 tp -71.62 -56.46 5.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 109.931 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.421 ' HB2' ' CB ' ' A' ' 126' ' ' CYS . 1.9 tttt -51.39 -34.44 34.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.182 -0.949 . . . . 0.0 109.733 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.504 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 0.5 OUTLIER -73.93 -55.03 6.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 109.906 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.441 ' C ' ' O ' ' A' ' 115' ' ' ASP . 60.2 t80 -47.36 -31.19 3.76 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.531 -1.268 . . . . 0.0 108.118 178.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.624 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 12.8 m-85 -90.72 -10.43 43.06 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.166 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.504 ' HB3' ' HA ' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -65.09 -10.96 34.58 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.839 -1.163 . . . . 0.0 109.386 179.233 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -80.77 -16.65 53.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.477 -0.765 . . . . 0.0 109.991 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.892 ' CG ' HG22 ' A' ' 154' ' ' VAL . 75.7 m-85 -88.76 -62.66 1.44 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 109.399 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.511 ' HA3' ' HB3' ' A' ' 150' ' ' SER . . . -157.72 164.99 33.4 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 146' ' ' LYS . 19.4 mt-10 -62.15 119.58 9.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.017 -1.284 . . . . 0.0 110.176 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 125' ' ' ASP . 2.0 t -89.62 135.38 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 110.617 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.15 -23.73 6.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.517 ' HB2' ' HB2' ' A' ' 144' ' ' LEU . 6.5 m-20 -152.22 157.04 40.9 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 118.443 -1.303 . . . . 0.0 112.575 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.501 ' SG ' HD23 ' A' ' 113' ' ' LEU . 26.2 t -164.47 141.88 6.58 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.486 ' HA ' ' HB2' ' A' ' 110' ' ' LYS . 0.9 OUTLIER -151.22 166.19 31.64 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.582 -1.247 . . . . 0.0 112.348 -177.532 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.771 ' C ' HD13 ' A' ' 128' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.718 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.676 ' HA ' HD23 ' A' ' 104' ' ' LEU . 12.0 p90 . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.869 0.842 . . . . 0.0 111.894 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.524 ' O ' ' CE1' ' A' ' 100' ' ' PHE . . . -121.0 -176.44 15.42 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.716 ' CE1' ' CE1' ' A' ' 100' ' ' PHE . 8.0 m-85 -122.68 166.18 15.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.879 -1.365 . . . . 0.0 110.94 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.639 ' C ' HD12 ' A' ' 144' ' ' LEU . 2.5 t -146.6 139.77 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.456 -0.777 . . . . 0.0 109.727 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.639 HD12 ' C ' ' A' ' 143' ' ' VAL . 5.9 mp -127.71 111.61 13.88 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.605 -0.685 . . . . 0.0 109.307 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 1.149 ' CZ ' HG21 ' A' ' 154' ' ' VAL . 38.6 m-85 -79.41 150.69 31.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.684 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 122' ' ' GLU . 18.0 tttm -75.25 -19.8 59.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.433 -0.792 . . . . 0.0 110.901 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.786 ' O ' HG23 ' A' ' 151' ' ' VAL . 3.5 tt0 -138.63 157.89 45.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.813 -1.18 . . . . 0.0 111.111 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 4.4 p -67.61 -41.76 83.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 109.439 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.542 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 0.0 OUTLIER -56.97 -55.53 33.49 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.29 -0.881 . . . . 0.0 109.41 179.417 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.688 ' O ' HG23 ' A' ' 154' ' ' VAL . 4.0 p -45.71 -44.29 13.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.075 -1.016 . . . . 0.0 109.277 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.818 HG22 ' HB2' ' A' ' 145' ' ' PHE . 16.9 t -58.43 -47.81 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.905 . . . . 0.0 109.83 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.542 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.3 OUTLIER -58.64 -35.52 72.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.085 -1.01 . . . . 0.0 109.476 179.618 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.469 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 9.4 mmtt -63.35 -28.5 70.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.473 -0.767 . . . . 0.0 109.591 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 1.149 HG21 ' CZ ' ' A' ' 145' ' ' PHE . 2.8 t -88.87 -34.19 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.362 -0.836 . . . . 0.0 109.897 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.408 ' O ' ' C ' ' A' ' 156' ' ' ASP . 1.1 ttp -73.2 -36.6 66.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.863 . . . . 0.0 110.511 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 31.5 p-10 -44.63 -29.27 0.72 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.083 -1.01 . . . . 0.0 110.254 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.518 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -136.9 98.78 3.85 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.165 -0.96 . . . . 0.0 110.393 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.442 ' HA ' ' HD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -86.63 10.14 16.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.0 -1.062 . . . . 0.0 109.891 179.518 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 27.5 mp0 -88.14 68.48 9.09 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 177.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.601 ' HB2' HG13 ' A' ' 167' ' ' ILE . 41.3 m-70 -86.09 -168.7 2.33 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.589 -177.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.455 ' O ' ' CG ' ' A' ' 161' ' ' LYS . 0.0 OUTLIER 177.9 73.11 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.36 -0.837 . . . . 0.0 110.021 179.802 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.767 HD12 ' HB2' ' A' ' 163' ' ' ASN . 2.4 pp -110.07 151.51 27.12 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.311 -0.868 . . . . 0.0 109.853 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.767 ' HB2' HD12 ' A' ' 162' ' ' LEU . 0.2 OUTLIER 63.13 18.09 10.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.149 -0.969 . . . . 0.0 109.861 -179.507 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 75.35 25.17 68.94 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -149.82 154.28 38.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -1.173 . . . . 0.0 110.66 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.466 HG12 ' N ' ' A' ' 167' ' ' ILE . 24.1 t -84.81 167.4 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.379 -0.825 . . . . 0.0 109.688 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.601 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.9 OUTLIER -133.68 175.52 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.137 -0.977 . . . . 0.0 111.15 -179.493 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 102' ' ' GLY . 31.6 t0 -120.08 89.81 43.38 Favored Pre-proline 0 C--N 1.303 -1.426 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.64 120.41 6.43 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.172 1.617 . . . . 0.0 110.891 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.463 ' O ' ' SD ' ' A' ' 99' ' ' MET . 0.1 OUTLIER -140.47 169.63 17.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.885 . . . . 0.0 109.908 179.461 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.47 ' HA ' ' HG2' ' A' ' 99' ' ' MET . 19.4 ptp180 . . . . . 0 C--N 1.3 -1.574 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.542 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.523 ' CG ' ' HG ' ' A' ' 144' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.302 0.572 . . . . 0.0 110.239 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.547 ' CE ' HD11 ' A' ' 101' ' ' ILE . 12.6 ptm -147.58 175.2 11.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.189 -0.944 . . . . 0.0 110.411 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.767 ' C ' HD13 ' A' ' 101' ' ' ILE . 2.5 t80 -119.73 130.87 55.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.465 -0.772 . . . . 0.0 109.252 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.767 HD13 ' C ' ' A' ' 100' ' ' PHE . 3.7 mm -117.05 105.04 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.245 -0.91 . . . . 0.0 109.715 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.536 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -97.34 139.22 14.36 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.737 -1.221 . . . . 0.0 110.12 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.51 33.9 2.38 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 1.078 HD12 HG21 ' A' ' 108' ' ' THR . 1.8 mm? -84.68 148.72 26.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.106 -1.232 . . . . 0.0 110.004 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.495 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -76.52 147.5 37.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.158 -0.963 . . . . 0.0 110.799 -179.529 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.991 ' HA ' HD12 ' A' ' 130' ' ' LEU . 1.1 t90 -52.07 -17.19 0.96 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.304 -0.873 . . . . 0.0 110.99 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.86 35.55 4.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.904 -1.122 . . . . 0.0 111.163 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . 1.078 HG21 HD12 ' A' ' 104' ' ' LEU . 1.5 m -88.35 171.29 10.26 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.986 -1.071 . . . . 0.0 110.057 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.478 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 73.0 p -149.12 170.56 18.13 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.178 -0.951 . . . . 0.0 110.242 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.532 ' O ' ' CB ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -70.5 -11.2 60.77 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.138 -0.977 . . . . 0.0 109.922 179.792 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -87.44 -58.68 2.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 110.539 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 5.4 p30 -60.56 -32.39 71.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.12 -0.988 . . . . 0.0 110.167 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 1.053 HD13 HD11 ' A' ' 104' ' ' LEU . 9.2 tp -79.96 -42.84 23.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.095 -1.003 . . . . 0.0 109.577 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 4.3 ttmt -63.21 -46.47 86.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.869 . . . . 0.0 109.346 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.413 ' O ' ' C ' ' A' ' 116' ' ' TYR . 1.5 t70 -66.05 -49.17 68.59 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.139 -0.976 . . . . 0.0 109.35 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.413 ' C ' ' O ' ' A' ' 115' ' ' ASP . 67.8 t80 -48.31 -35.4 12.23 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.765 -1.174 . . . . 0.0 108.065 177.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.611 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 11.7 m-85 -90.73 -3.58 57.35 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.25 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.8 t -71.66 -9.5 58.36 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.075 -1.016 . . . . 0.0 109.294 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.66 -15.81 53.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.377 -0.827 . . . . 0.0 110.034 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.839 ' CE2' HG23 ' A' ' 154' ' ' VAL . 70.2 m-85 -89.52 -40.9 12.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.326 -0.859 . . . . 0.0 109.44 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -177.49 -156.2 15.64 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.53 157.77 17.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.138 -1.213 . . . . 0.0 110.195 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 1.9 t -134.75 131.23 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.212 -0.93 . . . . 0.0 111.167 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -94.99 -24.65 4.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -146.42 159.06 43.88 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.999 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.751 ' SG ' HD23 ' A' ' 113' ' ' LEU . 40.5 t -170.47 105.56 0.29 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.848 0.832 . . . . 0.0 109.347 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.68 166.15 11.63 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.474 0.654 . . . . 0.0 110.979 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.919 HD13 ' O ' ' A' ' 128' ' ' LEU . 1.0 OUTLIER -146.37 104.26 3.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.413 -0.805 . . . . 0.0 110.268 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.955 ' O ' HD22 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -89.93 77.39 6.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.138 -0.976 . . . . 0.0 109.517 179.62 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.991 HD12 ' HA ' ' A' ' 106' ' ' TRP . 0.3 OUTLIER -149.36 21.08 0.95 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -45.85 109.26 0.93 Allowed Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.524 -0.735 . . . . 0.0 111.122 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.517 ' HA ' ' CD1' ' A' ' 106' ' ' TRP . 51.3 Cg_endo -84.13 -14.65 7.09 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.097 1.577 . . . . 0.0 110.285 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.527 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -101.62 -41.0 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.312 -0.868 . . . . 0.0 110.517 -179.526 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.506 ' N ' ' CG2' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -89.19 21.39 3.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.279 -0.888 . . . . 0.0 110.506 -179.604 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 134' ' ' THR . . . 45.04 25.74 1.08 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.97 30.46 5.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.334 -1.097 . . . . 0.0 109.959 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.572 ' HA ' ' CA ' ' A' ' 130' ' ' LEU . 88.5 p -82.63 108.59 16.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.204 -0.935 . . . . 0.0 110.398 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.518 ' CD ' ' HG2' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -89.61 -5.46 57.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.275 -0.891 . . . . 0.0 110.051 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.718 ' C ' HD21 ' A' ' 130' ' ' LEU . . . 89.84 3.86 73.24 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 120.077 -1.059 . . . . 0.0 110.675 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.543 ' O ' ' CB ' ' A' ' 129' ' ' LYS . 46.3 p90 -161.34 165.35 29.16 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.711 -1.464 . . . . 0.0 111.093 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.511 ' HA3' ' HA ' ' A' ' 128' ' ' LEU . . . -136.82 -170.65 11.99 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.712 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 13.9 m-85 -128.65 160.71 31.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.069 -1.254 . . . . 0.0 110.492 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.6 ' O ' HD12 ' A' ' 144' ' ' LEU . 4.1 t -134.22 140.4 46.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.371 -0.831 . . . . 0.0 108.944 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.6 HD12 ' O ' ' A' ' 143' ' ' VAL . 3.1 mp -132.07 98.81 4.53 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.161 -0.962 . . . . 0.0 109.704 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.948 ' HB2' HG22 ' A' ' 151' ' ' VAL . 39.4 m-85 -71.04 170.23 13.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.434 -0.791 . . . . 0.0 110.635 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 18.2 tttt -96.18 -18.93 19.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.369 -0.832 . . . . 0.0 110.994 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.865 ' O ' HG23 ' A' ' 151' ' ' VAL . 2.4 tm-20 -131.39 162.33 30.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.862 -1.149 . . . . 0.0 110.686 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 34.5 p -74.69 -47.44 31.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.913 . . . . 0.0 109.547 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.535 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 0.5 OUTLIER -54.41 -35.08 62.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.369 -0.832 . . . . 0.0 109.752 179.701 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.485 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 3.1 p -68.76 -40.93 79.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 109.889 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.948 HG22 ' HB2' ' A' ' 145' ' ' PHE . 5.6 t -66.67 -53.14 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 110.286 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.535 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -51.89 -37.78 53.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 0.0 109.955 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.46 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -59.23 -62.07 2.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.334 -0.854 . . . . 0.0 110.082 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.839 HG23 ' CE2' ' A' ' 120' ' ' PHE . 3.3 p -55.36 -20.5 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.198 -0.939 . . . . 0.0 110.141 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.82 -13.19 37.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.364 -0.835 . . . . 0.0 109.686 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.8 OUTLIER -61.12 -33.5 73.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.226 -0.921 . . . . 0.0 109.614 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.516 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.0 tt0 -142.3 104.46 4.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.287 -0.883 . . . . 0.0 110.065 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.5 pttm -81.8 20.26 0.98 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.229 -0.919 . . . . 0.0 111.037 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -87.58 62.9 7.32 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.77 ' HE1' HG22 ' A' ' 154' ' ' VAL . 14.2 m170 -86.76 -169.34 2.59 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.309 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 160' ' ' HIS . 33.3 ttpt 179.86 74.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.35 -0.844 . . . . 0.0 110.317 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.851 HD12 ' HB2' ' A' ' 163' ' ' ASN . 3.8 pp -103.69 157.56 16.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 0.0 109.989 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.851 ' HB2' HD12 ' A' ' 162' ' ' LEU . 1.5 m-80 58.38 15.19 3.32 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.183 -0.948 . . . . 0.0 110.228 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.98 20.15 61.63 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp -150.82 146.89 26.66 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.303 -1.116 . . . . 0.0 110.152 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 160' ' ' HIS . 1.4 p -69.36 -174.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.052 -1.03 . . . . 0.0 110.163 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.638 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -150.61 178.24 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.163 -0.96 . . . . 0.0 110.352 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -126.01 93.2 44.32 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.54 -0.725 . . . . 0.0 109.386 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 48.2 Cg_endo -77.58 135.85 14.97 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.245 1.655 . . . . 0.0 110.643 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 99' ' ' MET . 0.0 OUTLIER -146.76 -177.92 5.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.319 -0.863 . . . . 0.0 110.268 179.607 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.483 ' O ' ' O ' ' A' ' 172' ' ' ALA . 1.6 mtt180 -91.83 45.27 1.21 Allowed 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.953 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 171' ' ' ARG . . . . . . . . 0 C--N 1.301 -1.518 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.987 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.889 ' HB2' ' HB3' ' A' ' 172' ' ' ALA . 14.7 mtmt . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.001 0.429 . . . . 0.0 110.09 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.535 ' HE2' HD11 ' A' ' 101' ' ' ILE . 7.9 ptm -133.39 172.31 12.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.118 -0.989 . . . . 0.0 110.562 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.766 ' C ' HD13 ' A' ' 101' ' ' ILE . 2.1 t80 -120.99 130.07 53.66 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.608 -0.682 . . . . 0.0 110.041 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.766 HD13 ' C ' ' A' ' 100' ' ' PHE . 3.8 mm -112.66 95.27 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.294 -0.879 . . . . 0.0 109.469 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.532 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -89.75 127.01 8.53 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 127.48 34.01 0.59 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 1.064 HD12 HG21 ' A' ' 108' ' ' THR . 2.3 mm? -89.38 152.95 21.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.048 -1.266 . . . . 0.0 110.186 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.487 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -90.49 152.67 20.84 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.291 -0.88 . . . . 0.0 111.234 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.696 ' HA ' HD12 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -51.46 -22.69 3.25 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.445 -0.785 . . . . 0.0 110.765 179.626 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -107.04 28.82 7.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.028 -1.045 . . . . 0.0 111.765 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . 1.064 HG21 HD12 ' A' ' 104' ' ' LEU . 0.8 OUTLIER -90.44 170.8 9.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.752 -1.218 . . . . 0.0 109.798 179.17 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.467 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 28.7 p -145.94 159.16 43.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.227 -0.921 . . . . 0.0 110.155 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.487 ' CE ' ' O ' ' A' ' 126' ' ' CYS . 0.7 OUTLIER -62.91 -12.76 27.36 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.171 -0.955 . . . . 0.0 109.639 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.49 -59.31 2.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.367 -0.833 . . . . 0.0 110.377 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -52.61 -41.93 64.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.056 -1.028 . . . . 0.0 109.909 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.8 HD13 HD11 ' A' ' 104' ' ' LEU . 10.6 tp -70.3 -48.82 54.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.911 . . . . 0.0 109.577 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -52.1 -48.01 64.97 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.428 -0.795 . . . . 0.0 109.772 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.544 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 54.7 m-20 -67.41 -50.74 58.18 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.16 -0.962 . . . . 0.0 110.296 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.412 ' C ' ' O ' ' A' ' 115' ' ' ASP . 73.0 t80 -47.78 -34.01 7.96 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 118.532 -1.267 . . . . 0.0 108.528 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.577 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 15.3 m-85 -91.14 -7.24 52.09 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.869 -0.732 . . . . 0.0 111.351 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.544 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 1.9 t -71.02 -7.35 45.76 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.956 -1.09 . . . . 0.0 109.225 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -82.88 -14.42 54.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 0.0 110.285 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.577 ' CD2' ' HA ' ' A' ' 117' ' ' PHE . 89.1 m-85 -88.8 -56.02 3.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.073 -1.017 . . . . 0.0 109.275 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.47 ' HA3' ' HB3' ' A' ' 150' ' ' SER . . . -162.02 -162.27 13.02 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -83.06 151.03 25.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -1.192 . . . . 0.0 110.061 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.9 t -128.8 130.03 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.357 -0.839 . . . . 0.0 110.484 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.01 -24.68 5.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.538 ' O ' HG13 ' A' ' 123' ' ' VAL . 4.2 m-20 -151.06 171.27 17.59 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 118.526 -1.27 . . . . 0.0 112.364 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.608 ' SG ' HD23 ' A' ' 113' ' ' LEU . 9.6 t -170.38 155.59 5.24 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.66 151.74 32.93 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.876 -1.14 . . . . 0.0 110.937 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.928 HD13 ' O ' ' A' ' 128' ' ' LEU . 1.6 tm? -128.89 100.56 5.72 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.531 -0.73 . . . . 0.0 109.703 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 1.038 ' O ' HD22 ' A' ' 130' ' ' LEU . 0.2 OUTLIER -85.92 77.5 9.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.248 -0.907 . . . . 0.0 109.219 179.657 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 1.038 HD22 ' O ' ' A' ' 129' ' ' LYS . 0.4 OUTLIER -149.82 27.69 0.79 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 2.5 m-20 -40.9 107.66 0.49 Allowed Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.526 -0.734 . . . . 0.0 111.243 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.428 ' HG3' ' O ' ' A' ' 106' ' ' TRP . 51.6 Cg_endo -86.83 -18.84 2.84 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 124.088 1.572 . . . . 0.0 110.739 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.687 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -92.73 -45.28 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.071 -1.018 . . . . 0.0 110.837 -179.293 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.565 ' N ' ' CG2' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -89.51 0.24 57.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.934 . . . . 0.0 110.324 -179.529 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 69.48 12.54 66.79 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.426 ' C ' ' HB2' ' A' ' 131' ' ' ASP . 0.8 OUTLIER -88.49 26.02 1.56 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -1.133 . . . . 0.0 110.17 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.574 ' HA ' ' CA ' ' A' ' 130' ' ' LEU . 0.9 OUTLIER -72.22 116.3 12.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.39 -0.819 . . . . 0.0 109.902 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.56 ' HG2' ' CZ ' ' A' ' 140' ' ' PHE . 0.0 OUTLIER -89.01 -3.93 58.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.154 -0.966 . . . . 0.0 109.977 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.616 ' C ' HD21 ' A' ' 130' ' ' LEU . . . 86.39 1.4 86.02 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.576 ' CD1' ' CZ ' ' A' ' 100' ' ' PHE . 35.5 p90 -155.22 -178.23 7.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.87 -1.37 . . . . 0.0 110.786 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -150.4 -171.05 18.32 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.698 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 19.7 m-85 -131.38 171.36 13.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.153 -1.204 . . . . 0.0 110.719 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.58 ' O ' HD22 ' A' ' 144' ' ' LEU . 32.0 t -147.46 129.06 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.58 HD22 ' O ' ' A' ' 143' ' ' VAL . 3.8 mm? -114.53 101.6 9.27 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.584 -0.697 . . . . 0.0 109.821 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.754 ' HB2' HG22 ' A' ' 151' ' ' VAL . 8.2 m-85 -78.36 170.15 17.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 110.78 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.444 ' O ' ' HE2' ' A' ' 146' ' ' LYS . 0.1 OUTLIER -89.87 -26.61 20.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.614 -0.679 . . . . 0.0 110.562 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.493 ' OE2' ' CB ' ' A' ' 149' ' ' GLU . 1.0 OUTLIER -143.08 161.76 37.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.785 -1.197 . . . . 0.0 111.181 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 18.7 m -64.37 -31.7 73.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.441 -0.787 . . . . 0.0 110.091 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.493 ' CB ' ' OE2' ' A' ' 147' ' ' GLU . 0.1 OUTLIER -60.29 -38.67 84.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 0.0 110.012 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 22.4 p -71.27 -36.76 71.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.458 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.754 HG22 ' HB2' ' A' ' 145' ' ' PHE . 3.5 t -76.12 -45.42 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.987 -1.071 . . . . 0.0 110.805 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 153' ' ' LYS . 0.2 OUTLIER -61.58 -33.89 74.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.143 -0.973 . . . . 0.0 110.126 -179.555 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 152' ' ' ASP . 6.6 tttt -70.37 -42.2 72.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -0.918 . . . . 0.0 110.041 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 151' ' ' VAL . 7.4 p -72.67 -27.35 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.145 -0.972 . . . . 0.0 110.458 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.405 ' O ' ' C ' ' A' ' 156' ' ' ASP . 0.2 OUTLIER -80.39 -34.87 36.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.939 . . . . 0.0 110.288 -179.751 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.489 ' OD1' ' HG2' ' A' ' 157' ' ' GLN . 0.0 OUTLIER -45.37 -42.6 10.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 109.342 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.561 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -118.76 87.25 2.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.397 -0.814 . . . . 0.0 109.65 179.335 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.497 ' HB2' ' CG ' ' A' ' 169' ' ' PRO . 3.4 pttt -85.94 17.45 3.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.892 . . . . 0.0 110.542 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -87.52 63.85 7.83 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.561 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 11.7 m170 -86.56 -167.59 1.93 Allowed 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.726 -177.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt 179.2 67.99 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.496 -0.753 . . . . 0.0 109.601 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.801 HD12 ' HB2' ' A' ' 163' ' ' ASN . 2.6 pp -99.8 148.42 24.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.346 -0.847 . . . . 0.0 110.076 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.801 ' HB2' HD12 ' A' ' 162' ' ' LEU . 0.4 OUTLIER 64.18 20.77 12.32 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.184 -0.948 . . . . 0.0 109.517 -179.401 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.9 26.05 70.08 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.37 147.35 27.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.273 -1.134 . . . . 0.0 110.726 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 167' ' ' ILE . 4.8 t -80.31 173.12 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.347 -0.846 . . . . 0.0 109.252 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.503 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -141.66 163.56 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.087 -1.008 . . . . 0.0 110.9 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -112.26 96.77 36.69 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.611 -0.681 . . . . 0.0 109.235 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.497 ' CG ' ' HB2' ' A' ' 158' ' ' LYS . 49.2 Cg_endo -76.65 119.47 5.19 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.205 1.634 . . . . 0.0 110.524 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -136.42 -163.5 1.42 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 110.293 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.13 -170.89 2.8 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.811 -0.755 . . . . 0.0 110.48 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.889 ' HB3' ' HB2' ' A' ' 98' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.446 -0.784 . . . . 0.0 109.911 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.478 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 4.5 mttp . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.185 0.517 . . . . 0.0 109.996 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.666 ' HE2' HD11 ' A' ' 101' ' ' ILE . 0.6 OUTLIER -139.88 179.72 6.44 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.229 -0.919 . . . . 0.0 110.107 179.716 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.727 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 2.5 t80 -125.26 128.93 49.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.361 -0.837 . . . . 0.0 110.807 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.666 HD11 ' HE2' ' A' ' 99' ' ' MET . 4.7 mm -107.37 96.19 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.494 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -89.92 145.71 18.38 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.243 -178.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.512 ' O ' ' HD2' ' A' ' 165' ' ' LYS . . . 96.99 17.68 31.68 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.826 ' HB3' HD12 ' A' ' 130' ' ' LEU . 1.4 mm? -54.73 166.47 0.47 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.636 -1.508 . . . . 0.0 109.737 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.898 ' C ' HD13 ' A' ' 130' ' ' LEU . 0.3 OUTLIER -90.89 140.72 29.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.132 -0.98 . . . . 0.0 110.114 179.511 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.647 ' HA ' HD22 ' A' ' 130' ' ' LEU . 20.6 m0 -49.75 -19.87 0.72 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.154 -0.966 . . . . 0.0 110.472 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -113.57 26.38 10.44 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.126 -0.984 . . . . 0.0 111.18 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.758 HG21 ' CD1' ' A' ' 104' ' ' LEU . 0.8 OUTLIER -89.09 166.13 14.06 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.983 -1.073 . . . . 0.0 109.952 179.568 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.471 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 31.7 p -145.42 -176.8 5.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.191 -0.943 . . . . 0.0 110.399 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.463 ' O ' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -84.57 -14.86 47.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 109.595 179.663 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.44 -44.86 15.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.871 . . . . 0.0 109.857 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 32.5 p-10 -77.35 -38.29 50.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.842 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.73 HD13 HD11 ' A' ' 104' ' ' LEU . 19.7 tp -69.84 -42.69 73.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.099 -1.001 . . . . 0.0 109.351 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -59.85 -50.72 72.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 0.0 109.234 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' A' ' 118' ' ' SER . 17.1 t70 -64.04 -46.66 83.41 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.195 -0.941 . . . . 0.0 109.346 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.688 ' CD2' HD21 ' A' ' 162' ' ' LEU . 68.4 t80 -48.0 -36.35 12.58 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.622 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 15.1 m-85 -91.75 -3.46 56.18 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.843 -0.536 . . . . 0.0 111.489 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 12.4 t -70.63 -5.73 31.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.905 -1.122 . . . . 0.0 109.55 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.01 -13.29 44.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.378 -0.826 . . . . 0.0 110.039 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.831 ' CE2' HG23 ' A' ' 154' ' ' VAL . 79.8 m-85 -89.57 -45.36 9.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.366 -0.834 . . . . 0.0 109.84 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -176.16 -172.98 41.41 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.53 ' O ' ' CB ' ' A' ' 146' ' ' LYS . 19.1 mm-40 -81.3 115.43 20.67 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.142 -1.211 . . . . 0.0 110.199 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 125' ' ' ASP . 2.0 t -91.14 133.84 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.269 -0.894 . . . . 0.0 111.018 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.91 -25.65 5.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.538 ' O ' HG13 ' A' ' 123' ' ' VAL . 4.0 m-20 -148.26 160.93 42.46 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.034 -1.067 . . . . 0.0 111.837 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 5.7 t -170.11 149.94 3.64 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.7 164.78 35.3 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.042 -1.036 . . . . 0.0 111.098 -178.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 1.041 HD22 ' N ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -140.77 129.15 22.49 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.009 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 1.041 ' N ' HD22 ' A' ' 128' ' ' LEU . 0.4 OUTLIER -111.77 71.33 0.74 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.172 -0.955 . . . . 0.0 110.156 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.937 ' HB2' HD21 ' A' ' 128' ' ' LEU . 5.6 mt -151.62 14.65 0.66 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.478 -0.764 . . . . 0.0 110.638 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -50.75 113.83 4.09 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.172 -0.955 . . . . 0.0 110.952 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -84.98 0.1 9.02 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.892 1.469 . . . . 0.0 110.906 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.885 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -94.97 -32.59 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.023 -1.048 . . . . 0.0 110.49 -179.585 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.47 -12.7 39.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 0.0 110.149 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.22 38.14 35.16 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.52 25.37 2.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -1.199 . . . . 0.0 110.225 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.63 ' HB2' HD23 ' A' ' 130' ' ' LEU . 5.5 p -60.01 116.85 4.45 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.364 -0.835 . . . . 0.0 109.555 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.592 ' HG2' ' CZ ' ' A' ' 140' ' ' PHE . 0.0 OUTLIER -89.3 -16.7 30.52 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.142 -0.973 . . . . 0.0 110.235 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.701 ' HA2' HD21 ' A' ' 130' ' ' LEU . . . 91.05 19.16 43.86 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 120.035 -1.078 . . . . 0.0 111.048 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.592 ' CZ ' ' HG2' ' A' ' 138' ' ' ARG . 21.7 p90 -166.89 144.3 4.82 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.58 -1.541 . . . . 0.0 111.526 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.698 ' H ' HD23 ' A' ' 104' ' ' LEU . . . -121.38 -174.55 14.85 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.727 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 15.2 m-85 -129.43 165.85 20.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.15 -1.206 . . . . 0.0 110.776 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.592 ' C ' HD12 ' A' ' 144' ' ' LEU . 3.8 t -139.41 133.34 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.454 -0.779 . . . . 0.0 109.214 178.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.592 HD12 ' C ' ' A' ' 143' ' ' VAL . 5.4 mp -123.96 92.77 3.75 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.61 -0.682 . . . . 0.0 109.312 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 1.044 ' HB2' HG22 ' A' ' 151' ' ' VAL . 17.7 m-85 -69.18 164.4 22.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.416 -0.802 . . . . 0.0 110.784 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.53 ' CB ' ' O ' ' A' ' 122' ' ' GLU . 10.8 tttp -93.4 -22.03 19.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.473 -0.767 . . . . 0.0 110.615 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.864 ' O ' HG23 ' A' ' 151' ' ' VAL . 14.8 tt0 -126.7 144.24 50.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.765 -1.209 . . . . 0.0 110.462 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 51.1 m -61.84 -35.51 78.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.966 . . . . 0.0 109.634 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.532 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 0.1 OUTLIER -63.2 -47.64 81.71 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.318 -0.864 . . . . 0.0 109.843 179.603 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 2.3 p -57.84 -37.38 73.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.326 -0.859 . . . . 0.0 109.881 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 1.044 HG22 ' HB2' ' A' ' 145' ' ' PHE . 2.8 t -66.23 -57.95 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.118 -0.989 . . . . 0.0 110.027 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.532 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -52.26 -29.83 24.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.094 -1.003 . . . . 0.0 110.012 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.471 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 6.7 mttt -68.68 -38.6 80.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.29 -0.881 . . . . 0.0 110.19 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.961 HG12 ' O ' ' A' ' 151' ' ' VAL . 9.9 p -77.16 -17.71 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.209 -0.932 . . . . 0.0 110.046 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.764 ' SD ' HG12 ' A' ' 151' ' ' VAL . 0.0 OUTLIER -90.21 -39.62 12.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 110.537 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 1.0 OUTLIER -52.87 -34.75 56.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.971 -1.081 . . . . 0.0 109.795 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.505 ' O ' ' NE2' ' A' ' 160' ' ' HIS . 4.2 mt-30 -117.69 88.47 2.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.486 -0.759 . . . . 0.0 109.747 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.52 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 6.8 pttt -86.62 26.09 1.15 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 110.946 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.08 62.06 6.61 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.656 ' HE1' HG22 ' A' ' 154' ' ' VAL . 11.6 m170 -87.2 154.88 20.38 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.61 -177.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 165' ' ' LYS . 41.4 mttm -150.8 85.45 1.36 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.351 -0.843 . . . . 0.0 109.783 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.793 HD12 ' H ' ' A' ' 162' ' ' LEU . 1.0 OUTLIER -99.77 138.01 37.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.354 -0.841 . . . . 0.0 109.714 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.682 ' OD1' HG23 ' A' ' 108' ' ' THR . 10.8 m120 59.37 19.44 7.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.259 -0.901 . . . . 0.0 110.318 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.29 32.11 29.32 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.533 ' CE ' ' O ' ' A' ' 166' ' ' VAL . 0.9 OUTLIER -150.18 149.97 30.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.186 -1.184 . . . . 0.0 110.208 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 160' ' ' HIS . 26.4 t -90.01 159.52 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.078 -1.014 . . . . 0.0 110.383 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.572 HG13 ' HB2' ' A' ' 160' ' ' HIS . 1.3 pt -120.46 -176.57 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 122.071 0.939 . . . . 0.0 111.219 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -123.41 81.6 53.18 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -74.21 131.08 14.84 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.305 1.687 . . . . 0.0 110.877 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.407 ' O ' ' CB ' ' A' ' 99' ' ' MET . 2.1 mmtm -147.25 -166.9 2.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.458 -0.776 . . . . 0.0 110.3 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -89.87 -170.77 2.92 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.1 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.483 0 O-C-N 121.267 -0.895 . . . . 0.0 110.376 -179.535 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.512 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.289 0.566 . . . . 0.0 110.331 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.885 ' CE ' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -136.47 166.45 23.47 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.445 -0.784 . . . . 0.0 109.178 179.385 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.846 ' O ' HD13 ' A' ' 101' ' ' ILE . 15.6 t80 -112.2 148.52 33.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.963 -1.085 . . . . 0.0 110.623 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.885 HD11 ' CE ' ' A' ' 99' ' ' MET . 8.8 mm -123.09 108.33 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.643 -0.661 . . . . 0.0 110.095 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.54 ' HA2' ' CB ' ' A' ' 140' ' ' PHE . . . -101.85 128.68 9.64 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.61 38.03 0.64 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.9 ' CD2' HD23 ' A' ' 128' ' ' LEU . 1.1 mp -90.06 153.77 20.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.14 -1.212 . . . . 0.0 110.234 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.486 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 3.1 m -82.4 154.35 25.24 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.256 -0.902 . . . . 0.0 110.411 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.604 ' HA ' HD12 ' A' ' 130' ' ' LEU . 12.1 m-90 -57.54 -14.17 4.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.118 -0.989 . . . . 0.0 110.369 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.422 ' OD1' ' HB3' ' A' ' 105' ' ' SER . 4.6 p-10 -108.57 21.76 16.85 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.928 -1.107 . . . . 0.0 111.613 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.465 ' HB ' HD23 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -85.99 149.6 25.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.883 -1.136 . . . . 0.0 109.986 179.425 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.445 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 72.5 p -134.97 162.9 31.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 110.175 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 126' ' ' CYS . 26.9 mtmt -60.4 -14.18 17.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 109.845 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -82.77 -59.65 2.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.405 -0.81 . . . . 0.0 110.655 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 1.6 p-10 -63.41 -35.05 79.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.103 -0.998 . . . . 0.0 110.258 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 15.0 tp -72.91 -51.61 17.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.184 -0.947 . . . . 0.0 109.964 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 110' ' ' LYS . 4.6 tttt -56.63 -37.95 71.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -0.955 . . . . 0.0 109.695 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.471 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 3.1 m-20 -73.14 -54.82 7.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.381 -0.824 . . . . 0.0 110.038 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.552 ' HE2' ' CD2' ' A' ' 160' ' ' HIS . 71.1 t80 -46.61 -31.93 3.15 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.719 -1.192 . . . . 0.0 108.356 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.629 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 18.7 m-85 -91.45 -11.29 38.03 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.789 -0.765 . . . . 0.0 111.423 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.471 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 0.5 OUTLIER -71.14 -5.75 34.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.94 -1.1 . . . . 0.0 109.372 178.755 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.6 ttpt -84.92 -12.8 52.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.378 -0.826 . . . . 0.0 110.212 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.629 ' CD2' ' HA ' ' A' ' 117' ' ' PHE . 84.8 m-85 -89.59 -44.45 10.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 110.001 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.53 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -174.53 -152.55 9.22 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -90.4 146.96 23.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.229 -1.159 . . . . 0.0 110.633 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.7 t -129.24 129.8 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.446 -0.783 . . . . 0.0 110.088 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.482 HG23 ' CG ' ' A' ' 146' ' ' LYS . 2.2 t -88.8 -25.38 5.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.49 ' HB3' HD22 ' A' ' 144' ' ' LEU . 13.7 m-20 -150.88 166.91 29.12 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.389 -1.324 . . . . 0.0 112.309 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 11.8 t -167.22 135.87 2.65 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.462 0.649 . . . . 0.0 109.301 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.33 165.76 22.72 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.386 -0.821 . . . . 0.0 109.92 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 1.035 HD22 ' N ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -150.54 128.93 12.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.312 -0.867 . . . . 0.0 109.566 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 1.035 ' N ' HD22 ' A' ' 128' ' ' LEU . 2.8 mmpt? -119.67 82.39 1.87 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.294 -0.879 . . . . 0.0 109.774 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 1.026 HD22 ' O ' ' A' ' 129' ' ' LYS . 0.3 OUTLIER -149.55 21.94 0.92 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.353 0.597 . . . . 0.0 109.844 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' A' ' 137' ' ' SER . 5.6 m-20 -71.71 115.23 35.68 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.184 -0.948 . . . . 0.0 110.918 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 106' ' ' TRP . 51.4 Cg_endo -89.07 -19.93 1.5 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.947 1.498 . . . . 0.0 110.343 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.458 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -89.57 -33.11 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.215 -0.928 . . . . 0.0 109.97 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 131' ' ' ASP . 0.2 OUTLIER -89.74 -9.2 50.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.276 -0.89 . . . . 0.0 110.192 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 74.19 33.7 56.39 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.78 29.56 5.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.226 -1.161 . . . . 0.0 110.118 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.557 ' HA ' ' CA ' ' A' ' 130' ' ' LEU . 5.8 p -88.39 102.8 15.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.26 -0.9 . . . . 0.0 110.032 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.589 ' HB3' ' CE2' ' A' ' 140' ' ' PHE . 0.1 OUTLIER -89.55 -2.59 58.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.351 -0.843 . . . . 0.0 110.131 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.758 ' C ' HD21 ' A' ' 130' ' ' LEU . . . 90.6 7.95 66.25 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 120.188 -1.006 . . . . 0.0 110.742 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.589 ' CE2' ' HB3' ' A' ' 138' ' ' ARG . 18.9 p90 -159.64 171.65 19.22 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.529 -1.571 . . . . 0.0 111.651 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.531 ' N ' HD13 ' A' ' 104' ' ' LEU . . . -140.0 -179.0 17.41 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.734 ' CE1' ' CE1' ' A' ' 100' ' ' PHE . 18.0 m-85 -128.17 156.94 42.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.213 -1.169 . . . . 0.0 110.786 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.659 ' O ' HD12 ' A' ' 144' ' ' LEU . 8.9 t -138.22 131.77 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.659 HD12 ' O ' ' A' ' 143' ' ' VAL . 6.5 mp -116.84 107.61 14.83 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.512 -0.743 . . . . 0.0 109.926 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.645 ' CB ' HG22 ' A' ' 151' ' ' VAL . 10.4 m-85 -80.27 167.73 19.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.409 -0.807 . . . . 0.0 110.919 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.482 ' CG ' HG23 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -97.73 -23.67 15.82 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.493 -0.755 . . . . 0.0 110.664 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.61 ' O ' HG23 ' A' ' 151' ' ' VAL . 0.9 OUTLIER -142.07 160.37 40.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.748 -1.22 . . . . 0.0 110.934 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.4 t -64.25 -31.81 73.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 0.0 109.861 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.54 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 6.2 mt-10 -60.28 -46.9 88.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.287 -0.883 . . . . 0.0 109.869 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.535 ' HB2' ' CD1' ' A' ' 145' ' ' PHE . 37.0 p -60.97 -40.99 95.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.273 -0.892 . . . . 0.0 110.257 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.765 ' O ' HG12 ' A' ' 154' ' ' VAL . 3.2 t -69.72 -46.2 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.126 -0.984 . . . . 0.0 110.758 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.54 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -52.46 -38.19 58.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.094 -1.004 . . . . 0.0 109.959 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.47 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 0.6 OUTLIER -66.42 -60.88 2.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 0.0 110.389 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.765 HG12 ' O ' ' A' ' 151' ' ' VAL . 12.6 p -48.97 -22.77 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.052 -1.03 . . . . 0.0 110.332 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 2.0 ttt -89.93 -24.79 21.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.178 -0.951 . . . . 0.0 109.744 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.47 ' OD2' ' O ' ' A' ' 153' ' ' LYS . 0.2 OUTLIER -53.81 -36.14 62.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.269 -0.894 . . . . 0.0 109.47 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.584 ' O ' ' CE1' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -131.18 102.07 5.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.336 -0.852 . . . . 0.0 110.085 179.473 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt -85.12 23.54 1.24 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -0.946 . . . . 0.0 110.936 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -87.96 57.45 4.33 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.807 ' O ' HD23 ' A' ' 162' ' ' LEU . 25.8 m80 -87.9 65.45 8.32 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.691 -176.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.6 ttpp -81.81 72.29 8.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.059 -1.025 . . . . 0.0 109.671 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.807 HD23 ' O ' ' A' ' 160' ' ' HIS . 0.5 OUTLIER -94.02 156.06 16.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 109.945 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 1.6 m-80 56.72 21.43 5.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.173 -0.954 . . . . 0.0 109.46 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 75.52 23.46 73.1 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.69 138.86 20.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -1.093 . . . . 0.0 110.618 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.597 HG12 ' H ' ' A' ' 167' ' ' ILE . 3.6 t -80.27 -179.54 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 109.233 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.597 ' H ' HG12 ' A' ' 166' ' ' VAL . 1.0 OUTLIER -141.7 170.99 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.973 -1.08 . . . . 0.0 111.52 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 102' ' ' GLY . 10.9 t0 -116.71 92.19 37.17 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 46.1 Cg_endo -72.15 136.72 27.48 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.312 1.69 . . . . 0.0 111.287 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -138.04 -178.95 5.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.52 -0.737 . . . . 0.0 109.703 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 172' ' ' ALA . 0.2 OUTLIER -91.61 50.78 1.76 Allowed 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.484 179.21 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.497 ' N ' ' HA ' ' A' ' 99' ' ' MET . . . . . . . . 0 N--CA 1.493 1.675 0 O-C-N 121.473 -0.767 . . . . 0.0 110.495 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.548 ' HG2' ' CD2' ' A' ' 144' ' ' LEU . 9.9 mtpt . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.51 ' CG ' ' O ' ' A' ' 143' ' ' VAL . 5.9 ptm -141.98 175.5 9.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.122 -0.986 . . . . 0.0 110.883 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.688 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 1.7 t80 -119.7 129.27 54.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.597 -0.689 . . . . 0.0 109.69 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.646 HD13 ' C ' ' A' ' 100' ' ' PHE . 3.1 mm -109.88 94.18 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.301 -0.875 . . . . 0.0 109.453 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.533 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -97.22 112.14 4.4 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 141.32 38.73 0.08 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.689 HD21 HD13 ' A' ' 113' ' ' LEU . 5.4 mp -89.9 164.6 14.52 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.231 -1.158 . . . . 0.0 110.102 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' A' ' 163' ' ' ASN . 0.6 OUTLIER -81.56 -171.73 3.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.322 -0.861 . . . . 0.0 109.862 179.715 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 17.3 m0 -83.85 -9.86 58.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.182 -0.949 . . . . 0.0 110.414 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.48 19.75 8.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 110.399 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.781 HG23 ' OD1' ' A' ' 163' ' ' ASN . 2.5 m -63.52 159.7 18.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.109 -0.994 . . . . 0.0 109.773 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.477 HG23 ' C ' ' A' ' 108' ' ' THR . 63.7 p -149.57 171.73 16.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.907 . . . . 0.0 110.448 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.509 ' O ' ' CB ' ' A' ' 114' ' ' LYS . 5.9 ttpt -71.32 -11.0 60.67 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.412 -0.805 . . . . 0.0 109.127 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -84.0 -49.18 9.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.452 -0.78 . . . . 0.0 110.411 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -75.83 -31.72 59.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.961 -1.087 . . . . 0.0 110.199 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.972 HD23 ' SG ' ' A' ' 126' ' ' CYS . 1.7 tp -77.08 -43.44 34.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.02 -1.05 . . . . 0.0 109.593 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.509 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 17.3 tttt -59.97 -45.19 93.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.196 -0.94 . . . . 0.0 109.605 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 116' ' ' TYR . 0.6 OUTLIER -74.97 -42.03 58.4 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.178 -0.951 . . . . 0.0 109.526 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.793 ' CD2' HD21 ' A' ' 162' ' ' LEU . 72.5 t80 -48.32 -36.21 13.87 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 118.733 -1.187 . . . . 0.0 107.98 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.683 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 19.2 m-85 -91.48 -13.53 32.06 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.985 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 12.7 t -61.29 -14.28 25.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.114 -0.991 . . . . 0.0 109.594 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.72 -11.42 58.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.403 -0.81 . . . . 0.0 110.191 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.937 ' CD2' HG22 ' A' ' 154' ' ' VAL . 53.4 m-85 -89.54 -63.71 1.25 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.105 -0.997 . . . . 0.0 109.24 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -159.18 -177.57 32.39 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.5 133.84 48.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.063 -1.257 . . . . 0.0 110.414 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.9 t -109.72 133.64 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.332 -0.855 . . . . 0.0 110.885 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.476 ' O ' ' OD1' ' A' ' 125' ' ' ASP . 2.1 t -89.68 -28.25 5.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.56 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 0.8 OUTLIER -147.26 164.64 32.57 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 118.906 -1.118 . . . . 0.0 112.604 -178.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.972 ' SG ' HD23 ' A' ' 113' ' ' LEU . 36.9 t -170.34 140.37 1.85 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.64 161.25 42.95 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.962 -177.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.765 HD22 ' O ' ' A' ' 108' ' ' THR . 0.2 OUTLIER -119.32 117.92 29.85 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.024 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 140' ' ' PHE . 0.3 OUTLIER -96.7 130.17 43.97 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 110.152 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.547 ' HA ' ' H ' ' A' ' 138' ' ' ARG . 0.5 OUTLIER -111.01 176.35 5.06 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 120.193 -0.603 . . . . 0.0 109.774 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.525 ' N ' ' HB2' ' A' ' 138' ' ' ARG . 1.0 OUTLIER -59.55 110.07 2.45 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 120.944 -1.098 . . . . 0.0 109.963 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 130' ' ' LEU . 48.7 Cg_endo -78.63 -24.85 7.06 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.894 1.471 . . . . 0.0 110.803 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.717 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.2 OUTLIER -96.44 -33.17 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.166 -0.959 . . . . 0.0 110.484 -179.715 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.71 -10.56 45.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.249 -0.907 . . . . 0.0 110.224 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 69.07 22.23 75.87 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -127.29 -164.76 1.39 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.219 -1.165 . . . . 0.0 110.251 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.9 p -90.25 122.27 33.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 110.338 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.547 ' H ' ' HA ' ' A' ' 130' ' ' LEU . 0.2 OUTLIER -89.3 -26.41 21.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.314 -0.866 . . . . 0.0 109.252 179.354 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.84 52.33 2.46 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 120.371 -0.918 . . . . 0.0 111.62 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.628 ' HA ' HD13 ' A' ' 104' ' ' LEU . 2.6 p90 -170.3 138.67 1.62 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.626 -1.514 . . . . 0.0 110.52 178.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.496 ' HA2' ' HB2' ' A' ' 129' ' ' LYS . . . -142.66 -161.84 8.98 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.688 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 17.4 m-85 -126.87 163.21 24.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.159 -1.2 . . . . 0.0 111.306 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.655 HG21 ' CE2' ' A' ' 117' ' ' PHE . 4.0 t -138.49 138.05 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.56 ' HB2' ' CB ' ' A' ' 125' ' ' ASP . 4.6 mp -127.04 107.45 10.06 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.315 -0.866 . . . . 0.0 110.11 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 1.127 ' CZ ' HG21 ' A' ' 154' ' ' VAL . 26.3 m-85 -80.65 151.63 28.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.361 -0.837 . . . . 0.0 110.51 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -75.78 -17.04 60.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.49 -0.756 . . . . 0.0 110.917 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.829 ' O ' HG23 ' A' ' 151' ' ' VAL . 7.4 tt0 -137.63 154.39 49.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.836 -1.165 . . . . 0.0 110.901 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.443 ' N ' ' HG2' ' A' ' 147' ' ' GLU . 0.4 OUTLIER -65.42 -39.28 91.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 109.601 179.45 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.524 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 3.0 tt0 -57.65 -51.3 70.09 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.331 -0.855 . . . . 0.0 109.688 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.803 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.4 p -52.7 -34.39 51.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.761 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 1.009 HG22 ' HB2' ' A' ' 145' ' ' PHE . 2.4 t -74.84 -49.79 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.307 -0.87 . . . . 0.0 110.503 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.524 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -52.97 -35.2 58.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.139 -0.976 . . . . 0.0 110.447 -179.489 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.487 ' HA ' ' OD2' ' A' ' 156' ' ' ASP . 0.4 OUTLIER -71.78 -49.87 34.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.227 -0.921 . . . . 0.0 110.464 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 1.127 HG21 ' CZ ' ' A' ' 145' ' ' PHE . 18.0 t -56.02 -22.53 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.901 -1.124 . . . . 0.0 110.043 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 32.1 mmm -87.32 -46.08 10.0 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.151 -0.968 . . . . 0.0 110.157 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.487 ' OD2' ' HA ' ' A' ' 153' ' ' LYS . 0.5 OUTLIER -47.19 -37.2 9.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.117 -0.99 . . . . 0.0 109.811 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.576 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 0.6 OUTLIER -111.16 85.33 2.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.122 -0.986 . . . . 0.0 110.101 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.02 18.19 2.16 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.28 -0.887 . . . . 0.0 110.824 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.424 ' OE1' ' HG2' ' A' ' 157' ' ' GLN . 31.9 mp0 -87.67 60.84 6.18 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 177.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.714 ' ND1' HD11 ' A' ' 167' ' ' ILE . 15.1 m-70 -87.07 179.57 6.65 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.557 -177.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 160' ' ' HIS . 14.2 ttmt -179.21 88.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.323 -0.861 . . . . 0.0 110.154 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.793 HD21 ' CD2' ' A' ' 116' ' ' TYR . 2.1 mp -102.93 140.89 36.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.175 -0.953 . . . . 0.0 109.583 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.781 ' OD1' HG23 ' A' ' 108' ' ' THR . 25.6 m120 57.04 16.72 3.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.267 -0.896 . . . . 0.0 109.734 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.35 32.59 27.88 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.11 123.3 10.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.193 -1.181 . . . . 0.0 110.482 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 167' ' ' ILE . 16.9 t -57.66 172.63 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 0.0 109.926 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.714 HD11 ' ND1' ' A' ' 160' ' ' HIS . 0.7 OUTLIER -132.7 178.27 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.195 -0.941 . . . . 0.0 111.019 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 102' ' ' GLY . 10.3 t70 -127.9 80.25 72.39 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 42.8 Cg_endo -70.41 131.22 19.88 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.069 1.563 . . . . 0.0 111.241 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.401 ' O ' ' CB ' ' A' ' 99' ' ' MET . 4.6 mmtm -146.73 -174.01 4.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.401 -0.812 . . . . 0.0 110.302 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.74 -171.07 2.77 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.463 -0.773 . . . . 0.0 110.487 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.326 -0.858 . . . . 0.0 110.145 179.854 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.525 ' HG2' ' CD1' ' A' ' 144' ' ' LEU . 12.5 mtmm . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.344 0.592 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.926 ' CE ' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -145.33 160.0 42.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.656 179.2 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.836 ' O ' HD13 ' A' ' 101' ' ' ILE . 13.1 t80 -113.61 146.07 40.29 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.414 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.926 HD11 ' CE ' ' A' ' 99' ' ' MET . 12.7 mm -123.61 91.39 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.531 -0.731 . . . . 0.0 110.123 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 167' ' ' ILE . . . -91.34 178.77 41.79 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.65 10.89 61.25 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.722 HD13 ' H ' ' A' ' 141' ' ' GLY . 4.9 mp -73.36 163.72 27.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.098 -1.237 . . . . 0.0 110.349 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.521 ' HB3' ' ND2' ' A' ' 163' ' ' ASN . 13.3 t -90.37 -176.86 4.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.331 -0.856 . . . . 0.0 109.615 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.547 ' CD1' ' N ' ' A' ' 106' ' ' TRP . 37.0 m0 -87.67 23.21 2.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.081 -1.012 . . . . 0.0 110.143 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -144.25 9.5 1.44 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -0.9 . . . . 0.0 110.47 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.861 HG23 ' OD1' ' A' ' 163' ' ' ASN . 0.2 OUTLIER -73.41 172.47 11.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.106 -0.996 . . . . 0.0 109.822 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.512 HG23 ' C ' ' A' ' 108' ' ' THR . 71.4 p -150.36 166.41 30.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.132 -0.98 . . . . 0.0 110.366 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 114' ' ' LYS . 0.8 OUTLIER -67.68 -15.38 63.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.219 -0.925 . . . . 0.0 109.529 179.532 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -80.8 -62.66 1.6 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.315 -0.866 . . . . 0.0 110.38 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 109' ' ' THR . 1.1 p-10 -55.87 -37.75 69.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 110.249 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.646 HD23 ' SG ' ' A' ' 126' ' ' CYS . 13.3 tp -72.09 -41.46 67.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.156 -0.965 . . . . 0.0 110.178 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 110' ' ' LYS . 0.1 OUTLIER -60.87 -47.03 88.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.201 -0.937 . . . . 0.0 110.292 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 116' ' ' TYR . 26.4 t0 -69.91 -48.39 58.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.035 -1.041 . . . . 0.0 110.034 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.407 ' C ' ' O ' ' A' ' 115' ' ' ASP . 75.0 t80 -48.28 -34.89 11.14 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.62 -1.232 . . . . 0.0 108.104 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.655 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 13.5 m-85 -91.66 -8.08 48.13 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.409 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.5 m -71.15 -9.1 57.5 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.891 -1.131 . . . . 0.0 108.951 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -81.74 -16.09 52.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.6 -0.687 . . . . 0.0 110.091 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.655 ' CD1' ' HA ' ' A' ' 117' ' ' PHE . 70.7 m-85 -89.1 -55.35 3.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.179 -0.951 . . . . 0.0 109.153 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.531 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -164.57 -163.36 17.48 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.24 140.94 29.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.114 -1.227 . . . . 0.0 110.351 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.9 t -112.75 133.5 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.308 -0.87 . . . . 0.0 110.823 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.22 -25.64 5.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.561 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 1.0 OUTLIER -148.53 165.45 31.17 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.667 -1.213 . . . . 0.0 112.045 -179.203 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.646 ' SG ' HD23 ' A' ' 113' ' ' LEU . 14.3 t -170.52 148.68 3.14 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.45 ' O ' ' HA3' ' A' ' 141' ' ' GLY . 0.8 OUTLIER -150.28 162.28 40.81 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.116 -0.99 . . . . 0.0 110.599 -178.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 1.057 HD22 ' N ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -142.95 130.48 21.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.446 -0.784 . . . . 0.0 109.692 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 1.057 ' N ' HD22 ' A' ' 128' ' ' LEU . 10.4 mmtm -105.34 104.0 13.64 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.345 -0.847 . . . . 0.0 109.552 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.832 HD13 ' O ' ' A' ' 108' ' ' THR . 0.3 OUTLIER -145.55 13.42 1.36 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.573 ' N ' HD23 ' A' ' 130' ' ' LEU . 12.9 m-20 -40.15 100.83 0.22 Allowed Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.461 -0.774 . . . . 0.0 110.562 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 130' ' ' LEU . 50.7 Cg_endo -79.46 -18.05 11.06 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.174 1.618 . . . . 0.0 110.595 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.627 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -96.2 -39.56 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.214 -0.929 . . . . 0.0 110.285 -179.677 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.482 ' N ' ' CG2' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -89.91 9.81 26.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.191 -0.943 . . . . 0.0 110.438 -179.767 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.23 16.09 40.36 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.486 ' CB ' ' HB2' ' A' ' 131' ' ' ASP . 0.3 OUTLIER -92.68 19.97 6.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.172 -1.193 . . . . 0.0 110.222 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.526 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 42.4 p -90.92 78.49 6.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.619 -0.675 . . . . 0.0 110.214 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.626 ' HB3' ' CD1' ' A' ' 140' ' ' PHE . 0.0 OUTLIER -88.97 11.63 17.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.069 -1.02 . . . . 0.0 109.254 179.388 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 62.93 66.77 2.38 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.64 ' CE1' ' CB ' ' A' ' 129' ' ' LYS . 16.9 p90 -170.34 131.42 0.96 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.92 -1.341 . . . . 0.0 110.965 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.722 ' H ' HD13 ' A' ' 104' ' ' LEU . . . -125.42 173.69 17.45 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.72 ' CE1' ' CE1' ' A' ' 100' ' ' PHE . 10.1 m-85 -116.51 158.15 24.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.185 -1.185 . . . . 0.0 110.234 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.557 ' CG2' HG13 ' A' ' 101' ' ' ILE . 25.8 t -138.46 124.88 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.933 0.873 . . . . 0.0 109.939 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.561 ' HB2' ' CB ' ' A' ' 125' ' ' ASP . 1.6 mm? -110.27 111.65 23.09 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.658 ' CB ' HG22 ' A' ' 151' ' ' VAL . 11.7 m-85 -82.01 151.59 27.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.971 -1.081 . . . . 0.0 111.052 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 30.4 tttt -81.28 -25.24 36.7 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.674 -0.641 . . . . 0.0 111.157 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.486 ' OE2' ' HB3' ' A' ' 149' ' ' GLU . 1.0 OUTLIER -144.48 146.37 32.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.703 -1.248 . . . . 0.0 111.231 -179.333 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.3 t -49.17 -35.13 16.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.154 -0.966 . . . . 0.0 109.554 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.533 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 0.6 OUTLIER -55.78 -51.61 66.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.348 -0.845 . . . . 0.0 109.972 179.725 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.56 ' HB2' ' CD1' ' A' ' 145' ' ' PHE . 67.1 p -56.99 -36.68 70.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.297 -0.877 . . . . 0.0 110.322 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.658 HG22 ' CB ' ' A' ' 145' ' ' PHE . 3.1 t -72.22 -53.6 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.075 -1.016 . . . . 0.0 110.393 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.533 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -47.78 -35.52 10.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.062 -1.023 . . . . 0.0 110.051 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.485 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -69.25 -52.0 31.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.898 . . . . 0.0 110.375 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.603 HG12 ' O ' ' A' ' 151' ' ' VAL . 2.1 p -65.15 -14.39 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.989 -1.07 . . . . 0.0 110.17 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 28.1 tpp -90.48 -36.76 14.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.348 -0.845 . . . . 0.0 110.618 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 1.6 p-10 -57.73 -17.59 16.28 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.124 -0.985 . . . . 0.0 110.115 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.532 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 8.9 tp-100 -139.5 76.87 1.59 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.329 -0.857 . . . . 0.0 109.437 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.632 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -81.84 10.3 6.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.906 . . . . 0.0 110.666 -179.426 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.409 ' HB2' ' OE1' ' A' ' 157' ' ' GLN . 8.9 mm-40 -88.09 67.88 8.99 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.678 ' O ' HG13 ' A' ' 166' ' ' VAL . 77.5 m-70 -86.41 174.71 8.82 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.51 0.671 . . . . 0.0 110.901 -177.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.602 ' HG3' HG22 ' A' ' 166' ' ' VAL . 1.1 mppt? -168.95 74.17 0.09 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.523 -0.735 . . . . 0.0 109.226 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.696 ' H ' HD23 ' A' ' 162' ' ' LEU . 0.9 OUTLIER -109.89 155.8 21.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.38 -0.825 . . . . 0.0 110.178 -179.442 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.861 ' OD1' HG23 ' A' ' 108' ' ' THR . 0.3 OUTLIER 66.59 9.13 6.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.265 -0.897 . . . . 0.0 109.639 -179.348 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 89.08 15.38 59.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -150.92 163.49 38.57 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.051 -1.264 . . . . 0.0 110.671 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.678 HG13 ' O ' ' A' ' 160' ' ' HIS . 2.9 t -84.9 178.28 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 109.53 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.624 HD11 ' CG ' ' A' ' 160' ' ' HIS . 0.7 OUTLIER -134.15 169.0 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.966 -1.084 . . . . 0.0 111.04 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 102' ' ' GLY . 9.5 t70 -112.34 88.22 10.44 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 167' ' ' ILE . 48.7 Cg_endo -77.14 119.66 5.1 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.259 1.663 . . . . 0.0 110.607 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.5 mttp -135.64 175.25 9.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 0.0 110.544 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.571 ' O ' ' HB3' ' A' ' 172' ' ' ALA . 9.3 ptp180 -91.81 52.72 2.07 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.27 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 171' ' ' ARG . . . . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.277 -0.889 . . . . 0.0 110.377 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.504 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 9.8 mttt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.155 0.503 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.499 ' HG2' ' O ' ' A' ' 143' ' ' VAL . 6.9 ptm -141.29 174.67 10.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.313 -0.867 . . . . 0.0 110.181 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.697 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 2.3 t80 -115.15 129.11 56.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.388 -0.82 . . . . 0.0 110.176 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.677 HD13 ' C ' ' A' ' 100' ' ' PHE . 4.2 mm -111.53 95.94 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.287 -0.883 . . . . 0.0 109.251 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -93.13 113.92 4.57 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.468 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 145.08 34.51 0.07 OUTLIER Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 1.09 HD12 HG21 ' A' ' 108' ' ' THR . 3.5 mm? -91.17 151.82 20.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.088 -1.242 . . . . 0.0 110.116 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.441 ' HB3' ' HB3' ' A' ' 163' ' ' ASN . 52.7 p -75.27 -178.46 3.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.195 -0.941 . . . . 0.0 109.988 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.508 ' HA ' ' CB ' ' A' ' 137' ' ' SER . 7.7 m0 -82.1 6.42 16.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -0.923 . . . . 0.0 110.364 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 107' ' ' ASP . 2.9 p-10 -140.61 32.23 1.85 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.311 -0.868 . . . . 0.0 110.04 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . 1.09 HG21 HD12 ' A' ' 104' ' ' LEU . 18.1 m -77.7 154.35 32.17 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.313 -0.867 . . . . 0.0 110.344 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.487 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 12.2 p -126.05 161.78 26.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.224 -0.923 . . . . 0.0 110.358 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.559 ' CG ' ' HA ' ' A' ' 127' ' ' THR . 0.3 OUTLIER -64.76 -20.47 66.37 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.089 -1.007 . . . . 0.0 110.121 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -88.61 -47.22 8.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.231 -0.918 . . . . 0.0 110.955 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -60.13 -30.42 69.27 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.941 -1.099 . . . . 0.0 109.881 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.642 HD13 HD11 ' A' ' 104' ' ' LEU . 27.0 tp -84.19 -45.91 12.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.218 -0.926 . . . . 0.0 109.47 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -33.03 67.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.889 . . . . 0.0 109.254 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' A' ' 118' ' ' SER . 0.2 OUTLIER -75.37 -55.04 6.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.28 -0.888 . . . . 0.0 109.675 179.632 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.448 ' C ' ' O ' ' A' ' 115' ' ' ASP . 64.8 t80 -46.55 -31.6 2.88 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.664 -1.214 . . . . 0.0 108.256 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.579 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 14.5 m-85 -91.35 -12.31 35.31 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.23 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 115' ' ' ASP . 44.0 t -67.47 -9.26 40.43 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.869 -1.144 . . . . 0.0 109.015 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -79.26 -16.23 56.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.407 -0.808 . . . . 0.0 110.438 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.953 ' CZ ' HG23 ' A' ' 154' ' ' VAL . 90.4 m-85 -88.89 -53.18 4.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.155 -0.965 . . . . 0.0 109.685 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -164.15 -159.16 10.67 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.03 135.09 33.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -1.123 . . . . 0.0 110.262 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.563 HG13 ' O ' ' A' ' 125' ' ' ASP . 2.0 t -111.83 133.66 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.294 -0.879 . . . . 0.0 110.59 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.42 HG23 ' HD2' ' A' ' 146' ' ' LYS . 2.1 t -88.73 -25.58 5.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.563 ' O ' HG13 ' A' ' 123' ' ' VAL . 0.9 OUTLIER -150.67 168.93 22.87 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.603 -1.239 . . . . 0.0 112.293 -179.056 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.526 ' O ' ' CD ' ' A' ' 110' ' ' LYS . 38.8 t -167.15 149.16 5.98 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.559 ' HA ' ' CG ' ' A' ' 110' ' ' LYS . 0.9 OUTLIER -150.78 147.82 27.76 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.869 -1.144 . . . . 0.0 111.563 -178.354 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.834 HD13 ' O ' ' A' ' 128' ' ' LEU . 2.3 tm? -116.49 98.8 6.75 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.546 ' CB ' ' O ' ' A' ' 140' ' ' PHE . 1.9 tmtm? -74.71 132.61 41.8 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.257 -0.902 . . . . 0.0 111.29 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.457 ' HA ' ' H ' ' A' ' 138' ' ' ARG . 0.6 OUTLIER -107.21 -145.87 0.39 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.428 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 4.6 m-20 -91.14 121.65 67.51 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.092 -1.005 . . . . 0.0 109.652 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -82.12 22.18 0.89 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.74 1.389 . . . . 0.0 111.384 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.572 ' CG2' ' N ' ' A' ' 134' ' ' THR . 0.3 OUTLIER -140.37 -46.8 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.798 -1.188 . . . . 0.0 110.641 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.572 ' N ' ' CG2' ' A' ' 133' ' ' ILE . 0.8 OUTLIER -101.22 -9.6 21.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 110.578 -179.436 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.39 -0.66 87.47 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.501 ' O ' ' HB2' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -78.25 -173.89 3.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.209 -1.171 . . . . 0.0 110.184 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.508 ' CB ' ' HA ' ' A' ' 106' ' ' TRP . 1.9 m -91.64 123.71 35.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.208 -0.933 . . . . 0.0 110.449 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.457 ' H ' ' HA ' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -89.1 -26.98 21.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 108.83 179.11 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.442 ' C ' ' HB2' ' A' ' 104' ' ' LEU . . . 90.62 50.05 3.02 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.685 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.762 ' HA ' HD23 ' A' ' 104' ' ' LEU . 3.3 p90 -168.26 142.45 3.35 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.651 -1.499 . . . . 0.0 110.335 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.49 ' HA2' ' HB2' ' A' ' 129' ' ' LYS . . . -150.78 -165.46 12.78 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.466 -1.35 . . . . 0.0 110.5 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.697 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 16.4 m-85 -126.71 157.33 39.37 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.416 -1.049 . . . . 0.0 111.22 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.628 ' O ' HD12 ' A' ' 144' ' ' LEU . 2.8 t -130.34 134.39 62.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 143' ' ' VAL . 6.2 mp -121.82 90.2 3.26 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.104 -0.997 . . . . 0.0 110.333 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.796 ' HB2' HG22 ' A' ' 151' ' ' VAL . 29.6 m-85 -64.36 167.9 6.33 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.529 0.681 . . . . 0.0 109.98 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.42 ' HD2' HG23 ' A' ' 124' ' ' VAL . 7.9 tttt -103.05 -7.51 21.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.362 -0.837 . . . . 0.0 110.73 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.722 ' O ' HG23 ' A' ' 151' ' ' VAL . 0.9 OUTLIER -141.14 161.51 37.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.889 -1.132 . . . . 0.0 110.936 -179.524 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 4.8 t -75.26 -43.14 53.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 109.66 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.529 ' CB ' ' OE1' ' A' ' 147' ' ' GLU . 0.5 OUTLIER -60.62 -29.99 69.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.326 -0.859 . . . . 0.0 109.702 179.506 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.499 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 7.2 p -71.68 -40.58 69.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.041 -1.037 . . . . 0.0 109.431 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.796 HG22 ' HB2' ' A' ' 145' ' ' PHE . 8.3 t -72.42 -40.97 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -0.939 . . . . 0.0 110.154 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -67.6 -24.46 65.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.998 -1.063 . . . . 0.0 109.548 179.801 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.484 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 0.7 OUTLIER -74.39 -40.57 61.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.396 -0.815 . . . . 0.0 109.703 179.5 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.953 HG23 ' CZ ' ' A' ' 120' ' ' PHE . 11.4 p -79.56 -17.3 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.149 -0.97 . . . . 0.0 110.011 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -88.57 -32.31 18.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.497 -0.752 . . . . 0.0 110.388 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.484 ' OD2' ' O ' ' A' ' 153' ' ' LYS . 0.3 OUTLIER -51.92 -32.13 31.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.054 -1.029 . . . . 0.0 109.681 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.506 ' O ' ' NE2' ' A' ' 160' ' ' HIS . 1.4 mt-30 -130.05 96.96 4.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.308 -0.87 . . . . 0.0 110.028 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.523 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -89.54 24.68 2.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.13 -0.981 . . . . 0.0 110.264 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -88.1 62.16 6.66 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.692 ' ND1' HD11 ' A' ' 167' ' ' ILE . 11.5 m170 -86.9 178.8 6.86 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.942 -177.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 7.7 ttpt -175.27 68.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.383 -0.823 . . . . 0.0 109.823 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.679 HD11 HD13 ' A' ' 104' ' ' LEU . 2.4 pp -99.9 152.88 19.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.867 . . . . 0.0 109.814 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.523 ' HB2' HD12 ' A' ' 162' ' ' LEU . 5.4 m120 56.05 32.89 20.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.144 -0.973 . . . . 0.0 109.415 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 60.59 29.3 69.36 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.26 138.8 20.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.241 -1.152 . . . . 0.0 110.524 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.542 HG12 ' H ' ' A' ' 167' ' ' ILE . 21.6 t -75.19 176.9 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.934 . . . . 0.0 109.375 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.692 HD11 ' ND1' ' A' ' 160' ' ' HIS . 1.3 pt -137.19 -175.62 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.0 -1.063 . . . . 0.0 111.209 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -140.77 93.79 8.36 Favored Pre-proline 0 C--N 1.301 -1.515 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -77.11 115.26 3.95 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.378 1.725 . . . . 0.0 110.603 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.65 171.48 9.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.331 -0.856 . . . . 0.0 110.327 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.95 171.49 9.08 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.229 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.356 -0.84 . . . . 0.0 109.948 -179.86 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.517 ' CG ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.189 0.519 . . . . 0.0 109.943 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.647 ' HE2' ' O ' ' A' ' 170' ' ' LYS . 6.0 mtp -140.09 179.26 6.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.129 -0.982 . . . . 0.0 110.376 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.811 ' O ' HD13 ' A' ' 101' ' ' ILE . 2.4 t80 -124.42 136.54 54.13 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.45 -0.781 . . . . 0.0 110.077 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.811 HD13 ' O ' ' A' ' 100' ' ' PHE . 6.0 mm -122.19 106.08 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.12 -0.988 . . . . 0.0 110.009 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.552 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -103.27 139.84 14.62 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.88 10.85 8.83 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.86 HD21 HD22 ' A' ' 113' ' ' LEU . 4.3 mp -65.66 159.62 24.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.312 -1.11 . . . . 0.0 110.479 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.528 ' N ' ' OG1' ' A' ' 108' ' ' THR . 0.1 OUTLIER -83.94 177.11 8.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.37 -0.831 . . . . 0.0 109.823 179.541 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.564 ' CD1' ' N ' ' A' ' 106' ' ' TRP . 12.1 m0 -73.53 -23.75 60.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.153 -0.967 . . . . 0.0 110.352 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -104.97 11.77 33.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 110.887 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.618 HG21 ' HG ' ' A' ' 104' ' ' LEU . 1.8 m -60.92 161.24 8.49 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.986 -1.072 . . . . 0.0 110.023 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.51 HG23 ' C ' ' A' ' 108' ' ' THR . 68.3 p -150.33 179.53 8.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.342 -0.849 . . . . 0.0 110.391 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 23.2 ttmt -77.14 -19.07 57.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.387 -0.821 . . . . 0.0 109.342 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.56 -52.98 8.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.444 -0.785 . . . . 0.0 110.894 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 109' ' ' THR . 24.1 p-10 -70.01 -40.81 75.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.036 -1.04 . . . . 0.0 110.553 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.86 HD22 HD21 ' A' ' 104' ' ' LEU . 24.4 tp -65.1 -50.05 67.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.964 -1.085 . . . . 0.0 109.792 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -57.82 -32.5 67.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.914 . . . . 0.0 110.139 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.462 ' O ' ' C ' ' A' ' 116' ' ' TYR . 3.1 m-20 -80.0 -54.69 5.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.145 -0.972 . . . . 0.0 110.255 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.717 ' HE2' ' HD2' ' A' ' 160' ' ' HIS . 59.0 t80 -45.97 -32.6 2.83 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 118.711 -1.196 . . . . 0.0 108.177 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.743 ' HE2' HD11 ' A' ' 113' ' ' LEU . 12.8 m-85 -90.83 -17.14 27.08 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.22 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 115' ' ' ASP . 22.6 t -60.22 -20.47 58.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.981 -1.075 . . . . 0.0 109.445 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -74.92 -11.84 60.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.442 -0.786 . . . . 0.0 109.978 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.69 ' HB3' HG22 ' A' ' 154' ' ' VAL . 61.3 m-85 -89.78 -72.73 0.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.282 -0.886 . . . . 0.0 109.172 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -148.76 152.28 24.34 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.491 ' HB3' ' HE2' ' A' ' 146' ' ' LYS . 1.4 mt-10 -45.23 128.45 7.59 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.227 -1.161 . . . . 0.0 110.76 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.8 t -106.71 132.06 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.425 -0.797 . . . . 0.0 110.214 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.17 -24.4 5.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.442 ' O ' HG13 ' A' ' 123' ' ' VAL . 1.9 m-20 -150.81 161.24 43.04 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 118.447 -1.301 . . . . 0.0 112.33 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.481 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 43.3 t -161.37 147.78 14.41 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -151.25 154.7 37.31 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 118.538 -1.265 . . . . 0.0 111.842 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.943 HD13 ' O ' ' A' ' 128' ' ' LEU . 0.4 OUTLIER -115.94 113.01 22.69 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.104 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.643 ' N ' HD22 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -94.64 135.03 36.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.08 -1.013 . . . . 0.0 111.794 -178.252 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.521 ' HA ' ' H ' ' A' ' 138' ' ' ARG . 2.2 mp -100.89 -144.81 0.34 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.498 ' OD1' ' CA ' ' A' ' 138' ' ' ARG . 1.2 m-20 -88.74 123.1 68.56 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.623 -1.298 . . . . 0.0 109.885 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.11 -11.13 23.17 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.842 1.443 . . . . 0.0 111.14 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.652 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -128.17 -38.64 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.956 -1.09 . . . . 0.0 110.514 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.477 ' N ' ' CG2' ' A' ' 133' ' ' ILE . 16.5 m -89.91 -22.87 21.79 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.191 -0.943 . . . . 0.0 110.129 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.417 ' C ' ' HB2' ' A' ' 131' ' ' ASP . . . 87.51 -43.46 3.19 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.476 ' O ' ' HB2' ' A' ' 131' ' ' ASP . 15.9 ttt-85 -52.59 152.13 3.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.149 -1.206 . . . . 0.0 110.411 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.1 m -52.31 124.17 12.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.136 -0.977 . . . . 0.0 110.42 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.521 ' H ' ' HA ' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -89.41 -22.71 22.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.08 179.306 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.79 47.39 3.69 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.983 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.563 ' CD2' ' CZ ' ' A' ' 100' ' ' PHE . 8.7 p90 -168.15 146.12 4.32 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.456 -1.614 . . . . 0.0 110.629 178.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.483 ' HA2' ' HB2' ' A' ' 129' ' ' LYS . . . -144.91 -159.78 8.23 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.694 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 17.9 m-85 -129.28 170.2 13.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.317 -1.107 . . . . 0.0 111.279 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.506 ' O ' HD12 ' A' ' 144' ' ' LEU . 3.1 t -145.03 128.3 11.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.517 ' HG ' ' CG ' ' A' ' 98' ' ' LYS . 6.6 mp -116.0 104.35 11.49 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.417 -0.802 . . . . 0.0 109.752 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 1.181 ' CZ ' HG21 ' A' ' 154' ' ' VAL . 52.6 m-85 -78.21 148.69 33.9 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.582 -0.699 . . . . 0.0 110.699 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.491 ' HE2' ' HB3' ' A' ' 122' ' ' GLU . 1.8 ttmt -59.98 -38.22 81.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.641 -0.662 . . . . 0.0 111.061 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.472 ' OE2' ' HB2' ' A' ' 149' ' ' GLU . 0.5 OUTLIER -133.87 149.49 51.34 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.969 -1.082 . . . . 0.0 111.186 -179.321 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.9 p -52.45 -27.92 18.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.322 -0.861 . . . . 0.0 109.824 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.544 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 1.9 mm-40 -62.74 -56.35 18.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.388 -0.82 . . . . 0.0 109.93 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.631 ' O ' HG23 ' A' ' 154' ' ' VAL . 3.5 p -51.7 -32.15 28.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.171 -0.956 . . . . 0.0 109.757 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.796 HG22 ' HB2' ' A' ' 145' ' ' PHE . 17.7 t -65.81 -57.84 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.322 -0.861 . . . . 0.0 110.189 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.544 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 1.1 p30 -51.5 -28.89 14.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.172 -0.955 . . . . 0.0 109.99 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.47 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -68.28 -44.36 75.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.444 -0.785 . . . . 0.0 110.004 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 1.181 HG21 ' CZ ' ' A' ' 145' ' ' PHE . 3.8 t -69.86 -18.33 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.103 -0.998 . . . . 0.0 109.973 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.55 -23.96 21.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.88 . . . . 0.0 110.02 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.4 OUTLIER -55.41 -35.54 65.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 109.821 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.621 ' O ' ' CE1' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -127.16 95.5 4.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.814 . . . . 0.0 109.583 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.474 ' HG3' ' HD2' ' A' ' 169' ' ' PRO . 9.5 tmtt? -85.29 12.43 8.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.904 . . . . 0.0 110.561 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -87.5 66.15 8.9 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 177.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.717 ' HD2' ' HE2' ' A' ' 116' ' ' TYR . 21.1 m80 -87.2 177.76 7.08 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.487 -177.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.639 ' HG3' HG22 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -174.18 70.51 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.285 -0.885 . . . . 0.0 110.085 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.886 HD12 ' HB2' ' A' ' 163' ' ' ASN . 3.6 pp -96.09 154.33 17.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 109.73 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.886 ' HB2' HD12 ' A' ' 162' ' ' LEU . 0.9 OUTLIER 58.99 15.38 3.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.898 . . . . 0.0 109.969 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.16 24.58 54.39 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -150.07 149.09 29.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -1.166 . . . . 0.0 110.702 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.639 HG22 ' HG3' ' A' ' 161' ' ' LYS . 30.1 t -77.2 176.12 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.438 -0.789 . . . . 0.0 109.7 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.579 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -142.38 -176.13 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.131 -0.98 . . . . 0.0 110.971 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 102' ' ' GLY . 60.8 t0 -127.87 94.03 38.14 Favored Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.474 ' HD2' ' HG3' ' A' ' 158' ' ' LYS . 49.8 Cg_endo -74.85 113.64 3.84 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.395 1.734 . . . . 0.0 111.71 -178.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.647 ' O ' ' HE2' ' A' ' 99' ' ' MET . 1.0 OUTLIER -130.51 -171.63 2.6 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.607 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.508 ' HA ' ' HG2' ' A' ' 99' ' ' MET . 14.7 mtp180 -92.48 -172.56 3.11 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 118.861 -1.136 . . . . 0.0 110.363 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.907 . . . . 0.0 110.122 -179.791 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.553 ' HD3' HD21 ' A' ' 144' ' ' LEU . 18.1 mttp . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.22 0.533 . . . . 0.0 110.294 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.556 ' CE ' HD11 ' A' ' 101' ' ' ILE . 17.3 ptm -144.33 175.5 10.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.157 -0.964 . . . . 0.0 110.621 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.8 ' C ' HD13 ' A' ' 101' ' ' ILE . 2.4 t80 -117.3 135.36 53.89 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.533 -0.729 . . . . 0.0 109.174 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.8 HD13 ' C ' ' A' ' 100' ' ' PHE . 4.9 mm -119.42 110.56 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.182 -0.949 . . . . 0.0 109.78 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.447 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -111.37 98.71 1.05 Allowed Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.046 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 168.35 33.67 0.02 OUTLIER Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 1.007 HD12 HG21 ' A' ' 108' ' ' THR . 3.8 mm? -90.71 159.59 16.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -1.208 . . . . 0.0 109.808 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.457 ' N ' ' OG1' ' A' ' 108' ' ' THR . 14.0 t -85.33 -175.38 5.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.1 -1.0 . . . . 0.0 109.815 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 73.4 t90 -69.65 -33.37 72.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.062 -1.024 . . . . 0.0 110.148 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -103.77 48.13 0.86 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.204 -0.935 . . . . 0.0 110.335 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . 1.007 HG21 HD12 ' A' ' 104' ' ' LEU . 19.8 m -88.02 155.03 20.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -0.988 . . . . 0.0 110.335 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.456 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 46.3 p -143.67 156.04 44.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.456 -0.778 . . . . 0.0 109.935 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.438 ' O ' ' HB3' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -62.42 -14.7 43.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.065 -1.022 . . . . 0.0 109.453 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.9 mmtt -74.06 -56.08 5.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.363 -0.836 . . . . 0.0 110.013 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 12.1 p30 -69.06 -20.75 64.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.136 -0.978 . . . . 0.0 109.934 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 1.004 HD13 HD11 ' A' ' 104' ' ' LEU . 15.8 tp -86.73 -54.84 4.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.889 . . . . 0.0 109.641 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.438 ' HB3' ' O ' ' A' ' 110' ' ' LYS . 10.3 tttm -54.01 -35.59 62.07 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.456 -0.777 . . . . 0.0 109.73 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 116' ' ' TYR . 12.8 m-20 -76.16 -52.51 9.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.192 -0.943 . . . . 0.0 109.782 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.533 ' HH ' ' CG ' ' A' ' 160' ' ' HIS . 65.4 t80 -47.63 -33.74 7.08 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.723 -1.191 . . . . 0.0 108.063 178.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.648 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 15.3 m-85 -91.96 -9.7 42.07 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.394 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.426 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 7.6 t -72.34 -4.02 27.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.051 -1.031 . . . . 0.0 109.386 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -89.95 -11.37 41.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.544 -0.723 . . . . 0.0 110.429 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.648 ' CD2' ' HA ' ' A' ' 117' ' ' PHE . 90.8 m-85 -88.59 -52.48 5.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.124 -0.985 . . . . 0.0 109.643 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -164.77 -161.81 14.52 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 146' ' ' LYS . 4.1 tt0 -86.02 115.24 23.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.221 -1.164 . . . . 0.0 110.446 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.9 t -94.11 132.07 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.303 -0.873 . . . . 0.0 110.912 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.38 -24.21 5.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.551 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 5.5 m-20 -147.75 163.05 37.92 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 118.766 -1.174 . . . . 0.0 112.373 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 44.0 t -170.15 140.63 1.97 Allowed 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.462 ' CG2' ' N ' ' A' ' 128' ' ' LEU . 0.9 OUTLIER -150.73 168.16 25.2 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 118.675 -1.21 . . . . 0.0 112.01 -177.781 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.734 HD22 ' O ' ' A' ' 108' ' ' THR . 0.0 OUTLIER -123.6 124.86 43.73 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.217 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.668 ' N ' HD12 ' A' ' 128' ' ' LEU . 0.1 OUTLIER -99.7 131.23 45.82 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.988 -1.07 . . . . 0.0 110.979 -178.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.503 ' HB2' ' HA ' ' A' ' 137' ' ' SER . 0.5 OUTLIER -135.66 -179.89 5.92 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.565 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -87.4 111.29 40.45 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.104 -0.998 . . . . 0.0 109.999 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 130' ' ' LEU . 49.5 Cg_endo -80.28 1.11 9.52 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.0 1.526 . . . . 0.0 110.899 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.744 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -104.38 -42.98 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.087 -1.008 . . . . 0.0 110.481 -179.793 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.54 ' N ' ' CG2' ' A' ' 133' ' ' ILE . 0.5 OUTLIER -95.85 7.38 46.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.135 -0.978 . . . . 0.0 110.291 -179.734 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.35 25.05 53.97 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.47 158.8 23.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.36 -1.082 . . . . 0.0 110.308 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.503 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 0.1 OUTLIER -90.12 139.17 30.89 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.27 -0.894 . . . . 0.0 110.446 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.502 ' HD3' ' CE2' ' A' ' 140' ' ' PHE . 8.3 ttt180 -90.97 -24.19 20.19 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.61 43.18 4.93 Favored Glycine 0 N--CA 1.487 2.051 0 C-N-CA 120.305 -0.95 . . . . 0.0 111.152 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.683 ' HA ' HD23 ' A' ' 104' ' ' LEU . 4.1 p90 -160.71 134.31 6.82 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.494 -1.592 . . . . 0.0 110.469 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 128' ' ' LEU . . . -134.87 -166.15 11.04 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.968 -1.111 . . . . 0.0 110.418 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.697 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 16.5 m-85 -122.84 168.1 12.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.418 -1.048 . . . . 0.0 111.325 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.558 ' CG2' HG13 ' A' ' 101' ' ' ILE . 8.9 t -144.76 134.04 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.553 HD21 ' HD3' ' A' ' 98' ' ' LYS . 3.1 mp -121.59 101.5 7.64 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.301 -0.874 . . . . 0.0 110.368 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.839 ' HB2' HG22 ' A' ' 151' ' ' VAL . 12.6 m-85 -76.42 158.08 31.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.296 -0.877 . . . . 0.0 110.382 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 122' ' ' GLU . 24.4 tptp -85.28 -11.94 53.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.819 . . . . 0.0 111.205 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.792 ' O ' HG23 ' A' ' 151' ' ' VAL . 2.6 tt0 -144.92 151.06 38.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.75 -1.219 . . . . 0.0 110.883 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 19.9 m -61.98 -36.91 82.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.9 . . . . 0.0 109.437 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.521 ' CB ' ' OE1' ' A' ' 147' ' ' GLU . 2.3 tt0 -62.11 -56.18 21.45 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.329 -0.857 . . . . 0.0 109.42 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 49.7 p -45.6 -37.0 5.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.149 -0.969 . . . . 0.0 109.361 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.839 HG22 ' HB2' ' A' ' 145' ' ' PHE . 2.9 t -74.3 -35.15 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 0.0 109.635 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.52 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -66.01 -28.08 68.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -0.872 . . . . 0.0 109.521 179.583 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.479 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 4.2 mttm -74.99 -48.51 23.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.377 -0.827 . . . . 0.0 109.908 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.699 HG23 ' HE1' ' A' ' 160' ' ' HIS . 9.0 p -66.13 -18.28 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.009 -1.057 . . . . 0.0 109.916 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 5.3 ttt -89.95 -43.51 10.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.262 -0.899 . . . . 0.0 110.115 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.479 ' OD2' ' O ' ' A' ' 153' ' ' LYS . 0.5 OUTLIER -46.39 -33.78 4.15 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.175 -0.953 . . . . 0.0 109.766 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.571 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 3.2 tt0 -119.43 90.26 3.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.29 -0.881 . . . . 0.0 110.105 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 158' ' ' LYS . 38.3 ttpt -87.14 19.77 3.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.325 -0.859 . . . . 0.0 110.295 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.6 58.28 4.83 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 177.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.974 ' ND1' HD11 ' A' ' 167' ' ' ILE . 13.7 m-70 -86.47 173.78 9.4 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.372 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -177.64 67.94 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.439 -0.788 . . . . 0.0 109.467 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.806 HD11 ' CD1' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -97.04 157.69 15.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.413 -0.804 . . . . 0.0 110.152 -179.575 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.466 ' HB2' HD12 ' A' ' 162' ' ' LEU . 0.4 OUTLIER 58.17 16.45 3.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 109.627 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 81.29 21.94 61.6 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.54 149.65 30.21 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.1 -1.235 . . . . 0.0 110.394 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 160' ' ' HIS . 1.1 p -76.95 -177.28 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.177 -0.952 . . . . 0.0 109.668 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.974 HD11 ' ND1' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -135.78 166.76 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.956 -1.09 . . . . 0.0 111.651 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -117.31 88.86 29.44 Favored Pre-proline 0 C--N 1.303 -1.436 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.491 ' HD2' ' HD2' ' A' ' 158' ' ' LYS . 46.7 Cg_endo -72.7 132.02 18.09 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.359 1.715 . . . . 0.0 111.184 -178.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 99' ' ' MET . 2.5 mttm -147.9 -169.8 3.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.53 -0.731 . . . . 0.0 109.964 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.32 -168.99 2.18 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.222 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 98' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.359 -0.838 . . . . 0.0 110.161 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.62 ' O ' ' HB3' ' A' ' 172' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.237 0.542 . . . . 0.0 110.527 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.885 ' HE2' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -123.38 167.25 14.07 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.193 -0.942 . . . . 0.0 108.84 178.711 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.691 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 1.6 t80 -105.73 125.28 50.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.06 -1.025 . . . . 0.0 110.305 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.885 HD11 ' HE2' ' A' ' 99' ' ' MET . 16.5 mm -116.95 94.92 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 110.169 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.603 ' O ' HG22 ' A' ' 167' ' ' ILE . . . -92.71 178.28 39.36 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.47 6.74 70.29 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.981 HD12 HG21 ' A' ' 108' ' ' THR . 3.1 mm? -61.68 164.13 6.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.094 -1.239 . . . . 0.0 109.536 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.423 ' HB3' ' HB3' ' A' ' 163' ' ' ASN . 0.9 OUTLIER -89.05 177.78 6.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.042 -1.036 . . . . 0.0 109.97 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.848 ' C ' HD11 ' A' ' 130' ' ' LEU . 33.3 m95 -84.99 19.23 2.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.223 -0.923 . . . . 0.0 110.217 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.7 ' HA ' HD21 ' A' ' 130' ' ' LEU . 37.6 t70 -148.12 21.88 1.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.9 . . . . 0.0 109.878 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.981 HG21 HD12 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -76.1 169.37 18.32 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.203 -0.935 . . . . 0.0 110.639 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.497 HG23 ' C ' ' A' ' 108' ' ' THR . 82.8 p -150.42 151.36 32.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.437 -0.789 . . . . 0.0 109.98 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.486 ' HD3' ' O ' ' A' ' 126' ' ' CYS . 7.1 ttpt -56.08 -16.34 4.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.162 -0.961 . . . . 0.0 109.881 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -80.15 -57.98 3.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.37 -0.831 . . . . 0.0 111.11 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 1.5 p-10 -65.38 -40.31 93.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.06 -1.025 . . . . 0.0 110.844 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.881 HD13 HD11 ' A' ' 104' ' ' LEU . 20.2 tp -69.05 -48.54 62.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.019 -1.051 . . . . 0.0 109.984 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 110' ' ' LYS . 11.7 tttt -52.16 -40.47 61.49 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.234 -0.916 . . . . 0.0 110.127 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.532 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 4.2 t0 -74.69 -50.86 16.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.234 -0.916 . . . . 0.0 110.257 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.448 ' C ' ' O ' ' A' ' 115' ' ' ASP . 78.1 t80 -46.21 -34.85 4.66 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.402 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.616 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 9.1 m-85 -91.63 -12.45 34.17 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.441 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.532 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 0.9 OUTLIER -72.65 -5.26 36.26 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.917 -1.115 . . . . 0.0 108.998 178.5 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.486 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 2.1 tttm -85.77 -12.27 51.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.521 -0.737 . . . . 0.0 110.347 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.616 ' CD2' ' HA ' ' A' ' 117' ' ' PHE . 93.0 m-85 -88.9 -51.54 5.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.021 -1.049 . . . . 0.0 109.286 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.473 ' HA3' ' HB3' ' A' ' 150' ' ' SER . . . -158.71 -161.17 10.85 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -86.01 142.5 28.72 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.144 -1.209 . . . . 0.0 109.896 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.471 HG23 ' CD1' ' A' ' 145' ' ' PHE . 1.8 t -127.48 133.9 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.169 -0.957 . . . . 0.0 110.923 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.592 HG23 ' CE ' ' A' ' 146' ' ' LYS . 2.3 t -94.73 -22.03 5.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.425 ' O ' HG13 ' A' ' 123' ' ' VAL . 1.9 m-20 -149.82 170.68 18.19 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 118.049 -1.46 . . . . 0.0 113.135 -178.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.486 ' O ' ' HD3' ' A' ' 110' ' ' LYS . 16.2 t -170.85 131.48 0.84 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.36 162.08 25.58 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.448 -0.783 . . . . 0.0 111.45 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 1.022 HD11 ' CB ' ' A' ' 130' ' ' LEU . 0.1 OUTLIER -149.53 126.32 11.1 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.362 -0.836 . . . . 0.0 110.294 179.219 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.989 ' N ' HD22 ' A' ' 128' ' ' LEU . 25.8 tptt -91.11 101.69 14.43 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 1.022 ' CB ' HD11 ' A' ' 128' ' ' LEU . 13.6 tp -150.69 55.76 0.91 Allowed 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.69 -178.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.544 ' CB ' ' HB2' ' A' ' 136' ' ' ARG . 4.4 m-20 -51.03 114.69 5.08 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 120.851 -1.156 . . . . 0.0 109.987 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -77.49 -49.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.869 1.457 . . . . 0.0 111.376 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.902 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.2 OUTLIER -91.31 -24.31 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.033 -1.042 . . . . 0.0 111.035 -179.14 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -89.17 9.78 24.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.114 -0.991 . . . . 0.0 110.01 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 134' ' ' THR . . . 42.86 29.76 0.87 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.544 ' HB2' ' CB ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -105.43 23.07 14.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.165 -1.197 . . . . 0.0 110.308 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.734 ' HB2' HD12 ' A' ' 130' ' ' LEU . 17.1 p -72.6 103.51 3.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.406 -0.809 . . . . 0.0 109.466 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.43 ' CB ' ' CD1' ' A' ' 140' ' ' PHE . 4.6 mtp-105 -88.6 16.56 6.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.918 . . . . 0.0 109.336 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.425 ' C ' ' HB2' ' A' ' 104' ' ' LEU . . . 48.77 55.11 11.81 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.503 ' CD2' ' CZ ' ' A' ' 100' ' ' PHE . 3.1 p90 -167.39 138.07 2.98 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.787 -1.419 . . . . 0.0 110.542 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.602 ' HA3' ' HA ' ' A' ' 128' ' ' LEU . . . -139.24 -169.07 11.47 Favored Glycine 0 N--CA 1.488 2.114 0 C-N-CA 119.804 -1.189 . . . . 0.0 110.494 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.691 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 9.9 m-85 -124.48 170.6 10.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.732 -0.864 . . . . 0.0 110.008 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.638 ' C ' HD12 ' A' ' 144' ' ' LEU . 35.7 t -141.59 140.93 30.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.638 HD12 ' C ' ' A' ' 143' ' ' VAL . 5.8 mp -124.83 107.94 11.42 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.783 -178.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.766 ' CE2' HG11 ' A' ' 154' ' ' VAL . 42.9 m-85 -82.68 165.58 19.86 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.518 -0.739 . . . . 0.0 110.344 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.592 ' CE ' HG23 ' A' ' 124' ' ' VAL . 10.6 ttmt -86.77 -24.65 25.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.439 -0.788 . . . . 0.0 111.002 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.524 ' O ' HG23 ' A' ' 151' ' ' VAL . 0.7 OUTLIER -145.02 155.16 43.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.786 -1.196 . . . . 0.0 110.92 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 25.6 p -55.19 -35.8 65.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.271 -0.893 . . . . 0.0 109.948 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.544 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 1.0 OUTLIER -52.97 -54.14 39.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.425 -0.797 . . . . 0.0 110.008 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.485 ' OG ' ' HG3' ' A' ' 147' ' ' GLU . 3.6 p -57.59 -39.44 76.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.187 -0.945 . . . . 0.0 110.233 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.626 ' O ' HG12 ' A' ' 154' ' ' VAL . 6.6 t -62.0 -44.69 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.12 -0.988 . . . . 0.0 110.62 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.544 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.5 OUTLIER -67.16 -27.56 67.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.044 -1.035 . . . . 0.0 110.097 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.473 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -70.75 -32.36 69.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.847 . . . . 0.0 110.163 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.766 HG11 ' CE2' ' A' ' 145' ' ' PHE . 6.0 p -90.66 -20.87 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.158 -0.964 . . . . 0.0 110.329 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.04 -34.5 16.77 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.371 -0.83 . . . . 0.0 109.892 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 8.4 p-10 -47.38 -31.9 4.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.295 -0.878 . . . . 0.0 109.865 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.517 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -131.95 94.95 3.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.976 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.499 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -89.52 27.31 1.5 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.127 -0.983 . . . . 0.0 110.431 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -89.03 55.66 3.42 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.811 ' O ' HG23 ' A' ' 166' ' ' VAL . 12.2 m170 -86.23 176.31 8.01 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.684 -177.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -177.21 75.05 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.46 -0.775 . . . . 0.0 109.452 179.718 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.624 HD11 HD13 ' A' ' 104' ' ' LEU . 1.5 pp -98.49 157.99 15.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.321 -0.862 . . . . 0.0 109.948 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 0.8 OUTLIER 60.04 13.92 4.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.328 -0.858 . . . . 0.0 109.675 -179.265 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 85.43 20.85 55.94 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 161' ' ' LYS . 5.8 mttt -151.21 150.55 30.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.086 -1.243 . . . . 0.0 110.736 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 160' ' ' HIS . 1.3 p -74.71 -178.79 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.4 -0.813 . . . . 0.0 109.683 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.603 HG22 ' O ' ' A' ' 102' ' ' GLY . 0.1 OUTLIER -135.39 -171.78 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.097 -1.002 . . . . 0.0 110.701 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 102' ' ' GLY . 23.9 t0 -132.71 84.63 49.68 Favored Pre-proline 0 N--CA 1.488 1.473 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.51 ' HA ' HD13 ' A' ' 101' ' ' ILE . 47.8 Cg_endo -74.93 127.18 10.53 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.218 1.641 . . . . 0.0 111.033 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.55 -173.48 4.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.462 -0.774 . . . . 0.0 109.794 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -91.99 -168.9 2.11 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.499 -0.881 . . . . 0.0 110.566 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 98' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.609 -0.682 . . . . 0.0 109.946 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.509 ' HD3' HD21 ' A' ' 144' ' ' LEU . 8.2 mttp . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.372 0.606 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.659 ' CE ' HD11 ' A' ' 101' ' ' ILE . 5.4 ptm -138.73 169.56 17.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 109.982 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.795 ' C ' HD13 ' A' ' 101' ' ' ILE . 2.5 t80 -112.72 138.68 49.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.904 . . . . 0.0 110.593 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.795 HD13 ' C ' ' A' ' 100' ' ' PHE . 2.8 mm -121.85 110.77 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.418 -0.801 . . . . 0.0 109.822 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.477 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -108.57 123.92 7.21 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 138.89 33.63 0.18 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.739 HD21 HD22 ' A' ' 113' ' ' LEU . 2.2 mp -90.5 159.37 16.54 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.139 -1.212 . . . . 0.0 110.323 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.6 t -84.06 -170.3 3.01 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.208 -0.932 . . . . 0.0 110.32 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 20.2 m0 -87.53 4.1 44.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.208 -0.932 . . . . 0.0 110.332 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -138.0 22.99 2.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.205 -0.935 . . . . 0.0 110.15 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.712 HG21 ' CD2' ' A' ' 104' ' ' LEU . 2.8 m -68.06 163.28 22.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.171 -0.956 . . . . 0.0 110.059 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.457 HG23 ' C ' ' A' ' 108' ' ' THR . 30.3 p -148.61 153.76 38.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.198 -0.939 . . . . 0.0 110.171 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.548 ' O ' ' CB ' ' A' ' 114' ' ' LYS . 10.5 ttpt -58.4 -15.34 10.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.225 -0.922 . . . . 0.0 109.735 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.35 -54.61 6.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.219 -0.925 . . . . 0.0 110.273 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 3.2 p30 -70.12 -30.29 67.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.235 -0.916 . . . . 0.0 110.574 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.739 HD22 HD21 ' A' ' 104' ' ' LEU . 14.7 tp -81.11 -48.97 11.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.021 . . . . 0.0 109.996 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.548 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 1.3 tttt -55.04 -35.87 64.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.154 -0.966 . . . . 0.0 109.716 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.478 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 5.3 m-20 -79.59 -47.69 15.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.919 . . . . 0.0 109.748 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.799 ' HE2' ' HD2' ' A' ' 160' ' ' HIS . 75.6 t80 -48.23 -36.73 14.46 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 118.566 -1.253 . . . . 0.0 107.995 178.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.692 ' CD2' HG21 ' A' ' 143' ' ' VAL . 16.3 m-85 -91.56 -11.7 36.52 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.948 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.478 ' HB3' ' HA ' ' A' ' 115' ' ' ASP . 29.2 t -71.08 -6.49 39.57 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.907 -1.12 . . . . 0.0 108.81 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 11.4 tttt -83.47 -15.74 48.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.407 -0.808 . . . . 0.0 110.036 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.909 ' CG ' HG22 ' A' ' 154' ' ' VAL . 72.8 m-85 -89.18 -39.74 13.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.274 -0.891 . . . . 0.0 109.122 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.448 ' HA3' ' HB3' ' A' ' 150' ' ' SER . . . -174.19 176.99 46.57 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 0.9 OUTLIER -73.83 118.17 16.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.234 -1.156 . . . . 0.0 110.466 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.8 t -93.36 130.62 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.26 -0.9 . . . . 0.0 111.375 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -90.28 -23.73 5.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.522 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -142.76 153.02 42.9 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 118.984 -1.087 . . . . 0.0 112.09 -179.106 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 49.6 t -161.66 145.56 12.69 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.28 156.73 42.1 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.702 -1.199 . . . . 0.0 111.566 -178.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.736 ' C ' HD12 ' A' ' 128' ' ' LEU . 0.1 OUTLIER -123.46 110.37 15.01 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.46 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.61 ' HG2' ' CZ ' ' A' ' 140' ' ' PHE . 4.5 tppt? -76.44 113.04 13.59 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.065 -1.022 . . . . 0.0 110.183 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.593 HD23 ' O ' ' A' ' 128' ' ' LEU . 0.6 OUTLIER -124.62 -165.91 1.45 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.519 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.463 ' HB3' ' N ' ' A' ' 135' ' ' GLY . 0.5 OUTLIER -90.86 112.14 51.9 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.891 -1.131 . . . . 0.0 109.794 179.1 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.65 -4.63 15.67 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.882 1.464 . . . . 0.0 111.229 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.644 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -134.16 -43.76 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.972 -1.08 . . . . 0.0 110.781 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.541 ' N ' ' CG2' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -89.49 -9.37 50.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.099 -1.001 . . . . 0.0 110.701 -179.631 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 137' ' ' SER . . . 80.02 -49.05 3.67 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.429 ' O ' ' CG ' ' A' ' 131' ' ' ASP . 6.1 mtt180 -47.59 93.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.119 -1.224 . . . . 0.0 110.536 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 130' ' ' LEU . 1.4 t -42.09 159.89 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.309 -0.87 . . . . 0.0 110.79 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.541 ' HB3' ' CE2' ' A' ' 140' ' ' PHE . 12.5 mtt180 -89.19 -15.33 33.96 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.284 -0.885 . . . . 0.0 108.62 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 91.3 31.55 9.57 Favored Glycine 0 N--CA 1.486 2.0 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.408 178.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.61 ' CZ ' ' HG2' ' A' ' 129' ' ' LYS . 11.6 p90 -167.09 158.14 11.96 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.239 -1.742 . . . . 0.0 110.964 178.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.404 ' C ' ' CD1' ' A' ' 142' ' ' PHE . . . -153.91 -159.41 9.15 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.944 -1.263 . . . . 0.0 109.944 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.699 ' CZ ' ' CE2' ' A' ' 100' ' ' PHE . 18.9 m-85 -129.32 170.87 13.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -1.172 . . . . 0.0 111.429 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.692 HG21 ' CD2' ' A' ' 117' ' ' PHE . 7.3 t -145.9 129.83 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.633 HD12 ' C ' ' A' ' 143' ' ' VAL . 7.6 mp -120.84 102.96 8.71 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.398 -0.814 . . . . 0.0 110.355 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.901 ' CE2' HG21 ' A' ' 154' ' ' VAL . 26.2 m-85 -74.71 165.08 25.81 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.587 0.708 . . . . 0.0 110.899 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 17.5 ttpt -85.27 -26.5 26.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.512 -0.742 . . . . 0.0 111.104 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.504 ' HG3' ' OG ' ' A' ' 150' ' ' SER . 0.1 OUTLIER -137.11 142.05 42.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.654 -1.279 . . . . 0.0 110.772 -179.757 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 75.1 m -50.52 -30.67 13.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 109.996 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.545 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 1.8 mm-40 -59.25 -48.1 82.88 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.272 -0.892 . . . . 0.0 110.042 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.53 ' O ' HG23 ' A' ' 154' ' ' VAL . 11.2 p -62.75 -32.33 73.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.235 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.889 HG22 ' HB2' ' A' ' 145' ' ' PHE . 2.7 t -73.94 -55.31 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.065 -1.022 . . . . 0.0 110.103 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.545 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.1 OUTLIER -51.47 -27.14 9.59 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.159 -0.963 . . . . 0.0 109.341 179.772 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.475 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 8.7 tmtt? -69.5 -61.73 1.67 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.459 -0.775 . . . . 0.0 109.708 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.909 HG22 ' CG ' ' A' ' 120' ' ' PHE . 23.4 t -45.33 -28.65 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.127 -0.983 . . . . 0.0 109.948 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 6.7 ttt -77.46 -41.15 40.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.371 -0.831 . . . . 0.0 110.462 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.475 ' OD2' ' O ' ' A' ' 153' ' ' LYS . 0.4 OUTLIER -48.19 -22.99 0.74 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.132 -0.98 . . . . 0.0 109.962 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.629 ' O ' ' CE1' ' A' ' 160' ' ' HIS . 3.0 pt20 -140.44 90.89 2.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.286 -0.884 . . . . 0.0 110.135 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.74 16.38 5.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.122 -0.986 . . . . 0.0 110.372 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -87.67 63.64 7.63 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.799 ' HD2' ' HE2' ' A' ' 116' ' ' TYR . 14.5 m80 -87.35 -179.76 6.45 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.648 -177.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 165' ' ' LYS . 16.2 ttmt -179.06 74.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.26 -0.9 . . . . 0.0 110.23 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.585 HD12 ' HB2' ' A' ' 163' ' ' ASN . 1.8 pp -96.07 151.38 19.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 109.873 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.585 ' HB2' HD12 ' A' ' 162' ' ' LEU . 0.5 OUTLIER 61.39 12.36 4.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.232 -0.917 . . . . 0.0 110.217 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 88.2 23.01 39.06 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 161' ' ' LYS . 4.3 mtpp -150.12 138.96 20.89 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.183 -1.187 . . . . 0.0 110.579 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 160' ' ' HIS . 4.2 p -66.78 -179.39 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.311 -0.868 . . . . 0.0 109.995 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.651 HD11 ' HB3' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -145.13 176.74 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.176 -0.953 . . . . 0.0 110.642 -179.55 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 102' ' ' GLY . 34.2 t0 -128.09 90.78 46.44 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.526 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 52.3 Cg_endo -78.44 139.36 16.31 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 124.118 1.588 . . . . 0.0 110.862 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.08 -173.01 4.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.922 . . . . 0.0 110.122 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -91.0 -168.06 1.98 Allowed 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.319 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.545 0 O-C-N 121.427 -0.795 . . . . 0.0 110.319 -179.564 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.452 ' HB3' ' HG ' ' A' ' 144' ' ' LEU . 43.3 mttt . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.448 0.642 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.793 ' CE ' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -134.49 165.78 24.39 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.779 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.728 ' C ' HD13 ' A' ' 101' ' ' ILE . 17.4 t80 -111.78 144.35 41.23 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.077 -1.014 . . . . 0.0 110.67 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.793 HD11 ' CE ' ' A' ' 99' ' ' MET . 3.2 mm -117.63 96.53 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.555 -0.716 . . . . 0.0 109.227 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.565 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -93.99 120.39 6.31 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.84 -1.172 . . . . 0.0 110.627 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.52 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 133.65 35.03 0.29 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.957 HD11 HD12 ' A' ' 113' ' ' LEU . 4.0 mm? -90.21 161.64 15.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.12 -1.224 . . . . 0.0 110.106 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . 1.033 ' O ' HD13 ' A' ' 130' ' ' LEU . 0.1 OUTLIER -90.64 160.4 15.9 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.212 -0.93 . . . . 0.0 110.332 179.835 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.981 ' HA ' HD22 ' A' ' 130' ' ' LEU . 5.2 m-90 -62.14 -10.92 11.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.052 -1.03 . . . . 0.0 110.218 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -116.09 12.68 15.64 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.143 -0.973 . . . . 0.0 111.321 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . 1.04 HG23 ' CG ' ' A' ' 163' ' ' ASN . 0.3 OUTLIER -76.84 169.89 17.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.829 -1.169 . . . . 0.0 110.034 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.485 HG23 ' C ' ' A' ' 108' ' ' THR . 33.8 p -149.89 155.45 40.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.15 -0.969 . . . . 0.0 109.887 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 114' ' ' LYS . 1.9 pttp -63.6 -11.06 21.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.159 -0.963 . . . . 0.0 109.663 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -78.65 -61.96 1.84 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.0 110.42 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 0.9 OUTLIER -62.5 -41.41 98.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.084 -1.01 . . . . 0.0 110.182 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.957 HD12 HD11 ' A' ' 104' ' ' LEU . 6.9 tt -64.79 -61.14 2.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 109.752 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 110' ' ' LYS . 14.3 ttpt -44.44 -34.92 2.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 109.433 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 118' ' ' SER . 0.5 OUTLIER -72.94 -54.38 8.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.144 -0.972 . . . . 0.0 109.2 179.187 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.435 ' C ' ' O ' ' A' ' 115' ' ' ASP . 48.1 t80 -47.69 -28.39 2.4 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.622 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 20.1 m-85 -91.21 -12.41 35.4 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.232 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 115' ' ' ASP . 95.1 p -65.4 -10.18 31.45 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.922 -1.111 . . . . 0.0 109.406 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.0 tptt -81.73 -14.78 56.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.466 -0.771 . . . . 0.0 110.544 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.622 ' CD2' ' HA ' ' A' ' 117' ' ' PHE . 92.3 m-85 -89.17 -61.91 1.6 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.145 -0.972 . . . . 0.0 109.498 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.495 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -155.95 -163.5 12.3 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 146' ' ' LYS . 0.6 OUTLIER -88.76 126.41 35.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -1.212 . . . . 0.0 110.352 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.6 t -101.05 129.63 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.205 -0.935 . . . . 0.0 111.062 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.472 HG23 ' HB2' ' A' ' 146' ' ' LYS . 2.2 t -90.07 -23.01 6.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.528 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 2.2 m-20 -145.51 162.16 38.04 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 118.663 -1.215 . . . . 0.0 112.288 -178.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.446 ' CB ' ' HD3' ' A' ' 114' ' ' LYS . 9.2 t -169.95 143.98 2.66 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.528 ' CG2' ' N ' ' A' ' 128' ' ' LEU . 0.9 OUTLIER -150.59 173.85 13.65 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 110.39 -178.709 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.713 HD13 ' O ' ' A' ' 108' ' ' THR . 0.1 OUTLIER -143.85 125.49 15.0 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.403 -0.811 . . . . 0.0 110.003 179.266 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.578 ' HG3' ' HB2' ' A' ' 138' ' ' ARG . 7.8 tptp -96.65 64.92 2.17 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 1.033 HD13 ' O ' ' A' ' 105' ' ' SER . 6.0 mt -150.76 18.78 0.8 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.481 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 2.7 m-20 -44.11 105.94 0.48 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.645 -0.66 . . . . 0.0 111.178 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -80.08 -5.06 13.58 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.199 1.631 . . . . 0.0 110.145 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.761 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -96.23 -36.92 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 110.267 -179.806 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 131' ' ' ASP . 0.8 OUTLIER -92.78 1.97 57.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 110.247 -179.742 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.88 17.9 58.96 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.438 ' HD3' ' HB ' ' A' ' 134' ' ' THR . 4.9 mtp85 -106.95 32.73 4.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.304 -1.115 . . . . 0.0 110.108 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 130' ' ' LEU . 0.6 OUTLIER -71.73 130.86 42.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.205 -0.935 . . . . 0.0 110.018 -179.766 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.598 ' HB3' ' CE2' ' A' ' 140' ' ' PHE . 0.1 OUTLIER -109.26 -8.41 15.11 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.31 -0.869 . . . . 0.0 110.081 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.791 ' HA2' HD21 ' A' ' 130' ' ' LEU . . . 91.3 14.77 56.86 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 120.323 -0.941 . . . . 0.0 111.902 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.598 ' CE2' ' HB3' ' A' ' 138' ' ' ARG . 17.5 p90 -157.68 146.92 19.8 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.264 -1.727 . . . . 0.0 111.512 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.725 ' H ' HD23 ' A' ' 104' ' ' LEU . . . -115.68 178.47 17.64 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.719 ' CE1' ' CE1' ' A' ' 100' ' ' PHE . 13.3 m-85 -126.07 160.66 29.52 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.517 -0.99 . . . . 0.0 110.804 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.673 ' C ' HD12 ' A' ' 144' ' ' LEU . 19.5 t -145.07 141.75 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.584 -0.698 . . . . 0.0 109.237 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.673 HD12 ' C ' ' A' ' 143' ' ' VAL . 6.3 mp -127.31 102.71 7.03 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.515 -0.74 . . . . 0.0 109.536 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.817 ' HB2' HG22 ' A' ' 151' ' ' VAL . 29.2 m-85 -74.44 153.08 39.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.472 -0.768 . . . . 0.0 110.614 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.472 ' HB2' HG23 ' A' ' 124' ' ' VAL . 10.7 tttt -83.47 -18.98 36.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.476 -0.765 . . . . 0.0 110.882 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.811 ' O ' HG23 ' A' ' 151' ' ' VAL . 5.7 tt0 -134.36 154.63 51.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.794 -1.191 . . . . 0.0 110.895 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.9 t -67.39 -39.09 85.58 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.229 -0.919 . . . . 0.0 109.232 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.563 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 1.7 tt0 -59.63 -49.78 76.43 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.496 -0.752 . . . . 0.0 109.686 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.495 ' CB ' ' HA3' ' A' ' 121' ' ' GLY . 4.8 p -52.94 -37.97 61.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.159 -0.963 . . . . 0.0 109.498 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.817 HG22 ' HB2' ' A' ' 145' ' ' PHE . 5.7 t -68.27 -46.98 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -0.88 . . . . 0.0 109.921 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.563 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -57.05 -33.32 67.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.218 -0.926 . . . . 0.0 109.562 179.688 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.475 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 19.9 mttt -63.71 -50.98 67.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.434 -0.791 . . . . 0.0 109.905 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.725 HG12 ' O ' ' A' ' 151' ' ' VAL . 10.5 p -69.42 -10.77 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.962 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.21 -30.97 17.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.397 -0.814 . . . . 0.0 109.948 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 1.6 p-10 -55.29 -23.5 23.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.152 -0.968 . . . . 0.0 110.388 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.516 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 0.8 OUTLIER -139.72 94.76 2.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 0.0 109.961 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.58 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 3.1 pttp -89.91 15.06 10.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.158 -0.963 . . . . 0.0 110.606 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -87.94 67.77 9.09 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.611 ' HB2' ' CG1' ' A' ' 167' ' ' ILE . 84.9 m-70 -86.94 151.9 22.89 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.324 -177.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 160' ' ' HIS . 23.6 mttt -146.9 72.45 1.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.463 -0.773 . . . . 0.0 109.599 178.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.466 HD11 ' CD1' ' A' ' 104' ' ' LEU . 0.7 OUTLIER -106.43 151.9 24.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.0 110.579 -179.538 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 1.04 ' CG ' HG23 ' A' ' 108' ' ' THR . 0.7 OUTLIER 59.61 20.75 9.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.298 -0.876 . . . . 0.0 110.123 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.94 26.46 71.07 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.61 150.37 33.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.311 -1.111 . . . . 0.0 110.446 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.407 ' O ' ' HA3' ' A' ' 103' ' ' GLY . 57.7 t -92.15 160.6 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.33 -0.856 . . . . 0.0 109.745 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.611 ' CG1' ' HB2' ' A' ' 160' ' ' HIS . 3.8 pt -125.41 -177.65 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.014 -1.054 . . . . 0.0 111.602 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 102' ' ' GLY . 1.8 t70 -129.5 94.31 32.96 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.49 ' CG ' ' HB2' ' A' ' 158' ' ' LYS . 47.9 Cg_endo -74.44 124.3 8.8 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 124.302 1.685 . . . . 0.0 111.048 -178.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.457 ' O ' ' CB ' ' A' ' 99' ' ' MET . 4.7 mttm -150.24 -165.6 2.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.425 -0.797 . . . . 0.0 109.961 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -90.55 -170.73 2.82 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.654 -0.819 . . . . 0.0 109.345 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.004 -1.06 . . . . 0.0 110.596 -179.933 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.485 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 26.9 mtmt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.061 0.457 . . . . 0.0 109.797 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.578 ' HE2' HD11 ' A' ' 101' ' ' ILE . 8.5 ptm -136.13 178.55 6.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.154 -0.966 . . . . 0.0 110.762 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.748 ' C ' HD13 ' A' ' 101' ' ' ILE . 1.7 t80 -119.88 130.94 55.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.495 -0.753 . . . . 0.0 109.948 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.748 HD13 ' C ' ' A' ' 100' ' ' PHE . 3.8 mm -114.21 90.42 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.435 -0.791 . . . . 0.0 109.149 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -92.48 148.64 19.21 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.1 23.19 6.82 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.788 HD22 HD23 ' A' ' 128' ' ' LEU . 5.9 mp -82.74 163.36 21.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.992 -1.299 . . . . 0.0 109.995 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.928 ' O ' HD13 ' A' ' 130' ' ' LEU . 0.4 OUTLIER -91.52 178.55 5.91 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.315 -0.866 . . . . 0.0 111.051 -179.665 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.668 ' HA ' HD22 ' A' ' 130' ' ' LEU . 6.1 m-90 -72.64 -4.14 29.15 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.292 -0.88 . . . . 0.0 109.936 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.56 14.2 12.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.18 -0.95 . . . . 0.0 111.178 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.583 ' HB ' HD23 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -75.35 157.91 33.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.959 -1.088 . . . . 0.0 109.355 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.492 HG23 ' C ' ' A' ' 108' ' ' THR . 68.1 p -150.49 174.22 13.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.165 -0.959 . . . . 0.0 110.704 -179.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 126' ' ' CYS . 8.2 ttpt -66.93 -17.59 64.98 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.511 -0.743 . . . . 0.0 109.35 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -61.31 1.92 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.352 -0.843 . . . . 0.0 110.807 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 14.6 p30 -63.84 -18.15 63.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.997 -1.064 . . . . 0.0 109.879 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.74 ' HA ' HD21 ' A' ' 162' ' ' LEU . 36.8 tp -87.95 -53.55 4.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.898 . . . . 0.0 109.331 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.532 ' HB2' ' CB ' ' A' ' 126' ' ' CYS . 7.0 tmtt? -61.68 -38.57 88.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.558 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.551 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 6.3 t70 -72.5 -54.87 8.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.249 -0.907 . . . . 0.0 110.035 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.811 ' CG ' HD13 ' A' ' 162' ' ' LEU . 55.4 t80 -49.46 -30.28 7.87 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.395 -1.322 . . . . 0.0 108.0 178.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.665 ' HZ ' HD12 ' A' ' 167' ' ' ILE . 12.9 m-85 -90.71 -9.13 47.88 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 119.736 -0.786 . . . . 0.0 111.122 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.551 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 0.1 OUTLIER -69.07 -14.16 62.86 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.83 -1.169 . . . . 0.0 108.708 178.41 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -18.65 60.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.534 -0.729 . . . . 0.0 110.056 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.806 ' CG ' HG22 ' A' ' 154' ' ' VAL . 71.2 m-85 -89.03 -64.34 1.16 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.23 -0.918 . . . . 0.0 109.176 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 150' ' ' SER . . . -152.68 175.53 31.22 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.65 146.68 51.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.061 -1.258 . . . . 0.0 110.211 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 125' ' ' ASP . 2.0 t -123.06 132.14 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.357 -0.839 . . . . 0.0 110.674 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.1 -24.5 5.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.584 ' O ' HG13 ' A' ' 123' ' ' VAL . 1.0 OUTLIER -145.18 160.64 41.14 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 118.797 -1.161 . . . . 0.0 112.258 -179.163 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.532 ' CB ' ' HB2' ' A' ' 114' ' ' LYS . 34.1 t -169.57 118.9 0.64 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.402 ' CG2' ' N ' ' A' ' 128' ' ' LEU . 0.8 OUTLIER -118.56 166.68 12.42 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.498 -0.751 . . . . 0.0 110.823 -178.573 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.996 HD22 ' N ' ' A' ' 129' ' ' LYS . 0.3 OUTLIER -146.92 125.65 12.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.501 -0.749 . . . . 0.0 109.739 179.252 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.996 ' N ' HD22 ' A' ' 128' ' ' LEU . 1.9 tptp -104.04 73.79 1.17 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.142 -0.974 . . . . 0.0 109.449 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.932 ' HB2' HD21 ' A' ' 128' ' ' LEU . 3.0 mt -151.42 32.27 0.58 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.864 -0.523 . . . . 0.0 110.257 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.1 111.55 7.47 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.248 -0.907 . . . . 0.0 110.727 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 130' ' ' LEU . 52.1 Cg_endo -82.71 8.87 4.32 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 124.026 1.54 . . . . 0.0 110.973 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.558 ' CG2' ' N ' ' A' ' 134' ' ' THR . 0.2 OUTLIER -96.62 -46.24 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.974 -1.078 . . . . 0.0 110.37 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.558 ' N ' ' CG2' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -93.2 7.99 42.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.128 -0.983 . . . . 0.0 110.08 179.729 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 64.36 30.92 79.19 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -113.66 27.61 9.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -1.144 . . . . 0.0 110.378 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.633 ' HA ' ' HA ' ' A' ' 130' ' ' LEU . 96.9 p -88.06 116.08 25.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 109.875 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.413 ' HB2' ' CE1' ' A' ' 140' ' ' PHE . 0.6 OUTLIER -103.74 -6.05 21.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.174 -0.954 . . . . 0.0 110.554 -179.442 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.881 ' HA2' HD21 ' A' ' 130' ' ' LEU . . . 90.74 34.17 7.96 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.715 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.522 ' CD2' ' CZ ' ' A' ' 100' ' ' PHE . 19.1 p90 -162.88 145.86 10.79 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.307 -1.701 . . . . 0.0 111.884 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 128' ' ' LEU . . . -135.76 -179.27 16.43 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.725 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 7.8 m-85 -123.02 167.08 14.08 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.119 -1.224 . . . . 0.0 110.767 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.572 ' CG2' HG13 ' A' ' 101' ' ' ILE . 3.5 t -142.89 134.23 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.376 -0.828 . . . . 0.0 109.474 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.485 ' HG ' ' HG2' ' A' ' 98' ' ' LYS . 5.0 mp -120.87 103.44 9.08 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.42 -0.8 . . . . 0.0 109.786 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 1.032 ' CZ ' HG21 ' A' ' 154' ' ' VAL . 16.5 m-85 -77.49 169.52 18.16 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.453 -0.78 . . . . 0.0 110.899 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -84.36 -32.57 24.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.694 -0.629 . . . . 0.0 111.039 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.663 ' O ' HG23 ' A' ' 151' ' ' VAL . 0.3 OUTLIER -135.9 158.49 44.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.803 -1.186 . . . . 0.0 110.616 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.63 -31.56 72.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.293 -0.879 . . . . 0.0 110.28 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.538 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 0.0 OUTLIER -61.81 -45.54 93.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.936 . . . . 0.0 110.079 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.763 ' O ' HG23 ' A' ' 154' ' ' VAL . 43.0 p -63.59 -40.06 95.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.353 -0.842 . . . . 0.0 110.297 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.955 HG22 ' HB2' ' A' ' 145' ' ' PHE . 5.2 t -60.41 -59.06 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.096 -1.003 . . . . 0.0 109.823 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.538 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.5 OUTLIER -53.06 -41.69 65.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.103 -0.998 . . . . 0.0 109.439 179.612 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.464 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 9.7 tttt -51.83 -35.84 45.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.337 -0.852 . . . . 0.0 109.813 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 1.032 HG21 ' CZ ' ' A' ' 145' ' ' PHE . 3.7 t -82.32 -22.5 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.277 -0.89 . . . . 0.0 110.4 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 6.7 tmm? -86.05 -24.52 26.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.869 . . . . 0.0 110.375 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 40.8 p30 -65.83 -13.18 59.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.17 -0.956 . . . . 0.0 110.162 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.58 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 8.5 tt0 -142.37 88.21 2.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.92 . . . . 0.0 109.815 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.447 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -86.49 19.4 2.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.286 -0.884 . . . . 0.0 110.594 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -87.99 58.9 5.05 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.581 ' HB2' HG13 ' A' ' 167' ' ' ILE . 16.4 m-70 -86.58 -168.3 2.19 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.898 -177.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.484 ' CE ' ' C ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -176.31 64.94 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.582 -0.699 . . . . 0.0 109.406 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.811 HD13 ' CG ' ' A' ' 116' ' ' TYR . 10.6 tp -89.2 147.32 24.22 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.452 -0.78 . . . . 0.0 110.228 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.575 ' OD1' HG23 ' A' ' 108' ' ' THR . 0.1 OUTLIER 59.91 20.31 9.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.348 -0.845 . . . . 0.0 109.66 -179.604 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.484 ' C ' ' CE ' ' A' ' 161' ' ' LYS . . . 80.57 20.1 67.03 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.11 149.48 30.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -1.167 . . . . 0.0 110.202 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.9 t -67.7 163.9 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 109.963 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.665 HD12 ' HZ ' ' A' ' 117' ' ' PHE . 0.1 OUTLIER -120.95 -177.54 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.175 -0.953 . . . . 0.0 111.021 -179.412 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -133.07 83.28 52.06 Favored Pre-proline 0 C--N 1.304 -1.391 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.36 131.31 14.95 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.267 1.667 . . . . 0.0 110.559 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.1 mmtm -145.02 -176.79 5.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.326 -0.859 . . . . 0.0 110.307 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 -91.67 -169.58 2.33 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.363 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.461 -0.775 . . . . 0.0 110.059 179.955 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.547 ' CG ' ' HG ' ' A' ' 144' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.237 0.541 . . . . 0.0 110.505 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.636 ' HE2' ' CD1' ' A' ' 101' ' ' ILE . 7.7 ptm -115.15 176.89 4.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.296 -0.878 . . . . 0.0 109.736 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.711 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 1.2 t80 -116.55 125.52 52.0 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.351 -0.843 . . . . 0.0 110.155 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.662 HG13 HG23 ' A' ' 143' ' ' VAL . 1.3 mm -110.48 92.55 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.515 -0.741 . . . . 0.0 109.081 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -94.49 125.59 8.36 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.844 -1.169 . . . . 0.0 110.233 -179.146 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 131.97 2.01 4.37 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.964 HD12 ' CG2' ' A' ' 108' ' ' THR . 3.9 mm? -52.45 162.28 0.56 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.212 -1.169 . . . . 0.0 110.003 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.478 ' HB2' ' HB3' ' A' ' 163' ' ' ASN . 0.5 OUTLIER -87.33 -176.75 5.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.174 -0.954 . . . . 0.0 110.302 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -75.67 -22.92 56.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.287 -0.883 . . . . 0.0 110.282 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 29.1 p-10 -113.99 41.64 2.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.939 . . . . 0.0 110.163 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.964 ' CG2' HD12 ' A' ' 104' ' ' LEU . 0.7 OUTLIER -86.3 130.5 34.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 110.471 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.44 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 38.4 p -117.01 149.74 39.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.294 -0.879 . . . . 0.0 109.871 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.548 ' CG ' ' HA ' ' A' ' 127' ' ' THR . 3.8 mtpt -55.9 -16.36 4.58 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.182 -0.949 . . . . 0.0 110.057 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.35 -56.68 4.48 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.183 -0.948 . . . . 0.0 110.779 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 2.9 p30 -65.53 -34.09 77.44 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.002 -1.061 . . . . 0.0 110.915 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.903 HD13 HD11 ' A' ' 104' ' ' LEU . 12.4 tp -75.6 -55.44 5.66 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.986 -1.071 . . . . 0.0 109.876 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.437 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -49.17 -41.55 37.01 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.217 -0.927 . . . . 0.0 109.818 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.447 ' O ' ' C ' ' A' ' 116' ' ' TYR . 2.3 m-20 -75.83 -48.5 21.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.896 . . . . 0.0 110.218 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.948 ' CD1' HD13 ' A' ' 162' ' ' LEU . 70.1 t80 -47.15 -33.35 5.1 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.665 -1.214 . . . . 0.0 108.261 178.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.658 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 18.1 m-85 -91.2 -14.75 30.47 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.035 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 115' ' ' ASP . 40.2 t -63.45 -12.39 30.97 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.94 -1.1 . . . . 0.0 109.316 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -80.86 -13.42 58.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.475 -0.765 . . . . 0.0 110.008 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 1.015 ' CD2' HG22 ' A' ' 154' ' ' VAL . 67.4 m-85 -88.9 -36.53 15.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.249 -0.907 . . . . 0.0 109.479 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -177.44 -164.64 31.33 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.492 ' HB3' ' HG3' ' A' ' 146' ' ' LYS . 0.4 OUTLIER -88.84 108.76 19.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.188 -1.184 . . . . 0.0 110.27 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.563 HG23 ' CD1' ' A' ' 145' ' ' PHE . 1.8 t -90.3 130.06 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.234 -0.916 . . . . 0.0 111.163 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.459 ' O ' ' OD1' ' A' ' 125' ' ' ASP . 2.1 t -89.46 -23.16 6.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.569 ' CB ' HD22 ' A' ' 144' ' ' LEU . 3.8 m-20 -147.58 167.88 23.41 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 118.345 -1.342 . . . . 0.0 112.901 -178.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.807 ' SG ' HD23 ' A' ' 113' ' ' LEU . 25.9 t -169.03 148.05 4.0 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.548 ' HA ' ' CG ' ' A' ' 110' ' ' LYS . 0.9 OUTLIER -151.27 162.69 40.44 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.652 -1.219 . . . . 0.0 111.926 -177.907 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.865 HD13 ' O ' ' A' ' 128' ' ' LEU . 1.1 tm? -127.81 111.61 13.84 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.596 ' HB3' ' CE2' ' A' ' 140' ' ' PHE . 0.5 OUTLIER -92.63 134.74 34.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.086 -1.009 . . . . 0.0 111.205 -178.753 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.481 ' HA ' ' H ' ' A' ' 138' ' ' ARG . 4.5 mt -105.62 -157.9 0.63 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.842 -0.537 . . . . 0.0 109.654 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.461 ' OD1' ' CB ' ' A' ' 138' ' ' ARG . 66.4 m-20 -88.21 112.59 50.51 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.108 -0.995 . . . . 0.0 109.581 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -74.2 -12.53 23.31 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.969 1.51 . . . . 0.0 111.435 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.795 HG23 HG23 ' A' ' 134' ' ' THR . 0.1 OUTLIER -105.04 -45.16 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.959 -1.088 . . . . 0.0 110.798 -179.551 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.795 HG23 HG23 ' A' ' 133' ' ' ILE . 70.8 p -91.54 -16.73 26.73 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.154 -0.966 . . . . 0.0 110.332 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.84 -27.01 7.62 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 131' ' ' ASP . 4.6 mmp_? -65.62 -175.05 0.24 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.323 -1.104 . . . . 0.0 110.288 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.405 ' C ' ' OD2' ' A' ' 131' ' ' ASP . 1.3 m -90.59 129.88 36.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.4 -0.813 . . . . 0.0 110.161 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.594 ' HD2' ' CE2' ' A' ' 140' ' ' PHE . 4.2 ttt180 -88.7 -25.1 22.53 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.44 49.07 3.32 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.634 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.665 ' CD1' ' CZ ' ' A' ' 100' ' ' PHE . 2.6 p90 -159.98 116.94 2.53 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.45 -1.617 . . . . 0.0 111.496 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 127' ' ' THR . . . -121.91 -175.9 15.02 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.711 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 7.2 m-85 -120.04 171.73 8.25 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.02 -1.283 . . . . 0.0 110.987 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.662 HG23 HG13 ' A' ' 101' ' ' ILE . 6.4 t -140.76 129.42 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.569 HD22 ' CB ' ' A' ' 125' ' ' ASP . 6.3 mp -111.25 100.54 9.15 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.432 -0.792 . . . . 0.0 110.088 -178.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 1.009 ' CE2' HG21 ' A' ' 154' ' ' VAL . 8.1 m-85 -81.05 162.76 23.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.591 -0.693 . . . . 0.0 110.893 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.492 ' HG3' ' HB3' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -61.66 -48.86 78.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.523 -0.736 . . . . 0.0 110.073 179.225 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.551 ' O ' HG23 ' A' ' 151' ' ' VAL . 1.4 pm0 -144.51 171.55 14.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.267 -0.896 . . . . 0.0 110.667 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 149' ' ' GLU . 0.2 OUTLIER -55.67 -43.05 75.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.238 -0.914 . . . . 0.0 109.979 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.525 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 0.1 OUTLIER -42.1 -51.68 4.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 110.336 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.697 ' O ' HG23 ' A' ' 154' ' ' VAL . 2.2 p -66.32 -36.55 83.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.199 -0.938 . . . . 0.0 110.446 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.663 HG22 ' HB2' ' A' ' 145' ' ' PHE . 5.3 t -66.38 -56.65 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.074 -1.016 . . . . 0.0 110.446 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.525 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.7 OUTLIER -50.3 -38.78 43.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.141 -0.974 . . . . 0.0 109.666 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.486 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -57.33 -47.75 80.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.407 -0.808 . . . . 0.0 109.57 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 1.015 HG22 ' CD2' ' A' ' 120' ' ' PHE . 11.4 t -60.25 -31.98 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -0.876 . . . . 0.0 109.909 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 156' ' ' ASP . 6.4 mtt -75.5 -26.55 58.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.304 -0.872 . . . . 0.0 110.084 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.9 OUTLIER -46.71 -27.72 1.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.934 -1.104 . . . . 0.0 108.642 179.256 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.678 ' O ' ' CE1' ' A' ' 160' ' ' HIS . 5.0 mt-30 -143.4 114.11 7.6 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.706 -0.621 . . . . 0.0 109.357 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.08 20.39 14.58 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.27 -0.894 . . . . 0.0 110.187 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -88.39 57.39 4.22 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.678 ' CE1' ' O ' ' A' ' 157' ' ' GLN . 18.5 m80 -87.13 81.76 7.91 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.327 -176.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -78.35 70.23 4.67 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.179 -0.95 . . . . 0.0 109.263 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.948 HD13 ' CD1' ' A' ' 116' ' ' TYR . 15.9 tp -87.96 145.49 25.99 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.443 -0.785 . . . . 0.0 110.235 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 105' ' ' SER . 0.8 OUTLIER 58.09 22.62 9.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.349 -0.845 . . . . 0.0 109.661 -179.584 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 75.83 22.59 74.28 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.93 144.63 26.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -1.108 . . . . 0.0 110.319 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 160' ' ' HIS . 3.8 t -78.27 160.87 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 109.674 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.525 ' CG1' ' HB2' ' A' ' 160' ' ' HIS . 1.3 pt -123.58 -174.98 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.114 -0.991 . . . . 0.0 111.046 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.55 ' N ' ' O ' ' A' ' 102' ' ' GLY . 5.6 t70 -128.91 89.81 47.71 Favored Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 47.6 Cg_endo -74.71 125.52 9.54 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.399 1.736 . . . . 0.0 110.655 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -150.27 -164.02 1.92 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.453 -0.779 . . . . 0.0 110.215 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.39 -167.02 1.74 Allowed 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.179 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.517 0 O-C-N 121.315 -0.866 . . . . 0.0 110.691 -179.172 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.671 ' HE3' HD11 ' A' ' 144' ' ' LEU . 2.8 mtpp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.214 0.53 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.585 ' CE ' ' CD1' ' A' ' 101' ' ' ILE . 17.4 ttp -147.17 154.66 41.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.21 -0.931 . . . . 0.0 110.105 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.694 ' CE2' ' CZ ' ' A' ' 142' ' ' PHE . 2.3 t80 -110.15 135.4 51.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.359 -0.838 . . . . 0.0 109.994 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.585 ' CD1' ' CE ' ' A' ' 99' ' ' MET . 3.6 mm -112.87 97.66 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.28 -0.888 . . . . 0.0 109.48 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.545 ' HA2' ' CB ' ' A' ' 140' ' ' PHE . . . -89.36 109.32 3.58 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.508 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 134.06 36.86 0.24 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.867 HD12 HG21 ' A' ' 108' ' ' THR . 0.4 OUTLIER -83.68 149.22 26.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.335 -1.097 . . . . 0.0 109.442 179.507 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.678 ' O ' HD13 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -69.8 146.24 51.55 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.054 -1.029 . . . . 0.0 109.545 179.478 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.575 ' CE2' ' HB2' ' A' ' 137' ' ' SER . 0.8 OUTLIER -62.03 -11.2 12.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.271 -0.893 . . . . 0.0 110.115 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.61 16.22 13.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.251 -0.906 . . . . 0.0 110.595 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.867 HG21 HD12 ' A' ' 104' ' ' LEU . 11.0 m -70.27 174.43 5.6 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.122 -0.986 . . . . 0.0 110.408 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.51 ' H ' HG22 ' A' ' 108' ' ' THR . 31.2 p -148.39 154.32 39.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.384 -0.822 . . . . 0.0 109.575 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.511 ' O ' ' HB2' ' A' ' 114' ' ' LYS . 13.7 mtmt -57.97 -16.86 13.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.337 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.47 -62.02 1.77 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.192 -0.942 . . . . 0.0 111.172 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 6.6 p30 -57.94 -28.37 64.23 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.038 -1.039 . . . . 0.0 110.775 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.823 HD13 HD11 ' A' ' 104' ' ' LEU . 16.0 tp -78.86 -40.53 32.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.983 -1.073 . . . . 0.0 109.696 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 110' ' ' LYS . 3.9 ttpt -55.37 -59.26 5.05 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.123 -0.986 . . . . 0.0 109.711 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.514 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 63.3 m-20 -61.78 -40.83 96.54 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.2 -0.937 . . . . 0.0 109.213 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.558 ' CG ' HD23 ' A' ' 162' ' ' LEU . 69.8 t80 -47.35 -40.48 17.42 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.203 177.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.665 ' HE2' HD11 ' A' ' 113' ' ' LEU . 27.0 m-85 -91.6 -4.56 55.16 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.673 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.514 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 1.4 m -70.16 -6.36 33.69 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.783 -1.198 . . . . 0.0 109.221 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.415 ' HA ' ' HE3' ' A' ' 119' ' ' LYS . 0.5 OUTLIER -80.46 -18.66 48.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.367 -0.833 . . . . 0.0 110.23 -179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 1.04 ' CG ' HG22 ' A' ' 154' ' ' VAL . 70.1 m-85 -89.49 -68.35 0.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.675 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.499 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -147.43 -165.11 11.61 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.47 ' O ' ' CB ' ' A' ' 146' ' ' LYS . 0.6 OUTLIER -90.3 119.82 30.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.159 -1.201 . . . . 0.0 110.863 -179.706 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.701 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.9 t -91.96 132.34 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -0.856 . . . . 0.0 110.244 179.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.4 HG12 ' OD2' ' A' ' 125' ' ' ASP . 2.1 t -89.07 -26.88 5.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.701 ' O ' HG13 ' A' ' 123' ' ' VAL . 1.4 m-20 -145.63 167.25 23.53 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.226 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 42.3 t -165.74 150.35 8.47 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.636 -0.665 . . . . 0.0 109.363 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.519 ' CG2' ' N ' ' A' ' 128' ' ' LEU . 0.9 OUTLIER -149.95 174.08 13.1 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.368 -0.833 . . . . 0.0 109.862 -179.099 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.881 HD13 ' HG ' ' A' ' 130' ' ' LEU . 2.8 pp -149.7 165.43 32.41 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.426 -0.796 . . . . 0.0 110.068 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.668 ' N ' HD12 ' A' ' 128' ' ' LEU . 5.4 mmtt -140.96 71.58 1.37 Allowed 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.719 0.771 . . . . 0.0 109.042 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.881 ' HG ' HD13 ' A' ' 128' ' ' LEU . 0.9 OUTLIER -150.65 18.62 0.81 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -179.55 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.482 ' O ' ' OG ' ' A' ' 137' ' ' SER . 2.4 m-20 -39.14 99.3 0.19 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.559 -0.713 . . . . 0.0 111.045 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 130' ' ' LEU . 53.5 Cg_endo -79.23 -24.12 6.94 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.156 1.609 . . . . 0.0 110.574 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.896 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -89.8 -34.63 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.177 -0.952 . . . . 0.0 110.344 -179.579 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.418 ' N ' ' CG2' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -89.42 -0.59 57.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.201 -0.937 . . . . 0.0 109.854 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 64.53 19.78 65.08 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.2 27.64 8.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.32 -1.106 . . . . 0.0 110.271 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.617 ' HA ' ' CA ' ' A' ' 130' ' ' LEU . 0.9 OUTLIER -73.94 133.75 43.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.301 -0.874 . . . . 0.0 109.359 179.562 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.627 ' HB3' ' CE2' ' A' ' 140' ' ' PHE . 1.6 mtp180 -116.76 -0.44 12.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.8 -1.188 . . . . 0.0 110.816 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 91.41 6.38 66.28 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.899 -1.143 . . . . 0.0 111.535 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.627 ' CE2' ' HB3' ' A' ' 138' ' ' ARG . 42.2 p90 -149.76 -170.21 3.58 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.39 -1.653 . . . . 0.0 111.197 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.553 ' CA ' ' HA ' ' A' ' 128' ' ' LEU . . . -162.7 -164.64 18.16 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.694 ' CZ ' ' CE2' ' A' ' 100' ' ' PHE . 28.1 m-85 -140.37 167.19 22.74 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.893 -1.357 . . . . 0.0 111.27 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.675 ' O ' HD22 ' A' ' 144' ' ' LEU . 3.0 t -148.99 133.75 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.675 HD22 ' O ' ' A' ' 143' ' ' VAL . 3.2 mm? -116.12 94.33 4.61 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.665 -0.647 . . . . 0.0 109.569 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.946 ' CZ ' HG21 ' A' ' 154' ' ' VAL . 9.1 m-85 -73.0 161.18 30.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.418 -0.801 . . . . 0.0 110.992 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.47 ' CB ' ' O ' ' A' ' 122' ' ' GLU . 18.0 tptt -80.71 -39.4 27.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.594 -0.691 . . . . 0.0 111.182 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.609 ' O ' HG23 ' A' ' 151' ' ' VAL . 0.7 OUTLIER -133.66 158.48 43.13 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.853 -1.154 . . . . 0.0 110.851 -179.305 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 78.0 p -63.23 -27.7 69.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 109.964 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.519 ' CB ' ' OE2' ' A' ' 147' ' ' GLU . 0.3 OUTLIER -64.41 -43.47 94.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.371 -0.83 . . . . 0.0 109.761 179.721 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.499 ' CB ' ' HA3' ' A' ' 121' ' ' GLY . 11.5 p -64.46 -41.18 96.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.109 -0.994 . . . . 0.0 109.653 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.794 HG22 ' CB ' ' A' ' 145' ' ' PHE . 2.9 t -65.46 -45.44 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.635 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.449 ' OD2' ' O ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -54.23 -36.02 63.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.125 -0.984 . . . . 0.0 109.182 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.471 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 6.7 tttt -62.88 -43.58 98.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.469 -0.769 . . . . 0.0 109.379 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 1.04 HG22 ' CG ' ' A' ' 120' ' ' PHE . 20.5 t -64.7 -42.18 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.294 -0.879 . . . . 0.0 110.09 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 2.8 ttp -71.75 -21.71 61.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.331 -0.856 . . . . 0.0 109.944 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.0 OUTLIER -52.26 -31.49 32.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.14 -0.975 . . . . 0.0 109.423 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.526 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 0.4 OUTLIER -147.97 108.36 4.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.46 -0.775 . . . . 0.0 109.819 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.8 36.14 0.75 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.216 -0.928 . . . . 0.0 110.71 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -89.33 48.96 1.68 Allowed 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 176.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.837 ' CB ' HD11 ' A' ' 167' ' ' ILE . 20.2 m80 -87.68 93.75 9.53 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.267 -177.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -103.07 87.19 2.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 0.0 110.215 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.707 HD12 ' H ' ' A' ' 162' ' ' LEU . 0.4 OUTLIER -90.48 141.67 28.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.169 -0.957 . . . . 0.0 109.64 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 15.1 m120 50.42 23.78 1.37 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.138 -0.977 . . . . 0.0 110.215 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.72 37.25 26.98 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.96 136.24 18.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.165 -1.197 . . . . 0.0 110.272 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 160' ' ' HIS . 34.9 t -81.59 164.74 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.24 -0.913 . . . . 0.0 110.154 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.837 HD11 ' CB ' ' A' ' 160' ' ' HIS . 0.6 OUTLIER -128.68 174.17 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.186 -0.946 . . . . 0.0 110.709 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 102' ' ' GLY . 16.1 t0 -119.97 94.34 48.51 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.96 111.86 3.27 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.158 1.61 . . . . 0.0 110.83 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.536 ' O ' ' CG ' ' A' ' 99' ' ' MET . 2.1 mttt -125.72 152.87 44.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.572 -0.705 . . . . 0.0 109.652 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.54 159.64 15.82 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.987 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.465 0 O-C-N 121.323 -0.86 . . . . 0.0 110.781 -179.257 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.427 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 3.7 mtpp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.271 0.558 . . . . 0.0 110.294 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.988 ' CE ' HD11 ' A' ' 101' ' ' ILE . 4.0 ptm -141.41 170.11 16.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.334 -0.854 . . . . 0.0 109.98 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.881 ' O ' HD13 ' A' ' 101' ' ' ILE . 2.2 t80 -112.96 142.84 45.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.907 . . . . 0.0 110.489 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.988 HD11 ' CE ' ' A' ' 99' ' ' MET . 15.9 mm -131.22 99.14 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.306 -0.871 . . . . 0.0 109.548 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.566 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -99.83 132.85 11.08 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.809 -1.186 . . . . 0.0 110.557 -179.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.443 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 127.9 28.03 0.9 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.773 HD11 HD13 ' A' ' 113' ' ' LEU . 3.4 mm? -87.97 167.5 13.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.004 -1.292 . . . . 0.0 110.082 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.514 ' O ' HD22 ' A' ' 130' ' ' LEU . 3.1 p -88.43 144.48 26.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.857 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.506 ' O ' ' O ' ' A' ' 130' ' ' LEU . 15.7 m-90 -45.74 -21.38 0.11 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.153 -0.967 . . . . 0.0 110.422 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 105' ' ' SER . 4.6 t0 -112.29 44.57 1.41 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.842 -1.162 . . . . 0.0 110.103 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.702 HG21 HD12 ' A' ' 104' ' ' LEU . 87.6 m -90.67 167.74 12.29 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.145 -0.972 . . . . 0.0 110.713 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.532 ' N ' HG22 ' A' ' 108' ' ' THR . 64.1 p -146.42 152.09 38.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.379 -0.826 . . . . 0.0 109.862 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 114' ' ' LYS . 7.6 pttm -63.7 -11.95 30.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.125 -0.984 . . . . 0.0 109.482 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.59 -56.23 4.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.373 -0.83 . . . . 0.0 110.525 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.427 ' OD1' ' C ' ' A' ' 112' ' ' ASP . 0.6 OUTLIER -63.74 -36.76 84.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.118 -0.989 . . . . 0.0 109.938 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.773 HD13 HD11 ' A' ' 104' ' ' LEU . 3.6 tp -73.49 -45.16 55.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 109.746 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 5.8 ttpt -57.11 -38.88 74.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.296 -0.878 . . . . 0.0 109.555 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.501 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 83.8 m-20 -74.08 -49.77 22.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.239 -0.913 . . . . 0.0 109.736 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.422 ' C ' ' O ' ' A' ' 115' ' ' ASP . 65.2 t80 -47.75 -33.2 6.77 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 118.669 -1.212 . . . . 0.0 108.154 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.667 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 17.1 m-85 -91.03 -11.92 37.36 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.972 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.501 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 0.4 OUTLIER -64.34 -13.17 48.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.005 -1.059 . . . . 0.0 109.133 179.06 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -80.44 -13.2 59.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.432 -0.793 . . . . 0.0 109.839 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.995 ' CD2' HG22 ' A' ' 154' ' ' VAL . 64.1 m-85 -89.45 -64.27 1.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.298 -0.877 . . . . 0.0 109.48 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.434 ' HA3' ' HB3' ' A' ' 150' ' ' SER . . . -153.19 -170.36 19.33 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -85.27 119.87 26.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.182 -1.187 . . . . 0.0 110.24 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.614 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.9 t -93.92 130.08 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.144 -0.972 . . . . 0.0 111.048 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.405 ' O ' ' OD1' ' A' ' 125' ' ' ASP . 2.2 t -89.37 -26.02 5.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.614 ' O ' HG13 ' A' ' 123' ' ' VAL . 2.2 m-20 -143.98 161.61 38.3 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.24 -0.984 . . . . 0.0 111.704 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.591 ' SG ' HD23 ' A' ' 113' ' ' LEU . 45.1 t -166.27 120.76 1.15 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.635 -0.665 . . . . 0.0 109.302 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.412 ' CG2' ' N ' ' A' ' 128' ' ' LEU . 0.8 OUTLIER -114.52 167.99 10.25 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.384 -0.822 . . . . 0.0 110.294 -179.063 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.894 HD13 ' O ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -151.85 125.04 8.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 110.766 179.243 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 140' ' ' PHE . 0.2 OUTLIER -106.58 71.79 0.88 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.705 -1.247 . . . . 0.0 109.151 179.242 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.621 HD11 ' HB2' ' A' ' 104' ' ' LEU . 1.4 mp -146.71 7.67 0.97 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.779 -0.576 . . . . 0.0 110.218 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.409 ' O ' ' HB3' ' A' ' 137' ' ' SER . 7.7 m-20 -53.2 107.03 0.74 Allowed Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.03 -1.044 . . . . 0.0 110.669 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 130' ' ' LEU . 51.3 Cg_endo -79.95 -4.27 13.23 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.044 1.549 . . . . 0.0 110.53 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.553 ' CG2' ' N ' ' A' ' 134' ' ' THR . 0.0 OUTLIER -93.61 -43.63 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.145 -0.972 . . . . 0.0 110.323 -179.675 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.553 ' N ' ' CG2' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -90.01 24.66 2.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 110.046 -179.668 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 46.65 25.25 2.11 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -111.9 27.47 9.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.374 -1.074 . . . . 0.0 110.269 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.571 ' HA ' ' CA ' ' A' ' 130' ' ' LEU . 33.1 p -88.52 111.26 21.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 110.057 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.627 ' HB3' ' CE2' ' A' ' 140' ' ' PHE . 0.0 OUTLIER -99.33 -6.47 27.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.296 -179.707 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.433 ' H ' ' HG ' ' A' ' 130' ' ' LEU . . . 91.17 7.02 66.06 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 120.171 -1.014 . . . . 0.0 111.389 178.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.627 ' CE2' ' HB3' ' A' ' 138' ' ' ARG . 18.9 p90 -148.39 149.0 30.97 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.504 -1.586 . . . . 0.0 111.416 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.541 ' CA ' ' HA ' ' A' ' 128' ' ' LEU . . . -129.04 170.6 20.11 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.723 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 6.6 m-85 -114.31 173.05 6.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -1.149 . . . . 0.0 110.763 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.625 ' HB ' ' HE2' ' A' ' 99' ' ' MET . 13.8 t -146.18 137.51 19.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.558 HD12 ' C ' ' A' ' 143' ' ' VAL . 5.8 mp -123.12 101.18 7.25 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.416 -0.803 . . . . 0.0 109.727 -179.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 1.072 ' CZ ' HG21 ' A' ' 154' ' ' VAL . 18.7 m-85 -75.53 152.43 37.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.369 -0.832 . . . . 0.0 110.245 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.23 -25.59 55.22 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.426 -0.796 . . . . 0.0 111.087 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.668 ' O ' HG23 ' A' ' 151' ' ' VAL . 11.9 tt0 -133.04 147.36 52.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.677 -1.264 . . . . 0.0 110.765 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.447 ' N ' ' HG2' ' A' ' 147' ' ' GLU . 7.4 t -56.47 -45.87 80.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.086 -1.009 . . . . 0.0 109.442 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.555 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 14.1 tt0 -49.75 -60.99 2.38 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.498 -0.751 . . . . 0.0 109.993 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.471 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 0.2 OUTLIER -43.23 -39.72 3.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.19 -0.944 . . . . 0.0 109.716 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.894 HG22 ' HB2' ' A' ' 145' ' ' PHE . 5.3 t -66.2 -51.05 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.899 . . . . 0.0 110.262 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.555 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.3 OUTLIER -52.16 -27.18 13.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.133 -0.979 . . . . 0.0 109.924 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.459 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 5.8 mmtt -72.67 -49.42 31.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.459 -0.776 . . . . 0.0 110.317 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 1.072 HG21 ' CZ ' ' A' ' 145' ' ' PHE . 5.6 t -63.93 -18.7 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.097 -1.002 . . . . 0.0 110.339 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 12.7 mmt -85.53 -38.23 18.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.121 -0.987 . . . . 0.0 110.489 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.2 OUTLIER -48.67 -34.64 12.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.118 -0.989 . . . . 0.0 110.233 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.529 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.6 mt-30 -128.51 94.89 3.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.312 -0.867 . . . . 0.0 110.013 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.621 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -90.39 21.84 3.69 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.154 -0.966 . . . . 0.0 110.412 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.554 ' CG ' ' O ' ' A' ' 159' ' ' GLU . 2.1 tt0 -88.39 67.21 8.58 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 177.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.624 ' HB3' HD11 ' A' ' 167' ' ' ILE . 87.3 m-70 -86.41 176.5 7.84 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.266 -177.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 160' ' ' HIS . 0.3 OUTLIER 179.62 74.3 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.487 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.693 HD12 ' HB2' ' A' ' 163' ' ' ASN . 1.4 pp -110.95 153.99 24.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.405 -0.809 . . . . 0.0 110.326 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.693 ' HB2' HD12 ' A' ' 162' ' ' LEU . 0.3 OUTLIER 67.09 8.56 6.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.378 -0.826 . . . . 0.0 109.859 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' A' ' 165' ' ' LYS . . . 89.38 18.14 53.51 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 164' ' ' GLY . 37.5 mmtt -150.28 161.45 42.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.129 -1.218 . . . . 0.0 110.353 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.523 HG22 ' H ' ' A' ' 167' ' ' ILE . 4.2 p -87.14 177.36 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.355 -0.841 . . . . 0.0 110.232 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.625 HD13 HD23 ' A' ' 162' ' ' LEU . 0.6 OUTLIER -135.29 -168.05 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.216 -0.928 . . . . 0.0 110.943 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 102' ' ' GLY . 8.4 t70 -143.04 87.05 8.9 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 43.8 Cg_endo -71.88 131.69 18.73 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.314 1.691 . . . . 0.0 110.73 -178.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.82 166.25 27.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.443 -0.785 . . . . 0.0 110.26 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 172' ' ' ALA . 1.3 ttp180 -92.07 48.13 1.4 Allowed 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.264 -0.975 . . . . 0.0 109.869 178.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 171' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.47 -0.769 . . . . 0.0 110.449 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.503 ' HA ' ' HG ' ' A' ' 144' ' ' LEU . 70.0 mttt . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.143 0.496 . . . . 0.0 110.026 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.474 ' HE3' ' HB3' ' A' ' 99' ' ' MET . 10.2 mmm -142.19 177.42 8.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 110.763 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.741 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 3.6 t80 -132.85 142.51 48.99 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.544 -0.722 . . . . 0.0 110.203 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.65 HD13 ' O ' ' A' ' 100' ' ' PHE . 4.2 mm -125.57 98.86 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.293 -0.879 . . . . 0.0 109.792 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -98.82 130.07 10.1 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 134.15 3.53 3.13 Favored Glycine 0 N--CA 1.492 2.383 0 O-C-N 121.123 -1.222 . . . . 0.0 110.163 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.899 HD21 HD13 ' A' ' 113' ' ' LEU . 6.7 mp -64.86 166.16 9.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.073 -1.251 . . . . 0.0 110.186 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.6 p -90.72 -174.56 4.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.297 -0.877 . . . . 0.0 109.793 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.681 ' O ' HD13 ' A' ' 130' ' ' LEU . 46.4 m0 -87.48 16.82 5.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.0 109.968 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -144.56 16.61 1.65 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.309 -0.87 . . . . 0.0 110.454 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.811 HG23 ' OD1' ' A' ' 163' ' ' ASN . 11.3 m -73.43 168.16 19.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.939 -1.101 . . . . 0.0 109.78 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.467 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 29.8 p -144.6 152.04 39.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.134 -0.979 . . . . 0.0 110.604 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 114' ' ' LYS . 4.2 ttpt -53.51 -19.61 3.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.141 -0.974 . . . . 0.0 109.578 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.1 OUTLIER -72.12 -55.1 7.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.394 -0.817 . . . . 0.0 110.285 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 109' ' ' THR . 0.4 OUTLIER -65.71 -33.14 75.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.124 -0.985 . . . . 0.0 109.95 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.907 HD12 ' CD2' ' A' ' 162' ' ' LEU . 5.7 tp -73.85 -51.7 15.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 109.804 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 110' ' ' LYS . 1.1 ttpm? -60.0 -39.37 85.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 110.155 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 116' ' ' TYR . 0.5 OUTLIER -76.33 -54.38 6.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.081 -1.012 . . . . 0.0 110.572 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.719 ' CG ' HD13 ' A' ' 162' ' ' LEU . 65.4 t80 -46.39 -32.49 3.25 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.683 -1.207 . . . . 0.0 108.302 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.665 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 17.4 m-85 -91.23 -13.54 32.62 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.894 -0.723 . . . . 0.0 111.302 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 115' ' ' ASP . 5.7 t -64.11 -11.26 28.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.946 -1.096 . . . . 0.0 109.424 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 0.8 OUTLIER -83.83 -12.41 55.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.411 -0.805 . . . . 0.0 110.545 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.665 ' CD1' ' HA ' ' A' ' 117' ' ' PHE . 81.6 m-85 -89.03 -50.05 6.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.063 -1.023 . . . . 0.0 109.354 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.537 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -164.89 -164.73 20.88 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.408 ' O ' ' CB ' ' A' ' 146' ' ' LYS . 1.2 tt0 -90.12 107.67 19.27 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.388 -1.066 . . . . 0.0 110.086 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.8 t -89.46 132.34 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 111.19 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.433 HG12 ' OD1' ' A' ' 125' ' ' ASP . 2.4 t -90.15 -23.34 6.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.568 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 0.4 OUTLIER -143.51 158.98 43.23 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 118.525 -1.27 . . . . 0.0 112.848 -178.801 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.803 ' SG ' HD23 ' A' ' 113' ' ' LEU . 6.2 t -169.24 147.76 3.81 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.501 ' O ' HD22 ' A' ' 113' ' ' LEU . 0.8 OUTLIER -150.8 169.96 20.42 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.992 -1.067 . . . . 0.0 110.828 -178.92 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 1.103 HD22 ' N ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -144.4 135.29 25.05 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.662 -0.649 . . . . 0.0 109.473 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 1.103 ' N ' HD22 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -105.24 103.75 13.34 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.12 -0.987 . . . . 0.0 109.483 179.182 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.938 HD23 HD11 ' A' ' 128' ' ' LEU . 0.2 OUTLIER -143.8 19.25 1.82 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.51 0.671 . . . . 0.0 109.279 -179.708 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.432 ' CB ' ' HB2' ' A' ' 136' ' ' ARG . 1.2 m-20 -39.24 99.35 0.19 Allowed Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.276 -0.89 . . . . 0.0 110.809 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 130' ' ' LEU . 53.6 Cg_endo -83.56 -17.89 6.02 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.107 1.583 . . . . 0.0 110.51 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.559 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -93.34 -37.11 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.246 -0.909 . . . . 0.0 110.694 -179.406 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.448 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -91.7 -0.64 57.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.105 -0.997 . . . . 0.0 110.175 -179.838 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 67.61 41.73 89.25 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.448 ' HD3' ' HB ' ' A' ' 134' ' ' THR . 21.9 mtp85 -123.55 25.34 8.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -1.134 . . . . 0.0 110.079 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.567 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 60.4 p -89.2 83.2 6.48 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.499 -0.75 . . . . 0.0 109.935 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -88.53 15.61 7.74 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.069 -1.02 . . . . 0.0 109.332 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 60.34 67.32 2.2 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.589 ' CE1' ' HB3' ' A' ' 129' ' ' LYS . 13.9 p90 -170.44 134.41 1.13 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.082 -1.246 . . . . 0.0 110.484 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.614 ' H ' HD13 ' A' ' 104' ' ' LEU . . . -126.61 -165.8 12.05 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.741 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 10.7 m-85 -129.45 168.6 16.1 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.415 -1.05 . . . . 0.0 110.414 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.698 ' C ' HD12 ' A' ' 144' ' ' LEU . 3.5 t -145.66 144.95 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.418 -0.801 . . . . 0.0 109.378 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.698 HD12 ' C ' ' A' ' 143' ' ' VAL . 4.5 mp -134.09 98.31 4.1 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.565 -0.709 . . . . 0.0 109.828 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.703 ' HB2' HG22 ' A' ' 151' ' ' VAL . 38.2 m-85 -76.4 160.45 29.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.528 -0.732 . . . . 0.0 110.47 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.408 ' CB ' ' O ' ' A' ' 122' ' ' GLU . 4.6 tttm -104.0 -3.07 25.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.484 -0.76 . . . . 0.0 111.011 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.777 ' O ' HG23 ' A' ' 151' ' ' VAL . 1.1 tt0 -139.97 145.41 37.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.865 -1.147 . . . . 0.0 110.706 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.5 p -59.95 -36.5 77.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.99 -1.069 . . . . 0.0 109.296 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.51 ' CB ' ' OE1' ' A' ' 147' ' ' GLU . 0.4 OUTLIER -63.06 -53.99 45.07 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.425 -0.797 . . . . 0.0 109.792 179.398 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.537 ' CB ' ' HA3' ' A' ' 121' ' ' GLY . 60.9 p -48.59 -34.32 11.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.076 -1.015 . . . . 0.0 109.664 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 147' ' ' GLU . 3.4 t -78.55 -47.7 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.416 -0.803 . . . . 0.0 110.185 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -61.23 -22.28 64.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.968 -1.082 . . . . 0.0 109.336 179.775 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.474 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -76.19 -58.8 3.07 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.441 -0.787 . . . . 0.0 109.866 179.597 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.654 HG23 ' CE2' ' A' ' 120' ' ' PHE . 5.3 p -55.6 -20.9 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.048 -1.032 . . . . 0.0 109.979 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 2.6 ttp -88.06 -29.96 20.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.408 -0.808 . . . . 0.0 110.384 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.474 ' OD2' ' O ' ' A' ' 153' ' ' LYS . 0.2 OUTLIER -53.78 -36.46 62.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 109.705 179.964 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.584 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 0.7 OUTLIER -128.5 97.51 4.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.352 -0.843 . . . . 0.0 109.509 179.634 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -88.2 10.5 19.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.245 -0.91 . . . . 0.0 110.757 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.451 ' CG ' ' O ' ' A' ' 159' ' ' GLU . 3.2 pt-20 -87.38 68.51 9.76 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 11.6 m-70 -87.75 -167.38 1.86 Allowed 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.613 -177.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -176.44 73.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.512 -0.743 . . . . 0.0 109.818 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.907 ' CD2' HD12 ' A' ' 113' ' ' LEU . 10.1 tp -88.56 134.75 33.78 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.285 -0.885 . . . . 0.0 110.127 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.811 ' OD1' HG23 ' A' ' 108' ' ' THR . 2.3 m120 58.21 24.48 11.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.83 . . . . 0.0 109.961 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 75.9 33.29 51.17 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.75 134.23 16.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -1.184 . . . . 0.0 110.527 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 167' ' ' ILE . 75.5 t -65.37 162.22 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 109.742 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.513 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -126.41 177.56 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.104 -0.998 . . . . 0.0 110.79 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 102' ' ' GLY . 23.8 t0 -124.18 90.1 51.13 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.84 113.37 3.74 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.313 1.691 . . . . 0.0 111.339 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.461 ' HE2' ' OD2' ' A' ' 168' ' ' ASP . 24.6 mmtt -131.29 169.15 16.37 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.542 -0.724 . . . . 0.0 109.334 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 172' ' ' ALA . 5.8 mtp85 -92.41 47.27 1.3 Allowed 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.499 -1.28 . . . . 0.0 109.806 178.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 171' ' ' ARG . . . . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.406 -0.808 . . . . 0.0 110.22 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.481 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 12.8 mttt . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.207 0.527 . . . . 0.0 109.816 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.677 ' SD ' HD11 ' A' ' 101' ' ' ILE . 10.9 ptm -126.05 175.25 7.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.086 -1.009 . . . . 0.0 110.475 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.709 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 1.6 t80 -121.38 122.85 40.73 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.677 HD11 ' SD ' ' A' ' 99' ' ' MET . 3.7 mm -108.36 96.91 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 109.382 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -89.61 98.4 2.44 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 156.87 36.52 0.02 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.924 HD12 HG21 ' A' ' 108' ' ' THR . 3.5 mm? -90.45 155.67 18.76 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.181 -1.188 . . . . 0.0 110.007 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.485 ' N ' ' OG1' ' A' ' 108' ' ' THR . 0.0 OUTLIER -78.45 -171.98 2.69 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.205 -0.934 . . . . 0.0 109.754 179.543 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.415 ' N ' ' OG ' ' A' ' 105' ' ' SER . 7.1 m0 -84.0 -17.77 39.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.02 -1.05 . . . . 0.0 110.32 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -122.84 31.02 6.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.909 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.924 HG21 HD12 ' A' ' 104' ' ' LEU . 6.9 m -76.69 149.98 36.38 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.384 -0.822 . . . . 0.0 110.406 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.467 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 28.3 p -130.18 149.14 52.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.352 -0.843 . . . . 0.0 109.961 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.482 ' HG2' ' N ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -57.64 -17.78 16.58 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.127 -0.983 . . . . 0.0 109.16 179.256 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.482 ' N ' ' HG2' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -65.71 -58.61 5.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.502 -0.748 . . . . 0.0 109.978 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 109' ' ' THR . 1.7 p-10 -67.48 -42.49 82.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.105 -0.997 . . . . 0.0 110.097 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.552 HD13 HD11 ' A' ' 104' ' ' LEU . 26.2 tp -60.54 -48.46 81.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 109.703 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.625 ' HG3' HG11 ' A' ' 123' ' ' VAL . 27.6 ttpt -58.29 -31.97 67.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.313 -0.867 . . . . 0.0 109.748 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 118' ' ' SER . 86.8 m-20 -78.03 -54.31 6.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.274 -0.891 . . . . 0.0 110.199 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.454 ' C ' ' O ' ' A' ' 115' ' ' ASP . 62.7 t80 -47.18 -31.52 3.66 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 118.586 -1.246 . . . . 0.0 108.066 178.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.663 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 16.7 m-85 -90.35 -16.28 29.49 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.836 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 115' ' ' ASP . 22.4 t -61.45 -15.92 41.93 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.894 -1.129 . . . . 0.0 108.536 178.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.23 -18.01 61.28 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.533 0.682 . . . . 0.0 109.834 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 1.093 ' CE2' HG23 ' A' ' 154' ' ' VAL . 55.2 m-85 -89.48 -58.47 2.51 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.623 0.725 . . . . 0.0 109.414 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.32 -162.96 12.0 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -90.58 135.08 33.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.962 -1.316 . . . . 0.0 110.005 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.625 HG11 ' HG3' ' A' ' 114' ' ' LYS . 1.9 t -109.19 132.83 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.223 -0.923 . . . . 0.0 110.744 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.23 -26.24 5.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.49 ' O ' HG13 ' A' ' 123' ' ' VAL . 6.7 m-20 -148.76 162.94 38.76 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 118.715 -1.194 . . . . 0.0 112.413 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 11.6 t -164.94 143.42 6.53 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.523 ' CG2' ' N ' ' A' ' 128' ' ' LEU 0.25 1.0 OUTLIER -150.71 170.96 17.95 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 118.679 -1.209 . . . . 0.0 112.093 -177.318 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.618 ' HG ' HD21 ' A' ' 130' ' ' LEU . 8.5 tp -121.59 141.4 51.12 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.754 ' C ' HD13 ' A' ' 130' ' ' LEU . 9.5 mmtm -117.55 124.13 47.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.82 -1.175 . . . . 0.0 111.09 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.829 HD22 ' N ' ' A' ' 130' ' ' LEU . 0.5 OUTLIER -118.51 -161.31 0.83 Allowed 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.787 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.481 ' CG ' ' HG2' ' A' ' 138' ' ' ARG . 3.6 m-20 -90.44 110.22 39.38 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.292 -0.88 . . . . 0.0 110.499 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 130' ' ' LEU . 46.9 Cg_endo -73.95 -0.27 9.26 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.9 1.474 . . . . 0.0 110.118 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.718 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -114.4 -40.1 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 110.16 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.684 HG23 ' CG2' ' A' ' 133' ' ' ILE . 15.8 p -89.85 -12.21 39.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.931 . . . . 0.0 110.049 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 72.13 15.11 76.55 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.504 ' O ' ' HB3' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -117.96 -179.66 3.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.248 -1.148 . . . . 0.0 110.454 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.507 ' HA ' ' HB3' ' A' ' 130' ' ' LEU . 5.9 m -74.9 154.3 38.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.414 -0.804 . . . . 0.0 110.773 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.593 ' HB3' ' CD1' ' A' ' 140' ' ' PHE . 0.0 OUTLIER -115.54 -13.76 11.54 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.413 -0.804 . . . . 0.0 109.045 179.093 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 91.21 22.21 33.03 Favored Glycine 0 N--CA 1.486 2.012 0 C-N-CA 120.367 -0.92 . . . . 0.0 111.844 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.612 ' CZ ' ' HB3' ' A' ' 129' ' ' LYS . 18.7 p90 -155.56 153.63 30.47 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.109 -1.818 . . . . 0.0 110.68 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 128' ' ' LEU . . . -147.52 -164.11 11.02 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.709 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 14.6 m-85 -130.19 172.21 12.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.157 -1.201 . . . . 0.0 111.348 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.816 ' O ' HD12 ' A' ' 144' ' ' LEU . 3.9 t -146.47 145.58 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.816 HD12 ' O ' ' A' ' 143' ' ' VAL . 5.3 mp -130.59 106.03 8.23 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.984 -1.072 . . . . 0.0 109.898 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.752 ' HB2' HG22 ' A' ' 151' ' ' VAL . 15.9 m-85 -78.82 166.28 22.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.501 -0.75 . . . . 0.0 111.046 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -80.9 -31.97 34.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.696 -0.627 . . . . 0.0 110.408 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.561 ' O ' HG23 ' A' ' 151' ' ' VAL . 0.3 OUTLIER -143.09 152.03 41.4 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.108 -0.995 . . . . 0.0 110.64 -179.619 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.5 m -50.88 -41.0 57.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.915 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.546 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 2.8 tt0 -48.51 -62.92 1.25 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.326 -0.859 . . . . 0.0 110.159 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.479 ' OG ' ' HG3' ' A' ' 147' ' ' GLU . 4.4 p -48.14 -36.07 12.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.0 109.947 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.792 ' O ' HG12 ' A' ' 154' ' ' VAL . 4.6 t -68.56 -52.71 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.12 -0.988 . . . . 0.0 110.362 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.546 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -57.75 -35.1 70.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.974 -1.079 . . . . 0.0 109.783 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.47 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.1 OUTLIER -65.69 -33.82 76.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.368 -0.832 . . . . 0.0 110.162 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 1.093 HG23 ' CE2' ' A' ' 120' ' ' PHE . 5.9 p -87.86 -19.6 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.025 -1.047 . . . . 0.0 110.336 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 24.8 ttt -89.09 -25.76 21.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.946 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 4.5 p-10 -52.37 -32.24 37.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -0.903 . . . . 0.0 109.618 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.558 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -131.4 90.0 2.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.344 -0.848 . . . . 0.0 109.595 179.572 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.45 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -83.97 18.18 2.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.151 -0.968 . . . . 0.0 111.011 -179.482 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -87.68 64.3 7.95 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 177.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.715 ' ND1' HD11 ' A' ' 167' ' ' ILE . 14.1 m170 -87.05 -169.84 2.8 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.11 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 160' ' ' HIS . 5.9 ttpt 177.55 66.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.622 HD12 ' HB2' ' A' ' 163' ' ' ASN . 1.3 pp -101.67 157.85 16.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.844 . . . . 0.0 110.105 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.622 ' HB2' HD12 ' A' ' 162' ' ' LEU . 0.3 OUTLIER 59.5 15.33 4.43 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.163 -0.961 . . . . 0.0 109.461 -179.405 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.51 21.44 64.32 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.5 146.59 26.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -1.174 . . . . 0.0 110.715 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.574 HG12 ' N ' ' A' ' 167' ' ' ILE . 51.1 t -76.99 176.39 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.418 -0.801 . . . . 0.0 109.088 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.715 HD11 ' ND1' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -143.16 166.45 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.904 -1.122 . . . . 0.0 111.544 -179.458 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -115.55 82.88 10.35 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.517 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 45.1 Cg_endo -72.9 130.28 15.41 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.214 1.639 . . . . 0.0 111.155 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.1 -164.88 2.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.581 -0.699 . . . . 0.0 110.046 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.9 -173.09 3.57 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.06 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.459 ' HB3' ' HB2' ' A' ' 98' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.336 -0.852 . . . . 0.0 110.383 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.406 ' HA ' ' HG ' ' A' ' 144' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.226 0.536 . . . . 0.0 110.183 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.644 ' HE2' ' O ' ' A' ' 170' ' ' LYS . 6.4 mtp -143.11 173.89 11.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.148 -0.97 . . . . 0.0 110.432 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.7 ' O ' HD13 ' A' ' 101' ' ' ILE . 2.4 t80 -122.84 134.92 54.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.608 -0.683 . . . . 0.0 110.575 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.7 HD13 ' O ' ' A' ' 100' ' ' PHE . 15.1 mm -122.68 106.73 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.27 -0.894 . . . . 0.0 109.73 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -103.21 119.38 6.38 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.713 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 128.53 47.83 0.16 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 1.065 HD12 HG21 ' A' ' 108' ' ' THR . 2.3 mm? -90.56 167.67 12.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.118 -1.225 . . . . 0.0 110.354 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.887 ' C ' HD13 ' A' ' 130' ' ' LEU . 0.4 OUTLIER -90.16 138.9 31.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.272 -0.893 . . . . 0.0 110.19 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 1.054 ' HA ' HD22 ' A' ' 130' ' ' LEU . 5.9 m-90 -44.96 -22.77 0.1 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.881 -1.137 . . . . 0.0 110.718 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 105' ' ' SER . 6.7 t0 -114.86 38.53 3.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.106 -0.996 . . . . 0.0 111.134 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . 1.065 HG21 HD12 ' A' ' 104' ' ' LEU . 1.5 m -87.36 161.85 17.68 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.74 -1.225 . . . . 0.0 109.998 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 69.3 p -139.82 154.54 47.36 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.42 -0.8 . . . . 0.0 109.867 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 126' ' ' CYS . 4.9 mttp -58.85 -14.33 8.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.134 -0.979 . . . . 0.0 110.134 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.436 ' HE2' ' HE2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -81.04 -55.82 4.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.861 . . . . 0.0 110.702 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -63.38 -44.29 95.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.003 -1.061 . . . . 0.0 110.466 -179.491 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.805 ' CD1' HD11 ' A' ' 104' ' ' LEU . 0.6 OUTLIER -65.72 -46.89 77.22 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.895 -1.128 . . . . 0.0 109.586 179.681 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.454 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 7.2 ttpp -54.1 -40.78 67.59 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.146 -0.971 . . . . 0.0 109.82 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 116' ' ' TYR . 69.7 m-20 -75.38 -47.27 28.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 109.707 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.685 ' CD2' HD22 ' A' ' 162' ' ' LEU . 52.7 t80 -47.51 -34.65 7.79 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 118.841 -1.144 . . . . 0.0 108.089 178.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.546 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 11.5 m-85 -91.2 -13.78 32.23 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.116 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 115' ' ' ASP . 7.2 m -64.87 -12.67 51.32 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.76 -1.212 . . . . 0.0 108.431 178.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.42 -26.69 61.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.581 -0.699 . . . . 0.0 110.39 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.546 ' CD2' ' HA ' ' A' ' 117' ' ' PHE . 28.2 m-85 -88.67 -57.19 3.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.094 -1.004 . . . . 0.0 109.197 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.487 ' HA3' ' HB3' ' A' ' 150' ' ' SER . . . -159.52 167.52 35.16 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.31 156.52 22.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.138 -1.213 . . . . 0.0 109.913 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.628 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.7 t -125.27 129.91 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.179 -0.951 . . . . 0.0 110.922 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.904 HG23 ' HG2' ' A' ' 146' ' ' LYS . 2.2 t -89.64 -25.34 5.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.628 ' O ' HG13 ' A' ' 123' ' ' VAL . 2.7 m-20 -140.61 161.45 37.72 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.773 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.616 ' SG ' HD23 ' A' ' 113' ' ' LEU . 6.8 t -169.95 128.49 0.91 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.666 0.746 . . . . 0.0 109.708 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.428 ' OG1' ' HB2' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -125.88 146.74 49.7 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.605 -0.684 . . . . 0.0 110.875 -178.502 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.868 HD13 ' O ' ' A' ' 128' ' ' LEU . 1.0 OUTLIER -131.97 100.37 5.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 110.083 179.319 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 140' ' ' PHE . 0.1 OUTLIER -81.83 68.29 8.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.207 -0.933 . . . . 0.0 109.863 179.832 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 1.054 HD22 ' HA ' ' A' ' 106' ' ' TRP . 5.7 mt -152.31 35.03 0.51 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.671 -0.643 . . . . 0.0 109.74 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.464 ' HB3' ' OG1' ' A' ' 134' ' ' THR . 8.6 m-20 -49.42 114.03 3.69 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.32 -0.863 . . . . 0.0 110.727 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -82.42 -6.23 11.83 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.97 1.511 . . . . 0.0 110.715 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.949 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -109.65 -30.27 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.083 -1.011 . . . . 0.0 110.768 -179.514 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 131' ' ' ASP . 0.2 OUTLIER -89.27 -5.63 57.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.127 -0.983 . . . . 0.0 110.447 -179.504 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 69.17 6.76 54.99 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.72 39.59 1.36 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -1.144 . . . . 0.0 110.269 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.686 ' CB ' HD23 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -82.73 115.8 21.81 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.893 . . . . 0.0 110.179 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.562 ' HB3' ' CD1' ' A' ' 140' ' ' PHE . 1.4 mpt_? -89.74 -16.84 29.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.175 -0.953 . . . . 0.0 109.544 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.612 ' HA2' HD21 ' A' ' 130' ' ' LEU . . . 90.71 28.33 16.57 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.562 ' CD1' ' HB3' ' A' ' 138' ' ' ARG . 1.7 p90 -164.82 165.95 20.13 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.022 -1.281 . . . . 0.0 110.545 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -159.68 177.94 35.98 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.691 ' CZ ' ' CE2' ' A' ' 100' ' ' PHE . 19.4 m-85 -113.57 171.26 7.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.117 -1.225 . . . . 0.0 110.754 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.719 ' CG2' HD21 ' A' ' 113' ' ' LEU . 25.1 t -148.89 127.72 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.553 -0.717 . . . . 0.0 109.351 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.549 ' HB2' ' CB ' ' A' ' 125' ' ' ASP . 6.6 mp -115.96 103.95 11.11 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.546 -0.721 . . . . 0.0 110.214 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.824 ' HB2' HG22 ' A' ' 151' ' ' VAL . 46.0 m-85 -75.73 162.3 28.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.575 -0.703 . . . . 0.0 110.417 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.904 ' HG2' HG23 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -85.29 -23.61 28.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.535 -0.728 . . . . 0.0 111.117 -179.303 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.828 ' O ' HG23 ' A' ' 151' ' ' VAL . 0.6 OUTLIER -128.78 158.75 37.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.747 -1.221 . . . . 0.0 110.988 -179.568 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.3 p -71.88 -44.49 63.66 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.318 -0.864 . . . . 0.0 109.335 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.53 ' CB ' ' OE1' ' A' ' 147' ' ' GLU . 0.3 OUTLIER -55.87 -40.57 73.12 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.415 -0.803 . . . . 0.0 109.54 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.487 ' HB3' ' HA3' ' A' ' 121' ' ' GLY . 1.4 p -62.47 -34.19 76.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.153 -0.967 . . . . 0.0 109.356 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.828 HG23 ' O ' ' A' ' 147' ' ' GLU . 5.2 t -73.93 -52.89 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.213 -0.93 . . . . 0.0 110.216 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.506 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -51.49 -38.52 54.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.01 -1.056 . . . . 0.0 109.878 -179.781 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.479 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -65.04 -46.63 80.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.325 -0.859 . . . . 0.0 110.024 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.804 HG12 ' O ' ' A' ' 151' ' ' VAL . 1.4 p -66.12 -13.31 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.029 -1.044 . . . . 0.0 109.963 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.425 ' CE ' ' HA ' ' A' ' 170' ' ' LYS . 2.3 tpt -89.61 -52.94 4.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.348 -0.845 . . . . 0.0 110.748 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.5 OUTLIER -53.07 -31.25 40.64 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.071 -1.018 . . . . 0.0 110.017 -179.734 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.504 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.1 mm100 -112.65 78.37 1.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.299 -0.876 . . . . 0.0 109.686 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.613 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 10.6 pttp -86.86 25.65 1.26 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.27 -0.894 . . . . 0.0 111.014 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -88.2 67.08 8.7 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.613 ' CD2' ' HA ' ' A' ' 158' ' ' LYS . 84.1 m-70 -86.39 -179.99 6.77 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.727 -177.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.66 ' C ' HD23 ' A' ' 162' ' ' LEU . 23.0 ttpt -179.93 83.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.402 -0.811 . . . . 0.0 109.684 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.808 HD11 HD13 ' A' ' 167' ' ' ILE . 0.1 OUTLIER -101.96 146.17 28.24 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.175 -0.953 . . . . 0.0 109.707 -179.456 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.532 ' CB ' ' HB3' ' A' ' 105' ' ' SER . 6.4 m120 53.8 18.26 1.51 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.931 . . . . 0.0 109.996 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 83.23 28.83 35.45 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -145.71 143.53 29.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.132 -1.216 . . . . 0.0 110.427 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 167' ' ' ILE . 17.3 t -79.9 169.82 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.957 . . . . 0.0 110.303 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.808 HD13 HD11 ' A' ' 162' ' ' LEU . 0.7 OUTLIER -131.07 -178.66 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.208 -0.932 . . . . 0.0 110.702 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 102' ' ' GLY . 16.7 t70 -119.93 83.22 29.68 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.526 ' HG2' ' HB2' ' A' ' 158' ' ' LYS . 47.5 Cg_endo -72.62 114.24 3.96 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.353 1.712 . . . . 0.0 110.986 -178.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.644 ' O ' ' HE2' ' A' ' 99' ' ' MET . 2.4 mtmp? -136.03 173.36 11.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.512 -0.743 . . . . 0.0 109.246 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.527 ' HA ' ' HG2' ' A' ' 99' ' ' MET . 0.2 OUTLIER -92.29 -166.08 1.47 Allowed 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 118.689 -1.205 . . . . 0.0 109.876 178.596 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.649 0 O-C-N 121.473 -0.767 . . . . 0.0 110.564 -179.242 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.487 ' HA ' ' HG ' ' A' ' 144' ' ' LEU . 47.3 mttt . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.344 0.593 . . . . 0.0 110.506 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.494 ' HG3' HG13 ' A' ' 151' ' ' VAL . 0.0 OUTLIER -143.29 -174.9 4.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.892 . . . . 0.0 110.217 179.724 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.95 ' O ' HD13 ' A' ' 101' ' ' ILE . 10.5 t80 -143.08 148.5 36.77 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.304 -0.872 . . . . 0.0 110.526 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.95 HD13 ' O ' ' A' ' 100' ' ' PHE . 4.0 mm -125.04 108.58 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.504 -0.748 . . . . 0.0 110.14 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -103.25 118.27 6.01 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.416 ' C ' HD22 ' A' ' 104' ' ' LEU . . . 133.86 41.29 0.17 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.983 HD12 HG21 ' A' ' 108' ' ' THR . 4.0 mm? -90.26 155.03 19.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.337 -1.096 . . . . 0.0 109.916 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.49 ' N ' ' OG1' ' A' ' 108' ' ' THR . 24.1 p -72.08 -176.78 1.85 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.154 -0.966 . . . . 0.0 110.318 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 83.7 t90 -75.11 -27.08 59.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.174 -0.954 . . . . 0.0 110.326 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -113.72 37.16 3.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.215 -0.928 . . . . 0.0 110.22 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.983 HG21 HD12 ' A' ' 104' ' ' LEU . 1.5 m -77.55 149.03 34.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.13 -0.981 . . . . 0.0 110.271 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.481 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 44.0 p -130.5 159.63 36.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.292 -0.88 . . . . 0.0 110.455 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.486 ' HB2' ' HA ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -65.26 -14.72 61.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.18 -0.95 . . . . 0.0 109.911 179.702 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -82.54 -53.88 5.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 110.842 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.481 ' OD1' ' O ' ' A' ' 109' ' ' THR . 0.7 OUTLIER -61.77 -35.65 78.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.979 -1.076 . . . . 0.0 110.284 -179.553 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.705 HD13 HD11 ' A' ' 104' ' ' LEU . 23.6 tp -71.62 -56.46 5.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 109.931 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.421 ' HB2' ' CB ' ' A' ' 126' ' ' CYS . 1.9 tttt -51.39 -34.44 34.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.182 -0.949 . . . . 0.0 109.733 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.504 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 0.5 OUTLIER -73.93 -55.03 6.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 109.906 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.441 ' C ' ' O ' ' A' ' 115' ' ' ASP . 60.2 t80 -47.36 -31.19 3.76 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.531 -1.268 . . . . 0.0 108.118 178.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.624 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 12.8 m-85 -90.72 -10.43 43.06 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.166 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.504 ' HB3' ' HA ' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -65.09 -10.96 34.58 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.839 -1.163 . . . . 0.0 109.386 179.233 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -80.77 -16.65 53.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.477 -0.765 . . . . 0.0 109.991 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.892 ' CG ' HG22 ' A' ' 154' ' ' VAL . 75.7 m-85 -88.76 -62.66 1.44 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 109.399 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.511 ' HA3' ' HB3' ' A' ' 150' ' ' SER . . . -157.72 164.99 33.4 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 146' ' ' LYS . 19.4 mt-10 -62.15 119.58 9.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.017 -1.284 . . . . 0.0 110.176 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 125' ' ' ASP . 2.0 t -89.62 135.38 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 110.617 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.15 -23.73 6.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.517 ' HB2' ' HB2' ' A' ' 144' ' ' LEU . 6.5 m-20 -152.22 157.04 40.9 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 118.443 -1.303 . . . . 0.0 112.575 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.501 ' SG ' HD23 ' A' ' 113' ' ' LEU . 26.2 t -164.47 141.88 6.58 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.486 ' HA ' ' HB2' ' A' ' 110' ' ' LYS . 0.9 OUTLIER -151.22 166.19 31.64 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.582 -1.247 . . . . 0.0 112.348 -177.532 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.777 HD22 ' N ' ' A' ' 129' ' ' LYS . 0.4 OUTLIER -122.23 124.28 43.45 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.024 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.777 ' N ' HD22 ' A' ' 128' ' ' LEU . 0.4 OUTLIER -111.93 139.78 47.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.786 -1.196 . . . . 0.0 111.767 -178.433 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.9 HD23 ' HA ' ' A' ' 137' ' ' SER . 1.5 mp -109.51 -144.46 0.39 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.019 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.512 ' HB2' ' N ' ' A' ' 136' ' ' ARG . 31.0 m-20 -80.33 125.63 80.73 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.145 -0.972 . . . . 0.0 110.129 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.41 -16.83 19.12 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.916 1.482 . . . . 0.0 111.075 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.568 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -122.78 -35.79 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.081 -1.012 . . . . 0.0 110.372 -179.795 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.433 ' OG1' ' HB3' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -89.95 -26.81 20.2 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 110.169 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.05 -18.0 34.03 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.512 ' N ' ' HB2' ' A' ' 131' ' ' ASP . 12.4 ttp180 -72.85 149.98 43.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.222 -1.163 . . . . 0.0 110.276 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.9 ' HA ' HD23 ' A' ' 130' ' ' LEU . 32.7 m -43.64 145.55 0.63 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 110.352 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.563 ' HG2' ' CD1' ' A' ' 140' ' ' PHE . 4.4 ttt-85 -117.33 -23.88 7.63 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.24 36.24 7.17 Favored Glycine 0 N--CA 1.485 1.913 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.426 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.676 ' HA ' HD23 ' A' ' 104' ' ' LEU . 12.0 p90 -157.42 125.46 5.46 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.285 -1.715 . . . . 0.0 111.894 178.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.524 ' O ' ' CE1' ' A' ' 100' ' ' PHE . . . -121.0 -176.44 15.42 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.716 ' CE1' ' CE1' ' A' ' 100' ' ' PHE . 8.0 m-85 -122.68 166.18 15.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.879 -1.365 . . . . 0.0 110.94 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.639 ' C ' HD12 ' A' ' 144' ' ' LEU . 2.5 t -146.6 139.77 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.456 -0.777 . . . . 0.0 109.727 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.639 HD12 ' C ' ' A' ' 143' ' ' VAL . 5.9 mp -127.71 111.61 13.88 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.605 -0.685 . . . . 0.0 109.307 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 1.149 ' CZ ' HG21 ' A' ' 154' ' ' VAL . 38.6 m-85 -79.41 150.69 31.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.684 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 122' ' ' GLU . 18.0 tttm -75.25 -19.8 59.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.433 -0.792 . . . . 0.0 110.901 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.786 ' O ' HG23 ' A' ' 151' ' ' VAL . 3.5 tt0 -138.63 157.89 45.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.813 -1.18 . . . . 0.0 111.111 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 4.4 p -67.61 -41.76 83.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 109.439 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.542 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 0.0 OUTLIER -56.97 -55.53 33.49 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.29 -0.881 . . . . 0.0 109.41 179.417 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.688 ' O ' HG23 ' A' ' 154' ' ' VAL . 4.0 p -45.71 -44.29 13.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.075 -1.016 . . . . 0.0 109.277 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.818 HG22 ' HB2' ' A' ' 145' ' ' PHE . 16.9 t -58.43 -47.81 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.905 . . . . 0.0 109.83 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.542 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.3 OUTLIER -58.64 -35.52 72.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.085 -1.01 . . . . 0.0 109.476 179.618 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.469 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 9.4 mmtt -63.35 -28.5 70.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.473 -0.767 . . . . 0.0 109.591 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 1.149 HG21 ' CZ ' ' A' ' 145' ' ' PHE . 2.8 t -88.87 -34.19 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.362 -0.836 . . . . 0.0 109.897 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.408 ' O ' ' C ' ' A' ' 156' ' ' ASP . 1.1 ttp -73.2 -36.6 66.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.863 . . . . 0.0 110.511 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 31.5 p-10 -44.63 -29.27 0.72 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.083 -1.01 . . . . 0.0 110.254 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.518 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -136.9 98.78 3.85 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.165 -0.96 . . . . 0.0 110.393 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.442 ' HA ' ' HD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -86.63 10.14 16.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.0 -1.062 . . . . 0.0 109.891 179.518 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 27.5 mp0 -88.14 68.48 9.09 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 177.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.601 ' HB2' HG13 ' A' ' 167' ' ' ILE . 41.3 m-70 -86.09 -168.7 2.33 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.589 -177.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.455 ' O ' ' CG ' ' A' ' 161' ' ' LYS . 0.0 OUTLIER 177.9 73.11 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.36 -0.837 . . . . 0.0 110.021 179.802 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.767 HD12 ' HB2' ' A' ' 163' ' ' ASN . 2.4 pp -110.07 151.51 27.12 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.311 -0.868 . . . . 0.0 109.853 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.767 ' HB2' HD12 ' A' ' 162' ' ' LEU . 0.2 OUTLIER 63.13 18.09 10.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.149 -0.969 . . . . 0.0 109.861 -179.507 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 75.35 25.17 68.94 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -149.82 154.28 38.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -1.173 . . . . 0.0 110.66 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.466 HG12 ' N ' ' A' ' 167' ' ' ILE . 24.1 t -84.81 167.4 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.379 -0.825 . . . . 0.0 109.688 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.601 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.9 OUTLIER -133.68 175.52 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.137 -0.977 . . . . 0.0 111.15 -179.493 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 102' ' ' GLY . 31.6 t0 -120.08 89.81 43.38 Favored Pre-proline 0 C--N 1.303 -1.426 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.64 120.41 6.43 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.172 1.617 . . . . 0.0 110.891 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.463 ' O ' ' SD ' ' A' ' 99' ' ' MET . 0.1 OUTLIER -140.47 169.63 17.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.885 . . . . 0.0 109.908 179.461 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.47 ' HA ' ' HG2' ' A' ' 99' ' ' MET . 19.4 ptp180 -91.75 -176.17 4.38 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.542 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.36 -0.837 . . . . 0.0 110.446 -179.589 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.523 ' CG ' ' HG ' ' A' ' 144' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.302 0.572 . . . . 0.0 110.239 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.547 ' CE ' HD11 ' A' ' 101' ' ' ILE . 12.6 ptm -147.58 175.2 11.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.189 -0.944 . . . . 0.0 110.411 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.767 ' C ' HD13 ' A' ' 101' ' ' ILE . 2.5 t80 -119.73 130.87 55.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.465 -0.772 . . . . 0.0 109.252 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.767 HD13 ' C ' ' A' ' 100' ' ' PHE . 3.7 mm -117.05 105.04 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.245 -0.91 . . . . 0.0 109.715 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.536 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -97.34 139.22 14.36 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.737 -1.221 . . . . 0.0 110.12 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.51 33.9 2.38 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 1.078 HD12 HG21 ' A' ' 108' ' ' THR . 1.8 mm? -84.68 148.72 26.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.106 -1.232 . . . . 0.0 110.004 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.447 ' O ' ' OG1' ' A' ' 108' ' ' THR . 0.0 OUTLIER -76.52 147.5 37.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.158 -0.963 . . . . 0.0 110.799 -179.529 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -52.07 -17.19 0.96 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.304 -0.873 . . . . 0.0 110.99 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.86 35.55 4.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.904 -1.122 . . . . 0.0 111.163 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 1.078 HG21 HD12 ' A' ' 104' ' ' LEU . 1.5 m -88.35 171.29 10.26 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.986 -1.071 . . . . 0.0 110.057 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.478 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 73.0 p -149.12 170.56 18.13 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.178 -0.951 . . . . 0.0 110.242 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.532 ' O ' ' CB ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -70.5 -11.2 60.77 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.138 -0.977 . . . . 0.0 109.922 179.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -87.44 -58.68 2.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 110.539 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 5.4 p30 -60.56 -32.39 71.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.12 -0.988 . . . . 0.0 110.167 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 1.053 HD13 HD11 ' A' ' 104' ' ' LEU . 9.2 tp -79.96 -42.84 23.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.095 -1.003 . . . . 0.0 109.577 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 4.3 ttmt -63.21 -46.47 86.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.869 . . . . 0.0 109.346 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.413 ' O ' ' C ' ' A' ' 116' ' ' TYR . 1.5 t70 -66.05 -49.17 68.59 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.139 -0.976 . . . . 0.0 109.35 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.413 ' C ' ' O ' ' A' ' 115' ' ' ASP . 67.8 t80 -48.31 -35.4 12.23 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.765 -1.174 . . . . 0.0 108.065 177.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.611 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 11.7 m-85 -90.73 -3.58 57.35 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.25 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.8 t -71.66 -9.5 58.36 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.075 -1.016 . . . . 0.0 109.294 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.66 -15.81 53.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.377 -0.827 . . . . 0.0 110.034 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.839 ' CE2' HG23 ' A' ' 154' ' ' VAL . 70.2 m-85 -89.52 -40.9 12.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.326 -0.859 . . . . 0.0 109.44 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -177.49 -156.2 15.64 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.53 157.77 17.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.138 -1.213 . . . . 0.0 110.195 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 1.9 t -134.75 131.23 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.212 -0.93 . . . . 0.0 111.167 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -94.99 -24.65 4.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -146.42 159.06 43.88 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.999 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.751 ' SG ' HD23 ' A' ' 113' ' ' LEU . 40.5 t -170.47 105.56 0.29 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.848 0.832 . . . . 0.0 109.347 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.68 166.15 11.63 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.474 0.654 . . . . 0.0 110.979 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.919 HD13 ' O ' ' A' ' 128' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.413 -0.805 . . . . 0.0 110.268 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.536 ' HB2' ' HA2' ' A' ' 102' ' ' GLY . 46.3 p90 . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 121.526 0.679 . . . . 0.0 111.093 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.511 ' HA3' ' HA ' ' A' ' 128' ' ' LEU . . . -136.82 -170.65 11.99 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.712 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 13.9 m-85 -128.65 160.71 31.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.069 -1.254 . . . . 0.0 110.492 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.6 ' O ' HD12 ' A' ' 144' ' ' LEU . 4.1 t -134.22 140.4 46.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.371 -0.831 . . . . 0.0 108.944 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.6 HD12 ' O ' ' A' ' 143' ' ' VAL . 3.1 mp -132.07 98.81 4.53 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.161 -0.962 . . . . 0.0 109.704 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.948 ' HB2' HG22 ' A' ' 151' ' ' VAL . 39.4 m-85 -71.04 170.23 13.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.434 -0.791 . . . . 0.0 110.635 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 18.2 tttt -96.18 -18.93 19.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.369 -0.832 . . . . 0.0 110.994 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.865 ' O ' HG23 ' A' ' 151' ' ' VAL . 2.4 tm-20 -131.39 162.33 30.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.862 -1.149 . . . . 0.0 110.686 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 34.5 p -74.69 -47.44 31.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.913 . . . . 0.0 109.547 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.535 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 0.5 OUTLIER -54.41 -35.08 62.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.369 -0.832 . . . . 0.0 109.752 179.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.485 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 3.1 p -68.76 -40.93 79.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 109.889 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.948 HG22 ' HB2' ' A' ' 145' ' ' PHE . 5.6 t -66.67 -53.14 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 110.286 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.535 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -51.89 -37.78 53.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 0.0 109.955 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.46 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -59.23 -62.07 2.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.334 -0.854 . . . . 0.0 110.082 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.839 HG23 ' CE2' ' A' ' 120' ' ' PHE . 3.3 p -55.36 -20.5 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.198 -0.939 . . . . 0.0 110.141 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.82 -13.19 37.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.364 -0.835 . . . . 0.0 109.686 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.8 OUTLIER -61.12 -33.5 73.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.226 -0.921 . . . . 0.0 109.614 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.516 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.0 tt0 -142.3 104.46 4.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.287 -0.883 . . . . 0.0 110.065 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.5 pttm -81.8 20.26 0.98 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.229 -0.919 . . . . 0.0 111.037 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -87.58 62.9 7.32 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.77 ' HE1' HG22 ' A' ' 154' ' ' VAL . 14.2 m170 -86.76 -169.34 2.59 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.309 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 160' ' ' HIS . 33.3 ttpt 179.86 74.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.35 -0.844 . . . . 0.0 110.317 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.851 HD12 ' HB2' ' A' ' 163' ' ' ASN . 3.8 pp -103.69 157.56 16.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 0.0 109.989 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.851 ' HB2' HD12 ' A' ' 162' ' ' LEU . 1.5 m-80 58.38 15.19 3.32 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.183 -0.948 . . . . 0.0 110.228 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.98 20.15 61.63 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp -150.82 146.89 26.66 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.303 -1.116 . . . . 0.0 110.152 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 160' ' ' HIS . 1.4 p -69.36 -174.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.052 -1.03 . . . . 0.0 110.163 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.638 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -150.61 178.24 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.163 -0.96 . . . . 0.0 110.352 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -126.01 93.2 44.32 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.54 -0.725 . . . . 0.0 109.386 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 48.2 Cg_endo -77.58 135.85 14.97 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.245 1.655 . . . . 0.0 110.643 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 99' ' ' MET . 0.0 OUTLIER -146.76 -177.92 5.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.319 -0.863 . . . . 0.0 110.268 179.607 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 . . . . . 0 C--N 1.303 -1.454 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.953 179.047 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.528 ' HG2' ' CD1' ' A' ' 144' ' ' LEU . 14.7 mtmt . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.001 0.429 . . . . 0.0 110.09 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.535 ' HE2' HD11 ' A' ' 101' ' ' ILE . 7.9 ptm -133.39 172.31 12.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.118 -0.989 . . . . 0.0 110.562 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.766 ' C ' HD13 ' A' ' 101' ' ' ILE . 2.1 t80 -120.99 130.07 53.66 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.608 -0.682 . . . . 0.0 110.041 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.766 HD13 ' C ' ' A' ' 100' ' ' PHE . 3.8 mm -112.66 95.27 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.294 -0.879 . . . . 0.0 109.469 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.532 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -89.75 127.01 8.53 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 127.48 34.01 0.59 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 1.064 HD12 HG21 ' A' ' 108' ' ' THR . 2.3 mm? -89.38 152.95 21.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.048 -1.266 . . . . 0.0 110.186 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.466 ' O ' ' OG1' ' A' ' 108' ' ' THR . 0.0 OUTLIER -90.49 152.67 20.84 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.291 -0.88 . . . . 0.0 111.234 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.46 -22.69 3.25 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.445 -0.785 . . . . 0.0 110.765 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -107.04 28.82 7.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.028 -1.045 . . . . 0.0 111.765 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 1.064 HG21 HD12 ' A' ' 104' ' ' LEU . 0.8 OUTLIER -90.44 170.8 9.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.752 -1.218 . . . . 0.0 109.798 179.17 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.467 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 28.7 p -145.94 159.16 43.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.227 -0.921 . . . . 0.0 110.155 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.487 ' CE ' ' O ' ' A' ' 126' ' ' CYS . 0.7 OUTLIER -62.91 -12.76 27.36 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.171 -0.955 . . . . 0.0 109.639 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.49 -59.31 2.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.367 -0.833 . . . . 0.0 110.377 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -52.61 -41.93 64.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.056 -1.028 . . . . 0.0 109.909 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.8 HD13 HD11 ' A' ' 104' ' ' LEU . 10.6 tp -70.3 -48.82 54.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.911 . . . . 0.0 109.577 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -52.1 -48.01 64.97 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.428 -0.795 . . . . 0.0 109.772 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.544 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 54.7 m-20 -67.41 -50.74 58.18 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.16 -0.962 . . . . 0.0 110.296 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.412 ' C ' ' O ' ' A' ' 115' ' ' ASP . 73.0 t80 -47.78 -34.01 7.96 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 118.532 -1.267 . . . . 0.0 108.528 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.577 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 15.3 m-85 -91.14 -7.24 52.09 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.869 -0.732 . . . . 0.0 111.351 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.544 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 1.9 t -71.02 -7.35 45.76 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.956 -1.09 . . . . 0.0 109.225 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -82.88 -14.42 54.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 0.0 110.285 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.577 ' CD2' ' HA ' ' A' ' 117' ' ' PHE . 89.1 m-85 -88.8 -56.02 3.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.073 -1.017 . . . . 0.0 109.275 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.47 ' HA3' ' HB3' ' A' ' 150' ' ' SER . . . -162.02 -162.27 13.02 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -83.06 151.03 25.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -1.192 . . . . 0.0 110.061 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.9 t -128.8 130.03 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.357 -0.839 . . . . 0.0 110.484 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.01 -24.68 5.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.538 ' O ' HG13 ' A' ' 123' ' ' VAL . 4.2 m-20 -151.06 171.27 17.59 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 118.526 -1.27 . . . . 0.0 112.364 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.608 ' SG ' HD23 ' A' ' 113' ' ' LEU . 9.6 t -170.38 155.59 5.24 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.66 151.74 32.93 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.876 -1.14 . . . . 0.0 110.937 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.928 HD13 ' O ' ' A' ' 128' ' ' LEU . 1.6 tm? . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.531 -0.73 . . . . 0.0 109.703 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.576 ' CD1' ' CZ ' ' A' ' 100' ' ' PHE . 35.5 p90 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.287 0.565 . . . . 0.0 110.786 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -150.4 -171.05 18.32 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.698 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 19.7 m-85 -131.38 171.36 13.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.153 -1.204 . . . . 0.0 110.719 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.58 ' O ' HD22 ' A' ' 144' ' ' LEU . 32.0 t -147.46 129.06 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.58 HD22 ' O ' ' A' ' 143' ' ' VAL . 3.8 mm? -114.53 101.6 9.27 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.584 -0.697 . . . . 0.0 109.821 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.754 ' HB2' HG22 ' A' ' 151' ' ' VAL . 8.2 m-85 -78.36 170.15 17.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 110.78 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.444 ' HE2' ' O ' ' A' ' 146' ' ' LYS . 0.1 OUTLIER -89.87 -26.61 20.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.614 -0.679 . . . . 0.0 110.562 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.493 ' OE2' ' CB ' ' A' ' 149' ' ' GLU . 1.0 OUTLIER -143.08 161.76 37.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.785 -1.197 . . . . 0.0 111.181 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 18.7 m -64.37 -31.7 73.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.441 -0.787 . . . . 0.0 110.091 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.493 ' CB ' ' OE2' ' A' ' 147' ' ' GLU . 0.1 OUTLIER -60.29 -38.67 84.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 0.0 110.012 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 22.4 p -71.27 -36.76 71.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.458 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.754 HG22 ' HB2' ' A' ' 145' ' ' PHE . 3.5 t -76.12 -45.42 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.987 -1.071 . . . . 0.0 110.805 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 153' ' ' LYS . 0.2 OUTLIER -61.58 -33.89 74.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.143 -0.973 . . . . 0.0 110.126 -179.555 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 152' ' ' ASP . 6.6 tttt -70.37 -42.2 72.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -0.918 . . . . 0.0 110.041 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 151' ' ' VAL . 7.4 p -72.67 -27.35 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.145 -0.972 . . . . 0.0 110.458 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.405 ' O ' ' C ' ' A' ' 156' ' ' ASP . 0.2 OUTLIER -80.39 -34.87 36.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.939 . . . . 0.0 110.288 -179.751 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.489 ' OD1' ' HG2' ' A' ' 157' ' ' GLN . 0.0 OUTLIER -45.37 -42.6 10.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 109.342 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.561 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -118.76 87.25 2.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.397 -0.814 . . . . 0.0 109.65 179.335 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.497 ' HB2' ' CG ' ' A' ' 169' ' ' PRO . 3.4 pttt -85.94 17.45 3.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.892 . . . . 0.0 110.542 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -87.52 63.85 7.83 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.561 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 11.7 m170 -86.56 -167.59 1.93 Allowed 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.726 -177.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt 179.2 67.99 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.496 -0.753 . . . . 0.0 109.601 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.801 HD12 ' HB2' ' A' ' 163' ' ' ASN . 2.6 pp -99.8 148.42 24.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.346 -0.847 . . . . 0.0 110.076 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.801 ' HB2' HD12 ' A' ' 162' ' ' LEU . 0.4 OUTLIER 64.18 20.77 12.32 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.184 -0.948 . . . . 0.0 109.517 -179.401 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.9 26.05 70.08 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.37 147.35 27.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.273 -1.134 . . . . 0.0 110.726 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 167' ' ' ILE . 4.8 t -80.31 173.12 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.347 -0.846 . . . . 0.0 109.252 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.503 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -141.66 163.56 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.087 -1.008 . . . . 0.0 110.9 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -112.26 96.77 36.69 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.611 -0.681 . . . . 0.0 109.235 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.497 ' CG ' ' HB2' ' A' ' 158' ' ' LYS . 49.2 Cg_endo -76.65 119.47 5.19 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.205 1.634 . . . . 0.0 110.524 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -136.42 -163.5 1.42 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 110.293 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.299 -1.608 0 C-N-CA 119.811 -0.755 . . . . 0.0 110.48 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.478 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 4.5 mttp . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.185 0.517 . . . . 0.0 109.996 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.666 ' HE2' HD11 ' A' ' 101' ' ' ILE . 0.6 OUTLIER -139.88 179.72 6.44 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.229 -0.919 . . . . 0.0 110.107 179.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.727 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 2.5 t80 -125.26 128.93 49.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.361 -0.837 . . . . 0.0 110.807 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.666 HD11 ' HE2' ' A' ' 99' ' ' MET . 4.7 mm -107.37 96.19 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.494 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -89.92 145.71 18.38 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.243 -178.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.512 ' O ' ' HD2' ' A' ' 165' ' ' LYS . . . 96.99 17.68 31.68 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.758 ' CD1' HG21 ' A' ' 108' ' ' THR . 1.4 mm? -54.73 166.47 0.47 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.636 -1.508 . . . . 0.0 109.737 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.423 ' N ' ' OG1' ' A' ' 108' ' ' THR . 0.3 OUTLIER -90.89 140.72 29.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.132 -0.98 . . . . 0.0 110.114 179.511 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 20.6 m0 -49.75 -19.87 0.72 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.154 -0.966 . . . . 0.0 110.472 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -113.57 26.38 10.44 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.126 -0.984 . . . . 0.0 111.18 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.758 HG21 ' CD1' ' A' ' 104' ' ' LEU . 0.8 OUTLIER -89.09 166.13 14.06 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.983 -1.073 . . . . 0.0 109.952 179.568 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.471 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 31.7 p -145.42 -176.8 5.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.191 -0.943 . . . . 0.0 110.399 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.463 ' O ' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -84.57 -14.86 47.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 109.595 179.663 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.44 -44.86 15.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.871 . . . . 0.0 109.857 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 32.5 p-10 -77.35 -38.29 50.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.842 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.73 HD13 HD11 ' A' ' 104' ' ' LEU . 19.7 tp -69.84 -42.69 73.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.099 -1.001 . . . . 0.0 109.351 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -59.85 -50.72 72.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 0.0 109.234 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' A' ' 118' ' ' SER . 17.1 t70 -64.04 -46.66 83.41 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.195 -0.941 . . . . 0.0 109.346 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.688 ' CD2' HD21 ' A' ' 162' ' ' LEU . 68.4 t80 -48.0 -36.35 12.58 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.622 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 15.1 m-85 -91.75 -3.46 56.18 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.843 -0.536 . . . . 0.0 111.489 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 12.4 t -70.63 -5.73 31.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.905 -1.122 . . . . 0.0 109.55 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.01 -13.29 44.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.378 -0.826 . . . . 0.0 110.039 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.831 ' CE2' HG23 ' A' ' 154' ' ' VAL . 79.8 m-85 -89.57 -45.36 9.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.366 -0.834 . . . . 0.0 109.84 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -176.16 -172.98 41.41 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.53 ' O ' ' CB ' ' A' ' 146' ' ' LYS . 19.1 mm-40 -81.3 115.43 20.67 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.142 -1.211 . . . . 0.0 110.199 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 125' ' ' ASP . 2.0 t -91.14 133.84 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.269 -0.894 . . . . 0.0 111.018 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.91 -25.65 5.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.538 ' O ' HG13 ' A' ' 123' ' ' VAL . 4.0 m-20 -148.26 160.93 42.46 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.034 -1.067 . . . . 0.0 111.837 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 5.7 t -170.11 149.94 3.64 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.7 164.78 35.3 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.042 -1.036 . . . . 0.0 111.098 -178.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.756 ' C ' HD22 ' A' ' 128' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.504 ' HA ' ' HB2' ' A' ' 104' ' ' LEU . 21.7 p90 . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 121.64 0.734 . . . . 0.0 111.526 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.698 ' H ' HD23 ' A' ' 104' ' ' LEU . . . -121.38 -174.55 14.85 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.727 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 15.2 m-85 -129.43 165.85 20.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.15 -1.206 . . . . 0.0 110.776 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.592 ' C ' HD12 ' A' ' 144' ' ' LEU . 3.8 t -139.41 133.34 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.454 -0.779 . . . . 0.0 109.214 178.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.592 HD12 ' C ' ' A' ' 143' ' ' VAL . 5.4 mp -123.96 92.77 3.75 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.61 -0.682 . . . . 0.0 109.312 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 1.044 ' HB2' HG22 ' A' ' 151' ' ' VAL . 17.7 m-85 -69.18 164.4 22.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.416 -0.802 . . . . 0.0 110.784 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.53 ' CB ' ' O ' ' A' ' 122' ' ' GLU . 10.8 tttp -93.4 -22.03 19.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.473 -0.767 . . . . 0.0 110.615 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.864 ' O ' HG23 ' A' ' 151' ' ' VAL . 14.8 tt0 -126.7 144.24 50.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.765 -1.209 . . . . 0.0 110.462 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 51.1 m -61.84 -35.51 78.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.966 . . . . 0.0 109.634 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.532 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 0.1 OUTLIER -63.2 -47.64 81.71 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.318 -0.864 . . . . 0.0 109.843 179.603 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 2.3 p -57.84 -37.38 73.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.326 -0.859 . . . . 0.0 109.881 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 1.044 HG22 ' HB2' ' A' ' 145' ' ' PHE . 2.8 t -66.23 -57.95 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.118 -0.989 . . . . 0.0 110.027 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.532 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -52.26 -29.83 24.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.094 -1.003 . . . . 0.0 110.012 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.471 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 6.7 mttt -68.68 -38.6 80.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.29 -0.881 . . . . 0.0 110.19 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.961 HG12 ' O ' ' A' ' 151' ' ' VAL . 9.9 p -77.16 -17.71 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.209 -0.932 . . . . 0.0 110.046 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.764 ' SD ' HG12 ' A' ' 151' ' ' VAL . 0.0 OUTLIER -90.21 -39.62 12.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 110.537 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 1.0 OUTLIER -52.87 -34.75 56.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.971 -1.081 . . . . 0.0 109.795 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.505 ' O ' ' NE2' ' A' ' 160' ' ' HIS . 4.2 mt-30 -117.69 88.47 2.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.486 -0.759 . . . . 0.0 109.747 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.52 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 6.8 pttt -86.62 26.09 1.15 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 110.946 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.08 62.06 6.61 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.656 ' HE1' HG22 ' A' ' 154' ' ' VAL . 11.6 m170 -87.2 154.88 20.38 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.61 -177.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 165' ' ' LYS . 41.4 mttm -150.8 85.45 1.36 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.351 -0.843 . . . . 0.0 109.783 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.793 ' H ' HD12 ' A' ' 162' ' ' LEU . 1.0 OUTLIER -99.77 138.01 37.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.354 -0.841 . . . . 0.0 109.714 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.682 ' OD1' HG23 ' A' ' 108' ' ' THR . 10.8 m120 59.37 19.44 7.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.259 -0.901 . . . . 0.0 110.318 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.29 32.11 29.32 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.533 ' CE ' ' O ' ' A' ' 166' ' ' VAL . 0.9 OUTLIER -150.18 149.97 30.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.186 -1.184 . . . . 0.0 110.208 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 160' ' ' HIS . 26.4 t -90.01 159.52 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.078 -1.014 . . . . 0.0 110.383 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.572 HG13 ' HB2' ' A' ' 160' ' ' HIS . 1.3 pt -120.46 -176.57 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 122.071 0.939 . . . . 0.0 111.219 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -123.41 81.6 53.18 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -74.21 131.08 14.84 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.305 1.687 . . . . 0.0 110.877 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.407 ' O ' ' CB ' ' A' ' 99' ' ' MET . 2.1 mmtm -147.25 -166.9 2.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.458 -0.776 . . . . 0.0 110.3 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 . . . . . 0 C--N 1.301 -1.54 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.1 179.502 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.512 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.289 0.566 . . . . 0.0 110.331 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.885 ' CE ' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -136.47 166.45 23.47 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.445 -0.784 . . . . 0.0 109.178 179.385 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.846 ' O ' HD13 ' A' ' 101' ' ' ILE . 15.6 t80 -112.2 148.52 33.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.963 -1.085 . . . . 0.0 110.623 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.885 HD11 ' CE ' ' A' ' 99' ' ' MET . 8.8 mm -123.09 108.33 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.643 -0.661 . . . . 0.0 110.095 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.54 ' HA2' ' CB ' ' A' ' 140' ' ' PHE . . . -101.85 128.68 9.64 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.61 38.03 0.64 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.9 ' CD2' HD23 ' A' ' 128' ' ' LEU . 1.1 mp -90.06 153.77 20.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.14 -1.212 . . . . 0.0 110.234 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.459 ' O ' ' OG1' ' A' ' 108' ' ' THR . 3.1 m -82.4 154.35 25.24 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.256 -0.902 . . . . 0.0 110.411 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 12.1 m-90 -57.54 -14.17 4.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.118 -0.989 . . . . 0.0 110.369 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.422 ' OD1' ' HB3' ' A' ' 105' ' ' SER . 4.6 p-10 -108.57 21.76 16.85 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.928 -1.107 . . . . 0.0 111.613 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.465 ' HB ' HD23 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -85.99 149.6 25.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.883 -1.136 . . . . 0.0 109.986 179.425 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.445 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 72.5 p -134.97 162.9 31.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 110.175 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 126' ' ' CYS . 26.9 mtmt -60.4 -14.18 17.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 109.845 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -82.77 -59.65 2.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.405 -0.81 . . . . 0.0 110.655 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 1.6 p-10 -63.41 -35.05 79.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.103 -0.998 . . . . 0.0 110.258 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 15.0 tp -72.91 -51.61 17.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.184 -0.947 . . . . 0.0 109.964 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 110' ' ' LYS . 4.6 tttt -56.63 -37.95 71.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -0.955 . . . . 0.0 109.695 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.471 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 3.1 m-20 -73.14 -54.82 7.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.381 -0.824 . . . . 0.0 110.038 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.445 ' C ' ' O ' ' A' ' 115' ' ' ASP . 71.1 t80 -46.61 -31.93 3.15 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.719 -1.192 . . . . 0.0 108.356 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.629 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 18.7 m-85 -91.45 -11.29 38.03 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.789 -0.765 . . . . 0.0 111.423 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.471 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 0.5 OUTLIER -71.14 -5.75 34.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.94 -1.1 . . . . 0.0 109.372 178.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.6 ttpt -84.92 -12.8 52.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.378 -0.826 . . . . 0.0 110.212 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.629 ' CD2' ' HA ' ' A' ' 117' ' ' PHE . 84.8 m-85 -89.59 -44.45 10.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 110.001 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.53 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -174.53 -152.55 9.22 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -90.4 146.96 23.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.229 -1.159 . . . . 0.0 110.633 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.7 t -129.24 129.8 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.446 -0.783 . . . . 0.0 110.088 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.482 HG23 ' CG ' ' A' ' 146' ' ' LYS . 2.2 t -88.8 -25.38 5.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.49 ' HB3' HD22 ' A' ' 144' ' ' LEU . 13.7 m-20 -150.88 166.91 29.12 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.389 -1.324 . . . . 0.0 112.309 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 11.8 t -167.22 135.87 2.65 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.462 0.649 . . . . 0.0 109.301 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.33 165.76 22.72 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.386 -0.821 . . . . 0.0 109.92 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.982 HD13 ' O ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.312 -0.867 . . . . 0.0 109.566 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.54 ' CB ' ' HA2' ' A' ' 102' ' ' GLY . 18.9 p90 . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 121.77 0.795 . . . . 0.0 111.651 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.531 ' N ' HD13 ' A' ' 104' ' ' LEU . . . -140.0 -179.0 17.41 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.734 ' CE1' ' CE1' ' A' ' 100' ' ' PHE . 18.0 m-85 -128.17 156.94 42.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.213 -1.169 . . . . 0.0 110.786 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.659 ' O ' HD12 ' A' ' 144' ' ' LEU . 8.9 t -138.22 131.77 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.659 HD12 ' O ' ' A' ' 143' ' ' VAL . 6.5 mp -116.84 107.61 14.83 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.512 -0.743 . . . . 0.0 109.926 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.645 ' CB ' HG22 ' A' ' 151' ' ' VAL . 10.4 m-85 -80.27 167.73 19.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.409 -0.807 . . . . 0.0 110.919 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.482 ' CG ' HG23 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -97.73 -23.67 15.82 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.493 -0.755 . . . . 0.0 110.664 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.61 ' O ' HG23 ' A' ' 151' ' ' VAL . 0.9 OUTLIER -142.07 160.37 40.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.748 -1.22 . . . . 0.0 110.934 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.4 t -64.25 -31.81 73.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 0.0 109.861 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.54 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 6.2 mt-10 -60.28 -46.9 88.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.287 -0.883 . . . . 0.0 109.869 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.535 ' HB2' ' CD1' ' A' ' 145' ' ' PHE . 37.0 p -60.97 -40.99 95.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.273 -0.892 . . . . 0.0 110.257 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.765 ' O ' HG12 ' A' ' 154' ' ' VAL . 3.2 t -69.72 -46.2 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.126 -0.984 . . . . 0.0 110.758 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.54 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -52.46 -38.19 58.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.094 -1.004 . . . . 0.0 109.959 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.47 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 0.6 OUTLIER -66.42 -60.88 2.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 0.0 110.389 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.806 HG23 ' HE1' ' A' ' 160' ' ' HIS . 12.6 p -48.97 -22.77 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.052 -1.03 . . . . 0.0 110.332 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 2.0 ttt -89.93 -24.79 21.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.178 -0.951 . . . . 0.0 109.744 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.47 ' OD2' ' O ' ' A' ' 153' ' ' LYS . 0.2 OUTLIER -53.81 -36.14 62.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.269 -0.894 . . . . 0.0 109.47 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.56 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -131.18 102.07 5.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.336 -0.852 . . . . 0.0 110.085 179.473 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.416 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 26.6 mtmt -85.12 23.54 1.24 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -0.946 . . . . 0.0 110.936 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -87.96 57.45 4.33 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.807 ' O ' HD23 ' A' ' 162' ' ' LEU . 17.5 m-70 -87.9 65.45 8.32 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.691 -176.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.6 ttpp -81.81 72.29 8.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.059 -1.025 . . . . 0.0 109.671 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.807 HD23 ' O ' ' A' ' 160' ' ' HIS . 0.5 OUTLIER -94.02 156.06 16.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 109.945 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 1.6 m-80 56.72 21.43 5.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.173 -0.954 . . . . 0.0 109.46 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 75.52 23.46 73.1 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.69 138.86 20.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -1.093 . . . . 0.0 110.618 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.597 HG12 ' H ' ' A' ' 167' ' ' ILE . 3.6 t -80.27 -179.54 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 109.233 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.597 ' H ' HG12 ' A' ' 166' ' ' VAL . 1.0 OUTLIER -141.7 170.99 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.973 -1.08 . . . . 0.0 111.52 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 102' ' ' GLY . 10.9 t0 -116.71 92.19 37.17 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 46.1 Cg_endo -72.15 136.72 27.48 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.312 1.69 . . . . 0.0 111.287 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -138.04 -178.95 5.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.52 -0.737 . . . . 0.0 109.703 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.553 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.484 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.548 ' HG2' ' CD2' ' A' ' 144' ' ' LEU . 9.9 mtpt . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.51 ' CG ' ' O ' ' A' ' 143' ' ' VAL . 5.9 ptm -141.98 175.5 9.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.122 -0.986 . . . . 0.0 110.883 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.688 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 1.7 t80 -119.7 129.27 54.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.597 -0.689 . . . . 0.0 109.69 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.646 HD13 ' C ' ' A' ' 100' ' ' PHE . 3.1 mm -109.88 94.18 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.301 -0.875 . . . . 0.0 109.453 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.533 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -97.22 112.14 4.4 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 141.32 38.73 0.08 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.689 HD21 HD13 ' A' ' 113' ' ' LEU . 5.4 mp -89.9 164.6 14.52 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.231 -1.158 . . . . 0.0 110.102 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' A' ' 163' ' ' ASN . 0.6 OUTLIER -81.56 -171.73 3.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.322 -0.861 . . . . 0.0 109.862 179.715 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 17.3 m0 -83.85 -9.86 58.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.182 -0.949 . . . . 0.0 110.414 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.48 19.75 8.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 110.399 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.781 HG23 ' OD1' ' A' ' 163' ' ' ASN . 2.5 m -63.52 159.7 18.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.109 -0.994 . . . . 0.0 109.773 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.477 HG23 ' C ' ' A' ' 108' ' ' THR . 63.7 p -149.57 171.73 16.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.907 . . . . 0.0 110.448 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.509 ' O ' ' CB ' ' A' ' 114' ' ' LYS . 5.9 ttpt -71.32 -11.0 60.67 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.412 -0.805 . . . . 0.0 109.127 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -84.0 -49.18 9.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.452 -0.78 . . . . 0.0 110.411 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -75.83 -31.72 59.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.961 -1.087 . . . . 0.0 110.199 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.972 HD23 ' SG ' ' A' ' 126' ' ' CYS . 1.7 tp -77.08 -43.44 34.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.02 -1.05 . . . . 0.0 109.593 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.509 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 17.3 tttt -59.97 -45.19 93.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.196 -0.94 . . . . 0.0 109.605 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 116' ' ' TYR . 0.6 OUTLIER -74.97 -42.03 58.4 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.178 -0.951 . . . . 0.0 109.526 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.793 ' CD2' HD21 ' A' ' 162' ' ' LEU . 72.5 t80 -48.32 -36.21 13.87 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 118.733 -1.187 . . . . 0.0 107.98 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.683 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 19.2 m-85 -91.48 -13.53 32.06 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.985 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 12.7 t -61.29 -14.28 25.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.114 -0.991 . . . . 0.0 109.594 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.72 -11.42 58.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.403 -0.81 . . . . 0.0 110.191 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.937 ' CD2' HG22 ' A' ' 154' ' ' VAL . 53.4 m-85 -89.54 -63.71 1.25 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.105 -0.997 . . . . 0.0 109.24 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -159.18 -177.57 32.39 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.5 133.84 48.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.063 -1.257 . . . . 0.0 110.414 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.9 t -109.72 133.64 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.332 -0.855 . . . . 0.0 110.885 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.476 ' O ' ' OD1' ' A' ' 125' ' ' ASP . 2.1 t -89.68 -28.25 5.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.56 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 0.8 OUTLIER -147.26 164.64 32.57 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 118.906 -1.118 . . . . 0.0 112.604 -178.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.972 ' SG ' HD23 ' A' ' 113' ' ' LEU . 36.9 t -170.34 140.37 1.85 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.64 161.25 42.95 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.962 -177.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.765 HD22 ' O ' ' A' ' 108' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.628 ' HA ' HD13 ' A' ' 104' ' ' LEU . 2.6 p90 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 120.942 0.401 . . . . 0.0 110.52 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -142.66 -161.84 8.98 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.688 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 17.4 m-85 -126.87 163.21 24.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.159 -1.2 . . . . 0.0 111.306 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.655 HG21 ' CE2' ' A' ' 117' ' ' PHE . 4.0 t -138.49 138.05 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.56 ' HB2' ' CB ' ' A' ' 125' ' ' ASP . 4.6 mp -127.04 107.45 10.06 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.315 -0.866 . . . . 0.0 110.11 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 1.127 ' CZ ' HG21 ' A' ' 154' ' ' VAL . 26.3 m-85 -80.65 151.63 28.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.361 -0.837 . . . . 0.0 110.51 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -75.78 -17.04 60.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.49 -0.756 . . . . 0.0 110.917 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.829 ' O ' HG23 ' A' ' 151' ' ' VAL . 7.4 tt0 -137.63 154.39 49.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.836 -1.165 . . . . 0.0 110.901 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.443 ' N ' ' HG2' ' A' ' 147' ' ' GLU . 0.4 OUTLIER -65.42 -39.28 91.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 109.601 179.45 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.524 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 3.0 tt0 -57.65 -51.3 70.09 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.331 -0.855 . . . . 0.0 109.688 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.803 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.4 p -52.7 -34.39 51.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.761 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 1.009 HG22 ' HB2' ' A' ' 145' ' ' PHE . 2.4 t -74.84 -49.79 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.307 -0.87 . . . . 0.0 110.503 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.524 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -52.97 -35.2 58.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.139 -0.976 . . . . 0.0 110.447 -179.489 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.487 ' HA ' ' OD2' ' A' ' 156' ' ' ASP . 0.4 OUTLIER -71.78 -49.87 34.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.227 -0.921 . . . . 0.0 110.464 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 1.127 HG21 ' CZ ' ' A' ' 145' ' ' PHE . 18.0 t -56.02 -22.53 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.901 -1.124 . . . . 0.0 110.043 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 32.1 mmm -87.32 -46.08 10.0 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.151 -0.968 . . . . 0.0 110.157 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.487 ' OD2' ' HA ' ' A' ' 153' ' ' LYS . 0.5 OUTLIER -47.19 -37.2 9.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.117 -0.99 . . . . 0.0 109.811 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.576 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 0.6 OUTLIER -111.16 85.33 2.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.122 -0.986 . . . . 0.0 110.101 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.02 18.19 2.16 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.28 -0.887 . . . . 0.0 110.824 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.424 ' OE1' ' HG2' ' A' ' 157' ' ' GLN . 31.9 mp0 -87.67 60.84 6.18 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 177.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.714 ' ND1' HD11 ' A' ' 167' ' ' ILE . 15.1 m-70 -87.07 179.57 6.65 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.557 -177.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 160' ' ' HIS . 14.2 ttmt -179.21 88.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.323 -0.861 . . . . 0.0 110.154 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.793 HD21 ' CD2' ' A' ' 116' ' ' TYR . 2.1 mp -102.93 140.89 36.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.175 -0.953 . . . . 0.0 109.583 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.781 ' OD1' HG23 ' A' ' 108' ' ' THR . 25.6 m120 57.04 16.72 3.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.267 -0.896 . . . . 0.0 109.734 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.35 32.59 27.88 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.11 123.3 10.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.193 -1.181 . . . . 0.0 110.482 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 167' ' ' ILE . 16.9 t -57.66 172.63 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 0.0 109.926 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.714 HD11 ' ND1' ' A' ' 160' ' ' HIS . 0.7 OUTLIER -132.7 178.27 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.195 -0.941 . . . . 0.0 111.019 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 102' ' ' GLY . 10.3 t70 -127.9 80.25 72.39 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 42.8 Cg_endo -70.41 131.22 19.88 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.069 1.563 . . . . 0.0 111.241 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.401 ' O ' ' CB ' ' A' ' 99' ' ' MET . 4.6 mmtm -146.73 -174.01 4.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.401 -0.812 . . . . 0.0 110.302 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.385 0 O-C-N 121.463 -0.773 . . . . 0.0 110.487 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.525 ' HG2' ' CD1' ' A' ' 144' ' ' LEU . 12.5 mtmm . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.344 0.592 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.926 ' CE ' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -145.33 160.0 42.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.656 179.2 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.836 ' O ' HD13 ' A' ' 101' ' ' ILE . 13.1 t80 -113.61 146.07 40.29 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.414 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.926 HD11 ' CE ' ' A' ' 99' ' ' MET . 12.7 mm -123.61 91.39 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.531 -0.731 . . . . 0.0 110.123 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 167' ' ' ILE . . . -91.34 178.77 41.79 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.65 10.89 61.25 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.722 HD13 ' H ' ' A' ' 141' ' ' GLY . 4.9 mp -73.36 163.72 27.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.098 -1.237 . . . . 0.0 110.349 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.521 ' HB3' ' ND2' ' A' ' 163' ' ' ASN . 13.3 t -90.37 -176.86 4.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.331 -0.856 . . . . 0.0 109.615 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.547 ' N ' ' CD1' ' A' ' 106' ' ' TRP . 37.0 m0 -87.67 23.21 2.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.081 -1.012 . . . . 0.0 110.143 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -144.25 9.5 1.44 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -0.9 . . . . 0.0 110.47 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.861 HG23 ' OD1' ' A' ' 163' ' ' ASN . 0.2 OUTLIER -73.41 172.47 11.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.106 -0.996 . . . . 0.0 109.822 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.512 HG23 ' C ' ' A' ' 108' ' ' THR . 71.4 p -150.36 166.41 30.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.132 -0.98 . . . . 0.0 110.366 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 114' ' ' LYS . 0.8 OUTLIER -67.68 -15.38 63.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.219 -0.925 . . . . 0.0 109.529 179.532 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -80.8 -62.66 1.6 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.315 -0.866 . . . . 0.0 110.38 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 109' ' ' THR . 1.1 p-10 -55.87 -37.75 69.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 110.249 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.646 HD23 ' SG ' ' A' ' 126' ' ' CYS . 13.3 tp -72.09 -41.46 67.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.156 -0.965 . . . . 0.0 110.178 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 110' ' ' LYS . 0.1 OUTLIER -60.87 -47.03 88.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.201 -0.937 . . . . 0.0 110.292 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 116' ' ' TYR . 26.4 t0 -69.91 -48.39 58.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.035 -1.041 . . . . 0.0 110.034 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.407 ' C ' ' O ' ' A' ' 115' ' ' ASP . 75.0 t80 -48.28 -34.89 11.14 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.62 -1.232 . . . . 0.0 108.104 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.655 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 13.5 m-85 -91.66 -8.08 48.13 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.409 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.5 m -71.15 -9.1 57.5 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.891 -1.131 . . . . 0.0 108.951 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -81.74 -16.09 52.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.6 -0.687 . . . . 0.0 110.091 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.655 ' CD1' ' HA ' ' A' ' 117' ' ' PHE . 70.7 m-85 -89.1 -55.35 3.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.179 -0.951 . . . . 0.0 109.153 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.531 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -164.57 -163.36 17.48 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.24 140.94 29.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.114 -1.227 . . . . 0.0 110.351 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.9 t -112.75 133.5 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.308 -0.87 . . . . 0.0 110.823 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.22 -25.64 5.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.561 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 1.0 OUTLIER -148.53 165.45 31.17 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.667 -1.213 . . . . 0.0 112.045 -179.203 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.646 ' SG ' HD23 ' A' ' 113' ' ' LEU . 14.3 t -170.52 148.68 3.14 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.45 ' O ' ' HA3' ' A' ' 141' ' ' GLY . 0.8 OUTLIER -150.28 162.28 40.81 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.116 -0.99 . . . . 0.0 110.599 -178.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.931 HD13 ' O ' ' A' ' 128' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.446 -0.784 . . . . 0.0 109.692 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.496 ' CA ' ' HB2' ' A' ' 104' ' ' LEU . 16.9 p90 . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 121.528 0.68 . . . . 0.0 110.965 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.722 ' H ' HD13 ' A' ' 104' ' ' LEU . . . -125.42 173.69 17.45 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.72 ' CE1' ' CE1' ' A' ' 100' ' ' PHE . 10.1 m-85 -116.51 158.15 24.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.185 -1.185 . . . . 0.0 110.234 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.557 ' CG2' HG13 ' A' ' 101' ' ' ILE . 25.8 t -138.46 124.88 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.933 0.873 . . . . 0.0 109.939 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.561 ' HB2' ' CB ' ' A' ' 125' ' ' ASP . 1.6 mm? -110.27 111.65 23.09 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.658 ' CB ' HG22 ' A' ' 151' ' ' VAL . 11.7 m-85 -82.01 151.59 27.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.971 -1.081 . . . . 0.0 111.052 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 30.4 tttt -81.28 -25.24 36.7 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.674 -0.641 . . . . 0.0 111.157 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.486 ' OE2' ' HB3' ' A' ' 149' ' ' GLU . 1.0 OUTLIER -144.48 146.37 32.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.703 -1.248 . . . . 0.0 111.231 -179.333 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.3 t -49.17 -35.13 16.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.154 -0.966 . . . . 0.0 109.554 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.533 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 0.6 OUTLIER -55.78 -51.61 66.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.348 -0.845 . . . . 0.0 109.972 179.725 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.56 ' HB2' ' CD1' ' A' ' 145' ' ' PHE . 67.1 p -56.99 -36.68 70.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.297 -0.877 . . . . 0.0 110.322 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.658 HG22 ' CB ' ' A' ' 145' ' ' PHE . 3.1 t -72.22 -53.6 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.075 -1.016 . . . . 0.0 110.393 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.533 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -47.78 -35.52 10.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.062 -1.023 . . . . 0.0 110.051 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.485 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -69.25 -52.0 31.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.898 . . . . 0.0 110.375 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.603 HG12 ' O ' ' A' ' 151' ' ' VAL . 2.1 p -65.15 -14.39 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.989 -1.07 . . . . 0.0 110.17 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 28.1 tpp -90.48 -36.76 14.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.348 -0.845 . . . . 0.0 110.618 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 1.6 p-10 -57.73 -17.59 16.28 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.124 -0.985 . . . . 0.0 110.115 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.532 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 8.9 tp-100 -139.5 76.87 1.59 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.329 -0.857 . . . . 0.0 109.437 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.632 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -81.84 10.3 6.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.906 . . . . 0.0 110.666 -179.426 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.409 ' HB2' ' OE1' ' A' ' 157' ' ' GLN . 8.9 mm-40 -88.09 67.88 8.99 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.678 ' O ' HG13 ' A' ' 166' ' ' VAL . 77.5 m-70 -86.41 174.71 8.82 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.51 0.671 . . . . 0.0 110.901 -177.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.602 ' HG3' HG22 ' A' ' 166' ' ' VAL . 1.1 mppt? -168.95 74.17 0.09 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.523 -0.735 . . . . 0.0 109.226 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.696 HD23 ' H ' ' A' ' 162' ' ' LEU . 0.9 OUTLIER -109.89 155.8 21.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.38 -0.825 . . . . 0.0 110.178 -179.442 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.861 ' OD1' HG23 ' A' ' 108' ' ' THR . 0.3 OUTLIER 66.59 9.13 6.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.265 -0.897 . . . . 0.0 109.639 -179.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 89.08 15.38 59.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -150.92 163.49 38.57 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.051 -1.264 . . . . 0.0 110.671 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.678 HG13 ' O ' ' A' ' 160' ' ' HIS . 2.9 t -84.9 178.28 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 109.53 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.624 HD11 ' CG ' ' A' ' 160' ' ' HIS . 0.7 OUTLIER -134.15 169.0 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.966 -1.084 . . . . 0.0 111.04 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 102' ' ' GLY . 9.5 t70 -112.34 88.22 10.44 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 167' ' ' ILE . 48.7 Cg_endo -77.14 119.66 5.1 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.259 1.663 . . . . 0.0 110.607 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.5 mttp -135.64 175.25 9.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 0.0 110.544 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.424 ' O ' ' HG3' ' A' ' 171' ' ' ARG . 9.3 ptp180 . . . . . 0 C--N 1.303 -1.449 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.27 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.504 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 9.8 mttt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.155 0.503 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.499 ' HG2' ' O ' ' A' ' 143' ' ' VAL . 6.9 ptm -141.29 174.67 10.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.313 -0.867 . . . . 0.0 110.181 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.697 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 2.3 t80 -115.15 129.11 56.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.388 -0.82 . . . . 0.0 110.176 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.677 HD13 ' C ' ' A' ' 100' ' ' PHE . 4.2 mm -111.53 95.94 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.287 -0.883 . . . . 0.0 109.251 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -93.13 113.92 4.57 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.468 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 145.08 34.51 0.07 OUTLIER Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 1.09 HD12 HG21 ' A' ' 108' ' ' THR . 3.5 mm? -91.17 151.82 20.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.088 -1.242 . . . . 0.0 110.116 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.441 ' HB3' ' HB3' ' A' ' 163' ' ' ASN . 52.7 p -75.27 -178.46 3.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.195 -0.941 . . . . 0.0 109.988 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -82.1 6.42 16.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -0.923 . . . . 0.0 110.364 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 2.9 p-10 -140.61 32.23 1.85 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.311 -0.868 . . . . 0.0 110.04 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 1.09 HG21 HD12 ' A' ' 104' ' ' LEU . 18.1 m -77.7 154.35 32.17 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.313 -0.867 . . . . 0.0 110.344 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.487 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 12.2 p -126.05 161.78 26.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.224 -0.923 . . . . 0.0 110.358 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.559 ' CG ' ' HA ' ' A' ' 127' ' ' THR . 0.3 OUTLIER -64.76 -20.47 66.37 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.089 -1.007 . . . . 0.0 110.121 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -88.61 -47.22 8.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.231 -0.918 . . . . 0.0 110.955 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -60.13 -30.42 69.27 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.941 -1.099 . . . . 0.0 109.881 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.642 HD13 HD11 ' A' ' 104' ' ' LEU . 27.0 tp -84.19 -45.91 12.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.218 -0.926 . . . . 0.0 109.47 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -33.03 67.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.889 . . . . 0.0 109.254 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' A' ' 118' ' ' SER . 0.2 OUTLIER -75.37 -55.04 6.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.28 -0.888 . . . . 0.0 109.675 179.632 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.448 ' C ' ' O ' ' A' ' 115' ' ' ASP . 64.8 t80 -46.55 -31.6 2.88 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.664 -1.214 . . . . 0.0 108.256 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.579 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 14.5 m-85 -91.35 -12.31 35.31 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.23 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 115' ' ' ASP . 44.0 t -67.47 -9.26 40.43 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.869 -1.144 . . . . 0.0 109.015 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -79.26 -16.23 56.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.407 -0.808 . . . . 0.0 110.438 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.953 ' CZ ' HG23 ' A' ' 154' ' ' VAL . 90.4 m-85 -88.89 -53.18 4.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.155 -0.965 . . . . 0.0 109.685 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -164.15 -159.16 10.67 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.03 135.09 33.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -1.123 . . . . 0.0 110.262 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.563 HG13 ' O ' ' A' ' 125' ' ' ASP . 2.0 t -111.83 133.66 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.294 -0.879 . . . . 0.0 110.59 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.42 HG23 ' HD2' ' A' ' 146' ' ' LYS . 2.1 t -88.73 -25.58 5.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.563 ' O ' HG13 ' A' ' 123' ' ' VAL . 0.9 OUTLIER -150.67 168.93 22.87 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.603 -1.239 . . . . 0.0 112.293 -179.056 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.526 ' O ' ' CD ' ' A' ' 110' ' ' LYS . 38.8 t -167.15 149.16 5.98 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.559 ' HA ' ' CG ' ' A' ' 110' ' ' LYS . 0.9 OUTLIER -150.78 147.82 27.76 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.869 -1.144 . . . . 0.0 111.563 -178.354 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.834 HD13 ' O ' ' A' ' 128' ' ' LEU . 2.3 tm? . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.762 ' HA ' HD23 ' A' ' 104' ' ' LEU . 3.3 p90 . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.019 0.438 . . . . 0.0 110.335 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -150.78 -165.46 12.78 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.466 -1.35 . . . . 0.0 110.5 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.697 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 16.4 m-85 -126.71 157.33 39.37 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.416 -1.049 . . . . 0.0 111.22 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.628 ' O ' HD12 ' A' ' 144' ' ' LEU . 2.8 t -130.34 134.39 62.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 143' ' ' VAL . 6.2 mp -121.82 90.2 3.26 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.104 -0.997 . . . . 0.0 110.333 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.796 ' HB2' HG22 ' A' ' 151' ' ' VAL . 29.6 m-85 -64.36 167.9 6.33 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.529 0.681 . . . . 0.0 109.98 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.42 ' HD2' HG23 ' A' ' 124' ' ' VAL . 7.9 tttt -103.05 -7.51 21.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.362 -0.837 . . . . 0.0 110.73 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.722 ' O ' HG23 ' A' ' 151' ' ' VAL . 0.9 OUTLIER -141.14 161.51 37.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.889 -1.132 . . . . 0.0 110.936 -179.524 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 4.8 t -75.26 -43.14 53.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 109.66 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.529 ' CB ' ' OE1' ' A' ' 147' ' ' GLU . 0.5 OUTLIER -60.62 -29.99 69.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.326 -0.859 . . . . 0.0 109.702 179.506 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.499 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 7.2 p -71.68 -40.58 69.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.041 -1.037 . . . . 0.0 109.431 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.796 HG22 ' HB2' ' A' ' 145' ' ' PHE . 8.3 t -72.42 -40.97 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -0.939 . . . . 0.0 110.154 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -67.6 -24.46 65.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.998 -1.063 . . . . 0.0 109.548 179.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.484 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 0.7 OUTLIER -74.39 -40.57 61.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.396 -0.815 . . . . 0.0 109.703 179.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.953 HG23 ' CZ ' ' A' ' 120' ' ' PHE . 11.4 p -79.56 -17.3 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.149 -0.97 . . . . 0.0 110.011 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -88.57 -32.31 18.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.497 -0.752 . . . . 0.0 110.388 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.484 ' OD2' ' O ' ' A' ' 153' ' ' LYS . 0.3 OUTLIER -51.92 -32.13 31.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.054 -1.029 . . . . 0.0 109.681 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.506 ' O ' ' NE2' ' A' ' 160' ' ' HIS . 1.4 mt-30 -130.05 96.96 4.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.308 -0.87 . . . . 0.0 110.028 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.523 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -89.54 24.68 2.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.13 -0.981 . . . . 0.0 110.264 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -88.1 62.16 6.66 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.692 ' ND1' HD11 ' A' ' 167' ' ' ILE . 11.5 m170 -86.9 178.8 6.86 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.942 -177.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 7.7 ttpt -175.27 68.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.383 -0.823 . . . . 0.0 109.823 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.679 HD11 HD13 ' A' ' 104' ' ' LEU . 2.4 pp -99.9 152.88 19.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.867 . . . . 0.0 109.814 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.523 ' HB2' HD12 ' A' ' 162' ' ' LEU . 5.4 m120 56.05 32.89 20.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.144 -0.973 . . . . 0.0 109.415 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 60.59 29.3 69.36 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.26 138.8 20.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.241 -1.152 . . . . 0.0 110.524 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.542 HG12 ' H ' ' A' ' 167' ' ' ILE . 21.6 t -75.19 176.9 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.934 . . . . 0.0 109.375 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.692 HD11 ' ND1' ' A' ' 160' ' ' HIS . 1.3 pt -137.19 -175.62 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.0 -1.063 . . . . 0.0 111.209 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -140.77 93.79 8.36 Favored Pre-proline 0 C--N 1.301 -1.515 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -77.11 115.26 3.95 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.378 1.725 . . . . 0.0 110.603 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.65 171.48 9.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.331 -0.856 . . . . 0.0 110.327 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.3 -1.559 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.229 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.517 ' CG ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.189 0.519 . . . . 0.0 109.943 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.647 ' HE2' ' O ' ' A' ' 170' ' ' LYS . 6.0 mtp -140.09 179.26 6.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.129 -0.982 . . . . 0.0 110.376 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.811 ' O ' HD13 ' A' ' 101' ' ' ILE . 2.4 t80 -124.42 136.54 54.13 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.45 -0.781 . . . . 0.0 110.077 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.811 HD13 ' O ' ' A' ' 100' ' ' PHE . 6.0 mm -122.19 106.08 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.12 -0.988 . . . . 0.0 110.009 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.552 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -103.27 139.84 14.62 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.88 10.85 8.83 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.86 HD21 HD22 ' A' ' 113' ' ' LEU . 4.3 mp -65.66 159.62 24.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.312 -1.11 . . . . 0.0 110.479 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.528 ' N ' ' OG1' ' A' ' 108' ' ' THR . 0.1 OUTLIER -83.94 177.11 8.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.37 -0.831 . . . . 0.0 109.823 179.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.564 ' N ' ' CD1' ' A' ' 106' ' ' TRP . 12.1 m0 -73.53 -23.75 60.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.153 -0.967 . . . . 0.0 110.352 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -104.97 11.77 33.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 110.887 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.618 HG21 ' HG ' ' A' ' 104' ' ' LEU . 1.8 m -60.92 161.24 8.49 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.986 -1.072 . . . . 0.0 110.023 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.51 HG23 ' C ' ' A' ' 108' ' ' THR . 68.3 p -150.33 179.53 8.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.342 -0.849 . . . . 0.0 110.391 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 23.2 ttmt -77.14 -19.07 57.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.387 -0.821 . . . . 0.0 109.342 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.56 -52.98 8.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.444 -0.785 . . . . 0.0 110.894 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 109' ' ' THR . 24.1 p-10 -70.01 -40.81 75.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.036 -1.04 . . . . 0.0 110.553 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.86 HD22 HD21 ' A' ' 104' ' ' LEU . 24.4 tp -65.1 -50.05 67.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.964 -1.085 . . . . 0.0 109.792 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -57.82 -32.5 67.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.914 . . . . 0.0 110.139 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.462 ' O ' ' C ' ' A' ' 116' ' ' TYR . 3.1 m-20 -80.0 -54.69 5.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.145 -0.972 . . . . 0.0 110.255 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.462 ' C ' ' O ' ' A' ' 115' ' ' ASP . 59.0 t80 -45.97 -32.6 2.83 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 118.711 -1.196 . . . . 0.0 108.177 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.743 ' HE2' HD11 ' A' ' 113' ' ' LEU . 12.8 m-85 -90.83 -17.14 27.08 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.22 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 115' ' ' ASP . 22.6 t -60.22 -20.47 58.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.981 -1.075 . . . . 0.0 109.445 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -74.92 -11.84 60.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.442 -0.786 . . . . 0.0 109.978 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.69 ' HB3' HG22 ' A' ' 154' ' ' VAL . 61.3 m-85 -89.78 -72.73 0.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.282 -0.886 . . . . 0.0 109.172 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -148.76 152.28 24.34 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.491 ' HB3' ' HE2' ' A' ' 146' ' ' LYS . 1.4 mt-10 -45.23 128.45 7.59 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.227 -1.161 . . . . 0.0 110.76 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.8 t -106.71 132.06 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.425 -0.797 . . . . 0.0 110.214 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.17 -24.4 5.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.442 ' O ' HG13 ' A' ' 123' ' ' VAL . 1.9 m-20 -150.81 161.24 43.04 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 118.447 -1.301 . . . . 0.0 112.33 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.481 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 43.3 t -161.37 147.78 14.41 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -151.25 154.7 37.31 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 118.538 -1.265 . . . . 0.0 111.842 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.943 HD13 ' O ' ' A' ' 128' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.563 ' CD2' ' CZ ' ' A' ' 100' ' ' PHE . 8.7 p90 . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 121.219 0.533 . . . . 0.0 110.629 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -144.91 -159.78 8.23 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.694 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 17.9 m-85 -129.28 170.2 13.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.317 -1.107 . . . . 0.0 111.279 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.506 ' O ' HD12 ' A' ' 144' ' ' LEU . 3.1 t -145.03 128.3 11.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.517 ' HG ' ' CG ' ' A' ' 98' ' ' LYS . 6.6 mp -116.0 104.35 11.49 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.417 -0.802 . . . . 0.0 109.752 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 1.181 ' CZ ' HG21 ' A' ' 154' ' ' VAL . 52.6 m-85 -78.21 148.69 33.9 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.582 -0.699 . . . . 0.0 110.699 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.491 ' HE2' ' HB3' ' A' ' 122' ' ' GLU . 1.8 ttmt -59.98 -38.22 81.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.641 -0.662 . . . . 0.0 111.061 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.472 ' OE2' ' HB2' ' A' ' 149' ' ' GLU . 0.5 OUTLIER -133.87 149.49 51.34 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.969 -1.082 . . . . 0.0 111.186 -179.321 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.9 p -52.45 -27.92 18.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.322 -0.861 . . . . 0.0 109.824 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.544 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 1.9 mm-40 -62.74 -56.35 18.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.388 -0.82 . . . . 0.0 109.93 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.631 ' O ' HG23 ' A' ' 154' ' ' VAL . 3.5 p -51.7 -32.15 28.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.171 -0.956 . . . . 0.0 109.757 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.796 HG22 ' HB2' ' A' ' 145' ' ' PHE . 17.7 t -65.81 -57.84 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.322 -0.861 . . . . 0.0 110.189 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.544 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 1.1 p30 -51.5 -28.89 14.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.172 -0.955 . . . . 0.0 109.99 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.47 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -68.28 -44.36 75.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.444 -0.785 . . . . 0.0 110.004 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 1.181 HG21 ' CZ ' ' A' ' 145' ' ' PHE . 3.8 t -69.86 -18.33 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.103 -0.998 . . . . 0.0 109.973 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.55 -23.96 21.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.88 . . . . 0.0 110.02 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.4 OUTLIER -55.41 -35.54 65.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 109.821 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.589 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -127.16 95.5 4.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.814 . . . . 0.0 109.583 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.474 ' HG3' ' HD2' ' A' ' 169' ' ' PRO . 9.5 tmtt? -85.29 12.43 8.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.904 . . . . 0.0 110.561 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -87.5 66.15 8.9 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 177.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.589 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 13.6 m-70 -87.2 177.76 7.08 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.487 -177.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.639 ' HG3' HG22 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -174.18 70.51 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.285 -0.885 . . . . 0.0 110.085 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.886 HD12 ' HB2' ' A' ' 163' ' ' ASN . 3.6 pp -96.09 154.33 17.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 109.73 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.886 ' HB2' HD12 ' A' ' 162' ' ' LEU . 0.9 OUTLIER 58.99 15.38 3.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.898 . . . . 0.0 109.969 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.16 24.58 54.39 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -150.07 149.09 29.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -1.166 . . . . 0.0 110.702 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.639 HG22 ' HG3' ' A' ' 161' ' ' LYS . 30.1 t -77.2 176.12 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.438 -0.789 . . . . 0.0 109.7 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.579 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -142.38 -176.13 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.131 -0.98 . . . . 0.0 110.971 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 102' ' ' GLY . 60.8 t0 -127.87 94.03 38.14 Favored Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.474 ' HD2' ' HG3' ' A' ' 158' ' ' LYS . 49.8 Cg_endo -74.85 113.64 3.84 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.395 1.734 . . . . 0.0 111.71 -178.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.647 ' O ' ' HE2' ' A' ' 99' ' ' MET . 1.0 OUTLIER -130.51 -171.63 2.6 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.607 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.508 ' HA ' ' HG2' ' A' ' 99' ' ' MET . 14.7 mtp180 . . . . . 0 C--N 1.297 -1.714 0 C-N-CA 118.861 -1.136 . . . . 0.0 110.363 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.553 ' HD3' HD21 ' A' ' 144' ' ' LEU . 18.1 mttp . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.22 0.533 . . . . 0.0 110.294 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.556 ' CE ' HD11 ' A' ' 101' ' ' ILE . 17.3 ptm -144.33 175.5 10.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.157 -0.964 . . . . 0.0 110.621 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.8 ' C ' HD13 ' A' ' 101' ' ' ILE . 2.4 t80 -117.3 135.36 53.89 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.533 -0.729 . . . . 0.0 109.174 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.8 HD13 ' C ' ' A' ' 100' ' ' PHE . 4.9 mm -119.42 110.56 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.182 -0.949 . . . . 0.0 109.78 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.447 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -111.37 98.71 1.05 Allowed Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.046 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 168.35 33.67 0.02 OUTLIER Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 1.007 HD12 HG21 ' A' ' 108' ' ' THR . 3.8 mm? -90.71 159.59 16.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -1.208 . . . . 0.0 109.808 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.457 ' N ' ' OG1' ' A' ' 108' ' ' THR . 14.0 t -85.33 -175.38 5.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.1 -1.0 . . . . 0.0 109.815 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 73.4 t90 -69.65 -33.37 72.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.062 -1.024 . . . . 0.0 110.148 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -103.77 48.13 0.86 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.204 -0.935 . . . . 0.0 110.335 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 1.007 HG21 HD12 ' A' ' 104' ' ' LEU . 19.8 m -88.02 155.03 20.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -0.988 . . . . 0.0 110.335 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.456 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 46.3 p -143.67 156.04 44.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.456 -0.778 . . . . 0.0 109.935 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.438 ' O ' ' HB3' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -62.42 -14.7 43.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.065 -1.022 . . . . 0.0 109.453 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.9 mmtt -74.06 -56.08 5.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.363 -0.836 . . . . 0.0 110.013 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 12.1 p30 -69.06 -20.75 64.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.136 -0.978 . . . . 0.0 109.934 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 1.004 HD13 HD11 ' A' ' 104' ' ' LEU . 15.8 tp -86.73 -54.84 4.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.889 . . . . 0.0 109.641 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.438 ' HB3' ' O ' ' A' ' 110' ' ' LYS . 10.3 tttm -54.01 -35.59 62.07 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.456 -0.777 . . . . 0.0 109.73 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 116' ' ' TYR . 12.8 m-20 -76.16 -52.51 9.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.192 -0.943 . . . . 0.0 109.782 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.533 ' HH ' ' CG ' ' A' ' 160' ' ' HIS . 65.4 t80 -47.63 -33.74 7.08 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.723 -1.191 . . . . 0.0 108.063 178.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.648 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 15.3 m-85 -91.96 -9.7 42.07 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.394 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.426 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 7.6 t -72.34 -4.02 27.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.051 -1.031 . . . . 0.0 109.386 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -89.95 -11.37 41.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.544 -0.723 . . . . 0.0 110.429 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.648 ' CD2' ' HA ' ' A' ' 117' ' ' PHE . 90.8 m-85 -88.59 -52.48 5.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.124 -0.985 . . . . 0.0 109.643 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -164.77 -161.81 14.52 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 146' ' ' LYS . 4.1 tt0 -86.02 115.24 23.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.221 -1.164 . . . . 0.0 110.446 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.9 t -94.11 132.07 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.303 -0.873 . . . . 0.0 110.912 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.38 -24.21 5.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.551 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 5.5 m-20 -147.75 163.05 37.92 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 118.766 -1.174 . . . . 0.0 112.373 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 44.0 t -170.15 140.63 1.97 Allowed 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.462 ' CG2' ' N ' ' A' ' 128' ' ' LEU . 0.9 OUTLIER -150.73 168.16 25.2 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 118.675 -1.21 . . . . 0.0 112.01 -177.781 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.734 HD22 ' O ' ' A' ' 108' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.683 ' HA ' HD23 ' A' ' 104' ' ' LEU . 4.1 p90 . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 120.97 0.414 . . . . 0.0 110.469 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 128' ' ' LEU . . . -134.87 -166.15 11.04 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.968 -1.111 . . . . 0.0 110.418 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.697 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 16.5 m-85 -122.84 168.1 12.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.418 -1.048 . . . . 0.0 111.325 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.558 ' CG2' HG13 ' A' ' 101' ' ' ILE . 8.9 t -144.76 134.04 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.553 HD21 ' HD3' ' A' ' 98' ' ' LYS . 3.1 mp -121.59 101.5 7.64 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.301 -0.874 . . . . 0.0 110.368 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.839 ' HB2' HG22 ' A' ' 151' ' ' VAL . 12.6 m-85 -76.42 158.08 31.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.296 -0.877 . . . . 0.0 110.382 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 122' ' ' GLU . 24.4 tptp -85.28 -11.94 53.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.819 . . . . 0.0 111.205 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.792 ' O ' HG23 ' A' ' 151' ' ' VAL . 2.6 tt0 -144.92 151.06 38.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.75 -1.219 . . . . 0.0 110.883 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 19.9 m -61.98 -36.91 82.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.9 . . . . 0.0 109.437 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.521 ' CB ' ' OE1' ' A' ' 147' ' ' GLU . 2.3 tt0 -62.11 -56.18 21.45 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.329 -0.857 . . . . 0.0 109.42 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 49.7 p -45.6 -37.0 5.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.149 -0.969 . . . . 0.0 109.361 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.839 HG22 ' HB2' ' A' ' 145' ' ' PHE . 2.9 t -74.3 -35.15 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 0.0 109.635 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.52 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -66.01 -28.08 68.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -0.872 . . . . 0.0 109.521 179.583 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.479 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 4.2 mttm -74.99 -48.51 23.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.377 -0.827 . . . . 0.0 109.908 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.699 HG23 ' HE1' ' A' ' 160' ' ' HIS . 9.0 p -66.13 -18.28 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.009 -1.057 . . . . 0.0 109.916 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 5.3 ttt -89.95 -43.51 10.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.262 -0.899 . . . . 0.0 110.115 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.479 ' OD2' ' O ' ' A' ' 153' ' ' LYS . 0.5 OUTLIER -46.39 -33.78 4.15 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.175 -0.953 . . . . 0.0 109.766 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.571 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 3.2 tt0 -119.43 90.26 3.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.29 -0.881 . . . . 0.0 110.105 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 158' ' ' LYS . 38.3 ttpt -87.14 19.77 3.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.325 -0.859 . . . . 0.0 110.295 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.6 58.28 4.83 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 177.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.974 ' ND1' HD11 ' A' ' 167' ' ' ILE . 13.7 m-70 -86.47 173.78 9.4 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.372 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -177.64 67.94 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.439 -0.788 . . . . 0.0 109.467 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.806 HD11 ' CD1' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -97.04 157.69 15.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.413 -0.804 . . . . 0.0 110.152 -179.575 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.466 ' HB2' HD12 ' A' ' 162' ' ' LEU . 0.4 OUTLIER 58.17 16.45 3.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 109.627 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 81.29 21.94 61.6 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.54 149.65 30.21 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.1 -1.235 . . . . 0.0 110.394 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 160' ' ' HIS . 1.1 p -76.95 -177.28 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.177 -0.952 . . . . 0.0 109.668 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.974 HD11 ' ND1' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -135.78 166.76 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.956 -1.09 . . . . 0.0 111.651 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -117.31 88.86 29.44 Favored Pre-proline 0 C--N 1.303 -1.436 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.491 ' HD2' ' HD2' ' A' ' 158' ' ' LYS . 46.7 Cg_endo -72.7 132.02 18.09 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.359 1.715 . . . . 0.0 111.184 -178.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 99' ' ' MET . 2.5 mttm -147.9 -169.8 3.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.53 -0.731 . . . . 0.0 109.964 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.541 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.222 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.56 ' CG ' ' HG ' ' A' ' 144' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.237 0.542 . . . . 0.0 110.527 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.885 ' HE2' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -123.38 167.25 14.07 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.193 -0.942 . . . . 0.0 108.84 178.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.691 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 1.6 t80 -105.73 125.28 50.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.06 -1.025 . . . . 0.0 110.305 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.885 HD11 ' HE2' ' A' ' 99' ' ' MET . 16.5 mm -116.95 94.92 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 110.169 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.603 ' O ' HG22 ' A' ' 167' ' ' ILE . . . -92.71 178.28 39.36 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.47 6.74 70.29 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.981 HD12 HG21 ' A' ' 108' ' ' THR . 3.1 mm? -61.68 164.13 6.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.094 -1.239 . . . . 0.0 109.536 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.423 ' HB3' ' HB3' ' A' ' 163' ' ' ASN . 0.9 OUTLIER -89.05 177.78 6.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.042 -1.036 . . . . 0.0 109.97 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.422 ' CD1' ' N ' ' A' ' 106' ' ' TRP . 33.3 m95 -84.99 19.23 2.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.223 -0.923 . . . . 0.0 110.217 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -148.12 21.88 1.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.9 . . . . 0.0 109.878 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.981 HG21 HD12 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -76.1 169.37 18.32 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.203 -0.935 . . . . 0.0 110.639 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.497 HG23 ' C ' ' A' ' 108' ' ' THR . 82.8 p -150.42 151.36 32.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.437 -0.789 . . . . 0.0 109.98 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.486 ' HD3' ' O ' ' A' ' 126' ' ' CYS . 7.1 ttpt -56.08 -16.34 4.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.162 -0.961 . . . . 0.0 109.881 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -80.15 -57.98 3.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.37 -0.831 . . . . 0.0 111.11 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 1.5 p-10 -65.38 -40.31 93.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.06 -1.025 . . . . 0.0 110.844 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.881 HD13 HD11 ' A' ' 104' ' ' LEU . 20.2 tp -69.05 -48.54 62.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.019 -1.051 . . . . 0.0 109.984 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 110' ' ' LYS . 11.7 tttt -52.16 -40.47 61.49 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.234 -0.916 . . . . 0.0 110.127 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.532 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 4.2 t0 -74.69 -50.86 16.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.234 -0.916 . . . . 0.0 110.257 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.448 ' C ' ' O ' ' A' ' 115' ' ' ASP . 78.1 t80 -46.21 -34.85 4.66 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.402 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.616 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 9.1 m-85 -91.63 -12.45 34.17 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.441 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.532 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 0.9 OUTLIER -72.65 -5.26 36.26 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.917 -1.115 . . . . 0.0 108.998 178.5 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 119' ' ' LYS . 2.1 tttm -85.77 -12.27 51.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.521 -0.737 . . . . 0.0 110.347 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.616 ' CD2' ' HA ' ' A' ' 117' ' ' PHE . 93.0 m-85 -88.9 -51.54 5.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.021 -1.049 . . . . 0.0 109.286 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.473 ' HA3' ' HB3' ' A' ' 150' ' ' SER . . . -158.71 -161.17 10.85 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -86.01 142.5 28.72 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.144 -1.209 . . . . 0.0 109.896 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.471 HG23 ' CD1' ' A' ' 145' ' ' PHE . 1.8 t -127.48 133.9 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.169 -0.957 . . . . 0.0 110.923 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.592 HG23 ' CE ' ' A' ' 146' ' ' LYS . 2.3 t -94.73 -22.03 5.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.425 ' O ' HG13 ' A' ' 123' ' ' VAL . 1.9 m-20 -149.82 170.68 18.19 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 118.049 -1.46 . . . . 0.0 113.135 -178.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.486 ' O ' ' HD3' ' A' ' 110' ' ' LYS . 16.2 t -170.85 131.48 0.84 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.36 162.08 25.58 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.448 -0.783 . . . . 0.0 111.45 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.983 HD13 ' O ' ' A' ' 128' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.803 0 O-C-N 121.362 -0.836 . . . . 0.0 110.294 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.503 ' CD2' ' CZ ' ' A' ' 100' ' ' PHE . 3.1 p90 . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.239 0.542 . . . . 0.0 110.542 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.602 ' HA3' ' HA ' ' A' ' 128' ' ' LEU . . . -139.24 -169.07 11.47 Favored Glycine 0 N--CA 1.488 2.114 0 C-N-CA 119.804 -1.189 . . . . 0.0 110.494 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.691 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 9.9 m-85 -124.48 170.6 10.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.732 -0.864 . . . . 0.0 110.008 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.638 ' C ' HD12 ' A' ' 144' ' ' LEU . 35.7 t -141.59 140.93 30.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.638 HD12 ' C ' ' A' ' 143' ' ' VAL . 5.8 mp -124.83 107.94 11.42 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.783 -178.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.766 ' CE2' HG11 ' A' ' 154' ' ' VAL . 42.9 m-85 -82.68 165.58 19.86 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.518 -0.739 . . . . 0.0 110.344 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.592 ' CE ' HG23 ' A' ' 124' ' ' VAL . 10.6 ttmt -86.77 -24.65 25.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.439 -0.788 . . . . 0.0 111.002 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.524 ' O ' HG23 ' A' ' 151' ' ' VAL . 0.7 OUTLIER -145.02 155.16 43.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.786 -1.196 . . . . 0.0 110.92 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 25.6 p -55.19 -35.8 65.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.271 -0.893 . . . . 0.0 109.948 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.544 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 1.0 OUTLIER -52.97 -54.14 39.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.425 -0.797 . . . . 0.0 110.008 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.485 ' OG ' ' HG3' ' A' ' 147' ' ' GLU . 3.6 p -57.59 -39.44 76.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.187 -0.945 . . . . 0.0 110.233 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.626 ' O ' HG12 ' A' ' 154' ' ' VAL . 6.6 t -62.0 -44.69 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.12 -0.988 . . . . 0.0 110.62 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.544 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.5 OUTLIER -67.16 -27.56 67.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.044 -1.035 . . . . 0.0 110.097 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.473 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -70.75 -32.36 69.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.847 . . . . 0.0 110.163 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.766 HG11 ' CE2' ' A' ' 145' ' ' PHE . 6.0 p -90.66 -20.87 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.158 -0.964 . . . . 0.0 110.329 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.04 -34.5 16.77 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.371 -0.83 . . . . 0.0 109.892 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 8.4 p-10 -47.38 -31.9 4.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.295 -0.878 . . . . 0.0 109.865 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.517 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -131.95 94.95 3.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.976 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.499 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -89.52 27.31 1.5 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.127 -0.983 . . . . 0.0 110.431 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -89.03 55.66 3.42 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.811 ' O ' HG23 ' A' ' 166' ' ' VAL . 12.2 m170 -86.23 176.31 8.01 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.684 -177.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -177.21 75.05 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.46 -0.775 . . . . 0.0 109.452 179.718 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.624 HD11 HD13 ' A' ' 104' ' ' LEU . 1.5 pp -98.49 157.99 15.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.321 -0.862 . . . . 0.0 109.948 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 0.8 OUTLIER 60.04 13.92 4.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.328 -0.858 . . . . 0.0 109.675 -179.265 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 85.43 20.85 55.94 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 161' ' ' LYS . 5.8 mttt -151.21 150.55 30.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.086 -1.243 . . . . 0.0 110.736 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 160' ' ' HIS . 1.3 p -74.71 -178.79 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.4 -0.813 . . . . 0.0 109.683 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.603 HG22 ' O ' ' A' ' 102' ' ' GLY . 0.1 OUTLIER -135.39 -171.78 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.097 -1.002 . . . . 0.0 110.701 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 102' ' ' GLY . 23.9 t0 -132.71 84.63 49.68 Favored Pre-proline 0 N--CA 1.488 1.473 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.51 ' HA ' HD13 ' A' ' 101' ' ' ILE . 47.8 Cg_endo -74.93 127.18 10.53 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.218 1.641 . . . . 0.0 111.033 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.55 -173.48 4.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.462 -0.774 . . . . 0.0 109.794 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 . . . . . 0 C--N 1.301 -1.543 0 C-N-CA 119.499 -0.881 . . . . 0.0 110.566 179.364 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.509 ' HD3' HD21 ' A' ' 144' ' ' LEU . 8.2 mttp . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.372 0.606 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.659 ' CE ' HD11 ' A' ' 101' ' ' ILE . 5.4 ptm -138.73 169.56 17.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 109.982 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.795 ' C ' HD13 ' A' ' 101' ' ' ILE . 2.5 t80 -112.72 138.68 49.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.904 . . . . 0.0 110.593 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.795 HD13 ' C ' ' A' ' 100' ' ' PHE . 2.8 mm -121.85 110.77 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.418 -0.801 . . . . 0.0 109.822 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.477 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -108.57 123.92 7.21 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 138.89 33.63 0.18 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.739 HD21 HD22 ' A' ' 113' ' ' LEU . 2.2 mp -90.5 159.37 16.54 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.139 -1.212 . . . . 0.0 110.323 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.6 t -84.06 -170.3 3.01 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.208 -0.932 . . . . 0.0 110.32 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 20.2 m0 -87.53 4.1 44.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.208 -0.932 . . . . 0.0 110.332 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -138.0 22.99 2.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.205 -0.935 . . . . 0.0 110.15 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.712 HG21 ' CD2' ' A' ' 104' ' ' LEU . 2.8 m -68.06 163.28 22.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.171 -0.956 . . . . 0.0 110.059 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.457 HG23 ' C ' ' A' ' 108' ' ' THR . 30.3 p -148.61 153.76 38.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.198 -0.939 . . . . 0.0 110.171 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.548 ' O ' ' CB ' ' A' ' 114' ' ' LYS . 10.5 ttpt -58.4 -15.34 10.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.225 -0.922 . . . . 0.0 109.735 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.35 -54.61 6.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.219 -0.925 . . . . 0.0 110.273 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 3.2 p30 -70.12 -30.29 67.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.235 -0.916 . . . . 0.0 110.574 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.739 HD22 HD21 ' A' ' 104' ' ' LEU . 14.7 tp -81.11 -48.97 11.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.021 . . . . 0.0 109.996 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.548 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 1.3 tttt -55.04 -35.87 64.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.154 -0.966 . . . . 0.0 109.716 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.478 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 5.3 m-20 -79.59 -47.69 15.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.919 . . . . 0.0 109.748 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.409 ' C ' ' O ' ' A' ' 115' ' ' ASP . 75.6 t80 -48.23 -36.73 14.46 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 118.566 -1.253 . . . . 0.0 107.995 178.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.692 ' CD2' HG21 ' A' ' 143' ' ' VAL . 16.3 m-85 -91.56 -11.7 36.52 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.948 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.478 ' HB3' ' HA ' ' A' ' 115' ' ' ASP . 29.2 t -71.08 -6.49 39.57 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.907 -1.12 . . . . 0.0 108.81 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 11.4 tttt -83.47 -15.74 48.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.407 -0.808 . . . . 0.0 110.036 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.909 ' CG ' HG22 ' A' ' 154' ' ' VAL . 72.8 m-85 -89.18 -39.74 13.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.274 -0.891 . . . . 0.0 109.122 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.448 ' HA3' ' HB3' ' A' ' 150' ' ' SER . . . -174.19 176.99 46.57 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 0.9 OUTLIER -73.83 118.17 16.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.234 -1.156 . . . . 0.0 110.466 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.8 t -93.36 130.62 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.26 -0.9 . . . . 0.0 111.375 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -90.28 -23.73 5.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.522 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -142.76 153.02 42.9 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 118.984 -1.087 . . . . 0.0 112.09 -179.106 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 49.6 t -161.66 145.56 12.69 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.28 156.73 42.1 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.702 -1.199 . . . . 0.0 111.566 -178.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.736 ' C ' HD12 ' A' ' 128' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.524 ' CD1' ' CZ ' ' A' ' 100' ' ' PHE . 11.6 p90 . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 120.982 0.42 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.404 ' C ' ' CD1' ' A' ' 142' ' ' PHE . . . -153.91 -159.41 9.15 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.944 -1.263 . . . . 0.0 109.944 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.699 ' CZ ' ' CE2' ' A' ' 100' ' ' PHE . 18.9 m-85 -129.32 170.87 13.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -1.172 . . . . 0.0 111.429 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.692 HG21 ' CD2' ' A' ' 117' ' ' PHE . 7.3 t -145.9 129.83 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.633 HD12 ' C ' ' A' ' 143' ' ' VAL . 7.6 mp -120.84 102.96 8.71 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.398 -0.814 . . . . 0.0 110.355 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.901 ' CE2' HG21 ' A' ' 154' ' ' VAL . 26.2 m-85 -74.71 165.08 25.81 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.587 0.708 . . . . 0.0 110.899 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 17.5 ttpt -85.27 -26.5 26.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.512 -0.742 . . . . 0.0 111.104 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.504 ' HG3' ' OG ' ' A' ' 150' ' ' SER . 0.1 OUTLIER -137.11 142.05 42.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.654 -1.279 . . . . 0.0 110.772 -179.757 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 75.1 m -50.52 -30.67 13.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 109.996 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.545 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 1.8 mm-40 -59.25 -48.1 82.88 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.272 -0.892 . . . . 0.0 110.042 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.53 ' O ' HG23 ' A' ' 154' ' ' VAL . 11.2 p -62.75 -32.33 73.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.235 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.889 HG22 ' HB2' ' A' ' 145' ' ' PHE . 2.7 t -73.94 -55.31 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.065 -1.022 . . . . 0.0 110.103 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.545 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.1 OUTLIER -51.47 -27.14 9.59 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.159 -0.963 . . . . 0.0 109.341 179.772 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.475 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 8.7 tmtt? -69.5 -61.73 1.67 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.459 -0.775 . . . . 0.0 109.708 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.909 HG22 ' CG ' ' A' ' 120' ' ' PHE . 23.4 t -45.33 -28.65 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.127 -0.983 . . . . 0.0 109.948 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 6.7 ttt -77.46 -41.15 40.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.371 -0.831 . . . . 0.0 110.462 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.475 ' OD2' ' O ' ' A' ' 153' ' ' LYS . 0.4 OUTLIER -48.19 -22.99 0.74 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.132 -0.98 . . . . 0.0 109.962 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.569 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 3.0 pt20 -140.44 90.89 2.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.286 -0.884 . . . . 0.0 110.135 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.74 16.38 5.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.122 -0.986 . . . . 0.0 110.372 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -87.67 63.64 7.63 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.739 ' O ' HG23 ' A' ' 166' ' ' VAL . 11.7 m-70 -87.35 -179.76 6.45 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.648 -177.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 165' ' ' LYS . 16.2 ttmt -179.06 74.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.26 -0.9 . . . . 0.0 110.23 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.585 HD12 ' HB2' ' A' ' 163' ' ' ASN . 1.8 pp -96.07 151.38 19.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 109.873 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.585 ' HB2' HD12 ' A' ' 162' ' ' LEU . 0.5 OUTLIER 61.39 12.36 4.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.232 -0.917 . . . . 0.0 110.217 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 88.2 23.01 39.06 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 161' ' ' LYS . 4.3 mtpp -150.12 138.96 20.89 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.183 -1.187 . . . . 0.0 110.579 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 160' ' ' HIS . 4.2 p -66.78 -179.39 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.311 -0.868 . . . . 0.0 109.995 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.651 HD11 ' HB3' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -145.13 176.74 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.176 -0.953 . . . . 0.0 110.642 -179.55 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 102' ' ' GLY . 34.2 t0 -128.09 90.78 46.44 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.526 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 52.3 Cg_endo -78.44 139.36 16.31 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 124.118 1.588 . . . . 0.0 110.862 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.08 -173.01 4.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.922 . . . . 0.0 110.122 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 . . . . . 0 C--N 1.302 -1.482 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.319 179.378 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.452 ' HB3' ' HG ' ' A' ' 144' ' ' LEU . 43.3 mttt . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.448 0.642 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.793 ' CE ' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -134.49 165.78 24.39 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.779 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.728 ' C ' HD13 ' A' ' 101' ' ' ILE . 17.4 t80 -111.78 144.35 41.23 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.077 -1.014 . . . . 0.0 110.67 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.793 HD11 ' CE ' ' A' ' 99' ' ' MET . 3.2 mm -117.63 96.53 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.555 -0.716 . . . . 0.0 109.227 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.565 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -93.99 120.39 6.31 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.84 -1.172 . . . . 0.0 110.627 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.52 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 133.65 35.03 0.29 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.957 HD11 HD12 ' A' ' 113' ' ' LEU . 4.0 mm? -90.21 161.64 15.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.12 -1.224 . . . . 0.0 110.106 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.494 ' N ' ' OG1' ' A' ' 108' ' ' THR . 0.1 OUTLIER -90.64 160.4 15.9 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.212 -0.93 . . . . 0.0 110.332 179.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -62.14 -10.92 11.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.052 -1.03 . . . . 0.0 110.218 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -116.09 12.68 15.64 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.143 -0.973 . . . . 0.0 111.321 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 1.04 HG23 ' CG ' ' A' ' 163' ' ' ASN . 0.3 OUTLIER -76.84 169.89 17.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.829 -1.169 . . . . 0.0 110.034 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.485 HG23 ' C ' ' A' ' 108' ' ' THR . 33.8 p -149.89 155.45 40.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.15 -0.969 . . . . 0.0 109.887 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 114' ' ' LYS . 1.9 pttp -63.6 -11.06 21.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.159 -0.963 . . . . 0.0 109.663 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -78.65 -61.96 1.84 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.0 110.42 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 0.9 OUTLIER -62.5 -41.41 98.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.084 -1.01 . . . . 0.0 110.182 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.957 HD12 HD11 ' A' ' 104' ' ' LEU . 6.9 tt -64.79 -61.14 2.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 109.752 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 110' ' ' LYS . 14.3 ttpt -44.44 -34.92 2.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 109.433 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 118' ' ' SER . 0.5 OUTLIER -72.94 -54.38 8.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.144 -0.972 . . . . 0.0 109.2 179.187 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.435 ' C ' ' O ' ' A' ' 115' ' ' ASP . 48.1 t80 -47.69 -28.39 2.4 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.622 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 20.1 m-85 -91.21 -12.41 35.4 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.232 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 115' ' ' ASP . 95.1 p -65.4 -10.18 31.45 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.922 -1.111 . . . . 0.0 109.406 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.0 tptt -81.73 -14.78 56.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.466 -0.771 . . . . 0.0 110.544 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.622 ' CD2' ' HA ' ' A' ' 117' ' ' PHE . 92.3 m-85 -89.17 -61.91 1.6 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.145 -0.972 . . . . 0.0 109.498 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.495 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -155.95 -163.5 12.3 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 146' ' ' LYS . 0.6 OUTLIER -88.76 126.41 35.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -1.212 . . . . 0.0 110.352 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.6 t -101.05 129.63 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.205 -0.935 . . . . 0.0 111.062 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.472 HG23 ' HB2' ' A' ' 146' ' ' LYS . 2.2 t -90.07 -23.01 6.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.528 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 2.2 m-20 -145.51 162.16 38.04 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 118.663 -1.215 . . . . 0.0 112.288 -178.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.446 ' CB ' ' HD3' ' A' ' 114' ' ' LYS . 9.2 t -169.95 143.98 2.66 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.528 ' CG2' ' N ' ' A' ' 128' ' ' LEU . 0.9 OUTLIER -150.59 173.85 13.65 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 110.39 -178.709 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.713 HD13 ' O ' ' A' ' 108' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 O-C-N 121.403 -0.811 . . . . 0.0 110.003 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.565 ' HB2' ' HA2' ' A' ' 102' ' ' GLY . 17.5 p90 . . . . . 0 N--CA 1.499 2.018 0 CA-C-O 121.395 0.617 . . . . 0.0 111.512 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.725 ' H ' HD23 ' A' ' 104' ' ' LEU . . . -115.68 178.47 17.64 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.719 ' CE1' ' CE1' ' A' ' 100' ' ' PHE . 13.3 m-85 -126.07 160.66 29.52 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.517 -0.99 . . . . 0.0 110.804 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.673 ' C ' HD12 ' A' ' 144' ' ' LEU . 19.5 t -145.07 141.75 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.584 -0.698 . . . . 0.0 109.237 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.673 HD12 ' C ' ' A' ' 143' ' ' VAL . 6.3 mp -127.31 102.71 7.03 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.515 -0.74 . . . . 0.0 109.536 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.817 ' HB2' HG22 ' A' ' 151' ' ' VAL . 29.2 m-85 -74.44 153.08 39.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.472 -0.768 . . . . 0.0 110.614 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.472 ' HB2' HG23 ' A' ' 124' ' ' VAL . 10.7 tttt -83.47 -18.98 36.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.476 -0.765 . . . . 0.0 110.882 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.811 ' O ' HG23 ' A' ' 151' ' ' VAL . 5.7 tt0 -134.36 154.63 51.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.794 -1.191 . . . . 0.0 110.895 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.9 t -67.39 -39.09 85.58 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.229 -0.919 . . . . 0.0 109.232 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.563 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 1.7 tt0 -59.63 -49.78 76.43 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.496 -0.752 . . . . 0.0 109.686 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.495 ' CB ' ' HA3' ' A' ' 121' ' ' GLY . 4.8 p -52.94 -37.97 61.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.159 -0.963 . . . . 0.0 109.498 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.817 HG22 ' HB2' ' A' ' 145' ' ' PHE . 5.7 t -68.27 -46.98 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -0.88 . . . . 0.0 109.921 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.563 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -57.05 -33.32 67.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.218 -0.926 . . . . 0.0 109.562 179.688 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.475 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 19.9 mttt -63.71 -50.98 67.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.434 -0.791 . . . . 0.0 109.905 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.725 HG12 ' O ' ' A' ' 151' ' ' VAL . 10.5 p -69.42 -10.77 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.962 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.21 -30.97 17.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.397 -0.814 . . . . 0.0 109.948 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 1.6 p-10 -55.29 -23.5 23.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.152 -0.968 . . . . 0.0 110.388 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.516 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 0.8 OUTLIER -139.72 94.76 2.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 0.0 109.961 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.58 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 3.1 pttp -89.91 15.06 10.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.158 -0.963 . . . . 0.0 110.606 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -87.94 67.77 9.09 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.611 ' HB2' ' CG1' ' A' ' 167' ' ' ILE . 84.9 m-70 -86.94 151.9 22.89 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.324 -177.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 160' ' ' HIS . 23.6 mttt -146.9 72.45 1.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.463 -0.773 . . . . 0.0 109.599 178.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.466 HD11 ' CD1' ' A' ' 104' ' ' LEU . 0.7 OUTLIER -106.43 151.9 24.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.0 110.579 -179.538 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 1.04 ' CG ' HG23 ' A' ' 108' ' ' THR . 0.7 OUTLIER 59.61 20.75 9.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.298 -0.876 . . . . 0.0 110.123 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.94 26.46 71.07 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.61 150.37 33.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.311 -1.111 . . . . 0.0 110.446 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.407 ' O ' ' HA3' ' A' ' 103' ' ' GLY . 57.7 t -92.15 160.6 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.33 -0.856 . . . . 0.0 109.745 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.611 ' CG1' ' HB2' ' A' ' 160' ' ' HIS . 3.8 pt -125.41 -177.65 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.014 -1.054 . . . . 0.0 111.602 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 102' ' ' GLY . 1.8 t70 -129.5 94.31 32.96 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.49 ' CG ' ' HB2' ' A' ' 158' ' ' LYS . 47.9 Cg_endo -74.44 124.3 8.8 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 124.302 1.685 . . . . 0.0 111.048 -178.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.457 ' O ' ' CB ' ' A' ' 99' ' ' MET . 4.7 mttm -150.24 -165.6 2.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.425 -0.797 . . . . 0.0 109.961 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 . . . . . 0 C--N 1.299 -1.611 0 C-N-CA 119.654 -0.819 . . . . 0.0 109.345 178.876 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.485 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 26.9 mtmt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.061 0.457 . . . . 0.0 109.797 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.578 ' HE2' HD11 ' A' ' 101' ' ' ILE . 8.5 ptm -136.13 178.55 6.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.154 -0.966 . . . . 0.0 110.762 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.748 ' C ' HD13 ' A' ' 101' ' ' ILE . 1.7 t80 -119.88 130.94 55.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.495 -0.753 . . . . 0.0 109.948 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.748 HD13 ' C ' ' A' ' 100' ' ' PHE . 3.8 mm -114.21 90.42 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.435 -0.791 . . . . 0.0 109.149 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -92.48 148.64 19.21 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.1 23.19 6.82 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.788 HD22 HD23 ' A' ' 128' ' ' LEU . 5.9 mp -82.74 163.36 21.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.992 -1.299 . . . . 0.0 109.995 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.479 ' O ' ' OG1' ' A' ' 108' ' ' THR . 0.4 OUTLIER -91.52 178.55 5.91 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.315 -0.866 . . . . 0.0 111.051 -179.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -72.64 -4.14 29.15 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.292 -0.88 . . . . 0.0 109.936 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.56 14.2 12.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.18 -0.95 . . . . 0.0 111.178 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.583 ' HB ' HD23 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -75.35 157.91 33.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.959 -1.088 . . . . 0.0 109.355 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.492 HG23 ' C ' ' A' ' 108' ' ' THR . 68.1 p -150.49 174.22 13.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.165 -0.959 . . . . 0.0 110.704 -179.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 126' ' ' CYS . 8.2 ttpt -66.93 -17.59 64.98 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.511 -0.743 . . . . 0.0 109.35 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -61.31 1.92 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.352 -0.843 . . . . 0.0 110.807 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 14.6 p30 -63.84 -18.15 63.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.997 -1.064 . . . . 0.0 109.879 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.74 ' HA ' HD21 ' A' ' 162' ' ' LEU . 36.8 tp -87.95 -53.55 4.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.898 . . . . 0.0 109.331 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.532 ' HB2' ' CB ' ' A' ' 126' ' ' CYS . 7.0 tmtt? -61.68 -38.57 88.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.558 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.551 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 6.3 t70 -72.5 -54.87 8.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.249 -0.907 . . . . 0.0 110.035 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.811 ' CG ' HD13 ' A' ' 162' ' ' LEU . 55.4 t80 -49.46 -30.28 7.87 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.395 -1.322 . . . . 0.0 108.0 178.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.665 ' HZ ' HD12 ' A' ' 167' ' ' ILE . 12.9 m-85 -90.71 -9.13 47.88 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 119.736 -0.786 . . . . 0.0 111.122 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.551 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 0.1 OUTLIER -69.07 -14.16 62.86 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.83 -1.169 . . . . 0.0 108.708 178.41 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -18.65 60.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.534 -0.729 . . . . 0.0 110.056 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.806 ' CG ' HG22 ' A' ' 154' ' ' VAL . 71.2 m-85 -89.03 -64.34 1.16 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.23 -0.918 . . . . 0.0 109.176 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 150' ' ' SER . . . -152.68 175.53 31.22 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.65 146.68 51.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.061 -1.258 . . . . 0.0 110.211 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 125' ' ' ASP . 2.0 t -123.06 132.14 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.357 -0.839 . . . . 0.0 110.674 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.1 -24.5 5.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.584 ' O ' HG13 ' A' ' 123' ' ' VAL . 1.0 OUTLIER -145.18 160.64 41.14 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 118.797 -1.161 . . . . 0.0 112.258 -179.163 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.532 ' CB ' ' HB2' ' A' ' 114' ' ' LYS . 34.1 t -169.57 118.9 0.64 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.402 ' CG2' ' N ' ' A' ' 128' ' ' LEU . 0.8 OUTLIER -118.56 166.68 12.42 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.498 -0.751 . . . . 0.0 110.823 -178.573 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.788 HD23 HD22 ' A' ' 104' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.501 -0.749 . . . . 0.0 109.739 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.522 ' CD2' ' CZ ' ' A' ' 100' ' ' PHE . 19.1 p90 . . . . . 0 N--CA 1.498 1.938 0 CA-C-O 121.623 0.725 . . . . 0.0 111.884 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 128' ' ' LEU . . . -135.76 -179.27 16.43 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.725 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 7.8 m-85 -123.02 167.08 14.08 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.119 -1.224 . . . . 0.0 110.767 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.572 ' CG2' HG13 ' A' ' 101' ' ' ILE . 3.5 t -142.89 134.23 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.376 -0.828 . . . . 0.0 109.474 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.485 ' HG ' ' HG2' ' A' ' 98' ' ' LYS . 5.0 mp -120.87 103.44 9.08 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.42 -0.8 . . . . 0.0 109.786 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 1.032 ' CZ ' HG21 ' A' ' 154' ' ' VAL . 16.5 m-85 -77.49 169.52 18.16 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.453 -0.78 . . . . 0.0 110.899 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -84.36 -32.57 24.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.694 -0.629 . . . . 0.0 111.039 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.663 ' O ' HG23 ' A' ' 151' ' ' VAL . 0.3 OUTLIER -135.9 158.49 44.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.803 -1.186 . . . . 0.0 110.616 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.63 -31.56 72.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.293 -0.879 . . . . 0.0 110.28 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.538 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 0.0 OUTLIER -61.81 -45.54 93.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.936 . . . . 0.0 110.079 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.763 ' O ' HG23 ' A' ' 154' ' ' VAL . 43.0 p -63.59 -40.06 95.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.353 -0.842 . . . . 0.0 110.297 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.955 HG22 ' HB2' ' A' ' 145' ' ' PHE . 5.2 t -60.41 -59.06 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.096 -1.003 . . . . 0.0 109.823 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.538 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.5 OUTLIER -53.06 -41.69 65.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.103 -0.998 . . . . 0.0 109.439 179.612 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.464 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 9.7 tttt -51.83 -35.84 45.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.337 -0.852 . . . . 0.0 109.813 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 1.032 HG21 ' CZ ' ' A' ' 145' ' ' PHE . 3.7 t -82.32 -22.5 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.277 -0.89 . . . . 0.0 110.4 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 6.7 tmm? -86.05 -24.52 26.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.869 . . . . 0.0 110.375 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 40.8 p30 -65.83 -13.18 59.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.17 -0.956 . . . . 0.0 110.162 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.58 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 8.5 tt0 -142.37 88.21 2.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.92 . . . . 0.0 109.815 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.447 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -86.49 19.4 2.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.286 -0.884 . . . . 0.0 110.594 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -87.99 58.9 5.05 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.581 ' HB2' HG13 ' A' ' 167' ' ' ILE . 16.4 m-70 -86.58 -168.3 2.19 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.898 -177.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.484 ' CE ' ' C ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -176.31 64.94 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.582 -0.699 . . . . 0.0 109.406 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.811 HD13 ' CG ' ' A' ' 116' ' ' TYR . 10.6 tp -89.2 147.32 24.22 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.452 -0.78 . . . . 0.0 110.228 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.575 ' OD1' HG23 ' A' ' 108' ' ' THR . 0.1 OUTLIER 59.91 20.31 9.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.348 -0.845 . . . . 0.0 109.66 -179.604 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.484 ' C ' ' CE ' ' A' ' 161' ' ' LYS . . . 80.57 20.1 67.03 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.11 149.48 30.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -1.167 . . . . 0.0 110.202 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.9 t -67.7 163.9 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 109.963 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.665 HD12 ' HZ ' ' A' ' 117' ' ' PHE . 0.1 OUTLIER -120.95 -177.54 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.175 -0.953 . . . . 0.0 111.021 -179.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -133.07 83.28 52.06 Favored Pre-proline 0 C--N 1.304 -1.391 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.36 131.31 14.95 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.267 1.667 . . . . 0.0 110.559 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.1 mmtm -145.02 -176.79 5.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.326 -0.859 . . . . 0.0 110.307 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 . . . . . 0 C--N 1.3 -1.564 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.363 179.253 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.547 ' CG ' ' HG ' ' A' ' 144' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.237 0.541 . . . . 0.0 110.505 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.636 ' HE2' ' CD1' ' A' ' 101' ' ' ILE . 7.7 ptm -115.15 176.89 4.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.296 -0.878 . . . . 0.0 109.736 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.711 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 1.2 t80 -116.55 125.52 52.0 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.351 -0.843 . . . . 0.0 110.155 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.662 HG13 HG23 ' A' ' 143' ' ' VAL . 1.3 mm -110.48 92.55 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.515 -0.741 . . . . 0.0 109.081 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -94.49 125.59 8.36 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.844 -1.169 . . . . 0.0 110.233 -179.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 131.97 2.01 4.37 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.964 HD12 ' CG2' ' A' ' 108' ' ' THR . 3.9 mm? -52.45 162.28 0.56 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.212 -1.169 . . . . 0.0 110.003 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.478 ' HB2' ' HB3' ' A' ' 163' ' ' ASN . 0.5 OUTLIER -87.33 -176.75 5.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.174 -0.954 . . . . 0.0 110.302 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -75.67 -22.92 56.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.287 -0.883 . . . . 0.0 110.282 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 29.1 p-10 -113.99 41.64 2.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.939 . . . . 0.0 110.163 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.964 ' CG2' HD12 ' A' ' 104' ' ' LEU . 0.7 OUTLIER -86.3 130.5 34.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 110.471 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.44 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 38.4 p -117.01 149.74 39.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.294 -0.879 . . . . 0.0 109.871 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.548 ' CG ' ' HA ' ' A' ' 127' ' ' THR . 3.8 mtpt -55.9 -16.36 4.58 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.182 -0.949 . . . . 0.0 110.057 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.35 -56.68 4.48 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.183 -0.948 . . . . 0.0 110.779 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 2.9 p30 -65.53 -34.09 77.44 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.002 -1.061 . . . . 0.0 110.915 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.903 HD13 HD11 ' A' ' 104' ' ' LEU . 12.4 tp -75.6 -55.44 5.66 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.986 -1.071 . . . . 0.0 109.876 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.437 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -49.17 -41.55 37.01 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.217 -0.927 . . . . 0.0 109.818 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.447 ' O ' ' C ' ' A' ' 116' ' ' TYR . 2.3 m-20 -75.83 -48.5 21.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.896 . . . . 0.0 110.218 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.948 ' CD1' HD13 ' A' ' 162' ' ' LEU . 70.1 t80 -47.15 -33.35 5.1 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.665 -1.214 . . . . 0.0 108.261 178.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.658 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 18.1 m-85 -91.2 -14.75 30.47 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.035 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 115' ' ' ASP . 40.2 t -63.45 -12.39 30.97 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.94 -1.1 . . . . 0.0 109.316 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -80.86 -13.42 58.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.475 -0.765 . . . . 0.0 110.008 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 1.015 ' CD2' HG22 ' A' ' 154' ' ' VAL . 67.4 m-85 -88.9 -36.53 15.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.249 -0.907 . . . . 0.0 109.479 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -177.44 -164.64 31.33 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.492 ' HB3' ' HG3' ' A' ' 146' ' ' LYS . 0.4 OUTLIER -88.84 108.76 19.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.188 -1.184 . . . . 0.0 110.27 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.563 HG23 ' CD1' ' A' ' 145' ' ' PHE . 1.8 t -90.3 130.06 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.234 -0.916 . . . . 0.0 111.163 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.459 ' O ' ' OD1' ' A' ' 125' ' ' ASP . 2.1 t -89.46 -23.16 6.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.569 ' CB ' HD22 ' A' ' 144' ' ' LEU . 3.8 m-20 -147.58 167.88 23.41 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 118.345 -1.342 . . . . 0.0 112.901 -178.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.807 ' SG ' HD23 ' A' ' 113' ' ' LEU . 25.9 t -169.03 148.05 4.0 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.548 ' HA ' ' CG ' ' A' ' 110' ' ' LYS . 0.9 OUTLIER -151.27 162.69 40.44 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.652 -1.219 . . . . 0.0 111.926 -177.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.865 HD13 ' O ' ' A' ' 128' ' ' LEU . 1.1 tm? . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.665 ' CD1' ' CZ ' ' A' ' 100' ' ' PHE . 2.6 p90 . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 121.649 0.738 . . . . 0.0 111.496 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 127' ' ' THR . . . -121.91 -175.9 15.02 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.711 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 7.2 m-85 -120.04 171.73 8.25 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.02 -1.283 . . . . 0.0 110.987 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.662 HG23 HG13 ' A' ' 101' ' ' ILE . 6.4 t -140.76 129.42 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.569 HD22 ' CB ' ' A' ' 125' ' ' ASP . 6.3 mp -111.25 100.54 9.15 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.432 -0.792 . . . . 0.0 110.088 -178.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 1.009 ' CE2' HG21 ' A' ' 154' ' ' VAL . 8.1 m-85 -81.05 162.76 23.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.591 -0.693 . . . . 0.0 110.893 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.492 ' HG3' ' HB3' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -61.66 -48.86 78.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.523 -0.736 . . . . 0.0 110.073 179.225 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.551 ' O ' HG23 ' A' ' 151' ' ' VAL . 1.4 pm0 -144.51 171.55 14.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.267 -0.896 . . . . 0.0 110.667 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 149' ' ' GLU . 0.2 OUTLIER -55.67 -43.05 75.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.238 -0.914 . . . . 0.0 109.979 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.525 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 0.1 OUTLIER -42.1 -51.68 4.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 110.336 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.697 ' O ' HG23 ' A' ' 154' ' ' VAL . 2.2 p -66.32 -36.55 83.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.199 -0.938 . . . . 0.0 110.446 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.663 HG22 ' HB2' ' A' ' 145' ' ' PHE . 5.3 t -66.38 -56.65 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.074 -1.016 . . . . 0.0 110.446 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.525 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.7 OUTLIER -50.3 -38.78 43.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.141 -0.974 . . . . 0.0 109.666 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.486 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -57.33 -47.75 80.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.407 -0.808 . . . . 0.0 109.57 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 1.015 HG22 ' CD2' ' A' ' 120' ' ' PHE . 11.4 t -60.25 -31.98 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -0.876 . . . . 0.0 109.909 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 156' ' ' ASP . 6.4 mtt -75.5 -26.55 58.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.304 -0.872 . . . . 0.0 110.084 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.9 OUTLIER -46.71 -27.72 1.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.934 -1.104 . . . . 0.0 108.642 179.256 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.556 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 5.0 mt-30 -143.4 114.11 7.6 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.706 -0.621 . . . . 0.0 109.357 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.08 20.39 14.58 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.27 -0.894 . . . . 0.0 110.187 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -88.39 57.39 4.22 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.591 ' HE1' HG13 ' A' ' 154' ' ' VAL . 12.1 m-70 -87.13 81.76 7.91 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.327 -176.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -78.35 70.23 4.67 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.179 -0.95 . . . . 0.0 109.263 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.948 HD13 ' CD1' ' A' ' 116' ' ' TYR . 15.9 tp -87.96 145.49 25.99 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.443 -0.785 . . . . 0.0 110.235 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 105' ' ' SER . 0.8 OUTLIER 58.09 22.62 9.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.349 -0.845 . . . . 0.0 109.661 -179.584 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 75.83 22.59 74.28 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.93 144.63 26.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -1.108 . . . . 0.0 110.319 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 160' ' ' HIS . 3.8 t -78.27 160.87 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 109.674 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.525 ' CG1' ' HB2' ' A' ' 160' ' ' HIS . 1.3 pt -123.58 -174.98 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.114 -0.991 . . . . 0.0 111.046 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.55 ' N ' ' O ' ' A' ' 102' ' ' GLY . 5.6 t70 -128.91 89.81 47.71 Favored Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 47.6 Cg_endo -74.71 125.52 9.54 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.399 1.736 . . . . 0.0 110.655 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -150.27 -164.02 1.92 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.453 -0.779 . . . . 0.0 110.215 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.56 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.179 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.671 ' HE3' HD11 ' A' ' 144' ' ' LEU . 2.8 mtpp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.214 0.53 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.585 ' CE ' ' CD1' ' A' ' 101' ' ' ILE . 17.4 ttp -147.17 154.66 41.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.21 -0.931 . . . . 0.0 110.105 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.694 ' CE2' ' CZ ' ' A' ' 142' ' ' PHE . 2.3 t80 -110.15 135.4 51.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.359 -0.838 . . . . 0.0 109.994 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.585 ' CD1' ' CE ' ' A' ' 99' ' ' MET . 3.6 mm -112.87 97.66 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.28 -0.888 . . . . 0.0 109.48 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.545 ' HA2' ' CB ' ' A' ' 140' ' ' PHE . . . -89.36 109.32 3.58 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.508 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 134.06 36.86 0.24 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.867 HD12 HG21 ' A' ' 108' ' ' THR . 0.4 OUTLIER -83.68 149.22 26.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.335 -1.097 . . . . 0.0 109.442 179.507 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.51 ' CB ' ' HG1' ' A' ' 108' ' ' THR . 0.0 OUTLIER -69.8 146.24 51.55 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.054 -1.029 . . . . 0.0 109.545 179.478 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -62.03 -11.2 12.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.271 -0.893 . . . . 0.0 110.115 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.61 16.22 13.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.251 -0.906 . . . . 0.0 110.595 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.867 HG21 HD12 ' A' ' 104' ' ' LEU . 11.0 m -70.27 174.43 5.6 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.122 -0.986 . . . . 0.0 110.408 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.51 ' H ' HG22 ' A' ' 108' ' ' THR . 31.2 p -148.39 154.32 39.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.384 -0.822 . . . . 0.0 109.575 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.511 ' O ' ' HB2' ' A' ' 114' ' ' LYS . 13.7 mtmt -57.97 -16.86 13.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.337 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.47 -62.02 1.77 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.192 -0.942 . . . . 0.0 111.172 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 6.6 p30 -57.94 -28.37 64.23 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.038 -1.039 . . . . 0.0 110.775 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.823 HD13 HD11 ' A' ' 104' ' ' LEU . 16.0 tp -78.86 -40.53 32.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.983 -1.073 . . . . 0.0 109.696 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 110' ' ' LYS . 3.9 ttpt -55.37 -59.26 5.05 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.123 -0.986 . . . . 0.0 109.711 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.514 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 63.3 m-20 -61.78 -40.83 96.54 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.2 -0.937 . . . . 0.0 109.213 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.558 ' CG ' HD23 ' A' ' 162' ' ' LEU . 69.8 t80 -47.35 -40.48 17.42 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.203 177.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.665 ' HE2' HD11 ' A' ' 113' ' ' LEU . 27.0 m-85 -91.6 -4.56 55.16 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.673 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.514 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 1.4 m -70.16 -6.36 33.69 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.783 -1.198 . . . . 0.0 109.221 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.415 ' HA ' ' HE3' ' A' ' 119' ' ' LYS . 0.5 OUTLIER -80.46 -18.66 48.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.367 -0.833 . . . . 0.0 110.23 -179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 1.04 ' CG ' HG22 ' A' ' 154' ' ' VAL . 70.1 m-85 -89.49 -68.35 0.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.675 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.499 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -147.43 -165.11 11.61 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.47 ' O ' ' CB ' ' A' ' 146' ' ' LYS . 0.6 OUTLIER -90.3 119.82 30.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.159 -1.201 . . . . 0.0 110.863 -179.706 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.701 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.9 t -91.96 132.34 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -0.856 . . . . 0.0 110.244 179.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.4 HG12 ' OD2' ' A' ' 125' ' ' ASP . 2.1 t -89.07 -26.88 5.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.701 ' O ' HG13 ' A' ' 123' ' ' VAL . 1.4 m-20 -145.63 167.25 23.53 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.226 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 42.3 t -165.74 150.35 8.47 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.636 -0.665 . . . . 0.0 109.363 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.519 ' CG2' ' N ' ' A' ' 128' ' ' LEU . 0.9 OUTLIER -149.95 174.08 13.1 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.368 -0.833 . . . . 0.0 109.862 -179.099 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.782 ' C ' HD12 ' A' ' 128' ' ' LEU . 2.8 pp . . . . . 0 C--N 1.302 -1.46 0 O-C-N 121.426 -0.796 . . . . 0.0 110.068 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.594 ' CD1' ' CZ ' ' A' ' 100' ' ' PHE . 42.2 p90 . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 121.144 0.497 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.553 ' CA ' ' HA ' ' A' ' 128' ' ' LEU . . . -162.7 -164.64 18.16 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.694 ' CZ ' ' CE2' ' A' ' 100' ' ' PHE . 28.1 m-85 -140.37 167.19 22.74 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.893 -1.357 . . . . 0.0 111.27 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.675 ' O ' HD22 ' A' ' 144' ' ' LEU . 3.0 t -148.99 133.75 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.675 HD22 ' O ' ' A' ' 143' ' ' VAL . 3.2 mm? -116.12 94.33 4.61 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.665 -0.647 . . . . 0.0 109.569 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.946 ' CZ ' HG21 ' A' ' 154' ' ' VAL . 9.1 m-85 -73.0 161.18 30.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.418 -0.801 . . . . 0.0 110.992 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.47 ' CB ' ' O ' ' A' ' 122' ' ' GLU . 18.0 tptt -80.71 -39.4 27.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.594 -0.691 . . . . 0.0 111.182 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.609 ' O ' HG23 ' A' ' 151' ' ' VAL . 0.7 OUTLIER -133.66 158.48 43.13 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.853 -1.154 . . . . 0.0 110.851 -179.305 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 78.0 p -63.23 -27.7 69.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 109.964 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.519 ' CB ' ' OE2' ' A' ' 147' ' ' GLU . 0.3 OUTLIER -64.41 -43.47 94.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.371 -0.83 . . . . 0.0 109.761 179.721 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.499 ' CB ' ' HA3' ' A' ' 121' ' ' GLY . 11.5 p -64.46 -41.18 96.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.109 -0.994 . . . . 0.0 109.653 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.794 HG22 ' CB ' ' A' ' 145' ' ' PHE . 2.9 t -65.46 -45.44 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.635 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.449 ' OD2' ' O ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -54.23 -36.02 63.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.125 -0.984 . . . . 0.0 109.182 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.471 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 6.7 tttt -62.88 -43.58 98.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.469 -0.769 . . . . 0.0 109.379 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 1.04 HG22 ' CG ' ' A' ' 120' ' ' PHE . 20.5 t -64.7 -42.18 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.294 -0.879 . . . . 0.0 110.09 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 2.8 ttp -71.75 -21.71 61.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.331 -0.856 . . . . 0.0 109.944 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.0 OUTLIER -52.26 -31.49 32.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.14 -0.975 . . . . 0.0 109.423 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.526 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 0.8 OUTLIER -147.97 108.36 4.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.46 -0.775 . . . . 0.0 109.819 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.475 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -87.8 36.14 0.75 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.216 -0.928 . . . . 0.0 110.71 -179.658 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -89.33 48.96 1.68 Allowed 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 176.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.837 ' CB ' HD11 ' A' ' 167' ' ' ILE . 17.8 m-70 -87.68 93.75 9.53 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.267 -177.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -103.07 87.19 2.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 0.0 110.215 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.707 ' H ' HD12 ' A' ' 162' ' ' LEU . 0.4 OUTLIER -90.48 141.67 28.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.169 -0.957 . . . . 0.0 109.64 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 15.1 m120 50.42 23.78 1.37 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.138 -0.977 . . . . 0.0 110.215 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.72 37.25 26.98 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.96 136.24 18.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.165 -1.197 . . . . 0.0 110.272 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 160' ' ' HIS . 34.9 t -81.59 164.74 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.24 -0.913 . . . . 0.0 110.154 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.837 HD11 ' CB ' ' A' ' 160' ' ' HIS . 0.6 OUTLIER -128.68 174.17 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.186 -0.946 . . . . 0.0 110.709 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 102' ' ' GLY . 16.1 t0 -119.97 94.34 48.51 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.96 111.86 3.27 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.158 1.61 . . . . 0.0 110.83 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.536 ' O ' ' CG ' ' A' ' 99' ' ' MET . 2.1 mttt -125.72 152.87 44.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.572 -0.705 . . . . 0.0 109.652 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.296 -1.734 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.987 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.427 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 3.7 mtpp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.271 0.558 . . . . 0.0 110.294 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.988 ' CE ' HD11 ' A' ' 101' ' ' ILE . 4.0 ptm -141.41 170.11 16.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.334 -0.854 . . . . 0.0 109.98 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.881 ' O ' HD13 ' A' ' 101' ' ' ILE . 2.2 t80 -112.96 142.84 45.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.907 . . . . 0.0 110.489 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.988 HD11 ' CE ' ' A' ' 99' ' ' MET . 15.9 mm -131.22 99.14 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.306 -0.871 . . . . 0.0 109.548 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.566 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -99.83 132.85 11.08 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.809 -1.186 . . . . 0.0 110.557 -179.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.443 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 127.9 28.03 0.9 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.773 HD11 HD13 ' A' ' 113' ' ' LEU . 3.4 mm? -87.97 167.5 13.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.004 -1.292 . . . . 0.0 110.082 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.435 ' N ' ' OG1' ' A' ' 108' ' ' THR . 3.1 p -88.43 144.48 26.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.857 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 15.7 m-90 -45.74 -21.38 0.11 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.153 -0.967 . . . . 0.0 110.422 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 105' ' ' SER . 4.6 t0 -112.29 44.57 1.41 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.842 -1.162 . . . . 0.0 110.103 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.702 HG21 HD12 ' A' ' 104' ' ' LEU . 87.6 m -90.67 167.74 12.29 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.145 -0.972 . . . . 0.0 110.713 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.532 ' N ' HG22 ' A' ' 108' ' ' THR . 64.1 p -146.42 152.09 38.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.379 -0.826 . . . . 0.0 109.862 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 114' ' ' LYS . 7.6 pttm -63.7 -11.95 30.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.125 -0.984 . . . . 0.0 109.482 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.59 -56.23 4.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.373 -0.83 . . . . 0.0 110.525 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.427 ' OD1' ' C ' ' A' ' 112' ' ' ASP . 0.6 OUTLIER -63.74 -36.76 84.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.118 -0.989 . . . . 0.0 109.938 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.773 HD13 HD11 ' A' ' 104' ' ' LEU . 3.6 tp -73.49 -45.16 55.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 109.746 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 5.8 ttpt -57.11 -38.88 74.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.296 -0.878 . . . . 0.0 109.555 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.501 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 83.8 m-20 -74.08 -49.77 22.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.239 -0.913 . . . . 0.0 109.736 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.422 ' C ' ' O ' ' A' ' 115' ' ' ASP . 65.2 t80 -47.75 -33.2 6.77 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 118.669 -1.212 . . . . 0.0 108.154 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.667 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 17.1 m-85 -91.03 -11.92 37.36 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.972 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.501 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 0.4 OUTLIER -64.34 -13.17 48.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.005 -1.059 . . . . 0.0 109.133 179.06 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -80.44 -13.2 59.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.432 -0.793 . . . . 0.0 109.839 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.995 ' CD2' HG22 ' A' ' 154' ' ' VAL . 64.1 m-85 -89.45 -64.27 1.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.298 -0.877 . . . . 0.0 109.48 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.434 ' HA3' ' HB3' ' A' ' 150' ' ' SER . . . -153.19 -170.36 19.33 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -85.27 119.87 26.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.182 -1.187 . . . . 0.0 110.24 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.614 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.9 t -93.92 130.08 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.144 -0.972 . . . . 0.0 111.048 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.405 ' O ' ' OD1' ' A' ' 125' ' ' ASP . 2.2 t -89.37 -26.02 5.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.614 ' O ' HG13 ' A' ' 123' ' ' VAL . 2.2 m-20 -143.98 161.61 38.3 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.24 -0.984 . . . . 0.0 111.704 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.591 ' SG ' HD23 ' A' ' 113' ' ' LEU . 45.1 t -166.27 120.76 1.15 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.635 -0.665 . . . . 0.0 109.302 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.412 ' CG2' ' N ' ' A' ' 128' ' ' LEU . 0.8 OUTLIER -114.52 167.99 10.25 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.384 -0.822 . . . . 0.0 110.294 -179.063 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.894 HD13 ' O ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 110.766 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.566 ' HB2' ' HA2' ' A' ' 102' ' ' GLY . 18.9 p90 . . . . . 0 N--CA 1.497 1.919 0 CA-C-O 121.619 0.724 . . . . 0.0 111.416 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.541 ' CA ' ' HA ' ' A' ' 128' ' ' LEU . . . -129.04 170.6 20.11 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.723 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 6.6 m-85 -114.31 173.05 6.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -1.149 . . . . 0.0 110.763 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.625 ' HB ' ' HE2' ' A' ' 99' ' ' MET . 13.8 t -146.18 137.51 19.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.558 HD12 ' C ' ' A' ' 143' ' ' VAL . 5.8 mp -123.12 101.18 7.25 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.416 -0.803 . . . . 0.0 109.727 -179.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 1.072 ' CZ ' HG21 ' A' ' 154' ' ' VAL . 18.7 m-85 -75.53 152.43 37.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.369 -0.832 . . . . 0.0 110.245 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.23 -25.59 55.22 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.426 -0.796 . . . . 0.0 111.087 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.668 ' O ' HG23 ' A' ' 151' ' ' VAL . 11.9 tt0 -133.04 147.36 52.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.677 -1.264 . . . . 0.0 110.765 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.447 ' N ' ' HG2' ' A' ' 147' ' ' GLU . 7.4 t -56.47 -45.87 80.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.086 -1.009 . . . . 0.0 109.442 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.555 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 14.1 tt0 -49.75 -60.99 2.38 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.498 -0.751 . . . . 0.0 109.993 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.471 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 0.2 OUTLIER -43.23 -39.72 3.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.19 -0.944 . . . . 0.0 109.716 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.894 HG22 ' HB2' ' A' ' 145' ' ' PHE . 5.3 t -66.2 -51.05 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.899 . . . . 0.0 110.262 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.555 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.3 OUTLIER -52.16 -27.18 13.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.133 -0.979 . . . . 0.0 109.924 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.459 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 5.8 mmtt -72.67 -49.42 31.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.459 -0.776 . . . . 0.0 110.317 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 1.072 HG21 ' CZ ' ' A' ' 145' ' ' PHE . 5.6 t -63.93 -18.7 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.097 -1.002 . . . . 0.0 110.339 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 12.7 mmt -85.53 -38.23 18.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.121 -0.987 . . . . 0.0 110.489 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.2 OUTLIER -48.67 -34.64 12.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.118 -0.989 . . . . 0.0 110.233 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.529 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.6 mt-30 -128.51 94.89 3.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.312 -0.867 . . . . 0.0 110.013 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.621 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -90.39 21.84 3.69 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.154 -0.966 . . . . 0.0 110.412 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.554 ' CG ' ' O ' ' A' ' 159' ' ' GLU . 2.1 tt0 -88.39 67.21 8.58 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 177.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.624 ' HB3' HD11 ' A' ' 167' ' ' ILE . 87.3 m-70 -86.41 176.5 7.84 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.266 -177.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 160' ' ' HIS . 0.3 OUTLIER 179.62 74.3 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.487 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.693 HD12 ' HB2' ' A' ' 163' ' ' ASN . 1.4 pp -110.95 153.99 24.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.405 -0.809 . . . . 0.0 110.326 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.693 ' HB2' HD12 ' A' ' 162' ' ' LEU . 0.3 OUTLIER 67.09 8.56 6.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.378 -0.826 . . . . 0.0 109.859 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' A' ' 165' ' ' LYS . . . 89.38 18.14 53.51 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 164' ' ' GLY . 37.5 mmtt -150.28 161.45 42.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.129 -1.218 . . . . 0.0 110.353 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.523 HG22 ' H ' ' A' ' 167' ' ' ILE . 4.2 p -87.14 177.36 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.355 -0.841 . . . . 0.0 110.232 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.625 HD13 HD23 ' A' ' 162' ' ' LEU . 0.6 OUTLIER -135.29 -168.05 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.216 -0.928 . . . . 0.0 110.943 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 102' ' ' GLY . 8.4 t70 -143.04 87.05 8.9 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 43.8 Cg_endo -71.88 131.69 18.73 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.314 1.691 . . . . 0.0 110.73 -178.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.82 166.25 27.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.443 -0.785 . . . . 0.0 110.26 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 . . . . . 0 C--N 1.3 -1.548 0 C-N-CA 119.264 -0.975 . . . . 0.0 109.869 178.631 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.503 ' HA ' ' HG ' ' A' ' 144' ' ' LEU . 70.0 mttt . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.143 0.496 . . . . 0.0 110.026 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.474 ' HE3' ' HB3' ' A' ' 99' ' ' MET . 10.2 mmm -142.19 177.42 8.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 110.763 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.741 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 3.6 t80 -132.85 142.51 48.99 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.544 -0.722 . . . . 0.0 110.203 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.65 HD13 ' O ' ' A' ' 100' ' ' PHE . 4.2 mm -125.57 98.86 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.293 -0.879 . . . . 0.0 109.792 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -98.82 130.07 10.1 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 134.15 3.53 3.13 Favored Glycine 0 N--CA 1.492 2.383 0 O-C-N 121.123 -1.222 . . . . 0.0 110.163 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.899 HD21 HD13 ' A' ' 113' ' ' LEU . 6.7 mp -64.86 166.16 9.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.073 -1.251 . . . . 0.0 110.186 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.6 p -90.72 -174.56 4.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.297 -0.877 . . . . 0.0 109.793 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -87.48 16.82 5.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.0 109.968 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -144.56 16.61 1.65 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.309 -0.87 . . . . 0.0 110.454 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.811 HG23 ' OD1' ' A' ' 163' ' ' ASN . 11.3 m -73.43 168.16 19.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.939 -1.101 . . . . 0.0 109.78 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.467 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 29.8 p -144.6 152.04 39.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.134 -0.979 . . . . 0.0 110.604 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 114' ' ' LYS . 4.2 ttpt -53.51 -19.61 3.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.141 -0.974 . . . . 0.0 109.578 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.1 OUTLIER -72.12 -55.1 7.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.394 -0.817 . . . . 0.0 110.285 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 109' ' ' THR . 0.4 OUTLIER -65.71 -33.14 75.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.124 -0.985 . . . . 0.0 109.95 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.907 HD12 ' CD2' ' A' ' 162' ' ' LEU . 5.7 tp -73.85 -51.7 15.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 109.804 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 110' ' ' LYS . 1.1 ttpm? -60.0 -39.37 85.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 110.155 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 116' ' ' TYR . 0.5 OUTLIER -76.33 -54.38 6.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.081 -1.012 . . . . 0.0 110.572 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.719 ' CG ' HD13 ' A' ' 162' ' ' LEU . 65.4 t80 -46.39 -32.49 3.25 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.683 -1.207 . . . . 0.0 108.302 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.665 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 17.4 m-85 -91.23 -13.54 32.62 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.894 -0.723 . . . . 0.0 111.302 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 115' ' ' ASP . 5.7 t -64.11 -11.26 28.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.946 -1.096 . . . . 0.0 109.424 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 0.8 OUTLIER -83.83 -12.41 55.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.411 -0.805 . . . . 0.0 110.545 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.665 ' CD1' ' HA ' ' A' ' 117' ' ' PHE . 81.6 m-85 -89.03 -50.05 6.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.063 -1.023 . . . . 0.0 109.354 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.537 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -164.89 -164.73 20.88 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.408 ' O ' ' CB ' ' A' ' 146' ' ' LYS . 1.2 tt0 -90.12 107.67 19.27 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.388 -1.066 . . . . 0.0 110.086 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.8 t -89.46 132.34 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 111.19 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.433 HG12 ' OD1' ' A' ' 125' ' ' ASP . 2.4 t -90.15 -23.34 6.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.568 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 0.4 OUTLIER -143.51 158.98 43.23 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 118.525 -1.27 . . . . 0.0 112.848 -178.801 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.803 ' SG ' HD23 ' A' ' 113' ' ' LEU . 6.2 t -169.24 147.76 3.81 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.501 ' O ' HD22 ' A' ' 113' ' ' LEU . 0.8 OUTLIER -150.8 169.96 20.42 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.992 -1.067 . . . . 0.0 110.828 -178.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.965 HD13 ' O ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.662 -0.649 . . . . 0.0 109.473 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.491 ' CA ' ' HB2' ' A' ' 104' ' ' LEU . 13.9 p90 . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.306 0.574 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.614 ' H ' HD13 ' A' ' 104' ' ' LEU . . . -126.61 -165.8 12.05 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.741 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 10.7 m-85 -129.45 168.6 16.1 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.415 -1.05 . . . . 0.0 110.414 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.698 ' C ' HD12 ' A' ' 144' ' ' LEU . 3.5 t -145.66 144.95 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.418 -0.801 . . . . 0.0 109.378 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.698 HD12 ' C ' ' A' ' 143' ' ' VAL . 4.5 mp -134.09 98.31 4.1 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.565 -0.709 . . . . 0.0 109.828 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.703 ' HB2' HG22 ' A' ' 151' ' ' VAL . 38.2 m-85 -76.4 160.45 29.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.528 -0.732 . . . . 0.0 110.47 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.408 ' CB ' ' O ' ' A' ' 122' ' ' GLU . 4.6 tttm -104.0 -3.07 25.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.484 -0.76 . . . . 0.0 111.011 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.777 ' O ' HG23 ' A' ' 151' ' ' VAL . 1.1 tt0 -139.97 145.41 37.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.865 -1.147 . . . . 0.0 110.706 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.5 p -59.95 -36.5 77.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.99 -1.069 . . . . 0.0 109.296 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.51 ' CB ' ' OE1' ' A' ' 147' ' ' GLU . 0.4 OUTLIER -63.06 -53.99 45.07 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.425 -0.797 . . . . 0.0 109.792 179.398 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.537 ' CB ' ' HA3' ' A' ' 121' ' ' GLY . 60.9 p -48.59 -34.32 11.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.076 -1.015 . . . . 0.0 109.664 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 147' ' ' GLU . 3.4 t -78.55 -47.7 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.416 -0.803 . . . . 0.0 110.185 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -61.23 -22.28 64.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.968 -1.082 . . . . 0.0 109.336 179.775 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.474 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -76.19 -58.8 3.07 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.441 -0.787 . . . . 0.0 109.866 179.597 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.654 HG23 ' CE2' ' A' ' 120' ' ' PHE . 5.3 p -55.6 -20.9 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.048 -1.032 . . . . 0.0 109.979 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 2.6 ttp -88.06 -29.96 20.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.408 -0.808 . . . . 0.0 110.384 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.474 ' OD2' ' O ' ' A' ' 153' ' ' LYS . 0.2 OUTLIER -53.78 -36.46 62.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 109.705 179.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.584 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 0.7 OUTLIER -128.5 97.51 4.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.352 -0.843 . . . . 0.0 109.509 179.634 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -88.2 10.5 19.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.245 -0.91 . . . . 0.0 110.757 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.451 ' CG ' ' O ' ' A' ' 159' ' ' GLU . 3.2 pt-20 -87.38 68.51 9.76 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 11.6 m-70 -87.75 -167.38 1.86 Allowed 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.613 -177.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -176.44 73.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.512 -0.743 . . . . 0.0 109.818 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.907 ' CD2' HD12 ' A' ' 113' ' ' LEU . 10.1 tp -88.56 134.75 33.78 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.285 -0.885 . . . . 0.0 110.127 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.811 ' OD1' HG23 ' A' ' 108' ' ' THR . 2.3 m120 58.21 24.48 11.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.83 . . . . 0.0 109.961 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 75.9 33.29 51.17 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.75 134.23 16.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -1.184 . . . . 0.0 110.527 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 167' ' ' ILE . 75.5 t -65.37 162.22 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 109.742 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.513 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -126.41 177.56 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.104 -0.998 . . . . 0.0 110.79 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 102' ' ' GLY . 23.8 t0 -124.18 90.1 51.13 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.84 113.37 3.74 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.313 1.691 . . . . 0.0 111.339 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.461 ' HE2' ' OD2' ' A' ' 168' ' ' ASP . 24.6 mmtt -131.29 169.15 16.37 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.542 -0.724 . . . . 0.0 109.334 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.439 ' HA ' ' SD ' ' A' ' 99' ' ' MET . 5.8 mtp85 . . . . . 0 C--N 1.296 -1.73 0 C-N-CA 118.499 -1.28 . . . . 0.0 109.806 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.481 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 12.8 mttt . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.207 0.527 . . . . 0.0 109.816 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.677 ' SD ' HD11 ' A' ' 101' ' ' ILE . 10.9 ptm -126.05 175.25 7.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.086 -1.009 . . . . 0.0 110.475 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.709 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 1.6 t80 -121.38 122.85 40.73 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.677 HD11 ' SD ' ' A' ' 99' ' ' MET . 3.7 mm -108.36 96.91 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 109.382 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -89.61 98.4 2.44 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 156.87 36.52 0.02 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.924 HD12 HG21 ' A' ' 108' ' ' THR . 3.5 mm? -90.45 155.67 18.76 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.181 -1.188 . . . . 0.0 110.007 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.485 ' N ' ' OG1' ' A' ' 108' ' ' THR . 0.0 OUTLIER -78.45 -171.98 2.69 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.205 -0.934 . . . . 0.0 109.754 179.543 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.415 ' N ' ' OG ' ' A' ' 105' ' ' SER . 7.1 m0 -84.0 -17.77 39.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.02 -1.05 . . . . 0.0 110.32 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -122.84 31.02 6.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.909 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.924 HG21 HD12 ' A' ' 104' ' ' LEU . 6.9 m -76.69 149.98 36.38 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.384 -0.822 . . . . 0.0 110.406 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.467 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 28.3 p -130.18 149.14 52.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.352 -0.843 . . . . 0.0 109.961 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.482 ' HG2' ' N ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -57.64 -17.78 16.58 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.127 -0.983 . . . . 0.0 109.16 179.256 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.482 ' N ' ' HG2' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -65.71 -58.61 5.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.502 -0.748 . . . . 0.0 109.978 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 109' ' ' THR . 1.7 p-10 -67.48 -42.49 82.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.105 -0.997 . . . . 0.0 110.097 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.552 HD13 HD11 ' A' ' 104' ' ' LEU . 26.2 tp -60.54 -48.46 81.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 109.703 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.625 ' HG3' HG11 ' A' ' 123' ' ' VAL . 27.6 ttpt -58.29 -31.97 67.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.313 -0.867 . . . . 0.0 109.748 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 118' ' ' SER . 86.8 m-20 -78.03 -54.31 6.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.274 -0.891 . . . . 0.0 110.199 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.454 ' C ' ' O ' ' A' ' 115' ' ' ASP . 62.7 t80 -47.18 -31.52 3.66 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 118.586 -1.246 . . . . 0.0 108.066 178.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.663 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 16.7 m-85 -90.35 -16.28 29.49 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.836 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 115' ' ' ASP . 22.4 t -61.45 -15.92 41.93 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.894 -1.129 . . . . 0.0 108.536 178.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.23 -18.01 61.28 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.533 0.682 . . . . 0.0 109.834 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 1.093 ' CE2' HG23 ' A' ' 154' ' ' VAL . 55.2 m-85 -89.48 -58.47 2.51 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.623 0.725 . . . . 0.0 109.414 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.32 -162.96 12.0 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -90.58 135.08 33.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.962 -1.316 . . . . 0.0 110.005 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.625 HG11 ' HG3' ' A' ' 114' ' ' LYS . 1.9 t -109.19 132.83 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.223 -0.923 . . . . 0.0 110.744 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.23 -26.24 5.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.49 ' O ' HG13 ' A' ' 123' ' ' VAL . 6.7 m-20 -148.76 162.94 38.76 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 118.715 -1.194 . . . . 0.0 112.413 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 11.6 t -164.94 143.42 6.53 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.523 ' CG2' ' N ' ' A' ' 128' ' ' LEU 0.25 1.0 OUTLIER -150.71 170.96 17.95 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 118.679 -1.209 . . . . 0.0 112.093 -177.318 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.573 HD22 ' O ' ' A' ' 108' ' ' THR . 8.5 tp . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.608 ' CD2' ' CZ ' ' A' ' 100' ' ' PHE . 18.7 p90 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.148 0.499 . . . . 0.0 110.68 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 128' ' ' LEU . . . -147.52 -164.11 11.02 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.709 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 14.6 m-85 -130.19 172.21 12.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.157 -1.201 . . . . 0.0 111.348 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.816 ' O ' HD12 ' A' ' 144' ' ' LEU . 3.9 t -146.47 145.58 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.816 HD12 ' O ' ' A' ' 143' ' ' VAL . 5.3 mp -130.59 106.03 8.23 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.984 -1.072 . . . . 0.0 109.898 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.752 ' HB2' HG22 ' A' ' 151' ' ' VAL . 15.9 m-85 -78.82 166.28 22.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.501 -0.75 . . . . 0.0 111.046 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -80.9 -31.97 34.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.696 -0.627 . . . . 0.0 110.408 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.561 ' O ' HG23 ' A' ' 151' ' ' VAL . 0.3 OUTLIER -143.09 152.03 41.4 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.108 -0.995 . . . . 0.0 110.64 -179.619 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.5 m -50.88 -41.0 57.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.915 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.546 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 2.8 tt0 -48.51 -62.92 1.25 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.326 -0.859 . . . . 0.0 110.159 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.479 ' OG ' ' HG3' ' A' ' 147' ' ' GLU . 4.4 p -48.14 -36.07 12.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.0 109.947 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.792 ' O ' HG12 ' A' ' 154' ' ' VAL . 4.6 t -68.56 -52.71 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.12 -0.988 . . . . 0.0 110.362 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.546 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -57.75 -35.1 70.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.974 -1.079 . . . . 0.0 109.783 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.47 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.1 OUTLIER -65.69 -33.82 76.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.368 -0.832 . . . . 0.0 110.162 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 1.093 HG23 ' CE2' ' A' ' 120' ' ' PHE . 5.9 p -87.86 -19.6 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.025 -1.047 . . . . 0.0 110.336 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 24.8 ttt -89.09 -25.76 21.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.946 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 4.5 p-10 -52.37 -32.24 37.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -0.903 . . . . 0.0 109.618 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.558 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -131.4 90.0 2.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.344 -0.848 . . . . 0.0 109.595 179.572 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.45 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -83.97 18.18 2.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.151 -0.968 . . . . 0.0 111.011 -179.482 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -87.68 64.3 7.95 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 177.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.715 ' ND1' HD11 ' A' ' 167' ' ' ILE . 14.1 m170 -87.05 -169.84 2.8 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.11 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 160' ' ' HIS . 5.9 ttpt 177.55 66.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.622 HD12 ' HB2' ' A' ' 163' ' ' ASN . 1.3 pp -101.67 157.85 16.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.844 . . . . 0.0 110.105 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.622 ' HB2' HD12 ' A' ' 162' ' ' LEU . 0.3 OUTLIER 59.5 15.33 4.43 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.163 -0.961 . . . . 0.0 109.461 -179.405 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.51 21.44 64.32 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.5 146.59 26.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -1.174 . . . . 0.0 110.715 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.574 HG12 ' N ' ' A' ' 167' ' ' ILE . 51.1 t -76.99 176.39 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.418 -0.801 . . . . 0.0 109.088 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.715 HD11 ' ND1' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -143.16 166.45 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.904 -1.122 . . . . 0.0 111.544 -179.458 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -115.55 82.88 10.35 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.517 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 45.1 Cg_endo -72.9 130.28 15.41 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.214 1.639 . . . . 0.0 111.155 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.1 -164.88 2.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.581 -0.699 . . . . 0.0 110.046 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.299 -1.614 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.06 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.406 ' HA ' ' HG ' ' A' ' 144' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.226 0.536 . . . . 0.0 110.183 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.644 ' HE2' ' O ' ' A' ' 170' ' ' LYS . 6.4 mtp -143.11 173.89 11.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.148 -0.97 . . . . 0.0 110.432 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.7 ' O ' HD13 ' A' ' 101' ' ' ILE . 2.4 t80 -122.84 134.92 54.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.608 -0.683 . . . . 0.0 110.575 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.7 HD13 ' O ' ' A' ' 100' ' ' PHE . 15.1 mm -122.68 106.73 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.27 -0.894 . . . . 0.0 109.73 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -103.21 119.38 6.38 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.713 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 128.53 47.83 0.16 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 1.065 HD12 HG21 ' A' ' 108' ' ' THR . 2.3 mm? -90.56 167.67 12.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.118 -1.225 . . . . 0.0 110.354 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.532 ' HB3' ' CB ' ' A' ' 163' ' ' ASN . 0.4 OUTLIER -90.16 138.9 31.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.272 -0.893 . . . . 0.0 110.19 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -44.96 -22.77 0.1 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.881 -1.137 . . . . 0.0 110.718 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 105' ' ' SER . 6.7 t0 -114.86 38.53 3.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.106 -0.996 . . . . 0.0 111.134 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 1.065 HG21 HD12 ' A' ' 104' ' ' LEU . 1.5 m -87.36 161.85 17.68 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.74 -1.225 . . . . 0.0 109.998 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 69.3 p -139.82 154.54 47.36 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.42 -0.8 . . . . 0.0 109.867 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 126' ' ' CYS . 4.9 mttp -58.85 -14.33 8.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.134 -0.979 . . . . 0.0 110.134 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.436 ' HE2' ' HE2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -81.04 -55.82 4.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.861 . . . . 0.0 110.702 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -63.38 -44.29 95.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.003 -1.061 . . . . 0.0 110.466 -179.491 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.805 ' CD1' HD11 ' A' ' 104' ' ' LEU . 0.6 OUTLIER -65.72 -46.89 77.22 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.895 -1.128 . . . . 0.0 109.586 179.681 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.454 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 7.2 ttpp -54.1 -40.78 67.59 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.146 -0.971 . . . . 0.0 109.82 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 116' ' ' TYR . 69.7 m-20 -75.38 -47.27 28.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 109.707 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.685 ' CD2' HD22 ' A' ' 162' ' ' LEU . 52.7 t80 -47.51 -34.65 7.79 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 118.841 -1.144 . . . . 0.0 108.089 178.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.546 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 11.5 m-85 -91.2 -13.78 32.23 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.116 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 115' ' ' ASP . 7.2 m -64.87 -12.67 51.32 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.76 -1.212 . . . . 0.0 108.431 178.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.42 -26.69 61.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.581 -0.699 . . . . 0.0 110.39 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.546 ' CD2' ' HA ' ' A' ' 117' ' ' PHE . 28.2 m-85 -88.67 -57.19 3.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.094 -1.004 . . . . 0.0 109.197 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.487 ' HA3' ' HB3' ' A' ' 150' ' ' SER . . . -159.52 167.52 35.16 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.31 156.52 22.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.138 -1.213 . . . . 0.0 109.913 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.628 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.7 t -125.27 129.91 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.179 -0.951 . . . . 0.0 110.922 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.904 HG23 ' HG2' ' A' ' 146' ' ' LYS . 2.2 t -89.64 -25.34 5.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.628 ' O ' HG13 ' A' ' 123' ' ' VAL . 2.7 m-20 -140.61 161.45 37.72 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.773 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.616 ' SG ' HD23 ' A' ' 113' ' ' LEU . 6.8 t -169.95 128.49 0.91 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.666 0.746 . . . . 0.0 109.708 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.428 ' OG1' ' HB2' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -125.88 146.74 49.7 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.605 -0.684 . . . . 0.0 110.875 -178.502 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.868 HD13 ' O ' ' A' ' 128' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 110.083 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.536 ' HB2' ' HA2' ' A' ' 102' ' ' GLY . 1.7 p90 . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.034 0.445 . . . . 0.0 110.545 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -159.68 177.94 35.98 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.691 ' CZ ' ' CE2' ' A' ' 100' ' ' PHE . 19.4 m-85 -113.57 171.26 7.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.117 -1.225 . . . . 0.0 110.754 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.719 ' CG2' HD21 ' A' ' 113' ' ' LEU . 25.1 t -148.89 127.72 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.553 -0.717 . . . . 0.0 109.351 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.549 ' HB2' ' CB ' ' A' ' 125' ' ' ASP . 6.6 mp -115.96 103.95 11.11 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.546 -0.721 . . . . 0.0 110.214 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.824 ' HB2' HG22 ' A' ' 151' ' ' VAL . 46.0 m-85 -75.73 162.3 28.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.575 -0.703 . . . . 0.0 110.417 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.904 ' HG2' HG23 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -85.29 -23.61 28.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.535 -0.728 . . . . 0.0 111.117 -179.303 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.828 ' O ' HG23 ' A' ' 151' ' ' VAL . 0.6 OUTLIER -128.78 158.75 37.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.747 -1.221 . . . . 0.0 110.988 -179.568 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.3 p -71.88 -44.49 63.66 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.318 -0.864 . . . . 0.0 109.335 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.53 ' CB ' ' OE1' ' A' ' 147' ' ' GLU . 0.3 OUTLIER -55.87 -40.57 73.12 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.415 -0.803 . . . . 0.0 109.54 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.487 ' HB3' ' HA3' ' A' ' 121' ' ' GLY . 1.4 p -62.47 -34.19 76.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.153 -0.967 . . . . 0.0 109.356 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.828 HG23 ' O ' ' A' ' 147' ' ' GLU . 5.2 t -73.93 -52.89 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.213 -0.93 . . . . 0.0 110.216 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.506 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -51.49 -38.52 54.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.01 -1.056 . . . . 0.0 109.878 -179.781 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.479 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -65.04 -46.63 80.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.325 -0.859 . . . . 0.0 110.024 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.804 HG12 ' O ' ' A' ' 151' ' ' VAL . 1.4 p -66.12 -13.31 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.029 -1.044 . . . . 0.0 109.963 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.425 ' CE ' ' HA ' ' A' ' 170' ' ' LYS . 2.3 tpt -89.61 -52.94 4.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.348 -0.845 . . . . 0.0 110.748 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.5 OUTLIER -53.07 -31.25 40.64 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.071 -1.018 . . . . 0.0 110.017 -179.734 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.504 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.1 mm100 -112.65 78.37 1.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.299 -0.876 . . . . 0.0 109.686 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.613 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 10.6 pttp -86.86 25.65 1.26 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.27 -0.894 . . . . 0.0 111.014 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -88.2 67.08 8.7 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.613 ' CD2' ' HA ' ' A' ' 158' ' ' LYS . 84.1 m-70 -86.39 -179.99 6.77 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.727 -177.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.66 ' C ' HD23 ' A' ' 162' ' ' LEU . 23.0 ttpt -179.93 83.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.402 -0.811 . . . . 0.0 109.684 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.808 HD11 HD13 ' A' ' 167' ' ' ILE . 0.1 OUTLIER -101.96 146.17 28.24 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.175 -0.953 . . . . 0.0 109.707 -179.456 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.532 ' CB ' ' HB3' ' A' ' 105' ' ' SER . 6.4 m120 53.8 18.26 1.51 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.931 . . . . 0.0 109.996 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 83.23 28.83 35.45 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -145.71 143.53 29.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.132 -1.216 . . . . 0.0 110.427 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 167' ' ' ILE . 17.3 t -79.9 169.82 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.957 . . . . 0.0 110.303 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.808 HD13 HD11 ' A' ' 162' ' ' LEU . 0.7 OUTLIER -131.07 -178.66 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.208 -0.932 . . . . 0.0 110.702 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 102' ' ' GLY . 16.7 t70 -119.93 83.22 29.68 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.526 ' CG ' ' HB2' ' A' ' 158' ' ' LYS . 47.5 Cg_endo -72.62 114.24 3.96 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.353 1.712 . . . . 0.0 110.986 -178.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.644 ' O ' ' HE2' ' A' ' 99' ' ' MET . 2.4 mtmp? -136.03 173.36 11.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.512 -0.743 . . . . 0.0 109.246 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.527 ' HA ' ' HG2' ' A' ' 99' ' ' MET . 0.2 OUTLIER . . . . . 0 C--N 1.295 -1.789 0 C-N-CA 118.689 -1.205 . . . . 0.0 109.876 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.487 ' HA ' ' HG ' ' A' ' 144' ' ' LEU . 47.3 mttt . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.344 0.593 . . . . 0.0 110.506 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.494 ' HG3' HG13 ' A' ' 151' ' ' VAL . 0.0 OUTLIER -143.29 -174.9 4.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.892 . . . . 0.0 110.217 179.724 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.95 ' O ' HD13 ' A' ' 101' ' ' ILE . 10.5 t80 -143.08 148.5 36.77 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.304 -0.872 . . . . 0.0 110.526 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.95 HD13 ' O ' ' A' ' 100' ' ' PHE . 4.0 mm -125.04 108.58 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.504 -0.748 . . . . 0.0 110.14 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -103.25 118.27 6.01 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.416 ' C ' HD22 ' A' ' 104' ' ' LEU . . . 133.86 41.29 0.17 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.983 HD12 HG21 ' A' ' 108' ' ' THR . 4.0 mm? -90.26 155.03 19.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.337 -1.096 . . . . 0.0 109.916 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.49 ' N ' ' OG1' ' A' ' 108' ' ' THR . 24.1 p -72.08 -176.78 1.85 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.154 -0.966 . . . . 0.0 110.318 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 83.7 t90 -75.11 -27.08 59.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.174 -0.954 . . . . 0.0 110.326 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -113.72 37.16 3.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.215 -0.928 . . . . 0.0 110.22 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.983 HG21 HD12 ' A' ' 104' ' ' LEU . 1.5 m -77.55 149.03 34.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.13 -0.981 . . . . 0.0 110.271 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.481 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 44.0 p -130.5 159.63 36.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.292 -0.88 . . . . 0.0 110.455 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.486 ' HB2' ' HA ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -65.26 -14.72 61.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.18 -0.95 . . . . 0.0 109.911 179.702 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -82.54 -53.88 5.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 110.842 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.481 ' OD1' ' O ' ' A' ' 109' ' ' THR . 0.7 OUTLIER -61.77 -35.65 78.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.979 -1.076 . . . . 0.0 110.284 -179.553 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.705 HD13 HD11 ' A' ' 104' ' ' LEU . 23.6 tp -71.62 -56.46 5.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 109.931 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.421 ' HB2' ' CB ' ' A' ' 126' ' ' CYS . 1.9 tttt -51.39 -34.44 34.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.182 -0.949 . . . . 0.0 109.733 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.504 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 0.5 OUTLIER -73.93 -55.03 6.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 109.906 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.441 ' C ' ' O ' ' A' ' 115' ' ' ASP . 60.2 t80 -47.36 -31.19 3.76 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.531 -1.268 . . . . 0.0 108.118 178.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.624 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 12.8 m-85 -90.72 -10.43 43.06 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.166 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.504 ' HB3' ' HA ' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -65.09 -10.96 34.58 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.839 -1.163 . . . . 0.0 109.386 179.233 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -80.77 -16.65 53.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.477 -0.765 . . . . 0.0 109.991 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.892 ' CG ' HG22 ' A' ' 154' ' ' VAL . 75.7 m-85 -88.76 -62.66 1.44 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 109.399 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.511 ' HA3' ' HB3' ' A' ' 150' ' ' SER . . . -157.72 164.99 33.4 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 146' ' ' LYS . 19.4 mt-10 -62.15 119.58 9.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.017 -1.284 . . . . 0.0 110.176 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 125' ' ' ASP . 2.0 t -89.62 135.38 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 110.617 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.15 -23.73 6.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.517 ' HB2' ' HB2' ' A' ' 144' ' ' LEU . 6.5 m-20 -152.22 157.04 40.9 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 118.443 -1.303 . . . . 0.0 112.575 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.501 ' SG ' HD23 ' A' ' 113' ' ' LEU . 26.2 t -164.47 141.88 6.58 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.486 ' HA ' ' HB2' ' A' ' 110' ' ' LYS . 0.9 OUTLIER -151.22 166.19 31.64 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.582 -1.247 . . . . 0.0 112.348 -177.532 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.771 ' C ' HD13 ' A' ' 128' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.718 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.676 ' HA ' HD23 ' A' ' 104' ' ' LEU . 12.0 p90 . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.869 0.842 . . . . 0.0 111.894 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.524 ' O ' ' CE1' ' A' ' 100' ' ' PHE . . . -121.0 -176.44 15.42 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.716 ' CE1' ' CE1' ' A' ' 100' ' ' PHE . 8.0 m-85 -122.68 166.18 15.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.879 -1.365 . . . . 0.0 110.94 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.639 ' C ' HD12 ' A' ' 144' ' ' LEU . 2.5 t -146.6 139.77 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.456 -0.777 . . . . 0.0 109.727 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.639 HD12 ' C ' ' A' ' 143' ' ' VAL . 5.9 mp -127.71 111.61 13.88 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.605 -0.685 . . . . 0.0 109.307 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 1.149 ' CZ ' HG21 ' A' ' 154' ' ' VAL . 38.6 m-85 -79.41 150.69 31.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.684 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 122' ' ' GLU . 18.0 tttm -75.25 -19.8 59.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.433 -0.792 . . . . 0.0 110.901 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.786 ' O ' HG23 ' A' ' 151' ' ' VAL . 3.5 tt0 -138.63 157.89 45.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.813 -1.18 . . . . 0.0 111.111 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 4.4 p -67.61 -41.76 83.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 109.439 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.542 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 0.0 OUTLIER -56.97 -55.53 33.49 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.29 -0.881 . . . . 0.0 109.41 179.417 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.688 ' O ' HG23 ' A' ' 154' ' ' VAL . 4.0 p -45.71 -44.29 13.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.075 -1.016 . . . . 0.0 109.277 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.818 HG22 ' HB2' ' A' ' 145' ' ' PHE . 16.9 t -58.43 -47.81 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.905 . . . . 0.0 109.83 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.542 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.3 OUTLIER -58.64 -35.52 72.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.085 -1.01 . . . . 0.0 109.476 179.618 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.469 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 9.4 mmtt -63.35 -28.5 70.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.473 -0.767 . . . . 0.0 109.591 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 1.149 HG21 ' CZ ' ' A' ' 145' ' ' PHE . 2.8 t -88.87 -34.19 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.362 -0.836 . . . . 0.0 109.897 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.408 ' O ' ' C ' ' A' ' 156' ' ' ASP . 1.1 ttp -73.2 -36.6 66.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.863 . . . . 0.0 110.511 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 31.5 p-10 -44.63 -29.27 0.72 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.083 -1.01 . . . . 0.0 110.254 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.518 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -136.9 98.78 3.85 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.165 -0.96 . . . . 0.0 110.393 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.442 ' HA ' ' HD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -86.63 10.14 16.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.0 -1.062 . . . . 0.0 109.891 179.518 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 27.5 mp0 -88.14 68.48 9.09 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 177.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.601 ' HB2' HG13 ' A' ' 167' ' ' ILE . 41.3 m-70 -86.09 -168.7 2.33 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.589 -177.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.455 ' O ' ' CG ' ' A' ' 161' ' ' LYS . 0.0 OUTLIER 177.9 73.11 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.36 -0.837 . . . . 0.0 110.021 179.802 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.767 HD12 ' HB2' ' A' ' 163' ' ' ASN . 2.4 pp -110.07 151.51 27.12 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.311 -0.868 . . . . 0.0 109.853 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.767 ' HB2' HD12 ' A' ' 162' ' ' LEU . 0.2 OUTLIER 63.13 18.09 10.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.149 -0.969 . . . . 0.0 109.861 -179.507 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 75.35 25.17 68.94 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -149.82 154.28 38.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -1.173 . . . . 0.0 110.66 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.466 HG12 ' N ' ' A' ' 167' ' ' ILE . 24.1 t -84.81 167.4 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.379 -0.825 . . . . 0.0 109.688 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.601 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.9 OUTLIER -133.68 175.52 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.137 -0.977 . . . . 0.0 111.15 -179.493 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 102' ' ' GLY . 31.6 t0 -120.08 89.81 43.38 Favored Pre-proline 0 C--N 1.303 -1.426 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.64 120.41 6.43 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.172 1.617 . . . . 0.0 110.891 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.463 ' O ' ' SD ' ' A' ' 99' ' ' MET . 0.1 OUTLIER -140.47 169.63 17.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.885 . . . . 0.0 109.908 179.461 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.47 ' HA ' ' HG2' ' A' ' 99' ' ' MET . 19.4 ptp180 . . . . . 0 C--N 1.3 -1.574 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.542 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.523 ' CG ' ' HG ' ' A' ' 144' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.302 0.572 . . . . 0.0 110.239 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.547 ' CE ' HD11 ' A' ' 101' ' ' ILE . 12.6 ptm -147.58 175.2 11.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.189 -0.944 . . . . 0.0 110.411 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.767 ' C ' HD13 ' A' ' 101' ' ' ILE . 2.5 t80 -119.73 130.87 55.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.465 -0.772 . . . . 0.0 109.252 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.767 HD13 ' C ' ' A' ' 100' ' ' PHE . 3.7 mm -117.05 105.04 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.245 -0.91 . . . . 0.0 109.715 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.536 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -97.34 139.22 14.36 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.737 -1.221 . . . . 0.0 110.12 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.51 33.9 2.38 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 1.078 HD12 HG21 ' A' ' 108' ' ' THR . 1.8 mm? -84.68 148.72 26.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.106 -1.232 . . . . 0.0 110.004 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.495 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -76.52 147.5 37.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.158 -0.963 . . . . 0.0 110.799 -179.529 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.991 ' HA ' HD12 ' A' ' 130' ' ' LEU . 1.1 t90 -52.07 -17.19 0.96 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.304 -0.873 . . . . 0.0 110.99 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.86 35.55 4.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.904 -1.122 . . . . 0.0 111.163 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 1.078 HG21 HD12 ' A' ' 104' ' ' LEU . 1.5 m -88.35 171.29 10.26 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.986 -1.071 . . . . 0.0 110.057 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.478 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 73.0 p -149.12 170.56 18.13 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.178 -0.951 . . . . 0.0 110.242 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.532 ' O ' ' CB ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -70.5 -11.2 60.77 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.138 -0.977 . . . . 0.0 109.922 179.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -87.44 -58.68 2.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 110.539 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 5.4 p30 -60.56 -32.39 71.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.12 -0.988 . . . . 0.0 110.167 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 1.053 HD13 HD11 ' A' ' 104' ' ' LEU . 9.2 tp -79.96 -42.84 23.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.095 -1.003 . . . . 0.0 109.577 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 4.3 ttmt -63.21 -46.47 86.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.869 . . . . 0.0 109.346 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.413 ' O ' ' C ' ' A' ' 116' ' ' TYR . 1.5 t70 -66.05 -49.17 68.59 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.139 -0.976 . . . . 0.0 109.35 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.413 ' C ' ' O ' ' A' ' 115' ' ' ASP . 67.8 t80 -48.31 -35.4 12.23 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.765 -1.174 . . . . 0.0 108.065 177.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.611 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 11.7 m-85 -90.73 -3.58 57.35 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.25 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.8 t -71.66 -9.5 58.36 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.075 -1.016 . . . . 0.0 109.294 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.66 -15.81 53.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.377 -0.827 . . . . 0.0 110.034 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.839 ' CE2' HG23 ' A' ' 154' ' ' VAL . 70.2 m-85 -89.52 -40.9 12.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.326 -0.859 . . . . 0.0 109.44 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -177.49 -156.2 15.64 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.53 157.77 17.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.138 -1.213 . . . . 0.0 110.195 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 1.9 t -134.75 131.23 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.212 -0.93 . . . . 0.0 111.167 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -94.99 -24.65 4.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -146.42 159.06 43.88 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.999 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.751 ' SG ' HD23 ' A' ' 113' ' ' LEU . 40.5 t -170.47 105.56 0.29 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.848 0.832 . . . . 0.0 109.347 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.68 166.15 11.63 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.474 0.654 . . . . 0.0 110.979 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.919 HD13 ' O ' ' A' ' 128' ' ' LEU . 1.0 OUTLIER -146.37 104.26 3.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.413 -0.805 . . . . 0.0 110.268 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.955 ' O ' HD22 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -89.93 77.39 6.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.138 -0.976 . . . . 0.0 109.517 179.62 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.991 HD12 ' HA ' ' A' ' 106' ' ' TRP . 0.3 OUTLIER -149.36 21.08 0.95 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -45.85 109.26 0.93 Allowed Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.524 -0.735 . . . . 0.0 111.122 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.517 ' HA ' ' CD1' ' A' ' 106' ' ' TRP . 51.3 Cg_endo -84.13 -14.65 7.09 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.097 1.577 . . . . 0.0 110.285 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.527 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -101.62 -41.0 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.312 -0.868 . . . . 0.0 110.517 -179.526 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.506 ' N ' ' CG2' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -89.19 21.39 3.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.279 -0.888 . . . . 0.0 110.506 -179.604 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 134' ' ' THR . . . 45.04 25.74 1.08 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.97 30.46 5.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.334 -1.097 . . . . 0.0 109.959 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.572 ' HA ' ' CA ' ' A' ' 130' ' ' LEU . 88.5 p -82.63 108.59 16.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.204 -0.935 . . . . 0.0 110.398 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.518 ' CD ' ' HG2' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -89.61 -5.46 57.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.275 -0.891 . . . . 0.0 110.051 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.718 ' C ' HD21 ' A' ' 130' ' ' LEU . . . 89.84 3.86 73.24 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 120.077 -1.059 . . . . 0.0 110.675 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.543 ' O ' ' CB ' ' A' ' 129' ' ' LYS . 46.3 p90 -161.34 165.35 29.16 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.711 -1.464 . . . . 0.0 111.093 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.511 ' HA3' ' HA ' ' A' ' 128' ' ' LEU . . . -136.82 -170.65 11.99 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.712 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 13.9 m-85 -128.65 160.71 31.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.069 -1.254 . . . . 0.0 110.492 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.6 ' O ' HD12 ' A' ' 144' ' ' LEU . 4.1 t -134.22 140.4 46.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.371 -0.831 . . . . 0.0 108.944 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.6 HD12 ' O ' ' A' ' 143' ' ' VAL . 3.1 mp -132.07 98.81 4.53 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.161 -0.962 . . . . 0.0 109.704 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.948 ' HB2' HG22 ' A' ' 151' ' ' VAL . 39.4 m-85 -71.04 170.23 13.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.434 -0.791 . . . . 0.0 110.635 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 18.2 tttt -96.18 -18.93 19.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.369 -0.832 . . . . 0.0 110.994 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.865 ' O ' HG23 ' A' ' 151' ' ' VAL . 2.4 tm-20 -131.39 162.33 30.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.862 -1.149 . . . . 0.0 110.686 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 34.5 p -74.69 -47.44 31.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.913 . . . . 0.0 109.547 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.535 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 0.5 OUTLIER -54.41 -35.08 62.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.369 -0.832 . . . . 0.0 109.752 179.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.485 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 3.1 p -68.76 -40.93 79.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 109.889 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.948 HG22 ' HB2' ' A' ' 145' ' ' PHE . 5.6 t -66.67 -53.14 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 110.286 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.535 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -51.89 -37.78 53.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 0.0 109.955 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.46 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -59.23 -62.07 2.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.334 -0.854 . . . . 0.0 110.082 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.839 HG23 ' CE2' ' A' ' 120' ' ' PHE . 3.3 p -55.36 -20.5 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.198 -0.939 . . . . 0.0 110.141 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.82 -13.19 37.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.364 -0.835 . . . . 0.0 109.686 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.8 OUTLIER -61.12 -33.5 73.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.226 -0.921 . . . . 0.0 109.614 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.516 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.0 tt0 -142.3 104.46 4.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.287 -0.883 . . . . 0.0 110.065 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.5 pttm -81.8 20.26 0.98 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.229 -0.919 . . . . 0.0 111.037 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -87.58 62.9 7.32 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.77 ' HE1' HG22 ' A' ' 154' ' ' VAL . 14.2 m170 -86.76 -169.34 2.59 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.309 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 160' ' ' HIS . 33.3 ttpt 179.86 74.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.35 -0.844 . . . . 0.0 110.317 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.851 HD12 ' HB2' ' A' ' 163' ' ' ASN . 3.8 pp -103.69 157.56 16.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 0.0 109.989 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.851 ' HB2' HD12 ' A' ' 162' ' ' LEU . 1.5 m-80 58.38 15.19 3.32 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.183 -0.948 . . . . 0.0 110.228 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.98 20.15 61.63 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp -150.82 146.89 26.66 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.303 -1.116 . . . . 0.0 110.152 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 160' ' ' HIS . 1.4 p -69.36 -174.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.052 -1.03 . . . . 0.0 110.163 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.638 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -150.61 178.24 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.163 -0.96 . . . . 0.0 110.352 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -126.01 93.2 44.32 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.54 -0.725 . . . . 0.0 109.386 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 48.2 Cg_endo -77.58 135.85 14.97 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.245 1.655 . . . . 0.0 110.643 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 99' ' ' MET . 0.0 OUTLIER -146.76 -177.92 5.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.319 -0.863 . . . . 0.0 110.268 179.607 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.483 ' O ' ' O ' ' A' ' 172' ' ' ALA . 1.6 mtt180 -91.83 45.27 1.21 Allowed 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.953 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 171' ' ' ARG . . . . . . . . 0 C--N 1.301 -1.518 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.987 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.889 ' HB2' ' HB3' ' A' ' 172' ' ' ALA . 14.7 mtmt . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.001 0.429 . . . . 0.0 110.09 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.535 ' HE2' HD11 ' A' ' 101' ' ' ILE . 7.9 ptm -133.39 172.31 12.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.118 -0.989 . . . . 0.0 110.562 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.766 ' C ' HD13 ' A' ' 101' ' ' ILE . 2.1 t80 -120.99 130.07 53.66 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.608 -0.682 . . . . 0.0 110.041 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.766 HD13 ' C ' ' A' ' 100' ' ' PHE . 3.8 mm -112.66 95.27 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.294 -0.879 . . . . 0.0 109.469 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.532 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -89.75 127.01 8.53 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 127.48 34.01 0.59 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 1.064 HD12 HG21 ' A' ' 108' ' ' THR . 2.3 mm? -89.38 152.95 21.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.048 -1.266 . . . . 0.0 110.186 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.487 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -90.49 152.67 20.84 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.291 -0.88 . . . . 0.0 111.234 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.696 ' HA ' HD12 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -51.46 -22.69 3.25 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.445 -0.785 . . . . 0.0 110.765 179.626 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -107.04 28.82 7.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.028 -1.045 . . . . 0.0 111.765 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 1.064 HG21 HD12 ' A' ' 104' ' ' LEU . 0.8 OUTLIER -90.44 170.8 9.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.752 -1.218 . . . . 0.0 109.798 179.17 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.467 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 28.7 p -145.94 159.16 43.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.227 -0.921 . . . . 0.0 110.155 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.487 ' CE ' ' O ' ' A' ' 126' ' ' CYS . 0.7 OUTLIER -62.91 -12.76 27.36 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.171 -0.955 . . . . 0.0 109.639 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.49 -59.31 2.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.367 -0.833 . . . . 0.0 110.377 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -52.61 -41.93 64.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.056 -1.028 . . . . 0.0 109.909 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.8 HD13 HD11 ' A' ' 104' ' ' LEU . 10.6 tp -70.3 -48.82 54.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.911 . . . . 0.0 109.577 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -52.1 -48.01 64.97 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.428 -0.795 . . . . 0.0 109.772 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.544 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 54.7 m-20 -67.41 -50.74 58.18 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.16 -0.962 . . . . 0.0 110.296 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.412 ' C ' ' O ' ' A' ' 115' ' ' ASP . 73.0 t80 -47.78 -34.01 7.96 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 118.532 -1.267 . . . . 0.0 108.528 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.577 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 15.3 m-85 -91.14 -7.24 52.09 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.869 -0.732 . . . . 0.0 111.351 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.544 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 1.9 t -71.02 -7.35 45.76 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.956 -1.09 . . . . 0.0 109.225 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -82.88 -14.42 54.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 0.0 110.285 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.577 ' CD2' ' HA ' ' A' ' 117' ' ' PHE . 89.1 m-85 -88.8 -56.02 3.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.073 -1.017 . . . . 0.0 109.275 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.47 ' HA3' ' HB3' ' A' ' 150' ' ' SER . . . -162.02 -162.27 13.02 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -83.06 151.03 25.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -1.192 . . . . 0.0 110.061 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.9 t -128.8 130.03 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.357 -0.839 . . . . 0.0 110.484 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.01 -24.68 5.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.538 ' O ' HG13 ' A' ' 123' ' ' VAL . 4.2 m-20 -151.06 171.27 17.59 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 118.526 -1.27 . . . . 0.0 112.364 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.608 ' SG ' HD23 ' A' ' 113' ' ' LEU . 9.6 t -170.38 155.59 5.24 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.66 151.74 32.93 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.876 -1.14 . . . . 0.0 110.937 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.928 HD13 ' O ' ' A' ' 128' ' ' LEU . 1.6 tm? -128.89 100.56 5.72 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.531 -0.73 . . . . 0.0 109.703 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 1.038 ' O ' HD22 ' A' ' 130' ' ' LEU . 0.2 OUTLIER -85.92 77.5 9.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.248 -0.907 . . . . 0.0 109.219 179.657 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 1.038 HD22 ' O ' ' A' ' 129' ' ' LYS . 0.4 OUTLIER -149.82 27.69 0.79 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 2.5 m-20 -40.9 107.66 0.49 Allowed Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.526 -0.734 . . . . 0.0 111.243 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.428 ' HG3' ' O ' ' A' ' 106' ' ' TRP . 51.6 Cg_endo -86.83 -18.84 2.84 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 124.088 1.572 . . . . 0.0 110.739 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.687 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -92.73 -45.28 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.071 -1.018 . . . . 0.0 110.837 -179.293 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.565 ' N ' ' CG2' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -89.51 0.24 57.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.934 . . . . 0.0 110.324 -179.529 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 69.48 12.54 66.79 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.426 ' C ' ' HB2' ' A' ' 131' ' ' ASP . 0.8 OUTLIER -88.49 26.02 1.56 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -1.133 . . . . 0.0 110.17 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.574 ' HA ' ' CA ' ' A' ' 130' ' ' LEU . 0.9 OUTLIER -72.22 116.3 12.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.39 -0.819 . . . . 0.0 109.902 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.56 ' HG2' ' CZ ' ' A' ' 140' ' ' PHE . 0.0 OUTLIER -89.01 -3.93 58.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.154 -0.966 . . . . 0.0 109.977 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.616 ' C ' HD21 ' A' ' 130' ' ' LEU . . . 86.39 1.4 86.02 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.576 ' CD1' ' CZ ' ' A' ' 100' ' ' PHE . 35.5 p90 -155.22 -178.23 7.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.87 -1.37 . . . . 0.0 110.786 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -150.4 -171.05 18.32 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.698 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 19.7 m-85 -131.38 171.36 13.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.153 -1.204 . . . . 0.0 110.719 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.58 ' O ' HD22 ' A' ' 144' ' ' LEU . 32.0 t -147.46 129.06 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.58 HD22 ' O ' ' A' ' 143' ' ' VAL . 3.8 mm? -114.53 101.6 9.27 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.584 -0.697 . . . . 0.0 109.821 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.754 ' HB2' HG22 ' A' ' 151' ' ' VAL . 8.2 m-85 -78.36 170.15 17.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 110.78 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.444 ' HE2' ' O ' ' A' ' 146' ' ' LYS . 0.1 OUTLIER -89.87 -26.61 20.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.614 -0.679 . . . . 0.0 110.562 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.493 ' OE2' ' CB ' ' A' ' 149' ' ' GLU . 1.0 OUTLIER -143.08 161.76 37.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.785 -1.197 . . . . 0.0 111.181 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 18.7 m -64.37 -31.7 73.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.441 -0.787 . . . . 0.0 110.091 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.493 ' CB ' ' OE2' ' A' ' 147' ' ' GLU . 0.1 OUTLIER -60.29 -38.67 84.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 0.0 110.012 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 22.4 p -71.27 -36.76 71.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.458 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.754 HG22 ' HB2' ' A' ' 145' ' ' PHE . 3.5 t -76.12 -45.42 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.987 -1.071 . . . . 0.0 110.805 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 153' ' ' LYS . 0.2 OUTLIER -61.58 -33.89 74.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.143 -0.973 . . . . 0.0 110.126 -179.555 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 152' ' ' ASP . 6.6 tttt -70.37 -42.2 72.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -0.918 . . . . 0.0 110.041 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 151' ' ' VAL . 7.4 p -72.67 -27.35 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.145 -0.972 . . . . 0.0 110.458 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.405 ' O ' ' C ' ' A' ' 156' ' ' ASP . 0.2 OUTLIER -80.39 -34.87 36.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.939 . . . . 0.0 110.288 -179.751 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.489 ' OD1' ' HG2' ' A' ' 157' ' ' GLN . 0.0 OUTLIER -45.37 -42.6 10.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 109.342 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.561 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -118.76 87.25 2.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.397 -0.814 . . . . 0.0 109.65 179.335 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.497 ' HB2' ' CG ' ' A' ' 169' ' ' PRO . 3.4 pttt -85.94 17.45 3.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.892 . . . . 0.0 110.542 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -87.52 63.85 7.83 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.561 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 11.7 m170 -86.56 -167.59 1.93 Allowed 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.726 -177.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt 179.2 67.99 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.496 -0.753 . . . . 0.0 109.601 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.801 HD12 ' HB2' ' A' ' 163' ' ' ASN . 2.6 pp -99.8 148.42 24.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.346 -0.847 . . . . 0.0 110.076 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.801 ' HB2' HD12 ' A' ' 162' ' ' LEU . 0.4 OUTLIER 64.18 20.77 12.32 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.184 -0.948 . . . . 0.0 109.517 -179.401 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.9 26.05 70.08 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.37 147.35 27.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.273 -1.134 . . . . 0.0 110.726 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 167' ' ' ILE . 4.8 t -80.31 173.12 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.347 -0.846 . . . . 0.0 109.252 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.503 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -141.66 163.56 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.087 -1.008 . . . . 0.0 110.9 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -112.26 96.77 36.69 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.611 -0.681 . . . . 0.0 109.235 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.497 ' CG ' ' HB2' ' A' ' 158' ' ' LYS . 49.2 Cg_endo -76.65 119.47 5.19 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.205 1.634 . . . . 0.0 110.524 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -136.42 -163.5 1.42 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 110.293 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.13 -170.89 2.8 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.811 -0.755 . . . . 0.0 110.48 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.889 ' HB3' ' HB2' ' A' ' 98' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.446 -0.784 . . . . 0.0 109.911 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.478 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 4.5 mttp . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.185 0.517 . . . . 0.0 109.996 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.666 ' HE2' HD11 ' A' ' 101' ' ' ILE . 0.6 OUTLIER -139.88 179.72 6.44 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.229 -0.919 . . . . 0.0 110.107 179.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.727 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 2.5 t80 -125.26 128.93 49.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.361 -0.837 . . . . 0.0 110.807 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.666 HD11 ' HE2' ' A' ' 99' ' ' MET . 4.7 mm -107.37 96.19 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.494 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -89.92 145.71 18.38 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.243 -178.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.512 ' O ' ' HD2' ' A' ' 165' ' ' LYS . . . 96.99 17.68 31.68 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.826 ' HB3' HD12 ' A' ' 130' ' ' LEU . 1.4 mm? -54.73 166.47 0.47 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.636 -1.508 . . . . 0.0 109.737 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.898 ' C ' HD13 ' A' ' 130' ' ' LEU . 0.3 OUTLIER -90.89 140.72 29.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.132 -0.98 . . . . 0.0 110.114 179.511 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.647 ' HA ' HD22 ' A' ' 130' ' ' LEU . 20.6 m0 -49.75 -19.87 0.72 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.154 -0.966 . . . . 0.0 110.472 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -113.57 26.38 10.44 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.126 -0.984 . . . . 0.0 111.18 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.758 HG21 ' CD1' ' A' ' 104' ' ' LEU . 0.8 OUTLIER -89.09 166.13 14.06 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.983 -1.073 . . . . 0.0 109.952 179.568 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.471 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 31.7 p -145.42 -176.8 5.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.191 -0.943 . . . . 0.0 110.399 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.463 ' O ' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -84.57 -14.86 47.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 109.595 179.663 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.44 -44.86 15.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.871 . . . . 0.0 109.857 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 32.5 p-10 -77.35 -38.29 50.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.842 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.73 HD13 HD11 ' A' ' 104' ' ' LEU . 19.7 tp -69.84 -42.69 73.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.099 -1.001 . . . . 0.0 109.351 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -59.85 -50.72 72.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 0.0 109.234 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' A' ' 118' ' ' SER . 17.1 t70 -64.04 -46.66 83.41 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.195 -0.941 . . . . 0.0 109.346 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.688 ' CD2' HD21 ' A' ' 162' ' ' LEU . 68.4 t80 -48.0 -36.35 12.58 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.622 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 15.1 m-85 -91.75 -3.46 56.18 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.843 -0.536 . . . . 0.0 111.489 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 12.4 t -70.63 -5.73 31.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.905 -1.122 . . . . 0.0 109.55 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.01 -13.29 44.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.378 -0.826 . . . . 0.0 110.039 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.831 ' CE2' HG23 ' A' ' 154' ' ' VAL . 79.8 m-85 -89.57 -45.36 9.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.366 -0.834 . . . . 0.0 109.84 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -176.16 -172.98 41.41 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.53 ' O ' ' CB ' ' A' ' 146' ' ' LYS . 19.1 mm-40 -81.3 115.43 20.67 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.142 -1.211 . . . . 0.0 110.199 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 125' ' ' ASP . 2.0 t -91.14 133.84 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.269 -0.894 . . . . 0.0 111.018 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.91 -25.65 5.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.538 ' O ' HG13 ' A' ' 123' ' ' VAL . 4.0 m-20 -148.26 160.93 42.46 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.034 -1.067 . . . . 0.0 111.837 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 5.7 t -170.11 149.94 3.64 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.7 164.78 35.3 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.042 -1.036 . . . . 0.0 111.098 -178.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 1.041 HD22 ' N ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -140.77 129.15 22.49 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.009 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 1.041 ' N ' HD22 ' A' ' 128' ' ' LEU . 0.4 OUTLIER -111.77 71.33 0.74 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.172 -0.955 . . . . 0.0 110.156 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.937 ' HB2' HD21 ' A' ' 128' ' ' LEU . 5.6 mt -151.62 14.65 0.66 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.478 -0.764 . . . . 0.0 110.638 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -50.75 113.83 4.09 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.172 -0.955 . . . . 0.0 110.952 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -84.98 0.1 9.02 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.892 1.469 . . . . 0.0 110.906 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.885 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -94.97 -32.59 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.023 -1.048 . . . . 0.0 110.49 -179.585 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.47 -12.7 39.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 0.0 110.149 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.22 38.14 35.16 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.52 25.37 2.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -1.199 . . . . 0.0 110.225 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.63 ' HB2' HD23 ' A' ' 130' ' ' LEU . 5.5 p -60.01 116.85 4.45 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.364 -0.835 . . . . 0.0 109.555 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.592 ' HG2' ' CZ ' ' A' ' 140' ' ' PHE . 0.0 OUTLIER -89.3 -16.7 30.52 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.142 -0.973 . . . . 0.0 110.235 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.701 ' HA2' HD21 ' A' ' 130' ' ' LEU . . . 91.05 19.16 43.86 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 120.035 -1.078 . . . . 0.0 111.048 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.592 ' CZ ' ' HG2' ' A' ' 138' ' ' ARG . 21.7 p90 -166.89 144.3 4.82 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.58 -1.541 . . . . 0.0 111.526 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.698 ' H ' HD23 ' A' ' 104' ' ' LEU . . . -121.38 -174.55 14.85 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.727 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 15.2 m-85 -129.43 165.85 20.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.15 -1.206 . . . . 0.0 110.776 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.592 ' C ' HD12 ' A' ' 144' ' ' LEU . 3.8 t -139.41 133.34 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.454 -0.779 . . . . 0.0 109.214 178.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.592 HD12 ' C ' ' A' ' 143' ' ' VAL . 5.4 mp -123.96 92.77 3.75 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.61 -0.682 . . . . 0.0 109.312 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 1.044 ' HB2' HG22 ' A' ' 151' ' ' VAL . 17.7 m-85 -69.18 164.4 22.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.416 -0.802 . . . . 0.0 110.784 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.53 ' CB ' ' O ' ' A' ' 122' ' ' GLU . 10.8 tttp -93.4 -22.03 19.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.473 -0.767 . . . . 0.0 110.615 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.864 ' O ' HG23 ' A' ' 151' ' ' VAL . 14.8 tt0 -126.7 144.24 50.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.765 -1.209 . . . . 0.0 110.462 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 51.1 m -61.84 -35.51 78.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.966 . . . . 0.0 109.634 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.532 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 0.1 OUTLIER -63.2 -47.64 81.71 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.318 -0.864 . . . . 0.0 109.843 179.603 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 2.3 p -57.84 -37.38 73.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.326 -0.859 . . . . 0.0 109.881 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 1.044 HG22 ' HB2' ' A' ' 145' ' ' PHE . 2.8 t -66.23 -57.95 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.118 -0.989 . . . . 0.0 110.027 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.532 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -52.26 -29.83 24.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.094 -1.003 . . . . 0.0 110.012 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.471 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 6.7 mttt -68.68 -38.6 80.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.29 -0.881 . . . . 0.0 110.19 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.961 HG12 ' O ' ' A' ' 151' ' ' VAL . 9.9 p -77.16 -17.71 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.209 -0.932 . . . . 0.0 110.046 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.764 ' SD ' HG12 ' A' ' 151' ' ' VAL . 0.0 OUTLIER -90.21 -39.62 12.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 110.537 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 1.0 OUTLIER -52.87 -34.75 56.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.971 -1.081 . . . . 0.0 109.795 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.505 ' O ' ' NE2' ' A' ' 160' ' ' HIS . 4.2 mt-30 -117.69 88.47 2.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.486 -0.759 . . . . 0.0 109.747 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.52 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 6.8 pttt -86.62 26.09 1.15 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 110.946 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.08 62.06 6.61 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.656 ' HE1' HG22 ' A' ' 154' ' ' VAL . 11.6 m170 -87.2 154.88 20.38 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.61 -177.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 165' ' ' LYS . 41.4 mttm -150.8 85.45 1.36 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.351 -0.843 . . . . 0.0 109.783 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.793 ' H ' HD12 ' A' ' 162' ' ' LEU . 1.0 OUTLIER -99.77 138.01 37.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.354 -0.841 . . . . 0.0 109.714 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.682 ' OD1' HG23 ' A' ' 108' ' ' THR . 10.8 m120 59.37 19.44 7.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.259 -0.901 . . . . 0.0 110.318 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.29 32.11 29.32 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.533 ' CE ' ' O ' ' A' ' 166' ' ' VAL . 0.9 OUTLIER -150.18 149.97 30.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.186 -1.184 . . . . 0.0 110.208 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 160' ' ' HIS . 26.4 t -90.01 159.52 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.078 -1.014 . . . . 0.0 110.383 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.572 HG13 ' HB2' ' A' ' 160' ' ' HIS . 1.3 pt -120.46 -176.57 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 122.071 0.939 . . . . 0.0 111.219 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -123.41 81.6 53.18 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -74.21 131.08 14.84 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.305 1.687 . . . . 0.0 110.877 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.407 ' O ' ' CB ' ' A' ' 99' ' ' MET . 2.1 mmtm -147.25 -166.9 2.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.458 -0.776 . . . . 0.0 110.3 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -89.87 -170.77 2.92 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.1 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.483 0 O-C-N 121.267 -0.895 . . . . 0.0 110.376 -179.535 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.512 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.289 0.566 . . . . 0.0 110.331 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.885 ' CE ' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -136.47 166.45 23.47 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.445 -0.784 . . . . 0.0 109.178 179.385 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.846 ' O ' HD13 ' A' ' 101' ' ' ILE . 15.6 t80 -112.2 148.52 33.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.963 -1.085 . . . . 0.0 110.623 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.885 HD11 ' CE ' ' A' ' 99' ' ' MET . 8.8 mm -123.09 108.33 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.643 -0.661 . . . . 0.0 110.095 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.54 ' HA2' ' CB ' ' A' ' 140' ' ' PHE . . . -101.85 128.68 9.64 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.61 38.03 0.64 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.9 ' CD2' HD23 ' A' ' 128' ' ' LEU . 1.1 mp -90.06 153.77 20.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.14 -1.212 . . . . 0.0 110.234 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.486 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 3.1 m -82.4 154.35 25.24 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.256 -0.902 . . . . 0.0 110.411 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.604 ' HA ' HD12 ' A' ' 130' ' ' LEU . 12.1 m-90 -57.54 -14.17 4.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.118 -0.989 . . . . 0.0 110.369 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.422 ' OD1' ' HB3' ' A' ' 105' ' ' SER . 4.6 p-10 -108.57 21.76 16.85 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.928 -1.107 . . . . 0.0 111.613 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.465 ' HB ' HD23 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -85.99 149.6 25.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.883 -1.136 . . . . 0.0 109.986 179.425 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.445 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 72.5 p -134.97 162.9 31.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 110.175 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 126' ' ' CYS . 26.9 mtmt -60.4 -14.18 17.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 109.845 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -82.77 -59.65 2.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.405 -0.81 . . . . 0.0 110.655 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 1.6 p-10 -63.41 -35.05 79.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.103 -0.998 . . . . 0.0 110.258 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 15.0 tp -72.91 -51.61 17.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.184 -0.947 . . . . 0.0 109.964 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 110' ' ' LYS . 4.6 tttt -56.63 -37.95 71.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -0.955 . . . . 0.0 109.695 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.471 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 3.1 m-20 -73.14 -54.82 7.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.381 -0.824 . . . . 0.0 110.038 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.445 ' C ' ' O ' ' A' ' 115' ' ' ASP . 71.1 t80 -46.61 -31.93 3.15 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.719 -1.192 . . . . 0.0 108.356 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.629 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 18.7 m-85 -91.45 -11.29 38.03 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.789 -0.765 . . . . 0.0 111.423 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.471 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 0.5 OUTLIER -71.14 -5.75 34.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.94 -1.1 . . . . 0.0 109.372 178.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.6 ttpt -84.92 -12.8 52.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.378 -0.826 . . . . 0.0 110.212 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.629 ' CD2' ' HA ' ' A' ' 117' ' ' PHE . 84.8 m-85 -89.59 -44.45 10.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 110.001 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.53 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -174.53 -152.55 9.22 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -90.4 146.96 23.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.229 -1.159 . . . . 0.0 110.633 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.7 t -129.24 129.8 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.446 -0.783 . . . . 0.0 110.088 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.482 HG23 ' CG ' ' A' ' 146' ' ' LYS . 2.2 t -88.8 -25.38 5.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.49 ' HB3' HD22 ' A' ' 144' ' ' LEU . 13.7 m-20 -150.88 166.91 29.12 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.389 -1.324 . . . . 0.0 112.309 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 11.8 t -167.22 135.87 2.65 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.462 0.649 . . . . 0.0 109.301 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.33 165.76 22.72 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.386 -0.821 . . . . 0.0 109.92 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 1.035 HD22 ' N ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -150.54 128.93 12.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.312 -0.867 . . . . 0.0 109.566 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 1.035 ' N ' HD22 ' A' ' 128' ' ' LEU . 2.8 mmpt? -119.67 82.39 1.87 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.294 -0.879 . . . . 0.0 109.774 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 1.026 HD22 ' O ' ' A' ' 129' ' ' LYS . 0.3 OUTLIER -149.55 21.94 0.92 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.353 0.597 . . . . 0.0 109.844 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' A' ' 137' ' ' SER . 5.6 m-20 -71.71 115.23 35.68 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.184 -0.948 . . . . 0.0 110.918 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 106' ' ' TRP . 51.4 Cg_endo -89.07 -19.93 1.5 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.947 1.498 . . . . 0.0 110.343 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.458 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -89.57 -33.11 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.215 -0.928 . . . . 0.0 109.97 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 131' ' ' ASP . 0.2 OUTLIER -89.74 -9.2 50.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.276 -0.89 . . . . 0.0 110.192 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 74.19 33.7 56.39 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.78 29.56 5.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.226 -1.161 . . . . 0.0 110.118 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.557 ' HA ' ' CA ' ' A' ' 130' ' ' LEU . 5.8 p -88.39 102.8 15.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.26 -0.9 . . . . 0.0 110.032 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.589 ' HB3' ' CE2' ' A' ' 140' ' ' PHE . 0.1 OUTLIER -89.55 -2.59 58.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.351 -0.843 . . . . 0.0 110.131 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.758 ' C ' HD21 ' A' ' 130' ' ' LEU . . . 90.6 7.95 66.25 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 120.188 -1.006 . . . . 0.0 110.742 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.589 ' CE2' ' HB3' ' A' ' 138' ' ' ARG . 18.9 p90 -159.64 171.65 19.22 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.529 -1.571 . . . . 0.0 111.651 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.531 ' N ' HD13 ' A' ' 104' ' ' LEU . . . -140.0 -179.0 17.41 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.734 ' CE1' ' CE1' ' A' ' 100' ' ' PHE . 18.0 m-85 -128.17 156.94 42.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.213 -1.169 . . . . 0.0 110.786 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.659 ' O ' HD12 ' A' ' 144' ' ' LEU . 8.9 t -138.22 131.77 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.659 HD12 ' O ' ' A' ' 143' ' ' VAL . 6.5 mp -116.84 107.61 14.83 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.512 -0.743 . . . . 0.0 109.926 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.645 ' CB ' HG22 ' A' ' 151' ' ' VAL . 10.4 m-85 -80.27 167.73 19.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.409 -0.807 . . . . 0.0 110.919 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.482 ' CG ' HG23 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -97.73 -23.67 15.82 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.493 -0.755 . . . . 0.0 110.664 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.61 ' O ' HG23 ' A' ' 151' ' ' VAL . 0.9 OUTLIER -142.07 160.37 40.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.748 -1.22 . . . . 0.0 110.934 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.4 t -64.25 -31.81 73.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 0.0 109.861 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.54 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 6.2 mt-10 -60.28 -46.9 88.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.287 -0.883 . . . . 0.0 109.869 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.535 ' HB2' ' CD1' ' A' ' 145' ' ' PHE . 37.0 p -60.97 -40.99 95.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.273 -0.892 . . . . 0.0 110.257 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.765 ' O ' HG12 ' A' ' 154' ' ' VAL . 3.2 t -69.72 -46.2 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.126 -0.984 . . . . 0.0 110.758 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.54 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -52.46 -38.19 58.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.094 -1.004 . . . . 0.0 109.959 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.47 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 0.6 OUTLIER -66.42 -60.88 2.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 0.0 110.389 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.806 HG23 ' HE1' ' A' ' 160' ' ' HIS . 12.6 p -48.97 -22.77 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.052 -1.03 . . . . 0.0 110.332 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 2.0 ttt -89.93 -24.79 21.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.178 -0.951 . . . . 0.0 109.744 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.47 ' OD2' ' O ' ' A' ' 153' ' ' LYS . 0.2 OUTLIER -53.81 -36.14 62.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.269 -0.894 . . . . 0.0 109.47 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.56 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -131.18 102.07 5.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.336 -0.852 . . . . 0.0 110.085 179.473 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.416 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 26.6 mtmt -85.12 23.54 1.24 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -0.946 . . . . 0.0 110.936 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -87.96 57.45 4.33 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.807 ' O ' HD23 ' A' ' 162' ' ' LEU . 17.5 m-70 -87.9 65.45 8.32 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.691 -176.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.6 ttpp -81.81 72.29 8.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.059 -1.025 . . . . 0.0 109.671 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.807 HD23 ' O ' ' A' ' 160' ' ' HIS . 0.5 OUTLIER -94.02 156.06 16.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 109.945 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 1.6 m-80 56.72 21.43 5.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.173 -0.954 . . . . 0.0 109.46 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 75.52 23.46 73.1 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.69 138.86 20.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -1.093 . . . . 0.0 110.618 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.597 HG12 ' H ' ' A' ' 167' ' ' ILE . 3.6 t -80.27 -179.54 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 109.233 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.597 ' H ' HG12 ' A' ' 166' ' ' VAL . 1.0 OUTLIER -141.7 170.99 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.973 -1.08 . . . . 0.0 111.52 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 102' ' ' GLY . 10.9 t0 -116.71 92.19 37.17 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 46.1 Cg_endo -72.15 136.72 27.48 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.312 1.69 . . . . 0.0 111.287 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -138.04 -178.95 5.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.52 -0.737 . . . . 0.0 109.703 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 172' ' ' ALA . 0.2 OUTLIER -91.61 50.78 1.76 Allowed 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.484 179.21 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.497 ' N ' ' HA ' ' A' ' 99' ' ' MET . . . . . . . . 0 N--CA 1.493 1.675 0 O-C-N 121.473 -0.767 . . . . 0.0 110.495 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.548 ' HG2' ' CD2' ' A' ' 144' ' ' LEU . 9.9 mtpt . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.51 ' CG ' ' O ' ' A' ' 143' ' ' VAL . 5.9 ptm -141.98 175.5 9.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.122 -0.986 . . . . 0.0 110.883 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.688 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 1.7 t80 -119.7 129.27 54.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.597 -0.689 . . . . 0.0 109.69 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.646 HD13 ' C ' ' A' ' 100' ' ' PHE . 3.1 mm -109.88 94.18 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.301 -0.875 . . . . 0.0 109.453 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.533 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -97.22 112.14 4.4 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 141.32 38.73 0.08 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.689 HD21 HD13 ' A' ' 113' ' ' LEU . 5.4 mp -89.9 164.6 14.52 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.231 -1.158 . . . . 0.0 110.102 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' A' ' 163' ' ' ASN . 0.6 OUTLIER -81.56 -171.73 3.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.322 -0.861 . . . . 0.0 109.862 179.715 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 17.3 m0 -83.85 -9.86 58.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.182 -0.949 . . . . 0.0 110.414 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.48 19.75 8.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 110.399 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.781 HG23 ' OD1' ' A' ' 163' ' ' ASN . 2.5 m -63.52 159.7 18.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.109 -0.994 . . . . 0.0 109.773 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.477 HG23 ' C ' ' A' ' 108' ' ' THR . 63.7 p -149.57 171.73 16.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.907 . . . . 0.0 110.448 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.509 ' O ' ' CB ' ' A' ' 114' ' ' LYS . 5.9 ttpt -71.32 -11.0 60.67 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.412 -0.805 . . . . 0.0 109.127 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -84.0 -49.18 9.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.452 -0.78 . . . . 0.0 110.411 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -75.83 -31.72 59.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.961 -1.087 . . . . 0.0 110.199 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.972 HD23 ' SG ' ' A' ' 126' ' ' CYS . 1.7 tp -77.08 -43.44 34.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.02 -1.05 . . . . 0.0 109.593 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.509 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 17.3 tttt -59.97 -45.19 93.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.196 -0.94 . . . . 0.0 109.605 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 116' ' ' TYR . 0.6 OUTLIER -74.97 -42.03 58.4 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.178 -0.951 . . . . 0.0 109.526 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.793 ' CD2' HD21 ' A' ' 162' ' ' LEU . 72.5 t80 -48.32 -36.21 13.87 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 118.733 -1.187 . . . . 0.0 107.98 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.683 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 19.2 m-85 -91.48 -13.53 32.06 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.985 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 12.7 t -61.29 -14.28 25.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.114 -0.991 . . . . 0.0 109.594 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.72 -11.42 58.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.403 -0.81 . . . . 0.0 110.191 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.937 ' CD2' HG22 ' A' ' 154' ' ' VAL . 53.4 m-85 -89.54 -63.71 1.25 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.105 -0.997 . . . . 0.0 109.24 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -159.18 -177.57 32.39 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.5 133.84 48.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.063 -1.257 . . . . 0.0 110.414 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.9 t -109.72 133.64 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.332 -0.855 . . . . 0.0 110.885 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.476 ' O ' ' OD1' ' A' ' 125' ' ' ASP . 2.1 t -89.68 -28.25 5.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.56 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 0.8 OUTLIER -147.26 164.64 32.57 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 118.906 -1.118 . . . . 0.0 112.604 -178.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.972 ' SG ' HD23 ' A' ' 113' ' ' LEU . 36.9 t -170.34 140.37 1.85 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.64 161.25 42.95 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.962 -177.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.765 HD22 ' O ' ' A' ' 108' ' ' THR . 0.2 OUTLIER -119.32 117.92 29.85 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.024 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 140' ' ' PHE . 0.3 OUTLIER -96.7 130.17 43.97 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 110.152 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.547 ' HA ' ' H ' ' A' ' 138' ' ' ARG . 0.5 OUTLIER -111.01 176.35 5.06 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 120.193 -0.603 . . . . 0.0 109.774 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.525 ' N ' ' HB2' ' A' ' 138' ' ' ARG . 1.0 OUTLIER -59.55 110.07 2.45 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 120.944 -1.098 . . . . 0.0 109.963 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 130' ' ' LEU . 48.7 Cg_endo -78.63 -24.85 7.06 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.894 1.471 . . . . 0.0 110.803 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.717 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.2 OUTLIER -96.44 -33.17 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.166 -0.959 . . . . 0.0 110.484 -179.715 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.71 -10.56 45.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.249 -0.907 . . . . 0.0 110.224 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 69.07 22.23 75.87 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -127.29 -164.76 1.39 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.219 -1.165 . . . . 0.0 110.251 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.9 p -90.25 122.27 33.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 110.338 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.547 ' H ' ' HA ' ' A' ' 130' ' ' LEU . 0.2 OUTLIER -89.3 -26.41 21.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.314 -0.866 . . . . 0.0 109.252 179.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.84 52.33 2.46 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 120.371 -0.918 . . . . 0.0 111.62 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.628 ' HA ' HD13 ' A' ' 104' ' ' LEU . 2.6 p90 -170.3 138.67 1.62 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.626 -1.514 . . . . 0.0 110.52 178.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.496 ' HA2' ' HB2' ' A' ' 129' ' ' LYS . . . -142.66 -161.84 8.98 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.688 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 17.4 m-85 -126.87 163.21 24.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.159 -1.2 . . . . 0.0 111.306 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.655 HG21 ' CE2' ' A' ' 117' ' ' PHE . 4.0 t -138.49 138.05 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.56 ' HB2' ' CB ' ' A' ' 125' ' ' ASP . 4.6 mp -127.04 107.45 10.06 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.315 -0.866 . . . . 0.0 110.11 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 1.127 ' CZ ' HG21 ' A' ' 154' ' ' VAL . 26.3 m-85 -80.65 151.63 28.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.361 -0.837 . . . . 0.0 110.51 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -75.78 -17.04 60.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.49 -0.756 . . . . 0.0 110.917 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.829 ' O ' HG23 ' A' ' 151' ' ' VAL . 7.4 tt0 -137.63 154.39 49.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.836 -1.165 . . . . 0.0 110.901 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.443 ' N ' ' HG2' ' A' ' 147' ' ' GLU . 0.4 OUTLIER -65.42 -39.28 91.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 109.601 179.45 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.524 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 3.0 tt0 -57.65 -51.3 70.09 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.331 -0.855 . . . . 0.0 109.688 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.803 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.4 p -52.7 -34.39 51.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.761 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 1.009 HG22 ' HB2' ' A' ' 145' ' ' PHE . 2.4 t -74.84 -49.79 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.307 -0.87 . . . . 0.0 110.503 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.524 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -52.97 -35.2 58.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.139 -0.976 . . . . 0.0 110.447 -179.489 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.487 ' HA ' ' OD2' ' A' ' 156' ' ' ASP . 0.4 OUTLIER -71.78 -49.87 34.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.227 -0.921 . . . . 0.0 110.464 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 1.127 HG21 ' CZ ' ' A' ' 145' ' ' PHE . 18.0 t -56.02 -22.53 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.901 -1.124 . . . . 0.0 110.043 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 32.1 mmm -87.32 -46.08 10.0 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.151 -0.968 . . . . 0.0 110.157 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.487 ' OD2' ' HA ' ' A' ' 153' ' ' LYS . 0.5 OUTLIER -47.19 -37.2 9.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.117 -0.99 . . . . 0.0 109.811 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.576 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 0.6 OUTLIER -111.16 85.33 2.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.122 -0.986 . . . . 0.0 110.101 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.02 18.19 2.16 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.28 -0.887 . . . . 0.0 110.824 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.424 ' OE1' ' HG2' ' A' ' 157' ' ' GLN . 31.9 mp0 -87.67 60.84 6.18 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 177.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.714 ' ND1' HD11 ' A' ' 167' ' ' ILE . 15.1 m-70 -87.07 179.57 6.65 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.557 -177.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 160' ' ' HIS . 14.2 ttmt -179.21 88.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.323 -0.861 . . . . 0.0 110.154 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.793 HD21 ' CD2' ' A' ' 116' ' ' TYR . 2.1 mp -102.93 140.89 36.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.175 -0.953 . . . . 0.0 109.583 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.781 ' OD1' HG23 ' A' ' 108' ' ' THR . 25.6 m120 57.04 16.72 3.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.267 -0.896 . . . . 0.0 109.734 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.35 32.59 27.88 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.11 123.3 10.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.193 -1.181 . . . . 0.0 110.482 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 167' ' ' ILE . 16.9 t -57.66 172.63 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 0.0 109.926 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.714 HD11 ' ND1' ' A' ' 160' ' ' HIS . 0.7 OUTLIER -132.7 178.27 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.195 -0.941 . . . . 0.0 111.019 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 102' ' ' GLY . 10.3 t70 -127.9 80.25 72.39 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 42.8 Cg_endo -70.41 131.22 19.88 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.069 1.563 . . . . 0.0 111.241 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.401 ' O ' ' CB ' ' A' ' 99' ' ' MET . 4.6 mmtm -146.73 -174.01 4.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.401 -0.812 . . . . 0.0 110.302 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.74 -171.07 2.77 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.463 -0.773 . . . . 0.0 110.487 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.326 -0.858 . . . . 0.0 110.145 179.854 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.525 ' HG2' ' CD1' ' A' ' 144' ' ' LEU . 12.5 mtmm . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.344 0.592 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.926 ' CE ' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -145.33 160.0 42.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.656 179.2 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.836 ' O ' HD13 ' A' ' 101' ' ' ILE . 13.1 t80 -113.61 146.07 40.29 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.414 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.926 HD11 ' CE ' ' A' ' 99' ' ' MET . 12.7 mm -123.61 91.39 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.531 -0.731 . . . . 0.0 110.123 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 167' ' ' ILE . . . -91.34 178.77 41.79 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.65 10.89 61.25 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.722 HD13 ' H ' ' A' ' 141' ' ' GLY . 4.9 mp -73.36 163.72 27.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.098 -1.237 . . . . 0.0 110.349 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.521 ' HB3' ' ND2' ' A' ' 163' ' ' ASN . 13.3 t -90.37 -176.86 4.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.331 -0.856 . . . . 0.0 109.615 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.547 ' N ' ' CD1' ' A' ' 106' ' ' TRP . 37.0 m0 -87.67 23.21 2.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.081 -1.012 . . . . 0.0 110.143 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -144.25 9.5 1.44 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -0.9 . . . . 0.0 110.47 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.861 HG23 ' OD1' ' A' ' 163' ' ' ASN . 0.2 OUTLIER -73.41 172.47 11.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.106 -0.996 . . . . 0.0 109.822 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.512 HG23 ' C ' ' A' ' 108' ' ' THR . 71.4 p -150.36 166.41 30.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.132 -0.98 . . . . 0.0 110.366 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 114' ' ' LYS . 0.8 OUTLIER -67.68 -15.38 63.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.219 -0.925 . . . . 0.0 109.529 179.532 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -80.8 -62.66 1.6 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.315 -0.866 . . . . 0.0 110.38 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 109' ' ' THR . 1.1 p-10 -55.87 -37.75 69.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 110.249 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.646 HD23 ' SG ' ' A' ' 126' ' ' CYS . 13.3 tp -72.09 -41.46 67.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.156 -0.965 . . . . 0.0 110.178 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 110' ' ' LYS . 0.1 OUTLIER -60.87 -47.03 88.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.201 -0.937 . . . . 0.0 110.292 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 116' ' ' TYR . 26.4 t0 -69.91 -48.39 58.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.035 -1.041 . . . . 0.0 110.034 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.407 ' C ' ' O ' ' A' ' 115' ' ' ASP . 75.0 t80 -48.28 -34.89 11.14 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.62 -1.232 . . . . 0.0 108.104 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.655 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 13.5 m-85 -91.66 -8.08 48.13 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.409 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.5 m -71.15 -9.1 57.5 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.891 -1.131 . . . . 0.0 108.951 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -81.74 -16.09 52.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.6 -0.687 . . . . 0.0 110.091 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.655 ' CD1' ' HA ' ' A' ' 117' ' ' PHE . 70.7 m-85 -89.1 -55.35 3.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.179 -0.951 . . . . 0.0 109.153 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.531 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -164.57 -163.36 17.48 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.24 140.94 29.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.114 -1.227 . . . . 0.0 110.351 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.9 t -112.75 133.5 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.308 -0.87 . . . . 0.0 110.823 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.22 -25.64 5.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.561 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 1.0 OUTLIER -148.53 165.45 31.17 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.667 -1.213 . . . . 0.0 112.045 -179.203 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.646 ' SG ' HD23 ' A' ' 113' ' ' LEU . 14.3 t -170.52 148.68 3.14 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.45 ' O ' ' HA3' ' A' ' 141' ' ' GLY . 0.8 OUTLIER -150.28 162.28 40.81 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.116 -0.99 . . . . 0.0 110.599 -178.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 1.057 HD22 ' N ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -142.95 130.48 21.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.446 -0.784 . . . . 0.0 109.692 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 1.057 ' N ' HD22 ' A' ' 128' ' ' LEU . 10.4 mmtm -105.34 104.0 13.64 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.345 -0.847 . . . . 0.0 109.552 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.832 HD13 ' O ' ' A' ' 108' ' ' THR . 0.3 OUTLIER -145.55 13.42 1.36 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.573 ' N ' HD23 ' A' ' 130' ' ' LEU . 12.9 m-20 -40.15 100.83 0.22 Allowed Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.461 -0.774 . . . . 0.0 110.562 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 130' ' ' LEU . 50.7 Cg_endo -79.46 -18.05 11.06 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.174 1.618 . . . . 0.0 110.595 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.627 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -96.2 -39.56 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.214 -0.929 . . . . 0.0 110.285 -179.677 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.482 ' N ' ' CG2' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -89.91 9.81 26.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.191 -0.943 . . . . 0.0 110.438 -179.767 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.23 16.09 40.36 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.486 ' CB ' ' HB2' ' A' ' 131' ' ' ASP . 0.3 OUTLIER -92.68 19.97 6.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.172 -1.193 . . . . 0.0 110.222 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.526 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 42.4 p -90.92 78.49 6.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.619 -0.675 . . . . 0.0 110.214 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.626 ' HB3' ' CD1' ' A' ' 140' ' ' PHE . 0.0 OUTLIER -88.97 11.63 17.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.069 -1.02 . . . . 0.0 109.254 179.388 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 62.93 66.77 2.38 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.64 ' CE1' ' CB ' ' A' ' 129' ' ' LYS . 16.9 p90 -170.34 131.42 0.96 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.92 -1.341 . . . . 0.0 110.965 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.722 ' H ' HD13 ' A' ' 104' ' ' LEU . . . -125.42 173.69 17.45 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.72 ' CE1' ' CE1' ' A' ' 100' ' ' PHE . 10.1 m-85 -116.51 158.15 24.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.185 -1.185 . . . . 0.0 110.234 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.557 ' CG2' HG13 ' A' ' 101' ' ' ILE . 25.8 t -138.46 124.88 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.933 0.873 . . . . 0.0 109.939 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.561 ' HB2' ' CB ' ' A' ' 125' ' ' ASP . 1.6 mm? -110.27 111.65 23.09 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.658 ' CB ' HG22 ' A' ' 151' ' ' VAL . 11.7 m-85 -82.01 151.59 27.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.971 -1.081 . . . . 0.0 111.052 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 30.4 tttt -81.28 -25.24 36.7 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.674 -0.641 . . . . 0.0 111.157 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.486 ' OE2' ' HB3' ' A' ' 149' ' ' GLU . 1.0 OUTLIER -144.48 146.37 32.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.703 -1.248 . . . . 0.0 111.231 -179.333 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.3 t -49.17 -35.13 16.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.154 -0.966 . . . . 0.0 109.554 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.533 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 0.6 OUTLIER -55.78 -51.61 66.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.348 -0.845 . . . . 0.0 109.972 179.725 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.56 ' HB2' ' CD1' ' A' ' 145' ' ' PHE . 67.1 p -56.99 -36.68 70.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.297 -0.877 . . . . 0.0 110.322 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.658 HG22 ' CB ' ' A' ' 145' ' ' PHE . 3.1 t -72.22 -53.6 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.075 -1.016 . . . . 0.0 110.393 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.533 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -47.78 -35.52 10.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.062 -1.023 . . . . 0.0 110.051 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.485 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -69.25 -52.0 31.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.898 . . . . 0.0 110.375 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.603 HG12 ' O ' ' A' ' 151' ' ' VAL . 2.1 p -65.15 -14.39 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.989 -1.07 . . . . 0.0 110.17 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 28.1 tpp -90.48 -36.76 14.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.348 -0.845 . . . . 0.0 110.618 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 1.6 p-10 -57.73 -17.59 16.28 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.124 -0.985 . . . . 0.0 110.115 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.532 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 8.9 tp-100 -139.5 76.87 1.59 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.329 -0.857 . . . . 0.0 109.437 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.632 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -81.84 10.3 6.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.906 . . . . 0.0 110.666 -179.426 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.409 ' HB2' ' OE1' ' A' ' 157' ' ' GLN . 8.9 mm-40 -88.09 67.88 8.99 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.678 ' O ' HG13 ' A' ' 166' ' ' VAL . 77.5 m-70 -86.41 174.71 8.82 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.51 0.671 . . . . 0.0 110.901 -177.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.602 ' HG3' HG22 ' A' ' 166' ' ' VAL . 1.1 mppt? -168.95 74.17 0.09 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.523 -0.735 . . . . 0.0 109.226 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.696 HD23 ' H ' ' A' ' 162' ' ' LEU . 0.9 OUTLIER -109.89 155.8 21.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.38 -0.825 . . . . 0.0 110.178 -179.442 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.861 ' OD1' HG23 ' A' ' 108' ' ' THR . 0.3 OUTLIER 66.59 9.13 6.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.265 -0.897 . . . . 0.0 109.639 -179.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 89.08 15.38 59.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -150.92 163.49 38.57 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.051 -1.264 . . . . 0.0 110.671 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.678 HG13 ' O ' ' A' ' 160' ' ' HIS . 2.9 t -84.9 178.28 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 109.53 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.624 HD11 ' CG ' ' A' ' 160' ' ' HIS . 0.7 OUTLIER -134.15 169.0 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.966 -1.084 . . . . 0.0 111.04 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 102' ' ' GLY . 9.5 t70 -112.34 88.22 10.44 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 167' ' ' ILE . 48.7 Cg_endo -77.14 119.66 5.1 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.259 1.663 . . . . 0.0 110.607 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.5 mttp -135.64 175.25 9.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 0.0 110.544 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.571 ' O ' ' HB3' ' A' ' 172' ' ' ALA . 9.3 ptp180 -91.81 52.72 2.07 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.27 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 171' ' ' ARG . . . . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.277 -0.889 . . . . 0.0 110.377 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.504 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 9.8 mttt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.155 0.503 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.499 ' HG2' ' O ' ' A' ' 143' ' ' VAL . 6.9 ptm -141.29 174.67 10.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.313 -0.867 . . . . 0.0 110.181 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.697 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 2.3 t80 -115.15 129.11 56.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.388 -0.82 . . . . 0.0 110.176 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.677 HD13 ' C ' ' A' ' 100' ' ' PHE . 4.2 mm -111.53 95.94 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.287 -0.883 . . . . 0.0 109.251 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -93.13 113.92 4.57 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.468 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 145.08 34.51 0.07 OUTLIER Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 1.09 HD12 HG21 ' A' ' 108' ' ' THR . 3.5 mm? -91.17 151.82 20.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.088 -1.242 . . . . 0.0 110.116 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.441 ' HB3' ' HB3' ' A' ' 163' ' ' ASN . 52.7 p -75.27 -178.46 3.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.195 -0.941 . . . . 0.0 109.988 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.508 ' HA ' ' CB ' ' A' ' 137' ' ' SER . 7.7 m0 -82.1 6.42 16.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -0.923 . . . . 0.0 110.364 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 2.9 p-10 -140.61 32.23 1.85 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.311 -0.868 . . . . 0.0 110.04 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 1.09 HG21 HD12 ' A' ' 104' ' ' LEU . 18.1 m -77.7 154.35 32.17 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.313 -0.867 . . . . 0.0 110.344 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.487 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 12.2 p -126.05 161.78 26.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.224 -0.923 . . . . 0.0 110.358 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.559 ' CG ' ' HA ' ' A' ' 127' ' ' THR . 0.3 OUTLIER -64.76 -20.47 66.37 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.089 -1.007 . . . . 0.0 110.121 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -88.61 -47.22 8.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.231 -0.918 . . . . 0.0 110.955 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -60.13 -30.42 69.27 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.941 -1.099 . . . . 0.0 109.881 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.642 HD13 HD11 ' A' ' 104' ' ' LEU . 27.0 tp -84.19 -45.91 12.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.218 -0.926 . . . . 0.0 109.47 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -33.03 67.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.889 . . . . 0.0 109.254 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' A' ' 118' ' ' SER . 0.2 OUTLIER -75.37 -55.04 6.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.28 -0.888 . . . . 0.0 109.675 179.632 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.448 ' C ' ' O ' ' A' ' 115' ' ' ASP . 64.8 t80 -46.55 -31.6 2.88 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.664 -1.214 . . . . 0.0 108.256 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.579 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 14.5 m-85 -91.35 -12.31 35.31 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.23 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 115' ' ' ASP . 44.0 t -67.47 -9.26 40.43 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.869 -1.144 . . . . 0.0 109.015 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -79.26 -16.23 56.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.407 -0.808 . . . . 0.0 110.438 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.953 ' CZ ' HG23 ' A' ' 154' ' ' VAL . 90.4 m-85 -88.89 -53.18 4.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.155 -0.965 . . . . 0.0 109.685 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -164.15 -159.16 10.67 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.03 135.09 33.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -1.123 . . . . 0.0 110.262 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.563 HG13 ' O ' ' A' ' 125' ' ' ASP . 2.0 t -111.83 133.66 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.294 -0.879 . . . . 0.0 110.59 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.42 HG23 ' HD2' ' A' ' 146' ' ' LYS . 2.1 t -88.73 -25.58 5.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.563 ' O ' HG13 ' A' ' 123' ' ' VAL . 0.9 OUTLIER -150.67 168.93 22.87 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.603 -1.239 . . . . 0.0 112.293 -179.056 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.526 ' O ' ' CD ' ' A' ' 110' ' ' LYS . 38.8 t -167.15 149.16 5.98 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.559 ' HA ' ' CG ' ' A' ' 110' ' ' LYS . 0.9 OUTLIER -150.78 147.82 27.76 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.869 -1.144 . . . . 0.0 111.563 -178.354 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.834 HD13 ' O ' ' A' ' 128' ' ' LEU . 2.3 tm? -116.49 98.8 6.75 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.546 ' CB ' ' O ' ' A' ' 140' ' ' PHE . 1.9 tmtm? -74.71 132.61 41.8 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.257 -0.902 . . . . 0.0 111.29 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.457 ' HA ' ' H ' ' A' ' 138' ' ' ARG . 0.6 OUTLIER -107.21 -145.87 0.39 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.428 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 4.6 m-20 -91.14 121.65 67.51 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.092 -1.005 . . . . 0.0 109.652 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -82.12 22.18 0.89 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.74 1.389 . . . . 0.0 111.384 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.572 ' CG2' ' N ' ' A' ' 134' ' ' THR . 0.3 OUTLIER -140.37 -46.8 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.798 -1.188 . . . . 0.0 110.641 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.572 ' N ' ' CG2' ' A' ' 133' ' ' ILE . 0.8 OUTLIER -101.22 -9.6 21.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 110.578 -179.436 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.39 -0.66 87.47 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.501 ' O ' ' HB2' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -78.25 -173.89 3.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.209 -1.171 . . . . 0.0 110.184 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.508 ' CB ' ' HA ' ' A' ' 106' ' ' TRP . 1.9 m -91.64 123.71 35.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.208 -0.933 . . . . 0.0 110.449 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.457 ' H ' ' HA ' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -89.1 -26.98 21.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 108.83 179.11 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.442 ' C ' ' HB2' ' A' ' 104' ' ' LEU . . . 90.62 50.05 3.02 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.685 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.762 ' HA ' HD23 ' A' ' 104' ' ' LEU . 3.3 p90 -168.26 142.45 3.35 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.651 -1.499 . . . . 0.0 110.335 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.49 ' HA2' ' HB2' ' A' ' 129' ' ' LYS . . . -150.78 -165.46 12.78 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.466 -1.35 . . . . 0.0 110.5 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.697 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 16.4 m-85 -126.71 157.33 39.37 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.416 -1.049 . . . . 0.0 111.22 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.628 ' O ' HD12 ' A' ' 144' ' ' LEU . 2.8 t -130.34 134.39 62.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 143' ' ' VAL . 6.2 mp -121.82 90.2 3.26 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.104 -0.997 . . . . 0.0 110.333 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.796 ' HB2' HG22 ' A' ' 151' ' ' VAL . 29.6 m-85 -64.36 167.9 6.33 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.529 0.681 . . . . 0.0 109.98 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.42 ' HD2' HG23 ' A' ' 124' ' ' VAL . 7.9 tttt -103.05 -7.51 21.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.362 -0.837 . . . . 0.0 110.73 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.722 ' O ' HG23 ' A' ' 151' ' ' VAL . 0.9 OUTLIER -141.14 161.51 37.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.889 -1.132 . . . . 0.0 110.936 -179.524 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 4.8 t -75.26 -43.14 53.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 109.66 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.529 ' CB ' ' OE1' ' A' ' 147' ' ' GLU . 0.5 OUTLIER -60.62 -29.99 69.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.326 -0.859 . . . . 0.0 109.702 179.506 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.499 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 7.2 p -71.68 -40.58 69.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.041 -1.037 . . . . 0.0 109.431 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.796 HG22 ' HB2' ' A' ' 145' ' ' PHE . 8.3 t -72.42 -40.97 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -0.939 . . . . 0.0 110.154 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -67.6 -24.46 65.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.998 -1.063 . . . . 0.0 109.548 179.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.484 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 0.7 OUTLIER -74.39 -40.57 61.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.396 -0.815 . . . . 0.0 109.703 179.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.953 HG23 ' CZ ' ' A' ' 120' ' ' PHE . 11.4 p -79.56 -17.3 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.149 -0.97 . . . . 0.0 110.011 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -88.57 -32.31 18.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.497 -0.752 . . . . 0.0 110.388 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.484 ' OD2' ' O ' ' A' ' 153' ' ' LYS . 0.3 OUTLIER -51.92 -32.13 31.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.054 -1.029 . . . . 0.0 109.681 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.506 ' O ' ' NE2' ' A' ' 160' ' ' HIS . 1.4 mt-30 -130.05 96.96 4.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.308 -0.87 . . . . 0.0 110.028 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.523 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -89.54 24.68 2.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.13 -0.981 . . . . 0.0 110.264 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -88.1 62.16 6.66 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.692 ' ND1' HD11 ' A' ' 167' ' ' ILE . 11.5 m170 -86.9 178.8 6.86 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.942 -177.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 7.7 ttpt -175.27 68.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.383 -0.823 . . . . 0.0 109.823 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.679 HD11 HD13 ' A' ' 104' ' ' LEU . 2.4 pp -99.9 152.88 19.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.867 . . . . 0.0 109.814 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.523 ' HB2' HD12 ' A' ' 162' ' ' LEU . 5.4 m120 56.05 32.89 20.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.144 -0.973 . . . . 0.0 109.415 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 60.59 29.3 69.36 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.26 138.8 20.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.241 -1.152 . . . . 0.0 110.524 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.542 HG12 ' H ' ' A' ' 167' ' ' ILE . 21.6 t -75.19 176.9 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.934 . . . . 0.0 109.375 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.692 HD11 ' ND1' ' A' ' 160' ' ' HIS . 1.3 pt -137.19 -175.62 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.0 -1.063 . . . . 0.0 111.209 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -140.77 93.79 8.36 Favored Pre-proline 0 C--N 1.301 -1.515 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -77.11 115.26 3.95 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.378 1.725 . . . . 0.0 110.603 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.65 171.48 9.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.331 -0.856 . . . . 0.0 110.327 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.95 171.49 9.08 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.229 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.356 -0.84 . . . . 0.0 109.948 -179.86 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.517 ' CG ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.189 0.519 . . . . 0.0 109.943 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.647 ' HE2' ' O ' ' A' ' 170' ' ' LYS . 6.0 mtp -140.09 179.26 6.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.129 -0.982 . . . . 0.0 110.376 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.811 ' O ' HD13 ' A' ' 101' ' ' ILE . 2.4 t80 -124.42 136.54 54.13 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.45 -0.781 . . . . 0.0 110.077 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.811 HD13 ' O ' ' A' ' 100' ' ' PHE . 6.0 mm -122.19 106.08 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.12 -0.988 . . . . 0.0 110.009 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.552 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -103.27 139.84 14.62 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.88 10.85 8.83 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.86 HD21 HD22 ' A' ' 113' ' ' LEU . 4.3 mp -65.66 159.62 24.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.312 -1.11 . . . . 0.0 110.479 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.528 ' N ' ' OG1' ' A' ' 108' ' ' THR . 0.1 OUTLIER -83.94 177.11 8.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.37 -0.831 . . . . 0.0 109.823 179.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.564 ' N ' ' CD1' ' A' ' 106' ' ' TRP . 12.1 m0 -73.53 -23.75 60.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.153 -0.967 . . . . 0.0 110.352 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -104.97 11.77 33.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 110.887 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.618 HG21 ' HG ' ' A' ' 104' ' ' LEU . 1.8 m -60.92 161.24 8.49 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.986 -1.072 . . . . 0.0 110.023 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.51 HG23 ' C ' ' A' ' 108' ' ' THR . 68.3 p -150.33 179.53 8.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.342 -0.849 . . . . 0.0 110.391 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 23.2 ttmt -77.14 -19.07 57.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.387 -0.821 . . . . 0.0 109.342 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.56 -52.98 8.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.444 -0.785 . . . . 0.0 110.894 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 109' ' ' THR . 24.1 p-10 -70.01 -40.81 75.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.036 -1.04 . . . . 0.0 110.553 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.86 HD22 HD21 ' A' ' 104' ' ' LEU . 24.4 tp -65.1 -50.05 67.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.964 -1.085 . . . . 0.0 109.792 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -57.82 -32.5 67.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.914 . . . . 0.0 110.139 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.462 ' O ' ' C ' ' A' ' 116' ' ' TYR . 3.1 m-20 -80.0 -54.69 5.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.145 -0.972 . . . . 0.0 110.255 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.462 ' C ' ' O ' ' A' ' 115' ' ' ASP . 59.0 t80 -45.97 -32.6 2.83 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 118.711 -1.196 . . . . 0.0 108.177 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.743 ' HE2' HD11 ' A' ' 113' ' ' LEU . 12.8 m-85 -90.83 -17.14 27.08 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.22 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 115' ' ' ASP . 22.6 t -60.22 -20.47 58.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.981 -1.075 . . . . 0.0 109.445 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -74.92 -11.84 60.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.442 -0.786 . . . . 0.0 109.978 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.69 ' HB3' HG22 ' A' ' 154' ' ' VAL . 61.3 m-85 -89.78 -72.73 0.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.282 -0.886 . . . . 0.0 109.172 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -148.76 152.28 24.34 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.491 ' HB3' ' HE2' ' A' ' 146' ' ' LYS . 1.4 mt-10 -45.23 128.45 7.59 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.227 -1.161 . . . . 0.0 110.76 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.8 t -106.71 132.06 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.425 -0.797 . . . . 0.0 110.214 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.17 -24.4 5.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.442 ' O ' HG13 ' A' ' 123' ' ' VAL . 1.9 m-20 -150.81 161.24 43.04 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 118.447 -1.301 . . . . 0.0 112.33 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.481 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 43.3 t -161.37 147.78 14.41 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -151.25 154.7 37.31 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 118.538 -1.265 . . . . 0.0 111.842 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.943 HD13 ' O ' ' A' ' 128' ' ' LEU . 0.4 OUTLIER -115.94 113.01 22.69 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.104 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.643 ' N ' HD22 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -94.64 135.03 36.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.08 -1.013 . . . . 0.0 111.794 -178.252 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.521 ' HA ' ' H ' ' A' ' 138' ' ' ARG . 2.2 mp -100.89 -144.81 0.34 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.498 ' OD1' ' CA ' ' A' ' 138' ' ' ARG . 1.2 m-20 -88.74 123.1 68.56 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.623 -1.298 . . . . 0.0 109.885 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.11 -11.13 23.17 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.842 1.443 . . . . 0.0 111.14 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.652 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -128.17 -38.64 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.956 -1.09 . . . . 0.0 110.514 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.477 ' N ' ' CG2' ' A' ' 133' ' ' ILE . 16.5 m -89.91 -22.87 21.79 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.191 -0.943 . . . . 0.0 110.129 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.417 ' C ' ' HB2' ' A' ' 131' ' ' ASP . . . 87.51 -43.46 3.19 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.476 ' O ' ' HB2' ' A' ' 131' ' ' ASP . 15.9 ttt-85 -52.59 152.13 3.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.149 -1.206 . . . . 0.0 110.411 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.1 m -52.31 124.17 12.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.136 -0.977 . . . . 0.0 110.42 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.521 ' H ' ' HA ' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -89.41 -22.71 22.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.08 179.306 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.79 47.39 3.69 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.983 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.563 ' CD2' ' CZ ' ' A' ' 100' ' ' PHE . 8.7 p90 -168.15 146.12 4.32 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.456 -1.614 . . . . 0.0 110.629 178.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.483 ' HA2' ' HB2' ' A' ' 129' ' ' LYS . . . -144.91 -159.78 8.23 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.694 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 17.9 m-85 -129.28 170.2 13.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.317 -1.107 . . . . 0.0 111.279 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.506 ' O ' HD12 ' A' ' 144' ' ' LEU . 3.1 t -145.03 128.3 11.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.517 ' HG ' ' CG ' ' A' ' 98' ' ' LYS . 6.6 mp -116.0 104.35 11.49 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.417 -0.802 . . . . 0.0 109.752 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 1.181 ' CZ ' HG21 ' A' ' 154' ' ' VAL . 52.6 m-85 -78.21 148.69 33.9 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.582 -0.699 . . . . 0.0 110.699 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.491 ' HE2' ' HB3' ' A' ' 122' ' ' GLU . 1.8 ttmt -59.98 -38.22 81.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.641 -0.662 . . . . 0.0 111.061 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.472 ' OE2' ' HB2' ' A' ' 149' ' ' GLU . 0.5 OUTLIER -133.87 149.49 51.34 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.969 -1.082 . . . . 0.0 111.186 -179.321 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.9 p -52.45 -27.92 18.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.322 -0.861 . . . . 0.0 109.824 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.544 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 1.9 mm-40 -62.74 -56.35 18.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.388 -0.82 . . . . 0.0 109.93 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.631 ' O ' HG23 ' A' ' 154' ' ' VAL . 3.5 p -51.7 -32.15 28.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.171 -0.956 . . . . 0.0 109.757 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.796 HG22 ' HB2' ' A' ' 145' ' ' PHE . 17.7 t -65.81 -57.84 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.322 -0.861 . . . . 0.0 110.189 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.544 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 1.1 p30 -51.5 -28.89 14.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.172 -0.955 . . . . 0.0 109.99 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.47 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -68.28 -44.36 75.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.444 -0.785 . . . . 0.0 110.004 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 1.181 HG21 ' CZ ' ' A' ' 145' ' ' PHE . 3.8 t -69.86 -18.33 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.103 -0.998 . . . . 0.0 109.973 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.55 -23.96 21.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.88 . . . . 0.0 110.02 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.4 OUTLIER -55.41 -35.54 65.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 109.821 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.589 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -127.16 95.5 4.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.814 . . . . 0.0 109.583 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.474 ' HG3' ' HD2' ' A' ' 169' ' ' PRO . 9.5 tmtt? -85.29 12.43 8.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.904 . . . . 0.0 110.561 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -87.5 66.15 8.9 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 177.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.589 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 13.6 m-70 -87.2 177.76 7.08 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.487 -177.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.639 ' HG3' HG22 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -174.18 70.51 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.285 -0.885 . . . . 0.0 110.085 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.886 HD12 ' HB2' ' A' ' 163' ' ' ASN . 3.6 pp -96.09 154.33 17.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 109.73 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.886 ' HB2' HD12 ' A' ' 162' ' ' LEU . 0.9 OUTLIER 58.99 15.38 3.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.898 . . . . 0.0 109.969 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.16 24.58 54.39 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -150.07 149.09 29.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -1.166 . . . . 0.0 110.702 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.639 HG22 ' HG3' ' A' ' 161' ' ' LYS . 30.1 t -77.2 176.12 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.438 -0.789 . . . . 0.0 109.7 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.579 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -142.38 -176.13 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.131 -0.98 . . . . 0.0 110.971 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 102' ' ' GLY . 60.8 t0 -127.87 94.03 38.14 Favored Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.474 ' HD2' ' HG3' ' A' ' 158' ' ' LYS . 49.8 Cg_endo -74.85 113.64 3.84 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.395 1.734 . . . . 0.0 111.71 -178.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.647 ' O ' ' HE2' ' A' ' 99' ' ' MET . 1.0 OUTLIER -130.51 -171.63 2.6 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.607 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.508 ' HA ' ' HG2' ' A' ' 99' ' ' MET . 14.7 mtp180 -92.48 -172.56 3.11 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 118.861 -1.136 . . . . 0.0 110.363 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.907 . . . . 0.0 110.122 -179.791 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.553 ' HD3' HD21 ' A' ' 144' ' ' LEU . 18.1 mttp . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.22 0.533 . . . . 0.0 110.294 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.556 ' CE ' HD11 ' A' ' 101' ' ' ILE . 17.3 ptm -144.33 175.5 10.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.157 -0.964 . . . . 0.0 110.621 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.8 ' C ' HD13 ' A' ' 101' ' ' ILE . 2.4 t80 -117.3 135.36 53.89 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.533 -0.729 . . . . 0.0 109.174 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.8 HD13 ' C ' ' A' ' 100' ' ' PHE . 4.9 mm -119.42 110.56 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.182 -0.949 . . . . 0.0 109.78 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.447 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -111.37 98.71 1.05 Allowed Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.046 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 168.35 33.67 0.02 OUTLIER Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 1.007 HD12 HG21 ' A' ' 108' ' ' THR . 3.8 mm? -90.71 159.59 16.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -1.208 . . . . 0.0 109.808 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.457 ' N ' ' OG1' ' A' ' 108' ' ' THR . 14.0 t -85.33 -175.38 5.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.1 -1.0 . . . . 0.0 109.815 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 73.4 t90 -69.65 -33.37 72.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.062 -1.024 . . . . 0.0 110.148 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -103.77 48.13 0.86 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.204 -0.935 . . . . 0.0 110.335 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 1.007 HG21 HD12 ' A' ' 104' ' ' LEU . 19.8 m -88.02 155.03 20.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -0.988 . . . . 0.0 110.335 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.456 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 46.3 p -143.67 156.04 44.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.456 -0.778 . . . . 0.0 109.935 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.438 ' O ' ' HB3' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -62.42 -14.7 43.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.065 -1.022 . . . . 0.0 109.453 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.9 mmtt -74.06 -56.08 5.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.363 -0.836 . . . . 0.0 110.013 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 12.1 p30 -69.06 -20.75 64.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.136 -0.978 . . . . 0.0 109.934 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 1.004 HD13 HD11 ' A' ' 104' ' ' LEU . 15.8 tp -86.73 -54.84 4.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.889 . . . . 0.0 109.641 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.438 ' HB3' ' O ' ' A' ' 110' ' ' LYS . 10.3 tttm -54.01 -35.59 62.07 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.456 -0.777 . . . . 0.0 109.73 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 116' ' ' TYR . 12.8 m-20 -76.16 -52.51 9.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.192 -0.943 . . . . 0.0 109.782 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.533 ' HH ' ' CG ' ' A' ' 160' ' ' HIS . 65.4 t80 -47.63 -33.74 7.08 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.723 -1.191 . . . . 0.0 108.063 178.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.648 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 15.3 m-85 -91.96 -9.7 42.07 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.394 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.426 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 7.6 t -72.34 -4.02 27.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.051 -1.031 . . . . 0.0 109.386 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -89.95 -11.37 41.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.544 -0.723 . . . . 0.0 110.429 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.648 ' CD2' ' HA ' ' A' ' 117' ' ' PHE . 90.8 m-85 -88.59 -52.48 5.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.124 -0.985 . . . . 0.0 109.643 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -164.77 -161.81 14.52 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 146' ' ' LYS . 4.1 tt0 -86.02 115.24 23.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.221 -1.164 . . . . 0.0 110.446 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.9 t -94.11 132.07 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.303 -0.873 . . . . 0.0 110.912 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.38 -24.21 5.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.551 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 5.5 m-20 -147.75 163.05 37.92 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 118.766 -1.174 . . . . 0.0 112.373 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 44.0 t -170.15 140.63 1.97 Allowed 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.462 ' CG2' ' N ' ' A' ' 128' ' ' LEU . 0.9 OUTLIER -150.73 168.16 25.2 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 118.675 -1.21 . . . . 0.0 112.01 -177.781 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.734 HD22 ' O ' ' A' ' 108' ' ' THR . 0.0 OUTLIER -123.6 124.86 43.73 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.217 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.668 ' N ' HD12 ' A' ' 128' ' ' LEU . 0.1 OUTLIER -99.7 131.23 45.82 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.988 -1.07 . . . . 0.0 110.979 -178.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.503 ' HB2' ' HA ' ' A' ' 137' ' ' SER . 0.5 OUTLIER -135.66 -179.89 5.92 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.565 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -87.4 111.29 40.45 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.104 -0.998 . . . . 0.0 109.999 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 130' ' ' LEU . 49.5 Cg_endo -80.28 1.11 9.52 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.0 1.526 . . . . 0.0 110.899 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.744 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -104.38 -42.98 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.087 -1.008 . . . . 0.0 110.481 -179.793 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.54 ' N ' ' CG2' ' A' ' 133' ' ' ILE . 0.5 OUTLIER -95.85 7.38 46.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.135 -0.978 . . . . 0.0 110.291 -179.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.35 25.05 53.97 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.47 158.8 23.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.36 -1.082 . . . . 0.0 110.308 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.503 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 0.1 OUTLIER -90.12 139.17 30.89 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.27 -0.894 . . . . 0.0 110.446 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.502 ' HD3' ' CE2' ' A' ' 140' ' ' PHE . 8.3 ttt180 -90.97 -24.19 20.19 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.61 43.18 4.93 Favored Glycine 0 N--CA 1.487 2.051 0 C-N-CA 120.305 -0.95 . . . . 0.0 111.152 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.683 ' HA ' HD23 ' A' ' 104' ' ' LEU . 4.1 p90 -160.71 134.31 6.82 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.494 -1.592 . . . . 0.0 110.469 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 128' ' ' LEU . . . -134.87 -166.15 11.04 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.968 -1.111 . . . . 0.0 110.418 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.697 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 16.5 m-85 -122.84 168.1 12.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.418 -1.048 . . . . 0.0 111.325 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.558 ' CG2' HG13 ' A' ' 101' ' ' ILE . 8.9 t -144.76 134.04 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.553 HD21 ' HD3' ' A' ' 98' ' ' LYS . 3.1 mp -121.59 101.5 7.64 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.301 -0.874 . . . . 0.0 110.368 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.839 ' HB2' HG22 ' A' ' 151' ' ' VAL . 12.6 m-85 -76.42 158.08 31.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.296 -0.877 . . . . 0.0 110.382 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 122' ' ' GLU . 24.4 tptp -85.28 -11.94 53.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.819 . . . . 0.0 111.205 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.792 ' O ' HG23 ' A' ' 151' ' ' VAL . 2.6 tt0 -144.92 151.06 38.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.75 -1.219 . . . . 0.0 110.883 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 19.9 m -61.98 -36.91 82.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.9 . . . . 0.0 109.437 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.521 ' CB ' ' OE1' ' A' ' 147' ' ' GLU . 2.3 tt0 -62.11 -56.18 21.45 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.329 -0.857 . . . . 0.0 109.42 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 49.7 p -45.6 -37.0 5.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.149 -0.969 . . . . 0.0 109.361 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.839 HG22 ' HB2' ' A' ' 145' ' ' PHE . 2.9 t -74.3 -35.15 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 0.0 109.635 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.52 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -66.01 -28.08 68.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -0.872 . . . . 0.0 109.521 179.583 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.479 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 4.2 mttm -74.99 -48.51 23.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.377 -0.827 . . . . 0.0 109.908 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.699 HG23 ' HE1' ' A' ' 160' ' ' HIS . 9.0 p -66.13 -18.28 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.009 -1.057 . . . . 0.0 109.916 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 5.3 ttt -89.95 -43.51 10.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.262 -0.899 . . . . 0.0 110.115 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.479 ' OD2' ' O ' ' A' ' 153' ' ' LYS . 0.5 OUTLIER -46.39 -33.78 4.15 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.175 -0.953 . . . . 0.0 109.766 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.571 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 3.2 tt0 -119.43 90.26 3.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.29 -0.881 . . . . 0.0 110.105 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 158' ' ' LYS . 38.3 ttpt -87.14 19.77 3.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.325 -0.859 . . . . 0.0 110.295 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.6 58.28 4.83 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 177.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.974 ' ND1' HD11 ' A' ' 167' ' ' ILE . 13.7 m-70 -86.47 173.78 9.4 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.372 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -177.64 67.94 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.439 -0.788 . . . . 0.0 109.467 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.806 HD11 ' CD1' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -97.04 157.69 15.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.413 -0.804 . . . . 0.0 110.152 -179.575 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.466 ' HB2' HD12 ' A' ' 162' ' ' LEU . 0.4 OUTLIER 58.17 16.45 3.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 109.627 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 81.29 21.94 61.6 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.54 149.65 30.21 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.1 -1.235 . . . . 0.0 110.394 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 160' ' ' HIS . 1.1 p -76.95 -177.28 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.177 -0.952 . . . . 0.0 109.668 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.974 HD11 ' ND1' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -135.78 166.76 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.956 -1.09 . . . . 0.0 111.651 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -117.31 88.86 29.44 Favored Pre-proline 0 C--N 1.303 -1.436 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.491 ' HD2' ' HD2' ' A' ' 158' ' ' LYS . 46.7 Cg_endo -72.7 132.02 18.09 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.359 1.715 . . . . 0.0 111.184 -178.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 99' ' ' MET . 2.5 mttm -147.9 -169.8 3.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.53 -0.731 . . . . 0.0 109.964 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.32 -168.99 2.18 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.222 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 98' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.359 -0.838 . . . . 0.0 110.161 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.62 ' O ' ' HB3' ' A' ' 172' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.237 0.542 . . . . 0.0 110.527 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.885 ' HE2' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -123.38 167.25 14.07 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.193 -0.942 . . . . 0.0 108.84 178.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.691 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 1.6 t80 -105.73 125.28 50.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.06 -1.025 . . . . 0.0 110.305 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.885 HD11 ' HE2' ' A' ' 99' ' ' MET . 16.5 mm -116.95 94.92 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 110.169 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.603 ' O ' HG22 ' A' ' 167' ' ' ILE . . . -92.71 178.28 39.36 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.47 6.74 70.29 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.981 HD12 HG21 ' A' ' 108' ' ' THR . 3.1 mm? -61.68 164.13 6.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.094 -1.239 . . . . 0.0 109.536 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.423 ' HB3' ' HB3' ' A' ' 163' ' ' ASN . 0.9 OUTLIER -89.05 177.78 6.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.042 -1.036 . . . . 0.0 109.97 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.848 ' C ' HD11 ' A' ' 130' ' ' LEU . 33.3 m95 -84.99 19.23 2.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.223 -0.923 . . . . 0.0 110.217 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.7 ' HA ' HD21 ' A' ' 130' ' ' LEU . 37.6 t70 -148.12 21.88 1.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.9 . . . . 0.0 109.878 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.981 HG21 HD12 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -76.1 169.37 18.32 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.203 -0.935 . . . . 0.0 110.639 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.497 HG23 ' C ' ' A' ' 108' ' ' THR . 82.8 p -150.42 151.36 32.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.437 -0.789 . . . . 0.0 109.98 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.486 ' HD3' ' O ' ' A' ' 126' ' ' CYS . 7.1 ttpt -56.08 -16.34 4.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.162 -0.961 . . . . 0.0 109.881 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -80.15 -57.98 3.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.37 -0.831 . . . . 0.0 111.11 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 1.5 p-10 -65.38 -40.31 93.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.06 -1.025 . . . . 0.0 110.844 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.881 HD13 HD11 ' A' ' 104' ' ' LEU . 20.2 tp -69.05 -48.54 62.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.019 -1.051 . . . . 0.0 109.984 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 110' ' ' LYS . 11.7 tttt -52.16 -40.47 61.49 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.234 -0.916 . . . . 0.0 110.127 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.532 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 4.2 t0 -74.69 -50.86 16.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.234 -0.916 . . . . 0.0 110.257 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.448 ' C ' ' O ' ' A' ' 115' ' ' ASP . 78.1 t80 -46.21 -34.85 4.66 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.402 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.616 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 9.1 m-85 -91.63 -12.45 34.17 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.441 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.532 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 0.9 OUTLIER -72.65 -5.26 36.26 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.917 -1.115 . . . . 0.0 108.998 178.5 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 119' ' ' LYS . 2.1 tttm -85.77 -12.27 51.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.521 -0.737 . . . . 0.0 110.347 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.616 ' CD2' ' HA ' ' A' ' 117' ' ' PHE . 93.0 m-85 -88.9 -51.54 5.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.021 -1.049 . . . . 0.0 109.286 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.473 ' HA3' ' HB3' ' A' ' 150' ' ' SER . . . -158.71 -161.17 10.85 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -86.01 142.5 28.72 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.144 -1.209 . . . . 0.0 109.896 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.471 HG23 ' CD1' ' A' ' 145' ' ' PHE . 1.8 t -127.48 133.9 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.169 -0.957 . . . . 0.0 110.923 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.592 HG23 ' CE ' ' A' ' 146' ' ' LYS . 2.3 t -94.73 -22.03 5.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.425 ' O ' HG13 ' A' ' 123' ' ' VAL . 1.9 m-20 -149.82 170.68 18.19 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 118.049 -1.46 . . . . 0.0 113.135 -178.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.486 ' O ' ' HD3' ' A' ' 110' ' ' LYS . 16.2 t -170.85 131.48 0.84 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.36 162.08 25.58 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.448 -0.783 . . . . 0.0 111.45 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 1.022 HD11 ' CB ' ' A' ' 130' ' ' LEU . 0.1 OUTLIER -149.53 126.32 11.1 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.362 -0.836 . . . . 0.0 110.294 179.219 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.989 ' N ' HD22 ' A' ' 128' ' ' LEU . 25.8 tptt -91.11 101.69 14.43 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 1.022 ' CB ' HD11 ' A' ' 128' ' ' LEU . 13.6 tp -150.69 55.76 0.91 Allowed 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.69 -178.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.544 ' CB ' ' HB2' ' A' ' 136' ' ' ARG . 4.4 m-20 -51.03 114.69 5.08 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 120.851 -1.156 . . . . 0.0 109.987 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -77.49 -49.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.869 1.457 . . . . 0.0 111.376 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.902 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.2 OUTLIER -91.31 -24.31 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.033 -1.042 . . . . 0.0 111.035 -179.14 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -89.17 9.78 24.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.114 -0.991 . . . . 0.0 110.01 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 134' ' ' THR . . . 42.86 29.76 0.87 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.544 ' HB2' ' CB ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -105.43 23.07 14.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.165 -1.197 . . . . 0.0 110.308 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.734 ' HB2' HD12 ' A' ' 130' ' ' LEU . 17.1 p -72.6 103.51 3.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.406 -0.809 . . . . 0.0 109.466 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.43 ' CB ' ' CD1' ' A' ' 140' ' ' PHE . 4.6 mtp-105 -88.6 16.56 6.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.918 . . . . 0.0 109.336 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.425 ' C ' ' HB2' ' A' ' 104' ' ' LEU . . . 48.77 55.11 11.81 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.503 ' CD2' ' CZ ' ' A' ' 100' ' ' PHE . 3.1 p90 -167.39 138.07 2.98 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.787 -1.419 . . . . 0.0 110.542 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.602 ' HA3' ' HA ' ' A' ' 128' ' ' LEU . . . -139.24 -169.07 11.47 Favored Glycine 0 N--CA 1.488 2.114 0 C-N-CA 119.804 -1.189 . . . . 0.0 110.494 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.691 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 9.9 m-85 -124.48 170.6 10.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.732 -0.864 . . . . 0.0 110.008 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.638 ' C ' HD12 ' A' ' 144' ' ' LEU . 35.7 t -141.59 140.93 30.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.638 HD12 ' C ' ' A' ' 143' ' ' VAL . 5.8 mp -124.83 107.94 11.42 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.783 -178.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.766 ' CE2' HG11 ' A' ' 154' ' ' VAL . 42.9 m-85 -82.68 165.58 19.86 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.518 -0.739 . . . . 0.0 110.344 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.592 ' CE ' HG23 ' A' ' 124' ' ' VAL . 10.6 ttmt -86.77 -24.65 25.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.439 -0.788 . . . . 0.0 111.002 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.524 ' O ' HG23 ' A' ' 151' ' ' VAL . 0.7 OUTLIER -145.02 155.16 43.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.786 -1.196 . . . . 0.0 110.92 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 25.6 p -55.19 -35.8 65.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.271 -0.893 . . . . 0.0 109.948 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.544 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 1.0 OUTLIER -52.97 -54.14 39.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.425 -0.797 . . . . 0.0 110.008 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.485 ' OG ' ' HG3' ' A' ' 147' ' ' GLU . 3.6 p -57.59 -39.44 76.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.187 -0.945 . . . . 0.0 110.233 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.626 ' O ' HG12 ' A' ' 154' ' ' VAL . 6.6 t -62.0 -44.69 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.12 -0.988 . . . . 0.0 110.62 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.544 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.5 OUTLIER -67.16 -27.56 67.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.044 -1.035 . . . . 0.0 110.097 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.473 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -70.75 -32.36 69.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.847 . . . . 0.0 110.163 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.766 HG11 ' CE2' ' A' ' 145' ' ' PHE . 6.0 p -90.66 -20.87 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.158 -0.964 . . . . 0.0 110.329 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.04 -34.5 16.77 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.371 -0.83 . . . . 0.0 109.892 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 8.4 p-10 -47.38 -31.9 4.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.295 -0.878 . . . . 0.0 109.865 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.517 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -131.95 94.95 3.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.976 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.499 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -89.52 27.31 1.5 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.127 -0.983 . . . . 0.0 110.431 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -89.03 55.66 3.42 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.811 ' O ' HG23 ' A' ' 166' ' ' VAL . 12.2 m170 -86.23 176.31 8.01 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.684 -177.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -177.21 75.05 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.46 -0.775 . . . . 0.0 109.452 179.718 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.624 HD11 HD13 ' A' ' 104' ' ' LEU . 1.5 pp -98.49 157.99 15.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.321 -0.862 . . . . 0.0 109.948 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 0.8 OUTLIER 60.04 13.92 4.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.328 -0.858 . . . . 0.0 109.675 -179.265 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 85.43 20.85 55.94 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 161' ' ' LYS . 5.8 mttt -151.21 150.55 30.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.086 -1.243 . . . . 0.0 110.736 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 160' ' ' HIS . 1.3 p -74.71 -178.79 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.4 -0.813 . . . . 0.0 109.683 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.603 HG22 ' O ' ' A' ' 102' ' ' GLY . 0.1 OUTLIER -135.39 -171.78 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.097 -1.002 . . . . 0.0 110.701 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 102' ' ' GLY . 23.9 t0 -132.71 84.63 49.68 Favored Pre-proline 0 N--CA 1.488 1.473 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.51 ' HA ' HD13 ' A' ' 101' ' ' ILE . 47.8 Cg_endo -74.93 127.18 10.53 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.218 1.641 . . . . 0.0 111.033 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.55 -173.48 4.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.462 -0.774 . . . . 0.0 109.794 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -91.99 -168.9 2.11 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.499 -0.881 . . . . 0.0 110.566 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 98' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.609 -0.682 . . . . 0.0 109.946 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.509 ' HD3' HD21 ' A' ' 144' ' ' LEU . 8.2 mttp . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.372 0.606 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.659 ' CE ' HD11 ' A' ' 101' ' ' ILE . 5.4 ptm -138.73 169.56 17.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 109.982 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.795 ' C ' HD13 ' A' ' 101' ' ' ILE . 2.5 t80 -112.72 138.68 49.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.904 . . . . 0.0 110.593 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.795 HD13 ' C ' ' A' ' 100' ' ' PHE . 2.8 mm -121.85 110.77 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.418 -0.801 . . . . 0.0 109.822 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.477 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -108.57 123.92 7.21 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 138.89 33.63 0.18 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.739 HD21 HD22 ' A' ' 113' ' ' LEU . 2.2 mp -90.5 159.37 16.54 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.139 -1.212 . . . . 0.0 110.323 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.6 t -84.06 -170.3 3.01 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.208 -0.932 . . . . 0.0 110.32 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 20.2 m0 -87.53 4.1 44.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.208 -0.932 . . . . 0.0 110.332 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -138.0 22.99 2.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.205 -0.935 . . . . 0.0 110.15 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.712 HG21 ' CD2' ' A' ' 104' ' ' LEU . 2.8 m -68.06 163.28 22.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.171 -0.956 . . . . 0.0 110.059 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.457 HG23 ' C ' ' A' ' 108' ' ' THR . 30.3 p -148.61 153.76 38.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.198 -0.939 . . . . 0.0 110.171 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.548 ' O ' ' CB ' ' A' ' 114' ' ' LYS . 10.5 ttpt -58.4 -15.34 10.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.225 -0.922 . . . . 0.0 109.735 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.35 -54.61 6.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.219 -0.925 . . . . 0.0 110.273 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 3.2 p30 -70.12 -30.29 67.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.235 -0.916 . . . . 0.0 110.574 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.739 HD22 HD21 ' A' ' 104' ' ' LEU . 14.7 tp -81.11 -48.97 11.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.021 . . . . 0.0 109.996 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.548 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 1.3 tttt -55.04 -35.87 64.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.154 -0.966 . . . . 0.0 109.716 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.478 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 5.3 m-20 -79.59 -47.69 15.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.919 . . . . 0.0 109.748 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.409 ' C ' ' O ' ' A' ' 115' ' ' ASP . 75.6 t80 -48.23 -36.73 14.46 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 118.566 -1.253 . . . . 0.0 107.995 178.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.692 ' CD2' HG21 ' A' ' 143' ' ' VAL . 16.3 m-85 -91.56 -11.7 36.52 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.948 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.478 ' HB3' ' HA ' ' A' ' 115' ' ' ASP . 29.2 t -71.08 -6.49 39.57 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.907 -1.12 . . . . 0.0 108.81 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 11.4 tttt -83.47 -15.74 48.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.407 -0.808 . . . . 0.0 110.036 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.909 ' CG ' HG22 ' A' ' 154' ' ' VAL . 72.8 m-85 -89.18 -39.74 13.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.274 -0.891 . . . . 0.0 109.122 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.448 ' HA3' ' HB3' ' A' ' 150' ' ' SER . . . -174.19 176.99 46.57 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 0.9 OUTLIER -73.83 118.17 16.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.234 -1.156 . . . . 0.0 110.466 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.8 t -93.36 130.62 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.26 -0.9 . . . . 0.0 111.375 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -90.28 -23.73 5.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.522 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -142.76 153.02 42.9 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 118.984 -1.087 . . . . 0.0 112.09 -179.106 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 49.6 t -161.66 145.56 12.69 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.28 156.73 42.1 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.702 -1.199 . . . . 0.0 111.566 -178.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.736 ' C ' HD12 ' A' ' 128' ' ' LEU . 0.1 OUTLIER -123.46 110.37 15.01 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.46 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.61 ' HG2' ' CZ ' ' A' ' 140' ' ' PHE . 4.5 tppt? -76.44 113.04 13.59 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.065 -1.022 . . . . 0.0 110.183 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.593 HD23 ' O ' ' A' ' 128' ' ' LEU . 0.6 OUTLIER -124.62 -165.91 1.45 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.519 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.463 ' HB3' ' N ' ' A' ' 135' ' ' GLY . 0.5 OUTLIER -90.86 112.14 51.9 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.891 -1.131 . . . . 0.0 109.794 179.1 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.65 -4.63 15.67 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.882 1.464 . . . . 0.0 111.229 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.644 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -134.16 -43.76 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.972 -1.08 . . . . 0.0 110.781 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.541 ' N ' ' CG2' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -89.49 -9.37 50.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.099 -1.001 . . . . 0.0 110.701 -179.631 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 137' ' ' SER . . . 80.02 -49.05 3.67 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.429 ' O ' ' CG ' ' A' ' 131' ' ' ASP . 6.1 mtt180 -47.59 93.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.119 -1.224 . . . . 0.0 110.536 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 130' ' ' LEU . 1.4 t -42.09 159.89 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.309 -0.87 . . . . 0.0 110.79 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.541 ' HB3' ' CE2' ' A' ' 140' ' ' PHE . 12.5 mtt180 -89.19 -15.33 33.96 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.284 -0.885 . . . . 0.0 108.62 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 91.3 31.55 9.57 Favored Glycine 0 N--CA 1.486 2.0 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.408 178.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.61 ' CZ ' ' HG2' ' A' ' 129' ' ' LYS . 11.6 p90 -167.09 158.14 11.96 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.239 -1.742 . . . . 0.0 110.964 178.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.404 ' C ' ' CD1' ' A' ' 142' ' ' PHE . . . -153.91 -159.41 9.15 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.944 -1.263 . . . . 0.0 109.944 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.699 ' CZ ' ' CE2' ' A' ' 100' ' ' PHE . 18.9 m-85 -129.32 170.87 13.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -1.172 . . . . 0.0 111.429 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.692 HG21 ' CD2' ' A' ' 117' ' ' PHE . 7.3 t -145.9 129.83 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.633 HD12 ' C ' ' A' ' 143' ' ' VAL . 7.6 mp -120.84 102.96 8.71 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.398 -0.814 . . . . 0.0 110.355 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.901 ' CE2' HG21 ' A' ' 154' ' ' VAL . 26.2 m-85 -74.71 165.08 25.81 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.587 0.708 . . . . 0.0 110.899 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 17.5 ttpt -85.27 -26.5 26.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.512 -0.742 . . . . 0.0 111.104 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.504 ' HG3' ' OG ' ' A' ' 150' ' ' SER . 0.1 OUTLIER -137.11 142.05 42.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.654 -1.279 . . . . 0.0 110.772 -179.757 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 75.1 m -50.52 -30.67 13.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 109.996 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.545 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 1.8 mm-40 -59.25 -48.1 82.88 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.272 -0.892 . . . . 0.0 110.042 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.53 ' O ' HG23 ' A' ' 154' ' ' VAL . 11.2 p -62.75 -32.33 73.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.235 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.889 HG22 ' HB2' ' A' ' 145' ' ' PHE . 2.7 t -73.94 -55.31 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.065 -1.022 . . . . 0.0 110.103 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.545 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.1 OUTLIER -51.47 -27.14 9.59 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.159 -0.963 . . . . 0.0 109.341 179.772 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.475 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 8.7 tmtt? -69.5 -61.73 1.67 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.459 -0.775 . . . . 0.0 109.708 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.909 HG22 ' CG ' ' A' ' 120' ' ' PHE . 23.4 t -45.33 -28.65 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.127 -0.983 . . . . 0.0 109.948 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 6.7 ttt -77.46 -41.15 40.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.371 -0.831 . . . . 0.0 110.462 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.475 ' OD2' ' O ' ' A' ' 153' ' ' LYS . 0.4 OUTLIER -48.19 -22.99 0.74 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.132 -0.98 . . . . 0.0 109.962 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.569 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 3.0 pt20 -140.44 90.89 2.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.286 -0.884 . . . . 0.0 110.135 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.74 16.38 5.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.122 -0.986 . . . . 0.0 110.372 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -87.67 63.64 7.63 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.739 ' O ' HG23 ' A' ' 166' ' ' VAL . 11.7 m-70 -87.35 -179.76 6.45 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.648 -177.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 165' ' ' LYS . 16.2 ttmt -179.06 74.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.26 -0.9 . . . . 0.0 110.23 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.585 HD12 ' HB2' ' A' ' 163' ' ' ASN . 1.8 pp -96.07 151.38 19.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 109.873 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.585 ' HB2' HD12 ' A' ' 162' ' ' LEU . 0.5 OUTLIER 61.39 12.36 4.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.232 -0.917 . . . . 0.0 110.217 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 88.2 23.01 39.06 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 161' ' ' LYS . 4.3 mtpp -150.12 138.96 20.89 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.183 -1.187 . . . . 0.0 110.579 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 160' ' ' HIS . 4.2 p -66.78 -179.39 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.311 -0.868 . . . . 0.0 109.995 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.651 HD11 ' HB3' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -145.13 176.74 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.176 -0.953 . . . . 0.0 110.642 -179.55 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 102' ' ' GLY . 34.2 t0 -128.09 90.78 46.44 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.526 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 52.3 Cg_endo -78.44 139.36 16.31 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 124.118 1.588 . . . . 0.0 110.862 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.08 -173.01 4.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.922 . . . . 0.0 110.122 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -91.0 -168.06 1.98 Allowed 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.319 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.545 0 O-C-N 121.427 -0.795 . . . . 0.0 110.319 -179.564 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.452 ' HB3' ' HG ' ' A' ' 144' ' ' LEU . 43.3 mttt . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.448 0.642 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.793 ' CE ' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -134.49 165.78 24.39 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.779 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.728 ' C ' HD13 ' A' ' 101' ' ' ILE . 17.4 t80 -111.78 144.35 41.23 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.077 -1.014 . . . . 0.0 110.67 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.793 HD11 ' CE ' ' A' ' 99' ' ' MET . 3.2 mm -117.63 96.53 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.555 -0.716 . . . . 0.0 109.227 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.565 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -93.99 120.39 6.31 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.84 -1.172 . . . . 0.0 110.627 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.52 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 133.65 35.03 0.29 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.957 HD11 HD12 ' A' ' 113' ' ' LEU . 4.0 mm? -90.21 161.64 15.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.12 -1.224 . . . . 0.0 110.106 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 1.033 ' O ' HD13 ' A' ' 130' ' ' LEU . 0.1 OUTLIER -90.64 160.4 15.9 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.212 -0.93 . . . . 0.0 110.332 179.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.981 ' HA ' HD22 ' A' ' 130' ' ' LEU . 5.2 m-90 -62.14 -10.92 11.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.052 -1.03 . . . . 0.0 110.218 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -116.09 12.68 15.64 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.143 -0.973 . . . . 0.0 111.321 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 1.04 HG23 ' CG ' ' A' ' 163' ' ' ASN . 0.3 OUTLIER -76.84 169.89 17.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.829 -1.169 . . . . 0.0 110.034 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.485 HG23 ' C ' ' A' ' 108' ' ' THR . 33.8 p -149.89 155.45 40.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.15 -0.969 . . . . 0.0 109.887 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 114' ' ' LYS . 1.9 pttp -63.6 -11.06 21.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.159 -0.963 . . . . 0.0 109.663 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -78.65 -61.96 1.84 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.0 110.42 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 0.9 OUTLIER -62.5 -41.41 98.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.084 -1.01 . . . . 0.0 110.182 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.957 HD12 HD11 ' A' ' 104' ' ' LEU . 6.9 tt -64.79 -61.14 2.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 109.752 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 110' ' ' LYS . 14.3 ttpt -44.44 -34.92 2.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 109.433 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 118' ' ' SER . 0.5 OUTLIER -72.94 -54.38 8.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.144 -0.972 . . . . 0.0 109.2 179.187 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.435 ' C ' ' O ' ' A' ' 115' ' ' ASP . 48.1 t80 -47.69 -28.39 2.4 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.622 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 20.1 m-85 -91.21 -12.41 35.4 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.232 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 115' ' ' ASP . 95.1 p -65.4 -10.18 31.45 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.922 -1.111 . . . . 0.0 109.406 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.0 tptt -81.73 -14.78 56.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.466 -0.771 . . . . 0.0 110.544 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.622 ' CD2' ' HA ' ' A' ' 117' ' ' PHE . 92.3 m-85 -89.17 -61.91 1.6 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.145 -0.972 . . . . 0.0 109.498 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.495 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -155.95 -163.5 12.3 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 146' ' ' LYS . 0.6 OUTLIER -88.76 126.41 35.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -1.212 . . . . 0.0 110.352 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.6 t -101.05 129.63 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.205 -0.935 . . . . 0.0 111.062 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.472 HG23 ' HB2' ' A' ' 146' ' ' LYS . 2.2 t -90.07 -23.01 6.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.528 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 2.2 m-20 -145.51 162.16 38.04 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 118.663 -1.215 . . . . 0.0 112.288 -178.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.446 ' CB ' ' HD3' ' A' ' 114' ' ' LYS . 9.2 t -169.95 143.98 2.66 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.528 ' CG2' ' N ' ' A' ' 128' ' ' LEU . 0.9 OUTLIER -150.59 173.85 13.65 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 110.39 -178.709 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.713 HD13 ' O ' ' A' ' 108' ' ' THR . 0.1 OUTLIER -143.85 125.49 15.0 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.403 -0.811 . . . . 0.0 110.003 179.266 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.578 ' HG3' ' HB2' ' A' ' 138' ' ' ARG . 7.8 tptp -96.65 64.92 2.17 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 1.033 HD13 ' O ' ' A' ' 105' ' ' SER . 6.0 mt -150.76 18.78 0.8 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 2.7 m-20 -44.11 105.94 0.48 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.645 -0.66 . . . . 0.0 111.178 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -80.08 -5.06 13.58 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.199 1.631 . . . . 0.0 110.145 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.761 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -96.23 -36.92 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 110.267 -179.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 131' ' ' ASP . 0.8 OUTLIER -92.78 1.97 57.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 110.247 -179.742 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.88 17.9 58.96 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.438 ' HD3' ' HB ' ' A' ' 134' ' ' THR . 4.9 mtp85 -106.95 32.73 4.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.304 -1.115 . . . . 0.0 110.108 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 130' ' ' LEU . 0.6 OUTLIER -71.73 130.86 42.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.205 -0.935 . . . . 0.0 110.018 -179.766 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.598 ' HB3' ' CE2' ' A' ' 140' ' ' PHE . 0.1 OUTLIER -109.26 -8.41 15.11 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.31 -0.869 . . . . 0.0 110.081 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.791 ' HA2' HD21 ' A' ' 130' ' ' LEU . . . 91.3 14.77 56.86 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 120.323 -0.941 . . . . 0.0 111.902 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.598 ' CE2' ' HB3' ' A' ' 138' ' ' ARG . 17.5 p90 -157.68 146.92 19.8 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.264 -1.727 . . . . 0.0 111.512 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.725 ' H ' HD23 ' A' ' 104' ' ' LEU . . . -115.68 178.47 17.64 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.719 ' CE1' ' CE1' ' A' ' 100' ' ' PHE . 13.3 m-85 -126.07 160.66 29.52 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.517 -0.99 . . . . 0.0 110.804 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.673 ' C ' HD12 ' A' ' 144' ' ' LEU . 19.5 t -145.07 141.75 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.584 -0.698 . . . . 0.0 109.237 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.673 HD12 ' C ' ' A' ' 143' ' ' VAL . 6.3 mp -127.31 102.71 7.03 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.515 -0.74 . . . . 0.0 109.536 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.817 ' HB2' HG22 ' A' ' 151' ' ' VAL . 29.2 m-85 -74.44 153.08 39.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.472 -0.768 . . . . 0.0 110.614 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.472 ' HB2' HG23 ' A' ' 124' ' ' VAL . 10.7 tttt -83.47 -18.98 36.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.476 -0.765 . . . . 0.0 110.882 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.811 ' O ' HG23 ' A' ' 151' ' ' VAL . 5.7 tt0 -134.36 154.63 51.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.794 -1.191 . . . . 0.0 110.895 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.9 t -67.39 -39.09 85.58 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.229 -0.919 . . . . 0.0 109.232 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.563 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 1.7 tt0 -59.63 -49.78 76.43 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.496 -0.752 . . . . 0.0 109.686 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.495 ' CB ' ' HA3' ' A' ' 121' ' ' GLY . 4.8 p -52.94 -37.97 61.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.159 -0.963 . . . . 0.0 109.498 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.817 HG22 ' HB2' ' A' ' 145' ' ' PHE . 5.7 t -68.27 -46.98 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -0.88 . . . . 0.0 109.921 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.563 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -57.05 -33.32 67.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.218 -0.926 . . . . 0.0 109.562 179.688 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.475 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 19.9 mttt -63.71 -50.98 67.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.434 -0.791 . . . . 0.0 109.905 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.725 HG12 ' O ' ' A' ' 151' ' ' VAL . 10.5 p -69.42 -10.77 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.962 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.21 -30.97 17.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.397 -0.814 . . . . 0.0 109.948 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 1.6 p-10 -55.29 -23.5 23.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.152 -0.968 . . . . 0.0 110.388 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.516 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 0.8 OUTLIER -139.72 94.76 2.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 0.0 109.961 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.58 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 3.1 pttp -89.91 15.06 10.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.158 -0.963 . . . . 0.0 110.606 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -87.94 67.77 9.09 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.611 ' HB2' ' CG1' ' A' ' 167' ' ' ILE . 84.9 m-70 -86.94 151.9 22.89 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.324 -177.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 160' ' ' HIS . 23.6 mttt -146.9 72.45 1.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.463 -0.773 . . . . 0.0 109.599 178.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.466 HD11 ' CD1' ' A' ' 104' ' ' LEU . 0.7 OUTLIER -106.43 151.9 24.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.0 110.579 -179.538 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 1.04 ' CG ' HG23 ' A' ' 108' ' ' THR . 0.7 OUTLIER 59.61 20.75 9.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.298 -0.876 . . . . 0.0 110.123 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.94 26.46 71.07 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.61 150.37 33.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.311 -1.111 . . . . 0.0 110.446 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.407 ' O ' ' HA3' ' A' ' 103' ' ' GLY . 57.7 t -92.15 160.6 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.33 -0.856 . . . . 0.0 109.745 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.611 ' CG1' ' HB2' ' A' ' 160' ' ' HIS . 3.8 pt -125.41 -177.65 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.014 -1.054 . . . . 0.0 111.602 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 102' ' ' GLY . 1.8 t70 -129.5 94.31 32.96 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.49 ' CG ' ' HB2' ' A' ' 158' ' ' LYS . 47.9 Cg_endo -74.44 124.3 8.8 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 124.302 1.685 . . . . 0.0 111.048 -178.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.457 ' O ' ' CB ' ' A' ' 99' ' ' MET . 4.7 mttm -150.24 -165.6 2.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.425 -0.797 . . . . 0.0 109.961 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -90.55 -170.73 2.82 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.654 -0.819 . . . . 0.0 109.345 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.004 -1.06 . . . . 0.0 110.596 -179.933 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.485 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 26.9 mtmt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.061 0.457 . . . . 0.0 109.797 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.578 ' HE2' HD11 ' A' ' 101' ' ' ILE . 8.5 ptm -136.13 178.55 6.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.154 -0.966 . . . . 0.0 110.762 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.748 ' C ' HD13 ' A' ' 101' ' ' ILE . 1.7 t80 -119.88 130.94 55.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.495 -0.753 . . . . 0.0 109.948 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.748 HD13 ' C ' ' A' ' 100' ' ' PHE . 3.8 mm -114.21 90.42 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.435 -0.791 . . . . 0.0 109.149 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -92.48 148.64 19.21 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.1 23.19 6.82 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.788 HD22 HD23 ' A' ' 128' ' ' LEU . 5.9 mp -82.74 163.36 21.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.992 -1.299 . . . . 0.0 109.995 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.928 ' O ' HD13 ' A' ' 130' ' ' LEU . 0.4 OUTLIER -91.52 178.55 5.91 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.315 -0.866 . . . . 0.0 111.051 -179.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.668 ' HA ' HD22 ' A' ' 130' ' ' LEU . 6.1 m-90 -72.64 -4.14 29.15 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.292 -0.88 . . . . 0.0 109.936 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.56 14.2 12.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.18 -0.95 . . . . 0.0 111.178 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.583 ' HB ' HD23 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -75.35 157.91 33.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.959 -1.088 . . . . 0.0 109.355 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.492 HG23 ' C ' ' A' ' 108' ' ' THR . 68.1 p -150.49 174.22 13.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.165 -0.959 . . . . 0.0 110.704 -179.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 126' ' ' CYS . 8.2 ttpt -66.93 -17.59 64.98 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.511 -0.743 . . . . 0.0 109.35 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -61.31 1.92 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.352 -0.843 . . . . 0.0 110.807 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 14.6 p30 -63.84 -18.15 63.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.997 -1.064 . . . . 0.0 109.879 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.74 ' HA ' HD21 ' A' ' 162' ' ' LEU . 36.8 tp -87.95 -53.55 4.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.898 . . . . 0.0 109.331 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.532 ' HB2' ' CB ' ' A' ' 126' ' ' CYS . 7.0 tmtt? -61.68 -38.57 88.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.558 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.551 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 6.3 t70 -72.5 -54.87 8.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.249 -0.907 . . . . 0.0 110.035 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.811 ' CG ' HD13 ' A' ' 162' ' ' LEU . 55.4 t80 -49.46 -30.28 7.87 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.395 -1.322 . . . . 0.0 108.0 178.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.665 ' HZ ' HD12 ' A' ' 167' ' ' ILE . 12.9 m-85 -90.71 -9.13 47.88 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 119.736 -0.786 . . . . 0.0 111.122 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.551 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 0.1 OUTLIER -69.07 -14.16 62.86 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.83 -1.169 . . . . 0.0 108.708 178.41 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -18.65 60.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.534 -0.729 . . . . 0.0 110.056 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.806 ' CG ' HG22 ' A' ' 154' ' ' VAL . 71.2 m-85 -89.03 -64.34 1.16 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.23 -0.918 . . . . 0.0 109.176 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 150' ' ' SER . . . -152.68 175.53 31.22 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.65 146.68 51.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.061 -1.258 . . . . 0.0 110.211 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 125' ' ' ASP . 2.0 t -123.06 132.14 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.357 -0.839 . . . . 0.0 110.674 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.1 -24.5 5.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.584 ' O ' HG13 ' A' ' 123' ' ' VAL . 1.0 OUTLIER -145.18 160.64 41.14 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 118.797 -1.161 . . . . 0.0 112.258 -179.163 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.532 ' CB ' ' HB2' ' A' ' 114' ' ' LYS . 34.1 t -169.57 118.9 0.64 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.402 ' CG2' ' N ' ' A' ' 128' ' ' LEU . 0.8 OUTLIER -118.56 166.68 12.42 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.498 -0.751 . . . . 0.0 110.823 -178.573 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.996 HD22 ' N ' ' A' ' 129' ' ' LYS . 0.3 OUTLIER -146.92 125.65 12.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.501 -0.749 . . . . 0.0 109.739 179.252 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.996 ' N ' HD22 ' A' ' 128' ' ' LEU . 1.9 tptp -104.04 73.79 1.17 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.142 -0.974 . . . . 0.0 109.449 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.932 ' HB2' HD21 ' A' ' 128' ' ' LEU . 3.0 mt -151.42 32.27 0.58 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.864 -0.523 . . . . 0.0 110.257 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.1 111.55 7.47 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.248 -0.907 . . . . 0.0 110.727 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 130' ' ' LEU . 52.1 Cg_endo -82.71 8.87 4.32 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 124.026 1.54 . . . . 0.0 110.973 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.558 ' CG2' ' N ' ' A' ' 134' ' ' THR . 0.2 OUTLIER -96.62 -46.24 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.974 -1.078 . . . . 0.0 110.37 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.558 ' N ' ' CG2' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -93.2 7.99 42.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.128 -0.983 . . . . 0.0 110.08 179.729 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 64.36 30.92 79.19 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -113.66 27.61 9.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -1.144 . . . . 0.0 110.378 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.633 ' HA ' ' HA ' ' A' ' 130' ' ' LEU . 96.9 p -88.06 116.08 25.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 109.875 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.413 ' HB2' ' CE1' ' A' ' 140' ' ' PHE . 0.6 OUTLIER -103.74 -6.05 21.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.174 -0.954 . . . . 0.0 110.554 -179.442 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.881 ' HA2' HD21 ' A' ' 130' ' ' LEU . . . 90.74 34.17 7.96 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.715 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.522 ' CD2' ' CZ ' ' A' ' 100' ' ' PHE . 19.1 p90 -162.88 145.86 10.79 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.307 -1.701 . . . . 0.0 111.884 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 128' ' ' LEU . . . -135.76 -179.27 16.43 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.725 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 7.8 m-85 -123.02 167.08 14.08 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.119 -1.224 . . . . 0.0 110.767 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.572 ' CG2' HG13 ' A' ' 101' ' ' ILE . 3.5 t -142.89 134.23 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.376 -0.828 . . . . 0.0 109.474 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.485 ' HG ' ' HG2' ' A' ' 98' ' ' LYS . 5.0 mp -120.87 103.44 9.08 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.42 -0.8 . . . . 0.0 109.786 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 1.032 ' CZ ' HG21 ' A' ' 154' ' ' VAL . 16.5 m-85 -77.49 169.52 18.16 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.453 -0.78 . . . . 0.0 110.899 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -84.36 -32.57 24.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.694 -0.629 . . . . 0.0 111.039 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.663 ' O ' HG23 ' A' ' 151' ' ' VAL . 0.3 OUTLIER -135.9 158.49 44.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.803 -1.186 . . . . 0.0 110.616 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.63 -31.56 72.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.293 -0.879 . . . . 0.0 110.28 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.538 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 0.0 OUTLIER -61.81 -45.54 93.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.936 . . . . 0.0 110.079 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.763 ' O ' HG23 ' A' ' 154' ' ' VAL . 43.0 p -63.59 -40.06 95.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.353 -0.842 . . . . 0.0 110.297 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.955 HG22 ' HB2' ' A' ' 145' ' ' PHE . 5.2 t -60.41 -59.06 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.096 -1.003 . . . . 0.0 109.823 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.538 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.5 OUTLIER -53.06 -41.69 65.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.103 -0.998 . . . . 0.0 109.439 179.612 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.464 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 9.7 tttt -51.83 -35.84 45.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.337 -0.852 . . . . 0.0 109.813 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 1.032 HG21 ' CZ ' ' A' ' 145' ' ' PHE . 3.7 t -82.32 -22.5 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.277 -0.89 . . . . 0.0 110.4 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 6.7 tmm? -86.05 -24.52 26.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.869 . . . . 0.0 110.375 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 40.8 p30 -65.83 -13.18 59.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.17 -0.956 . . . . 0.0 110.162 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.58 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 8.5 tt0 -142.37 88.21 2.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.92 . . . . 0.0 109.815 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.447 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -86.49 19.4 2.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.286 -0.884 . . . . 0.0 110.594 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -87.99 58.9 5.05 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.581 ' HB2' HG13 ' A' ' 167' ' ' ILE . 16.4 m-70 -86.58 -168.3 2.19 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.898 -177.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.484 ' CE ' ' C ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -176.31 64.94 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.582 -0.699 . . . . 0.0 109.406 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.811 HD13 ' CG ' ' A' ' 116' ' ' TYR . 10.6 tp -89.2 147.32 24.22 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.452 -0.78 . . . . 0.0 110.228 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.575 ' OD1' HG23 ' A' ' 108' ' ' THR . 0.1 OUTLIER 59.91 20.31 9.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.348 -0.845 . . . . 0.0 109.66 -179.604 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.484 ' C ' ' CE ' ' A' ' 161' ' ' LYS . . . 80.57 20.1 67.03 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.11 149.48 30.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -1.167 . . . . 0.0 110.202 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.9 t -67.7 163.9 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 109.963 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.665 HD12 ' HZ ' ' A' ' 117' ' ' PHE . 0.1 OUTLIER -120.95 -177.54 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.175 -0.953 . . . . 0.0 111.021 -179.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -133.07 83.28 52.06 Favored Pre-proline 0 C--N 1.304 -1.391 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.36 131.31 14.95 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.267 1.667 . . . . 0.0 110.559 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.1 mmtm -145.02 -176.79 5.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.326 -0.859 . . . . 0.0 110.307 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 -91.67 -169.58 2.33 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.363 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.461 -0.775 . . . . 0.0 110.059 179.955 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.547 ' CG ' ' HG ' ' A' ' 144' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.237 0.541 . . . . 0.0 110.505 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.636 ' HE2' ' CD1' ' A' ' 101' ' ' ILE . 7.7 ptm -115.15 176.89 4.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.296 -0.878 . . . . 0.0 109.736 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.711 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 1.2 t80 -116.55 125.52 52.0 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.351 -0.843 . . . . 0.0 110.155 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.662 HG13 HG23 ' A' ' 143' ' ' VAL . 1.3 mm -110.48 92.55 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.515 -0.741 . . . . 0.0 109.081 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -94.49 125.59 8.36 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.844 -1.169 . . . . 0.0 110.233 -179.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 131.97 2.01 4.37 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.964 HD12 ' CG2' ' A' ' 108' ' ' THR . 3.9 mm? -52.45 162.28 0.56 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.212 -1.169 . . . . 0.0 110.003 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.478 ' HB2' ' HB3' ' A' ' 163' ' ' ASN . 0.5 OUTLIER -87.33 -176.75 5.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.174 -0.954 . . . . 0.0 110.302 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -75.67 -22.92 56.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.287 -0.883 . . . . 0.0 110.282 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 29.1 p-10 -113.99 41.64 2.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.939 . . . . 0.0 110.163 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.964 ' CG2' HD12 ' A' ' 104' ' ' LEU . 0.7 OUTLIER -86.3 130.5 34.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 110.471 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.44 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 38.4 p -117.01 149.74 39.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.294 -0.879 . . . . 0.0 109.871 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.548 ' CG ' ' HA ' ' A' ' 127' ' ' THR . 3.8 mtpt -55.9 -16.36 4.58 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.182 -0.949 . . . . 0.0 110.057 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.35 -56.68 4.48 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.183 -0.948 . . . . 0.0 110.779 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 2.9 p30 -65.53 -34.09 77.44 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.002 -1.061 . . . . 0.0 110.915 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.903 HD13 HD11 ' A' ' 104' ' ' LEU . 12.4 tp -75.6 -55.44 5.66 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.986 -1.071 . . . . 0.0 109.876 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.437 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -49.17 -41.55 37.01 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.217 -0.927 . . . . 0.0 109.818 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.447 ' O ' ' C ' ' A' ' 116' ' ' TYR . 2.3 m-20 -75.83 -48.5 21.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.896 . . . . 0.0 110.218 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.948 ' CD1' HD13 ' A' ' 162' ' ' LEU . 70.1 t80 -47.15 -33.35 5.1 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.665 -1.214 . . . . 0.0 108.261 178.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.658 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 18.1 m-85 -91.2 -14.75 30.47 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.035 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 115' ' ' ASP . 40.2 t -63.45 -12.39 30.97 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.94 -1.1 . . . . 0.0 109.316 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -80.86 -13.42 58.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.475 -0.765 . . . . 0.0 110.008 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 1.015 ' CD2' HG22 ' A' ' 154' ' ' VAL . 67.4 m-85 -88.9 -36.53 15.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.249 -0.907 . . . . 0.0 109.479 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -177.44 -164.64 31.33 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.492 ' HB3' ' HG3' ' A' ' 146' ' ' LYS . 0.4 OUTLIER -88.84 108.76 19.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.188 -1.184 . . . . 0.0 110.27 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.563 HG23 ' CD1' ' A' ' 145' ' ' PHE . 1.8 t -90.3 130.06 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.234 -0.916 . . . . 0.0 111.163 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.459 ' O ' ' OD1' ' A' ' 125' ' ' ASP . 2.1 t -89.46 -23.16 6.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.569 ' CB ' HD22 ' A' ' 144' ' ' LEU . 3.8 m-20 -147.58 167.88 23.41 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 118.345 -1.342 . . . . 0.0 112.901 -178.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.807 ' SG ' HD23 ' A' ' 113' ' ' LEU . 25.9 t -169.03 148.05 4.0 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.548 ' HA ' ' CG ' ' A' ' 110' ' ' LYS . 0.9 OUTLIER -151.27 162.69 40.44 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.652 -1.219 . . . . 0.0 111.926 -177.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.865 HD13 ' O ' ' A' ' 128' ' ' LEU . 1.1 tm? -127.81 111.61 13.84 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.596 ' HB3' ' CE2' ' A' ' 140' ' ' PHE . 0.5 OUTLIER -92.63 134.74 34.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.086 -1.009 . . . . 0.0 111.205 -178.753 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.481 ' HA ' ' H ' ' A' ' 138' ' ' ARG . 4.5 mt -105.62 -157.9 0.63 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.842 -0.537 . . . . 0.0 109.654 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.461 ' OD1' ' CB ' ' A' ' 138' ' ' ARG . 66.4 m-20 -88.21 112.59 50.51 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.108 -0.995 . . . . 0.0 109.581 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -74.2 -12.53 23.31 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.969 1.51 . . . . 0.0 111.435 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.795 HG23 HG23 ' A' ' 134' ' ' THR . 0.1 OUTLIER -105.04 -45.16 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.959 -1.088 . . . . 0.0 110.798 -179.551 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.795 HG23 HG23 ' A' ' 133' ' ' ILE . 70.8 p -91.54 -16.73 26.73 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.154 -0.966 . . . . 0.0 110.332 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.84 -27.01 7.62 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 131' ' ' ASP . 4.6 mmp_? -65.62 -175.05 0.24 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.323 -1.104 . . . . 0.0 110.288 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.405 ' C ' ' OD2' ' A' ' 131' ' ' ASP . 1.3 m -90.59 129.88 36.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.4 -0.813 . . . . 0.0 110.161 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.594 ' HD2' ' CE2' ' A' ' 140' ' ' PHE . 4.2 ttt180 -88.7 -25.1 22.53 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.44 49.07 3.32 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.634 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.665 ' CD1' ' CZ ' ' A' ' 100' ' ' PHE . 2.6 p90 -159.98 116.94 2.53 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.45 -1.617 . . . . 0.0 111.496 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 127' ' ' THR . . . -121.91 -175.9 15.02 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.711 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 7.2 m-85 -120.04 171.73 8.25 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.02 -1.283 . . . . 0.0 110.987 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.662 HG23 HG13 ' A' ' 101' ' ' ILE . 6.4 t -140.76 129.42 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.569 HD22 ' CB ' ' A' ' 125' ' ' ASP . 6.3 mp -111.25 100.54 9.15 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.432 -0.792 . . . . 0.0 110.088 -178.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 1.009 ' CE2' HG21 ' A' ' 154' ' ' VAL . 8.1 m-85 -81.05 162.76 23.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.591 -0.693 . . . . 0.0 110.893 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.492 ' HG3' ' HB3' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -61.66 -48.86 78.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.523 -0.736 . . . . 0.0 110.073 179.225 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.551 ' O ' HG23 ' A' ' 151' ' ' VAL . 1.4 pm0 -144.51 171.55 14.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.267 -0.896 . . . . 0.0 110.667 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 149' ' ' GLU . 0.2 OUTLIER -55.67 -43.05 75.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.238 -0.914 . . . . 0.0 109.979 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.525 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 0.1 OUTLIER -42.1 -51.68 4.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 110.336 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.697 ' O ' HG23 ' A' ' 154' ' ' VAL . 2.2 p -66.32 -36.55 83.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.199 -0.938 . . . . 0.0 110.446 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.663 HG22 ' HB2' ' A' ' 145' ' ' PHE . 5.3 t -66.38 -56.65 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.074 -1.016 . . . . 0.0 110.446 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.525 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.7 OUTLIER -50.3 -38.78 43.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.141 -0.974 . . . . 0.0 109.666 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.486 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -57.33 -47.75 80.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.407 -0.808 . . . . 0.0 109.57 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 1.015 HG22 ' CD2' ' A' ' 120' ' ' PHE . 11.4 t -60.25 -31.98 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -0.876 . . . . 0.0 109.909 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 156' ' ' ASP . 6.4 mtt -75.5 -26.55 58.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.304 -0.872 . . . . 0.0 110.084 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.9 OUTLIER -46.71 -27.72 1.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.934 -1.104 . . . . 0.0 108.642 179.256 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.556 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 5.0 mt-30 -143.4 114.11 7.6 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.706 -0.621 . . . . 0.0 109.357 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.08 20.39 14.58 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.27 -0.894 . . . . 0.0 110.187 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -88.39 57.39 4.22 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.591 ' HE1' HG13 ' A' ' 154' ' ' VAL . 12.1 m-70 -87.13 81.76 7.91 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.327 -176.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -78.35 70.23 4.67 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.179 -0.95 . . . . 0.0 109.263 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.948 HD13 ' CD1' ' A' ' 116' ' ' TYR . 15.9 tp -87.96 145.49 25.99 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.443 -0.785 . . . . 0.0 110.235 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 105' ' ' SER . 0.8 OUTLIER 58.09 22.62 9.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.349 -0.845 . . . . 0.0 109.661 -179.584 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 75.83 22.59 74.28 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.93 144.63 26.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -1.108 . . . . 0.0 110.319 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 160' ' ' HIS . 3.8 t -78.27 160.87 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 109.674 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.525 ' CG1' ' HB2' ' A' ' 160' ' ' HIS . 1.3 pt -123.58 -174.98 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.114 -0.991 . . . . 0.0 111.046 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.55 ' N ' ' O ' ' A' ' 102' ' ' GLY . 5.6 t70 -128.91 89.81 47.71 Favored Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 47.6 Cg_endo -74.71 125.52 9.54 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.399 1.736 . . . . 0.0 110.655 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -150.27 -164.02 1.92 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.453 -0.779 . . . . 0.0 110.215 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.39 -167.02 1.74 Allowed 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.179 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.517 0 O-C-N 121.315 -0.866 . . . . 0.0 110.691 -179.172 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.671 ' HE3' HD11 ' A' ' 144' ' ' LEU . 2.8 mtpp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.214 0.53 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.585 ' CE ' ' CD1' ' A' ' 101' ' ' ILE . 17.4 ttp -147.17 154.66 41.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.21 -0.931 . . . . 0.0 110.105 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.694 ' CE2' ' CZ ' ' A' ' 142' ' ' PHE . 2.3 t80 -110.15 135.4 51.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.359 -0.838 . . . . 0.0 109.994 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.585 ' CD1' ' CE ' ' A' ' 99' ' ' MET . 3.6 mm -112.87 97.66 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.28 -0.888 . . . . 0.0 109.48 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.545 ' HA2' ' CB ' ' A' ' 140' ' ' PHE . . . -89.36 109.32 3.58 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.508 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 134.06 36.86 0.24 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.867 HD12 HG21 ' A' ' 108' ' ' THR . 0.4 OUTLIER -83.68 149.22 26.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.335 -1.097 . . . . 0.0 109.442 179.507 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.678 ' O ' HD13 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -69.8 146.24 51.55 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.054 -1.029 . . . . 0.0 109.545 179.478 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.575 ' CE2' ' HB2' ' A' ' 137' ' ' SER . 0.8 OUTLIER -62.03 -11.2 12.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.271 -0.893 . . . . 0.0 110.115 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.61 16.22 13.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.251 -0.906 . . . . 0.0 110.595 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.867 HG21 HD12 ' A' ' 104' ' ' LEU . 11.0 m -70.27 174.43 5.6 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.122 -0.986 . . . . 0.0 110.408 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.51 ' H ' HG22 ' A' ' 108' ' ' THR . 31.2 p -148.39 154.32 39.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.384 -0.822 . . . . 0.0 109.575 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.511 ' O ' ' HB2' ' A' ' 114' ' ' LYS . 13.7 mtmt -57.97 -16.86 13.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.337 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.47 -62.02 1.77 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.192 -0.942 . . . . 0.0 111.172 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 6.6 p30 -57.94 -28.37 64.23 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.038 -1.039 . . . . 0.0 110.775 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.823 HD13 HD11 ' A' ' 104' ' ' LEU . 16.0 tp -78.86 -40.53 32.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.983 -1.073 . . . . 0.0 109.696 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 110' ' ' LYS . 3.9 ttpt -55.37 -59.26 5.05 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.123 -0.986 . . . . 0.0 109.711 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.514 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 63.3 m-20 -61.78 -40.83 96.54 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.2 -0.937 . . . . 0.0 109.213 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.558 ' CG ' HD23 ' A' ' 162' ' ' LEU . 69.8 t80 -47.35 -40.48 17.42 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.203 177.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.665 ' HE2' HD11 ' A' ' 113' ' ' LEU . 27.0 m-85 -91.6 -4.56 55.16 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.673 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.514 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 1.4 m -70.16 -6.36 33.69 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.783 -1.198 . . . . 0.0 109.221 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.415 ' HA ' ' HE3' ' A' ' 119' ' ' LYS . 0.5 OUTLIER -80.46 -18.66 48.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.367 -0.833 . . . . 0.0 110.23 -179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 1.04 ' CG ' HG22 ' A' ' 154' ' ' VAL . 70.1 m-85 -89.49 -68.35 0.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.675 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.499 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -147.43 -165.11 11.61 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.47 ' O ' ' CB ' ' A' ' 146' ' ' LYS . 0.6 OUTLIER -90.3 119.82 30.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.159 -1.201 . . . . 0.0 110.863 -179.706 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.701 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.9 t -91.96 132.34 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -0.856 . . . . 0.0 110.244 179.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.4 HG12 ' OD2' ' A' ' 125' ' ' ASP . 2.1 t -89.07 -26.88 5.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.701 ' O ' HG13 ' A' ' 123' ' ' VAL . 1.4 m-20 -145.63 167.25 23.53 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.226 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 42.3 t -165.74 150.35 8.47 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.636 -0.665 . . . . 0.0 109.363 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.519 ' CG2' ' N ' ' A' ' 128' ' ' LEU . 0.9 OUTLIER -149.95 174.08 13.1 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.368 -0.833 . . . . 0.0 109.862 -179.099 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.881 HD13 ' HG ' ' A' ' 130' ' ' LEU . 2.8 pp -149.7 165.43 32.41 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.426 -0.796 . . . . 0.0 110.068 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.668 ' N ' HD12 ' A' ' 128' ' ' LEU . 5.4 mmtt -140.96 71.58 1.37 Allowed 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.719 0.771 . . . . 0.0 109.042 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.881 ' HG ' HD13 ' A' ' 128' ' ' LEU . 0.9 OUTLIER -150.65 18.62 0.81 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -179.55 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.482 ' O ' ' OG ' ' A' ' 137' ' ' SER . 2.4 m-20 -39.14 99.3 0.19 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.559 -0.713 . . . . 0.0 111.045 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 130' ' ' LEU . 53.5 Cg_endo -79.23 -24.12 6.94 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.156 1.609 . . . . 0.0 110.574 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.896 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -89.8 -34.63 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.177 -0.952 . . . . 0.0 110.344 -179.579 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.418 ' N ' ' CG2' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -89.42 -0.59 57.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.201 -0.937 . . . . 0.0 109.854 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 64.53 19.78 65.08 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.2 27.64 8.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.32 -1.106 . . . . 0.0 110.271 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.617 ' HA ' ' CA ' ' A' ' 130' ' ' LEU . 0.9 OUTLIER -73.94 133.75 43.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.301 -0.874 . . . . 0.0 109.359 179.562 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.627 ' HB3' ' CE2' ' A' ' 140' ' ' PHE . 1.6 mtp180 -116.76 -0.44 12.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.8 -1.188 . . . . 0.0 110.816 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 91.41 6.38 66.28 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.899 -1.143 . . . . 0.0 111.535 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.627 ' CE2' ' HB3' ' A' ' 138' ' ' ARG . 42.2 p90 -149.76 -170.21 3.58 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.39 -1.653 . . . . 0.0 111.197 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.553 ' CA ' ' HA ' ' A' ' 128' ' ' LEU . . . -162.7 -164.64 18.16 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.694 ' CZ ' ' CE2' ' A' ' 100' ' ' PHE . 28.1 m-85 -140.37 167.19 22.74 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.893 -1.357 . . . . 0.0 111.27 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.675 ' O ' HD22 ' A' ' 144' ' ' LEU . 3.0 t -148.99 133.75 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.675 HD22 ' O ' ' A' ' 143' ' ' VAL . 3.2 mm? -116.12 94.33 4.61 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.665 -0.647 . . . . 0.0 109.569 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.946 ' CZ ' HG21 ' A' ' 154' ' ' VAL . 9.1 m-85 -73.0 161.18 30.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.418 -0.801 . . . . 0.0 110.992 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.47 ' CB ' ' O ' ' A' ' 122' ' ' GLU . 18.0 tptt -80.71 -39.4 27.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.594 -0.691 . . . . 0.0 111.182 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.609 ' O ' HG23 ' A' ' 151' ' ' VAL . 0.7 OUTLIER -133.66 158.48 43.13 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.853 -1.154 . . . . 0.0 110.851 -179.305 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 78.0 p -63.23 -27.7 69.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 109.964 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.519 ' CB ' ' OE2' ' A' ' 147' ' ' GLU . 0.3 OUTLIER -64.41 -43.47 94.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.371 -0.83 . . . . 0.0 109.761 179.721 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.499 ' CB ' ' HA3' ' A' ' 121' ' ' GLY . 11.5 p -64.46 -41.18 96.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.109 -0.994 . . . . 0.0 109.653 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.794 HG22 ' CB ' ' A' ' 145' ' ' PHE . 2.9 t -65.46 -45.44 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.635 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.449 ' OD2' ' O ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -54.23 -36.02 63.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.125 -0.984 . . . . 0.0 109.182 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.471 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 6.7 tttt -62.88 -43.58 98.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.469 -0.769 . . . . 0.0 109.379 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 1.04 HG22 ' CG ' ' A' ' 120' ' ' PHE . 20.5 t -64.7 -42.18 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.294 -0.879 . . . . 0.0 110.09 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 2.8 ttp -71.75 -21.71 61.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.331 -0.856 . . . . 0.0 109.944 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.0 OUTLIER -52.26 -31.49 32.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.14 -0.975 . . . . 0.0 109.423 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.526 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 0.8 OUTLIER -147.97 108.36 4.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.46 -0.775 . . . . 0.0 109.819 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.475 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -87.8 36.14 0.75 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.216 -0.928 . . . . 0.0 110.71 -179.658 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -89.33 48.96 1.68 Allowed 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 176.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.837 ' CB ' HD11 ' A' ' 167' ' ' ILE . 17.8 m-70 -87.68 93.75 9.53 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.267 -177.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -103.07 87.19 2.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 0.0 110.215 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.707 ' H ' HD12 ' A' ' 162' ' ' LEU . 0.4 OUTLIER -90.48 141.67 28.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.169 -0.957 . . . . 0.0 109.64 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 15.1 m120 50.42 23.78 1.37 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.138 -0.977 . . . . 0.0 110.215 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.72 37.25 26.98 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.96 136.24 18.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.165 -1.197 . . . . 0.0 110.272 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 160' ' ' HIS . 34.9 t -81.59 164.74 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.24 -0.913 . . . . 0.0 110.154 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.837 HD11 ' CB ' ' A' ' 160' ' ' HIS . 0.6 OUTLIER -128.68 174.17 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.186 -0.946 . . . . 0.0 110.709 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 102' ' ' GLY . 16.1 t0 -119.97 94.34 48.51 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.96 111.86 3.27 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.158 1.61 . . . . 0.0 110.83 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.536 ' O ' ' CG ' ' A' ' 99' ' ' MET . 2.1 mttt -125.72 152.87 44.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.572 -0.705 . . . . 0.0 109.652 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.54 159.64 15.82 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.987 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.465 0 O-C-N 121.323 -0.86 . . . . 0.0 110.781 -179.257 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.427 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 3.7 mtpp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.271 0.558 . . . . 0.0 110.294 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.988 ' CE ' HD11 ' A' ' 101' ' ' ILE . 4.0 ptm -141.41 170.11 16.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.334 -0.854 . . . . 0.0 109.98 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.881 ' O ' HD13 ' A' ' 101' ' ' ILE . 2.2 t80 -112.96 142.84 45.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.907 . . . . 0.0 110.489 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.988 HD11 ' CE ' ' A' ' 99' ' ' MET . 15.9 mm -131.22 99.14 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.306 -0.871 . . . . 0.0 109.548 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.566 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -99.83 132.85 11.08 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.809 -1.186 . . . . 0.0 110.557 -179.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.443 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 127.9 28.03 0.9 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.773 HD11 HD13 ' A' ' 113' ' ' LEU . 3.4 mm? -87.97 167.5 13.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.004 -1.292 . . . . 0.0 110.082 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.514 ' O ' HD22 ' A' ' 130' ' ' LEU . 3.1 p -88.43 144.48 26.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.857 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.506 ' O ' ' O ' ' A' ' 130' ' ' LEU . 15.7 m-90 -45.74 -21.38 0.11 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.153 -0.967 . . . . 0.0 110.422 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 105' ' ' SER . 4.6 t0 -112.29 44.57 1.41 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.842 -1.162 . . . . 0.0 110.103 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.702 HG21 HD12 ' A' ' 104' ' ' LEU . 87.6 m -90.67 167.74 12.29 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.145 -0.972 . . . . 0.0 110.713 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.532 ' N ' HG22 ' A' ' 108' ' ' THR . 64.1 p -146.42 152.09 38.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.379 -0.826 . . . . 0.0 109.862 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 114' ' ' LYS . 7.6 pttm -63.7 -11.95 30.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.125 -0.984 . . . . 0.0 109.482 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.59 -56.23 4.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.373 -0.83 . . . . 0.0 110.525 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.427 ' OD1' ' C ' ' A' ' 112' ' ' ASP . 0.6 OUTLIER -63.74 -36.76 84.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.118 -0.989 . . . . 0.0 109.938 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.773 HD13 HD11 ' A' ' 104' ' ' LEU . 3.6 tp -73.49 -45.16 55.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 109.746 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 5.8 ttpt -57.11 -38.88 74.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.296 -0.878 . . . . 0.0 109.555 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.501 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 83.8 m-20 -74.08 -49.77 22.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.239 -0.913 . . . . 0.0 109.736 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.422 ' C ' ' O ' ' A' ' 115' ' ' ASP . 65.2 t80 -47.75 -33.2 6.77 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 118.669 -1.212 . . . . 0.0 108.154 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.667 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 17.1 m-85 -91.03 -11.92 37.36 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.972 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.501 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 0.4 OUTLIER -64.34 -13.17 48.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.005 -1.059 . . . . 0.0 109.133 179.06 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -80.44 -13.2 59.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.432 -0.793 . . . . 0.0 109.839 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.995 ' CD2' HG22 ' A' ' 154' ' ' VAL . 64.1 m-85 -89.45 -64.27 1.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.298 -0.877 . . . . 0.0 109.48 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.434 ' HA3' ' HB3' ' A' ' 150' ' ' SER . . . -153.19 -170.36 19.33 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -85.27 119.87 26.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.182 -1.187 . . . . 0.0 110.24 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.614 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.9 t -93.92 130.08 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.144 -0.972 . . . . 0.0 111.048 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.405 ' O ' ' OD1' ' A' ' 125' ' ' ASP . 2.2 t -89.37 -26.02 5.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.614 ' O ' HG13 ' A' ' 123' ' ' VAL . 2.2 m-20 -143.98 161.61 38.3 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.24 -0.984 . . . . 0.0 111.704 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.591 ' SG ' HD23 ' A' ' 113' ' ' LEU . 45.1 t -166.27 120.76 1.15 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.635 -0.665 . . . . 0.0 109.302 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.412 ' CG2' ' N ' ' A' ' 128' ' ' LEU . 0.8 OUTLIER -114.52 167.99 10.25 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.384 -0.822 . . . . 0.0 110.294 -179.063 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.894 HD13 ' O ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -151.85 125.04 8.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 110.766 179.243 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 140' ' ' PHE . 0.2 OUTLIER -106.58 71.79 0.88 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.705 -1.247 . . . . 0.0 109.151 179.242 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.621 HD11 ' HB2' ' A' ' 104' ' ' LEU . 1.4 mp -146.71 7.67 0.97 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.779 -0.576 . . . . 0.0 110.218 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.409 ' O ' ' HB3' ' A' ' 137' ' ' SER . 7.7 m-20 -53.2 107.03 0.74 Allowed Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.03 -1.044 . . . . 0.0 110.669 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 130' ' ' LEU . 51.3 Cg_endo -79.95 -4.27 13.23 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.044 1.549 . . . . 0.0 110.53 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.553 ' CG2' ' N ' ' A' ' 134' ' ' THR . 0.0 OUTLIER -93.61 -43.63 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.145 -0.972 . . . . 0.0 110.323 -179.675 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.553 ' N ' ' CG2' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -90.01 24.66 2.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 110.046 -179.668 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 46.65 25.25 2.11 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -111.9 27.47 9.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.374 -1.074 . . . . 0.0 110.269 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.571 ' HA ' ' CA ' ' A' ' 130' ' ' LEU . 33.1 p -88.52 111.26 21.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 110.057 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.627 ' HB3' ' CE2' ' A' ' 140' ' ' PHE . 0.0 OUTLIER -99.33 -6.47 27.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.296 -179.707 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.433 ' H ' ' HG ' ' A' ' 130' ' ' LEU . . . 91.17 7.02 66.06 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 120.171 -1.014 . . . . 0.0 111.389 178.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.627 ' CE2' ' HB3' ' A' ' 138' ' ' ARG . 18.9 p90 -148.39 149.0 30.97 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.504 -1.586 . . . . 0.0 111.416 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.541 ' CA ' ' HA ' ' A' ' 128' ' ' LEU . . . -129.04 170.6 20.11 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.723 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 6.6 m-85 -114.31 173.05 6.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -1.149 . . . . 0.0 110.763 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.625 ' HB ' ' HE2' ' A' ' 99' ' ' MET . 13.8 t -146.18 137.51 19.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.558 HD12 ' C ' ' A' ' 143' ' ' VAL . 5.8 mp -123.12 101.18 7.25 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.416 -0.803 . . . . 0.0 109.727 -179.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 1.072 ' CZ ' HG21 ' A' ' 154' ' ' VAL . 18.7 m-85 -75.53 152.43 37.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.369 -0.832 . . . . 0.0 110.245 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.23 -25.59 55.22 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.426 -0.796 . . . . 0.0 111.087 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.668 ' O ' HG23 ' A' ' 151' ' ' VAL . 11.9 tt0 -133.04 147.36 52.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.677 -1.264 . . . . 0.0 110.765 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.447 ' N ' ' HG2' ' A' ' 147' ' ' GLU . 7.4 t -56.47 -45.87 80.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.086 -1.009 . . . . 0.0 109.442 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.555 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 14.1 tt0 -49.75 -60.99 2.38 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.498 -0.751 . . . . 0.0 109.993 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.471 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 0.2 OUTLIER -43.23 -39.72 3.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.19 -0.944 . . . . 0.0 109.716 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.894 HG22 ' HB2' ' A' ' 145' ' ' PHE . 5.3 t -66.2 -51.05 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.899 . . . . 0.0 110.262 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.555 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.3 OUTLIER -52.16 -27.18 13.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.133 -0.979 . . . . 0.0 109.924 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.459 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 5.8 mmtt -72.67 -49.42 31.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.459 -0.776 . . . . 0.0 110.317 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 1.072 HG21 ' CZ ' ' A' ' 145' ' ' PHE . 5.6 t -63.93 -18.7 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.097 -1.002 . . . . 0.0 110.339 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 12.7 mmt -85.53 -38.23 18.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.121 -0.987 . . . . 0.0 110.489 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.2 OUTLIER -48.67 -34.64 12.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.118 -0.989 . . . . 0.0 110.233 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.529 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.6 mt-30 -128.51 94.89 3.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.312 -0.867 . . . . 0.0 110.013 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.621 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -90.39 21.84 3.69 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.154 -0.966 . . . . 0.0 110.412 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.554 ' CG ' ' O ' ' A' ' 159' ' ' GLU . 2.1 tt0 -88.39 67.21 8.58 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 177.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.624 ' HB3' HD11 ' A' ' 167' ' ' ILE . 87.3 m-70 -86.41 176.5 7.84 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.266 -177.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 160' ' ' HIS . 0.3 OUTLIER 179.62 74.3 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.487 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.693 HD12 ' HB2' ' A' ' 163' ' ' ASN . 1.4 pp -110.95 153.99 24.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.405 -0.809 . . . . 0.0 110.326 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.693 ' HB2' HD12 ' A' ' 162' ' ' LEU . 0.3 OUTLIER 67.09 8.56 6.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.378 -0.826 . . . . 0.0 109.859 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' A' ' 165' ' ' LYS . . . 89.38 18.14 53.51 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 164' ' ' GLY . 37.5 mmtt -150.28 161.45 42.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.129 -1.218 . . . . 0.0 110.353 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.523 HG22 ' H ' ' A' ' 167' ' ' ILE . 4.2 p -87.14 177.36 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.355 -0.841 . . . . 0.0 110.232 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.625 HD13 HD23 ' A' ' 162' ' ' LEU . 0.6 OUTLIER -135.29 -168.05 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.216 -0.928 . . . . 0.0 110.943 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 102' ' ' GLY . 8.4 t70 -143.04 87.05 8.9 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 43.8 Cg_endo -71.88 131.69 18.73 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.314 1.691 . . . . 0.0 110.73 -178.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.82 166.25 27.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.443 -0.785 . . . . 0.0 110.26 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 172' ' ' ALA . 1.3 ttp180 -92.07 48.13 1.4 Allowed 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.264 -0.975 . . . . 0.0 109.869 178.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 171' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.47 -0.769 . . . . 0.0 110.449 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.503 ' HA ' ' HG ' ' A' ' 144' ' ' LEU . 70.0 mttt . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.143 0.496 . . . . 0.0 110.026 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.474 ' HE3' ' HB3' ' A' ' 99' ' ' MET . 10.2 mmm -142.19 177.42 8.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 110.763 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.741 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 3.6 t80 -132.85 142.51 48.99 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.544 -0.722 . . . . 0.0 110.203 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.65 HD13 ' O ' ' A' ' 100' ' ' PHE . 4.2 mm -125.57 98.86 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.293 -0.879 . . . . 0.0 109.792 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -98.82 130.07 10.1 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 134.15 3.53 3.13 Favored Glycine 0 N--CA 1.492 2.383 0 O-C-N 121.123 -1.222 . . . . 0.0 110.163 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.899 HD21 HD13 ' A' ' 113' ' ' LEU . 6.7 mp -64.86 166.16 9.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.073 -1.251 . . . . 0.0 110.186 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.6 p -90.72 -174.56 4.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.297 -0.877 . . . . 0.0 109.793 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.681 ' O ' HD13 ' A' ' 130' ' ' LEU . 46.4 m0 -87.48 16.82 5.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.0 109.968 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -144.56 16.61 1.65 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.309 -0.87 . . . . 0.0 110.454 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.811 HG23 ' OD1' ' A' ' 163' ' ' ASN . 11.3 m -73.43 168.16 19.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.939 -1.101 . . . . 0.0 109.78 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.467 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 29.8 p -144.6 152.04 39.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.134 -0.979 . . . . 0.0 110.604 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 114' ' ' LYS . 4.2 ttpt -53.51 -19.61 3.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.141 -0.974 . . . . 0.0 109.578 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.1 OUTLIER -72.12 -55.1 7.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.394 -0.817 . . . . 0.0 110.285 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 109' ' ' THR . 0.4 OUTLIER -65.71 -33.14 75.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.124 -0.985 . . . . 0.0 109.95 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.907 HD12 ' CD2' ' A' ' 162' ' ' LEU . 5.7 tp -73.85 -51.7 15.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 109.804 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 110' ' ' LYS . 1.1 ttpm? -60.0 -39.37 85.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 110.155 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 116' ' ' TYR . 0.5 OUTLIER -76.33 -54.38 6.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.081 -1.012 . . . . 0.0 110.572 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.719 ' CG ' HD13 ' A' ' 162' ' ' LEU . 65.4 t80 -46.39 -32.49 3.25 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.683 -1.207 . . . . 0.0 108.302 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.665 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 17.4 m-85 -91.23 -13.54 32.62 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.894 -0.723 . . . . 0.0 111.302 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 115' ' ' ASP . 5.7 t -64.11 -11.26 28.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.946 -1.096 . . . . 0.0 109.424 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 0.8 OUTLIER -83.83 -12.41 55.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.411 -0.805 . . . . 0.0 110.545 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.665 ' CD1' ' HA ' ' A' ' 117' ' ' PHE . 81.6 m-85 -89.03 -50.05 6.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.063 -1.023 . . . . 0.0 109.354 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.537 ' HA3' ' CB ' ' A' ' 150' ' ' SER . . . -164.89 -164.73 20.88 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.408 ' O ' ' CB ' ' A' ' 146' ' ' LYS . 1.2 tt0 -90.12 107.67 19.27 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.388 -1.066 . . . . 0.0 110.086 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.8 t -89.46 132.34 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 111.19 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.433 HG12 ' OD1' ' A' ' 125' ' ' ASP . 2.4 t -90.15 -23.34 6.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.568 ' CB ' ' HB2' ' A' ' 144' ' ' LEU . 0.4 OUTLIER -143.51 158.98 43.23 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 118.525 -1.27 . . . . 0.0 112.848 -178.801 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.803 ' SG ' HD23 ' A' ' 113' ' ' LEU . 6.2 t -169.24 147.76 3.81 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.501 ' O ' HD22 ' A' ' 113' ' ' LEU . 0.8 OUTLIER -150.8 169.96 20.42 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.992 -1.067 . . . . 0.0 110.828 -178.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 1.103 HD22 ' N ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -144.4 135.29 25.05 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.662 -0.649 . . . . 0.0 109.473 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 1.103 ' N ' HD22 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -105.24 103.75 13.34 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.12 -0.987 . . . . 0.0 109.483 179.182 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.938 HD23 HD11 ' A' ' 128' ' ' LEU . 0.2 OUTLIER -143.8 19.25 1.82 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.51 0.671 . . . . 0.0 109.279 -179.708 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.432 ' CB ' ' HB2' ' A' ' 136' ' ' ARG . 1.2 m-20 -39.24 99.35 0.19 Allowed Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.276 -0.89 . . . . 0.0 110.809 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 130' ' ' LEU . 53.6 Cg_endo -83.56 -17.89 6.02 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.107 1.583 . . . . 0.0 110.51 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.559 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -93.34 -37.11 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.246 -0.909 . . . . 0.0 110.694 -179.406 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.448 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -91.7 -0.64 57.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.105 -0.997 . . . . 0.0 110.175 -179.838 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 67.61 41.73 89.25 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.448 ' HD3' ' HB ' ' A' ' 134' ' ' THR . 21.9 mtp85 -123.55 25.34 8.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -1.134 . . . . 0.0 110.079 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.567 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 60.4 p -89.2 83.2 6.48 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.499 -0.75 . . . . 0.0 109.935 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -88.53 15.61 7.74 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.069 -1.02 . . . . 0.0 109.332 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 60.34 67.32 2.2 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.589 ' CE1' ' HB3' ' A' ' 129' ' ' LYS . 13.9 p90 -170.44 134.41 1.13 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.082 -1.246 . . . . 0.0 110.484 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.614 ' H ' HD13 ' A' ' 104' ' ' LEU . . . -126.61 -165.8 12.05 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.741 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 10.7 m-85 -129.45 168.6 16.1 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.415 -1.05 . . . . 0.0 110.414 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.698 ' C ' HD12 ' A' ' 144' ' ' LEU . 3.5 t -145.66 144.95 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.418 -0.801 . . . . 0.0 109.378 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.698 HD12 ' C ' ' A' ' 143' ' ' VAL . 4.5 mp -134.09 98.31 4.1 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.565 -0.709 . . . . 0.0 109.828 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.703 ' HB2' HG22 ' A' ' 151' ' ' VAL . 38.2 m-85 -76.4 160.45 29.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.528 -0.732 . . . . 0.0 110.47 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.408 ' CB ' ' O ' ' A' ' 122' ' ' GLU . 4.6 tttm -104.0 -3.07 25.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.484 -0.76 . . . . 0.0 111.011 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.777 ' O ' HG23 ' A' ' 151' ' ' VAL . 1.1 tt0 -139.97 145.41 37.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.865 -1.147 . . . . 0.0 110.706 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.5 p -59.95 -36.5 77.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.99 -1.069 . . . . 0.0 109.296 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.51 ' CB ' ' OE1' ' A' ' 147' ' ' GLU . 0.4 OUTLIER -63.06 -53.99 45.07 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.425 -0.797 . . . . 0.0 109.792 179.398 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.537 ' CB ' ' HA3' ' A' ' 121' ' ' GLY . 60.9 p -48.59 -34.32 11.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.076 -1.015 . . . . 0.0 109.664 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 147' ' ' GLU . 3.4 t -78.55 -47.7 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.416 -0.803 . . . . 0.0 110.185 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -61.23 -22.28 64.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.968 -1.082 . . . . 0.0 109.336 179.775 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.474 ' O ' ' OD2' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -76.19 -58.8 3.07 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.441 -0.787 . . . . 0.0 109.866 179.597 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.654 HG23 ' CE2' ' A' ' 120' ' ' PHE . 5.3 p -55.6 -20.9 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.048 -1.032 . . . . 0.0 109.979 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 2.6 ttp -88.06 -29.96 20.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.408 -0.808 . . . . 0.0 110.384 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.474 ' OD2' ' O ' ' A' ' 153' ' ' LYS . 0.2 OUTLIER -53.78 -36.46 62.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 109.705 179.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.584 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 0.7 OUTLIER -128.5 97.51 4.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.352 -0.843 . . . . 0.0 109.509 179.634 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -88.2 10.5 19.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.245 -0.91 . . . . 0.0 110.757 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.451 ' CG ' ' O ' ' A' ' 159' ' ' GLU . 3.2 pt-20 -87.38 68.51 9.76 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 157' ' ' GLN . 11.6 m-70 -87.75 -167.38 1.86 Allowed 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.613 -177.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -176.44 73.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.512 -0.743 . . . . 0.0 109.818 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.907 ' CD2' HD12 ' A' ' 113' ' ' LEU . 10.1 tp -88.56 134.75 33.78 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.285 -0.885 . . . . 0.0 110.127 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.811 ' OD1' HG23 ' A' ' 108' ' ' THR . 2.3 m120 58.21 24.48 11.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.83 . . . . 0.0 109.961 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 75.9 33.29 51.17 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.75 134.23 16.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -1.184 . . . . 0.0 110.527 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 167' ' ' ILE . 75.5 t -65.37 162.22 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 109.742 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.513 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -126.41 177.56 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.104 -0.998 . . . . 0.0 110.79 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 102' ' ' GLY . 23.8 t0 -124.18 90.1 51.13 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.84 113.37 3.74 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.313 1.691 . . . . 0.0 111.339 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.461 ' HE2' ' OD2' ' A' ' 168' ' ' ASP . 24.6 mmtt -131.29 169.15 16.37 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.542 -0.724 . . . . 0.0 109.334 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 172' ' ' ALA . 5.8 mtp85 -92.41 47.27 1.3 Allowed 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.499 -1.28 . . . . 0.0 109.806 178.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 171' ' ' ARG . . . . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.406 -0.808 . . . . 0.0 110.22 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.481 ' HG2' ' HG ' ' A' ' 144' ' ' LEU . 12.8 mttt . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.207 0.527 . . . . 0.0 109.816 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.677 ' SD ' HD11 ' A' ' 101' ' ' ILE . 10.9 ptm -126.05 175.25 7.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.086 -1.009 . . . . 0.0 110.475 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.709 ' CD2' ' CZ ' ' A' ' 142' ' ' PHE . 1.6 t80 -121.38 122.85 40.73 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.677 HD11 ' SD ' ' A' ' 99' ' ' MET . 3.7 mm -108.36 96.91 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 109.382 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' A' ' 140' ' ' PHE . . . -89.61 98.4 2.44 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 156.87 36.52 0.02 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.924 HD12 HG21 ' A' ' 108' ' ' THR . 3.5 mm? -90.45 155.67 18.76 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.181 -1.188 . . . . 0.0 110.007 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.485 ' N ' ' OG1' ' A' ' 108' ' ' THR . 0.0 OUTLIER -78.45 -171.98 2.69 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.205 -0.934 . . . . 0.0 109.754 179.543 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.415 ' N ' ' OG ' ' A' ' 105' ' ' SER . 7.1 m0 -84.0 -17.77 39.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.02 -1.05 . . . . 0.0 110.32 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -122.84 31.02 6.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.909 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.924 HG21 HD12 ' A' ' 104' ' ' LEU . 6.9 m -76.69 149.98 36.38 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.384 -0.822 . . . . 0.0 110.406 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.467 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 28.3 p -130.18 149.14 52.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.352 -0.843 . . . . 0.0 109.961 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.482 ' HG2' ' N ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -57.64 -17.78 16.58 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.127 -0.983 . . . . 0.0 109.16 179.256 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.482 ' N ' ' HG2' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -65.71 -58.61 5.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.502 -0.748 . . . . 0.0 109.978 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 109' ' ' THR . 1.7 p-10 -67.48 -42.49 82.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.105 -0.997 . . . . 0.0 110.097 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.552 HD13 HD11 ' A' ' 104' ' ' LEU . 26.2 tp -60.54 -48.46 81.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 109.703 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.625 ' HG3' HG11 ' A' ' 123' ' ' VAL . 27.6 ttpt -58.29 -31.97 67.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.313 -0.867 . . . . 0.0 109.748 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 118' ' ' SER . 86.8 m-20 -78.03 -54.31 6.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.274 -0.891 . . . . 0.0 110.199 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.454 ' C ' ' O ' ' A' ' 115' ' ' ASP . 62.7 t80 -47.18 -31.52 3.66 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 118.586 -1.246 . . . . 0.0 108.066 178.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.663 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 16.7 m-85 -90.35 -16.28 29.49 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.836 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 115' ' ' ASP . 22.4 t -61.45 -15.92 41.93 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.894 -1.129 . . . . 0.0 108.536 178.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.23 -18.01 61.28 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.533 0.682 . . . . 0.0 109.834 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 1.093 ' CE2' HG23 ' A' ' 154' ' ' VAL . 55.2 m-85 -89.48 -58.47 2.51 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.623 0.725 . . . . 0.0 109.414 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.32 -162.96 12.0 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -90.58 135.08 33.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.962 -1.316 . . . . 0.0 110.005 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.625 HG11 ' HG3' ' A' ' 114' ' ' LYS . 1.9 t -109.19 132.83 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.223 -0.923 . . . . 0.0 110.744 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.23 -26.24 5.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.49 ' O ' HG13 ' A' ' 123' ' ' VAL . 6.7 m-20 -148.76 162.94 38.76 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 118.715 -1.194 . . . . 0.0 112.413 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 11.6 t -164.94 143.42 6.53 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.523 ' CG2' ' N ' ' A' ' 128' ' ' LEU 0.25 1.0 OUTLIER -150.71 170.96 17.95 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 118.679 -1.209 . . . . 0.0 112.093 -177.318 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.618 ' HG ' HD21 ' A' ' 130' ' ' LEU . 8.5 tp -121.59 141.4 51.12 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.754 ' C ' HD13 ' A' ' 130' ' ' LEU . 9.5 mmtm -117.55 124.13 47.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.82 -1.175 . . . . 0.0 111.09 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.829 HD22 ' N ' ' A' ' 130' ' ' LEU . 0.5 OUTLIER -118.51 -161.31 0.83 Allowed 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.787 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.481 ' CG ' ' HG2' ' A' ' 138' ' ' ARG . 3.6 m-20 -90.44 110.22 39.38 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.292 -0.88 . . . . 0.0 110.499 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 130' ' ' LEU . 46.9 Cg_endo -73.95 -0.27 9.26 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.9 1.474 . . . . 0.0 110.118 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.718 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -114.4 -40.1 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 110.16 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.684 HG23 ' CG2' ' A' ' 133' ' ' ILE . 15.8 p -89.85 -12.21 39.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.931 . . . . 0.0 110.049 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 72.13 15.11 76.55 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.504 ' O ' ' HB3' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -117.96 -179.66 3.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.248 -1.148 . . . . 0.0 110.454 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.507 ' HA ' ' HB3' ' A' ' 130' ' ' LEU . 5.9 m -74.9 154.3 38.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.414 -0.804 . . . . 0.0 110.773 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.593 ' HB3' ' CD1' ' A' ' 140' ' ' PHE . 0.0 OUTLIER -115.54 -13.76 11.54 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.413 -0.804 . . . . 0.0 109.045 179.093 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 91.21 22.21 33.03 Favored Glycine 0 N--CA 1.486 2.012 0 C-N-CA 120.367 -0.92 . . . . 0.0 111.844 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.612 ' CZ ' ' HB3' ' A' ' 129' ' ' LYS . 18.7 p90 -155.56 153.63 30.47 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.109 -1.818 . . . . 0.0 110.68 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 128' ' ' LEU . . . -147.52 -164.11 11.02 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.709 ' CZ ' ' CD2' ' A' ' 100' ' ' PHE . 14.6 m-85 -130.19 172.21 12.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.157 -1.201 . . . . 0.0 111.348 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.816 ' O ' HD12 ' A' ' 144' ' ' LEU . 3.9 t -146.47 145.58 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.816 HD12 ' O ' ' A' ' 143' ' ' VAL . 5.3 mp -130.59 106.03 8.23 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.984 -1.072 . . . . 0.0 109.898 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.752 ' HB2' HG22 ' A' ' 151' ' ' VAL . 15.9 m-85 -78.82 166.28 22.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.501 -0.75 . . . . 0.0 111.046 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -80.9 -31.97 34.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.696 -0.627 . . . . 0.0 110.408 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.561 ' O ' HG23 ' A' ' 151' ' ' VAL . 0.3 OUTLIER -143.09 152.03 41.4 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.108 -0.995 . . . . 0.0 110.64 -179.619 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.5 m -50.88 -41.0 57.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.915 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.546 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 2.8 tt0 -48.51 -62.92 1.25 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.326 -0.859 . . . . 0.0 110.159 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.479 ' OG ' ' HG3' ' A' ' 147' ' ' GLU . 4.4 p -48.14 -36.07 12.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.0 109.947 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.792 ' O ' HG12 ' A' ' 154' ' ' VAL . 4.6 t -68.56 -52.71 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.12 -0.988 . . . . 0.0 110.362 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.546 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -57.75 -35.1 70.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.974 -1.079 . . . . 0.0 109.783 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.47 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.1 OUTLIER -65.69 -33.82 76.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.368 -0.832 . . . . 0.0 110.162 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 1.093 HG23 ' CE2' ' A' ' 120' ' ' PHE . 5.9 p -87.86 -19.6 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.025 -1.047 . . . . 0.0 110.336 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 24.8 ttt -89.09 -25.76 21.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.946 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 4.5 p-10 -52.37 -32.24 37.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -0.903 . . . . 0.0 109.618 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.558 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -131.4 90.0 2.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.344 -0.848 . . . . 0.0 109.595 179.572 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.45 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -83.97 18.18 2.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.151 -0.968 . . . . 0.0 111.011 -179.482 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -87.68 64.3 7.95 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 177.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.715 ' ND1' HD11 ' A' ' 167' ' ' ILE . 14.1 m170 -87.05 -169.84 2.8 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.11 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 160' ' ' HIS . 5.9 ttpt 177.55 66.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.622 HD12 ' HB2' ' A' ' 163' ' ' ASN . 1.3 pp -101.67 157.85 16.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.844 . . . . 0.0 110.105 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.622 ' HB2' HD12 ' A' ' 162' ' ' LEU . 0.3 OUTLIER 59.5 15.33 4.43 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.163 -0.961 . . . . 0.0 109.461 -179.405 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.51 21.44 64.32 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.5 146.59 26.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -1.174 . . . . 0.0 110.715 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.574 HG12 ' N ' ' A' ' 167' ' ' ILE . 51.1 t -76.99 176.39 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.418 -0.801 . . . . 0.0 109.088 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.715 HD11 ' ND1' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -143.16 166.45 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.904 -1.122 . . . . 0.0 111.544 -179.458 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -115.55 82.88 10.35 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.517 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 45.1 Cg_endo -72.9 130.28 15.41 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.214 1.639 . . . . 0.0 111.155 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.1 -164.88 2.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.581 -0.699 . . . . 0.0 110.046 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.9 -173.09 3.57 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.06 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.459 ' HB3' ' HB2' ' A' ' 98' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.336 -0.852 . . . . 0.0 110.383 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.406 ' HA ' ' HG ' ' A' ' 144' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.226 0.536 . . . . 0.0 110.183 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.644 ' HE2' ' O ' ' A' ' 170' ' ' LYS . 6.4 mtp -143.11 173.89 11.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.148 -0.97 . . . . 0.0 110.432 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.7 ' O ' HD13 ' A' ' 101' ' ' ILE . 2.4 t80 -122.84 134.92 54.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.608 -0.683 . . . . 0.0 110.575 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.7 HD13 ' O ' ' A' ' 100' ' ' PHE . 15.1 mm -122.68 106.73 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.27 -0.894 . . . . 0.0 109.73 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -103.21 119.38 6.38 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.713 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 128.53 47.83 0.16 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 1.065 HD12 HG21 ' A' ' 108' ' ' THR . 2.3 mm? -90.56 167.67 12.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.118 -1.225 . . . . 0.0 110.354 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.887 ' C ' HD13 ' A' ' 130' ' ' LEU . 0.4 OUTLIER -90.16 138.9 31.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.272 -0.893 . . . . 0.0 110.19 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 1.054 ' HA ' HD22 ' A' ' 130' ' ' LEU . 5.9 m-90 -44.96 -22.77 0.1 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.881 -1.137 . . . . 0.0 110.718 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 105' ' ' SER . 6.7 t0 -114.86 38.53 3.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.106 -0.996 . . . . 0.0 111.134 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 1.065 HG21 HD12 ' A' ' 104' ' ' LEU . 1.5 m -87.36 161.85 17.68 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.74 -1.225 . . . . 0.0 109.998 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 69.3 p -139.82 154.54 47.36 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.42 -0.8 . . . . 0.0 109.867 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 126' ' ' CYS . 4.9 mttp -58.85 -14.33 8.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.134 -0.979 . . . . 0.0 110.134 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.436 ' HE2' ' HE2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -81.04 -55.82 4.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.861 . . . . 0.0 110.702 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -63.38 -44.29 95.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.003 -1.061 . . . . 0.0 110.466 -179.491 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.805 ' CD1' HD11 ' A' ' 104' ' ' LEU . 0.6 OUTLIER -65.72 -46.89 77.22 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.895 -1.128 . . . . 0.0 109.586 179.681 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.454 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 7.2 ttpp -54.1 -40.78 67.59 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.146 -0.971 . . . . 0.0 109.82 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 116' ' ' TYR . 69.7 m-20 -75.38 -47.27 28.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 109.707 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.685 ' CD2' HD22 ' A' ' 162' ' ' LEU . 52.7 t80 -47.51 -34.65 7.79 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 118.841 -1.144 . . . . 0.0 108.089 178.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.546 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 11.5 m-85 -91.2 -13.78 32.23 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.116 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 115' ' ' ASP . 7.2 m -64.87 -12.67 51.32 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.76 -1.212 . . . . 0.0 108.431 178.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.42 -26.69 61.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.581 -0.699 . . . . 0.0 110.39 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.546 ' CD2' ' HA ' ' A' ' 117' ' ' PHE . 28.2 m-85 -88.67 -57.19 3.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.094 -1.004 . . . . 0.0 109.197 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.487 ' HA3' ' HB3' ' A' ' 150' ' ' SER . . . -159.52 167.52 35.16 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.31 156.52 22.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.138 -1.213 . . . . 0.0 109.913 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.628 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.7 t -125.27 129.91 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.179 -0.951 . . . . 0.0 110.922 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.904 HG23 ' HG2' ' A' ' 146' ' ' LYS . 2.2 t -89.64 -25.34 5.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.628 ' O ' HG13 ' A' ' 123' ' ' VAL . 2.7 m-20 -140.61 161.45 37.72 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.773 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.616 ' SG ' HD23 ' A' ' 113' ' ' LEU . 6.8 t -169.95 128.49 0.91 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.666 0.746 . . . . 0.0 109.708 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.428 ' OG1' ' HB2' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -125.88 146.74 49.7 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.605 -0.684 . . . . 0.0 110.875 -178.502 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.868 HD13 ' O ' ' A' ' 128' ' ' LEU . 1.0 OUTLIER -131.97 100.37 5.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 110.083 179.319 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 140' ' ' PHE . 0.1 OUTLIER -81.83 68.29 8.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.207 -0.933 . . . . 0.0 109.863 179.832 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 1.054 HD22 ' HA ' ' A' ' 106' ' ' TRP . 5.7 mt -152.31 35.03 0.51 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.671 -0.643 . . . . 0.0 109.74 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.464 ' HB3' ' OG1' ' A' ' 134' ' ' THR . 8.6 m-20 -49.42 114.03 3.69 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.32 -0.863 . . . . 0.0 110.727 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -82.42 -6.23 11.83 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.97 1.511 . . . . 0.0 110.715 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.949 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -109.65 -30.27 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.083 -1.011 . . . . 0.0 110.768 -179.514 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 131' ' ' ASP . 0.2 OUTLIER -89.27 -5.63 57.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.127 -0.983 . . . . 0.0 110.447 -179.504 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 69.17 6.76 54.99 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.72 39.59 1.36 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -1.144 . . . . 0.0 110.269 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.686 ' CB ' HD23 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -82.73 115.8 21.81 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.893 . . . . 0.0 110.179 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.562 ' HB3' ' CD1' ' A' ' 140' ' ' PHE . 1.4 mpt_? -89.74 -16.84 29.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.175 -0.953 . . . . 0.0 109.544 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.612 ' HA2' HD11 ' A' ' 130' ' ' LEU . . . 90.71 28.33 16.57 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.562 ' CD1' ' HB3' ' A' ' 138' ' ' ARG . 1.7 p90 -164.82 165.95 20.13 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.022 -1.281 . . . . 0.0 110.545 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -159.68 177.94 35.98 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.691 ' CZ ' ' CE2' ' A' ' 100' ' ' PHE . 19.4 m-85 -113.57 171.26 7.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.117 -1.225 . . . . 0.0 110.754 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.719 ' CG2' HD21 ' A' ' 113' ' ' LEU . 25.1 t -148.89 127.72 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.553 -0.717 . . . . 0.0 109.351 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.549 ' HB2' ' CB ' ' A' ' 125' ' ' ASP . 6.6 mp -115.96 103.95 11.11 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.546 -0.721 . . . . 0.0 110.214 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.824 ' HB2' HG22 ' A' ' 151' ' ' VAL . 46.0 m-85 -75.73 162.3 28.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.575 -0.703 . . . . 0.0 110.417 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.904 ' HG2' HG23 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -85.29 -23.61 28.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.535 -0.728 . . . . 0.0 111.117 -179.303 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.828 ' O ' HG23 ' A' ' 151' ' ' VAL . 0.6 OUTLIER -128.78 158.75 37.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.747 -1.221 . . . . 0.0 110.988 -179.568 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.3 p -71.88 -44.49 63.66 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.318 -0.864 . . . . 0.0 109.335 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.53 ' CB ' ' OE1' ' A' ' 147' ' ' GLU . 0.3 OUTLIER -55.87 -40.57 73.12 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.415 -0.803 . . . . 0.0 109.54 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.487 ' HB3' ' HA3' ' A' ' 121' ' ' GLY . 1.4 p -62.47 -34.19 76.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.153 -0.967 . . . . 0.0 109.356 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.828 HG23 ' O ' ' A' ' 147' ' ' GLU . 5.2 t -73.93 -52.89 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.213 -0.93 . . . . 0.0 110.216 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.506 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -51.49 -38.52 54.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.01 -1.056 . . . . 0.0 109.878 -179.781 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.479 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -65.04 -46.63 80.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.325 -0.859 . . . . 0.0 110.024 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.804 HG12 ' O ' ' A' ' 151' ' ' VAL . 1.4 p -66.12 -13.31 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.029 -1.044 . . . . 0.0 109.963 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.425 ' CE ' ' HA ' ' A' ' 170' ' ' LYS . 2.3 tpt -89.61 -52.94 4.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.348 -0.845 . . . . 0.0 110.748 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 0.5 OUTLIER -53.07 -31.25 40.64 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.071 -1.018 . . . . 0.0 110.017 -179.734 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.504 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.1 mm100 -112.65 78.37 1.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.299 -0.876 . . . . 0.0 109.686 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.613 ' HA ' ' CD2' ' A' ' 160' ' ' HIS . 10.6 pttp -86.86 25.65 1.26 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.27 -0.894 . . . . 0.0 111.014 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -88.2 67.08 8.7 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.613 ' CD2' ' HA ' ' A' ' 158' ' ' LYS . 84.1 m-70 -86.39 -179.99 6.77 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.727 -177.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.66 ' C ' HD23 ' A' ' 162' ' ' LEU . 23.0 ttpt -179.93 83.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.402 -0.811 . . . . 0.0 109.684 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.808 HD11 HD13 ' A' ' 167' ' ' ILE . 0.1 OUTLIER -101.96 146.17 28.24 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.175 -0.953 . . . . 0.0 109.707 -179.456 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.532 ' CB ' ' HB3' ' A' ' 105' ' ' SER . 6.4 m120 53.8 18.26 1.51 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.931 . . . . 0.0 109.996 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 83.23 28.83 35.45 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -145.71 143.53 29.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.132 -1.216 . . . . 0.0 110.427 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 167' ' ' ILE . 17.3 t -79.9 169.82 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.957 . . . . 0.0 110.303 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.808 HD13 HD11 ' A' ' 162' ' ' LEU . 0.7 OUTLIER -131.07 -178.66 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.208 -0.932 . . . . 0.0 110.702 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 102' ' ' GLY . 16.7 t70 -119.93 83.22 29.68 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.526 ' CG ' ' HB2' ' A' ' 158' ' ' LYS . 47.5 Cg_endo -72.62 114.24 3.96 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.353 1.712 . . . . 0.0 110.986 -178.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.644 ' O ' ' HE2' ' A' ' 99' ' ' MET . 2.4 mtmp? -136.03 173.36 11.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.512 -0.743 . . . . 0.0 109.246 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.527 ' HA ' ' HG2' ' A' ' 99' ' ' MET . 0.2 OUTLIER -92.29 -166.08 1.47 Allowed 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 118.689 -1.205 . . . . 0.0 109.876 178.596 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.649 0 O-C-N 121.473 -0.767 . . . . 0.0 110.564 -179.242 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.487 ' HA ' ' HG ' ' A' ' 144' ' ' LEU . 47.3 mttt . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.344 0.593 . . . . 0.0 110.506 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.494 ' HG3' HG13 ' A' ' 151' ' ' VAL . 0.0 OUTLIER -143.29 -174.9 4.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.892 . . . . 0.0 110.217 179.724 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.95 ' O ' HD13 ' A' ' 101' ' ' ILE . 10.5 t80 -143.08 148.5 36.77 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.304 -0.872 . . . . 0.0 110.526 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.95 HD13 ' O ' ' A' ' 100' ' ' PHE . 4.0 mm -125.04 108.58 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.504 -0.748 . . . . 0.0 110.14 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -103.25 118.27 6.01 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.416 ' C ' HD22 ' A' ' 104' ' ' LEU . . . 133.86 41.29 0.17 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.983 HD12 HG21 ' A' ' 108' ' ' THR . 4.0 mm? -90.26 155.03 19.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.337 -1.096 . . . . 0.0 109.916 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.49 ' N ' ' OG1' ' A' ' 108' ' ' THR . 24.1 p -72.08 -176.78 1.85 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.154 -0.966 . . . . 0.0 110.318 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 83.7 t90 -75.11 -27.08 59.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.174 -0.954 . . . . 0.0 110.326 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -113.72 37.16 3.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.215 -0.928 . . . . 0.0 110.22 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.983 HG21 HD12 ' A' ' 104' ' ' LEU . 1.5 m -77.55 149.03 34.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.13 -0.981 . . . . 0.0 110.271 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.481 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 44.0 p -130.5 159.63 36.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.292 -0.88 . . . . 0.0 110.455 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.486 ' HB2' ' HA ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -65.26 -14.72 61.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.18 -0.95 . . . . 0.0 109.911 179.702 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -82.54 -53.88 5.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 110.842 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.481 ' OD1' ' O ' ' A' ' 109' ' ' THR . 0.7 OUTLIER -61.77 -35.65 78.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.979 -1.076 . . . . 0.0 110.284 -179.553 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.705 HD13 HD11 ' A' ' 104' ' ' LEU . 23.6 tp -71.62 -56.46 5.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 109.931 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.421 ' HB2' ' CB ' ' A' ' 126' ' ' CYS . 1.9 tttt -51.39 -34.44 34.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.182 -0.949 . . . . 0.0 109.733 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.504 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 0.5 OUTLIER -73.93 -55.03 6.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 109.906 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.441 ' C ' ' O ' ' A' ' 115' ' ' ASP . 60.2 t80 -47.36 -31.19 3.76 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.531 -1.268 . . . . 0.0 108.118 178.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.624 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . 12.8 m-85 -90.72 -10.43 43.06 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.166 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.504 ' HB3' ' HA ' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -65.09 -10.96 34.58 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.839 -1.163 . . . . 0.0 109.386 179.233 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -80.77 -16.65 53.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.477 -0.765 . . . . 0.0 109.991 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.892 ' CG ' HG22 ' A' ' 154' ' ' VAL . 75.7 m-85 -88.76 -62.66 1.44 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 109.399 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.511 ' HA3' ' HB3' ' A' ' 150' ' ' SER . . . -157.72 164.99 33.4 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 146' ' ' LYS . 19.4 mt-10 -62.15 119.58 9.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.017 -1.284 . . . . 0.0 110.176 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 125' ' ' ASP . 2.0 t -89.62 135.38 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 110.617 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.15 -23.73 6.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.517 ' HB2' ' HB2' ' A' ' 144' ' ' LEU . 6.5 m-20 -152.22 157.04 40.9 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 118.443 -1.303 . . . . 0.0 112.575 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.501 ' SG ' HD23 ' A' ' 113' ' ' LEU . 26.2 t -164.47 141.88 6.58 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.486 ' HA ' ' HB2' ' A' ' 110' ' ' LYS . 0.9 OUTLIER -151.22 166.19 31.64 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.582 -1.247 . . . . 0.0 112.348 -177.532 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.777 HD22 ' N ' ' A' ' 129' ' ' LYS . 0.4 OUTLIER -122.23 124.28 43.45 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.024 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.777 ' N ' HD22 ' A' ' 128' ' ' LEU . 0.4 OUTLIER -111.93 139.78 47.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.786 -1.196 . . . . 0.0 111.767 -178.433 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.9 HD23 ' HA ' ' A' ' 137' ' ' SER . 1.5 mp -109.51 -144.46 0.39 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.019 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.512 ' HB2' ' N ' ' A' ' 136' ' ' ARG . 31.0 m-20 -80.33 125.63 80.73 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.145 -0.972 . . . . 0.0 110.129 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.41 -16.83 19.12 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.916 1.482 . . . . 0.0 111.075 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.568 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -122.78 -35.79 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.081 -1.012 . . . . 0.0 110.372 -179.795 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.433 ' OG1' ' HB3' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -89.95 -26.81 20.2 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 110.169 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.05 -18.0 34.03 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.512 ' N ' ' HB2' ' A' ' 131' ' ' ASP . 12.4 ttp180 -72.85 149.98 43.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.222 -1.163 . . . . 0.0 110.276 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.9 ' HA ' HD23 ' A' ' 130' ' ' LEU . 32.7 m -43.64 145.55 0.63 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 110.352 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.563 ' HG2' ' CD1' ' A' ' 140' ' ' PHE . 4.4 ttt-85 -117.33 -23.88 7.63 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.24 36.24 7.17 Favored Glycine 0 N--CA 1.485 1.913 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.426 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.676 ' HA ' HD23 ' A' ' 104' ' ' LEU . 12.0 p90 -157.42 125.46 5.46 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.285 -1.715 . . . . 0.0 111.894 178.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.524 ' O ' ' CE1' ' A' ' 100' ' ' PHE . . . -121.0 -176.44 15.42 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.716 ' CE1' ' CE1' ' A' ' 100' ' ' PHE . 8.0 m-85 -122.68 166.18 15.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.879 -1.365 . . . . 0.0 110.94 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.639 ' C ' HD12 ' A' ' 144' ' ' LEU . 2.5 t -146.6 139.77 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.456 -0.777 . . . . 0.0 109.727 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.639 HD12 ' C ' ' A' ' 143' ' ' VAL . 5.9 mp -127.71 111.61 13.88 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.605 -0.685 . . . . 0.0 109.307 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 1.149 ' CZ ' HG21 ' A' ' 154' ' ' VAL . 38.6 m-85 -79.41 150.69 31.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.684 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 122' ' ' GLU . 18.0 tttm -75.25 -19.8 59.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.433 -0.792 . . . . 0.0 110.901 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.786 ' O ' HG23 ' A' ' 151' ' ' VAL . 3.5 tt0 -138.63 157.89 45.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.813 -1.18 . . . . 0.0 111.111 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 4.4 p -67.61 -41.76 83.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 109.439 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.542 ' HA ' ' OD2' ' A' ' 152' ' ' ASP . 0.0 OUTLIER -56.97 -55.53 33.49 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.29 -0.881 . . . . 0.0 109.41 179.417 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.688 ' O ' HG23 ' A' ' 154' ' ' VAL . 4.0 p -45.71 -44.29 13.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.075 -1.016 . . . . 0.0 109.277 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.818 HG22 ' HB2' ' A' ' 145' ' ' PHE . 16.9 t -58.43 -47.81 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.905 . . . . 0.0 109.83 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.542 ' OD2' ' HA ' ' A' ' 149' ' ' GLU . 0.3 OUTLIER -58.64 -35.52 72.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.085 -1.01 . . . . 0.0 109.476 179.618 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.469 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 9.4 mmtt -63.35 -28.5 70.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.473 -0.767 . . . . 0.0 109.591 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 1.149 HG21 ' CZ ' ' A' ' 145' ' ' PHE . 2.8 t -88.87 -34.19 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.362 -0.836 . . . . 0.0 109.897 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.408 ' O ' ' C ' ' A' ' 156' ' ' ASP . 1.1 ttp -73.2 -36.6 66.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.863 . . . . 0.0 110.511 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 31.5 p-10 -44.63 -29.27 0.72 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.083 -1.01 . . . . 0.0 110.254 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.518 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -136.9 98.78 3.85 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.165 -0.96 . . . . 0.0 110.393 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.442 ' HA ' ' HD2' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -86.63 10.14 16.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.0 -1.062 . . . . 0.0 109.891 179.518 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 27.5 mp0 -88.14 68.48 9.09 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 177.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.601 ' HB2' HG13 ' A' ' 167' ' ' ILE . 41.3 m-70 -86.09 -168.7 2.33 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.589 -177.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.455 ' O ' ' CG ' ' A' ' 161' ' ' LYS . 0.0 OUTLIER 177.9 73.11 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.36 -0.837 . . . . 0.0 110.021 179.802 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.767 HD12 ' HB2' ' A' ' 163' ' ' ASN . 2.4 pp -110.07 151.51 27.12 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.311 -0.868 . . . . 0.0 109.853 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.767 ' HB2' HD12 ' A' ' 162' ' ' LEU . 0.2 OUTLIER 63.13 18.09 10.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.149 -0.969 . . . . 0.0 109.861 -179.507 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 75.35 25.17 68.94 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -149.82 154.28 38.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -1.173 . . . . 0.0 110.66 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.466 HG12 ' N ' ' A' ' 167' ' ' ILE . 24.1 t -84.81 167.4 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.379 -0.825 . . . . 0.0 109.688 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.601 HG13 ' HB2' ' A' ' 160' ' ' HIS . 0.9 OUTLIER -133.68 175.52 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.137 -0.977 . . . . 0.0 111.15 -179.493 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 102' ' ' GLY . 31.6 t0 -120.08 89.81 43.38 Favored Pre-proline 0 C--N 1.303 -1.426 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.64 120.41 6.43 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.172 1.617 . . . . 0.0 110.891 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.463 ' O ' ' SD ' ' A' ' 99' ' ' MET . 0.1 OUTLIER -140.47 169.63 17.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.885 . . . . 0.0 109.908 179.461 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.47 ' HA ' ' HG2' ' A' ' 99' ' ' MET . 19.4 ptp180 -91.75 -176.17 4.38 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.542 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.36 -0.837 . . . . 0.0 110.446 -179.589 . . . . . . . . 0 0 . 1 stop_ save_